data_1n9c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n9c _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t0 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.7 -46.77 81.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.607 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.2 -44.33 84.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -49.19 75.52 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 119.089 0.858 . . . . 0.0 111.436 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.7 t -49.03 -55.82 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.481 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.278 94.6 t -66.02 -43.18 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.512 -169.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.37 1.33 0.35 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.455 3.102 . . . . 0.0 114.115 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.73 -8.13 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -116.02 -26.01 7.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.853 1.261 . . . . 0.0 110.606 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -114.35 -42.06 3.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.489 0.586 . . . . 0.0 111.199 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -49.66 -30.91 5.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 111.563 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.1 m -39.4 -38.52 0.56 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.57 1.548 . . . . 0.0 112.968 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.67 -43.95 2.77 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.758 0.423 . . . . 0.0 110.603 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -68.04 -17.24 64.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.82 155.45 31.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.13 -56.21 5.4 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.826 1.203 . . . . 0.0 113.97 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.61 0.33 43.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.254 0.621 . . . . 0.0 112.416 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 62.58 27.73 16.35 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.962 1.305 . . . . 0.0 110.932 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 p -78.56 -8.81 58.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 128.778 2.831 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.84 76.75 1.23 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 118.293 0.497 . . . . 0.0 111.991 165.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.49 -85.31 0.1 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.897 0.479 . . . . 0.0 111.441 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.9 m -89.05 2.39 54.13 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 112.157 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.61 162.64 38.06 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.48 164.94 28.88 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.231 1.954 . . . . 0.0 111.128 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.93 119.31 10.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.389 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.77 -0.61 9.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.132 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -31.28 45.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.382 1.446 . . . . 0.0 112.147 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.93 5.97 36.0 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.016 1.726 . . . . 0.0 112.552 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.37 -31.15 54.03 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.318 -1.489 . . . . 0.0 111.754 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.73 -27.61 68.61 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 120.324 1.42 . . . . 0.0 114.423 171.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.48 34.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.886 . . . . 0.0 109.03 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -73.86 -45.82 48.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.36 162.17 26.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.523 1.929 . . . . 0.0 109.262 -170.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 m -93.99 162.09 14.03 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.429 0.692 . . . . 0.0 110.331 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -50.56 -41.96 54.82 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.141 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.49 -58.24 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.099 0.863 . . . . 0.0 112.336 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.93 -51.1 67.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 110.085 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.1 mt -64.61 -48.04 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -50.41 -55.42 15.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.47 1.908 . . . . 0.0 109.872 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -45.76 86.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.77 -41.77 86.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.085 -1.009 . . . . 0.0 111.269 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 mt -60.75 -47.72 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.046 -1.034 . . . . 0.0 109.544 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.275 0.63 . . . . 0.0 111.954 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -97.64 -54.26 3.18 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 111.636 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.75 -169.63 19.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.317 1.913 . . . . 0.0 110.301 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -170.59 122.16 0.61 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 127.431 2.293 . . . . 0.0 105.109 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.19 -113.83 1.03 Allowed Glycine 0 CA--C 1.538 1.52 0 CA-C-N 120.146 1.339 . . . . 0.0 113.027 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.52 -14.65 82.23 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 118.235 1.018 . . . . 0.0 114.069 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -66.82 129.96 94.02 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.193 0.997 . . . . 0.0 109.966 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -65.19 -40.01 21.28 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.08 2.52 . . . . 0.0 111.77 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.69 162.7 28.04 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.007 0.782 . . . . 0.0 111.774 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 17.65 66.27 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.737 0.684 . . . . 0.0 112.158 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 mm -61.16 -33.38 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.61 1.964 . . . . 0.0 110.391 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.75 144.34 47.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 157.99 43.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.437 0.695 . . . . 0.0 111.392 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.01 -137.34 32.65 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.08 -40.08 6.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.405 1.082 . . . . 0.0 112.726 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.0 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.531 0.605 . . . . 0.0 110.178 173.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.77 83.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.965 -0.46 . . . . 0.0 111.155 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.57 -55.15 38.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.411 0.684 . . . . 0.0 109.317 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.59 72.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.66 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.8 t -45.34 -66.94 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.79 70.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 111.601 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.38 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 110.769 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.505 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 7.2 t90 -55.14 -43.16 73.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.096 0.558 . . . . 0.0 110.755 176.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.505 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.55 -49.76 75.37 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.508 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.93 -40.64 63.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.451 0.7 . . . . 0.0 110.667 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -73.91 -18.66 60.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.96 0.904 . . . . 0.0 112.331 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -13.12 61.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.776 1.23 . . . . 0.0 111.482 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 pttt . . . . . 0 C--O 1.247 0.93 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -157.55 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.37 -53.23 23.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -156.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.63 -43.29 99.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.491 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.35 79.67 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.918 0.887 . . . . 0.0 110.983 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -51.43 -63.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 67.6 t -64.68 -40.43 89.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 121.066 -1.021 . . . . 0.0 112.498 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -61.23 0.76 0.23 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.808 2.843 . . . . 0.0 113.468 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.75 -25.6 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 165.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -104.5 -28.36 11.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.663 1.185 . . . . 0.0 111.452 -165.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -120.2 -39.79 2.77 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.248 0.619 . . . . 0.0 111.579 -167.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -48.62 -31.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 122.634 0.374 . . . . 0.0 111.143 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -36.75 -41.97 0.35 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.542 2.337 . . . . 0.0 113.38 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.9 -42.9 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.101 0.561 . . . . 0.0 110.649 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.84 -17.64 62.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.15 152.4 28.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.9 -53.91 7.12 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.037 1.303 . . . . 0.0 113.567 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.25 1.42 50.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.772 0.829 . . . . 0.0 112.056 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mt 66.28 25.16 10.56 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.895 0.878 . . . . 0.0 110.961 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -84.61 -4.41 58.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.969 2.908 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.63 77.12 1.32 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.399 0.545 . . . . 0.0 112.248 164.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.96 -78.43 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.067 0.434 . . . . 0.0 111.356 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -97.74 1.75 48.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.731 1.612 . . . . 0.0 111.965 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.92 162.7 39.65 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.54 164.75 31.69 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.839 1.692 . . . . 0.0 111.608 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.54 114.68 5.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.112 0.965 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 pp -102.52 -0.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 122.771 0.428 . . . . 0.0 111.845 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.06 -42.52 1.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.98 0.912 . . . . 0.0 111.986 162.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -99.81 5.09 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.058 1.343 . . . . 0.0 113.032 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.58 -42.65 34.42 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.634 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.72 68.28 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.604 1.093 . . . . 0.0 114.664 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.41 -47.66 26.35 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.12 0.96 . . . . 0.0 109.255 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.55 -39.3 62.39 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.236 0.615 . . . . 0.0 111.327 -170.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.74 161.58 34.3 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.02 2.128 . . . . 0.0 108.04 -171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -99.6 156.51 17.03 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.062 0.945 . . . . 0.0 110.378 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.26 -51.1 6.37 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.893 0.877 . . . . 0.0 111.316 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -40.87 -52.77 3.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.753 1.621 . . . . 0.0 113.839 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.09 -47.89 75.63 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.355 -0.841 . . . . 0.0 109.842 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.5 mt -61.77 -48.34 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -48.84 -56.28 9.18 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 126.748 2.019 . . . . 0.0 109.946 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.16 -48.29 76.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.7 mt -59.95 -42.24 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 122.028 -0.42 . . . . 0.0 110.749 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.39 -50.97 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.94 -36.86 85.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.962 0.505 . . . . 0.0 111.838 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -96.82 -58.39 2.05 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.572 1.549 . . . . 0.0 111.36 -169.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.29 -176.74 20.11 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.377 1.941 . . . . 0.0 110.354 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -145.33 163.21 35.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 103.298 -2.853 . . . . 0.0 103.298 166.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -23.63 -77.47 0.01 OUTLIER Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.704 1.621 . . . . 0.0 115.676 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 32.2 6.39 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.5 1.15 . . . . 0.0 113.506 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -124.32 124.72 25.78 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.197 1.399 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.97 -38.73 55.8 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.866 2.378 . . . . 0.0 113.173 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.45 163.33 32.85 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 121.802 0.668 . . . . 0.0 112.237 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.48 66.9 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mt -69.13 -29.07 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.177 1.391 . . . . 0.0 110.139 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.24 41.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -140.51 152.18 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.665 1.121 . . . . 0.0 113.267 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.06 -137.16 50.63 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.47 -38.68 4.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.236 1.414 . . . . 0.0 112.031 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -54.74 -57.37 11.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.826 1.25 . . . . 0.0 109.859 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.28 87.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 110.649 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.46 -53.36 55.21 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.332 0.653 . . . . 0.0 109.849 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.98 -55.12 25.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.99 0.916 . . . . 0.0 109.848 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.7 t -51.07 -54.41 10.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 122.922 0.139 . . . . 0.0 110.971 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.3 -52.34 65.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.092 0.557 . . . . 0.0 110.777 -172.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.23 -54.3 38.13 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.55 0.69 . . . . 0.0 109.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 51.6 t90 -57.6 -40.72 79.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.485 0.714 . . . . 0.0 112.14 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.452 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP 0.305 3.7 mt -68.05 -39.66 82.96 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.618 -1.301 . . . . 0.0 112.887 175.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.12 72.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.307 0.503 . . . . 0.0 111.108 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -73.24 -28.84 62.37 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.316 1.046 . . . . 0.0 111.211 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -20.72 66.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.548 1.139 . . . . 0.0 113.68 -169.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 pttt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -151.267 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.35 86.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.613 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.61 -43.31 73.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 -49.59 68.54 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.002 0.819 . . . . 0.0 111.246 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -47.99 -59.15 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.476 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.261 87.8 t -68.93 -38.47 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.37 -166.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.04 0.19 0.25 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 129.186 2.994 . . . . 0.0 113.947 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 -13.48 1.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.1 -26.63 8.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.93 1.292 . . . . 0.0 110.817 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.8 m -115.01 -40.72 3.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.706 0.684 . . . . 0.0 111.976 -172.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.6 pt -49.34 -30.14 4.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 122.619 0.368 . . . . 0.0 111.706 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.9 t -38.66 -42.24 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.067 1.747 . . . . 0.0 111.653 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -116.2 -42.65 3.02 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.267 0.627 . . . . 0.0 111.002 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -71.71 -13.21 61.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.24 153.0 21.71 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.01 -60.52 2.21 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.281 1.419 . . . . 0.0 113.53 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.55 -2.28 34.82 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.577 0.751 . . . . 0.0 112.571 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt 66.84 26.53 9.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.23 1.812 . . . . 0.0 111.007 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -79.29 -7.99 58.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.701 2.8 . . . . 0.0 111.563 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.86 83.62 1.69 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 168.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.68 -84.09 0.18 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.011 0.524 . . . . 0.0 110.549 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -88.97 2.1 54.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.263 1.425 . . . . 0.0 111.89 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.79 41.32 Favored Pre-proline 0 N--CA 1.452 -0.36 0 C-N-CA 126.925 2.09 . . . . 0.0 105.413 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.47 164.37 23.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.922 1.748 . . . . 0.0 111.007 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.59 122.88 18.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.296 1.9 pp -119.42 0.5 7.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.968 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -41.41 -43.95 2.7 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.783 1.174 . . . . 0.0 112.133 164.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -101.92 6.17 41.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.429 1.892 . . . . 0.0 112.12 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -33.02 42.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.02 -0.991 . . . . 0.0 111.552 172.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.1 -31.98 78.73 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.768 1.622 . . . . 0.0 113.647 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.0 -49.42 37.15 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.147 0.974 . . . . 0.0 109.746 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.79 -42.22 50.67 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.324 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -118.37 179.76 4.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.889 1.676 . . . . 0.0 107.639 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.2 m -120.14 163.37 17.81 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.577 -0.702 . . . . 0.0 109.987 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -52.51 19.45 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.471 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -35.69 -61.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.719 1.208 . . . . 0.0 113.421 168.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -55.77 30.81 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 121.855 0.835 . . . . 0.0 109.769 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.12 -47.06 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.9 -53.81 29.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.976 1.71 . . . . 0.0 109.99 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.11 -49.8 68.31 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.42 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.461 -0.775 . . . . 0.0 110.88 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.65 -49.11 84.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 120.813 -1.179 . . . . 0.0 109.638 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.3 -37.19 82.99 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.743 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -94.9 -58.15 2.25 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.211 1.404 . . . . 0.0 111.458 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.5 -171.03 21.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.177 2.322 . . . . 0.0 109.675 -168.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -156.73 163.73 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.48 -90.05 0.0 OUTLIER Glycine 0 CA--C 1.544 1.863 0 C-N-CA 126.27 1.89 . . . . 0.0 116.57 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.66 13.83 66.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.859 1.329 . . . . 0.0 114.202 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.6 ttt -99.12 126.14 39.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.547 . . . . 0.0 109.073 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.63 -40.65 22.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.698 2.266 . . . . 0.0 112.348 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.27 163.71 31.26 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.716 0.62 . . . . 0.0 112.161 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.44 20.11 65.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mt -66.97 -32.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 125.426 1.49 . . . . 0.0 109.619 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.02 146.49 47.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -146.73 162.83 37.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.2 -139.78 40.63 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.09 -38.56 1.06 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.546 1.539 . . . . 0.0 112.467 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -55.54 -61.09 2.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.405 1.082 . . . . 0.0 110.015 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.69 -38.01 80.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.699 -0.626 . . . . 0.0 110.788 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -55.49 -54.29 45.73 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.38 62.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.58 0.752 . . . . 0.0 109.663 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -46.82 -66.03 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 O-C-N 123.363 0.414 . . . . 0.0 110.256 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.24 -47.43 75.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.063 0.945 . . . . 0.0 110.616 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -56.31 23.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.385 0.274 . . . . 0.0 110.373 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.453 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 45.5 t90 -55.31 -43.04 74.5 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.568 0.747 . . . . 0.0 110.946 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.453 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -64.04 -51.48 63.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.679 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.25 68.28 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.035 0.534 . . . . 0.0 110.959 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.79 -20.5 61.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.244 0.618 . . . . 0.0 110.764 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.155 -0.966 . . . . 0.0 111.121 -165.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.788 2.435 . . . . 0.0 114.081 -151.575 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.42 -52.17 40.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.019 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -60.53 -40.75 92.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.815 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.79 -44.61 90.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.023 0.829 . . . . 0.0 110.659 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.5 -60.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.258 17.3 t -65.01 -41.16 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 116.462 -2.095 . . . . 0.0 111.968 -168.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -61.29 0.4 0.28 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.074 2.95 . . . . 0.0 114.28 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.81 -13.43 0.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -114.65 -21.38 10.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.434 1.494 . . . . 0.0 111.427 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.6 m -123.26 -40.13 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.377 0.535 . . . . 0.0 111.183 -168.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -48.59 -30.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 122.96 0.504 . . . . 0.0 111.746 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 m -40.82 -37.06 0.71 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.089 1.755 . . . . 0.0 112.885 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 m -119.66 -43.5 2.58 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 122.859 0.464 . . . . 0.0 110.739 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.4 -14.9 62.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.05 153.4 25.84 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.09 4.55 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.224 1.393 . . . . 0.0 113.564 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.52 -0.27 41.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.06 0.544 . . . . 0.0 112.136 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mt 64.71 25.85 13.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.59 1.556 . . . . 0.0 111.003 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -81.38 -8.31 59.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 128.901 2.88 . . . . 0.0 111.407 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.52 79.27 1.45 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 118.332 0.515 . . . . 0.0 112.21 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.57 -81.74 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.708 0.403 . . . . 0.0 111.226 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -91.64 1.97 56.78 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.548 1.539 . . . . 0.0 112.015 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.15 162.03 45.08 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.96 164.15 25.82 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.845 1.697 . . . . 0.0 111.088 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.47 122.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.323 2.4 pp -116.5 1.07 8.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.877 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -35.26 18.74 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.143 1.338 . . . . 0.0 112.344 168.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -99.16 4.31 46.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.172 1.389 . . . . 0.0 112.309 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -33.05 52.95 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 120.92 -1.113 . . . . 0.0 111.168 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.95 -31.15 79.62 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.45 1.023 . . . . 0.0 114.41 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -43.9 38.09 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.818 -0.813 . . . . 0.0 110.076 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -74.16 -39.92 62.93 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.678 0.391 . . . . 0.0 111.538 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -131.6 156.35 45.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.114 1.766 . . . . 0.0 108.054 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -92.88 162.56 14.04 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.753 -0.592 . . . . 0.0 110.506 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -46.56 -46.59 19.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.224 0.609 . . . . 0.0 110.772 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.39 -57.38 4.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.822 1.249 . . . . 0.0 112.899 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 -50.94 71.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.046 0.927 . . . . 0.0 110.073 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.9 mt -63.42 -47.26 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.1 tp -50.29 -54.89 18.08 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.745 1.618 . . . . 0.0 109.988 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.14 -49.8 70.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.29 -43.23 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.568 -0.708 . . . . 0.0 111.082 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.7 mt -60.88 -51.05 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.03 -29.9 69.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.551 0.741 . . . . 0.0 112.542 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.5 -60.17 1.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.27 1.828 . . . . 0.0 111.268 -170.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.23 -173.18 21.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.558 2.028 . . . . 0.0 110.655 -168.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -152.62 161.04 43.11 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 102.741 -3.059 . . . . 0.0 102.741 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.32 -71.09 0.07 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 120.489 1.495 . . . . 0.0 115.427 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.47 23.37 28.14 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 118.058 0.929 . . . . 0.0 113.763 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -117.94 131.97 23.9 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.075 1.35 . . . . 0.0 109.34 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.26 -40.72 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.661 2.241 . . . . 0.0 112.187 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.22 157.57 17.99 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 121.699 0.611 . . . . 0.0 112.426 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 17.84 61.39 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mm -58.76 -37.2 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.529 1.132 . . . . 0.0 109.587 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.82 146.35 52.24 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -144.22 154.6 43.28 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.67 -139.21 48.1 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.6 -37.16 5.29 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.017 1.327 . . . . 0.0 111.738 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -53.74 -60.99 2.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.478 1.111 . . . . 0.0 110.061 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.35 79.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.814 -0.554 . . . . 0.0 110.667 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.94 -52.92 63.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.02 0.438 . . . . 0.0 109.913 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.03 -52.52 60.59 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.829 0.851 . . . . 0.0 109.607 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -48.24 -65.2 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 119.172 -0.442 . . . . 0.0 109.87 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.05 -49.93 49.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.429 1.091 . . . . 0.0 111.453 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.65 -57.08 14.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.999 0.428 . . . . 0.0 110.566 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 68.7 t90 -56.36 -34.47 66.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.569 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.74 -43.85 52.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.16 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.13 -32.74 66.66 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.74 -0.6 . . . . 0.0 111.008 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.09 -23.14 59.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.079 0.952 . . . . 0.0 111.924 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.51 4.09 0.42 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.519 2.328 . . . . 0.0 115.671 -165.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.103 0 O-C-N 119.993 -1.692 . . . . 0.0 113.457 -125.594 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 123.024 1.392 . . . . 0.0 107.727 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.22 82.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.744 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -56.89 -45.32 82.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.942 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.58 96.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.687 0.676 . . . . 0.0 110.681 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -51.48 -65.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.1 -42.03 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 120.088 1.313 . . . . 0.0 110.793 -165.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -1.44 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.59 2.756 . . . . 0.0 113.261 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.78 0.96 2.05 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 169.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.01 -54.61 1.61 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.319 1.048 . . . . 0.0 109.986 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 m -90.0 -41.82 11.5 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.769 0.428 . . . . 0.0 110.248 -169.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 pt -52.74 -27.21 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.038 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -47.51 -29.33 2.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.923 1.289 . . . . 0.0 112.363 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 m -122.9 -41.58 2.34 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.542 0.61 . . . . 0.0 110.864 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -70.7 -17.35 62.83 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.81 150.15 18.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.46 -59.88 1.5 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.703 1.62 . . . . 0.0 113.969 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.01 -15.42 61.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.767 1.227 . . . . 0.0 112.77 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt 77.06 23.87 0.9 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.704 2.402 . . . . 0.0 111.098 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 p -75.73 -9.17 58.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 111.961 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.19 81.07 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.671 . . . . 0.0 111.797 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.66 -78.92 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.797 0.439 . . . . 0.0 111.1 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -93.98 2.6 56.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.609 1.563 . . . . 0.0 111.502 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.36 163.05 34.25 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.97 165.48 21.35 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.792 1.661 . . . . 0.0 111.189 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 119.7 11.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.319 2.1 pp -115.65 1.3 8.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.734 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.52 -40.31 18.39 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.519 1.054 . . . . 0.0 111.606 167.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -93.12 2.8 56.55 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 125.699 1.599 . . . . 0.0 111.315 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.13 -34.92 66.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.184 0.902 . . . . 0.0 111.183 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.47 -31.75 78.62 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.479 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.42 -46.23 28.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.514 1.157 . . . . 0.0 110.455 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -74.37 -40.67 61.95 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 111.264 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -124.91 -177.94 4.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.52 2.328 . . . . 0.0 107.893 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -122.92 169.47 11.11 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.607 -0.683 . . . . 0.0 110.32 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -42.73 67.29 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.436 0.694 . . . . 0.0 110.374 -171.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.12 -56.26 13.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 112.913 175.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -56.55 -49.35 75.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.185 1.394 . . . . 0.0 109.176 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.89 -51.22 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.75 -56.15 11.32 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.253 1.021 . . . . 0.0 109.912 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.67 -41.12 97.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.705 -0.798 . . . . 0.0 108.904 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.8 mt -62.72 -39.98 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.817 -0.552 . . . . 0.0 111.325 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.47 -51.09 76.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 O-C-N 120.719 -1.238 . . . . 0.0 109.571 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.87 -42.1 99.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -91.82 -50.6 5.64 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 112.323 -168.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.33 -167.66 14.84 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.976 1.75 . . . . 0.0 110.112 -168.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -169.37 131.02 1.14 Allowed 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.13 -112.38 0.5 Allowed Glycine 0 CA--C 1.539 1.559 0 CA-C-N 120.486 1.494 . . . . 0.0 113.078 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 -10.31 76.11 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.363 1.082 . . . . 0.0 114.263 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.5 ttt -64.46 126.43 90.58 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 118.549 1.175 . . . . 0.0 109.405 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.88 -34.82 37.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.007 2.471 . . . . 0.0 112.621 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.57 164.32 36.4 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.55 19.4 68.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.667 0.651 . . . . 0.0 112.077 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.09 -29.77 48.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.698 1.199 . . . . 0.0 110.445 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.61 153.21 42.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -146.87 162.12 39.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.39 -138.53 45.91 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.1 -6.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.176 1.791 . . . . 0.0 114.909 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.59 -67.19 0.79 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.243 1.817 . . . . 0.0 108.223 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.44 90.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.454 -0.779 . . . . 0.0 111.004 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.23 -48.58 76.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.66 91.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.694 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.1 t -53.05 -49.45 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.47 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.59 -56.58 6.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.096 0.862 . . . . 0.0 110.391 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.87 -55.67 30.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.745 0.418 . . . . 0.0 111.611 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -58.05 -49.9 75.3 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.023 0.916 . . . . 0.0 111.351 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -43.27 95.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.182 0.993 . . . . 0.0 109.6 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.71 -41.81 67.4 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 170.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.99 -13.61 60.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.035 0.934 . . . . 0.0 112.459 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -15.56 56.33 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.704 -1.247 . . . . 0.0 113.242 -169.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.596 1.158 . . . . 0.0 113.765 -150.146 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.35 63.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.901 -166.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -62.2 -43.08 99.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.283 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.31 85.9 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 119.452 1.024 . . . . 0.0 110.984 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -47.09 -64.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.438 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 69.3 t -64.41 -43.46 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 117.711 -1.596 . . . . 0.0 112.244 -167.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -56.02 -2.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.564 3.145 . . . . 0.0 112.984 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.66 2.59 2.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.286 0.948 . . . . 0.0 113.507 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -129.33 -53.06 1.18 Allowed 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.141 0.977 . . . . 0.0 110.541 -168.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.9 m -95.62 -40.3 9.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.934 0.494 . . . . 0.0 109.756 -171.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 pt -52.45 -28.02 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.054 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.17 -30.26 2.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.115 1.366 . . . . 0.0 112.571 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 m -126.28 -37.25 2.24 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.409 0.683 . . . . 0.0 111.316 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -78.71 -10.56 59.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.27 153.11 22.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.121 0.867 . . . . 0.0 110.946 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -47.5 5.99 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.424 1.488 . . . . 0.0 113.665 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -85.14 -10.3 56.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.824 1.25 . . . . 0.0 112.224 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt 70.18 23.05 5.32 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.855 2.062 . . . . 0.0 111.709 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -76.2 -7.37 54.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.722 2.409 . . . . 0.0 111.89 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.86 112.47 2.08 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.56 -72.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.469 0.708 . . . . 0.0 109.475 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -93.99 2.05 56.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.628 1.171 . . . . 0.0 110.737 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.63 162.06 38.01 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.579 1.951 . . . . 0.0 106.034 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.41 163.91 22.17 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.862 1.708 . . . . 0.0 110.622 174.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 121.55 14.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.25 2.0 pp -115.62 -1.59 9.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.972 174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -38.69 -46.82 1.28 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.359 0.982 . . . . 0.0 112.216 165.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -98.32 3.93 48.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.814 2.046 . . . . 0.0 111.177 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.25 -32.66 56.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.174 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.78 -30.42 72.69 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.886 1.221 . . . . 0.0 113.68 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.33 -45.55 38.8 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.281 1.04 . . . . 0.0 109.359 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -73.67 -41.16 63.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -130.4 165.01 23.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 127.186 2.194 . . . . 0.0 107.766 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 m -103.77 167.92 9.47 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.931 -0.481 . . . . 0.0 110.691 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -38.63 68.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.322 -173.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -53.87 -48.04 70.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.598 0.636 . . . . 0.0 112.449 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -66.17 -47.71 73.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.504 1.145 . . . . 0.0 108.503 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.72 -47.14 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.3 tp -51.81 -55.49 19.58 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 110.623 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.66 -54.57 11.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -63.8 -39.95 87.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.579 -171.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.83 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 121.294 -0.878 . . . . 0.0 109.396 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.46 -35.17 80.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -100.71 -55.79 2.5 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.376 1.471 . . . . 0.0 112.303 -168.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.12 -168.09 22.16 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.903 1.716 . . . . 0.0 110.383 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -164.06 160.99 22.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.16 2.984 . . . . 0.0 103.392 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 9.56 -99.41 0.01 OUTLIER Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.382 1.944 . . . . 0.0 116.302 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.55 17.79 57.13 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 118.491 1.146 . . . . 0.0 113.584 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.1 ttt -89.05 129.62 47.46 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 125.313 1.445 . . . . 0.0 108.464 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.48 -41.22 33.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.833 2.356 . . . . 0.0 112.048 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 159.38 17.23 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.14 20.56 62.92 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 122.165 -0.609 . . . . 0.0 111.614 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.5 mm -63.5 -29.12 46.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 124.518 1.127 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 149.15 45.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -142.19 157.77 44.49 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.294 0.952 . . . . 0.0 113.248 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.84 -141.51 44.86 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.05 -35.71 2.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.197 1.399 . . . . 0.0 112.563 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.36 -62.55 1.58 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.607 1.163 . . . . 0.0 110.179 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.16 80.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.173 0.589 . . . . 0.0 110.715 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.66 -50.36 74.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.544 0.687 . . . . 0.0 109.634 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.52 -48.09 81.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.027 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.0 t -49.95 -55.9 4.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.263 172.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.3 17.51 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.051 0.841 . . . . 0.0 110.556 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.85 78.96 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.005 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.49 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 71.7 t90 -61.13 -46.06 92.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.033 0.533 . . . . 0.0 111.72 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -66.56 -43.83 83.97 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.64 -47.81 58.33 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.11 -10.17 59.41 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.341 -0.85 . . . . 0.0 112.172 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 -5.45 59.24 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.871 -1.143 . . . . 0.0 112.079 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 C--O 1.247 0.948 0 C-N-CA 125.957 1.703 . . . . 0.0 114.194 -164.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.9 58.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.97 -1.013 . . . . 0.0 113.06 -165.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.18 -44.24 97.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.208 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.11 77.25 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.557 0.617 . . . . 0.0 110.852 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.03 -60.89 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 170.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.499 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.25 63.2 t -66.85 -40.76 86.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 121.078 -1.014 . . . . 0.0 112.047 -168.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -60.34 1.05 0.14 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.04 2.936 . . . . 0.0 113.746 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.31 -22.64 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 168.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -15.96 11.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 111.999 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.9 m -121.55 -41.39 2.49 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.58 0.627 . . . . 0.0 111.283 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.0 pt -48.68 -29.81 2.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 122.974 0.51 . . . . 0.0 111.561 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -38.1 -44.94 0.87 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.918 1.687 . . . . 0.0 112.02 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -113.19 -41.66 3.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.873 0.469 . . . . 0.0 110.73 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -71.27 -15.31 62.42 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.55 152.04 24.28 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -56.99 3.88 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.029 1.3 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 -5.86 49.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.956 1.302 . . . . 0.0 112.046 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 mt 66.53 20.38 10.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.099 1.759 . . . . 0.0 111.89 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 p -81.31 1.15 33.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.91 2.084 . . . . 0.0 111.647 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 79.21 1.44 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.596 0.635 . . . . 0.0 112.441 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.08 -80.37 0.13 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.973 0.387 . . . . 0.0 111.135 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m -94.51 1.94 55.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.442 1.497 . . . . 0.0 112.068 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.1 46.9 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.85 164.58 21.24 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.661 1.574 . . . . 0.0 110.992 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.85 113.22 6.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.861 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 2.3 pp -107.96 -2.02 10.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.604 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -32.92 -54.53 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.112 1.365 . . . . 0.0 112.261 163.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 3.14 54.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.923 2.089 . . . . 0.0 111.429 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.65 -37.76 42.57 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.196 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.97 -27.54 59.74 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.916 0.78 . . . . 0.0 115.001 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -44.5 55.67 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.266 1.033 . . . . 0.0 110.212 171.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -74.05 -38.45 63.98 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.66 0.384 . . . . 0.0 111.258 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -140.47 160.41 40.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 108.348 -167.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -94.59 165.84 12.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.541 0.736 . . . . 0.0 111.127 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.18 -45.87 53.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.42 0.688 . . . . 0.0 110.387 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.26 -49.84 31.93 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 112.573 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.48 -51.38 60.51 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.034 0.934 . . . . 0.0 110.276 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.24 -47.48 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.2 tp -48.02 -56.74 6.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.306 1.842 . . . . 0.0 110.12 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.34 -47.81 78.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.1 -44.18 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 122.277 -0.264 . . . . 0.0 110.762 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.2 mt -61.14 -50.65 79.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.115 -0.99 . . . . 0.0 109.724 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -39.74 89.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.562 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -94.81 -61.24 1.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.587 1.955 . . . . 0.0 111.59 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.33 -175.86 21.14 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.571 2.034 . . . . 0.0 110.202 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -150.97 164.46 36.32 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 167.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -4.97 -91.75 0.0 OUTLIER Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.965 2.221 . . . . 0.0 116.272 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.53 34.72 5.34 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.558 1.179 . . . . 0.0 112.58 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 ttt -114.49 123.97 31.43 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 125.592 1.557 . . . . 0.0 108.671 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.64 -38.67 59.83 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.869 2.38 . . . . 0.0 112.621 -170.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 162.61 27.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 122.077 0.82 . . . . 0.0 111.857 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.98 21.22 65.46 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 mt -64.55 -30.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.838 1.255 . . . . 0.0 109.559 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.48 149.48 44.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -143.83 164.5 30.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.231 0.923 . . . . 0.0 111.681 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.64 -140.85 43.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.38 -35.21 5.25 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.939 1.295 . . . . 0.0 112.095 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.04 -56.14 26.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.866 0.466 . . . . 0.0 109.921 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.32 81.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.643 -0.661 . . . . 0.0 110.72 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.53 -53.04 62.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.144 0.429 . . . . 0.0 110.214 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.01 57.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.402 0.681 . . . . 0.0 109.932 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.2 -61.96 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.28 -51.96 49.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.702 0.801 . . . . 0.0 111.374 -170.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.35 -56.18 25.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 110.656 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 20.4 t90 -54.09 -41.0 67.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.439 0.696 . . . . 0.0 111.467 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.43 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -79.02 -28.63 43.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.856 -1.153 . . . . 0.0 111.291 -175.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.88 67.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.576 0.75 . . . . 0.0 111.375 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.79 62.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.332 1.053 . . . . 0.0 110.75 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HA ' ' CE ' ' A' ' 91' ' ' LYS 0.33 0.0 OUTLIER -62.64 9.4 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 118.924 2.935 . . . . 0.0 118.924 -163.102 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--O 1.251 1.166 0 O-C-N 120.77 -1.206 . . . . 0.0 113.26 -149.811 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.99 -49.6 20.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.445 1.098 . . . . 0.0 112.339 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.15 -44.77 96.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.751 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.1 82.92 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.414 1.006 . . . . 0.0 111.476 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -51.57 -63.2 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.457 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.258 34.1 t -67.05 -39.54 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.696 -164.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.93 0.86 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.174 2.99 . . . . 0.0 112.987 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.45 -25.36 3.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.736 1.153 . . . . 0.0 113.996 165.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -117.85 -17.92 9.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.625 1.17 . . . . 0.0 113.041 -163.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.6 m -113.58 -39.72 3.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.679 1.127 . . . . 0.0 111.275 176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -50.3 -29.29 5.91 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.6 -29.58 3.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.812 1.245 . . . . 0.0 112.813 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -123.61 -41.52 2.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.696 0.799 . . . . 0.0 110.624 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -74.63 -10.63 59.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.81 152.3 13.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.56 -57.97 2.64 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.476 1.512 . . . . 0.0 113.452 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -5.84 53.3 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.856 1.662 . . . . 0.0 112.523 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mt 69.96 21.58 6.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.256 1.822 . . . . 0.0 111.485 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -75.28 -8.09 55.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.406 2.283 . . . . 0.0 111.766 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 99.29 1.49 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 -76.5 0.56 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.471 0.635 . . . . 0.0 109.811 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 m -93.98 2.06 56.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.506 1.523 . . . . 0.0 111.691 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.12 161.3 45.85 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 127.207 2.203 . . . . 0.0 105.303 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.7 165.67 22.48 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.33 2.02 . . . . 0.0 111.094 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 120.76 13.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.893 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 2.0 pp -117.23 0.54 8.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.063 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.26 -43.63 10.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.257 0.935 . . . . 0.0 111.207 164.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -96.53 3.89 52.39 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.561 1.544 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.81 -34.58 54.35 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.633 -0.667 . . . . 0.0 111.131 173.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.06 -30.47 75.68 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.045 0.839 . . . . 0.0 113.567 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.49 -47.24 17.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.987 0.893 . . . . 0.0 110.199 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.64 -44.58 49.73 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.704 0.402 . . . . 0.0 111.591 -171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.22 -178.28 3.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.833 2.053 . . . . 0.0 107.288 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.8 t -123.64 171.92 9.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 0.566 . . . . 0.0 110.294 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.79 -44.12 73.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.338 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -52.37 -48.19 65.73 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.959 0.8 . . . . 0.0 111.567 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.0 -50.38 64.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.512 0.672 . . . . 0.0 109.69 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.24 -47.16 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.4 tp -49.88 -55.48 14.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.76 -48.27 72.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -47.43 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.144 -0.348 . . . . 0.0 110.26 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.49 -48.32 87.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 120.835 -1.165 . . . . 0.0 110.022 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.7 -43.18 89.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -86.5 -56.42 3.43 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.19 1.396 . . . . 0.0 110.934 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.1 -160.69 21.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 126.841 2.162 . . . . 0.0 108.737 -166.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.38 162.71 37.66 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 101.811 -3.403 . . . . 0.0 101.811 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.16 -54.56 1.23 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.865 1.221 . . . . 0.0 113.983 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -105.74 30.64 9.45 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 117.478 0.639 . . . . 0.0 113.264 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.6 ttt -137.8 129.52 16.22 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 118.664 1.232 . . . . 0.0 109.449 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.55 -41.98 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.103 2.535 . . . . 0.0 113.058 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.23 166.55 39.94 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-O 121.841 0.69 . . . . 0.0 112.18 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.47 19.48 68.82 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.3 -35.11 70.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 125.757 1.623 . . . . 0.0 109.63 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.49 146.12 41.64 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 165.3 30.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.066 0.546 . . . . 0.0 112.436 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.47 -141.36 35.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -173.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.84 -38.94 0.73 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.746 1.619 . . . . 0.0 112.395 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.38 -58.83 6.9 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.925 0.49 . . . . 0.0 110.191 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.0 90.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.22 -51.95 55.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.471 0.708 . . . . 0.0 109.77 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.49 69.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.36 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -48.84 -61.3 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 118.396 0.543 . . . . 0.0 110.026 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.42 -55.79 9.9 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.168 0.987 . . . . 0.0 111.805 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.94 -53.49 57.36 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.707 0.765 . . . . 0.0 110.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.458 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 57.8 t90 -57.41 -37.36 72.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.203 0.525 . . . . 0.0 111.625 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.458 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -72.53 -42.97 64.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 121.241 -0.912 . . . . 0.0 109.475 -177.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -36.92 64.13 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.255 0.222 . . . . 0.0 110.736 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -18.68 60.78 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.733 -0.605 . . . . 0.0 112.411 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 7.62 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.962 2.505 . . . . 0.0 114.934 -172.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.251 1.158 0 O-C-N 119.791 -1.818 . . . . 0.0 113.144 -143.348 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.06 -50.68 35.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.179 0.991 . . . . 0.0 112.485 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.33 -44.51 97.07 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.715 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.96 78.58 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.181 0.901 . . . . 0.0 111.184 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.27 -64.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.434 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 72.3 t -67.64 -39.32 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 117.921 -1.512 . . . . 0.0 111.851 -163.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -57.89 0.46 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.999 3.32 . . . . 0.0 114.271 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.63 -37.58 1.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.607 1.094 . . . . 0.0 113.241 164.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 -32.32 15.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.436 1.494 . . . . 0.0 110.201 -163.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.9 m -110.77 -39.15 4.93 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.407 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 pt -51.6 -28.87 9.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 O-C-N 123.121 0.263 . . . . 0.0 111.651 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 t -37.55 -45.66 0.77 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.958 1.703 . . . . 0.0 111.768 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.9 m -110.88 -43.06 3.85 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 122.832 0.453 . . . . 0.0 110.619 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -72.49 -15.47 61.8 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.41 153.13 24.37 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.93 4.25 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.15 1.357 . . . . 0.0 113.664 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.4 -0.8 38.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.913 0.485 . . . . 0.0 112.172 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mt 66.28 23.65 10.75 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.134 1.774 . . . . 0.0 111.069 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -6.93 58.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.334 2.654 . . . . 0.0 111.565 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 78.21 1.38 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 118.434 0.561 . . . . 0.0 111.936 166.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.42 -78.27 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.643 0.377 . . . . 0.0 111.363 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.5 t -97.52 2.29 49.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.79 1.636 . . . . 0.0 111.64 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.36 162.09 41.34 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.01 165.23 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.773 1.649 . . . . 0.0 111.33 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.06 117.93 8.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.294 2.0 pp -114.07 0.31 8.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.835 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -35.15 48.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.727 1.149 . . . . 0.0 112.034 171.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.49 4.43 50.46 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.914 1.286 . . . . 0.0 111.974 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.2 -35.13 59.55 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.743 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.38 67.11 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.748 1.158 . . . . 0.0 114.526 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.99 -45.6 49.01 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.425 1.113 . . . . 0.0 109.535 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.608 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -136.78 160.43 38.87 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.026 2.131 . . . . 0.0 108.236 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.1 m -95.31 169.26 10.2 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.417 0.287 . . . . 0.0 110.645 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -40.09 76.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.093 -174.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -53.24 -53.17 54.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.705 1.202 . . . . 0.0 111.757 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.18 -50.19 73.62 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.181 0.992 . . . . 0.0 109.528 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.1 -51.77 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.29 -55.01 14.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.105 1.362 . . . . 0.0 109.892 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -44.08 97.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.07 -41.92 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.625 -0.672 . . . . 0.0 110.786 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mt -63.5 -50.08 79.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -38.41 90.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.608 0.363 . . . . 0.0 111.5 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -89.38 -59.18 2.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.048 1.739 . . . . 0.0 111.355 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.28 115.92 3.04 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.879 1.704 . . . . 0.0 109.157 -165.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.13 150.31 10.9 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -26.47 -65.64 0.07 OUTLIER Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.826 1.203 . . . . 0.0 115.989 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.59 22.99 21.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.167 0.983 . . . . 0.0 113.67 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.2 ttt -139.23 121.48 10.24 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.822 1.249 . . . . 0.0 110.554 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.58 140.73 58.01 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 N-CA-C 108.825 -1.259 . . . . 0.0 108.825 171.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.98 -172.26 21.8 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.25 12.67 63.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.64 -30.47 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.785 1.234 . . . . 0.0 109.569 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.46 145.88 45.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 168.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -143.02 161.97 36.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.629 0.771 . . . . 0.0 111.122 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.67 -137.59 26.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.99 -37.6 1.4 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.221 1.409 . . . . 0.0 112.343 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -60.67 -59.18 5.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.014 0.526 . . . . 0.0 109.915 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.17 92.98 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.365 -0.835 . . . . 0.0 110.626 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.98 -52.16 61.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 109.735 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.48 -51.31 67.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.118 0.567 . . . . 0.0 110.313 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.2 -60.76 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.449 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.09 -53.46 42.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 118.53 0.604 . . . . 0.0 110.869 -169.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.54 38.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.102 0.477 . . . . 0.0 110.63 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.507 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 56.9 t90 -62.49 -39.3 93.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.657 0.741 . . . . 0.0 112.229 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.507 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -76.24 -34.03 59.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.731 -1.231 . . . . 0.0 109.268 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.37 -54.07 45.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 161.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.2 -8.25 52.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.104 -0.998 . . . . 0.0 112.161 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -24.28 66.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.558 1.143 . . . . 0.0 110.926 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.767 -1.111 . . . . 0.0 113.043 -156.351 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.87 -51.23 58.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.115 -166.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.95 -42.55 94.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.304 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.8 -44.56 86.4 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.931 1.241 . . . . 0.0 111.055 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -48.94 -60.51 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.299 89.5 t -65.19 -42.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.678 -167.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -60.37 0.89 0.15 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.556 3.542 . . . . 0.0 113.997 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.75 -20.07 1.02 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -25.22 11.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.993 1.317 . . . . 0.0 110.855 -173.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.0 m -118.86 -41.08 2.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.474 0.579 . . . . 0.0 111.742 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -49.26 -30.06 3.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 122.681 0.392 . . . . 0.0 111.52 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -36.25 -43.55 0.37 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.298 1.839 . . . . 0.0 111.641 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.79 -44.81 2.91 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 110.934 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -69.17 -16.85 63.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.85 154.52 27.39 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.22 -60.42 2.31 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.366 1.46 . . . . 0.0 114.085 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.64 -3.3 43.29 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt 68.29 25.6 7.08 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.495 1.518 . . . . 0.0 110.548 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -78.16 -7.6 57.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 129.032 2.933 . . . . 0.0 111.265 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.19 76.99 1.31 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.447 0.567 . . . . 0.0 112.191 164.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.16 -80.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.748 0.419 . . . . 0.0 111.598 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -92.04 2.23 56.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.022 1.729 . . . . 0.0 112.066 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.69 162.27 39.56 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.67 162.3 32.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.796 1.664 . . . . 0.0 111.39 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.48 115.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.091 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 pp -105.06 0.5 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.252 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -36.69 37.04 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.226 0.921 . . . . 0.0 111.658 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.67 3.55 55.31 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.176 0.991 . . . . 0.0 112.824 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.53 69.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.076 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.59 66.83 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 121.76 2.073 . . . . 0.0 114.073 171.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.36 -45.91 57.75 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.321 -1.105 . . . . 0.0 109.718 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.26 -37.93 63.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.882 0.473 . . . . 0.0 111.547 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.33 160.57 39.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.434 1.894 . . . . 0.0 108.464 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -94.74 166.67 11.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.274 0.559 . . . . 0.0 110.763 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.58 -44.49 36.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.697 1.199 . . . . 0.0 110.718 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.78 -55.86 17.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.444 1.098 . . . . 0.0 112.007 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.99 -51.54 67.38 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.672 1.189 . . . . 0.0 109.412 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -61.24 -50.39 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -50.77 -55.31 17.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.795 1.238 . . . . 0.0 109.742 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.13 -46.11 89.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.039 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mt -58.55 -40.86 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 O-C-N 121.963 -0.46 . . . . 0.0 110.9 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.55 -50.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.25 -37.2 86.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -92.21 -45.19 8.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.88 1.672 . . . . 0.0 111.962 -170.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.81 113.66 3.03 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.32 1.438 . . . . 0.0 110.075 -168.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -55.34 155.52 5.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 159.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -32.56 -64.53 0.26 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.315 1.436 . . . . 0.0 116.114 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.12 2.73 85.56 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 117.951 0.876 . . . . 0.0 113.484 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.6 ttt -103.43 132.26 21.27 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.286 1.434 . . . . 0.0 110.569 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.45 136.33 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.883 1.722 . . . . 0.0 110.163 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.53 148.54 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.41 79.93 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.6 mm -56.26 -33.52 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.712 1.205 . . . . 0.0 110.259 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.75 149.92 49.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -143.34 157.53 44.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.452 0.644 . . . . 0.0 112.357 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.64 -137.05 31.59 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.91 -37.59 1.34 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.306 1.442 . . . . 0.0 112.519 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.15 -60.6 3.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.467 0.707 . . . . 0.0 109.757 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.66 82.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.498 -0.751 . . . . 0.0 110.764 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.6 -49.74 76.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.211 0.605 . . . . 0.0 110.253 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.63 -49.93 66.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -51.42 -60.74 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.202 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.36 -55.58 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.13 0.972 . . . . 0.0 110.982 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.32 69.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -63.59 -57.05 11.35 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.194 0.521 . . . . 0.0 111.481 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -36.48 70.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.356 -1.465 . . . . 0.0 109.847 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.25 -58.04 10.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 168.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.32 -12.87 61.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.233 -0.917 . . . . 0.0 111.947 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -23.67 66.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.66 -174.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.2 pttt . . . . . 0 C--O 1.251 1.133 0 C-N-CA 127.337 2.255 . . . . 0.0 113.931 -153.654 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.69 -50.41 68.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.604 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.197 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.6 79.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.888 1.222 . . . . 0.0 111.32 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.3 t -47.23 -63.95 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.452 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 77.8 t -67.9 -39.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.99 -165.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -56.63 -3.88 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 129.142 2.977 . . . . 0.0 113.297 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.22 -5.52 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -119.47 -27.92 5.45 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.61 1.164 . . . . 0.0 111.464 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.7 m -114.3 -37.81 4.27 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.251 0.621 . . . . 0.0 111.246 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -51.15 -30.75 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.313 0.245 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 m -37.22 -41.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.326 1.45 . . . . 0.0 113.252 170.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -120.2 -40.86 2.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.086 0.554 . . . . 0.0 110.809 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -75.81 -9.1 58.32 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.416 -0.803 . . . . 0.0 113.052 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.58 154.74 12.84 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 118.954 0.797 . . . . 0.0 111.131 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.6 -56.87 4.08 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.197 1.38 . . . . 0.0 113.66 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -81.44 -1.86 47.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.124 0.569 . . . . 0.0 112.199 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mt 70.46 22.67 5.13 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.02 1.728 . . . . 0.0 110.748 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.32 -7.79 58.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.634 2.774 . . . . 0.0 111.665 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.32 100.19 1.78 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.882 0.753 . . . . 0.0 111.613 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.8 -79.25 0.52 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.704 0.752 . . . . 0.0 110.042 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 m -92.4 1.5 57.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.47 160.73 55.84 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.577 1.951 . . . . 0.0 105.783 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.03 164.72 23.92 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.093 1.862 . . . . 0.0 111.421 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.67 14.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.296 2.2 pp -117.28 0.88 8.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.571 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -22.92 18.95 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.861 -1.149 . . . . 0.0 112.778 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 1.25 34.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.995 1.318 . . . . 0.0 112.724 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.69 67.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.481 1.037 . . . . 0.0 111.981 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.0 -30.01 74.25 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.354 1.434 . . . . 0.0 113.576 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.64 -46.11 23.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.113 0.957 . . . . 0.0 111.357 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -72.52 -42.78 64.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.69 173.35 8.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.794 1.637 . . . . 0.0 108.003 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 t -104.53 174.46 5.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.002 0.906 . . . . 0.0 112.548 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -44.01 92.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.03 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.9 -50.64 63.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.45 -51.9 66.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 109.91 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.11 -51.67 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.6 tp -49.27 -56.46 9.33 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.67 -49.28 77.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -56.42 -44.03 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.968 0.507 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mt -63.75 -51.47 69.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 O-C-N 121.776 -0.578 . . . . 0.0 109.908 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.82 -25.27 67.14 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.283 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.4 -62.31 1.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.359 1.864 . . . . 0.0 111.311 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.62 105.68 2.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.687 1.613 . . . . 0.0 110.64 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -57.07 154.07 10.45 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 161.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.76 -62.79 0.65 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.983 1.277 . . . . 0.0 115.191 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.77 22.17 22.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.83 0.815 . . . . 0.0 113.485 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -126.87 132.98 24.55 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 108.408 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.38 -35.88 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.131 1.887 . . . . 0.0 112.393 -171.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.91 161.71 26.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 121.854 0.697 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.06 26.59 61.27 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 122.367 -0.49 . . . . 0.0 111.99 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.2 mt -66.14 -30.47 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.24 1.016 . . . . 0.0 109.533 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.68 145.57 36.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -145.55 156.09 43.48 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.264 0.938 . . . . 0.0 112.593 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.4 -143.66 48.67 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.47 -37.45 1.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.04 1.736 . . . . 0.0 112.455 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -53.96 -64.17 0.91 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.014 1.326 . . . . 0.0 110.208 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.04 92.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.576 -0.702 . . . . 0.0 110.313 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -52.26 -51.78 56.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.436 0.636 . . . . 0.0 109.362 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.4 81.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.767 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.31 -57.78 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-N 118.429 0.559 . . . . 0.0 110.186 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.75 -56.23 13.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.734 0.814 . . . . 0.0 110.784 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.4 -53.34 59.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.663 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -54.52 -54.19 44.42 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.816 0.446 . . . . 0.0 110.899 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.71 -45.7 85.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.179 -0.951 . . . . 0.0 110.316 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.04 65.96 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -88.69 -22.42 23.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.68 1.592 . . . . 0.0 110.829 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -28.44 66.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.412 -0.805 . . . . 0.0 110.064 -164.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 pttt . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.887 1.275 . . . . 0.0 111.763 -146.189 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.84 -53.27 26.63 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.325 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.741 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.59 67.73 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.511 1.05 . . . . 0.0 110.171 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -51.68 -57.42 3.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.487 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 2.3 t -77.55 -1.36 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.128 -174.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 -99.89 1.64 43.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.787 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.27 -26.61 0.76 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -106.01 -14.52 15.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.709 1.204 . . . . 0.0 111.618 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 6.8 m -122.36 -41.49 2.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.845 0.858 . . . . 0.0 111.247 -168.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.0 pt -49.03 -31.11 3.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -40.27 -39.8 1.02 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.907 1.683 . . . . 0.0 111.461 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.9 m -117.24 -42.15 2.93 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 122.7 0.4 . . . . 0.0 111.088 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -72.15 -15.67 61.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.07 155.03 30.53 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.97 -56.31 4.52 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.162 1.363 . . . . 0.0 113.111 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -82.87 0.66 43.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.775 0.83 . . . . 0.0 112.399 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mt 64.91 23.96 12.66 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.155 1.382 . . . . 0.0 111.559 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -80.86 -6.05 58.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 128.557 2.743 . . . . 0.0 111.662 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.67 76.82 1.32 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 118.442 0.565 . . . . 0.0 111.91 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 -75.81 0.23 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.393 . . . . 0.0 111.462 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -96.83 1.7 50.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.168 1.787 . . . . 0.0 111.045 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.41 32.96 Favored Pre-proline 0 N--CA 1.452 -0.355 0 C-N-CA 127.081 2.152 . . . . 0.0 105.296 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.97 162.31 26.32 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.574 1.516 . . . . 0.0 110.848 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.72 125.11 23.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.274 2.2 pp -119.72 -3.22 9.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.46 174.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -38.64 -45.8 1.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.817 1.19 . . . . 0.0 111.913 164.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 2.56 51.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.557 1.543 . . . . 0.0 111.992 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.59 -28.71 56.63 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.274 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.06 73.42 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.279 0.945 . . . . 0.0 114.079 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -44.23 32.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.678 0.739 . . . . 0.0 109.483 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -74.61 -43.98 52.85 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.47 164.31 21.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.199 2.2 . . . . 0.0 108.523 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -99.3 163.92 12.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.177 0.591 . . . . 0.0 111.284 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -47.91 -48.05 31.87 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 110.441 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -48.16 -48.53 34.27 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.076 0.95 . . . . 0.0 112.268 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.06 -52.7 46.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.522 0.729 . . . . 0.0 109.679 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.93 -47.12 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.4 tp -48.18 -56.3 8.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.482 1.513 . . . . 0.0 110.174 172.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.4 -50.03 68.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.33 -44.22 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.8 mt -63.39 -46.02 96.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 120.433 -1.417 . . . . 0.0 110.08 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.79 -37.26 81.79 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.915 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -93.4 -36.67 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.985 2.114 . . . . 0.0 112.249 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.62 -178.75 27.63 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.955 1.74 . . . . 0.0 110.06 -163.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -137.76 164.27 29.29 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.81 -69.89 0.09 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.738 1.637 . . . . 0.0 114.868 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 31.62 6.02 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.02 0.91 . . . . 0.0 113.348 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.2 ttt -139.6 121.17 9.78 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.652 1.181 . . . . 0.0 111.564 -174.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.36 157.87 55.62 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.03 1.82 . . . . 0.0 110.424 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 148.3 18.7 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -172.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.58 16.3 66.45 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.769 -0.461 . . . . 0.0 112.373 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.62 -41.22 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.911 0.884 . . . . 0.0 108.973 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.89 143.23 50.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -140.68 158.72 43.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 0.0 108.83 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.98 -139.22 29.17 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.07 1.55 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.549 1.54 . . . . 0.0 112.384 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -59.02 6.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.134 0.574 . . . . 0.0 109.541 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.45 85.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.38 -52.65 64.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.265 0.626 . . . . 0.0 110.402 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.86 69.61 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 109.522 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.2 t -48.4 -63.24 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 O-C-N 123.388 0.43 . . . . 0.0 109.877 172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.8 51.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.21 1.004 . . . . 0.0 111.085 -171.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.23 37.63 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.42 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 60.6 t90 -57.74 -38.46 75.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.183 0.593 . . . . 0.0 111.564 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -45.35 60.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.559 0.744 . . . . 0.0 109.469 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.07 -33.07 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.733 0.813 . . . . 0.0 111.264 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -21.81 60.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.851 0.86 . . . . 0.0 110.904 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.433 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -66.93 8.75 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -161.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 pttt . . . . . 0 C--O 1.247 0.962 0 O-C-N 120.9 -1.125 . . . . 0.0 112.969 -131.731 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.31 -49.73 42.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.936 -168.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.74 -45.74 93.13 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.556 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -44.91 82.46 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.482 1.037 . . . . 0.0 110.808 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.91 -62.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.499 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 72.1 t -66.69 -39.33 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.203 -168.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -59.08 0.26 0.1 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 129.141 2.976 . . . . 0.0 113.502 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 -15.43 1.57 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.08 -20.98 11.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.818 1.247 . . . . 0.0 111.503 -171.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.8 m -118.73 -40.98 2.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.989 0.813 . . . . 0.0 112.123 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.7 pt -50.7 -29.85 7.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 111.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -41.27 -39.15 1.3 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.949 1.699 . . . . 0.0 113.048 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -116.66 -43.31 2.91 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.33 0.652 . . . . 0.0 110.575 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.42 -12.94 60.98 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.88 153.28 25.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.11 -53.69 6.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.88 1.229 . . . . 0.0 113.111 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -81.79 -1.53 47.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.27 0.628 . . . . 0.0 112.205 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mt 66.38 21.79 10.86 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.631 1.572 . . . . 0.0 111.26 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -78.98 -6.76 57.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.312 2.645 . . . . 0.0 111.572 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.56 82.92 1.65 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.461 0.573 . . . . 0.0 111.738 168.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.24 -77.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.768 0.427 . . . . 0.0 110.965 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -97.17 2.58 51.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.695 1.598 . . . . 0.0 111.58 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.0 161.28 46.26 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.98 163.19 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.73 1.62 . . . . 0.0 111.163 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 123.08 18.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.288 2.2 pp -119.04 -1.12 8.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.194 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -38.46 -45.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.574 1.079 . . . . 0.0 112.567 163.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.68 2.98 44.88 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.25 1.82 . . . . 0.0 112.59 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.14 -30.53 16.85 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.787 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.96 -30.29 76.75 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.12 0.873 . . . . 0.0 114.806 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.61 -44.15 44.42 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.663 -0.904 . . . . 0.0 109.374 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -73.36 -36.81 66.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.63 157.83 45.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 m -90.61 165.66 13.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.546 0.738 . . . . 0.0 111.806 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -46.72 63.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.474 0.71 . . . . 0.0 110.488 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -49.86 -49.03 50.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.053 . . . . 0.0 111.694 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.75 -49.72 71.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.467 0.651 . . . . 0.0 109.639 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.42 -48.05 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.3 tp -48.63 -53.51 18.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.653 1.181 . . . . 0.0 109.64 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.81 0.63 6.77 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.615 0.766 . . . . 0.0 113.037 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -104.35 -39.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 120.91 -1.119 . . . . 0.0 109.441 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 mt -66.24 -50.58 67.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.133 -0.98 . . . . 0.0 109.961 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.4 -39.8 94.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.469 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.38 -48.56 7.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.087 0.955 . . . . 0.0 112.373 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.12 107.99 3.06 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.641 1.591 . . . . 0.0 109.723 -167.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.48 149.52 16.95 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 163.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -19.18 -71.13 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 C-N-CA 126.286 1.898 . . . . 0.0 116.965 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.03 73.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 117.946 0.873 . . . . 0.0 113.793 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.8 ttt -87.99 127.49 57.44 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 126.095 1.758 . . . . 0.0 109.483 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.12 143.39 84.13 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 N-CA-C 109.237 -1.101 . . . . 0.0 109.237 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.45 166.97 28.39 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.52 18.05 75.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.922 -0.639 . . . . 0.0 112.307 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -54.66 -36.02 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.55 1.14 . . . . 0.0 109.967 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.28 146.38 38.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -143.0 154.76 44.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.395 1.078 . . . . 0.0 110.772 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.58 -136.36 49.59 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.53 -38.63 6.53 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.599 1.16 . . . . 0.0 111.978 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -51.9 -62.13 1.82 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.797 0.839 . . . . 0.0 109.348 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.89 71.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.019 0.527 . . . . 0.0 110.904 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.32 -51.05 71.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 0.0 109.928 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -50.18 71.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.759 -0.638 . . . . 0.0 109.362 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.85 -61.76 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.986 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.1 -54.15 14.18 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 111.195 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -54.63 44.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 110.873 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.436 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 59.3 t90 -57.85 -41.1 81.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 111.749 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.55 -45.12 66.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 108.938 -177.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.58 -31.96 68.5 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.432 0.693 . . . . 0.0 112.125 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -21.18 60.95 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 110.701 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.444 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -68.82 7.67 0.64 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -158.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.5 pttt . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.478 -1.249 . . . . 0.0 113.075 -128.465 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.438 -1.028 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.51 -69.86 0.76 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.78 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -58.51 -41.38 85.29 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.421 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.17 -39.15 74.71 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.673 0.67 . . . . 0.0 111.303 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.82 -55.87 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.504 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 3.5 t -66.32 -41.05 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 117.015 -1.874 . . . . 0.0 110.615 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -59.92 0.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 129.844 3.258 . . . . 0.0 114.761 169.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.47 -15.51 0.95 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.6 -23.56 11.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.09 1.356 . . . . 0.0 110.519 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -122.82 -39.09 2.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.018 0.527 . . . . 0.0 111.615 -165.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -49.11 -30.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 C-N-CA 122.797 0.439 . . . . 0.0 111.647 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 m -38.46 -39.67 0.48 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.864 1.665 . . . . 0.0 113.068 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.85 -43.97 2.64 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.943 0.497 . . . . 0.0 110.519 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.93 -16.24 63.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 113.017 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.69 153.44 26.9 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.8 -59.12 2.48 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.189 1.376 . . . . 0.0 113.13 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.98 -2.19 38.98 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.188 0.995 . . . . 0.0 112.378 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mt 65.33 24.15 12.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.026 1.73 . . . . 0.0 111.631 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -78.54 -8.33 58.46 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.765 2.826 . . . . 0.0 111.449 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.24 76.51 1.26 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-N 118.408 0.549 . . . . 0.0 111.984 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.59 -82.53 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.792 0.437 . . . . 0.0 111.443 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.72 1.46 56.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.699 1.999 . . . . 0.0 111.97 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.05 162.93 35.55 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.3 165.63 21.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.813 1.676 . . . . 0.0 111.148 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.45 117.2 7.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.265 2.2 pp -114.55 -3.78 11.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.207 176.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -38.23 -48.27 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.504 1.047 . . . . 0.0 111.996 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -99.95 5.55 45.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.395 1.878 . . . . 0.0 112.08 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.96 -44.46 20.05 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.918 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.49 -29.1 16.62 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.964 0.802 . . . . 0.0 114.839 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.08 68.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.413 -1.051 . . . . 0.0 110.497 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.77 -44.0 12.87 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.24 0.616 . . . . 0.0 110.816 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.25 154.85 38.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.817 2.047 . . . . 0.0 107.701 -171.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -95.44 169.82 9.79 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.736 0.415 . . . . 0.0 110.75 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -43.0 64.58 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.713 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -48.74 -52.71 22.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 111.863 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.57 -53.91 50.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.841 0.856 . . . . 0.0 109.684 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.01 -46.97 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -171.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.1 tp -47.31 -56.33 7.04 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.013 1.725 . . . . 0.0 109.95 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.07 -48.4 76.15 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -46.94 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.64 -47.84 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.965 -1.084 . . . . 0.0 109.917 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.5 -27.04 64.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.47 0.708 . . . . 0.0 112.852 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.42 -60.77 1.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.039 -171.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.83 -167.13 24.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.191 2.329 . . . . 0.0 109.469 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -157.97 163.89 37.36 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -15.81 -83.78 0.01 OUTLIER Glycine 0 CA--C 1.542 1.73 0 C-N-CA 126.005 1.764 . . . . 0.0 116.303 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.39 18.82 56.21 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.818 1.309 . . . . 0.0 113.566 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -103.81 127.71 28.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.01 1.324 . . . . 0.0 109.168 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.1 -40.98 24.13 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.569 2.179 . . . . 0.0 112.13 -172.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 161.67 23.09 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 121.851 0.695 . . . . 0.0 111.732 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.61 22.17 65.7 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 122.178 -0.601 . . . . 0.0 111.827 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.46 -29.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.448 1.499 . . . . 0.0 109.835 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.47 143.12 29.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -138.3 166.5 24.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.48 -135.09 41.78 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.9 -36.83 8.01 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.675 1.19 . . . . 0.0 112.027 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -60.63 -55.91 27.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.97 84.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.637 -0.664 . . . . 0.0 111.22 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.69 -54.14 49.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.305 0.502 . . . . 0.0 110.999 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.04 -51.19 62.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.8 t -50.03 -64.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.308 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.61 -51.87 25.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.495 1.118 . . . . 0.0 111.148 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -55.26 34.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 110.77 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.438 ' CZ3' ' CG2' ' A' ' 28' ' ' VAL . 66.3 t90 -59.36 -39.59 83.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.006 0.432 . . . . 0.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -41.65 77.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.98 -39.08 73.98 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 122.129 -0.357 . . . . 0.0 110.522 168.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.14 -19.05 61.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.99 0.516 . . . . 0.0 111.28 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.71 9.08 0.94 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.953 1.701 . . . . 0.0 114.649 -171.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 C--O 1.25 1.12 0 O-C-N 120.635 -1.29 . . . . 0.0 112.73 -154.428 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.442 -0.835 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.23 -53.05 60.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.555 -167.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.18 -43.59 98.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.088 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.32 78.13 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.168 0.895 . . . . 0.0 111.326 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -46.25 -63.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.51 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 80.2 t -67.97 -37.78 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 117.352 -1.739 . . . . 0.0 112.52 -166.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -60.1 -1.02 0.26 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.203 3.001 . . . . 0.0 113.179 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 -9.67 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 169.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -118.72 -25.19 6.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.188 1.395 . . . . 0.0 112.04 -171.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -117.21 -40.96 3.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.418 0.554 . . . . 0.0 110.499 -172.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -48.33 -32.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 122.942 0.497 . . . . 0.0 111.612 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -38.64 -37.38 0.32 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 113.206 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -120.08 -41.72 2.63 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.786 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.16 -6.33 49.04 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.66 -86.72 0.41 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.408 1.004 . . . . 0.0 112.788 163.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.53 -62.93 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.35 2.59 39.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 111.764 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.85 26.87 7.51 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.31 1.844 . . . . 0.0 111.505 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -72.83 -10.87 60.29 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.43 1.892 . . . . 0.0 111.721 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 104.14 1.8 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.4 -77.11 0.6 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.535 0.734 . . . . 0.0 110.01 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -92.26 2.1 56.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.922 1.289 . . . . 0.0 111.646 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.83 158.61 52.61 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -63.98 164.57 21.63 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.153 1.902 . . . . 0.0 111.105 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.24 123.72 18.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.631 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.253 2.5 pp -119.79 -2.42 8.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.322 -0.847 . . . . 0.0 112.266 172.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -42.06 -44.85 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.133 1.333 . . . . 0.0 111.594 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.68 4.14 45.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.608 1.563 . . . . 0.0 112.195 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.9 -36.97 18.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.358 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.07 -34.34 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 120.86 1.664 . . . . 0.0 114.379 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -53.27 32.04 Favored 'General case' 0 C--N 1.337 0.056 0 O-C-N 121.446 -1.032 . . . . 0.0 110.276 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -74.31 -37.02 63.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.474 -169.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -132.01 151.53 51.69 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.831 1.652 . . . . 0.0 107.822 -171.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.34 166.95 12.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.665 0.745 . . . . 0.0 110.899 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.37 -47.83 26.02 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.026 1.331 . . . . 0.0 110.498 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.94 -46.34 68.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.853 0.751 . . . . 0.0 111.764 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.99 -53.68 42.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.511 0.724 . . . . 0.0 109.27 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.07 -47.6 91.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.0 tp -49.85 -54.47 19.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.13 1.372 . . . . 0.0 110.322 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.38 -49.66 71.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -46.46 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.1 mt -58.95 -48.84 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 121.245 -0.909 . . . . 0.0 109.635 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.75 -32.63 73.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.485 0.714 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -101.78 -61.55 1.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.015 1.726 . . . . 0.0 111.481 -169.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.09 -173.36 22.71 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 126.776 2.131 . . . . 0.0 110.388 -171.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.92 163.94 38.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 168.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -17.83 -81.97 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.178 1.847 . . . . 0.0 116.102 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.13 25.71 24.35 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.858 1.329 . . . . 0.0 113.441 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -112.46 126.77 27.81 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.948 1.299 . . . . 0.0 108.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.93 -40.88 49.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.101 2.534 . . . . 0.0 112.381 -172.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.67 161.47 25.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-O 121.958 0.755 . . . . 0.0 111.869 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.63 62.12 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.09 -35.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.437 0.695 . . . . 0.0 109.344 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.5 52.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -145.05 152.24 39.8 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.925 0.869 . . . . 0.0 113.233 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.94 -138.86 47.97 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.76 -34.26 11.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.706 1.203 . . . . 0.0 112.034 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.23 -57.01 13.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.086 0.954 . . . . 0.0 109.906 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.77 -39.58 80.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.837 -0.539 . . . . 0.0 110.266 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -55.73 -53.38 57.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.909 0.322 . . . . 0.0 110.151 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.79 39.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.466 0.706 . . . . 0.0 109.643 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.24 -65.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 O-C-N 123.433 0.458 . . . . 0.0 110.21 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.86 -48.85 66.8 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.793 0.837 . . . . 0.0 111.235 -170.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.74 30.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.755 0.422 . . . . 0.0 110.337 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.5 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 31.9 t90 -54.9 -41.8 71.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.362 0.665 . . . . 0.0 111.247 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.5 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.88 -49.32 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.821 0.848 . . . . 0.0 110.366 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.07 69.22 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.522 0.729 . . . . 0.0 110.875 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.49 -23.21 60.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.427 1.091 . . . . 0.0 110.985 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -32.17 73.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.263 -0.898 . . . . 0.0 110.472 -166.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.989 1.716 . . . . 0.0 114.502 -145.446 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.64 -49.78 14.02 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.129 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -63.11 -44.03 96.78 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.928 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.43 75.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 120.002 1.273 . . . . 0.0 111.183 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -55.0 -63.52 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.402 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 25.6 t -65.32 -42.61 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.683 -164.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -3.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.025 2.93 . . . . 0.0 112.726 170.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.59 0.55 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mmtt -126.89 -30.51 2.73 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.114 0.966 . . . . 0.0 111.878 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.5 m -110.23 -38.47 5.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.76 0.709 . . . . 0.0 110.687 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.0 pt -51.55 -30.15 10.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -38.66 -39.22 0.47 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.396 1.878 . . . . 0.0 113.154 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -123.02 -38.8 2.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 110.993 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.16 -9.68 59.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.18 155.87 17.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.94 -57.02 3.63 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.257 1.408 . . . . 0.0 113.498 -174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.03 1.29 44.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 112.518 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt 68.42 21.36 8.28 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.051 1.341 . . . . 0.0 111.363 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -6.59 53.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.972 2.509 . . . . 0.0 111.654 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 113.51 2.34 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.64 -77.15 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.771 0.786 . . . . 0.0 109.449 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 m -93.08 1.85 57.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.938 1.295 . . . . 0.0 111.477 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.89 159.23 57.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 127.038 2.135 . . . . 0.0 105.591 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.0 164.66 21.36 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.08 1.854 . . . . 0.0 111.263 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 120.04 11.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.273 2.2 pp -115.14 -0.4 9.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-O 118.272 -0.871 . . . . 0.0 112.063 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -46.23 -41.26 12.65 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.46 1.027 . . . . 0.0 112.157 170.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.93 4.05 51.77 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.329 1.452 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -25.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.598 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.31 -33.03 76.79 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.901 1.228 . . . . 0.0 113.997 171.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.93 -43.21 59.05 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.624 -0.927 . . . . 0.0 109.646 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -74.36 -44.17 53.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.066 0.547 . . . . 0.0 111.109 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.49 164.43 23.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.707 2.003 . . . . 0.0 108.486 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.22 168.49 10.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.521 0.729 . . . . 0.0 111.6 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -44.0 73.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.34 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.158 0.983 . . . . 0.0 112.236 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.88 -49.21 78.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.53 -49.87 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.0 tp -47.39 -57.52 5.2 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.495 1.518 . . . . 0.0 110.121 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.5 -45.17 92.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.2 mt -59.63 -43.17 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.646 -0.659 . . . . 0.0 111.0 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.0 mt -59.69 -48.4 87.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 O-C-N 120.941 -1.099 . . . . 0.0 109.449 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 mt -65.82 -34.8 79.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.327 0.651 . . . . 0.0 112.21 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -102.97 -53.79 2.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.572 1.549 . . . . 0.0 112.356 -167.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -171.72 20.23 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.411 1.958 . . . . 0.0 110.269 -170.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -166.08 135.83 3.31 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.02 -110.75 0.15 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 120.333 1.424 . . . . 0.0 113.465 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.85 -9.2 68.52 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.157 0.979 . . . . 0.0 114.232 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -63.18 127.52 91.08 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 118.498 1.149 . . . . 0.0 109.122 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -63.79 -37.84 42.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.14 2.56 . . . . 0.0 111.817 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.48 165.41 32.69 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-O 121.987 0.771 . . . . 0.0 111.668 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.24 68.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -65.13 -32.62 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.069 0.948 . . . . 0.0 110.192 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.37 150.41 51.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -144.11 153.26 41.96 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.217 0.917 . . . . 0.0 113.359 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.76 -142.21 47.31 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.6 -36.91 1.52 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.614 1.565 . . . . 0.0 112.437 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -54.27 -61.99 1.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.426 1.09 . . . . 0.0 110.04 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.88 -38.82 87.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.711 -0.618 . . . . 0.0 110.487 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.94 -50.62 72.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 109.851 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.08 73.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.559 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.84 -57.82 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.347 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.14 -54.36 13.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.4 1.08 . . . . 0.0 111.224 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.85 71.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.955 0.407 . . . . 0.0 110.707 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.517 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 64.3 t90 -62.84 -27.24 69.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.578 1.151 . . . . 0.0 112.809 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.517 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -84.73 -43.33 14.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 176.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.12 -42.88 73.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.721 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -5.6 41.35 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.27 0.941 . . . . 0.0 112.22 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 6.9 1.35 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -163.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.989 -124.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.443 -0.8 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.94 -51.86 9.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.063 0.945 . . . . 0.0 111.916 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -62.73 -43.95 97.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.603 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.89 82.42 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 119.156 0.889 . . . . 0.0 110.858 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -49.99 -61.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 40.4 t -63.67 -41.99 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 116.803 -1.959 . . . . 0.0 112.697 -170.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -63.18 1.23 0.5 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.411 3.084 . . . . 0.0 113.628 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -134.92 -22.63 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -112.29 -20.42 11.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.719 1.608 . . . . 0.0 111.577 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -121.76 -42.65 2.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.463 0.574 . . . . 0.0 111.25 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.1 pt -48.78 -32.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.696 0.398 . . . . 0.0 111.609 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.24 -36.88 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.067 1.747 . . . . 0.0 113.384 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.0 -42.38 2.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.272 0.629 . . . . 0.0 110.837 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.79 -7.95 54.95 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.41 -84.45 0.37 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.409 1.004 . . . . 0.0 112.813 163.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.25 -64.36 0.02 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.97 3.58 37.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.9 0.88 . . . . 0.0 111.866 173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 67.61 28.1 7.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.583 1.553 . . . . 0.0 111.576 -175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -73.62 -13.07 60.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.036 2.135 . . . . 0.0 111.075 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.38 98.64 1.62 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 172.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.56 -77.47 0.56 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.473 0.709 . . . . 0.0 110.157 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -90.71 1.42 56.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.603 1.161 . . . . 0.0 111.542 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.91 160.2 44.34 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.726 2.011 . . . . 0.0 105.686 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -64.2 164.52 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.25 1.967 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.62 25.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.227 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.274 2.8 pp -119.78 -1.06 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 122.76 0.424 . . . . 0.0 112.131 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -35.39 64.11 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.009 -1.057 . . . . 0.0 111.426 167.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 4.07 51.91 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.486 1.514 . . . . 0.0 111.677 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.36 -53.87 12.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.92 9.22 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 115.156 0.822 . . . . 0.0 115.156 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.35 -29.65 28.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.023 0.912 . . . . 0.0 110.971 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -92.76 -51.95 4.85 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 124.036 0.934 . . . . 0.0 110.113 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.46 146.13 40.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.518 2.327 . . . . 0.0 108.276 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.4 m -86.87 164.16 16.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.256 0.48 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -45.52 58.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.898 0.479 . . . . 0.0 110.008 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -47.01 -53.31 12.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.371 1.468 . . . . 0.0 112.512 173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.39 -48.6 77.21 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.687 0.795 . . . . 0.0 110.175 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.05 -46.73 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -49.85 -55.29 14.84 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.084 1.753 . . . . 0.0 109.786 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.86 73.55 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.89 -37.15 77.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 121.307 -0.87 . . . . 0.0 111.62 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.8 mt -65.47 -44.87 94.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.501 -1.374 . . . . 0.0 109.819 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -68.74 -41.42 78.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.081 0.552 . . . . 0.0 111.594 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -91.28 -37.29 13.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.713 1.605 . . . . 0.0 111.62 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.8 -167.17 18.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.308 1.433 . . . . 0.0 110.139 -166.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -149.69 163.03 39.04 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -31.33 -66.66 0.16 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.641 1.591 . . . . 0.0 114.754 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.25 32.35 6.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.708 0.67 . . . . 0.0 113.266 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.7 ttt -139.4 128.76 14.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.399 1.079 . . . . 0.0 111.594 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.2 155.44 68.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.399 2.066 . . . . 0.0 111.312 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.25 142.67 15.57 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.34 24.95 60.08 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.877 0.751 . . . . 0.0 111.432 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.3 mt -51.83 -44.38 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 108.971 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.47 140.19 46.04 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.5 2.32 . . . . 0.0 105.302 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -147.25 153.71 40.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 109.189 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.78 -133.89 51.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.86 -46.89 11.03 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.436 1.095 . . . . 0.0 111.804 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 mp0 -52.42 -61.4 2.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.898 0.772 . . . . 0.0 110.432 175.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.42 97.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.911 -0.493 . . . . 0.0 110.839 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.46 -58.93 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.197 0.999 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.21 -53.55 49.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.725 1.21 . . . . 0.0 109.618 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -50.38 -61.9 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.045 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.34 -51.66 57.61 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.572 0.749 . . . . 0.0 110.571 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.91 63.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 110.798 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.456 ' CZ3' ' CD1' ' A' ' 88' ' ' LEU . 72.2 t90 -61.86 -31.96 72.28 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.093 0.557 . . . . 0.0 111.665 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' CD1' ' CZ3' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -75.76 -43.74 45.1 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.032 -1.043 . . . . 0.0 110.166 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.21 -37.71 62.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.599 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.4 -8.5 59.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.165 1.348 . . . . 0.0 113.443 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' CA ' ' HE2' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -73.21 5.24 3.67 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.053 2.141 . . . . 0.0 116.204 -170.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 pttp . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.534 -1.222 . . . . 0.0 111.192 -126.373 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -52.64 11.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 112.962 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.28 -46.55 89.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.315 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.52 78.56 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.093 0.86 . . . . 0.0 111.218 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.2 -61.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 170.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.439 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 81.9 t -68.92 -40.16 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 120.854 -1.154 . . . . 0.0 112.293 -167.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -58.06 0.61 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 129.136 2.974 . . . . 0.0 113.003 167.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.65 -12.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -122.59 -19.09 6.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.708 1.203 . . . . 0.0 112.101 -170.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.7 m -116.93 -41.59 3.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.42 1.009 . . . . 0.0 111.699 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -48.83 -32.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 122.47 0.308 . . . . 0.0 111.43 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -36.09 -38.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.22 2.208 . . . . 0.0 113.464 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -117.52 -42.31 2.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.617 0.767 . . . . 0.0 110.699 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -74.25 -8.35 55.93 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.67 -90.38 0.43 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.577 1.084 . . . . 0.0 112.751 164.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.1 -58.67 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.59 3.42 47.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.802 0.841 . . . . 0.0 111.367 172.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 65.68 27.59 11.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.741 1.617 . . . . 0.0 111.149 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -78.38 -5.22 51.64 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.727 2.411 . . . . 0.0 111.667 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 92.47 1.57 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.713 0.688 . . . . 0.0 111.599 166.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.31 -79.78 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.38 0.672 . . . . 0.0 110.617 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.9 t -90.81 1.64 56.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.278 1.031 . . . . 0.0 111.25 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.86 160.13 44.74 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.49 161.47 27.67 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.018 1.812 . . . . 0.0 111.198 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.61 116.7 8.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.989 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.7 pp -106.58 -6.81 10.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.053 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -43.85 -50.87 7.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.779 1.172 . . . . 0.0 111.036 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 1.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.534 -0.728 . . . . 0.0 112.103 -175.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.96 -40.45 63.69 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.049 -171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.67 -26.28 24.18 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 119.028 0.831 . . . . 0.0 114.045 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -45.3 62.13 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.31 -1.112 . . . . 0.0 110.264 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -80.82 -43.13 20.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.165 0.986 . . . . 0.0 111.099 -171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.61 158.96 37.86 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.959 2.103 . . . . 0.0 107.647 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -100.75 171.9 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.249 0.477 . . . . 0.0 112.028 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -40.57 75.11 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.47 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -53.34 -49.79 66.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.507 1.048 . . . . 0.0 111.429 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.56 -48.23 78.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.52 0.728 . . . . 0.0 110.029 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.33 -47.58 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -49.24 -57.24 7.12 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.667 1.587 . . . . 0.0 110.365 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -46.28 82.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.97 -43.7 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.526 -0.734 . . . . 0.0 111.268 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.9 mt -60.18 -47.4 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.104 -0.997 . . . . 0.0 109.536 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.36 -42.59 92.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -91.28 -51.8 5.12 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.368 1.467 . . . . 0.0 111.473 -166.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -166.94 17.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -164.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.79 167.21 28.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 175.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.63 72.32 0.02 OUTLIER Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.84 1.2 . . . . 0.0 113.118 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.11 -15.6 3.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.374 1.94 . . . . 0.0 112.585 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.7 ttt -112.37 132.14 22.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.776 1.288 . . . . 0.0 108.459 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.93 -38.09 7.89 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.224 2.616 . . . . 0.0 113.528 -169.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.44 173.18 48.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-O 122.003 0.78 . . . . 0.0 112.218 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 -1.73 62.3 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.267 0.937 . . . . 0.0 112.629 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.09 -31.61 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.171 2.188 . . . . 0.0 111.036 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.87 139.65 38.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -141.79 155.17 45.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.468 1.507 . . . . 0.0 108.675 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.56 -136.49 43.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.15 -41.53 3.74 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.036 1.334 . . . . 0.0 111.796 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -64.12 0.92 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.516 0.726 . . . . 0.0 109.377 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.94 96.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.995 -0.44 . . . . 0.0 110.918 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.06 -58.02 9.67 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.822 0.849 . . . . 0.0 110.077 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.41 -50.91 66.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.128 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -49.15 -63.03 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 123.577 0.548 . . . . 0.0 110.365 175.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.19 62.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.159 0.984 . . . . 0.0 111.095 -171.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.06 -55.52 33.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.279 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.569 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 35.4 t90 -52.31 -39.41 60.54 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.361 0.664 . . . . 0.0 110.771 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.569 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.35 -41.52 73.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -27.92 62.91 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.142 -0.349 . . . . 0.0 110.877 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -88.82 -12.36 42.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.041 0.937 . . . . 0.0 112.977 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -0.56 50.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 110.45 -174.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 O-C-N 119.867 -1.771 . . . . 0.0 112.407 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.56 -50.89 40.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.081 0.952 . . . . 0.0 112.485 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.37 -41.42 93.7 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.537 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.02 94.54 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.93 1.241 . . . . 0.0 111.216 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.9 -63.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 166.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.452 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 85.8 t -63.79 -41.27 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.517 -166.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -60.48 -1.98 0.44 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.227 3.011 . . . . 0.0 112.89 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -11.62 2.26 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 168.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -119.74 -23.86 6.36 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.87 1.268 . . . . 0.0 112.793 -169.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.1 m -122.47 -41.32 2.4 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.812 0.733 . . . . 0.0 111.589 -172.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.3 pt -50.39 -30.04 7.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 122.408 0.283 . . . . 0.0 111.066 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -35.93 -41.06 0.22 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.57 2.348 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.44 -40.37 2.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.295 0.638 . . . . 0.0 110.848 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -78.14 -8.73 58.64 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.33 157.96 16.31 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.148 0.886 . . . . 0.0 112.038 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -36.34 -62.12 0.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.337 1.922 . . . . 0.0 115.952 -168.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -92.86 4.62 53.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.424 1.112 . . . . 0.0 111.988 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 77.39 28.29 0.6 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.671 1.988 . . . . 0.0 110.953 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.2 -10.7 59.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.234 2.214 . . . . 0.0 112.505 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.39 100.26 1.52 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.958 0.79 . . . . 0.0 111.562 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.56 -76.75 0.58 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.732 0.766 . . . . 0.0 110.188 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -94.86 2.24 55.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 111.654 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.02 160.97 50.81 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 127.121 2.169 . . . . 0.0 105.238 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.74 165.03 24.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.903 1.735 . . . . 0.0 111.103 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 115.7 4.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.56 -0.96 9.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.492 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -44.48 -45.73 9.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.672 1.124 . . . . 0.0 112.049 168.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -90.65 3.84 53.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.249 1.42 . . . . 0.0 111.156 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.15 -31.58 65.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.774 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.76 -30.23 76.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 120.518 1.508 . . . . 0.0 113.195 170.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.44 54.38 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.016 -1.285 . . . . 0.0 110.487 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -74.21 -38.6 63.52 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.286 0.234 . . . . 0.0 111.302 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -135.31 175.64 9.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.253 2.221 . . . . 0.0 108.033 -172.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -112.18 167.74 10.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.247 0.619 . . . . 0.0 110.483 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -50.57 -41.28 54.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 111.531 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -57.01 -51.69 68.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.176 1.353 . . . . 0.0 111.959 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.34 -51.22 69.07 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.141 0.976 . . . . 0.0 109.261 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.49 -49.92 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.834 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.3 tp -48.81 -56.33 9.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.314 1.446 . . . . 0.0 110.333 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.43 -44.76 95.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.931 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.7 mt -59.93 -41.96 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 121.838 -0.539 . . . . 0.0 110.696 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.04 -50.04 81.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.138 -0.976 . . . . 0.0 109.659 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.83 -30.9 71.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.477 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -105.16 -57.31 2.05 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.441 1.497 . . . . 0.0 112.244 -168.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.57 -173.47 21.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.068 1.794 . . . . 0.0 110.554 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -165.48 125.02 1.75 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.88 -113.53 1.06 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.974 1.261 . . . . 0.0 112.779 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.26 82.61 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.207 1.004 . . . . 0.0 113.965 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.5 ttt -66.36 126.85 92.79 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.46 1.13 . . . . 0.0 109.468 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.25 -39.16 39.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.751 2.3 . . . . 0.0 112.082 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.18 163.74 28.78 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 121.956 0.753 . . . . 0.0 111.707 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.84 21.64 65.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.14 -35.3 73.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.286 1.434 . . . . 0.0 109.759 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.54 146.77 49.99 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -139.93 155.09 47.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.235 0.925 . . . . 0.0 112.903 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.84 -139.32 45.87 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.4 -37.21 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.366 1.467 . . . . 0.0 112.068 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.03 -61.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.2 -39.69 89.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.792 -0.568 . . . . 0.0 110.452 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -58.11 -50.9 71.88 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.048 0.539 . . . . 0.0 110.023 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.94 65.39 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.44 0.696 . . . . 0.0 109.687 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.13 -57.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.321 0 O-C-N 123.237 0.335 . . . . 0.0 110.179 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.7 -55.38 19.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.064 0.545 . . . . 0.0 111.279 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.39 58.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 110.783 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.464 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 21.0 t90 -51.13 -44.14 61.31 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.488 0.715 . . . . 0.0 111.187 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -76.2 -37.29 57.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.384 -0.823 . . . . 0.0 112.154 -173.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 109.462 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -76.22 -22.16 55.56 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.397 1.079 . . . . 0.0 113.256 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -18.71 55.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.435 -1.415 . . . . 0.0 112.789 -168.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.955 1.702 . . . . 0.0 113.121 -156.055 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.39 -53.06 59.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.2 -161.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -61.94 -40.18 94.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.492 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.8 91.1 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.792 0.724 . . . . 0.0 111.315 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.7 t -48.02 -65.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.487 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 58.4 t -64.63 -41.37 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.526 -165.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.91 0.65 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.985 2.914 . . . . 0.0 113.382 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -126.56 -33.42 2.55 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.135 0.974 . . . . 0.0 113.257 167.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -107.62 -19.68 13.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.924 1.69 . . . . 0.0 112.675 -160.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.6 m -123.37 -40.07 2.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.316 0.507 . . . . 0.0 110.862 -171.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.65 -28.55 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.558 0.343 . . . . 0.0 111.422 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -36.75 -43.7 0.44 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.962 2.105 . . . . 0.0 112.913 170.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.28 -37.68 3.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.56 0.744 . . . . 0.0 110.681 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -77.75 -9.42 59.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.4 153.19 10.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.8 -60.54 2.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.175 1.369 . . . . 0.0 113.314 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -3.23 39.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.513 1.125 . . . . 0.0 112.456 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt 71.06 24.38 3.95 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.138 1.775 . . . . 0.0 111.124 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -79.51 -6.03 56.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.397 2.279 . . . . 0.0 112.036 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.59 112.64 2.26 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.07 -73.23 0.67 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.148 0.974 . . . . 0.0 109.986 175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -98.3 2.2 47.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.55 56.54 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 127.356 2.262 . . . . 0.0 105.394 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.11 165.14 25.12 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.818 1.679 . . . . 0.0 110.751 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.98 122.49 15.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.316 2.2 pp -116.57 1.93 7.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.54 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -42.34 -48.81 5.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.662 1.119 . . . . 0.0 112.151 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -90.28 4.84 49.5 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.916 1.286 . . . . 0.0 112.02 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.24 -44.83 53.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.826 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.02 -33.52 44.54 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 120.862 1.665 . . . . 0.0 114.038 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.74 -35.77 77.54 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.375 -1.074 . . . . 0.0 110.891 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -89.78 -34.39 16.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.668 0.787 . . . . 0.0 111.166 -171.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -138.65 142.47 39.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.109 1.363 . . . . 0.0 108.035 -167.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 p -80.49 165.3 22.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.649 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -49.36 -49.56 43.89 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.367 1.067 . . . . 0.0 110.019 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -47.09 -52.6 14.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.646 1.179 . . . . 0.0 112.676 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.98 -49.01 77.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.515 -0.741 . . . . 0.0 110.336 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.98 -47.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.0 tp -50.29 -55.36 15.76 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.82 1.648 . . . . 0.0 109.943 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.76 -48.17 80.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -57.98 -43.46 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.56 0.344 . . . . 0.0 110.377 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.4 -50.42 80.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.08 -28.65 68.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -103.46 -60.95 1.48 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.137 1.775 . . . . 0.0 111.495 -171.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.8 -175.75 21.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.405 1.955 . . . . 0.0 110.365 -170.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.62 164.02 37.81 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.88 -91.97 0.0 OUTLIER Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.921 2.2 . . . . 0.0 116.2 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.36 37.27 3.59 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 118.571 1.186 . . . . 0.0 112.471 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.3 ttt -117.93 122.84 30.12 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 125.547 1.539 . . . . 0.0 108.617 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -61.92 -38.54 57.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.873 2.382 . . . . 0.0 112.688 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.49 163.57 29.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 122.003 0.779 . . . . 0.0 111.849 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.73 22.28 63.99 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.408 0.527 . . . . 0.0 111.872 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mt -64.39 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.168 1.387 . . . . 0.0 109.748 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.95 144.28 38.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -138.78 158.34 44.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.261 0.937 . . . . 0.0 112.931 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.93 -136.27 41.93 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.263 0.935 . . . . 0.0 110.89 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.15 -37.72 3.29 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.259 1.424 . . . . 0.0 112.172 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -59.01 -56.35 23.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.704 0.801 . . . . 0.0 110.214 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.36 88.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.671 -0.643 . . . . 0.0 110.266 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.26 -53.1 58.2 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.311 0.644 . . . . 0.0 109.968 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.14 41.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.609 0.763 . . . . 0.0 109.888 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.9 t -50.72 -58.2 2.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 117.897 0.317 . . . . 0.0 110.36 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.72 -54.16 41.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.02 0.528 . . . . 0.0 110.771 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.18 59.47 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.083 0.468 . . . . 0.0 110.545 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.44 ' CH2' HD21 ' A' ' 88' ' ' LEU . 14.0 t90 -58.33 -47.73 82.8 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.892 0.477 . . . . 0.0 111.69 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.44 HD21 ' CH2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -75.19 -29.75 60.45 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.861 -1.149 . . . . 0.0 110.736 -172.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.04 -56.24 21.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 160.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.69 -8.45 52.11 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.767 -1.208 . . . . 0.0 112.037 -172.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -27.4 61.07 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.289 -0.882 . . . . 0.0 110.11 -176.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.7 pttp . . . . . 0 C--O 1.252 1.223 0 C-N-CA 124.941 1.296 . . . . 0.0 113.702 -150.393 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 t0 . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.29 76.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.575 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -70.62 -41.38 72.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -175.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.25 58.93 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.259 0.936 . . . . 0.0 110.919 174.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -49.77 -59.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.1 t -71.11 -11.99 15.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 119.937 1.244 . . . . 0.0 114.071 -173.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -93.51 0.36 56.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.126 2.17 . . . . 0.0 110.86 174.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -6.59 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -112.25 -49.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.67 1.188 . . . . 0.0 109.947 -177.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -88.73 -37.93 15.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.124 0.569 . . . . 0.0 110.978 -170.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.0 pt -46.89 -36.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.069 0.948 . . . . 0.0 111.317 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 m -37.9 -36.71 0.21 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.326 2.25 . . . . 0.0 112.884 174.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.53 -43.42 2.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.723 . . . . 0.0 111.189 173.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -74.46 -7.12 51.95 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.94 -71.77 0.26 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.088 0.851 . . . . 0.0 113.198 163.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.53 -77.46 0.06 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 5.5 5.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.984 1.313 . . . . 0.0 112.367 169.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 69.09 24.71 6.05 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.507 1.523 . . . . 0.0 110.965 176.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.7 p -70.73 -15.0 62.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.056 1.343 . . . . 0.0 111.153 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 97.79 1.9 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -99.0 -80.21 0.47 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.252 0.621 . . . . 0.0 109.831 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 1.94 55.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.228 1.411 . . . . 0.0 111.705 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.92 54.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 127.295 2.238 . . . . 0.0 105.347 -176.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.59 164.31 29.43 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.91 123.36 17.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.03 -5.49 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.746 170.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -41.28 -46.22 3.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.739 1.154 . . . . 0.0 111.336 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 0.73 54.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.106 0.962 . . . . 0.0 110.927 -172.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.9 -41.61 62.08 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 121.376 -0.827 . . . . 0.0 112.056 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.7 -24.75 8.23 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.629 0.633 . . . . 0.0 114.679 177.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.07 -30.34 31.36 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.815 0.807 . . . . 0.0 111.52 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -89.56 -44.57 10.0 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.857 0.863 . . . . 0.0 110.513 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -126.58 149.86 49.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.106 1.763 . . . . 0.0 107.876 -171.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.3 m -88.05 162.8 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.787 0.435 . . . . 0.0 111.113 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -42.6 -52.41 4.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.554 1.142 . . . . 0.0 110.32 175.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -48.03 -55.59 9.76 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.12 -49.51 76.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.721 0.772 . . . . 0.0 109.96 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.2 mt -64.03 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.3 tp -49.41 -55.78 11.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.114 1.366 . . . . 0.0 110.185 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -44.19 90.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -61.69 -40.76 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.335 -0.853 . . . . 0.0 111.356 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.1 mt -61.03 -47.59 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 120.905 -1.122 . . . . 0.0 109.464 177.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.51 -40.03 88.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.486 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.34 -50.88 5.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.46 1.504 . . . . 0.0 112.318 -169.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.1 -170.83 15.11 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.092 1.806 . . . . 0.0 111.211 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -163.93 116.27 1.4 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 127.056 2.142 . . . . 0.0 105.495 168.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.9 -109.93 0.64 Allowed Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.062 1.301 . . . . 0.0 113.157 172.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -26.18 73.37 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 118.011 0.905 . . . . 0.0 113.061 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.1 ttt -72.74 118.85 71.57 Favored Pre-proline 0 N--CA 1.454 -0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 109.911 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.32 -34.11 28.18 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.594 2.863 . . . . 0.0 112.582 -173.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.48 165.64 40.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -176.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.32 12.65 66.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.754 0.692 . . . . 0.0 112.278 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.78 -34.65 52.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.845 1.658 . . . . 0.0 110.36 177.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.53 149.46 49.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -145.85 155.66 43.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 179.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.68 -136.93 49.15 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -175.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.17 -37.44 4.46 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.795 1.238 . . . . 0.0 112.186 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -54.29 -61.4 2.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.237 1.015 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.91 74.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.725 -0.61 . . . . 0.0 111.145 -175.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.24 -52.86 63.87 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.441 0.564 . . . . 0.0 109.873 175.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.44 -52.47 53.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.98 -62.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 123.176 0.298 . . . . 0.0 110.786 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.97 69.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 111.285 -171.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.97 -53.37 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.317 0.58 . . . . 0.0 110.662 177.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -60.11 -31.31 69.93 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.786 0.834 . . . . 0.0 112.001 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -43.41 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 172.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.39 77.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.067 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.99 -16.41 58.15 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 13.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.877 3.271 . . . . 0.0 114.953 -177.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.095 0 O-C-N 119.981 -1.7 . . . . 0.0 112.88 -151.19 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.47 66.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.561 -169.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.84 -42.14 88.59 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.638 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.45 93.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.543 0.61 . . . . 0.0 109.881 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.03 -60.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.491 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.267 87.1 t -65.19 -43.25 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.726 -168.871 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.72 0.72 0.74 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.354 2.261 . . . . 0.0 114.032 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -138.29 -12.13 1.41 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 172.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -128.42 -20.51 3.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.152 1.381 . . . . 0.0 112.067 -171.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.491 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 18.4 m -110.93 -43.6 3.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.138 0.881 . . . . 0.0 110.671 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -49.42 -29.21 3.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.185 0.594 . . . . 0.0 111.845 176.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -38.06 -43.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.868 1.667 . . . . 0.0 112.007 174.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.7 m -114.11 -41.65 3.48 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 117.888 0.313 . . . . 0.0 110.644 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.78 -16.5 62.75 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.9 25.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.7 -61.51 1.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.581 1.563 . . . . 0.0 113.753 -173.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.24 -5.61 47.67 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.215 1.006 . . . . 0.0 112.419 -177.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mt 69.65 23.68 5.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.085 1.754 . . . . 0.0 111.096 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -78.79 -6.49 56.09 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.552 2.341 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 77.17 1.32 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-N 118.595 0.634 . . . . 0.0 112.064 167.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 -76.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.681 0.392 . . . . 0.0 111.458 177.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -99.52 2.73 45.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.827 1.651 . . . . 0.0 111.552 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.53 162.45 39.17 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.42 166.36 21.9 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.806 1.67 . . . . 0.0 111.299 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.69 122.27 16.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.33 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.311 2.1 pp -117.24 -0.97 8.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.401 173.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 2.8 t0 -34.61 -47.13 0.31 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 112.087 159.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -102.65 6.33 39.57 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.984 1.314 . . . . 0.0 112.765 -175.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.31 57.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.102 0.865 . . . . 0.0 111.691 177.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.88 -32.6 75.42 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 119.84 1.2 . . . . 0.0 113.229 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.49 27.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.9 1.35 . . . . 0.0 110.455 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.41 -39.57 62.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.281 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -123.11 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 128.009 2.524 . . . . 0.0 107.606 -173.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.4 m -135.88 171.28 14.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.835 -1.165 . . . . 0.0 109.999 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -39.37 68.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.107 0.563 . . . . 0.0 110.795 -166.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.55 -53.14 61.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -57.99 -50.35 73.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.935 0.894 . . . . 0.0 109.383 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.41 -49.67 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.91 -57.27 6.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.872 1.269 . . . . 0.0 109.921 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.85 -43.55 94.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.049 -176.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.03 -41.22 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.736 -0.602 . . . . 0.0 111.14 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.3 mt -59.25 -50.57 79.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 O-C-N 120.899 -1.126 . . . . 0.0 109.408 175.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.82 -36.31 83.47 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.651 -177.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.65 -51.62 3.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.158 1.383 . . . . 0.0 112.12 -168.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.34 -171.67 18.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.857 1.694 . . . . 0.0 110.33 -171.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -165.06 127.9 2.24 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.42 -112.18 0.61 Allowed Glycine 0 CA--C 1.538 1.479 0 CA-C-N 120.098 1.317 . . . . 0.0 112.876 176.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.17 -12.68 75.87 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 118.161 0.981 . . . . 0.0 113.996 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.2 ttt -64.34 125.11 87.69 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 118.46 1.13 . . . . 0.0 109.175 178.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.41 -36.55 54.57 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -172.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.2 165.19 31.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.48 27.49 68.01 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.3 -32.26 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.151 0.98 . . . . 0.0 109.373 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.44 46.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.751 1.621 . . . . 0.0 106.755 173.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -145.32 154.64 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.02 -140.57 48.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -40.52 -37.33 0.69 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.709 1.604 . . . . 0.0 112.557 176.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.32 -61.98 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.308 1.043 . . . . 0.0 110.319 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.67 87.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.748 -0.595 . . . . 0.0 110.29 -177.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.23 -48.38 78.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.649 0.78 . . . . 0.0 110.002 178.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.41 82.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.897 176.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.28 -48.95 75.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.707 174.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.63 -55.14 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.162 0.892 . . . . 0.0 110.195 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.02 -58.05 10.13 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.771 0.428 . . . . 0.0 111.475 178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.42 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 54.9 t90 -57.14 -45.68 83.34 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.078 0.951 . . . . 0.0 111.482 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.42 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -70.78 -42.54 70.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.18 -175.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.65 66.86 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.021 -0.424 . . . . 0.0 110.651 169.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -74.04 -14.36 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.681 0.792 . . . . 0.0 112.438 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.417 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -83.99 -15.22 48.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.696 -1.253 . . . . 0.0 113.082 -166.902 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.923 1.289 . . . . 0.0 112.961 -153.716 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.84 -52.27 43.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.537 -167.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.34 -44.76 96.65 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.366 178.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.38 59.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 120.081 1.31 . . . . 0.0 110.849 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -46.99 -62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.48 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 40.2 t -77.78 2.42 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.363 -1.46 . . . . 0.0 113.239 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.28 0.9 38.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.569 2.348 . . . . 0.0 110.063 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -142.35 -13.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -106.93 -55.82 2.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.456 1.503 . . . . 0.0 109.574 -175.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.9 m -82.59 -37.2 25.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.475 0.31 . . . . 0.0 110.663 -171.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.1 pt -48.31 -32.73 3.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 123.383 0.673 . . . . 0.0 111.284 178.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -45.14 -29.52 0.94 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 112.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -127.2 -44.41 1.59 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.439 0.696 . . . . 0.0 111.311 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -71.86 -14.62 62.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.307 -0.87 . . . . 0.0 113.283 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.86 154.95 28.12 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.804 0.716 . . . . 0.0 111.562 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.76 -49.89 8.75 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.215 1.388 . . . . 0.0 113.274 -175.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -84.15 -8.42 59.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.787 0.835 . . . . 0.0 111.857 -176.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt 69.68 21.45 6.56 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.642 1.577 . . . . 0.0 111.181 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -77.66 -8.23 57.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 128.223 2.609 . . . . 0.0 111.431 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.54 87.0 1.74 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.46 -81.16 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.843 0.457 . . . . 0.0 110.524 175.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -90.45 2.01 56.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.343 1.457 . . . . 0.0 112.138 177.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.75 43.55 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.6 166.08 21.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.797 1.665 . . . . 0.0 111.441 -178.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.1 117.59 7.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.281 2.5 pp -112.7 -3.32 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.067 176.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -38.03 -46.49 1.01 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.644 1.111 . . . . 0.0 113.152 163.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -98.15 4.75 49.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.076 1.75 . . . . 0.0 112.116 -177.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.07 -38.58 62.61 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.767 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.35 -27.33 65.39 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.619 1.1 . . . . 0.0 113.463 173.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.38 -48.25 20.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.8 -0.824 . . . . 0.0 109.701 177.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -74.08 -45.21 50.69 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 122.634 0.373 . . . . 0.0 111.684 -174.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -122.55 157.36 32.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.284 1.834 . . . . 0.0 109.265 -169.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -89.11 167.18 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.39 0.614 . . . . 0.0 110.813 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.73 -45.59 49.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.078 0.951 . . . . 0.0 109.858 174.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -54.5 -49.56 69.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.593 0.633 . . . . 0.0 112.521 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.7 -51.22 70.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.697 0.761 . . . . 0.0 109.791 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.54 -50.1 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -174.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -47.14 -58.12 4.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.183 1.393 . . . . 0.0 110.271 172.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.14 -47.69 80.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -175.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.74 -44.31 89.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 122.329 0.252 . . . . 0.0 110.673 -178.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.7 mt -60.97 -50.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 121.79 -0.569 . . . . 0.0 110.045 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.48 -36.43 84.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.778 -178.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.11 -59.3 2.0 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.1 1.76 . . . . 0.0 111.565 -169.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.36 106.79 2.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.45 1.5 . . . . 0.0 110.595 -168.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -55.19 155.29 4.96 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 160.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.78 -61.64 0.73 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.028 1.299 . . . . 0.0 115.469 -175.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.88 17.49 52.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 117.902 0.851 . . . . 0.0 113.386 -177.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.0 ttt -119.41 136.97 24.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.846 1.658 . . . . 0.0 108.396 -176.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.76 -36.91 17.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.104 1.87 . . . . 0.0 112.034 -172.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 163.69 27.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.4 23.52 62.56 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.01 -32.58 58.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 123.57 0.748 . . . . 0.0 109.976 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.49 48.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -144.97 153.21 41.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -137.67 49.51 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.3 -35.99 1.68 Allowed 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 112.352 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.25 -60.37 3.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 110.237 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.01 88.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.556 -0.715 . . . . 0.0 110.52 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.38 -48.33 82.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.307 0.643 . . . . 0.0 110.13 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.59 -49.57 70.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.317 0.647 . . . . 0.0 109.478 175.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.9 t -52.44 -58.77 2.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.2 173.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.73 -55.12 6.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.932 0.893 . . . . 0.0 111.147 -172.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.87 29.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 110.965 178.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.48 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 65.3 t90 -58.99 -41.37 87.46 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.742 0.417 . . . . 0.0 111.515 -175.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 HD21 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -69.05 -46.02 68.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.293 1.037 . . . . 0.0 109.976 -179.622 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.35 59.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.871 0.468 . . . . 0.0 110.931 171.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.42 -17.93 60.72 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.866 1.267 . . . . 0.0 112.536 178.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 2.05 44.16 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.429 -1.419 . . . . 0.0 113.536 -164.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.305 1.442 . . . . 0.0 114.815 -148.444 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -49.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.27 -167.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.39 -39.65 91.47 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.544 178.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.46 96.65 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 120.274 1.397 . . . . 0.0 111.028 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -49.36 -65.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 167.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.97 -48.0 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.488 -167.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -56.58 -6.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.363 3.065 . . . . 0.0 113.268 174.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -132.75 2.22 3.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.992 0.917 . . . . 0.0 113.001 173.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -129.16 -59.85 1.09 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.124 0.97 . . . . 0.0 109.831 -169.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 m -86.9 -40.57 14.72 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.679 0.391 . . . . 0.0 110.284 -171.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.15 -26.78 8.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.77 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -46.73 -37.36 8.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.844 1.258 . . . . 0.0 111.549 176.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.5 m -116.02 -38.96 3.52 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 122.934 0.494 . . . . 0.0 111.301 174.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -76.16 -13.01 60.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.93 151.99 23.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -54.03 5.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.254 1.407 . . . . 0.0 112.902 -177.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 -7.56 58.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.82 1.648 . . . . 0.0 111.971 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt 69.08 21.35 7.35 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.808 1.643 . . . . 0.0 110.948 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 p -79.34 -5.54 54.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.011 2.524 . . . . 0.0 111.537 178.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.44 83.9 1.65 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 118.53 0.605 . . . . 0.0 111.701 167.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.12 -71.17 0.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.746 0.418 . . . . 0.0 110.853 177.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t -100.17 1.74 42.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.623 1.569 . . . . 0.0 110.839 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.23 163.9 29.79 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 126.273 1.829 . . . . 0.0 106.082 -173.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -63.26 160.64 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.633 1.555 . . . . 0.0 111.231 174.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 113.65 3.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.172 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -100.08 -5.86 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.748 173.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -37.89 6.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.839 1.199 . . . . 0.0 112.079 176.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -105.46 4.83 31.04 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.393 1.877 . . . . 0.0 112.371 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.9 -35.18 22.68 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 118.688 0.676 . . . . 0.0 110.882 176.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.11 -30.23 54.03 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.961 0.801 . . . . 0.0 114.588 174.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.51 -45.33 38.81 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 121.633 -0.922 . . . . 0.0 109.845 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -73.78 -38.41 64.66 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 122.869 0.467 . . . . 0.0 111.575 -171.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -135.85 154.23 51.24 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.322 1.849 . . . . 0.0 107.721 -171.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -89.46 168.23 12.37 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.161 -0.337 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.84 -43.39 65.99 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.928 0.491 . . . . 0.0 110.952 -175.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.58 -55.85 12.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.104 1.361 . . . . 0.0 112.713 174.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -53.88 -48.54 69.96 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.46 1.104 . . . . 0.0 109.854 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.48 -50.17 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -50.74 -55.58 15.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.872 1.269 . . . . 0.0 110.008 177.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -45.65 91.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.76 -41.25 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 121.378 -0.826 . . . . 0.0 111.25 -178.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.11 -52.3 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.849 0.75 . . . . 0.0 109.839 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.23 -36.92 84.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -174.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -90.28 -53.05 4.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.271 1.828 . . . . 0.0 111.508 -171.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 111.76 3.61 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -169.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -57.17 154.56 9.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 117.8 0.8 . . . . 0.0 108.846 167.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.59 86.8 0.03 OUTLIER Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.062 -1.024 . . . . 0.0 112.516 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.57 -12.38 4.29 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.161 2.315 . . . . 0.0 112.311 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.0 ttt -116.62 129.21 25.44 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 127.081 2.153 . . . . 0.0 108.783 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.45 136.18 33.14 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.306 1.337 . . . . 0.0 108.699 170.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.02 39.5 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.47 13.5 65.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.919 0.771 . . . . 0.0 112.339 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.45 -30.9 45.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.99 1.316 . . . . 0.0 110.204 175.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.47 148.42 42.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -139.92 156.11 46.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.271 0.941 . . . . 0.0 113.383 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.13 -139.02 41.85 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.42 -37.43 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.744 1.618 . . . . 0.0 112.714 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.53 -62.06 1.9 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.38 1.072 . . . . 0.0 109.675 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.38 82.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.65 -0.656 . . . . 0.0 110.761 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.16 -49.25 77.67 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.262 0.625 . . . . 0.0 109.994 178.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.81 76.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.57 -53.93 14.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.365 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.15 -56.34 8.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.588 0.755 . . . . 0.0 110.777 -174.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -54.49 45.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.497 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 7.6 t90 -60.29 -47.63 85.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.96 0.504 . . . . 0.0 112.151 -175.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -63.61 -43.05 98.02 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.367 -0.833 . . . . 0.0 108.957 -179.701 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.8 -44.02 73.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.315 -0.241 . . . . 0.0 110.866 171.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -73.82 -11.17 60.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.482 1.113 . . . . 0.0 111.927 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.13 60.17 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.028 -1.045 . . . . 0.0 110.277 -177.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.171 -158.982 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.84 -51.72 59.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.617 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.41 -43.73 98.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 118.194 -0.907 . . . . 0.0 109.142 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.18 81.57 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.558 1.072 . . . . 0.0 111.302 -176.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -45.8 -62.63 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.476 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.257 52.1 t -65.11 -40.65 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 118.564 -1.254 . . . . 0.0 113.262 -167.527 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.15 0.37 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.091 3.356 . . . . 0.0 113.196 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -137.37 -12.19 1.61 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -119.38 -25.77 5.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.132 1.373 . . . . 0.0 111.949 -168.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.7 m -114.12 -39.75 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.992 0.814 . . . . 0.0 111.004 -177.233 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -48.41 -32.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 122.545 0.338 . . . . 0.0 111.416 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -44.17 -30.67 0.81 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.222 1.409 . . . . 0.0 113.024 175.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -122.61 -43.98 2.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.689 0.796 . . . . 0.0 110.576 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -71.96 -10.06 59.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.49 -85.0 0.38 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.186 0.898 . . . . 0.0 112.746 163.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.59 -63.54 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -174.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.59 3.26 29.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 111.86 173.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 65.29 25.8 12.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.873 1.669 . . . . 0.0 111.453 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.6 -11.91 60.32 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.034 2.134 . . . . 0.0 111.42 177.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.43 89.44 1.82 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 168.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.18 -77.66 0.45 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.274 0.629 . . . . 0.0 110.616 177.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -92.96 2.34 56.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.071 1.349 . . . . 0.0 111.482 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 158.92 50.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -62.58 162.54 24.14 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.985 1.79 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 126.11 26.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.763 177.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.272 2.7 pp -116.78 -2.29 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.672 171.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -43.7 -45.69 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.499 1.045 . . . . 0.0 112.134 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -94.55 4.23 54.11 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.466 1.106 . . . . 0.0 112.463 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.68 -34.15 37.14 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.572 177.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.72 73.46 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.134 1.334 . . . . 0.0 114.018 173.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.26 -44.83 43.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.503 1.151 . . . . 0.0 110.037 170.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -73.31 -40.95 64.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.509 0.195 . . . . 0.0 111.269 -171.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -131.98 169.21 16.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.973 2.109 . . . . 0.0 107.194 -169.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 m -108.34 167.45 10.02 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.248 0.477 . . . . 0.0 109.764 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -50.57 -42.15 55.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.249 -176.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.3 -50.83 58.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.12 1.327 . . . . 0.0 112.035 177.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -61.87 -52.47 63.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 122.247 1.022 . . . . 0.0 109.252 -176.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.2 mt -62.57 -47.17 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.21 -53.76 32.08 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.929 1.292 . . . . 0.0 110.047 176.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -56.66 -48.22 78.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.31 -45.7 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.367 -0.833 . . . . 0.0 111.251 -178.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.5 mt -59.1 -48.0 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.094 -1.003 . . . . 0.0 109.59 178.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.1 -25.88 62.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.7 0.8 . . . . 0.0 113.104 -177.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.55 -60.29 1.65 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.508 1.523 . . . . 0.0 111.02 -171.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.31 -174.63 21.39 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.648 2.07 . . . . 0.0 109.884 -170.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -152.79 163.58 39.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -1.19 -91.78 0.0 OUTLIER Glycine 0 CA--C 1.543 1.814 0 C-N-CA 126.382 1.944 . . . . 0.0 116.622 175.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.98 12.29 67.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.501 1.151 . . . . 0.0 113.7 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.2 ttt -96.19 120.1 63.25 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.715 1.606 . . . . 0.0 109.023 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.96 -37.31 54.66 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.807 2.338 . . . . 0.0 112.176 -171.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.21 164.62 28.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-O 122.111 0.84 . . . . 0.0 111.743 177.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.51 17.14 61.79 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 122.407 -0.466 . . . . 0.0 112.159 -173.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.76 -31.28 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.441 1.496 . . . . 0.0 109.628 173.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.58 140.31 35.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -139.5 162.79 34.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.22 1.008 . . . . 0.0 111.768 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.73 -138.59 44.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.83 -37.48 2.81 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.98 1.312 . . . . 0.0 112.002 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.26 -58.37 8.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.836 0.454 . . . . 0.0 110.048 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.49 93.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.753 -0.592 . . . . 0.0 110.507 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.16 -54.07 47.94 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.157 0.583 . . . . 0.0 110.03 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.07 -54.44 30.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.377 0.671 . . . . 0.0 109.626 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.37 -66.99 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 123.432 0.458 . . . . 0.0 110.078 176.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.7 -46.78 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.241 0.617 . . . . 0.0 111.455 -170.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -58.72 7.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.367 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.468 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 9.6 t90 -53.14 -43.38 66.94 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.399 0.68 . . . . 0.0 110.793 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.62 -39.4 73.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.998 -1.064 . . . . 0.0 110.657 -175.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.56 72.39 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.889 -0.507 . . . . 0.0 110.978 166.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -16.25 60.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.648 0.779 . . . . 0.0 112.813 179.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -20.14 57.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.822 1.249 . . . . 0.0 111.472 -166.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -156.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.38 -52.66 7.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.495 1.118 . . . . 0.0 113.169 -170.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.27 -39.84 95.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.286 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.94 76.59 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 119.981 1.264 . . . . 0.0 110.381 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.9 t -52.31 -59.94 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.431 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 29.8 t -79.35 3.85 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -171.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -104.96 3.6 30.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.521 1.928 . . . . 0.0 110.465 170.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -128.79 -43.49 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.89 -14.28 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.247 1.419 . . . . 0.0 112.024 -159.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 4.5 m -120.91 -37.47 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.615 1.166 . . . . 0.0 111.026 -170.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 pt -50.97 -30.97 9.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.474 0.71 . . . . 0.0 111.659 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -38.18 -42.4 0.68 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.699 2.0 . . . . 0.0 112.737 173.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.3 m -121.3 -38.39 2.8 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.215 0.606 . . . . 0.0 110.799 -177.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -79.79 -8.05 59.03 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.517 -0.74 . . . . 0.0 112.851 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.61 156.21 19.3 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.16 -58.91 3.62 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.633 1.111 . . . . 0.0 112.534 -176.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.94 -4.52 47.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.622 1.169 . . . . 0.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt 72.0 20.43 4.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.764 1.626 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 p -80.23 -2.79 46.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.822 2.449 . . . . 0.0 112.112 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.18 102.36 1.56 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.916 0.77 . . . . 0.0 111.472 168.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.39 -70.66 0.75 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.924 0.862 . . . . 0.0 110.128 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -99.62 2.69 44.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.464 1.506 . . . . 0.0 111.109 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.84 161.79 44.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -175.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.36 163.4 29.65 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.781 1.654 . . . . 0.0 110.828 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.28 113.62 3.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.591 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.305 2.1 pp -105.2 0.69 10.21 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.009 172.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -41.42 14.57 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.239 -0.913 . . . . 0.0 112.801 170.253 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -97.88 4.99 49.54 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.656 1.183 . . . . 0.0 112.106 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.27 32.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.451 -1.261 . . . . 0.0 112.398 -178.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.73 -32.04 68.85 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 120.893 1.679 . . . . 0.0 113.881 174.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.17 -41.55 57.83 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.407 -1.055 . . . . 0.0 109.83 174.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -73.56 -35.17 65.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.828 -172.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -142.24 152.89 43.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.847 1.659 . . . . 0.0 108.674 -170.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.6 t -80.75 163.81 23.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.823 -0.548 . . . . 0.0 110.621 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.11 -44.92 68.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.24 -0.41 . . . . 0.0 109.951 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.53 -44.55 72.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.372 0.669 . . . . 0.0 112.494 178.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.9 -50.49 70.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.582 0.706 . . . . 0.0 109.833 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.53 -48.3 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 tp -48.38 -56.75 7.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.642 1.577 . . . . 0.0 109.97 175.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -56.54 -48.94 76.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -59.27 -43.73 90.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 122.248 -0.282 . . . . 0.0 110.454 -175.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.46 -50.38 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.525 -0.735 . . . . 0.0 109.559 177.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.23 -35.45 78.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.453 -179.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -102.48 -65.46 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.765 2.026 . . . . 0.0 112.527 -167.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.76 -176.96 22.82 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.952 1.739 . . . . 0.0 111.619 -170.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -157.07 170.44 22.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.875 3.27 . . . . 0.0 103.701 169.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -9.53 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 126.953 2.216 . . . . 0.0 116.343 175.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.88 42.01 2.0 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 118.599 1.199 . . . . 0.0 110.949 171.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.7 tpt -116.55 107.5 46.7 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -177.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.33 -36.22 88.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.499 2.8 . . . . 0.0 112.617 -162.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.17 161.49 17.66 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 122.264 0.924 . . . . 0.0 111.484 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.76 14.31 57.97 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 122.051 -0.676 . . . . 0.0 113.154 -177.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 -32.46 50.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.616 175.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.41 141.49 46.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -139.35 154.08 47.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 107.154 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.68 -139.54 35.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.86 -41.07 1.09 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.205 1.802 . . . . 0.0 112.418 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.17 -55.85 29.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.431 0.692 . . . . 0.0 110.032 178.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.84 78.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -178.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.87 -56.28 19.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.622 0.769 . . . . 0.0 109.879 177.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.53 -53.05 59.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.039 0.936 . . . . 0.0 109.762 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.7 t -48.64 -63.09 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 O-C-N 123.641 0.588 . . . . 0.0 109.805 176.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.55 -55.16 17.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.528 0.731 . . . . 0.0 111.76 -171.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.17 -53.22 60.73 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.467 0.651 . . . . 0.0 110.793 -177.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.579 ' CZ3' HD21 ' A' ' 88' ' ' LEU . 21.8 t90 -54.23 -45.81 72.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.287 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.579 HD21 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -62.97 -45.63 91.52 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.732 -1.23 . . . . 0.0 111.502 -177.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.6 51.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.672 0.789 . . . . 0.0 111.606 172.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.0 -26.91 33.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.241 1.016 . . . . 0.0 112.056 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -32.58 65.57 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.976 1.311 . . . . 0.0 110.91 -165.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 128.512 2.725 . . . . 0.0 112.822 -162.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.17 -53.01 56.78 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.311 -170.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.97 -43.76 97.92 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.446 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.48 76.14 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 119.904 1.229 . . . . 0.0 111.117 -177.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -46.68 -62.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 167.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.44 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.28 73.7 t -70.82 -33.08 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.463 -161.313 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -63.1 -0.78 0.8 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 130.249 3.419 . . . . 0.0 113.315 169.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.24 -22.73 0.91 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 173.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -104.43 -23.75 13.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.29 1.836 . . . . 0.0 110.778 -171.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.3 m -117.57 -40.37 3.05 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.653 0.661 . . . . 0.0 111.781 -174.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 pt -49.74 -31.11 6.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 117.941 0.337 . . . . 0.0 111.397 178.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -37.11 -43.4 0.49 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.313 1.845 . . . . 0.0 111.904 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -114.25 -44.09 3.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.145 0.578 . . . . 0.0 110.853 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -73.67 -14.65 61.19 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.0 152.85 23.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.032 0.833 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.17 -63.46 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.033 1.778 . . . . 0.0 113.895 -173.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.79 -7.89 54.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.144 1.377 . . . . 0.0 112.658 -176.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mt 72.41 25.1 2.82 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.996 2.118 . . . . 0.0 110.672 -178.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -78.65 -6.01 54.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.355 2.662 . . . . 0.0 112.131 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 80.73 1.52 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 118.593 0.633 . . . . 0.0 112.033 168.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.59 -79.41 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.858 0.463 . . . . 0.0 111.135 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -94.78 2.08 55.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.521 1.528 . . . . 0.0 111.833 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.17 162.79 35.9 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 127.577 2.351 . . . . 0.0 104.677 -177.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.96 166.19 19.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.035 1.823 . . . . 0.0 111.656 -178.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.02 114.35 6.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.261 2.2 pp -108.78 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.652 177.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -37.16 -48.31 0.83 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.651 1.114 . . . . 0.0 112.846 165.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -97.71 4.82 49.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.689 1.996 . . . . 0.0 111.545 -174.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.25 -32.74 25.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.08 171.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.67 72.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.665 1.12 . . . . 0.0 114.203 173.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.38 -47.18 18.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.45 1.125 . . . . 0.0 109.865 171.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -74.06 -42.96 59.42 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.938 0.495 . . . . 0.0 111.047 -168.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.26 -179.87 4.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.473 2.309 . . . . 0.0 107.964 -176.257 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m -119.21 170.16 9.33 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.567 0.747 . . . . 0.0 110.219 -178.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -40.8 72.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.556 -174.05 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -53.47 -53.81 46.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.48 1.112 . . . . 0.0 111.714 176.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -59.13 -49.59 77.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.188 0.995 . . . . 0.0 109.33 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.31 -52.24 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.8 tp -48.61 -57.0 6.89 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.081 1.352 . . . . 0.0 109.858 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.95 -41.84 98.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -59.98 -41.82 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 121.586 -0.696 . . . . 0.0 111.283 177.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.39 -50.94 78.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 109.521 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.71 -38.45 91.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.376 -176.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.77 -53.79 4.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.657 1.583 . . . . 0.0 111.903 -171.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.87 110.11 3.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.389 1.471 . . . . 0.0 110.208 -167.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.3 151.61 5.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 157.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.46 -58.52 1.09 Allowed Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.924 1.249 . . . . 0.0 115.477 -172.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.57 12.64 62.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.951 0.876 . . . . 0.0 113.775 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -120.47 132.2 24.21 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 126.12 1.768 . . . . 0.0 107.923 -174.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 -36.83 42.64 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.964 1.776 . . . . 0.0 112.793 -169.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.09 163.21 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.804 0.669 . . . . 0.0 111.691 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.01 17.81 61.51 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.93 -38.17 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.117 1.367 . . . . 0.0 108.961 179.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.38 147.28 48.99 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -141.3 152.23 44.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.486 0.66 . . . . 0.0 111.8 -175.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.5 -142.61 46.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.75 -33.36 1.24 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.83 1.652 . . . . 0.0 112.926 -179.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -53.98 -66.79 0.33 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 109.946 171.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.53 87.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.263 0.625 . . . . 0.0 110.554 -176.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -55.97 -50.17 71.55 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.98 0.512 . . . . 0.0 109.695 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.3 85.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.315 177.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -50.56 -58.16 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.011 173.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.48 -58.71 2.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.868 0.867 . . . . 0.0 111.549 -174.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.06 -54.43 46.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.165 -179.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -56.87 -45.78 82.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 111.07 -177.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -45.61 84.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.296 1.038 . . . . 0.0 109.72 -178.378 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.46 63.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.791 0.436 . . . . 0.0 111.171 171.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.9 -16.75 60.65 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.184 1.393 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 -4.81 58.41 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.842 -1.161 . . . . 0.0 113.203 -167.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.752 1.621 . . . . 0.0 114.059 -157.053 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.91 -49.52 73.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.239 -165.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.35 -41.69 94.18 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.384 177.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.61 -46.9 87.87 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.31 0.959 . . . . 0.0 111.004 -176.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -46.57 -62.27 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.459 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 43.0 t -62.46 -41.96 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.782 -167.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.85 1.44 1.36 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.44 3.096 . . . . 0.0 113.306 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.31 -23.42 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.282 0.946 . . . . 0.0 113.457 168.49 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 25.7 mttt -116.74 -18.79 10.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.757 1.223 . . . . 0.0 112.762 -166.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.5 m -113.31 -43.27 3.37 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.489 1.041 . . . . 0.0 111.246 179.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 pt -51.99 -30.03 12.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -37.05 -40.5 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.016 1.327 . . . . 0.0 113.053 170.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.3 m -115.81 -42.15 3.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.932 0.493 . . . . 0.0 110.623 174.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -70.74 -17.34 62.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.56 -89.22 0.33 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.361 0.981 . . . . 0.0 112.465 165.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.98 -65.36 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.54 2.49 13.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.054 0.942 . . . . 0.0 111.792 170.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mt 71.21 20.45 5.09 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.992 1.317 . . . . 0.0 110.353 177.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -76.48 -8.54 57.38 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.582 2.353 . . . . 0.0 111.722 -177.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.17 74.5 1.08 Allowed Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.446 0.567 . . . . 0.0 111.889 164.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.66 -77.38 0.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.541 0.336 . . . . 0.0 111.427 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 t -96.58 2.39 52.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.025 1.33 . . . . 0.0 111.419 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.34 162.01 39.0 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -176.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.2 164.56 24.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.876 1.717 . . . . 0.0 111.167 179.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.14 114.18 6.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.512 -177.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.291 2.7 pp -106.56 -2.26 9.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.515 173.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -33.23 -48.13 0.22 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.022 1.729 . . . . 0.0 112.51 163.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 4.84 28.74 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.705 2.002 . . . . 0.0 111.274 -171.324 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.25 -37.62 16.58 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.381 -175.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.06 -32.52 59.79 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 119.173 0.897 . . . . 0.0 114.592 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.01 54.74 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.529 -0.983 . . . . 0.0 110.32 174.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.3 -36.03 63.73 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.52 150.45 46.4 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.348 1.459 . . . . 0.0 108.956 -167.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 m -86.79 158.52 19.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.128 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -44.65 60.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.919 0.488 . . . . 0.0 110.79 -174.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -50.62 -48.13 58.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 112.95 174.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.42 -47.49 81.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.699 0.761 . . . . 0.0 109.32 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.2 -49.96 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -47.68 -57.51 5.42 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.9 1.68 . . . . 0.0 110.234 174.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.46 -46.3 83.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -61.44 -42.13 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 122.025 -0.422 . . . . 0.0 110.827 -177.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -58.43 -50.44 78.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.32 -37.82 88.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.699 0.399 . . . . 0.0 111.716 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -96.8 -56.63 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.459 1.504 . . . . 0.0 111.957 -168.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.76 -173.15 21.04 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.911 1.72 . . . . 0.0 110.585 -171.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -165.01 123.5 1.7 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.17 -113.42 1.08 Allowed Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.797 1.181 . . . . 0.0 112.811 175.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.11 -16.63 79.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.208 1.004 . . . . 0.0 113.695 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.4 ttt -65.92 122.21 79.81 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.219 1.009 . . . . 0.0 109.164 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.15 -34.58 56.7 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.985 2.457 . . . . 0.0 111.555 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.92 168.1 36.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 122.604 1.113 . . . . 0.0 111.507 177.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.88 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.142 -178.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -67.54 -32.45 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 127.531 2.333 . . . . 0.0 110.172 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.71 153.09 51.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 172.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 164.17 33.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.183 0.593 . . . . 0.0 112.388 178.231 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.15 -137.86 22.93 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.08 -38.33 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.411 1.484 . . . . 0.0 112.815 178.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 57.6 tt0 -62.09 -58.67 6.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.221 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.92 85.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.735 -0.603 . . . . 0.0 110.744 -177.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -58.1 -52.66 64.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.005 0.922 . . . . 0.0 110.141 174.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.32 -50.21 67.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.81 -55.24 12.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.371 174.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.47 24.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.82 0.736 . . . . 0.0 110.604 -174.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.6 -58.07 9.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.962 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.456 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 2.5 t90 -54.95 -50.75 68.12 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.851 0.461 . . . . 0.0 110.936 -178.223 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.146 -0.971 . . . . 0.0 108.724 -175.046 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.28 -38.99 69.31 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 122.132 -0.355 . . . . 0.0 111.223 172.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -22.0 60.8 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.713 -0.617 . . . . 0.0 111.15 178.016 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.4 9.74 0.74 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.282 2.233 . . . . 0.0 114.637 -172.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.252 1.197 0 O-C-N 120.504 -1.373 . . . . 0.0 112.193 -162.75 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.66 46.25 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -160.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -62.73 -46.23 89.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.58 177.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -41.57 72.63 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 118.744 0.702 . . . . 0.0 110.954 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -50.59 -64.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 167.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.466 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 92.6 t -66.86 -38.45 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 120.761 1.619 . . . . 0.0 112.211 -166.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -59.97 0.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.04 2.936 . . . . 0.0 113.331 170.059 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -125.4 -37.38 2.38 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.764 1.226 . . . . 0.0 112.404 168.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -102.42 -24.06 13.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.421 1.488 . . . . 0.0 111.577 -159.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.3 m -120.43 -40.59 2.67 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.289 0.636 . . . . 0.0 111.172 -169.063 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -49.68 -30.84 5.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 122.283 0.233 . . . . 0.0 111.462 178.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -34.73 -41.48 0.13 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.367 2.267 . . . . 0.0 113.164 170.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 m -119.91 -36.33 3.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.445 0.698 . . . . 0.0 111.118 176.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -80.84 -2.54 47.74 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.89 -85.52 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 123.811 0.72 . . . . 0.0 112.464 164.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.68 -66.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -173.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.11 2.21 24.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.312 -0.522 . . . . 0.0 111.733 173.33 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 70.1 22.25 5.73 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.393 1.877 . . . . 0.0 111.389 -172.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -5.56 37.75 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.994 2.118 . . . . 0.0 112.063 173.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.44 147.03 21.91 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 174.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.76 -82.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.913 0.885 . . . . 0.0 109.992 174.091 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 m -92.13 -0.15 57.45 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.021 0.928 . . . . 0.0 111.047 171.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.33 157.18 63.53 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 105.635 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.33 167.06 19.46 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.688 2.258 . . . . 0.0 111.645 -175.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 113.56 3.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.028 175.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp -108.02 -1.89 9.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.411 172.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -34.95 -50.45 0.48 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.285 1.434 . . . . 0.0 111.648 162.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -92.37 0.9 57.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.075 1.35 . . . . 0.0 110.74 -171.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.3 70.63 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.032 -1.043 . . . . 0.0 111.777 -174.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.12 -32.58 76.48 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 119.818 1.19 . . . . 0.0 112.557 174.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.34 -38.05 36.06 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.305 -1.115 . . . . 0.0 111.607 175.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -74.2 -38.94 63.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.307 0.503 . . . . 0.0 111.81 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -133.63 170.86 14.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.973 1.709 . . . . 0.0 108.292 -167.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.3 t -105.86 169.38 8.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.068 0.547 . . . . 0.0 110.38 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -51.39 64.55 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.137 0.575 . . . . 0.0 109.778 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -42.94 -55.79 3.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.678 1.591 . . . . 0.0 113.165 173.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -56.72 -52.25 65.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.04 0.936 . . . . 0.0 109.844 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.01 -48.35 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -173.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.7 tp -49.9 -56.04 12.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.448 1.899 . . . . 0.0 109.997 175.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.56 -47.82 81.03 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -58.83 -42.5 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 122.111 -0.368 . . . . 0.0 110.451 -177.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.45 -50.03 82.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 121.26 -0.9 . . . . 0.0 109.764 176.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.76 -32.66 74.23 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.027 0.531 . . . . 0.0 112.193 -178.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -103.39 -59.19 1.75 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.043 1.737 . . . . 0.0 112.01 -168.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.47 -175.61 21.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.207 1.861 . . . . 0.0 110.74 -173.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -150.64 164.63 35.62 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 166.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 3.14 -94.88 0.01 OUTLIER Glycine 0 CA--C 1.541 1.682 0 C-N-CA 126.887 2.184 . . . . 0.0 116.403 173.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.92 26.01 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 118.494 1.147 . . . . 0.0 112.928 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -104.05 121.11 48.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.952 1.701 . . . . 0.0 108.178 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.65 -36.5 63.4 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.088 2.525 . . . . 0.0 112.545 -169.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.81 165.71 34.03 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 122.158 0.866 . . . . 0.0 111.694 178.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.97 25.48 67.97 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -173.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.08 -26.72 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.079 1.351 . . . . 0.0 110.182 -177.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.54 146.68 32.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -139.07 164.16 30.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.24 0.927 . . . . 0.0 111.338 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.91 -134.66 16.53 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.366 0.984 . . . . 0.0 110.658 -175.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.21 -38.48 3.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.958 1.303 . . . . 0.0 112.26 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.79 -54.24 47.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.2 86.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.649 -0.657 . . . . 0.0 111.138 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.43 -52.73 62.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.295 0.638 . . . . 0.0 110.113 177.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.65 -52.9 53.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.867 0.867 . . . . 0.0 109.833 178.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.4 t -50.19 -63.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 123.341 0.4 . . . . 0.0 110.226 174.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.96 -49.69 49.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.86 0.864 . . . . 0.0 110.978 -171.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.87 -59.8 4.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 177.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.451 ' CZ3' HD21 ' A' ' 88' ' ' LEU . 47.0 t90 -55.93 -35.7 66.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.058 0.943 . . . . 0.0 112.085 -177.384 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.451 HD21 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.41 -44.73 50.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.39 -0.819 . . . . 0.0 110.554 178.3 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.89 -22.37 66.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.604 -0.685 . . . . 0.0 112.169 174.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.48 -26.93 58.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.187 1.395 . . . . 0.0 111.652 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -9.87 56.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -149.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.4 pttt . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.933 -1.032 . . . . 0.0 113.016 -107.281 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -55.56 9.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.587 -170.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.15 -41.34 83.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.204 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.78 81.96 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.151 0.887 . . . . 0.0 110.499 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.62 -58.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 168.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 2.0 t -68.85 -39.48 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 116.898 -1.921 . . . . 0.0 110.406 -165.348 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -62.31 -0.2 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.971 3.308 . . . . 0.0 114.079 170.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.93 -11.54 0.98 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 171.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.04 -18.47 11.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.888 1.275 . . . . 0.0 111.022 -176.169 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.3 m -127.25 -46.15 1.51 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.602 0.637 . . . . 0.0 111.762 -167.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.6 pt -53.91 -24.66 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -49.24 -27.38 3.66 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.911 0.884 . . . . 0.0 112.301 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.13 -42.77 3.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.212 0.605 . . . . 0.0 110.868 167.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.86 -9.95 58.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.28 -88.36 0.4 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.18 1.371 . . . . 0.0 112.564 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.82 -60.49 0.02 OUTLIER Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -176.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.9 4.0 39.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.713 0.805 . . . . 0.0 111.735 172.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt 74.85 20.86 2.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.134 179.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -76.49 -12.46 60.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.401 2.68 . . . . 0.0 111.321 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.32 83.4 1.71 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 169.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.1 -76.87 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.935 0.494 . . . . 0.0 110.663 177.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -94.62 2.06 55.61 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.405 1.082 . . . . 0.0 111.408 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.98 38.02 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 127.5 2.32 . . . . 0.0 105.414 -176.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.68 164.47 26.49 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.03 1.82 . . . . 0.0 111.68 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.18 13.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.959 0.904 . . . . 0.0 109.717 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.291 2.5 pp -112.1 -3.03 10.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 173.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -32.97 9.37 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.123 -0.985 . . . . 0.0 112.295 165.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.0 3.12 38.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.337 1.055 . . . . 0.0 112.629 177.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.33 -38.2 68.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 117.402 -1.285 . . . . 0.0 111.094 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.58 -26.69 60.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.841 1.655 . . . . 0.0 114.328 174.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.47 -47.08 16.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.958 0.879 . . . . 0.0 109.878 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -74.66 -44.82 48.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 122.501 0.32 . . . . 0.0 111.854 -173.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -123.3 157.2 33.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.658 1.983 . . . . 0.0 109.504 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -89.46 163.89 15.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 0.0 110.964 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -44.17 68.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.895 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -49.64 -53.12 26.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.861 1.665 . . . . 0.0 112.169 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.9 -48.91 79.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.491 0.717 . . . . 0.0 109.834 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.33 -52.24 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -48.9 -56.26 9.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.509 1.524 . . . . 0.0 110.076 177.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.14 -46.59 85.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -59.78 -38.86 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.904 -0.498 . . . . 0.0 111.387 -179.037 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -51.84 66.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 119.469 1.032 . . . . 0.0 109.755 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.15 -33.4 75.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.433 -175.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.7 -43.39 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.21 1.804 . . . . 0.0 112.238 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.07 111.4 2.65 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.163 1.363 . . . . 0.0 110.133 -169.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -55.19 145.88 20.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 161.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -13.48 -74.73 0.01 OUTLIER Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.902 2.191 . . . . 0.0 117.235 -175.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 -12.42 73.8 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.804 0.802 . . . . 0.0 113.775 -175.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.5 ttt -88.14 135.65 32.96 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 126.16 1.784 . . . . 0.0 109.518 -175.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.0 157.95 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.41 1.407 . . . . 0.0 110.959 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.89 146.99 18.67 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -175.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.32 71.7 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.5 mt -55.59 -35.42 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.549 1.14 . . . . 0.0 109.366 172.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.65 152.29 46.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -143.15 162.61 35.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.977 0.808 . . . . 0.0 111.413 177.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.91 -136.34 41.76 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.38 -36.26 4.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.582 1.153 . . . . 0.0 112.064 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.52 -55.79 24.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.17 85.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.553 -0.717 . . . . 0.0 110.408 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.66 -47.75 81.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.128 0.571 . . . . 0.0 110.998 177.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.82 62.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.16 -57.38 8.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.937 173.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.36 -55.99 5.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.12 0.873 . . . . 0.0 110.644 -175.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.04 -54.0 52.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.89 0.476 . . . . 0.0 111.306 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.435 ' CZ3' ' CG2' ' A' ' 28' ' ' VAL . 57.3 t90 -62.3 -54.7 36.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.286 -176.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -40.54 79.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.872 -1.143 . . . . 0.0 110.083 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.15 -50.37 71.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.782 0.264 . . . . 0.0 111.028 170.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.28 -8.88 57.72 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.808 0.731 . . . . 0.0 112.264 -177.005 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -16.76 64.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.652 1.181 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.789 1.236 . . . . 0.0 113.055 -162.987 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -68.81 105.51 2.36 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.7 -46.77 81.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.607 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.2 -44.33 84.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -49.19 75.52 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 119.089 0.858 . . . . 0.0 111.436 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.7 t -49.03 -55.82 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.481 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.278 94.6 t -66.02 -43.18 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.512 -169.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.37 1.33 0.35 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.455 3.102 . . . . 0.0 114.115 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.73 -8.13 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -116.02 -26.01 7.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.853 1.261 . . . . 0.0 110.606 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -114.35 -42.06 3.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.489 0.586 . . . . 0.0 111.199 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -49.66 -30.91 5.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 111.563 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.1 m -39.4 -38.52 0.56 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.57 1.548 . . . . 0.0 112.968 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.67 -43.95 2.77 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.758 0.423 . . . . 0.0 110.603 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -68.04 -17.24 64.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.82 155.45 31.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.13 -56.21 5.4 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.826 1.203 . . . . 0.0 113.97 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.61 0.33 43.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.254 0.621 . . . . 0.0 112.416 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 62.58 27.73 16.35 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.962 1.305 . . . . 0.0 110.932 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 p -78.56 -8.81 58.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 128.778 2.831 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.84 76.75 1.23 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 118.293 0.497 . . . . 0.0 111.991 165.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.49 -85.31 0.1 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.897 0.479 . . . . 0.0 111.441 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.9 m -89.05 2.39 54.13 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 112.157 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.61 162.64 38.06 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.48 164.94 28.88 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.231 1.954 . . . . 0.0 111.128 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.93 119.31 10.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.389 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.77 -0.61 9.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.132 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -31.28 45.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.382 1.446 . . . . 0.0 112.147 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.93 5.97 36.0 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.016 1.726 . . . . 0.0 112.552 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.37 -31.15 54.03 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.318 -1.489 . . . . 0.0 111.754 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.73 -27.61 68.61 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 120.324 1.42 . . . . 0.0 114.423 171.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.48 34.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.886 . . . . 0.0 109.03 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -73.86 -45.82 48.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.36 162.17 26.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.523 1.929 . . . . 0.0 109.262 -170.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 m -93.99 162.09 14.03 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.429 0.692 . . . . 0.0 110.331 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -50.56 -41.96 54.82 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.141 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.49 -58.24 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.099 0.863 . . . . 0.0 112.336 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.93 -51.1 67.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 110.085 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.1 mt -64.61 -48.04 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -50.41 -55.42 15.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.47 1.908 . . . . 0.0 109.872 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -45.76 86.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.77 -41.77 86.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.085 -1.009 . . . . 0.0 111.269 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 mt -60.75 -47.72 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.046 -1.034 . . . . 0.0 109.544 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.275 0.63 . . . . 0.0 111.954 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -97.64 -54.26 3.18 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 111.636 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.75 -169.63 19.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.317 1.913 . . . . 0.0 110.301 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -170.59 122.16 0.61 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 127.431 2.293 . . . . 0.0 105.109 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.19 -113.83 1.03 Allowed Glycine 0 CA--C 1.538 1.52 0 CA-C-N 120.146 1.339 . . . . 0.0 113.027 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.52 -14.65 82.23 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 118.235 1.018 . . . . 0.0 114.069 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -66.82 129.96 94.02 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.193 0.997 . . . . 0.0 109.966 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -65.19 -40.01 21.28 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.08 2.52 . . . . 0.0 111.77 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.69 162.7 28.04 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.007 0.782 . . . . 0.0 111.774 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 17.65 66.27 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.737 0.684 . . . . 0.0 112.158 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 mm -61.16 -33.38 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.61 1.964 . . . . 0.0 110.391 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.75 144.34 47.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 157.99 43.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.437 0.695 . . . . 0.0 111.392 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.01 -137.34 32.65 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.08 -40.08 6.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.405 1.082 . . . . 0.0 112.726 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.0 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.531 0.605 . . . . 0.0 110.178 173.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.77 83.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.965 -0.46 . . . . 0.0 111.155 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.57 -55.15 38.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.411 0.684 . . . . 0.0 109.317 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.59 72.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.66 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.8 t -45.34 -66.94 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.79 70.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 111.601 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.38 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 110.769 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.505 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 7.2 t90 -55.14 -43.16 73.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.096 0.558 . . . . 0.0 110.755 176.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.505 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.55 -49.76 75.37 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.508 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.93 -40.64 63.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.451 0.7 . . . . 0.0 110.667 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -73.91 -18.66 60.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.96 0.904 . . . . 0.0 112.331 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -13.12 61.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.776 1.23 . . . . 0.0 111.482 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 pttt . . . . . 0 C--O 1.247 0.93 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -157.55 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -97.28 113.37 24.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -138.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.37 -53.23 23.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -156.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.63 -43.29 99.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.491 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.35 79.67 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.918 0.887 . . . . 0.0 110.983 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -51.43 -63.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 67.6 t -64.68 -40.43 89.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 121.066 -1.021 . . . . 0.0 112.498 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -61.23 0.76 0.23 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.808 2.843 . . . . 0.0 113.468 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.75 -25.6 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 165.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -104.5 -28.36 11.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.663 1.185 . . . . 0.0 111.452 -165.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -120.2 -39.79 2.77 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.248 0.619 . . . . 0.0 111.579 -167.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -48.62 -31.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 122.634 0.374 . . . . 0.0 111.143 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -36.75 -41.97 0.35 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.542 2.337 . . . . 0.0 113.38 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.9 -42.9 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.101 0.561 . . . . 0.0 110.649 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.84 -17.64 62.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.15 152.4 28.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.9 -53.91 7.12 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.037 1.303 . . . . 0.0 113.567 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.25 1.42 50.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.772 0.829 . . . . 0.0 112.056 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mt 66.28 25.16 10.56 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.895 0.878 . . . . 0.0 110.961 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -84.61 -4.41 58.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.969 2.908 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.63 77.12 1.32 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.399 0.545 . . . . 0.0 112.248 164.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.96 -78.43 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.067 0.434 . . . . 0.0 111.356 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -97.74 1.75 48.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.731 1.612 . . . . 0.0 111.965 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.92 162.7 39.65 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.54 164.75 31.69 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.839 1.692 . . . . 0.0 111.608 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.54 114.68 5.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.112 0.965 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 pp -102.52 -0.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 122.771 0.428 . . . . 0.0 111.845 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.06 -42.52 1.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.98 0.912 . . . . 0.0 111.986 162.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -99.81 5.09 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.058 1.343 . . . . 0.0 113.032 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.58 -42.65 34.42 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.634 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.72 68.28 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.604 1.093 . . . . 0.0 114.664 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.41 -47.66 26.35 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.12 0.96 . . . . 0.0 109.255 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.55 -39.3 62.39 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.236 0.615 . . . . 0.0 111.327 -170.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.74 161.58 34.3 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.02 2.128 . . . . 0.0 108.04 -171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -99.6 156.51 17.03 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.062 0.945 . . . . 0.0 110.378 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.26 -51.1 6.37 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.893 0.877 . . . . 0.0 111.316 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -40.87 -52.77 3.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.753 1.621 . . . . 0.0 113.839 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.09 -47.89 75.63 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.355 -0.841 . . . . 0.0 109.842 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.5 mt -61.77 -48.34 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -48.84 -56.28 9.18 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 126.748 2.019 . . . . 0.0 109.946 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.16 -48.29 76.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.7 mt -59.95 -42.24 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 122.028 -0.42 . . . . 0.0 110.749 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.39 -50.97 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.94 -36.86 85.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.962 0.505 . . . . 0.0 111.838 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -96.82 -58.39 2.05 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.572 1.549 . . . . 0.0 111.36 -169.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.29 -176.74 20.11 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.377 1.941 . . . . 0.0 110.354 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -145.33 163.21 35.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 103.298 -2.853 . . . . 0.0 103.298 166.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -23.63 -77.47 0.01 OUTLIER Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.704 1.621 . . . . 0.0 115.676 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 32.2 6.39 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.5 1.15 . . . . 0.0 113.506 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -124.32 124.72 25.78 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.197 1.399 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.97 -38.73 55.8 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.866 2.378 . . . . 0.0 113.173 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.45 163.33 32.85 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 121.802 0.668 . . . . 0.0 112.237 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.48 66.9 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mt -69.13 -29.07 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.177 1.391 . . . . 0.0 110.139 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.24 41.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -140.51 152.18 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.665 1.121 . . . . 0.0 113.267 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.06 -137.16 50.63 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.47 -38.68 4.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.236 1.414 . . . . 0.0 112.031 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -54.74 -57.37 11.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.826 1.25 . . . . 0.0 109.859 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.28 87.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 110.649 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.46 -53.36 55.21 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.332 0.653 . . . . 0.0 109.849 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.98 -55.12 25.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.99 0.916 . . . . 0.0 109.848 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.7 t -51.07 -54.41 10.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 122.922 0.139 . . . . 0.0 110.971 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.3 -52.34 65.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.092 0.557 . . . . 0.0 110.777 -172.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.23 -54.3 38.13 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.55 0.69 . . . . 0.0 109.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 51.6 t90 -57.6 -40.72 79.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.485 0.714 . . . . 0.0 112.14 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP 0.305 3.7 mt -68.05 -39.66 82.96 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.618 -1.301 . . . . 0.0 112.887 175.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.12 72.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.307 0.503 . . . . 0.0 111.108 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -73.24 -28.84 62.37 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.316 1.046 . . . . 0.0 111.211 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -20.72 66.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.548 1.139 . . . . 0.0 113.68 -169.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 pttt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -151.267 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 103.101 -2.926 . . . . 0.0 103.101 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.13 110.62 4.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.35 86.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.613 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.61 -43.31 73.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 -49.59 68.54 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.002 0.819 . . . . 0.0 111.246 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -47.99 -59.15 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.476 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.261 87.8 t -68.93 -38.47 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.37 -166.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.04 0.19 0.25 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 129.186 2.994 . . . . 0.0 113.947 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 -13.48 1.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.1 -26.63 8.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.93 1.292 . . . . 0.0 110.817 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.8 m -115.01 -40.72 3.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.706 0.684 . . . . 0.0 111.976 -172.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.6 pt -49.34 -30.14 4.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 122.619 0.368 . . . . 0.0 111.706 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.9 t -38.66 -42.24 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.067 1.747 . . . . 0.0 111.653 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -116.2 -42.65 3.02 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.267 0.627 . . . . 0.0 111.002 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -71.71 -13.21 61.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.24 153.0 21.71 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.01 -60.52 2.21 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.281 1.419 . . . . 0.0 113.53 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.55 -2.28 34.82 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.577 0.751 . . . . 0.0 112.571 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt 66.84 26.53 9.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.23 1.812 . . . . 0.0 111.007 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -79.29 -7.99 58.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.701 2.8 . . . . 0.0 111.563 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.86 83.62 1.69 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 168.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.68 -84.09 0.18 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.011 0.524 . . . . 0.0 110.549 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -88.97 2.1 54.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.263 1.425 . . . . 0.0 111.89 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.79 41.32 Favored Pre-proline 0 N--CA 1.452 -0.36 0 C-N-CA 126.925 2.09 . . . . 0.0 105.413 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.47 164.37 23.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.922 1.748 . . . . 0.0 111.007 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.59 122.88 18.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.296 1.9 pp -119.42 0.5 7.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.968 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -41.41 -43.95 2.7 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.783 1.174 . . . . 0.0 112.133 164.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -101.92 6.17 41.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.429 1.892 . . . . 0.0 112.12 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -33.02 42.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.02 -0.991 . . . . 0.0 111.552 172.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.1 -31.98 78.73 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.768 1.622 . . . . 0.0 113.647 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.0 -49.42 37.15 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.147 0.974 . . . . 0.0 109.746 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.79 -42.22 50.67 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.324 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -118.37 179.76 4.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.889 1.676 . . . . 0.0 107.639 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.2 m -120.14 163.37 17.81 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.577 -0.702 . . . . 0.0 109.987 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -52.51 19.45 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.471 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -35.69 -61.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.719 1.208 . . . . 0.0 113.421 168.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -55.77 30.81 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 121.855 0.835 . . . . 0.0 109.769 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.12 -47.06 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.9 -53.81 29.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.976 1.71 . . . . 0.0 109.99 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.11 -49.8 68.31 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.42 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.461 -0.775 . . . . 0.0 110.88 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.65 -49.11 84.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 120.813 -1.179 . . . . 0.0 109.638 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.3 -37.19 82.99 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.743 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -94.9 -58.15 2.25 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.211 1.404 . . . . 0.0 111.458 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.5 -171.03 21.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.177 2.322 . . . . 0.0 109.675 -168.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -156.73 163.73 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.48 -90.05 0.0 OUTLIER Glycine 0 CA--C 1.544 1.863 0 C-N-CA 126.27 1.89 . . . . 0.0 116.57 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.66 13.83 66.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.859 1.329 . . . . 0.0 114.202 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.6 ttt -99.12 126.14 39.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.547 . . . . 0.0 109.073 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.63 -40.65 22.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.698 2.266 . . . . 0.0 112.348 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.27 163.71 31.26 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.716 0.62 . . . . 0.0 112.161 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.44 20.11 65.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mt -66.97 -32.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 125.426 1.49 . . . . 0.0 109.619 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.02 146.49 47.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -146.73 162.83 37.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.2 -139.78 40.63 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.09 -38.56 1.06 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.546 1.539 . . . . 0.0 112.467 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -55.54 -61.09 2.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.405 1.082 . . . . 0.0 110.015 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.69 -38.01 80.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.699 -0.626 . . . . 0.0 110.788 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -55.49 -54.29 45.73 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.38 62.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.58 0.752 . . . . 0.0 109.663 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -46.82 -66.03 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 O-C-N 123.363 0.414 . . . . 0.0 110.256 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.24 -47.43 75.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.063 0.945 . . . . 0.0 110.616 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -56.31 23.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.385 0.274 . . . . 0.0 110.373 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.453 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 45.5 t90 -55.31 -43.04 74.5 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.568 0.747 . . . . 0.0 110.946 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -64.04 -51.48 63.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.679 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.25 68.28 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.035 0.534 . . . . 0.0 110.959 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.79 -20.5 61.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.244 0.618 . . . . 0.0 110.764 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.155 -0.966 . . . . 0.0 111.121 -165.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.788 2.435 . . . . 0.0 114.081 -151.575 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.34 102.72 2.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.27 1.428 . . . . 0.0 107.526 -164.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.42 -52.17 40.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.019 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -60.53 -40.75 92.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.815 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.79 -44.61 90.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.023 0.829 . . . . 0.0 110.659 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.5 -60.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.258 17.3 t -65.01 -41.16 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 116.462 -2.095 . . . . 0.0 111.968 -168.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -61.29 0.4 0.28 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.074 2.95 . . . . 0.0 114.28 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.81 -13.43 0.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -114.65 -21.38 10.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.434 1.494 . . . . 0.0 111.427 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.6 m -123.26 -40.13 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.377 0.535 . . . . 0.0 111.183 -168.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -48.59 -30.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 122.96 0.504 . . . . 0.0 111.746 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 m -40.82 -37.06 0.71 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.089 1.755 . . . . 0.0 112.885 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 m -119.66 -43.5 2.58 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 122.859 0.464 . . . . 0.0 110.739 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.4 -14.9 62.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.05 153.4 25.84 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.09 4.55 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.224 1.393 . . . . 0.0 113.564 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.52 -0.27 41.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.06 0.544 . . . . 0.0 112.136 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mt 64.71 25.85 13.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.59 1.556 . . . . 0.0 111.003 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -81.38 -8.31 59.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 128.901 2.88 . . . . 0.0 111.407 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.52 79.27 1.45 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 118.332 0.515 . . . . 0.0 112.21 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.57 -81.74 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.708 0.403 . . . . 0.0 111.226 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -91.64 1.97 56.78 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.548 1.539 . . . . 0.0 112.015 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.15 162.03 45.08 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.96 164.15 25.82 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.845 1.697 . . . . 0.0 111.088 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.47 122.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.323 2.4 pp -116.5 1.07 8.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.877 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -35.26 18.74 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.143 1.338 . . . . 0.0 112.344 168.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -99.16 4.31 46.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.172 1.389 . . . . 0.0 112.309 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -33.05 52.95 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 120.92 -1.113 . . . . 0.0 111.168 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.95 -31.15 79.62 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.45 1.023 . . . . 0.0 114.41 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -43.9 38.09 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.818 -0.813 . . . . 0.0 110.076 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -74.16 -39.92 62.93 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.678 0.391 . . . . 0.0 111.538 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -131.6 156.35 45.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.114 1.766 . . . . 0.0 108.054 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -92.88 162.56 14.04 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.753 -0.592 . . . . 0.0 110.506 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -46.56 -46.59 19.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.224 0.609 . . . . 0.0 110.772 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.39 -57.38 4.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.822 1.249 . . . . 0.0 112.899 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 -50.94 71.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.046 0.927 . . . . 0.0 110.073 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.9 mt -63.42 -47.26 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.1 tp -50.29 -54.89 18.08 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.745 1.618 . . . . 0.0 109.988 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.14 -49.8 70.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.29 -43.23 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.568 -0.708 . . . . 0.0 111.082 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.7 mt -60.88 -51.05 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.03 -29.9 69.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.551 0.741 . . . . 0.0 112.542 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.5 -60.17 1.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.27 1.828 . . . . 0.0 111.268 -170.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.23 -173.18 21.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.558 2.028 . . . . 0.0 110.655 -168.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -152.62 161.04 43.11 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 102.741 -3.059 . . . . 0.0 102.741 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.32 -71.09 0.07 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 120.489 1.495 . . . . 0.0 115.427 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.47 23.37 28.14 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 118.058 0.929 . . . . 0.0 113.763 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -117.94 131.97 23.9 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.075 1.35 . . . . 0.0 109.34 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.26 -40.72 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.661 2.241 . . . . 0.0 112.187 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.22 157.57 17.99 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 121.699 0.611 . . . . 0.0 112.426 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 17.84 61.39 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mm -58.76 -37.2 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.529 1.132 . . . . 0.0 109.587 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.82 146.35 52.24 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -144.22 154.6 43.28 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.67 -139.21 48.1 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.6 -37.16 5.29 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.017 1.327 . . . . 0.0 111.738 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -53.74 -60.99 2.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.478 1.111 . . . . 0.0 110.061 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.35 79.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.814 -0.554 . . . . 0.0 110.667 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.94 -52.92 63.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.02 0.438 . . . . 0.0 109.913 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.03 -52.52 60.59 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.829 0.851 . . . . 0.0 109.607 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -48.24 -65.2 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 119.172 -0.442 . . . . 0.0 109.87 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.05 -49.93 49.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.429 1.091 . . . . 0.0 111.453 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.65 -57.08 14.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.999 0.428 . . . . 0.0 110.566 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 68.7 t90 -56.36 -34.47 66.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.569 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.74 -43.85 52.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.16 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.13 -32.74 66.66 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.74 -0.6 . . . . 0.0 111.008 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.09 -23.14 59.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.079 0.952 . . . . 0.0 111.924 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.51 4.09 0.42 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.519 2.328 . . . . 0.0 115.671 -165.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.103 0 O-C-N 119.993 -1.692 . . . . 0.0 113.457 -125.594 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.61 97.71 0.82 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 123.024 1.392 . . . . 0.0 107.727 -163.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.22 82.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.744 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -56.89 -45.32 82.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.942 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.58 96.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.687 0.676 . . . . 0.0 110.681 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -51.48 -65.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.1 -42.03 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 120.088 1.313 . . . . 0.0 110.793 -165.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -1.44 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.59 2.756 . . . . 0.0 113.261 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.78 0.96 2.05 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 169.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.01 -54.61 1.61 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.319 1.048 . . . . 0.0 109.986 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 m -90.0 -41.82 11.5 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.769 0.428 . . . . 0.0 110.248 -169.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 pt -52.74 -27.21 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.038 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -47.51 -29.33 2.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.923 1.289 . . . . 0.0 112.363 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 m -122.9 -41.58 2.34 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.542 0.61 . . . . 0.0 110.864 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -70.7 -17.35 62.83 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.81 150.15 18.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.46 -59.88 1.5 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.703 1.62 . . . . 0.0 113.969 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.01 -15.42 61.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.767 1.227 . . . . 0.0 112.77 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt 77.06 23.87 0.9 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.704 2.402 . . . . 0.0 111.098 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 p -75.73 -9.17 58.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 111.961 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.19 81.07 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.671 . . . . 0.0 111.797 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.66 -78.92 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.797 0.439 . . . . 0.0 111.1 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -93.98 2.6 56.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.609 1.563 . . . . 0.0 111.502 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.36 163.05 34.25 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.97 165.48 21.35 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.792 1.661 . . . . 0.0 111.189 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 119.7 11.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.319 2.1 pp -115.65 1.3 8.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.734 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.52 -40.31 18.39 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.519 1.054 . . . . 0.0 111.606 167.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -93.12 2.8 56.55 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 125.699 1.599 . . . . 0.0 111.315 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.13 -34.92 66.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.184 0.902 . . . . 0.0 111.183 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.47 -31.75 78.62 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.479 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.42 -46.23 28.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.514 1.157 . . . . 0.0 110.455 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -74.37 -40.67 61.95 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 111.264 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -124.91 -177.94 4.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.52 2.328 . . . . 0.0 107.893 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -122.92 169.47 11.11 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.607 -0.683 . . . . 0.0 110.32 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -42.73 67.29 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.436 0.694 . . . . 0.0 110.374 -171.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.12 -56.26 13.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 112.913 175.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -56.55 -49.35 75.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.185 1.394 . . . . 0.0 109.176 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.89 -51.22 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.75 -56.15 11.32 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.253 1.021 . . . . 0.0 109.912 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.67 -41.12 97.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.705 -0.798 . . . . 0.0 108.904 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.8 mt -62.72 -39.98 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.817 -0.552 . . . . 0.0 111.325 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.47 -51.09 76.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 O-C-N 120.719 -1.238 . . . . 0.0 109.571 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.87 -42.1 99.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -91.82 -50.6 5.64 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 112.323 -168.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.33 -167.66 14.84 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.976 1.75 . . . . 0.0 110.112 -168.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -169.37 131.02 1.14 Allowed 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.13 -112.38 0.5 Allowed Glycine 0 CA--C 1.539 1.559 0 CA-C-N 120.486 1.494 . . . . 0.0 113.078 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 -10.31 76.11 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.363 1.082 . . . . 0.0 114.263 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.5 ttt -64.46 126.43 90.58 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 118.549 1.175 . . . . 0.0 109.405 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.88 -34.82 37.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.007 2.471 . . . . 0.0 112.621 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.57 164.32 36.4 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.55 19.4 68.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.667 0.651 . . . . 0.0 112.077 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.09 -29.77 48.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.698 1.199 . . . . 0.0 110.445 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.61 153.21 42.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -146.87 162.12 39.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.39 -138.53 45.91 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.1 -6.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.176 1.791 . . . . 0.0 114.909 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.59 -67.19 0.79 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.243 1.817 . . . . 0.0 108.223 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.44 90.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.454 -0.779 . . . . 0.0 111.004 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.23 -48.58 76.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.66 91.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.694 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.1 t -53.05 -49.45 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.47 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.59 -56.58 6.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.096 0.862 . . . . 0.0 110.391 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.87 -55.67 30.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.745 0.418 . . . . 0.0 111.611 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -58.05 -49.9 75.3 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.023 0.916 . . . . 0.0 111.351 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -43.27 95.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.182 0.993 . . . . 0.0 109.6 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.71 -41.81 67.4 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 170.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.99 -13.61 60.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.035 0.934 . . . . 0.0 112.459 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -15.56 56.33 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.704 -1.247 . . . . 0.0 113.242 -169.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.596 1.158 . . . . 0.0 113.765 -150.146 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.56 1.41 Allowed 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 125.509 1.524 . . . . 0.0 107.928 -160.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.35 63.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.901 -166.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -62.2 -43.08 99.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.283 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.31 85.9 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 119.452 1.024 . . . . 0.0 110.984 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -47.09 -64.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.438 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 69.3 t -64.41 -43.46 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 117.711 -1.596 . . . . 0.0 112.244 -167.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -56.02 -2.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.564 3.145 . . . . 0.0 112.984 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.66 2.59 2.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.286 0.948 . . . . 0.0 113.507 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -129.33 -53.06 1.18 Allowed 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.141 0.977 . . . . 0.0 110.541 -168.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.9 m -95.62 -40.3 9.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.934 0.494 . . . . 0.0 109.756 -171.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 pt -52.45 -28.02 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.054 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.17 -30.26 2.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.115 1.366 . . . . 0.0 112.571 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 m -126.28 -37.25 2.24 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.409 0.683 . . . . 0.0 111.316 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -78.71 -10.56 59.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.27 153.11 22.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.121 0.867 . . . . 0.0 110.946 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -47.5 5.99 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.424 1.488 . . . . 0.0 113.665 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -85.14 -10.3 56.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.824 1.25 . . . . 0.0 112.224 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt 70.18 23.05 5.32 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.855 2.062 . . . . 0.0 111.709 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -76.2 -7.37 54.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.722 2.409 . . . . 0.0 111.89 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.86 112.47 2.08 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.56 -72.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.469 0.708 . . . . 0.0 109.475 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -93.99 2.05 56.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.628 1.171 . . . . 0.0 110.737 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.63 162.06 38.01 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.579 1.951 . . . . 0.0 106.034 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.41 163.91 22.17 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.862 1.708 . . . . 0.0 110.622 174.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 121.55 14.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.25 2.0 pp -115.62 -1.59 9.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.972 174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -38.69 -46.82 1.28 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.359 0.982 . . . . 0.0 112.216 165.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -98.32 3.93 48.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.814 2.046 . . . . 0.0 111.177 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.25 -32.66 56.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.174 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.78 -30.42 72.69 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.886 1.221 . . . . 0.0 113.68 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.33 -45.55 38.8 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.281 1.04 . . . . 0.0 109.359 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -73.67 -41.16 63.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -130.4 165.01 23.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 127.186 2.194 . . . . 0.0 107.766 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 m -103.77 167.92 9.47 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.931 -0.481 . . . . 0.0 110.691 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -38.63 68.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.322 -173.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -53.87 -48.04 70.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.598 0.636 . . . . 0.0 112.449 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -66.17 -47.71 73.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.504 1.145 . . . . 0.0 108.503 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.72 -47.14 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.3 tp -51.81 -55.49 19.58 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 110.623 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.66 -54.57 11.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -63.8 -39.95 87.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.579 -171.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.83 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 121.294 -0.878 . . . . 0.0 109.396 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.46 -35.17 80.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -100.71 -55.79 2.5 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.376 1.471 . . . . 0.0 112.303 -168.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.12 -168.09 22.16 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.903 1.716 . . . . 0.0 110.383 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -164.06 160.99 22.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.16 2.984 . . . . 0.0 103.392 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 9.56 -99.41 0.01 OUTLIER Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.382 1.944 . . . . 0.0 116.302 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.55 17.79 57.13 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 118.491 1.146 . . . . 0.0 113.584 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.1 ttt -89.05 129.62 47.46 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 125.313 1.445 . . . . 0.0 108.464 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.48 -41.22 33.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.833 2.356 . . . . 0.0 112.048 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 159.38 17.23 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.14 20.56 62.92 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 122.165 -0.609 . . . . 0.0 111.614 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.5 mm -63.5 -29.12 46.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 124.518 1.127 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 149.15 45.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -142.19 157.77 44.49 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.294 0.952 . . . . 0.0 113.248 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.84 -141.51 44.86 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.05 -35.71 2.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.197 1.399 . . . . 0.0 112.563 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.36 -62.55 1.58 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.607 1.163 . . . . 0.0 110.179 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.16 80.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.173 0.589 . . . . 0.0 110.715 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.66 -50.36 74.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.544 0.687 . . . . 0.0 109.634 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.52 -48.09 81.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.027 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.0 t -49.95 -55.9 4.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.263 172.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.3 17.51 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.051 0.841 . . . . 0.0 110.556 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.85 78.96 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.005 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.49 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 71.7 t90 -61.13 -46.06 92.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.033 0.533 . . . . 0.0 111.72 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -66.56 -43.83 83.97 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.64 -47.81 58.33 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.11 -10.17 59.41 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.341 -0.85 . . . . 0.0 112.172 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 -5.45 59.24 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.871 -1.143 . . . . 0.0 112.079 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 C--O 1.247 0.948 0 C-N-CA 125.957 1.703 . . . . 0.0 114.194 -164.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.5 98.15 2.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.414 1.085 . . . . 0.0 108.715 -161.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.9 58.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.97 -1.013 . . . . 0.0 113.06 -165.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.18 -44.24 97.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.208 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.11 77.25 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.557 0.617 . . . . 0.0 110.852 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.03 -60.89 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 170.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.499 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.25 63.2 t -66.85 -40.76 86.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 121.078 -1.014 . . . . 0.0 112.047 -168.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -60.34 1.05 0.14 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.04 2.936 . . . . 0.0 113.746 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.31 -22.64 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 168.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -15.96 11.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 111.999 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.9 m -121.55 -41.39 2.49 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.58 0.627 . . . . 0.0 111.283 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.0 pt -48.68 -29.81 2.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 122.974 0.51 . . . . 0.0 111.561 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -38.1 -44.94 0.87 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.918 1.687 . . . . 0.0 112.02 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -113.19 -41.66 3.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.873 0.469 . . . . 0.0 110.73 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -71.27 -15.31 62.42 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.55 152.04 24.28 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -56.99 3.88 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.029 1.3 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 -5.86 49.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.956 1.302 . . . . 0.0 112.046 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 mt 66.53 20.38 10.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.099 1.759 . . . . 0.0 111.89 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 p -81.31 1.15 33.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.91 2.084 . . . . 0.0 111.647 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 79.21 1.44 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.596 0.635 . . . . 0.0 112.441 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.08 -80.37 0.13 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.973 0.387 . . . . 0.0 111.135 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m -94.51 1.94 55.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.442 1.497 . . . . 0.0 112.068 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.1 46.9 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.85 164.58 21.24 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.661 1.574 . . . . 0.0 110.992 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.85 113.22 6.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.861 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 2.3 pp -107.96 -2.02 10.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.604 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -32.92 -54.53 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.112 1.365 . . . . 0.0 112.261 163.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 3.14 54.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.923 2.089 . . . . 0.0 111.429 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.65 -37.76 42.57 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.196 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.97 -27.54 59.74 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.916 0.78 . . . . 0.0 115.001 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -44.5 55.67 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.266 1.033 . . . . 0.0 110.212 171.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -74.05 -38.45 63.98 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.66 0.384 . . . . 0.0 111.258 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -140.47 160.41 40.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 108.348 -167.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -94.59 165.84 12.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.541 0.736 . . . . 0.0 111.127 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.18 -45.87 53.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.42 0.688 . . . . 0.0 110.387 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.26 -49.84 31.93 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 112.573 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.48 -51.38 60.51 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.034 0.934 . . . . 0.0 110.276 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.24 -47.48 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.2 tp -48.02 -56.74 6.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.306 1.842 . . . . 0.0 110.12 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.34 -47.81 78.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.1 -44.18 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 122.277 -0.264 . . . . 0.0 110.762 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.2 mt -61.14 -50.65 79.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.115 -0.99 . . . . 0.0 109.724 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -39.74 89.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.562 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -94.81 -61.24 1.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.587 1.955 . . . . 0.0 111.59 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.33 -175.86 21.14 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.571 2.034 . . . . 0.0 110.202 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -150.97 164.46 36.32 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 167.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -4.97 -91.75 0.0 OUTLIER Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.965 2.221 . . . . 0.0 116.272 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.53 34.72 5.34 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.558 1.179 . . . . 0.0 112.58 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 ttt -114.49 123.97 31.43 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 125.592 1.557 . . . . 0.0 108.671 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.64 -38.67 59.83 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.869 2.38 . . . . 0.0 112.621 -170.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 162.61 27.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 122.077 0.82 . . . . 0.0 111.857 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.98 21.22 65.46 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 mt -64.55 -30.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.838 1.255 . . . . 0.0 109.559 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.48 149.48 44.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -143.83 164.5 30.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.231 0.923 . . . . 0.0 111.681 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.64 -140.85 43.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.38 -35.21 5.25 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.939 1.295 . . . . 0.0 112.095 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.04 -56.14 26.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.866 0.466 . . . . 0.0 109.921 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.32 81.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.643 -0.661 . . . . 0.0 110.72 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.53 -53.04 62.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.144 0.429 . . . . 0.0 110.214 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.01 57.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.402 0.681 . . . . 0.0 109.932 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.2 -61.96 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.28 -51.96 49.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.702 0.801 . . . . 0.0 111.374 -170.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.35 -56.18 25.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 110.656 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 20.4 t90 -54.09 -41.0 67.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.439 0.696 . . . . 0.0 111.467 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.43 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -79.02 -28.63 43.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.856 -1.153 . . . . 0.0 111.291 -175.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.88 67.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.576 0.75 . . . . 0.0 111.375 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.79 62.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.332 1.053 . . . . 0.0 110.75 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HA ' ' CE ' ' A' ' 91' ' ' LYS 0.33 0.0 OUTLIER -62.64 9.4 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 118.924 2.935 . . . . 0.0 118.924 -163.102 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--O 1.251 1.166 0 O-C-N 120.77 -1.206 . . . . 0.0 113.26 -149.811 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -72.09 102.73 3.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -168.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.99 -49.6 20.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.445 1.098 . . . . 0.0 112.339 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.15 -44.77 96.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.751 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.1 82.92 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.414 1.006 . . . . 0.0 111.476 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -51.57 -63.2 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.457 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.258 34.1 t -67.05 -39.54 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.696 -164.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.93 0.86 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.174 2.99 . . . . 0.0 112.987 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.45 -25.36 3.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.736 1.153 . . . . 0.0 113.996 165.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -117.85 -17.92 9.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.625 1.17 . . . . 0.0 113.041 -163.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.6 m -113.58 -39.72 3.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.679 1.127 . . . . 0.0 111.275 176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -50.3 -29.29 5.91 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.6 -29.58 3.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.812 1.245 . . . . 0.0 112.813 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -123.61 -41.52 2.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.696 0.799 . . . . 0.0 110.624 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -74.63 -10.63 59.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.81 152.3 13.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.56 -57.97 2.64 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.476 1.512 . . . . 0.0 113.452 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -5.84 53.3 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.856 1.662 . . . . 0.0 112.523 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mt 69.96 21.58 6.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.256 1.822 . . . . 0.0 111.485 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -75.28 -8.09 55.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.406 2.283 . . . . 0.0 111.766 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 99.29 1.49 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 -76.5 0.56 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.471 0.635 . . . . 0.0 109.811 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 m -93.98 2.06 56.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.506 1.523 . . . . 0.0 111.691 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.12 161.3 45.85 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 127.207 2.203 . . . . 0.0 105.303 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.7 165.67 22.48 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.33 2.02 . . . . 0.0 111.094 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 120.76 13.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.893 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 2.0 pp -117.23 0.54 8.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.063 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.26 -43.63 10.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.257 0.935 . . . . 0.0 111.207 164.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -96.53 3.89 52.39 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.561 1.544 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.81 -34.58 54.35 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.633 -0.667 . . . . 0.0 111.131 173.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.06 -30.47 75.68 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.045 0.839 . . . . 0.0 113.567 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.49 -47.24 17.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.987 0.893 . . . . 0.0 110.199 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.64 -44.58 49.73 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.704 0.402 . . . . 0.0 111.591 -171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.22 -178.28 3.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.833 2.053 . . . . 0.0 107.288 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.8 t -123.64 171.92 9.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 0.566 . . . . 0.0 110.294 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.79 -44.12 73.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.338 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -52.37 -48.19 65.73 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.959 0.8 . . . . 0.0 111.567 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.0 -50.38 64.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.512 0.672 . . . . 0.0 109.69 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.24 -47.16 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.4 tp -49.88 -55.48 14.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.76 -48.27 72.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -47.43 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.144 -0.348 . . . . 0.0 110.26 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.49 -48.32 87.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 120.835 -1.165 . . . . 0.0 110.022 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.7 -43.18 89.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -86.5 -56.42 3.43 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.19 1.396 . . . . 0.0 110.934 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.1 -160.69 21.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 126.841 2.162 . . . . 0.0 108.737 -166.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.38 162.71 37.66 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 101.811 -3.403 . . . . 0.0 101.811 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.16 -54.56 1.23 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.865 1.221 . . . . 0.0 113.983 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -105.74 30.64 9.45 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 117.478 0.639 . . . . 0.0 113.264 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.6 ttt -137.8 129.52 16.22 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 118.664 1.232 . . . . 0.0 109.449 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.55 -41.98 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.103 2.535 . . . . 0.0 113.058 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.23 166.55 39.94 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-O 121.841 0.69 . . . . 0.0 112.18 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.47 19.48 68.82 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.3 -35.11 70.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 125.757 1.623 . . . . 0.0 109.63 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.49 146.12 41.64 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 165.3 30.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.066 0.546 . . . . 0.0 112.436 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.47 -141.36 35.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -173.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.84 -38.94 0.73 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.746 1.619 . . . . 0.0 112.395 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.38 -58.83 6.9 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.925 0.49 . . . . 0.0 110.191 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.0 90.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.22 -51.95 55.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.471 0.708 . . . . 0.0 109.77 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.49 69.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.36 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -48.84 -61.3 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 118.396 0.543 . . . . 0.0 110.026 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.42 -55.79 9.9 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.168 0.987 . . . . 0.0 111.805 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.94 -53.49 57.36 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.707 0.765 . . . . 0.0 110.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.458 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 57.8 t90 -57.41 -37.36 72.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.203 0.525 . . . . 0.0 111.625 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.458 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -72.53 -42.97 64.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 121.241 -0.912 . . . . 0.0 109.475 -177.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -36.92 64.13 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.255 0.222 . . . . 0.0 110.736 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -18.68 60.78 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.733 -0.605 . . . . 0.0 112.411 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 7.62 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.962 2.505 . . . . 0.0 114.934 -172.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.251 1.158 0 O-C-N 119.791 -1.818 . . . . 0.0 113.144 -143.348 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.411 HBA1 ' CHA' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.25 100.55 2.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.11 1.364 . . . . 0.0 107.591 -163.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.06 -50.68 35.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.179 0.991 . . . . 0.0 112.485 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.33 -44.51 97.07 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.715 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.96 78.58 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.181 0.901 . . . . 0.0 111.184 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.27 -64.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.434 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 72.3 t -67.64 -39.32 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 117.921 -1.512 . . . . 0.0 111.851 -163.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -57.89 0.46 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.999 3.32 . . . . 0.0 114.271 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.63 -37.58 1.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.607 1.094 . . . . 0.0 113.241 164.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 -32.32 15.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.436 1.494 . . . . 0.0 110.201 -163.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.9 m -110.77 -39.15 4.93 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.407 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 pt -51.6 -28.87 9.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 O-C-N 123.121 0.263 . . . . 0.0 111.651 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 t -37.55 -45.66 0.77 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.958 1.703 . . . . 0.0 111.768 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.9 m -110.88 -43.06 3.85 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 122.832 0.453 . . . . 0.0 110.619 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -72.49 -15.47 61.8 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.41 153.13 24.37 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.93 4.25 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.15 1.357 . . . . 0.0 113.664 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.4 -0.8 38.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.913 0.485 . . . . 0.0 112.172 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mt 66.28 23.65 10.75 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.134 1.774 . . . . 0.0 111.069 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -6.93 58.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.334 2.654 . . . . 0.0 111.565 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 78.21 1.38 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 118.434 0.561 . . . . 0.0 111.936 166.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.42 -78.27 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.643 0.377 . . . . 0.0 111.363 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.5 t -97.52 2.29 49.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.79 1.636 . . . . 0.0 111.64 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.36 162.09 41.34 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.01 165.23 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.773 1.649 . . . . 0.0 111.33 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.06 117.93 8.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.294 2.0 pp -114.07 0.31 8.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.835 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -35.15 48.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.727 1.149 . . . . 0.0 112.034 171.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.49 4.43 50.46 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.914 1.286 . . . . 0.0 111.974 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.2 -35.13 59.55 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.743 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.38 67.11 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.748 1.158 . . . . 0.0 114.526 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.99 -45.6 49.01 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.425 1.113 . . . . 0.0 109.535 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.608 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -136.78 160.43 38.87 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.026 2.131 . . . . 0.0 108.236 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.1 m -95.31 169.26 10.2 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.417 0.287 . . . . 0.0 110.645 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -40.09 76.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.093 -174.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -53.24 -53.17 54.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.705 1.202 . . . . 0.0 111.757 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.18 -50.19 73.62 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.181 0.992 . . . . 0.0 109.528 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.1 -51.77 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.29 -55.01 14.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.105 1.362 . . . . 0.0 109.892 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -44.08 97.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.07 -41.92 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.625 -0.672 . . . . 0.0 110.786 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mt -63.5 -50.08 79.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -38.41 90.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.608 0.363 . . . . 0.0 111.5 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -89.38 -59.18 2.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.048 1.739 . . . . 0.0 111.355 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.28 115.92 3.04 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.879 1.704 . . . . 0.0 109.157 -165.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.13 150.31 10.9 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -26.47 -65.64 0.07 OUTLIER Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.826 1.203 . . . . 0.0 115.989 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.59 22.99 21.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.167 0.983 . . . . 0.0 113.67 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.2 ttt -139.23 121.48 10.24 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.822 1.249 . . . . 0.0 110.554 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.58 140.73 58.01 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 N-CA-C 108.825 -1.259 . . . . 0.0 108.825 171.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.98 -172.26 21.8 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.25 12.67 63.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.64 -30.47 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.785 1.234 . . . . 0.0 109.569 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.46 145.88 45.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 168.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -143.02 161.97 36.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.629 0.771 . . . . 0.0 111.122 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.67 -137.59 26.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.99 -37.6 1.4 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.221 1.409 . . . . 0.0 112.343 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -60.67 -59.18 5.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.014 0.526 . . . . 0.0 109.915 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.17 92.98 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.365 -0.835 . . . . 0.0 110.626 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.98 -52.16 61.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 109.735 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.48 -51.31 67.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.118 0.567 . . . . 0.0 110.313 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.2 -60.76 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.449 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.09 -53.46 42.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 118.53 0.604 . . . . 0.0 110.869 -169.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.54 38.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.102 0.477 . . . . 0.0 110.63 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.507 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 56.9 t90 -62.49 -39.3 93.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.657 0.741 . . . . 0.0 112.229 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.507 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -76.24 -34.03 59.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.731 -1.231 . . . . 0.0 109.268 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.37 -54.07 45.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 161.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.2 -8.25 52.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.104 -0.998 . . . . 0.0 112.161 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -24.28 66.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.558 1.143 . . . . 0.0 110.926 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.767 -1.111 . . . . 0.0 113.043 -156.351 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.29 101.65 1.95 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 125.614 1.566 . . . . 0.0 107.274 -162.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.87 -51.23 58.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.115 -166.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.95 -42.55 94.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.304 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.8 -44.56 86.4 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.931 1.241 . . . . 0.0 111.055 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -48.94 -60.51 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.299 89.5 t -65.19 -42.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.678 -167.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -60.37 0.89 0.15 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.556 3.542 . . . . 0.0 113.997 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.75 -20.07 1.02 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -25.22 11.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.993 1.317 . . . . 0.0 110.855 -173.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.0 m -118.86 -41.08 2.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.474 0.579 . . . . 0.0 111.742 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -49.26 -30.06 3.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 122.681 0.392 . . . . 0.0 111.52 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -36.25 -43.55 0.37 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.298 1.839 . . . . 0.0 111.641 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.79 -44.81 2.91 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 110.934 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -69.17 -16.85 63.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.85 154.52 27.39 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.22 -60.42 2.31 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.366 1.46 . . . . 0.0 114.085 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.64 -3.3 43.29 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt 68.29 25.6 7.08 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.495 1.518 . . . . 0.0 110.548 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -78.16 -7.6 57.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 129.032 2.933 . . . . 0.0 111.265 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.19 76.99 1.31 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.447 0.567 . . . . 0.0 112.191 164.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.16 -80.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.748 0.419 . . . . 0.0 111.598 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -92.04 2.23 56.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.022 1.729 . . . . 0.0 112.066 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.69 162.27 39.56 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.67 162.3 32.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.796 1.664 . . . . 0.0 111.39 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.48 115.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.091 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 pp -105.06 0.5 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.252 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -36.69 37.04 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.226 0.921 . . . . 0.0 111.658 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.67 3.55 55.31 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.176 0.991 . . . . 0.0 112.824 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.53 69.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.076 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.59 66.83 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 121.76 2.073 . . . . 0.0 114.073 171.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.36 -45.91 57.75 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.321 -1.105 . . . . 0.0 109.718 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.26 -37.93 63.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.882 0.473 . . . . 0.0 111.547 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.33 160.57 39.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.434 1.894 . . . . 0.0 108.464 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -94.74 166.67 11.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.274 0.559 . . . . 0.0 110.763 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.58 -44.49 36.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.697 1.199 . . . . 0.0 110.718 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.78 -55.86 17.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.444 1.098 . . . . 0.0 112.007 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.99 -51.54 67.38 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.672 1.189 . . . . 0.0 109.412 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -61.24 -50.39 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -50.77 -55.31 17.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.795 1.238 . . . . 0.0 109.742 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.13 -46.11 89.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.039 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mt -58.55 -40.86 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 O-C-N 121.963 -0.46 . . . . 0.0 110.9 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.55 -50.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.25 -37.2 86.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -92.21 -45.19 8.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.88 1.672 . . . . 0.0 111.962 -170.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.81 113.66 3.03 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.32 1.438 . . . . 0.0 110.075 -168.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -55.34 155.52 5.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 159.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -32.56 -64.53 0.26 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.315 1.436 . . . . 0.0 116.114 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.12 2.73 85.56 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 117.951 0.876 . . . . 0.0 113.484 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.6 ttt -103.43 132.26 21.27 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.286 1.434 . . . . 0.0 110.569 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.45 136.33 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.883 1.722 . . . . 0.0 110.163 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.53 148.54 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.41 79.93 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.6 mm -56.26 -33.52 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.712 1.205 . . . . 0.0 110.259 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.75 149.92 49.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -143.34 157.53 44.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.452 0.644 . . . . 0.0 112.357 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.64 -137.05 31.59 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.91 -37.59 1.34 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.306 1.442 . . . . 0.0 112.519 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.15 -60.6 3.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.467 0.707 . . . . 0.0 109.757 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.66 82.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.498 -0.751 . . . . 0.0 110.764 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.6 -49.74 76.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.211 0.605 . . . . 0.0 110.253 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.63 -49.93 66.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -51.42 -60.74 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.202 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.36 -55.58 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.13 0.972 . . . . 0.0 110.982 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.32 69.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -63.59 -57.05 11.35 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.194 0.521 . . . . 0.0 111.481 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -36.48 70.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.356 -1.465 . . . . 0.0 109.847 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.25 -58.04 10.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 168.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.32 -12.87 61.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.233 -0.917 . . . . 0.0 111.947 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -23.67 66.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.66 -174.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.2 pttt . . . . . 0 C--O 1.251 1.133 0 C-N-CA 127.337 2.255 . . . . 0.0 113.931 -153.654 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.19 97.62 1.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 125.157 1.383 . . . . 0.0 107.678 -160.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.69 -50.41 68.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.604 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.197 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.6 79.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.888 1.222 . . . . 0.0 111.32 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.3 t -47.23 -63.95 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.452 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 77.8 t -67.9 -39.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.99 -165.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -56.63 -3.88 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 129.142 2.977 . . . . 0.0 113.297 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.22 -5.52 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -119.47 -27.92 5.45 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.61 1.164 . . . . 0.0 111.464 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.7 m -114.3 -37.81 4.27 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.251 0.621 . . . . 0.0 111.246 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -51.15 -30.75 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.313 0.245 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 m -37.22 -41.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.326 1.45 . . . . 0.0 113.252 170.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -120.2 -40.86 2.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.086 0.554 . . . . 0.0 110.809 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -75.81 -9.1 58.32 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.416 -0.803 . . . . 0.0 113.052 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.58 154.74 12.84 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 118.954 0.797 . . . . 0.0 111.131 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.6 -56.87 4.08 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.197 1.38 . . . . 0.0 113.66 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -81.44 -1.86 47.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.124 0.569 . . . . 0.0 112.199 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mt 70.46 22.67 5.13 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.02 1.728 . . . . 0.0 110.748 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.32 -7.79 58.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.634 2.774 . . . . 0.0 111.665 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.32 100.19 1.78 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.882 0.753 . . . . 0.0 111.613 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.8 -79.25 0.52 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.704 0.752 . . . . 0.0 110.042 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 m -92.4 1.5 57.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.47 160.73 55.84 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.577 1.951 . . . . 0.0 105.783 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.03 164.72 23.92 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.093 1.862 . . . . 0.0 111.421 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.67 14.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.296 2.2 pp -117.28 0.88 8.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.571 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -22.92 18.95 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.861 -1.149 . . . . 0.0 112.778 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 1.25 34.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.995 1.318 . . . . 0.0 112.724 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.69 67.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.481 1.037 . . . . 0.0 111.981 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.0 -30.01 74.25 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.354 1.434 . . . . 0.0 113.576 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.64 -46.11 23.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.113 0.957 . . . . 0.0 111.357 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -72.52 -42.78 64.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.69 173.35 8.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.794 1.637 . . . . 0.0 108.003 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 t -104.53 174.46 5.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.002 0.906 . . . . 0.0 112.548 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -44.01 92.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.03 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.9 -50.64 63.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.45 -51.9 66.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 109.91 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.11 -51.67 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.6 tp -49.27 -56.46 9.33 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.67 -49.28 77.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -56.42 -44.03 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.968 0.507 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mt -63.75 -51.47 69.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 O-C-N 121.776 -0.578 . . . . 0.0 109.908 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.82 -25.27 67.14 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.283 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.4 -62.31 1.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.359 1.864 . . . . 0.0 111.311 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.62 105.68 2.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.687 1.613 . . . . 0.0 110.64 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -57.07 154.07 10.45 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 161.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.76 -62.79 0.65 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.983 1.277 . . . . 0.0 115.191 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.77 22.17 22.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.83 0.815 . . . . 0.0 113.485 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -126.87 132.98 24.55 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 108.408 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.38 -35.88 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.131 1.887 . . . . 0.0 112.393 -171.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.91 161.71 26.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 121.854 0.697 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.06 26.59 61.27 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 122.367 -0.49 . . . . 0.0 111.99 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.2 mt -66.14 -30.47 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.24 1.016 . . . . 0.0 109.533 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.68 145.57 36.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -145.55 156.09 43.48 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.264 0.938 . . . . 0.0 112.593 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.4 -143.66 48.67 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.47 -37.45 1.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.04 1.736 . . . . 0.0 112.455 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -53.96 -64.17 0.91 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.014 1.326 . . . . 0.0 110.208 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.04 92.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.576 -0.702 . . . . 0.0 110.313 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -52.26 -51.78 56.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.436 0.636 . . . . 0.0 109.362 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.4 81.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.767 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.31 -57.78 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-N 118.429 0.559 . . . . 0.0 110.186 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.75 -56.23 13.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.734 0.814 . . . . 0.0 110.784 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.4 -53.34 59.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.663 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -54.52 -54.19 44.42 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.816 0.446 . . . . 0.0 110.899 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.71 -45.7 85.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.179 -0.951 . . . . 0.0 110.316 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.04 65.96 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -88.69 -22.42 23.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.68 1.592 . . . . 0.0 110.829 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -28.44 66.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.412 -0.805 . . . . 0.0 110.064 -164.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 pttt . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.887 1.275 . . . . 0.0 111.763 -146.189 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.513 -0.477 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.39 98.36 1.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.84 -53.27 26.63 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.325 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.741 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.59 67.73 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.511 1.05 . . . . 0.0 110.171 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -51.68 -57.42 3.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.487 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 2.3 t -77.55 -1.36 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.128 -174.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 -99.89 1.64 43.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.787 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.27 -26.61 0.76 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -106.01 -14.52 15.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.709 1.204 . . . . 0.0 111.618 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 6.8 m -122.36 -41.49 2.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.845 0.858 . . . . 0.0 111.247 -168.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.0 pt -49.03 -31.11 3.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -40.27 -39.8 1.02 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.907 1.683 . . . . 0.0 111.461 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.9 m -117.24 -42.15 2.93 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 122.7 0.4 . . . . 0.0 111.088 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -72.15 -15.67 61.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.07 155.03 30.53 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.97 -56.31 4.52 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.162 1.363 . . . . 0.0 113.111 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -82.87 0.66 43.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.775 0.83 . . . . 0.0 112.399 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mt 64.91 23.96 12.66 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.155 1.382 . . . . 0.0 111.559 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -80.86 -6.05 58.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 128.557 2.743 . . . . 0.0 111.662 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.67 76.82 1.32 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 118.442 0.565 . . . . 0.0 111.91 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 -75.81 0.23 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.393 . . . . 0.0 111.462 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -96.83 1.7 50.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.168 1.787 . . . . 0.0 111.045 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.41 32.96 Favored Pre-proline 0 N--CA 1.452 -0.355 0 C-N-CA 127.081 2.152 . . . . 0.0 105.296 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.97 162.31 26.32 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.574 1.516 . . . . 0.0 110.848 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.72 125.11 23.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.274 2.2 pp -119.72 -3.22 9.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.46 174.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -38.64 -45.8 1.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.817 1.19 . . . . 0.0 111.913 164.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 2.56 51.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.557 1.543 . . . . 0.0 111.992 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.59 -28.71 56.63 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.274 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.06 73.42 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.279 0.945 . . . . 0.0 114.079 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -44.23 32.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.678 0.739 . . . . 0.0 109.483 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -74.61 -43.98 52.85 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.47 164.31 21.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.199 2.2 . . . . 0.0 108.523 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -99.3 163.92 12.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.177 0.591 . . . . 0.0 111.284 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -47.91 -48.05 31.87 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 110.441 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -48.16 -48.53 34.27 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.076 0.95 . . . . 0.0 112.268 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.06 -52.7 46.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.522 0.729 . . . . 0.0 109.679 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.93 -47.12 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.4 tp -48.18 -56.3 8.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.482 1.513 . . . . 0.0 110.174 172.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.4 -50.03 68.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.33 -44.22 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.8 mt -63.39 -46.02 96.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 120.433 -1.417 . . . . 0.0 110.08 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.79 -37.26 81.79 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.915 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -93.4 -36.67 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.985 2.114 . . . . 0.0 112.249 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.62 -178.75 27.63 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.955 1.74 . . . . 0.0 110.06 -163.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -137.76 164.27 29.29 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.81 -69.89 0.09 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.738 1.637 . . . . 0.0 114.868 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 31.62 6.02 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.02 0.91 . . . . 0.0 113.348 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.2 ttt -139.6 121.17 9.78 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.652 1.181 . . . . 0.0 111.564 -174.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.36 157.87 55.62 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.03 1.82 . . . . 0.0 110.424 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 148.3 18.7 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -172.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.58 16.3 66.45 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.769 -0.461 . . . . 0.0 112.373 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.62 -41.22 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.911 0.884 . . . . 0.0 108.973 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.89 143.23 50.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -140.68 158.72 43.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 0.0 108.83 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.98 -139.22 29.17 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.07 1.55 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.549 1.54 . . . . 0.0 112.384 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -59.02 6.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.134 0.574 . . . . 0.0 109.541 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.45 85.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.38 -52.65 64.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.265 0.626 . . . . 0.0 110.402 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.86 69.61 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 109.522 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.2 t -48.4 -63.24 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 O-C-N 123.388 0.43 . . . . 0.0 109.877 172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.8 51.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.21 1.004 . . . . 0.0 111.085 -171.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.23 37.63 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.42 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 60.6 t90 -57.74 -38.46 75.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.183 0.593 . . . . 0.0 111.564 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -45.35 60.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.559 0.744 . . . . 0.0 109.469 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.07 -33.07 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.733 0.813 . . . . 0.0 111.264 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -21.81 60.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.851 0.86 . . . . 0.0 110.904 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.433 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -66.93 8.75 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -161.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 pttt . . . . . 0 C--O 1.247 0.962 0 O-C-N 120.9 -1.125 . . . . 0.0 112.969 -131.731 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.421 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.55 98.04 1.41 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 107.137 -162.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.31 -49.73 42.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.936 -168.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.74 -45.74 93.13 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.556 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -44.91 82.46 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.482 1.037 . . . . 0.0 110.808 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.91 -62.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.499 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 72.1 t -66.69 -39.33 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.203 -168.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -59.08 0.26 0.1 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 129.141 2.976 . . . . 0.0 113.502 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 -15.43 1.57 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.08 -20.98 11.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.818 1.247 . . . . 0.0 111.503 -171.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.8 m -118.73 -40.98 2.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.989 0.813 . . . . 0.0 112.123 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.7 pt -50.7 -29.85 7.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 111.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -41.27 -39.15 1.3 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.949 1.699 . . . . 0.0 113.048 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -116.66 -43.31 2.91 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.33 0.652 . . . . 0.0 110.575 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.42 -12.94 60.98 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.88 153.28 25.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.11 -53.69 6.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.88 1.229 . . . . 0.0 113.111 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -81.79 -1.53 47.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.27 0.628 . . . . 0.0 112.205 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mt 66.38 21.79 10.86 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.631 1.572 . . . . 0.0 111.26 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -78.98 -6.76 57.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.312 2.645 . . . . 0.0 111.572 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.56 82.92 1.65 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.461 0.573 . . . . 0.0 111.738 168.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.24 -77.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.768 0.427 . . . . 0.0 110.965 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -97.17 2.58 51.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.695 1.598 . . . . 0.0 111.58 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.0 161.28 46.26 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.98 163.19 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.73 1.62 . . . . 0.0 111.163 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 123.08 18.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.288 2.2 pp -119.04 -1.12 8.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.194 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -38.46 -45.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.574 1.079 . . . . 0.0 112.567 163.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.68 2.98 44.88 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.25 1.82 . . . . 0.0 112.59 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.14 -30.53 16.85 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.787 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.96 -30.29 76.75 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.12 0.873 . . . . 0.0 114.806 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.61 -44.15 44.42 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.663 -0.904 . . . . 0.0 109.374 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -73.36 -36.81 66.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.63 157.83 45.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 m -90.61 165.66 13.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.546 0.738 . . . . 0.0 111.806 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -46.72 63.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.474 0.71 . . . . 0.0 110.488 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -49.86 -49.03 50.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.053 . . . . 0.0 111.694 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.75 -49.72 71.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.467 0.651 . . . . 0.0 109.639 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.42 -48.05 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.3 tp -48.63 -53.51 18.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.653 1.181 . . . . 0.0 109.64 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.81 0.63 6.77 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.615 0.766 . . . . 0.0 113.037 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -104.35 -39.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 120.91 -1.119 . . . . 0.0 109.441 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 mt -66.24 -50.58 67.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.133 -0.98 . . . . 0.0 109.961 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.4 -39.8 94.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.469 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.38 -48.56 7.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.087 0.955 . . . . 0.0 112.373 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.12 107.99 3.06 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.641 1.591 . . . . 0.0 109.723 -167.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.48 149.52 16.95 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 163.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -19.18 -71.13 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 C-N-CA 126.286 1.898 . . . . 0.0 116.965 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.03 73.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 117.946 0.873 . . . . 0.0 113.793 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.8 ttt -87.99 127.49 57.44 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 126.095 1.758 . . . . 0.0 109.483 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.12 143.39 84.13 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 N-CA-C 109.237 -1.101 . . . . 0.0 109.237 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.45 166.97 28.39 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.52 18.05 75.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.922 -0.639 . . . . 0.0 112.307 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -54.66 -36.02 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.55 1.14 . . . . 0.0 109.967 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.28 146.38 38.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -143.0 154.76 44.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.395 1.078 . . . . 0.0 110.772 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.58 -136.36 49.59 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.53 -38.63 6.53 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.599 1.16 . . . . 0.0 111.978 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -51.9 -62.13 1.82 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.797 0.839 . . . . 0.0 109.348 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.89 71.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.019 0.527 . . . . 0.0 110.904 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.32 -51.05 71.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 0.0 109.928 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -50.18 71.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.759 -0.638 . . . . 0.0 109.362 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.85 -61.76 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.986 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.1 -54.15 14.18 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 111.195 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -54.63 44.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 110.873 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.436 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 59.3 t90 -57.85 -41.1 81.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 111.749 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.55 -45.12 66.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 108.938 -177.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.58 -31.96 68.5 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.432 0.693 . . . . 0.0 112.125 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -21.18 60.95 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 110.701 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -68.82 7.67 0.64 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -158.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.5 pttt . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.478 -1.249 . . . . 0.0 113.075 -128.465 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.36 162.42 29.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 127.16 2.184 . . . . 0.0 107.026 -172.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.51 -69.86 0.76 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.78 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -58.51 -41.38 85.29 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.421 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.17 -39.15 74.71 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.673 0.67 . . . . 0.0 111.303 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.82 -55.87 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.504 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 3.5 t -66.32 -41.05 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 117.015 -1.874 . . . . 0.0 110.615 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -59.92 0.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 129.844 3.258 . . . . 0.0 114.761 169.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.47 -15.51 0.95 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.6 -23.56 11.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.09 1.356 . . . . 0.0 110.519 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -122.82 -39.09 2.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.018 0.527 . . . . 0.0 111.615 -165.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -49.11 -30.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 C-N-CA 122.797 0.439 . . . . 0.0 111.647 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 m -38.46 -39.67 0.48 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.864 1.665 . . . . 0.0 113.068 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.85 -43.97 2.64 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.943 0.497 . . . . 0.0 110.519 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.93 -16.24 63.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 113.017 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.69 153.44 26.9 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.8 -59.12 2.48 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.189 1.376 . . . . 0.0 113.13 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.98 -2.19 38.98 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.188 0.995 . . . . 0.0 112.378 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mt 65.33 24.15 12.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.026 1.73 . . . . 0.0 111.631 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -78.54 -8.33 58.46 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.765 2.826 . . . . 0.0 111.449 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.24 76.51 1.26 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-N 118.408 0.549 . . . . 0.0 111.984 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.59 -82.53 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.792 0.437 . . . . 0.0 111.443 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.72 1.46 56.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.699 1.999 . . . . 0.0 111.97 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.05 162.93 35.55 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.3 165.63 21.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.813 1.676 . . . . 0.0 111.148 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.45 117.2 7.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.265 2.2 pp -114.55 -3.78 11.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.207 176.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -38.23 -48.27 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.504 1.047 . . . . 0.0 111.996 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -99.95 5.55 45.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.395 1.878 . . . . 0.0 112.08 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.96 -44.46 20.05 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.918 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.49 -29.1 16.62 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.964 0.802 . . . . 0.0 114.839 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.08 68.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.413 -1.051 . . . . 0.0 110.497 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.77 -44.0 12.87 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.24 0.616 . . . . 0.0 110.816 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.25 154.85 38.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.817 2.047 . . . . 0.0 107.701 -171.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -95.44 169.82 9.79 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.736 0.415 . . . . 0.0 110.75 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -43.0 64.58 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.713 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -48.74 -52.71 22.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 111.863 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.57 -53.91 50.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.841 0.856 . . . . 0.0 109.684 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.01 -46.97 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -171.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.1 tp -47.31 -56.33 7.04 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.013 1.725 . . . . 0.0 109.95 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.07 -48.4 76.15 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -46.94 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.64 -47.84 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.965 -1.084 . . . . 0.0 109.917 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.5 -27.04 64.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.47 0.708 . . . . 0.0 112.852 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.42 -60.77 1.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.039 -171.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.83 -167.13 24.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.191 2.329 . . . . 0.0 109.469 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -157.97 163.89 37.36 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -15.81 -83.78 0.01 OUTLIER Glycine 0 CA--C 1.542 1.73 0 C-N-CA 126.005 1.764 . . . . 0.0 116.303 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.39 18.82 56.21 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.818 1.309 . . . . 0.0 113.566 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -103.81 127.71 28.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.01 1.324 . . . . 0.0 109.168 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.1 -40.98 24.13 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.569 2.179 . . . . 0.0 112.13 -172.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 161.67 23.09 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 121.851 0.695 . . . . 0.0 111.732 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.61 22.17 65.7 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 122.178 -0.601 . . . . 0.0 111.827 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.46 -29.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.448 1.499 . . . . 0.0 109.835 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.47 143.12 29.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -138.3 166.5 24.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.48 -135.09 41.78 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.9 -36.83 8.01 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.675 1.19 . . . . 0.0 112.027 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -60.63 -55.91 27.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.97 84.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.637 -0.664 . . . . 0.0 111.22 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.69 -54.14 49.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.305 0.502 . . . . 0.0 110.999 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.04 -51.19 62.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.8 t -50.03 -64.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.308 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.61 -51.87 25.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.495 1.118 . . . . 0.0 111.148 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -55.26 34.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 110.77 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.438 ' CZ3' ' CG2' ' A' ' 28' ' ' VAL . 66.3 t90 -59.36 -39.59 83.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.006 0.432 . . . . 0.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -41.65 77.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.98 -39.08 73.98 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 122.129 -0.357 . . . . 0.0 110.522 168.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.14 -19.05 61.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.99 0.516 . . . . 0.0 111.28 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.71 9.08 0.94 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.953 1.701 . . . . 0.0 114.649 -171.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 C--O 1.25 1.12 0 O-C-N 120.635 -1.29 . . . . 0.0 112.73 -154.428 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 CA--C 1.514 -0.433 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 97.73 2.31 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.063 1.345 . . . . 0.0 108.093 -163.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.23 -53.05 60.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.555 -167.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.18 -43.59 98.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.088 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.32 78.13 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.168 0.895 . . . . 0.0 111.326 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -46.25 -63.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.51 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 80.2 t -67.97 -37.78 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 117.352 -1.739 . . . . 0.0 112.52 -166.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -60.1 -1.02 0.26 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.203 3.001 . . . . 0.0 113.179 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 -9.67 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 169.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -118.72 -25.19 6.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.188 1.395 . . . . 0.0 112.04 -171.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -117.21 -40.96 3.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.418 0.554 . . . . 0.0 110.499 -172.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -48.33 -32.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 122.942 0.497 . . . . 0.0 111.612 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -38.64 -37.38 0.32 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 113.206 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -120.08 -41.72 2.63 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.786 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.16 -6.33 49.04 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.66 -86.72 0.41 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.408 1.004 . . . . 0.0 112.788 163.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.53 -62.93 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.35 2.59 39.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 111.764 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.85 26.87 7.51 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.31 1.844 . . . . 0.0 111.505 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -72.83 -10.87 60.29 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.43 1.892 . . . . 0.0 111.721 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 104.14 1.8 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.4 -77.11 0.6 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.535 0.734 . . . . 0.0 110.01 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -92.26 2.1 56.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.922 1.289 . . . . 0.0 111.646 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.83 158.61 52.61 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -63.98 164.57 21.63 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.153 1.902 . . . . 0.0 111.105 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.24 123.72 18.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.631 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.253 2.5 pp -119.79 -2.42 8.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.322 -0.847 . . . . 0.0 112.266 172.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -42.06 -44.85 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.133 1.333 . . . . 0.0 111.594 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.68 4.14 45.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.608 1.563 . . . . 0.0 112.195 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.9 -36.97 18.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.358 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.07 -34.34 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 120.86 1.664 . . . . 0.0 114.379 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -53.27 32.04 Favored 'General case' 0 C--N 1.337 0.056 0 O-C-N 121.446 -1.032 . . . . 0.0 110.276 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -74.31 -37.02 63.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.474 -169.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -132.01 151.53 51.69 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.831 1.652 . . . . 0.0 107.822 -171.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.34 166.95 12.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.665 0.745 . . . . 0.0 110.899 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.37 -47.83 26.02 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.026 1.331 . . . . 0.0 110.498 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.94 -46.34 68.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.853 0.751 . . . . 0.0 111.764 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.99 -53.68 42.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.511 0.724 . . . . 0.0 109.27 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.07 -47.6 91.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.0 tp -49.85 -54.47 19.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.13 1.372 . . . . 0.0 110.322 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.38 -49.66 71.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -46.46 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.1 mt -58.95 -48.84 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 121.245 -0.909 . . . . 0.0 109.635 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.75 -32.63 73.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.485 0.714 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -101.78 -61.55 1.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.015 1.726 . . . . 0.0 111.481 -169.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.09 -173.36 22.71 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 126.776 2.131 . . . . 0.0 110.388 -171.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.92 163.94 38.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 168.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -17.83 -81.97 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.178 1.847 . . . . 0.0 116.102 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.13 25.71 24.35 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.858 1.329 . . . . 0.0 113.441 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -112.46 126.77 27.81 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.948 1.299 . . . . 0.0 108.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.93 -40.88 49.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.101 2.534 . . . . 0.0 112.381 -172.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.67 161.47 25.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-O 121.958 0.755 . . . . 0.0 111.869 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.63 62.12 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.09 -35.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.437 0.695 . . . . 0.0 109.344 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.5 52.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -145.05 152.24 39.8 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.925 0.869 . . . . 0.0 113.233 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.94 -138.86 47.97 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.76 -34.26 11.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.706 1.203 . . . . 0.0 112.034 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.23 -57.01 13.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.086 0.954 . . . . 0.0 109.906 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.77 -39.58 80.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.837 -0.539 . . . . 0.0 110.266 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -55.73 -53.38 57.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.909 0.322 . . . . 0.0 110.151 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.79 39.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.466 0.706 . . . . 0.0 109.643 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.24 -65.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 O-C-N 123.433 0.458 . . . . 0.0 110.21 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.86 -48.85 66.8 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.793 0.837 . . . . 0.0 111.235 -170.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.74 30.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.755 0.422 . . . . 0.0 110.337 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.5 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 31.9 t90 -54.9 -41.8 71.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.362 0.665 . . . . 0.0 111.247 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.5 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.88 -49.32 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.821 0.848 . . . . 0.0 110.366 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.07 69.22 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.522 0.729 . . . . 0.0 110.875 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.49 -23.21 60.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.427 1.091 . . . . 0.0 110.985 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -32.17 73.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.263 -0.898 . . . . 0.0 110.472 -166.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.989 1.716 . . . . 0.0 114.502 -145.446 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.14 98.63 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -169.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.64 -49.78 14.02 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.129 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -63.11 -44.03 96.78 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.928 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.43 75.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 120.002 1.273 . . . . 0.0 111.183 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -55.0 -63.52 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.402 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 25.6 t -65.32 -42.61 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.683 -164.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -3.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.025 2.93 . . . . 0.0 112.726 170.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.59 0.55 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mmtt -126.89 -30.51 2.73 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.114 0.966 . . . . 0.0 111.878 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.5 m -110.23 -38.47 5.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.76 0.709 . . . . 0.0 110.687 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.0 pt -51.55 -30.15 10.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -38.66 -39.22 0.47 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.396 1.878 . . . . 0.0 113.154 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -123.02 -38.8 2.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 110.993 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.16 -9.68 59.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.18 155.87 17.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.94 -57.02 3.63 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.257 1.408 . . . . 0.0 113.498 -174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.03 1.29 44.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 112.518 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt 68.42 21.36 8.28 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.051 1.341 . . . . 0.0 111.363 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -6.59 53.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.972 2.509 . . . . 0.0 111.654 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 113.51 2.34 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.64 -77.15 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.771 0.786 . . . . 0.0 109.449 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 m -93.08 1.85 57.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.938 1.295 . . . . 0.0 111.477 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.89 159.23 57.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 127.038 2.135 . . . . 0.0 105.591 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.0 164.66 21.36 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.08 1.854 . . . . 0.0 111.263 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 120.04 11.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.273 2.2 pp -115.14 -0.4 9.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-O 118.272 -0.871 . . . . 0.0 112.063 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -46.23 -41.26 12.65 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.46 1.027 . . . . 0.0 112.157 170.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.93 4.05 51.77 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.329 1.452 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -25.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.598 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.31 -33.03 76.79 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.901 1.228 . . . . 0.0 113.997 171.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.93 -43.21 59.05 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.624 -0.927 . . . . 0.0 109.646 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -74.36 -44.17 53.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.066 0.547 . . . . 0.0 111.109 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.49 164.43 23.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.707 2.003 . . . . 0.0 108.486 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.22 168.49 10.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.521 0.729 . . . . 0.0 111.6 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -44.0 73.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.34 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.158 0.983 . . . . 0.0 112.236 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.88 -49.21 78.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.53 -49.87 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.0 tp -47.39 -57.52 5.2 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.495 1.518 . . . . 0.0 110.121 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.5 -45.17 92.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.2 mt -59.63 -43.17 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.646 -0.659 . . . . 0.0 111.0 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.0 mt -59.69 -48.4 87.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 O-C-N 120.941 -1.099 . . . . 0.0 109.449 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 mt -65.82 -34.8 79.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.327 0.651 . . . . 0.0 112.21 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -102.97 -53.79 2.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.572 1.549 . . . . 0.0 112.356 -167.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -171.72 20.23 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.411 1.958 . . . . 0.0 110.269 -170.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -166.08 135.83 3.31 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.02 -110.75 0.15 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 120.333 1.424 . . . . 0.0 113.465 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.85 -9.2 68.52 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.157 0.979 . . . . 0.0 114.232 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -63.18 127.52 91.08 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 118.498 1.149 . . . . 0.0 109.122 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -63.79 -37.84 42.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.14 2.56 . . . . 0.0 111.817 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.48 165.41 32.69 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-O 121.987 0.771 . . . . 0.0 111.668 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.24 68.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -65.13 -32.62 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.069 0.948 . . . . 0.0 110.192 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.37 150.41 51.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -144.11 153.26 41.96 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.217 0.917 . . . . 0.0 113.359 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.76 -142.21 47.31 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.6 -36.91 1.52 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.614 1.565 . . . . 0.0 112.437 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -54.27 -61.99 1.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.426 1.09 . . . . 0.0 110.04 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.88 -38.82 87.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.711 -0.618 . . . . 0.0 110.487 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.94 -50.62 72.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 109.851 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.08 73.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.559 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.84 -57.82 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.347 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.14 -54.36 13.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.4 1.08 . . . . 0.0 111.224 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.85 71.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.955 0.407 . . . . 0.0 110.707 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.517 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 64.3 t90 -62.84 -27.24 69.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.578 1.151 . . . . 0.0 112.809 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.517 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -84.73 -43.33 14.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 176.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.12 -42.88 73.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.721 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -5.6 41.35 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.27 0.941 . . . . 0.0 112.22 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 6.9 1.35 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -163.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.989 -124.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.97 102.75 5.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -170.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.94 -51.86 9.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.063 0.945 . . . . 0.0 111.916 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -62.73 -43.95 97.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.603 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.89 82.42 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 119.156 0.889 . . . . 0.0 110.858 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -49.99 -61.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 40.4 t -63.67 -41.99 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 116.803 -1.959 . . . . 0.0 112.697 -170.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -63.18 1.23 0.5 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.411 3.084 . . . . 0.0 113.628 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -134.92 -22.63 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -112.29 -20.42 11.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.719 1.608 . . . . 0.0 111.577 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -121.76 -42.65 2.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.463 0.574 . . . . 0.0 111.25 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.1 pt -48.78 -32.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.696 0.398 . . . . 0.0 111.609 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.24 -36.88 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.067 1.747 . . . . 0.0 113.384 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.0 -42.38 2.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.272 0.629 . . . . 0.0 110.837 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.79 -7.95 54.95 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.41 -84.45 0.37 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.409 1.004 . . . . 0.0 112.813 163.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.25 -64.36 0.02 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.97 3.58 37.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.9 0.88 . . . . 0.0 111.866 173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 67.61 28.1 7.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.583 1.553 . . . . 0.0 111.576 -175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -73.62 -13.07 60.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.036 2.135 . . . . 0.0 111.075 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.38 98.64 1.62 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 172.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.56 -77.47 0.56 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.473 0.709 . . . . 0.0 110.157 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -90.71 1.42 56.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.603 1.161 . . . . 0.0 111.542 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.91 160.2 44.34 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.726 2.011 . . . . 0.0 105.686 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -64.2 164.52 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.25 1.967 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.62 25.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.227 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.274 2.8 pp -119.78 -1.06 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 122.76 0.424 . . . . 0.0 112.131 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -35.39 64.11 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.009 -1.057 . . . . 0.0 111.426 167.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 4.07 51.91 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.486 1.514 . . . . 0.0 111.677 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.36 -53.87 12.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.92 9.22 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 115.156 0.822 . . . . 0.0 115.156 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.35 -29.65 28.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.023 0.912 . . . . 0.0 110.971 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -92.76 -51.95 4.85 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 124.036 0.934 . . . . 0.0 110.113 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.46 146.13 40.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.518 2.327 . . . . 0.0 108.276 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.4 m -86.87 164.16 16.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.256 0.48 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -45.52 58.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.898 0.479 . . . . 0.0 110.008 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -47.01 -53.31 12.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.371 1.468 . . . . 0.0 112.512 173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.39 -48.6 77.21 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.687 0.795 . . . . 0.0 110.175 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.05 -46.73 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -49.85 -55.29 14.84 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.084 1.753 . . . . 0.0 109.786 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.86 73.55 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.89 -37.15 77.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 121.307 -0.87 . . . . 0.0 111.62 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.8 mt -65.47 -44.87 94.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.501 -1.374 . . . . 0.0 109.819 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -68.74 -41.42 78.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.081 0.552 . . . . 0.0 111.594 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -91.28 -37.29 13.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.713 1.605 . . . . 0.0 111.62 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.8 -167.17 18.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.308 1.433 . . . . 0.0 110.139 -166.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -149.69 163.03 39.04 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -31.33 -66.66 0.16 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.641 1.591 . . . . 0.0 114.754 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.25 32.35 6.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.708 0.67 . . . . 0.0 113.266 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.7 ttt -139.4 128.76 14.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.399 1.079 . . . . 0.0 111.594 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.2 155.44 68.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.399 2.066 . . . . 0.0 111.312 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.25 142.67 15.57 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.34 24.95 60.08 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.877 0.751 . . . . 0.0 111.432 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.3 mt -51.83 -44.38 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 108.971 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.47 140.19 46.04 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.5 2.32 . . . . 0.0 105.302 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -147.25 153.71 40.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 109.189 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.78 -133.89 51.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.86 -46.89 11.03 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.436 1.095 . . . . 0.0 111.804 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 mp0 -52.42 -61.4 2.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.898 0.772 . . . . 0.0 110.432 175.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.42 97.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.911 -0.493 . . . . 0.0 110.839 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.46 -58.93 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.197 0.999 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.21 -53.55 49.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.725 1.21 . . . . 0.0 109.618 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -50.38 -61.9 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.045 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.34 -51.66 57.61 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.572 0.749 . . . . 0.0 110.571 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.91 63.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 110.798 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.456 ' CZ3' ' CD1' ' A' ' 88' ' ' LEU . 72.2 t90 -61.86 -31.96 72.28 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.093 0.557 . . . . 0.0 111.665 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' CD1' ' CZ3' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -75.76 -43.74 45.1 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.032 -1.043 . . . . 0.0 110.166 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.21 -37.71 62.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.599 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.4 -8.5 59.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.165 1.348 . . . . 0.0 113.443 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' CA ' ' HE2' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -73.21 5.24 3.67 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.053 2.141 . . . . 0.0 116.204 -170.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 pttp . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.534 -1.222 . . . . 0.0 111.192 -126.373 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 101.29 9.55 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -158.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -52.64 11.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 112.962 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.28 -46.55 89.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.315 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.52 78.56 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.093 0.86 . . . . 0.0 111.218 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.2 -61.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 170.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.439 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 81.9 t -68.92 -40.16 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 120.854 -1.154 . . . . 0.0 112.293 -167.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -58.06 0.61 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 129.136 2.974 . . . . 0.0 113.003 167.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.65 -12.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -122.59 -19.09 6.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.708 1.203 . . . . 0.0 112.101 -170.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.7 m -116.93 -41.59 3.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.42 1.009 . . . . 0.0 111.699 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -48.83 -32.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 122.47 0.308 . . . . 0.0 111.43 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -36.09 -38.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.22 2.208 . . . . 0.0 113.464 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -117.52 -42.31 2.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.617 0.767 . . . . 0.0 110.699 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -74.25 -8.35 55.93 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.67 -90.38 0.43 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.577 1.084 . . . . 0.0 112.751 164.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.1 -58.67 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.59 3.42 47.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.802 0.841 . . . . 0.0 111.367 172.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 65.68 27.59 11.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.741 1.617 . . . . 0.0 111.149 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -78.38 -5.22 51.64 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.727 2.411 . . . . 0.0 111.667 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 92.47 1.57 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.713 0.688 . . . . 0.0 111.599 166.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.31 -79.78 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.38 0.672 . . . . 0.0 110.617 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.9 t -90.81 1.64 56.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.278 1.031 . . . . 0.0 111.25 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.86 160.13 44.74 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.49 161.47 27.67 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.018 1.812 . . . . 0.0 111.198 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.61 116.7 8.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.989 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.7 pp -106.58 -6.81 10.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.053 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -43.85 -50.87 7.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.779 1.172 . . . . 0.0 111.036 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 1.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.534 -0.728 . . . . 0.0 112.103 -175.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.96 -40.45 63.69 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.049 -171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.67 -26.28 24.18 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 119.028 0.831 . . . . 0.0 114.045 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -45.3 62.13 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.31 -1.112 . . . . 0.0 110.264 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -80.82 -43.13 20.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.165 0.986 . . . . 0.0 111.099 -171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.61 158.96 37.86 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.959 2.103 . . . . 0.0 107.647 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -100.75 171.9 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.249 0.477 . . . . 0.0 112.028 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -40.57 75.11 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.47 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -53.34 -49.79 66.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.507 1.048 . . . . 0.0 111.429 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.56 -48.23 78.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.52 0.728 . . . . 0.0 110.029 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.33 -47.58 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -49.24 -57.24 7.12 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.667 1.587 . . . . 0.0 110.365 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -46.28 82.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.97 -43.7 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.526 -0.734 . . . . 0.0 111.268 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.9 mt -60.18 -47.4 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.104 -0.997 . . . . 0.0 109.536 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.36 -42.59 92.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -91.28 -51.8 5.12 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.368 1.467 . . . . 0.0 111.473 -166.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -166.94 17.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -164.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.79 167.21 28.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 175.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.63 72.32 0.02 OUTLIER Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.84 1.2 . . . . 0.0 113.118 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.11 -15.6 3.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.374 1.94 . . . . 0.0 112.585 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.7 ttt -112.37 132.14 22.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.776 1.288 . . . . 0.0 108.459 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.93 -38.09 7.89 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.224 2.616 . . . . 0.0 113.528 -169.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.44 173.18 48.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-O 122.003 0.78 . . . . 0.0 112.218 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 -1.73 62.3 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.267 0.937 . . . . 0.0 112.629 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.09 -31.61 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.171 2.188 . . . . 0.0 111.036 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.87 139.65 38.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -141.79 155.17 45.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.468 1.507 . . . . 0.0 108.675 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.56 -136.49 43.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.15 -41.53 3.74 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.036 1.334 . . . . 0.0 111.796 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -64.12 0.92 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.516 0.726 . . . . 0.0 109.377 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.94 96.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.995 -0.44 . . . . 0.0 110.918 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.06 -58.02 9.67 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.822 0.849 . . . . 0.0 110.077 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.41 -50.91 66.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.128 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -49.15 -63.03 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 123.577 0.548 . . . . 0.0 110.365 175.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.19 62.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.159 0.984 . . . . 0.0 111.095 -171.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.06 -55.52 33.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.279 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.569 ' CZ3' ' CD2' ' A' ' 88' ' ' LEU . 35.4 t90 -52.31 -39.41 60.54 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.361 0.664 . . . . 0.0 110.771 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.569 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.35 -41.52 73.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -27.92 62.91 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.142 -0.349 . . . . 0.0 110.877 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -88.82 -12.36 42.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.041 0.937 . . . . 0.0 112.977 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -0.56 50.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 110.45 -174.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 O-C-N 119.867 -1.771 . . . . 0.0 112.407 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.59 104.29 5.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.316 1.447 . . . . 0.0 107.413 -167.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.56 -50.89 40.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.081 0.952 . . . . 0.0 112.485 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.37 -41.42 93.7 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.537 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.02 94.54 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.93 1.241 . . . . 0.0 111.216 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.9 -63.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 166.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.452 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 85.8 t -63.79 -41.27 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.517 -166.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -60.48 -1.98 0.44 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.227 3.011 . . . . 0.0 112.89 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -11.62 2.26 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 168.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -119.74 -23.86 6.36 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.87 1.268 . . . . 0.0 112.793 -169.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.1 m -122.47 -41.32 2.4 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.812 0.733 . . . . 0.0 111.589 -172.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.3 pt -50.39 -30.04 7.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 122.408 0.283 . . . . 0.0 111.066 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -35.93 -41.06 0.22 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.57 2.348 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.44 -40.37 2.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.295 0.638 . . . . 0.0 110.848 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -78.14 -8.73 58.64 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.33 157.96 16.31 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.148 0.886 . . . . 0.0 112.038 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -36.34 -62.12 0.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.337 1.922 . . . . 0.0 115.952 -168.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -92.86 4.62 53.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.424 1.112 . . . . 0.0 111.988 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 77.39 28.29 0.6 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.671 1.988 . . . . 0.0 110.953 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.2 -10.7 59.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.234 2.214 . . . . 0.0 112.505 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.39 100.26 1.52 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.958 0.79 . . . . 0.0 111.562 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.56 -76.75 0.58 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.732 0.766 . . . . 0.0 110.188 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -94.86 2.24 55.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 111.654 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.02 160.97 50.81 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 127.121 2.169 . . . . 0.0 105.238 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.74 165.03 24.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.903 1.735 . . . . 0.0 111.103 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 115.7 4.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.56 -0.96 9.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.492 174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -44.48 -45.73 9.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.672 1.124 . . . . 0.0 112.049 168.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -90.65 3.84 53.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.249 1.42 . . . . 0.0 111.156 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.15 -31.58 65.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.774 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.76 -30.23 76.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 120.518 1.508 . . . . 0.0 113.195 170.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.44 54.38 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.016 -1.285 . . . . 0.0 110.487 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -74.21 -38.6 63.52 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.286 0.234 . . . . 0.0 111.302 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -135.31 175.64 9.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.253 2.221 . . . . 0.0 108.033 -172.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -112.18 167.74 10.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.247 0.619 . . . . 0.0 110.483 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -50.57 -41.28 54.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 111.531 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -57.01 -51.69 68.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.176 1.353 . . . . 0.0 111.959 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.34 -51.22 69.07 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.141 0.976 . . . . 0.0 109.261 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.49 -49.92 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.834 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.3 tp -48.81 -56.33 9.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.314 1.446 . . . . 0.0 110.333 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.43 -44.76 95.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.931 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.7 mt -59.93 -41.96 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 121.838 -0.539 . . . . 0.0 110.696 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.04 -50.04 81.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.138 -0.976 . . . . 0.0 109.659 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.83 -30.9 71.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.477 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -105.16 -57.31 2.05 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.441 1.497 . . . . 0.0 112.244 -168.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.57 -173.47 21.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.068 1.794 . . . . 0.0 110.554 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -165.48 125.02 1.75 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.88 -113.53 1.06 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.974 1.261 . . . . 0.0 112.779 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.26 82.61 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.207 1.004 . . . . 0.0 113.965 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.5 ttt -66.36 126.85 92.79 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.46 1.13 . . . . 0.0 109.468 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.25 -39.16 39.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.751 2.3 . . . . 0.0 112.082 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.18 163.74 28.78 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 121.956 0.753 . . . . 0.0 111.707 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.84 21.64 65.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.14 -35.3 73.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.286 1.434 . . . . 0.0 109.759 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.54 146.77 49.99 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -139.93 155.09 47.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.235 0.925 . . . . 0.0 112.903 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.84 -139.32 45.87 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.4 -37.21 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.366 1.467 . . . . 0.0 112.068 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.03 -61.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.2 -39.69 89.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.792 -0.568 . . . . 0.0 110.452 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -58.11 -50.9 71.88 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.048 0.539 . . . . 0.0 110.023 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.94 65.39 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.44 0.696 . . . . 0.0 109.687 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.13 -57.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.321 0 O-C-N 123.237 0.335 . . . . 0.0 110.179 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.7 -55.38 19.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.064 0.545 . . . . 0.0 111.279 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.39 58.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 110.783 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.464 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 21.0 t90 -51.13 -44.14 61.31 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.488 0.715 . . . . 0.0 111.187 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -76.2 -37.29 57.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.384 -0.823 . . . . 0.0 112.154 -173.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 109.462 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -76.22 -22.16 55.56 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.397 1.079 . . . . 0.0 113.256 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -18.71 55.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.435 -1.415 . . . . 0.0 112.789 -168.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.955 1.702 . . . . 0.0 113.121 -156.055 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.7 109.98 8.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.795 1.238 . . . . 0.0 109.011 -155.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.39 -53.06 59.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.2 -161.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -61.94 -40.18 94.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.492 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.8 91.1 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.792 0.724 . . . . 0.0 111.315 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.7 t -48.02 -65.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.487 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 58.4 t -64.63 -41.37 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.526 -165.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.91 0.65 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.985 2.914 . . . . 0.0 113.382 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -126.56 -33.42 2.55 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.135 0.974 . . . . 0.0 113.257 167.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -107.62 -19.68 13.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.924 1.69 . . . . 0.0 112.675 -160.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.6 m -123.37 -40.07 2.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.316 0.507 . . . . 0.0 110.862 -171.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.65 -28.55 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.558 0.343 . . . . 0.0 111.422 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -36.75 -43.7 0.44 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.962 2.105 . . . . 0.0 112.913 170.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.28 -37.68 3.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.56 0.744 . . . . 0.0 110.681 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -77.75 -9.42 59.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.4 153.19 10.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.8 -60.54 2.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.175 1.369 . . . . 0.0 113.314 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -3.23 39.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.513 1.125 . . . . 0.0 112.456 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt 71.06 24.38 3.95 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.138 1.775 . . . . 0.0 111.124 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -79.51 -6.03 56.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.397 2.279 . . . . 0.0 112.036 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.59 112.64 2.26 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.07 -73.23 0.67 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.148 0.974 . . . . 0.0 109.986 175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -98.3 2.2 47.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.55 56.54 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 127.356 2.262 . . . . 0.0 105.394 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.11 165.14 25.12 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.818 1.679 . . . . 0.0 110.751 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.98 122.49 15.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.316 2.2 pp -116.57 1.93 7.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.54 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -42.34 -48.81 5.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.662 1.119 . . . . 0.0 112.151 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -90.28 4.84 49.5 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.916 1.286 . . . . 0.0 112.02 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.24 -44.83 53.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.826 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.02 -33.52 44.54 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 120.862 1.665 . . . . 0.0 114.038 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.74 -35.77 77.54 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.375 -1.074 . . . . 0.0 110.891 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -89.78 -34.39 16.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.668 0.787 . . . . 0.0 111.166 -171.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -138.65 142.47 39.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.109 1.363 . . . . 0.0 108.035 -167.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 p -80.49 165.3 22.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.649 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -49.36 -49.56 43.89 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.367 1.067 . . . . 0.0 110.019 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -47.09 -52.6 14.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.646 1.179 . . . . 0.0 112.676 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.98 -49.01 77.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.515 -0.741 . . . . 0.0 110.336 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.98 -47.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.0 tp -50.29 -55.36 15.76 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.82 1.648 . . . . 0.0 109.943 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.76 -48.17 80.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -57.98 -43.46 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.56 0.344 . . . . 0.0 110.377 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.4 -50.42 80.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.08 -28.65 68.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -103.46 -60.95 1.48 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.137 1.775 . . . . 0.0 111.495 -171.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.8 -175.75 21.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.405 1.955 . . . . 0.0 110.365 -170.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.62 164.02 37.81 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.88 -91.97 0.0 OUTLIER Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.921 2.2 . . . . 0.0 116.2 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.36 37.27 3.59 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 118.571 1.186 . . . . 0.0 112.471 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.3 ttt -117.93 122.84 30.12 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 125.547 1.539 . . . . 0.0 108.617 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -61.92 -38.54 57.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.873 2.382 . . . . 0.0 112.688 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.49 163.57 29.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 122.003 0.779 . . . . 0.0 111.849 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.73 22.28 63.99 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.408 0.527 . . . . 0.0 111.872 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mt -64.39 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.168 1.387 . . . . 0.0 109.748 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.95 144.28 38.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -138.78 158.34 44.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.261 0.937 . . . . 0.0 112.931 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.93 -136.27 41.93 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.263 0.935 . . . . 0.0 110.89 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.15 -37.72 3.29 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.259 1.424 . . . . 0.0 112.172 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -59.01 -56.35 23.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.704 0.801 . . . . 0.0 110.214 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.36 88.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.671 -0.643 . . . . 0.0 110.266 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.26 -53.1 58.2 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.311 0.644 . . . . 0.0 109.968 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.14 41.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.609 0.763 . . . . 0.0 109.888 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.9 t -50.72 -58.2 2.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 117.897 0.317 . . . . 0.0 110.36 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.72 -54.16 41.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.02 0.528 . . . . 0.0 110.771 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.18 59.47 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.083 0.468 . . . . 0.0 110.545 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.44 ' CH2' HD21 ' A' ' 88' ' ' LEU . 14.0 t90 -58.33 -47.73 82.8 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.892 0.477 . . . . 0.0 111.69 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.44 HD21 ' CH2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -75.19 -29.75 60.45 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.861 -1.149 . . . . 0.0 110.736 -172.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.04 -56.24 21.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 160.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.69 -8.45 52.11 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.767 -1.208 . . . . 0.0 112.037 -172.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -27.4 61.07 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.289 -0.882 . . . . 0.0 110.11 -176.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.7 pttp . . . . . 0 C--O 1.252 1.223 0 C-N-CA 124.941 1.296 . . . . 0.0 113.702 -150.393 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -70.17 108.04 3.96 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.29 76.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.575 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -70.62 -41.38 72.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -175.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.25 58.93 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.259 0.936 . . . . 0.0 110.919 174.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -49.77 -59.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.1 t -71.11 -11.99 15.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 119.937 1.244 . . . . 0.0 114.071 -173.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -93.51 0.36 56.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.126 2.17 . . . . 0.0 110.86 174.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -6.59 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -112.25 -49.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.67 1.188 . . . . 0.0 109.947 -177.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -88.73 -37.93 15.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.124 0.569 . . . . 0.0 110.978 -170.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.0 pt -46.89 -36.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.069 0.948 . . . . 0.0 111.317 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 m -37.9 -36.71 0.21 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.326 2.25 . . . . 0.0 112.884 174.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.53 -43.42 2.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.723 . . . . 0.0 111.189 173.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -74.46 -7.12 51.95 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.94 -71.77 0.26 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.088 0.851 . . . . 0.0 113.198 163.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.53 -77.46 0.06 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 5.5 5.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.984 1.313 . . . . 0.0 112.367 169.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 69.09 24.71 6.05 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.507 1.523 . . . . 0.0 110.965 176.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.7 p -70.73 -15.0 62.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.056 1.343 . . . . 0.0 111.153 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 97.79 1.9 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -99.0 -80.21 0.47 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.252 0.621 . . . . 0.0 109.831 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 1.94 55.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.228 1.411 . . . . 0.0 111.705 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.92 54.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 127.295 2.238 . . . . 0.0 105.347 -176.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.59 164.31 29.43 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.91 123.36 17.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.03 -5.49 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.746 170.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -41.28 -46.22 3.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.739 1.154 . . . . 0.0 111.336 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 0.73 54.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.106 0.962 . . . . 0.0 110.927 -172.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.9 -41.61 62.08 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 121.376 -0.827 . . . . 0.0 112.056 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.7 -24.75 8.23 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.629 0.633 . . . . 0.0 114.679 177.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.07 -30.34 31.36 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.815 0.807 . . . . 0.0 111.52 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -89.56 -44.57 10.0 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.857 0.863 . . . . 0.0 110.513 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -126.58 149.86 49.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.106 1.763 . . . . 0.0 107.876 -171.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.3 m -88.05 162.8 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.787 0.435 . . . . 0.0 111.113 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -42.6 -52.41 4.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.554 1.142 . . . . 0.0 110.32 175.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -48.03 -55.59 9.76 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.12 -49.51 76.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.721 0.772 . . . . 0.0 109.96 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.2 mt -64.03 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.3 tp -49.41 -55.78 11.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.114 1.366 . . . . 0.0 110.185 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -44.19 90.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -61.69 -40.76 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.335 -0.853 . . . . 0.0 111.356 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.1 mt -61.03 -47.59 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 120.905 -1.122 . . . . 0.0 109.464 177.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.51 -40.03 88.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.486 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.34 -50.88 5.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.46 1.504 . . . . 0.0 112.318 -169.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.1 -170.83 15.11 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.092 1.806 . . . . 0.0 111.211 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -163.93 116.27 1.4 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 127.056 2.142 . . . . 0.0 105.495 168.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.9 -109.93 0.64 Allowed Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.062 1.301 . . . . 0.0 113.157 172.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -26.18 73.37 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 118.011 0.905 . . . . 0.0 113.061 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.487 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 22.1 ttt -72.74 118.85 71.57 Favored Pre-proline 0 N--CA 1.454 -0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 109.911 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.32 -34.11 28.18 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.594 2.863 . . . . 0.0 112.582 -173.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.48 165.64 40.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -176.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.32 12.65 66.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.754 0.692 . . . . 0.0 112.278 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.78 -34.65 52.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.845 1.658 . . . . 0.0 110.36 177.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.53 149.46 49.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -145.85 155.66 43.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 179.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.68 -136.93 49.15 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -175.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.17 -37.44 4.46 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.795 1.238 . . . . 0.0 112.186 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -54.29 -61.4 2.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.237 1.015 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.91 74.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.725 -0.61 . . . . 0.0 111.145 -175.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.24 -52.86 63.87 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.441 0.564 . . . . 0.0 109.873 175.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.44 -52.47 53.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.98 -62.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 123.176 0.298 . . . . 0.0 110.786 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.97 69.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 111.285 -171.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.97 -53.37 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.317 0.58 . . . . 0.0 110.662 177.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -60.11 -31.31 69.93 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.786 0.834 . . . . 0.0 112.001 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -43.41 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 172.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.39 77.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.067 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.99 -16.41 58.15 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 13.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.877 3.271 . . . . 0.0 114.953 -177.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.095 0 O-C-N 119.981 -1.7 . . . . 0.0 112.88 -151.19 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.487 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 CA--C 1.513 -0.443 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.95 97.14 1.8 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.47 66.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.561 -169.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.84 -42.14 88.59 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.638 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.45 93.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.543 0.61 . . . . 0.0 109.881 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.03 -60.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.491 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.267 87.1 t -65.19 -43.25 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.726 -168.871 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.72 0.72 0.74 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.354 2.261 . . . . 0.0 114.032 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -138.29 -12.13 1.41 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 172.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -128.42 -20.51 3.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.152 1.381 . . . . 0.0 112.067 -171.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.491 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 18.4 m -110.93 -43.6 3.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.138 0.881 . . . . 0.0 110.671 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -49.42 -29.21 3.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.185 0.594 . . . . 0.0 111.845 176.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -38.06 -43.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.868 1.667 . . . . 0.0 112.007 174.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.7 m -114.11 -41.65 3.48 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 117.888 0.313 . . . . 0.0 110.644 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.78 -16.5 62.75 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.9 25.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.7 -61.51 1.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.581 1.563 . . . . 0.0 113.753 -173.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.24 -5.61 47.67 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.215 1.006 . . . . 0.0 112.419 -177.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mt 69.65 23.68 5.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.085 1.754 . . . . 0.0 111.096 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -78.79 -6.49 56.09 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.552 2.341 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 77.17 1.32 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-N 118.595 0.634 . . . . 0.0 112.064 167.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 -76.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.681 0.392 . . . . 0.0 111.458 177.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -99.52 2.73 45.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.827 1.651 . . . . 0.0 111.552 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.53 162.45 39.17 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.42 166.36 21.9 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.806 1.67 . . . . 0.0 111.299 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.69 122.27 16.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.33 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.311 2.1 pp -117.24 -0.97 8.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.401 173.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 2.8 t0 -34.61 -47.13 0.31 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 112.087 159.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -102.65 6.33 39.57 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.984 1.314 . . . . 0.0 112.765 -175.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.31 57.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.102 0.865 . . . . 0.0 111.691 177.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.88 -32.6 75.42 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 119.84 1.2 . . . . 0.0 113.229 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.49 27.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.9 1.35 . . . . 0.0 110.455 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.41 -39.57 62.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.281 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -123.11 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 128.009 2.524 . . . . 0.0 107.606 -173.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.4 m -135.88 171.28 14.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.835 -1.165 . . . . 0.0 109.999 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -39.37 68.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.107 0.563 . . . . 0.0 110.795 -166.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.55 -53.14 61.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -57.99 -50.35 73.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.935 0.894 . . . . 0.0 109.383 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.41 -49.67 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.91 -57.27 6.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.872 1.269 . . . . 0.0 109.921 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.85 -43.55 94.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.049 -176.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.03 -41.22 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.736 -0.602 . . . . 0.0 111.14 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.3 mt -59.25 -50.57 79.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 O-C-N 120.899 -1.126 . . . . 0.0 109.408 175.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.82 -36.31 83.47 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.651 -177.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.65 -51.62 3.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.158 1.383 . . . . 0.0 112.12 -168.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.34 -171.67 18.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.857 1.694 . . . . 0.0 110.33 -171.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -165.06 127.9 2.24 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.42 -112.18 0.61 Allowed Glycine 0 CA--C 1.538 1.479 0 CA-C-N 120.098 1.317 . . . . 0.0 112.876 176.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.17 -12.68 75.87 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 118.161 0.981 . . . . 0.0 113.996 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.2 ttt -64.34 125.11 87.69 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 118.46 1.13 . . . . 0.0 109.175 178.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.41 -36.55 54.57 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -172.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.2 165.19 31.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.48 27.49 68.01 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.3 -32.26 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.151 0.98 . . . . 0.0 109.373 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.44 46.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.751 1.621 . . . . 0.0 106.755 173.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -145.32 154.64 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.02 -140.57 48.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -40.52 -37.33 0.69 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.709 1.604 . . . . 0.0 112.557 176.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.32 -61.98 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.308 1.043 . . . . 0.0 110.319 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.67 87.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.748 -0.595 . . . . 0.0 110.29 -177.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.23 -48.38 78.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.649 0.78 . . . . 0.0 110.002 178.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.41 82.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.897 176.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.28 -48.95 75.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.707 174.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.63 -55.14 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.162 0.892 . . . . 0.0 110.195 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.02 -58.05 10.13 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.771 0.428 . . . . 0.0 111.475 178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.42 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 54.9 t90 -57.14 -45.68 83.34 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.078 0.951 . . . . 0.0 111.482 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.42 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -70.78 -42.54 70.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.18 -175.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.65 66.86 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.021 -0.424 . . . . 0.0 110.651 169.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -74.04 -14.36 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.681 0.792 . . . . 0.0 112.438 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -83.99 -15.22 48.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.696 -1.253 . . . . 0.0 113.082 -166.902 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.923 1.289 . . . . 0.0 112.961 -153.716 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 CA--C 1.513 -0.48 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.72 99.94 1.79 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 126.044 1.737 . . . . 0.0 107.641 -163.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.84 -52.27 43.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.537 -167.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.34 -44.76 96.65 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.366 178.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.38 59.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 120.081 1.31 . . . . 0.0 110.849 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -46.99 -62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.48 ' HB ' ' CZ3' ' A' ' 87' ' ' TRP . 40.2 t -77.78 2.42 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.363 -1.46 . . . . 0.0 113.239 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.28 0.9 38.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.569 2.348 . . . . 0.0 110.063 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -142.35 -13.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -106.93 -55.82 2.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.456 1.503 . . . . 0.0 109.574 -175.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.9 m -82.59 -37.2 25.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.475 0.31 . . . . 0.0 110.663 -171.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.1 pt -48.31 -32.73 3.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 123.383 0.673 . . . . 0.0 111.284 178.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -45.14 -29.52 0.94 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 112.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -127.2 -44.41 1.59 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.439 0.696 . . . . 0.0 111.311 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -71.86 -14.62 62.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.307 -0.87 . . . . 0.0 113.283 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.86 154.95 28.12 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.804 0.716 . . . . 0.0 111.562 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.76 -49.89 8.75 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.215 1.388 . . . . 0.0 113.274 -175.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -84.15 -8.42 59.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.787 0.835 . . . . 0.0 111.857 -176.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt 69.68 21.45 6.56 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.642 1.577 . . . . 0.0 111.181 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -77.66 -8.23 57.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 128.223 2.609 . . . . 0.0 111.431 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.54 87.0 1.74 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.46 -81.16 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.843 0.457 . . . . 0.0 110.524 175.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -90.45 2.01 56.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.343 1.457 . . . . 0.0 112.138 177.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.75 43.55 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.6 166.08 21.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.797 1.665 . . . . 0.0 111.441 -178.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.1 117.59 7.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.281 2.5 pp -112.7 -3.32 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.067 176.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -38.03 -46.49 1.01 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.644 1.111 . . . . 0.0 113.152 163.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -98.15 4.75 49.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.076 1.75 . . . . 0.0 112.116 -177.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.07 -38.58 62.61 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.767 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.35 -27.33 65.39 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.619 1.1 . . . . 0.0 113.463 173.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.38 -48.25 20.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.8 -0.824 . . . . 0.0 109.701 177.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -74.08 -45.21 50.69 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 122.634 0.373 . . . . 0.0 111.684 -174.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -122.55 157.36 32.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.284 1.834 . . . . 0.0 109.265 -169.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -89.11 167.18 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.39 0.614 . . . . 0.0 110.813 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.73 -45.59 49.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.078 0.951 . . . . 0.0 109.858 174.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -54.5 -49.56 69.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.593 0.633 . . . . 0.0 112.521 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.7 -51.22 70.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.697 0.761 . . . . 0.0 109.791 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.54 -50.1 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -174.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -47.14 -58.12 4.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.183 1.393 . . . . 0.0 110.271 172.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.14 -47.69 80.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -175.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.74 -44.31 89.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 122.329 0.252 . . . . 0.0 110.673 -178.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.7 mt -60.97 -50.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 121.79 -0.569 . . . . 0.0 110.045 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.48 -36.43 84.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.778 -178.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.11 -59.3 2.0 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.1 1.76 . . . . 0.0 111.565 -169.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.36 106.79 2.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.45 1.5 . . . . 0.0 110.595 -168.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -55.19 155.29 4.96 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 160.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.78 -61.64 0.73 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.028 1.299 . . . . 0.0 115.469 -175.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.88 17.49 52.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 117.902 0.851 . . . . 0.0 113.386 -177.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.0 ttt -119.41 136.97 24.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.846 1.658 . . . . 0.0 108.396 -176.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.76 -36.91 17.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.104 1.87 . . . . 0.0 112.034 -172.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 163.69 27.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.4 23.52 62.56 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.01 -32.58 58.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 123.57 0.748 . . . . 0.0 109.976 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.49 48.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -144.97 153.21 41.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -137.67 49.51 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.3 -35.99 1.68 Allowed 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 112.352 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.25 -60.37 3.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 110.237 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.01 88.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.556 -0.715 . . . . 0.0 110.52 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.38 -48.33 82.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.307 0.643 . . . . 0.0 110.13 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.59 -49.57 70.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.317 0.647 . . . . 0.0 109.478 175.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.9 t -52.44 -58.77 2.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.2 173.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.73 -55.12 6.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.932 0.893 . . . . 0.0 111.147 -172.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.87 29.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 110.965 178.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.48 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 65.3 t90 -58.99 -41.37 87.46 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.742 0.417 . . . . 0.0 111.515 -175.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 HD21 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -69.05 -46.02 68.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.293 1.037 . . . . 0.0 109.976 -179.622 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.35 59.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.871 0.468 . . . . 0.0 110.931 171.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.42 -17.93 60.72 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.866 1.267 . . . . 0.0 112.536 178.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 2.05 44.16 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.429 -1.419 . . . . 0.0 113.536 -164.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.305 1.442 . . . . 0.0 114.815 -148.444 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.56 99.13 2.0 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.154 1.382 . . . . 0.0 107.582 -164.118 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -49.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.27 -167.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.39 -39.65 91.47 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.544 178.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.46 96.65 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 120.274 1.397 . . . . 0.0 111.028 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -49.36 -65.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 167.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.97 -48.0 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.488 -167.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -56.58 -6.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.363 3.065 . . . . 0.0 113.268 174.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -132.75 2.22 3.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.992 0.917 . . . . 0.0 113.001 173.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -129.16 -59.85 1.09 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.124 0.97 . . . . 0.0 109.831 -169.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 m -86.9 -40.57 14.72 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.679 0.391 . . . . 0.0 110.284 -171.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.15 -26.78 8.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.77 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -46.73 -37.36 8.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.844 1.258 . . . . 0.0 111.549 176.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.5 m -116.02 -38.96 3.52 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 122.934 0.494 . . . . 0.0 111.301 174.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -76.16 -13.01 60.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.93 151.99 23.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -54.03 5.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.254 1.407 . . . . 0.0 112.902 -177.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 -7.56 58.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.82 1.648 . . . . 0.0 111.971 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt 69.08 21.35 7.35 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.808 1.643 . . . . 0.0 110.948 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 p -79.34 -5.54 54.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.011 2.524 . . . . 0.0 111.537 178.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.44 83.9 1.65 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 118.53 0.605 . . . . 0.0 111.701 167.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.12 -71.17 0.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.746 0.418 . . . . 0.0 110.853 177.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t -100.17 1.74 42.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.623 1.569 . . . . 0.0 110.839 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.23 163.9 29.79 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 126.273 1.829 . . . . 0.0 106.082 -173.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -63.26 160.64 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.633 1.555 . . . . 0.0 111.231 174.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 113.65 3.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.172 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -100.08 -5.86 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.748 173.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -37.89 6.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.839 1.199 . . . . 0.0 112.079 176.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -105.46 4.83 31.04 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.393 1.877 . . . . 0.0 112.371 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.9 -35.18 22.68 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 118.688 0.676 . . . . 0.0 110.882 176.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.11 -30.23 54.03 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.961 0.801 . . . . 0.0 114.588 174.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.51 -45.33 38.81 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 121.633 -0.922 . . . . 0.0 109.845 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -73.78 -38.41 64.66 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 122.869 0.467 . . . . 0.0 111.575 -171.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -135.85 154.23 51.24 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.322 1.849 . . . . 0.0 107.721 -171.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -89.46 168.23 12.37 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.161 -0.337 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.84 -43.39 65.99 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.928 0.491 . . . . 0.0 110.952 -175.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.58 -55.85 12.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.104 1.361 . . . . 0.0 112.713 174.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -53.88 -48.54 69.96 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.46 1.104 . . . . 0.0 109.854 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.48 -50.17 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -50.74 -55.58 15.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.872 1.269 . . . . 0.0 110.008 177.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -45.65 91.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.76 -41.25 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 121.378 -0.826 . . . . 0.0 111.25 -178.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.11 -52.3 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.849 0.75 . . . . 0.0 109.839 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.23 -36.92 84.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -174.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -90.28 -53.05 4.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.271 1.828 . . . . 0.0 111.508 -171.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 111.76 3.61 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -169.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -57.17 154.56 9.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 117.8 0.8 . . . . 0.0 108.846 167.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.59 86.8 0.03 OUTLIER Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.062 -1.024 . . . . 0.0 112.516 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.57 -12.38 4.29 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.161 2.315 . . . . 0.0 112.311 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.0 ttt -116.62 129.21 25.44 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 127.081 2.153 . . . . 0.0 108.783 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.45 136.18 33.14 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.306 1.337 . . . . 0.0 108.699 170.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.02 39.5 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.47 13.5 65.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.919 0.771 . . . . 0.0 112.339 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.45 -30.9 45.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.99 1.316 . . . . 0.0 110.204 175.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.47 148.42 42.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -139.92 156.11 46.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.271 0.941 . . . . 0.0 113.383 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.13 -139.02 41.85 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.42 -37.43 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.744 1.618 . . . . 0.0 112.714 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.53 -62.06 1.9 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.38 1.072 . . . . 0.0 109.675 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.38 82.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.65 -0.656 . . . . 0.0 110.761 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.16 -49.25 77.67 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.262 0.625 . . . . 0.0 109.994 178.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.81 76.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.57 -53.93 14.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.365 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.15 -56.34 8.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.588 0.755 . . . . 0.0 110.777 -174.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -54.49 45.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.497 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 7.6 t90 -60.29 -47.63 85.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.96 0.504 . . . . 0.0 112.151 -175.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -63.61 -43.05 98.02 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.367 -0.833 . . . . 0.0 108.957 -179.701 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.8 -44.02 73.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.315 -0.241 . . . . 0.0 110.866 171.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -73.82 -11.17 60.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.482 1.113 . . . . 0.0 111.927 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.13 60.17 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.028 -1.045 . . . . 0.0 110.277 -177.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.171 -158.982 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.59 102.79 3.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.967 1.707 . . . . 0.0 108.187 -163.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.84 -51.72 59.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.617 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.41 -43.73 98.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 118.194 -0.907 . . . . 0.0 109.142 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.18 81.57 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.558 1.072 . . . . 0.0 111.302 -176.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -45.8 -62.63 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.476 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.257 52.1 t -65.11 -40.65 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 118.564 -1.254 . . . . 0.0 113.262 -167.527 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.15 0.37 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.091 3.356 . . . . 0.0 113.196 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -137.37 -12.19 1.61 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -119.38 -25.77 5.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.132 1.373 . . . . 0.0 111.949 -168.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.7 m -114.12 -39.75 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.992 0.814 . . . . 0.0 111.004 -177.233 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -48.41 -32.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 122.545 0.338 . . . . 0.0 111.416 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -44.17 -30.67 0.81 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.222 1.409 . . . . 0.0 113.024 175.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -122.61 -43.98 2.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.689 0.796 . . . . 0.0 110.576 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -71.96 -10.06 59.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.49 -85.0 0.38 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.186 0.898 . . . . 0.0 112.746 163.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.59 -63.54 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -174.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.59 3.26 29.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 111.86 173.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 65.29 25.8 12.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.873 1.669 . . . . 0.0 111.453 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.6 -11.91 60.32 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.034 2.134 . . . . 0.0 111.42 177.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.43 89.44 1.82 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 168.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.18 -77.66 0.45 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.274 0.629 . . . . 0.0 110.616 177.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -92.96 2.34 56.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.071 1.349 . . . . 0.0 111.482 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 158.92 50.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -62.58 162.54 24.14 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.985 1.79 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 126.11 26.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.763 177.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.272 2.7 pp -116.78 -2.29 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.672 171.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -43.7 -45.69 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.499 1.045 . . . . 0.0 112.134 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -94.55 4.23 54.11 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.466 1.106 . . . . 0.0 112.463 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.68 -34.15 37.14 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.572 177.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.72 73.46 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.134 1.334 . . . . 0.0 114.018 173.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.26 -44.83 43.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.503 1.151 . . . . 0.0 110.037 170.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -73.31 -40.95 64.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.509 0.195 . . . . 0.0 111.269 -171.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -131.98 169.21 16.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.973 2.109 . . . . 0.0 107.194 -169.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 m -108.34 167.45 10.02 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.248 0.477 . . . . 0.0 109.764 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -50.57 -42.15 55.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.249 -176.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.3 -50.83 58.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.12 1.327 . . . . 0.0 112.035 177.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -61.87 -52.47 63.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 122.247 1.022 . . . . 0.0 109.252 -176.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.2 mt -62.57 -47.17 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.21 -53.76 32.08 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.929 1.292 . . . . 0.0 110.047 176.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -56.66 -48.22 78.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.31 -45.7 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.367 -0.833 . . . . 0.0 111.251 -178.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.5 mt -59.1 -48.0 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.094 -1.003 . . . . 0.0 109.59 178.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.1 -25.88 62.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.7 0.8 . . . . 0.0 113.104 -177.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.55 -60.29 1.65 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.508 1.523 . . . . 0.0 111.02 -171.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.31 -174.63 21.39 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.648 2.07 . . . . 0.0 109.884 -170.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -152.79 163.58 39.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -1.19 -91.78 0.0 OUTLIER Glycine 0 CA--C 1.543 1.814 0 C-N-CA 126.382 1.944 . . . . 0.0 116.622 175.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.98 12.29 67.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.501 1.151 . . . . 0.0 113.7 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.41 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.2 ttt -96.19 120.1 63.25 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.715 1.606 . . . . 0.0 109.023 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.96 -37.31 54.66 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.807 2.338 . . . . 0.0 112.176 -171.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.21 164.62 28.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-O 122.111 0.84 . . . . 0.0 111.743 177.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.51 17.14 61.79 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 122.407 -0.466 . . . . 0.0 112.159 -173.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.76 -31.28 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.441 1.496 . . . . 0.0 109.628 173.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.58 140.31 35.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -139.5 162.79 34.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.22 1.008 . . . . 0.0 111.768 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.73 -138.59 44.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.83 -37.48 2.81 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.98 1.312 . . . . 0.0 112.002 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.26 -58.37 8.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.836 0.454 . . . . 0.0 110.048 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.49 93.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.753 -0.592 . . . . 0.0 110.507 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.16 -54.07 47.94 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.157 0.583 . . . . 0.0 110.03 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.07 -54.44 30.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.377 0.671 . . . . 0.0 109.626 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.37 -66.99 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 123.432 0.458 . . . . 0.0 110.078 176.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.7 -46.78 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.241 0.617 . . . . 0.0 111.455 -170.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -58.72 7.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.367 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.468 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 9.6 t90 -53.14 -43.38 66.94 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.399 0.68 . . . . 0.0 110.793 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.62 -39.4 73.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.998 -1.064 . . . . 0.0 110.657 -175.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.56 72.39 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.889 -0.507 . . . . 0.0 110.978 166.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -16.25 60.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.648 0.779 . . . . 0.0 112.813 179.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -20.14 57.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.822 1.249 . . . . 0.0 111.472 -166.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -156.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.41 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.88 100.18 4.01 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.787 1.635 . . . . 0.0 107.847 -167.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.38 -52.66 7.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.495 1.118 . . . . 0.0 113.169 -170.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.27 -39.84 95.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.286 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.94 76.59 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 119.981 1.264 . . . . 0.0 110.381 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.9 t -52.31 -59.94 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.431 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 29.8 t -79.35 3.85 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -171.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -104.96 3.6 30.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.521 1.928 . . . . 0.0 110.465 170.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -128.79 -43.49 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.89 -14.28 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.247 1.419 . . . . 0.0 112.024 -159.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 4.5 m -120.91 -37.47 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.615 1.166 . . . . 0.0 111.026 -170.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 pt -50.97 -30.97 9.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.474 0.71 . . . . 0.0 111.659 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -38.18 -42.4 0.68 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.699 2.0 . . . . 0.0 112.737 173.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.3 m -121.3 -38.39 2.8 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.215 0.606 . . . . 0.0 110.799 -177.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -79.79 -8.05 59.03 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.517 -0.74 . . . . 0.0 112.851 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.61 156.21 19.3 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.16 -58.91 3.62 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.633 1.111 . . . . 0.0 112.534 -176.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.94 -4.52 47.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.622 1.169 . . . . 0.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt 72.0 20.43 4.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.764 1.626 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 p -80.23 -2.79 46.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.822 2.449 . . . . 0.0 112.112 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.18 102.36 1.56 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.916 0.77 . . . . 0.0 111.472 168.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.39 -70.66 0.75 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.924 0.862 . . . . 0.0 110.128 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -99.62 2.69 44.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.464 1.506 . . . . 0.0 111.109 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.84 161.79 44.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -175.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.36 163.4 29.65 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.781 1.654 . . . . 0.0 110.828 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.28 113.62 3.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.591 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.305 2.1 pp -105.2 0.69 10.21 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.009 172.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -41.42 14.57 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.239 -0.913 . . . . 0.0 112.801 170.253 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -97.88 4.99 49.54 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.656 1.183 . . . . 0.0 112.106 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.27 32.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.451 -1.261 . . . . 0.0 112.398 -178.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.73 -32.04 68.85 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 120.893 1.679 . . . . 0.0 113.881 174.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.17 -41.55 57.83 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.407 -1.055 . . . . 0.0 109.83 174.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -73.56 -35.17 65.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.828 -172.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -142.24 152.89 43.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.847 1.659 . . . . 0.0 108.674 -170.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.6 t -80.75 163.81 23.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.823 -0.548 . . . . 0.0 110.621 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.11 -44.92 68.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.24 -0.41 . . . . 0.0 109.951 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.53 -44.55 72.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.372 0.669 . . . . 0.0 112.494 178.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.9 -50.49 70.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.582 0.706 . . . . 0.0 109.833 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.53 -48.3 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 tp -48.38 -56.75 7.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.642 1.577 . . . . 0.0 109.97 175.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -56.54 -48.94 76.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -59.27 -43.73 90.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 122.248 -0.282 . . . . 0.0 110.454 -175.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.46 -50.38 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.525 -0.735 . . . . 0.0 109.559 177.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.23 -35.45 78.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.453 -179.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -102.48 -65.46 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.765 2.026 . . . . 0.0 112.527 -167.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.76 -176.96 22.82 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.952 1.739 . . . . 0.0 111.619 -170.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -157.07 170.44 22.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.875 3.27 . . . . 0.0 103.701 169.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -9.53 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 126.953 2.216 . . . . 0.0 116.343 175.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.88 42.01 2.0 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 118.599 1.199 . . . . 0.0 110.949 171.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.416 ' HB2' ' C4D' ' A' ' 93' ' ' HEC . 7.7 tpt -116.55 107.5 46.7 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -177.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.33 -36.22 88.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.499 2.8 . . . . 0.0 112.617 -162.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.17 161.49 17.66 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 122.264 0.924 . . . . 0.0 111.484 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.76 14.31 57.97 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 122.051 -0.676 . . . . 0.0 113.154 -177.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 -32.46 50.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.616 175.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.41 141.49 46.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -139.35 154.08 47.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 107.154 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.68 -139.54 35.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.86 -41.07 1.09 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.205 1.802 . . . . 0.0 112.418 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.17 -55.85 29.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.431 0.692 . . . . 0.0 110.032 178.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.84 78.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -178.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.87 -56.28 19.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.622 0.769 . . . . 0.0 109.879 177.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.53 -53.05 59.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.039 0.936 . . . . 0.0 109.762 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.7 t -48.64 -63.09 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 O-C-N 123.641 0.588 . . . . 0.0 109.805 176.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.55 -55.16 17.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.528 0.731 . . . . 0.0 111.76 -171.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.17 -53.22 60.73 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.467 0.651 . . . . 0.0 110.793 -177.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.579 ' CZ3' HD21 ' A' ' 88' ' ' LEU . 21.8 t90 -54.23 -45.81 72.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.287 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.579 HD21 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -62.97 -45.63 91.52 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.732 -1.23 . . . . 0.0 111.502 -177.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.6 51.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.672 0.789 . . . . 0.0 111.606 172.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.0 -26.91 33.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.241 1.016 . . . . 0.0 112.056 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -32.58 65.57 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.976 1.311 . . . . 0.0 110.91 -165.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 128.512 2.725 . . . . 0.0 112.822 -162.63 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.416 ' C4D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.42 97.65 1.31 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -169.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.17 -53.01 56.78 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.311 -170.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.97 -43.76 97.92 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.446 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.48 76.14 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 119.904 1.229 . . . . 0.0 111.117 -177.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -46.68 -62.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 167.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.44 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.28 73.7 t -70.82 -33.08 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.463 -161.313 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -63.1 -0.78 0.8 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 130.249 3.419 . . . . 0.0 113.315 169.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.24 -22.73 0.91 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 173.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -104.43 -23.75 13.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.29 1.836 . . . . 0.0 110.778 -171.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.3 m -117.57 -40.37 3.05 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.653 0.661 . . . . 0.0 111.781 -174.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 pt -49.74 -31.11 6.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 117.941 0.337 . . . . 0.0 111.397 178.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -37.11 -43.4 0.49 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.313 1.845 . . . . 0.0 111.904 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -114.25 -44.09 3.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.145 0.578 . . . . 0.0 110.853 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -73.67 -14.65 61.19 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.0 152.85 23.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.032 0.833 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.17 -63.46 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.033 1.778 . . . . 0.0 113.895 -173.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.79 -7.89 54.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.144 1.377 . . . . 0.0 112.658 -176.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mt 72.41 25.1 2.82 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.996 2.118 . . . . 0.0 110.672 -178.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -78.65 -6.01 54.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.355 2.662 . . . . 0.0 112.131 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 80.73 1.52 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 118.593 0.633 . . . . 0.0 112.033 168.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.59 -79.41 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.858 0.463 . . . . 0.0 111.135 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -94.78 2.08 55.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.521 1.528 . . . . 0.0 111.833 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.17 162.79 35.9 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 127.577 2.351 . . . . 0.0 104.677 -177.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.96 166.19 19.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.035 1.823 . . . . 0.0 111.656 -178.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.02 114.35 6.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.261 2.2 pp -108.78 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.652 177.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -37.16 -48.31 0.83 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.651 1.114 . . . . 0.0 112.846 165.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -97.71 4.82 49.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.689 1.996 . . . . 0.0 111.545 -174.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.25 -32.74 25.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.08 171.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.67 72.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.665 1.12 . . . . 0.0 114.203 173.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.38 -47.18 18.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.45 1.125 . . . . 0.0 109.865 171.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -74.06 -42.96 59.42 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.938 0.495 . . . . 0.0 111.047 -168.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.26 -179.87 4.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.473 2.309 . . . . 0.0 107.964 -176.257 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m -119.21 170.16 9.33 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.567 0.747 . . . . 0.0 110.219 -178.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -40.8 72.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.556 -174.05 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -53.47 -53.81 46.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.48 1.112 . . . . 0.0 111.714 176.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -59.13 -49.59 77.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.188 0.995 . . . . 0.0 109.33 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.31 -52.24 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.8 tp -48.61 -57.0 6.89 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.081 1.352 . . . . 0.0 109.858 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.95 -41.84 98.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -59.98 -41.82 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 121.586 -0.696 . . . . 0.0 111.283 177.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.39 -50.94 78.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 109.521 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.71 -38.45 91.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.376 -176.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.77 -53.79 4.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.657 1.583 . . . . 0.0 111.903 -171.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.87 110.11 3.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.389 1.471 . . . . 0.0 110.208 -167.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.3 151.61 5.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 157.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.46 -58.52 1.09 Allowed Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.924 1.249 . . . . 0.0 115.477 -172.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.57 12.64 62.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.951 0.876 . . . . 0.0 113.775 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -120.47 132.2 24.21 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 126.12 1.768 . . . . 0.0 107.923 -174.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 -36.83 42.64 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.964 1.776 . . . . 0.0 112.793 -169.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.09 163.21 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.804 0.669 . . . . 0.0 111.691 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.01 17.81 61.51 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.93 -38.17 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.117 1.367 . . . . 0.0 108.961 179.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.38 147.28 48.99 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -141.3 152.23 44.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.486 0.66 . . . . 0.0 111.8 -175.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.5 -142.61 46.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.75 -33.36 1.24 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.83 1.652 . . . . 0.0 112.926 -179.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -53.98 -66.79 0.33 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 109.946 171.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.53 87.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.263 0.625 . . . . 0.0 110.554 -176.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -55.97 -50.17 71.55 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.98 0.512 . . . . 0.0 109.695 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.3 85.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.315 177.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -50.56 -58.16 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.011 173.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.48 -58.71 2.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.868 0.867 . . . . 0.0 111.549 -174.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.06 -54.43 46.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.165 -179.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -56.87 -45.78 82.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 111.07 -177.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -45.61 84.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.296 1.038 . . . . 0.0 109.72 -178.378 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.46 63.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.791 0.436 . . . . 0.0 111.171 171.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.9 -16.75 60.65 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.184 1.393 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 -4.81 58.41 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.842 -1.161 . . . . 0.0 113.203 -167.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.752 1.621 . . . . 0.0 114.059 -157.053 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.4 110.32 7.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.38 1.072 . . . . 0.0 108.473 -160.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.91 -49.52 73.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.239 -165.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.35 -41.69 94.18 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.384 177.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.61 -46.9 87.87 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.31 0.959 . . . . 0.0 111.004 -176.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -46.57 -62.27 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 43.0 t -62.46 -41.96 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.782 -167.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.85 1.44 1.36 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.44 3.096 . . . . 0.0 113.306 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.31 -23.42 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.282 0.946 . . . . 0.0 113.457 168.49 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 25.7 mttt -116.74 -18.79 10.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.757 1.223 . . . . 0.0 112.762 -166.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.5 m -113.31 -43.27 3.37 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.489 1.041 . . . . 0.0 111.246 179.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 pt -51.99 -30.03 12.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -37.05 -40.5 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.016 1.327 . . . . 0.0 113.053 170.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.3 m -115.81 -42.15 3.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.932 0.493 . . . . 0.0 110.623 174.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -70.74 -17.34 62.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.56 -89.22 0.33 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.361 0.981 . . . . 0.0 112.465 165.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.98 -65.36 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.54 2.49 13.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.054 0.942 . . . . 0.0 111.792 170.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mt 71.21 20.45 5.09 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.992 1.317 . . . . 0.0 110.353 177.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -76.48 -8.54 57.38 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.582 2.353 . . . . 0.0 111.722 -177.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.17 74.5 1.08 Allowed Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.446 0.567 . . . . 0.0 111.889 164.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.66 -77.38 0.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.541 0.336 . . . . 0.0 111.427 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 t -96.58 2.39 52.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.025 1.33 . . . . 0.0 111.419 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.34 162.01 39.0 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -176.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.2 164.56 24.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.876 1.717 . . . . 0.0 111.167 179.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.14 114.18 6.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.512 -177.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.291 2.7 pp -106.56 -2.26 9.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.515 173.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -33.23 -48.13 0.22 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.022 1.729 . . . . 0.0 112.51 163.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 4.84 28.74 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.705 2.002 . . . . 0.0 111.274 -171.324 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.25 -37.62 16.58 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.381 -175.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.06 -32.52 59.79 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 119.173 0.897 . . . . 0.0 114.592 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.01 54.74 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.529 -0.983 . . . . 0.0 110.32 174.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.3 -36.03 63.73 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.52 150.45 46.4 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.348 1.459 . . . . 0.0 108.956 -167.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 m -86.79 158.52 19.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.128 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -44.65 60.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.919 0.488 . . . . 0.0 110.79 -174.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -50.62 -48.13 58.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 112.95 174.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.42 -47.49 81.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.699 0.761 . . . . 0.0 109.32 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.2 -49.96 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -47.68 -57.51 5.42 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.9 1.68 . . . . 0.0 110.234 174.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.46 -46.3 83.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -61.44 -42.13 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 122.025 -0.422 . . . . 0.0 110.827 -177.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -58.43 -50.44 78.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.32 -37.82 88.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.699 0.399 . . . . 0.0 111.716 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -96.8 -56.63 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.459 1.504 . . . . 0.0 111.957 -168.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.76 -173.15 21.04 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.911 1.72 . . . . 0.0 110.585 -171.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -165.01 123.5 1.7 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.17 -113.42 1.08 Allowed Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.797 1.181 . . . . 0.0 112.811 175.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.11 -16.63 79.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.208 1.004 . . . . 0.0 113.695 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.4 ttt -65.92 122.21 79.81 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.219 1.009 . . . . 0.0 109.164 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.15 -34.58 56.7 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.985 2.457 . . . . 0.0 111.555 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.92 168.1 36.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 122.604 1.113 . . . . 0.0 111.507 177.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.88 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.142 -178.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -67.54 -32.45 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 127.531 2.333 . . . . 0.0 110.172 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.71 153.09 51.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 172.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 164.17 33.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.183 0.593 . . . . 0.0 112.388 178.231 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.15 -137.86 22.93 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.08 -38.33 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.411 1.484 . . . . 0.0 112.815 178.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 57.6 tt0 -62.09 -58.67 6.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.221 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.92 85.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.735 -0.603 . . . . 0.0 110.744 -177.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -58.1 -52.66 64.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.005 0.922 . . . . 0.0 110.141 174.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.32 -50.21 67.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.81 -55.24 12.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.371 174.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.47 24.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.82 0.736 . . . . 0.0 110.604 -174.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.6 -58.07 9.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.962 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.456 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 2.5 t90 -54.95 -50.75 68.12 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.851 0.461 . . . . 0.0 110.936 -178.223 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.146 -0.971 . . . . 0.0 108.724 -175.046 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.28 -38.99 69.31 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 122.132 -0.355 . . . . 0.0 111.223 172.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -22.0 60.8 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.713 -0.617 . . . . 0.0 111.15 178.016 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.4 9.74 0.74 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.282 2.233 . . . . 0.0 114.637 -172.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.252 1.197 0 O-C-N 120.504 -1.373 . . . . 0.0 112.193 -162.75 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.62 99.36 8.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -146.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.66 46.25 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -160.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -62.73 -46.23 89.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.58 177.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -41.57 72.63 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 118.744 0.702 . . . . 0.0 110.954 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -50.59 -64.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 167.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.466 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 92.6 t -66.86 -38.45 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 120.761 1.619 . . . . 0.0 112.211 -166.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -59.97 0.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.04 2.936 . . . . 0.0 113.331 170.059 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -125.4 -37.38 2.38 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.764 1.226 . . . . 0.0 112.404 168.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -102.42 -24.06 13.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.421 1.488 . . . . 0.0 111.577 -159.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.3 m -120.43 -40.59 2.67 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.289 0.636 . . . . 0.0 111.172 -169.063 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -49.68 -30.84 5.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 122.283 0.233 . . . . 0.0 111.462 178.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -34.73 -41.48 0.13 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.367 2.267 . . . . 0.0 113.164 170.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 m -119.91 -36.33 3.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.445 0.698 . . . . 0.0 111.118 176.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -80.84 -2.54 47.74 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.89 -85.52 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 123.811 0.72 . . . . 0.0 112.464 164.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.68 -66.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -173.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.11 2.21 24.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.312 -0.522 . . . . 0.0 111.733 173.33 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 70.1 22.25 5.73 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.393 1.877 . . . . 0.0 111.389 -172.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -5.56 37.75 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.994 2.118 . . . . 0.0 112.063 173.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.44 147.03 21.91 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 174.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.76 -82.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.913 0.885 . . . . 0.0 109.992 174.091 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 m -92.13 -0.15 57.45 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.021 0.928 . . . . 0.0 111.047 171.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.33 157.18 63.53 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 105.635 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.33 167.06 19.46 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.688 2.258 . . . . 0.0 111.645 -175.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 113.56 3.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.028 175.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp -108.02 -1.89 9.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.411 172.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -34.95 -50.45 0.48 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.285 1.434 . . . . 0.0 111.648 162.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -92.37 0.9 57.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.075 1.35 . . . . 0.0 110.74 -171.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.3 70.63 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.032 -1.043 . . . . 0.0 111.777 -174.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.12 -32.58 76.48 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 119.818 1.19 . . . . 0.0 112.557 174.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.34 -38.05 36.06 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.305 -1.115 . . . . 0.0 111.607 175.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -74.2 -38.94 63.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.307 0.503 . . . . 0.0 111.81 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -133.63 170.86 14.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.973 1.709 . . . . 0.0 108.292 -167.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.3 t -105.86 169.38 8.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.068 0.547 . . . . 0.0 110.38 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -51.39 64.55 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.137 0.575 . . . . 0.0 109.778 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -42.94 -55.79 3.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.678 1.591 . . . . 0.0 113.165 173.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -56.72 -52.25 65.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.04 0.936 . . . . 0.0 109.844 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.01 -48.35 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -173.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.7 tp -49.9 -56.04 12.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.448 1.899 . . . . 0.0 109.997 175.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.56 -47.82 81.03 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -58.83 -42.5 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 122.111 -0.368 . . . . 0.0 110.451 -177.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.45 -50.03 82.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 121.26 -0.9 . . . . 0.0 109.764 176.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.76 -32.66 74.23 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.027 0.531 . . . . 0.0 112.193 -178.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -103.39 -59.19 1.75 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.043 1.737 . . . . 0.0 112.01 -168.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.47 -175.61 21.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.207 1.861 . . . . 0.0 110.74 -173.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -150.64 164.63 35.62 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 166.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 3.14 -94.88 0.01 OUTLIER Glycine 0 CA--C 1.541 1.682 0 C-N-CA 126.887 2.184 . . . . 0.0 116.403 173.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.92 26.01 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 118.494 1.147 . . . . 0.0 112.928 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -104.05 121.11 48.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.952 1.701 . . . . 0.0 108.178 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.65 -36.5 63.4 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.088 2.525 . . . . 0.0 112.545 -169.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.81 165.71 34.03 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 122.158 0.866 . . . . 0.0 111.694 178.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.97 25.48 67.97 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -173.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.08 -26.72 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.079 1.351 . . . . 0.0 110.182 -177.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.54 146.68 32.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -139.07 164.16 30.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.24 0.927 . . . . 0.0 111.338 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.91 -134.66 16.53 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.366 0.984 . . . . 0.0 110.658 -175.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.21 -38.48 3.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.958 1.303 . . . . 0.0 112.26 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.79 -54.24 47.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.2 86.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.649 -0.657 . . . . 0.0 111.138 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.43 -52.73 62.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.295 0.638 . . . . 0.0 110.113 177.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.65 -52.9 53.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.867 0.867 . . . . 0.0 109.833 178.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.4 t -50.19 -63.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 123.341 0.4 . . . . 0.0 110.226 174.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.96 -49.69 49.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.86 0.864 . . . . 0.0 110.978 -171.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.87 -59.8 4.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 177.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.451 ' CZ3' HD21 ' A' ' 88' ' ' LEU . 47.0 t90 -55.93 -35.7 66.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.058 0.943 . . . . 0.0 112.085 -177.384 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 HD21 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.41 -44.73 50.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.39 -0.819 . . . . 0.0 110.554 178.3 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.89 -22.37 66.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.604 -0.685 . . . . 0.0 112.169 174.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.48 -26.93 58.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.187 1.395 . . . . 0.0 111.652 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -9.87 56.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -149.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.4 pttt . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.933 -1.032 . . . . 0.0 113.016 -107.281 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.8 103.66 3.74 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.497 1.519 . . . . 0.0 107.066 -170.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -55.56 9.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.587 -170.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.15 -41.34 83.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.204 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.78 81.96 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.151 0.887 . . . . 0.0 110.499 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.62 -58.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 168.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 2.0 t -68.85 -39.48 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 116.898 -1.921 . . . . 0.0 110.406 -165.348 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -62.31 -0.2 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.971 3.308 . . . . 0.0 114.079 170.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.93 -11.54 0.98 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 171.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.04 -18.47 11.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.888 1.275 . . . . 0.0 111.022 -176.169 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.3 m -127.25 -46.15 1.51 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.602 0.637 . . . . 0.0 111.762 -167.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.6 pt -53.91 -24.66 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -49.24 -27.38 3.66 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.911 0.884 . . . . 0.0 112.301 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.13 -42.77 3.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.212 0.605 . . . . 0.0 110.868 167.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.86 -9.95 58.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.28 -88.36 0.4 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.18 1.371 . . . . 0.0 112.564 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.82 -60.49 0.02 OUTLIER Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -176.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.9 4.0 39.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.713 0.805 . . . . 0.0 111.735 172.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt 74.85 20.86 2.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.134 179.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -76.49 -12.46 60.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.401 2.68 . . . . 0.0 111.321 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.32 83.4 1.71 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 169.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.1 -76.87 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.935 0.494 . . . . 0.0 110.663 177.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -94.62 2.06 55.61 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.405 1.082 . . . . 0.0 111.408 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.98 38.02 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 127.5 2.32 . . . . 0.0 105.414 -176.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.68 164.47 26.49 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.03 1.82 . . . . 0.0 111.68 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.18 13.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.959 0.904 . . . . 0.0 109.717 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.291 2.5 pp -112.1 -3.03 10.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 173.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -32.97 9.37 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.123 -0.985 . . . . 0.0 112.295 165.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.0 3.12 38.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.337 1.055 . . . . 0.0 112.629 177.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.33 -38.2 68.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 117.402 -1.285 . . . . 0.0 111.094 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.58 -26.69 60.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.841 1.655 . . . . 0.0 114.328 174.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.47 -47.08 16.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.958 0.879 . . . . 0.0 109.878 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -74.66 -44.82 48.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 122.501 0.32 . . . . 0.0 111.854 -173.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -123.3 157.2 33.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.658 1.983 . . . . 0.0 109.504 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -89.46 163.89 15.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 0.0 110.964 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -44.17 68.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.895 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -49.64 -53.12 26.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.861 1.665 . . . . 0.0 112.169 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.9 -48.91 79.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.491 0.717 . . . . 0.0 109.834 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.33 -52.24 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -48.9 -56.26 9.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.509 1.524 . . . . 0.0 110.076 177.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.14 -46.59 85.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -59.78 -38.86 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.904 -0.498 . . . . 0.0 111.387 -179.037 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -51.84 66.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 119.469 1.032 . . . . 0.0 109.755 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.15 -33.4 75.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.433 -175.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.7 -43.39 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.21 1.804 . . . . 0.0 112.238 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.07 111.4 2.65 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.163 1.363 . . . . 0.0 110.133 -169.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -55.19 145.88 20.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 161.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -13.48 -74.73 0.01 OUTLIER Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.902 2.191 . . . . 0.0 117.235 -175.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 -12.42 73.8 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.804 0.802 . . . . 0.0 113.775 -175.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.5 ttt -88.14 135.65 32.96 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 126.16 1.784 . . . . 0.0 109.518 -175.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.0 157.95 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.41 1.407 . . . . 0.0 110.959 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.89 146.99 18.67 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -175.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.32 71.7 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.5 mt -55.59 -35.42 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.549 1.14 . . . . 0.0 109.366 172.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.65 152.29 46.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -143.15 162.61 35.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.977 0.808 . . . . 0.0 111.413 177.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.91 -136.34 41.76 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.38 -36.26 4.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.582 1.153 . . . . 0.0 112.064 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.52 -55.79 24.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.17 85.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.553 -0.717 . . . . 0.0 110.408 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.66 -47.75 81.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.128 0.571 . . . . 0.0 110.998 177.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.82 62.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.16 -57.38 8.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.937 173.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.36 -55.99 5.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.12 0.873 . . . . 0.0 110.644 -175.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.04 -54.0 52.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.89 0.476 . . . . 0.0 111.306 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.435 ' CZ3' ' CG2' ' A' ' 28' ' ' VAL . 57.3 t90 -62.3 -54.7 36.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.286 -176.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -40.54 79.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.872 -1.143 . . . . 0.0 110.083 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.15 -50.37 71.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.782 0.264 . . . . 0.0 111.028 170.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.28 -8.88 57.72 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.808 0.731 . . . . 0.0 112.264 -177.005 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -16.76 64.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.652 1.181 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.789 1.236 . . . . 0.0 113.055 -162.987 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t0 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.7 -46.77 81.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.607 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.2 -44.33 84.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -49.19 75.52 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 119.089 0.858 . . . . 0.0 111.436 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.7 t -49.03 -55.82 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.543 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.278 94.6 t -66.02 -43.18 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.512 -169.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.37 1.33 0.35 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.455 3.102 . . . . 0.0 114.115 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.73 -8.13 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -116.02 -26.01 7.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.853 1.261 . . . . 0.0 110.606 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -114.35 -42.06 3.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.489 0.586 . . . . 0.0 111.199 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -49.66 -30.91 5.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 111.563 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.1 m -39.4 -38.52 0.56 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.57 1.548 . . . . 0.0 112.968 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.67 -43.95 2.77 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.758 0.423 . . . . 0.0 110.603 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -68.04 -17.24 64.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.82 155.45 31.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.13 -56.21 5.4 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.826 1.203 . . . . 0.0 113.97 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.61 0.33 43.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.254 0.621 . . . . 0.0 112.416 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.615 HD22 HD11 ' A' ' 48' ' ' ILE . 1.0 OUTLIER 62.58 27.73 16.35 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.962 1.305 . . . . 0.0 110.932 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 p -78.56 -8.81 58.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 128.778 2.831 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.84 76.75 1.23 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 118.293 0.497 . . . . 0.0 111.991 165.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.49 -85.31 0.1 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.897 0.479 . . . . 0.0 111.441 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.9 m -89.05 2.39 54.13 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 112.157 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.61 162.64 38.06 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.48 164.94 28.88 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.231 1.954 . . . . 0.0 111.128 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.93 119.31 10.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.389 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 40' ' ' LEU . 2.8 pp -113.77 -0.61 9.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.132 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -31.28 45.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.382 1.446 . . . . 0.0 112.147 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.418 ' NZ ' ' OXT' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -103.93 5.97 36.0 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.016 1.726 . . . . 0.0 112.552 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB3' HD22 ' A' ' 88' ' ' LEU . . . -54.37 -31.15 54.03 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.318 -1.489 . . . . 0.0 111.754 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.73 -27.61 68.61 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 120.324 1.42 . . . . 0.0 114.423 171.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.48 34.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.886 . . . . 0.0 109.03 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -73.86 -45.82 48.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.36 162.17 26.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.523 1.929 . . . . 0.0 109.262 -170.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 m -93.99 162.09 14.03 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.429 0.692 . . . . 0.0 110.331 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -50.56 -41.96 54.82 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.141 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.49 -58.24 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.099 0.863 . . . . 0.0 112.336 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.93 -51.1 67.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 110.085 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.492 HG22 HD11 ' A' ' 64' ' ' ILE . 61.1 mt -64.61 -48.04 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -50.41 -55.42 15.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.47 1.908 . . . . 0.0 109.872 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -45.76 86.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.77 -41.77 86.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.085 -1.009 . . . . 0.0 111.269 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 60' ' ' ILE . 19.6 mt -60.75 -47.72 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.046 -1.034 . . . . 0.0 109.544 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.275 0.63 . . . . 0.0 111.954 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -97.64 -54.26 3.18 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 111.636 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.75 -169.63 19.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.317 1.913 . . . . 0.0 110.301 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -170.59 122.16 0.61 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 127.431 2.293 . . . . 0.0 105.109 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.19 -113.83 1.03 Allowed Glycine 0 CA--C 1.538 1.52 0 CA-C-N 120.146 1.339 . . . . 0.0 113.027 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.52 -14.65 82.23 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 118.235 1.018 . . . . 0.0 114.069 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -66.82 129.96 94.02 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.193 0.997 . . . . 0.0 109.966 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -65.19 -40.01 21.28 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.08 2.52 . . . . 0.0 111.77 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.69 162.7 28.04 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.007 0.782 . . . . 0.0 111.774 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 17.65 66.27 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.737 0.684 . . . . 0.0 112.158 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 mm -61.16 -33.38 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.61 1.964 . . . . 0.0 110.391 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB1' ' HB3' ' A' ' 80' ' ' GLU . . . -134.75 144.34 47.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 157.99 43.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.437 0.695 . . . . 0.0 111.392 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.01 -137.34 32.65 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.08 -40.08 6.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.405 1.082 . . . . 0.0 112.726 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.7 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -53.0 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.531 0.605 . . . . 0.0 110.178 173.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.77 83.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.965 -0.46 . . . . 0.0 111.155 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.57 -55.15 38.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.411 0.684 . . . . 0.0 109.317 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.59 72.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.66 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG22 HG23 ' A' ' 28' ' ' VAL . 55.8 t -45.34 -66.94 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.79 70.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 111.601 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.38 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 110.769 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.525 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 7.2 t90 -55.14 -43.16 73.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.096 0.558 . . . . 0.0 110.755 176.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.525 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.55 -49.76 75.37 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.508 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.93 -40.64 63.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.451 0.7 . . . . 0.0 110.667 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -73.91 -18.66 60.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.96 0.904 . . . . 0.0 112.331 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -13.12 61.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.776 1.23 . . . . 0.0 111.482 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.418 ' OXT' ' NZ ' ' A' ' 50' ' ' LYS . 8.4 pttt . . . . . 0 C--O 1.247 0.93 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -157.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.37 -53.23 23.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -156.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.63 -43.29 99.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.491 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.35 79.67 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.918 0.887 . . . . 0.0 110.983 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -51.43 -63.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.704 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 67.6 t -64.68 -40.43 89.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 121.066 -1.021 . . . . 0.0 112.498 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -61.23 0.76 0.23 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.808 2.843 . . . . 0.0 113.468 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.75 -25.6 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 165.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -104.5 -28.36 11.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.663 1.185 . . . . 0.0 111.452 -165.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.613 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.2 m -120.2 -39.79 2.77 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.248 0.619 . . . . 0.0 111.579 -167.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -48.62 -31.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 122.634 0.374 . . . . 0.0 111.143 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -36.75 -41.97 0.35 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.542 2.337 . . . . 0.0 113.38 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.9 -42.9 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.101 0.561 . . . . 0.0 110.649 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.84 -17.64 62.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.15 152.4 28.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.9 -53.91 7.12 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.037 1.303 . . . . 0.0 113.567 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.25 1.42 50.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.772 0.829 . . . . 0.0 112.056 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.69 HD22 HD11 ' A' ' 48' ' ' ILE . 9.7 mt 66.28 25.16 10.56 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.895 0.878 . . . . 0.0 110.961 171.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -84.61 -4.41 58.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.969 2.908 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.63 77.12 1.32 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.399 0.545 . . . . 0.0 112.248 164.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.96 -78.43 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.067 0.434 . . . . 0.0 111.356 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -97.74 1.75 48.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.731 1.612 . . . . 0.0 111.965 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.92 162.7 39.65 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.54 164.75 31.69 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.839 1.692 . . . . 0.0 111.608 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.54 114.68 5.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.112 0.965 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.753 HD13 HD11 ' A' ' 88' ' ' LEU . 2.5 pp -102.52 -0.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 122.771 0.428 . . . . 0.0 111.845 173.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.06 -42.52 1.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.98 0.912 . . . . 0.0 111.986 162.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -99.81 5.09 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.058 1.343 . . . . 0.0 113.032 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.58 -42.65 34.42 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.634 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.72 68.28 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.604 1.093 . . . . 0.0 114.664 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.41 -47.66 26.35 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.12 0.96 . . . . 0.0 109.255 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.55 -39.3 62.39 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.236 0.615 . . . . 0.0 111.327 -170.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.74 161.58 34.3 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.02 2.128 . . . . 0.0 108.04 -171.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -99.6 156.51 17.03 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.062 0.945 . . . . 0.0 110.378 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.26 -51.1 6.37 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.893 0.877 . . . . 0.0 111.316 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -40.87 -52.77 3.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.753 1.621 . . . . 0.0 113.839 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.09 -47.89 75.63 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.355 -0.841 . . . . 0.0 109.842 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.5 mt -61.77 -48.34 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -48.84 -56.28 9.18 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 126.748 2.019 . . . . 0.0 109.946 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.16 -48.29 76.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.7 mt -59.95 -42.24 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 122.028 -0.42 . . . . 0.0 110.749 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.39 -50.97 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.94 -36.86 85.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.962 0.505 . . . . 0.0 111.838 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -96.82 -58.39 2.05 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.572 1.549 . . . . 0.0 111.36 -169.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.29 -176.74 20.11 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.377 1.941 . . . . 0.0 110.354 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -145.33 163.21 35.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 103.298 -2.853 . . . . 0.0 103.298 166.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -23.63 -77.47 0.01 OUTLIER Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.704 1.621 . . . . 0.0 115.676 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 32.2 6.39 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.5 1.15 . . . . 0.0 113.506 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -124.32 124.72 25.78 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.197 1.399 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.97 -38.73 55.8 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.866 2.378 . . . . 0.0 113.173 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.45 163.33 32.85 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 121.802 0.668 . . . . 0.0 112.237 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.48 66.9 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mt -69.13 -29.07 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.177 1.391 . . . . 0.0 110.139 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.24 41.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -140.51 152.18 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.665 1.121 . . . . 0.0 113.267 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.06 -137.16 50.63 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.47 -38.68 4.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.236 1.414 . . . . 0.0 112.031 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -54.74 -57.37 11.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.826 1.25 . . . . 0.0 109.859 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.28 87.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 110.649 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.46 -53.36 55.21 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.332 0.653 . . . . 0.0 109.849 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.98 -55.12 25.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.99 0.916 . . . . 0.0 109.848 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.7 t -51.07 -54.41 10.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 122.922 0.139 . . . . 0.0 110.971 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.3 -52.34 65.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.092 0.557 . . . . 0.0 110.777 -172.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.23 -54.3 38.13 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.55 0.69 . . . . 0.0 109.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.704 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 51.6 t90 -57.6 -40.72 79.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.485 0.714 . . . . 0.0 112.14 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.753 HD11 HD13 ' A' ' 48' ' ' ILE 0.305 3.7 mt -68.05 -39.66 82.96 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.618 -1.301 . . . . 0.0 112.887 175.432 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.12 72.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.307 0.503 . . . . 0.0 111.108 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -73.24 -28.84 62.37 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.316 1.046 . . . . 0.0 111.211 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -20.72 66.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.548 1.139 . . . . 0.0 113.68 -169.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 pttt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -151.267 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.35 86.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.613 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.61 -43.31 73.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 -49.59 68.54 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.002 0.819 . . . . 0.0 111.246 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -47.99 -59.15 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.566 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.261 87.8 t -68.93 -38.47 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.37 -166.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.04 0.19 0.25 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 129.186 2.994 . . . . 0.0 113.947 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 -13.48 1.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.1 -26.63 8.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.93 1.292 . . . . 0.0 110.817 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.8 m -115.01 -40.72 3.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.706 0.684 . . . . 0.0 111.976 -172.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.6 pt -49.34 -30.14 4.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 122.619 0.368 . . . . 0.0 111.706 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.9 t -38.66 -42.24 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.067 1.747 . . . . 0.0 111.653 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -116.2 -42.65 3.02 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.267 0.627 . . . . 0.0 111.002 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -71.71 -13.21 61.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.24 153.0 21.71 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.01 -60.52 2.21 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.281 1.419 . . . . 0.0 113.53 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.55 -2.28 34.82 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.577 0.751 . . . . 0.0 112.571 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 28' ' ' VAL . 1.4 mt 66.84 26.53 9.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.23 1.812 . . . . 0.0 111.007 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -79.29 -7.99 58.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.701 2.8 . . . . 0.0 111.563 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.86 83.62 1.69 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 168.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.68 -84.09 0.18 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.011 0.524 . . . . 0.0 110.549 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -88.97 2.1 54.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.263 1.425 . . . . 0.0 111.89 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.79 41.32 Favored Pre-proline 0 N--CA 1.452 -0.36 0 C-N-CA 126.925 2.09 . . . . 0.0 105.413 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.47 164.37 23.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.922 1.748 . . . . 0.0 111.007 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.59 122.88 18.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.467 HD11 HD22 ' A' ' 40' ' ' LEU 0.296 1.9 pp -119.42 0.5 7.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.968 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -41.41 -43.95 2.7 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.783 1.174 . . . . 0.0 112.133 164.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -101.92 6.17 41.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.429 1.892 . . . . 0.0 112.12 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -33.02 42.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.02 -0.991 . . . . 0.0 111.552 172.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.1 -31.98 78.73 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.768 1.622 . . . . 0.0 113.647 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.0 -49.42 37.15 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.147 0.974 . . . . 0.0 109.746 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.79 -42.22 50.67 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.324 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -118.37 179.76 4.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.889 1.676 . . . . 0.0 107.639 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.2 m -120.14 163.37 17.81 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.577 -0.702 . . . . 0.0 109.987 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -52.51 19.45 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.471 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -35.69 -61.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.719 1.208 . . . . 0.0 113.421 168.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -55.77 30.81 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 121.855 0.835 . . . . 0.0 109.769 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.486 HG22 HD11 ' A' ' 64' ' ' ILE . 64.5 mt -60.12 -47.06 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -171.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.9 -53.81 29.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.976 1.71 . . . . 0.0 109.99 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.11 -49.8 68.31 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.42 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.461 -0.775 . . . . 0.0 110.88 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 60' ' ' ILE . 22.0 mt -59.65 -49.11 84.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 120.813 -1.179 . . . . 0.0 109.638 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.3 -37.19 82.99 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.743 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -94.9 -58.15 2.25 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.211 1.404 . . . . 0.0 111.458 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.5 -171.03 21.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.177 2.322 . . . . 0.0 109.675 -168.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -156.73 163.73 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.48 -90.05 0.0 OUTLIER Glycine 0 CA--C 1.544 1.863 0 C-N-CA 126.27 1.89 . . . . 0.0 116.57 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.66 13.83 66.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.859 1.329 . . . . 0.0 114.202 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.6 ttt -99.12 126.14 39.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.547 . . . . 0.0 109.073 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.63 -40.65 22.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.698 2.266 . . . . 0.0 112.348 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.27 163.71 31.26 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.716 0.62 . . . . 0.0 112.161 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.44 20.11 65.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mt -66.97 -32.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 125.426 1.49 . . . . 0.0 109.619 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.02 146.49 47.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -146.73 162.83 37.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.2 -139.78 40.63 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.09 -38.56 1.06 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.546 1.539 . . . . 0.0 112.467 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -55.54 -61.09 2.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.405 1.082 . . . . 0.0 110.015 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.69 -38.01 80.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.699 -0.626 . . . . 0.0 110.788 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -55.49 -54.29 45.73 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.38 62.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.58 0.752 . . . . 0.0 109.663 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 HG23 ' A' ' 28' ' ' VAL . 58.6 t -46.82 -66.03 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 O-C-N 123.363 0.414 . . . . 0.0 110.256 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.24 -47.43 75.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.063 0.945 . . . . 0.0 110.616 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -56.31 23.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.385 0.274 . . . . 0.0 110.373 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.453 ' HZ3' HG11 ' A' ' 28' ' ' VAL . 45.5 t90 -55.31 -43.04 74.5 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.568 0.747 . . . . 0.0 110.946 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.04 -51.48 63.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.679 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.25 68.28 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.035 0.534 . . . . 0.0 110.959 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.79 -20.5 61.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.244 0.618 . . . . 0.0 110.764 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.155 -0.966 . . . . 0.0 111.121 -165.187 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.788 2.435 . . . . 0.0 114.081 -151.575 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.42 -52.17 40.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.019 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -60.53 -40.75 92.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.815 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.79 -44.61 90.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.023 0.829 . . . . 0.0 110.659 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.5 -60.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.555 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.258 17.3 t -65.01 -41.16 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 116.462 -2.095 . . . . 0.0 111.968 -168.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -61.29 0.4 0.28 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.074 2.95 . . . . 0.0 114.28 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.81 -13.43 0.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -114.65 -21.38 10.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.434 1.494 . . . . 0.0 111.427 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.6 m -123.26 -40.13 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.377 0.535 . . . . 0.0 111.183 -168.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -48.59 -30.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 122.96 0.504 . . . . 0.0 111.746 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 m -40.82 -37.06 0.71 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.089 1.755 . . . . 0.0 112.885 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 m -119.66 -43.5 2.58 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 122.859 0.464 . . . . 0.0 110.739 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.4 -14.9 62.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.05 153.4 25.84 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.09 4.55 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.224 1.393 . . . . 0.0 113.564 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.52 -0.27 41.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.06 0.544 . . . . 0.0 112.136 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 HG12 ' A' ' 28' ' ' VAL . 4.8 mt 64.71 25.85 13.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.59 1.556 . . . . 0.0 111.003 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -81.38 -8.31 59.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 128.901 2.88 . . . . 0.0 111.407 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.52 79.27 1.45 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 118.332 0.515 . . . . 0.0 112.21 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.57 -81.74 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.708 0.403 . . . . 0.0 111.226 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -91.64 1.97 56.78 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.548 1.539 . . . . 0.0 112.015 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.15 162.03 45.08 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.96 164.15 25.82 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.845 1.697 . . . . 0.0 111.088 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.47 122.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 40' ' ' LEU 0.323 2.4 pp -116.5 1.07 8.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.877 174.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -35.26 18.74 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.143 1.338 . . . . 0.0 112.344 168.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -99.16 4.31 46.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.172 1.389 . . . . 0.0 112.309 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -33.05 52.95 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 120.92 -1.113 . . . . 0.0 111.168 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.95 -31.15 79.62 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.45 1.023 . . . . 0.0 114.41 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -43.9 38.09 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.818 -0.813 . . . . 0.0 110.076 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -74.16 -39.92 62.93 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.678 0.391 . . . . 0.0 111.538 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -131.6 156.35 45.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.114 1.766 . . . . 0.0 108.054 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -92.88 162.56 14.04 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.753 -0.592 . . . . 0.0 110.506 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -46.56 -46.59 19.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.224 0.609 . . . . 0.0 110.772 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.39 -57.38 4.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.822 1.249 . . . . 0.0 112.899 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 -50.94 71.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.046 0.927 . . . . 0.0 110.073 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 64' ' ' ILE . 59.9 mt -63.42 -47.26 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.1 tp -50.29 -54.89 18.08 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.745 1.618 . . . . 0.0 109.988 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.14 -49.8 70.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.29 -43.23 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.568 -0.708 . . . . 0.0 111.082 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 60' ' ' ILE . 28.7 mt -60.88 -51.05 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.03 -29.9 69.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.551 0.741 . . . . 0.0 112.542 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.5 -60.17 1.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.27 1.828 . . . . 0.0 111.268 -170.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.23 -173.18 21.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.558 2.028 . . . . 0.0 110.655 -168.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -152.62 161.04 43.11 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 102.741 -3.059 . . . . 0.0 102.741 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.32 -71.09 0.07 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 120.489 1.495 . . . . 0.0 115.427 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.47 23.37 28.14 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 118.058 0.929 . . . . 0.0 113.763 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -117.94 131.97 23.9 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.075 1.35 . . . . 0.0 109.34 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.26 -40.72 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.661 2.241 . . . . 0.0 112.187 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.22 157.57 17.99 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 121.699 0.611 . . . . 0.0 112.426 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 17.84 61.39 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mm -58.76 -37.2 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.529 1.132 . . . . 0.0 109.587 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.82 146.35 52.24 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -144.22 154.6 43.28 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.67 -139.21 48.1 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.6 -37.16 5.29 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.017 1.327 . . . . 0.0 111.738 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -53.74 -60.99 2.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.478 1.111 . . . . 0.0 110.061 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.35 79.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.814 -0.554 . . . . 0.0 110.667 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.94 -52.92 63.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.02 0.438 . . . . 0.0 109.913 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.03 -52.52 60.59 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.829 0.851 . . . . 0.0 109.607 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -48.24 -65.2 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 119.172 -0.442 . . . . 0.0 109.87 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.05 -49.93 49.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.429 1.091 . . . . 0.0 111.453 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.65 -57.08 14.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.999 0.428 . . . . 0.0 110.566 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.524 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 68.7 t90 -56.36 -34.47 66.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.569 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.74 -43.85 52.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.16 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.13 -32.74 66.66 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.74 -0.6 . . . . 0.0 111.008 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.09 -23.14 59.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.079 0.952 . . . . 0.0 111.924 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.51 4.09 0.42 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.519 2.328 . . . . 0.0 115.671 -165.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.103 0 O-C-N 119.993 -1.692 . . . . 0.0 113.457 -125.594 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 123.024 1.392 . . . . 0.0 107.727 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.22 82.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.744 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -56.89 -45.32 82.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.942 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.58 96.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.687 0.676 . . . . 0.0 110.681 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -51.48 -65.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 32' ' ' CYS . 73.7 t -63.1 -42.03 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 120.088 1.313 . . . . 0.0 110.793 -165.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -1.44 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.59 2.756 . . . . 0.0 113.261 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.78 0.96 2.05 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 169.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.01 -54.61 1.61 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.319 1.048 . . . . 0.0 109.986 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.794 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.9 m -90.0 -41.82 11.5 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.769 0.428 . . . . 0.0 110.248 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 pt -52.74 -27.21 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.038 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -47.51 -29.33 2.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.923 1.289 . . . . 0.0 112.363 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 m -122.9 -41.58 2.34 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.542 0.61 . . . . 0.0 110.864 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -70.7 -17.35 62.83 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.81 150.15 18.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.46 -59.88 1.5 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.703 1.62 . . . . 0.0 113.969 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.01 -15.42 61.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.767 1.227 . . . . 0.0 112.77 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.589 HD22 HD11 ' A' ' 48' ' ' ILE . 1.4 mt 77.06 23.87 0.9 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.704 2.402 . . . . 0.0 111.098 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 p -75.73 -9.17 58.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 111.961 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.19 81.07 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.671 . . . . 0.0 111.797 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.66 -78.92 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.797 0.439 . . . . 0.0 111.1 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -93.98 2.6 56.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.609 1.563 . . . . 0.0 111.502 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.36 163.05 34.25 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.97 165.48 21.35 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.792 1.661 . . . . 0.0 111.189 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 119.7 11.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 40' ' ' LEU 0.319 2.1 pp -115.65 1.3 8.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.734 174.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.52 -40.31 18.39 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.519 1.054 . . . . 0.0 111.606 167.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -93.12 2.8 56.55 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 125.699 1.599 . . . . 0.0 111.315 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.13 -34.92 66.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.184 0.902 . . . . 0.0 111.183 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.47 -31.75 78.62 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.479 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.42 -46.23 28.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.514 1.157 . . . . 0.0 110.455 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -74.37 -40.67 61.95 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 111.264 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -124.91 -177.94 4.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.52 2.328 . . . . 0.0 107.893 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -122.92 169.47 11.11 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.607 -0.683 . . . . 0.0 110.32 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -42.73 67.29 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.436 0.694 . . . . 0.0 110.374 -171.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -51.12 -56.26 13.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 112.913 175.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 31.5 mm-40 -56.55 -49.35 75.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.185 1.394 . . . . 0.0 109.176 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.89 -51.22 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.75 -56.15 11.32 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.253 1.021 . . . . 0.0 109.912 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.67 -41.12 97.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.705 -0.798 . . . . 0.0 108.904 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.8 mt -62.72 -39.98 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.817 -0.552 . . . . 0.0 111.325 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.47 -51.09 76.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 O-C-N 120.719 -1.238 . . . . 0.0 109.571 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.87 -42.1 99.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -91.82 -50.6 5.64 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 112.323 -168.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.33 -167.66 14.84 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.976 1.75 . . . . 0.0 110.112 -168.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -169.37 131.02 1.14 Allowed 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.13 -112.38 0.5 Allowed Glycine 0 CA--C 1.539 1.559 0 CA-C-N 120.486 1.494 . . . . 0.0 113.078 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 -10.31 76.11 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.363 1.082 . . . . 0.0 114.263 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.5 ttt -64.46 126.43 90.58 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 118.549 1.175 . . . . 0.0 109.405 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.88 -34.82 37.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.007 2.471 . . . . 0.0 112.621 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.57 164.32 36.4 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.55 19.4 68.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.667 0.651 . . . . 0.0 112.077 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.09 -29.77 48.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.698 1.199 . . . . 0.0 110.445 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.61 153.21 42.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -146.87 162.12 39.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.39 -138.53 45.91 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.1 -6.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.176 1.791 . . . . 0.0 114.909 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.59 -67.19 0.79 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.243 1.817 . . . . 0.0 108.223 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.44 90.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.454 -0.779 . . . . 0.0 111.004 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.23 -48.58 76.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.66 91.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.694 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.1 t -53.05 -49.45 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.47 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.59 -56.58 6.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.096 0.862 . . . . 0.0 110.391 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.87 -55.67 30.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.745 0.418 . . . . 0.0 111.611 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.62 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 55.8 t90 -58.05 -49.9 75.3 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.023 0.916 . . . . 0.0 111.351 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.495 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -64.37 -43.27 95.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.182 0.993 . . . . 0.0 109.6 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.71 -41.81 67.4 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 170.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.99 -13.61 60.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.035 0.934 . . . . 0.0 112.459 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -15.56 56.33 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.704 -1.247 . . . . 0.0 113.242 -169.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.596 1.158 . . . . 0.0 113.765 -150.146 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.35 63.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.901 -166.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -62.2 -43.08 99.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.283 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.31 85.9 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 119.452 1.024 . . . . 0.0 110.984 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -47.09 -64.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 32' ' ' CYS . 69.3 t -64.41 -43.46 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 117.711 -1.596 . . . . 0.0 112.244 -167.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -56.02 -2.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.564 3.145 . . . . 0.0 112.984 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.66 2.59 2.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.286 0.948 . . . . 0.0 113.507 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -129.33 -53.06 1.18 Allowed 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.141 0.977 . . . . 0.0 110.541 -168.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.691 ' HB2' HG13 ' A' ' 28' ' ' VAL . 1.9 m -95.62 -40.3 9.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.934 0.494 . . . . 0.0 109.756 -171.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 pt -52.45 -28.02 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.054 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.17 -30.26 2.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.115 1.366 . . . . 0.0 112.571 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 m -126.28 -37.25 2.24 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.409 0.683 . . . . 0.0 111.316 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -78.71 -10.56 59.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.27 153.11 22.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.121 0.867 . . . . 0.0 110.946 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -47.5 5.99 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.424 1.488 . . . . 0.0 113.665 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -85.14 -10.3 56.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.824 1.25 . . . . 0.0 112.224 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 48' ' ' ILE . 1.4 mt 70.18 23.05 5.32 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.855 2.062 . . . . 0.0 111.709 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -76.2 -7.37 54.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.722 2.409 . . . . 0.0 111.89 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.86 112.47 2.08 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.56 -72.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.469 0.708 . . . . 0.0 109.475 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -93.99 2.05 56.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.628 1.171 . . . . 0.0 110.737 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.63 162.06 38.01 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.579 1.951 . . . . 0.0 106.034 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.41 163.91 22.17 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.862 1.708 . . . . 0.0 110.622 174.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 121.55 14.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.595 HD11 HD22 ' A' ' 40' ' ' LEU 0.25 2.0 pp -115.62 -1.59 9.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.972 174.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -38.69 -46.82 1.28 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.359 0.982 . . . . 0.0 112.216 165.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -98.32 3.93 48.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.814 2.046 . . . . 0.0 111.177 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.25 -32.66 56.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.174 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.78 -30.42 72.69 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.886 1.221 . . . . 0.0 113.68 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.33 -45.55 38.8 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.281 1.04 . . . . 0.0 109.359 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -73.67 -41.16 63.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -130.4 165.01 23.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 127.186 2.194 . . . . 0.0 107.766 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 m -103.77 167.92 9.47 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.931 -0.481 . . . . 0.0 110.691 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -38.63 68.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.322 -173.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -53.87 -48.04 70.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.598 0.636 . . . . 0.0 112.449 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -66.17 -47.71 73.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.504 1.145 . . . . 0.0 108.503 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.72 -47.14 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.3 tp -51.81 -55.49 19.58 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 110.623 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.66 -54.57 11.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -63.8 -39.95 87.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.579 -171.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.83 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 121.294 -0.878 . . . . 0.0 109.396 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.46 -35.17 80.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -100.71 -55.79 2.5 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.376 1.471 . . . . 0.0 112.303 -168.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.12 -168.09 22.16 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.903 1.716 . . . . 0.0 110.383 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -164.06 160.99 22.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.16 2.984 . . . . 0.0 103.392 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 9.56 -99.41 0.01 OUTLIER Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.382 1.944 . . . . 0.0 116.302 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.55 17.79 57.13 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 118.491 1.146 . . . . 0.0 113.584 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.1 ttt -89.05 129.62 47.46 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 125.313 1.445 . . . . 0.0 108.464 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.48 -41.22 33.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.833 2.356 . . . . 0.0 112.048 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 159.38 17.23 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.14 20.56 62.92 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 122.165 -0.609 . . . . 0.0 111.614 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.5 mm -63.5 -29.12 46.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 124.518 1.127 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 149.15 45.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -142.19 157.77 44.49 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.294 0.952 . . . . 0.0 113.248 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.84 -141.51 44.86 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.05 -35.71 2.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.197 1.399 . . . . 0.0 112.563 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.36 -62.55 1.58 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.607 1.163 . . . . 0.0 110.179 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.16 80.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.173 0.589 . . . . 0.0 110.715 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.66 -50.36 74.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.544 0.687 . . . . 0.0 109.634 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.52 -48.09 81.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.027 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 28' ' ' VAL . 78.0 t -49.95 -55.9 4.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.263 172.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.3 17.51 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.051 0.841 . . . . 0.0 110.556 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.85 78.96 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.005 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.616 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 71.7 t90 -61.13 -46.06 92.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.033 0.533 . . . . 0.0 111.72 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -66.56 -43.83 83.97 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.64 -47.81 58.33 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.11 -10.17 59.41 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.341 -0.85 . . . . 0.0 112.172 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 -5.45 59.24 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.871 -1.143 . . . . 0.0 112.079 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 C--O 1.247 0.948 0 C-N-CA 125.957 1.703 . . . . 0.0 114.194 -164.953 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.9 58.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.97 -1.013 . . . . 0.0 113.06 -165.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.18 -44.24 97.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.208 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.11 77.25 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.557 0.617 . . . . 0.0 110.852 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.03 -60.89 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 170.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.708 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.25 63.2 t -66.85 -40.76 86.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 121.078 -1.014 . . . . 0.0 112.047 -168.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -60.34 1.05 0.14 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.04 2.936 . . . . 0.0 113.746 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.31 -22.64 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 168.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -15.96 11.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 111.999 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.9 m -121.55 -41.39 2.49 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.58 0.627 . . . . 0.0 111.283 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.0 pt -48.68 -29.81 2.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 122.974 0.51 . . . . 0.0 111.561 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -38.1 -44.94 0.87 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.918 1.687 . . . . 0.0 112.02 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -113.19 -41.66 3.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.873 0.469 . . . . 0.0 110.73 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -71.27 -15.31 62.42 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.55 152.04 24.28 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -56.99 3.88 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.029 1.3 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 -5.86 49.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.956 1.302 . . . . 0.0 112.046 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 mt 66.53 20.38 10.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.099 1.759 . . . . 0.0 111.89 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 p -81.31 1.15 33.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.91 2.084 . . . . 0.0 111.647 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 79.21 1.44 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.596 0.635 . . . . 0.0 112.441 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.08 -80.37 0.13 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.973 0.387 . . . . 0.0 111.135 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m -94.51 1.94 55.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.442 1.497 . . . . 0.0 112.068 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.1 46.9 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.85 164.58 21.24 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.661 1.574 . . . . 0.0 110.992 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.85 113.22 6.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.861 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.437 ' O ' HD11 ' A' ' 88' ' ' LEU 0.262 2.3 pp -107.96 -2.02 10.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.604 178.139 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -32.92 -54.53 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.112 1.365 . . . . 0.0 112.261 163.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 3.14 54.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.923 2.089 . . . . 0.0 111.429 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.65 -37.76 42.57 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.196 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.97 -27.54 59.74 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.916 0.78 . . . . 0.0 115.001 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -44.5 55.67 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.266 1.033 . . . . 0.0 110.212 171.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -74.05 -38.45 63.98 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.66 0.384 . . . . 0.0 111.258 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -140.47 160.41 40.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 108.348 -167.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -94.59 165.84 12.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.541 0.736 . . . . 0.0 111.127 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.18 -45.87 53.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.42 0.688 . . . . 0.0 110.387 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.26 -49.84 31.93 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 112.573 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.48 -51.38 60.51 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.034 0.934 . . . . 0.0 110.276 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.24 -47.48 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.2 tp -48.02 -56.74 6.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.306 1.842 . . . . 0.0 110.12 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.34 -47.81 78.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.1 -44.18 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 122.277 -0.264 . . . . 0.0 110.762 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.2 mt -61.14 -50.65 79.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.115 -0.99 . . . . 0.0 109.724 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -39.74 89.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.562 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -94.81 -61.24 1.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.587 1.955 . . . . 0.0 111.59 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.33 -175.86 21.14 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.571 2.034 . . . . 0.0 110.202 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -150.97 164.46 36.32 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 167.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -4.97 -91.75 0.0 OUTLIER Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.965 2.221 . . . . 0.0 116.272 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.53 34.72 5.34 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.558 1.179 . . . . 0.0 112.58 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 ttt -114.49 123.97 31.43 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 125.592 1.557 . . . . 0.0 108.671 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.64 -38.67 59.83 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.869 2.38 . . . . 0.0 112.621 -170.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 162.61 27.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 122.077 0.82 . . . . 0.0 111.857 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.98 21.22 65.46 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 mt -64.55 -30.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.838 1.255 . . . . 0.0 109.559 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.48 149.48 44.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -143.83 164.5 30.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.231 0.923 . . . . 0.0 111.681 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.64 -140.85 43.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.38 -35.21 5.25 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.939 1.295 . . . . 0.0 112.095 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.04 -56.14 26.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.866 0.466 . . . . 0.0 109.921 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.32 81.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.643 -0.661 . . . . 0.0 110.72 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.53 -53.04 62.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.144 0.429 . . . . 0.0 110.214 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.01 57.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.402 0.681 . . . . 0.0 109.932 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.2 -61.96 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.28 -51.96 49.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.702 0.801 . . . . 0.0 111.374 -170.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.35 -56.18 25.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 110.656 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.964 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 20.4 t90 -54.09 -41.0 67.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.439 0.696 . . . . 0.0 111.467 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.964 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -79.02 -28.63 43.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.856 -1.153 . . . . 0.0 111.291 -175.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.88 67.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.576 0.75 . . . . 0.0 111.375 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.79 62.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.332 1.053 . . . . 0.0 110.75 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.504 ' HA ' ' CE ' ' A' ' 91' ' ' LYS 0.33 0.0 OUTLIER -62.64 9.4 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 118.924 2.935 . . . . 0.0 118.924 -163.102 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--O 1.251 1.166 0 O-C-N 120.77 -1.206 . . . . 0.0 113.26 -149.811 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.99 -49.6 20.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.445 1.098 . . . . 0.0 112.339 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.15 -44.77 96.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.751 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.1 82.92 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.414 1.006 . . . . 0.0 111.476 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -51.57 -63.2 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.678 HG22 ' SG ' ' A' ' 32' ' ' CYS 0.258 34.1 t -67.05 -39.54 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.696 -164.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.93 0.86 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.174 2.99 . . . . 0.0 112.987 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.45 -25.36 3.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.736 1.153 . . . . 0.0 113.996 165.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -117.85 -17.92 9.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.625 1.17 . . . . 0.0 113.041 -163.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.678 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.6 m -113.58 -39.72 3.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.679 1.127 . . . . 0.0 111.275 176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -50.3 -29.29 5.91 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.6 -29.58 3.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.812 1.245 . . . . 0.0 112.813 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -123.61 -41.52 2.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.696 0.799 . . . . 0.0 110.624 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -74.63 -10.63 59.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.81 152.3 13.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.56 -57.97 2.64 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.476 1.512 . . . . 0.0 113.452 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -5.84 53.3 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.856 1.662 . . . . 0.0 112.523 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD21 HG12 ' A' ' 28' ' ' VAL . 8.0 mt 69.96 21.58 6.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.256 1.822 . . . . 0.0 111.485 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -75.28 -8.09 55.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.406 2.283 . . . . 0.0 111.766 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 99.29 1.49 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 -76.5 0.56 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.471 0.635 . . . . 0.0 109.811 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 m -93.98 2.06 56.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.506 1.523 . . . . 0.0 111.691 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.12 161.3 45.85 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 127.207 2.203 . . . . 0.0 105.303 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.7 165.67 22.48 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.33 2.02 . . . . 0.0 111.094 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 120.76 13.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.893 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 2.0 pp -117.23 0.54 8.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.063 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.26 -43.63 10.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.257 0.935 . . . . 0.0 111.207 164.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -96.53 3.89 52.39 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.561 1.544 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -52.81 -34.58 54.35 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.633 -0.667 . . . . 0.0 111.131 173.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.06 -30.47 75.68 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.045 0.839 . . . . 0.0 113.567 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.49 -47.24 17.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.987 0.893 . . . . 0.0 110.199 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.64 -44.58 49.73 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.704 0.402 . . . . 0.0 111.591 -171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.22 -178.28 3.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.833 2.053 . . . . 0.0 107.288 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.8 t -123.64 171.92 9.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 0.566 . . . . 0.0 110.294 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.79 -44.12 73.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.338 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -52.37 -48.19 65.73 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.959 0.8 . . . . 0.0 111.567 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.0 -50.38 64.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.512 0.672 . . . . 0.0 109.69 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.24 -47.16 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.4 tp -49.88 -55.48 14.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.76 -48.27 72.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -47.43 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.144 -0.348 . . . . 0.0 110.26 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.49 -48.32 87.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 120.835 -1.165 . . . . 0.0 110.022 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.7 -43.18 89.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -86.5 -56.42 3.43 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.19 1.396 . . . . 0.0 110.934 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.1 -160.69 21.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 126.841 2.162 . . . . 0.0 108.737 -166.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.38 162.71 37.66 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 101.811 -3.403 . . . . 0.0 101.811 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.16 -54.56 1.23 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.865 1.221 . . . . 0.0 113.983 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -105.74 30.64 9.45 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 117.478 0.639 . . . . 0.0 113.264 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.6 ttt -137.8 129.52 16.22 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 118.664 1.232 . . . . 0.0 109.449 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.55 -41.98 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.103 2.535 . . . . 0.0 113.058 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.23 166.55 39.94 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-O 121.841 0.69 . . . . 0.0 112.18 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.47 19.48 68.82 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.3 -35.11 70.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 125.757 1.623 . . . . 0.0 109.63 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.49 146.12 41.64 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 165.3 30.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.066 0.546 . . . . 0.0 112.436 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.47 -141.36 35.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -173.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.84 -38.94 0.73 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.746 1.619 . . . . 0.0 112.395 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.38 -58.83 6.9 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.925 0.49 . . . . 0.0 110.191 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.0 90.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.22 -51.95 55.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.471 0.708 . . . . 0.0 109.77 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.49 69.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.36 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -48.84 -61.3 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 118.396 0.543 . . . . 0.0 110.026 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.42 -55.79 9.9 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.168 0.987 . . . . 0.0 111.805 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.94 -53.49 57.36 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.707 0.765 . . . . 0.0 110.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.652 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 57.8 t90 -57.41 -37.36 72.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.203 0.525 . . . . 0.0 111.625 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.527 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -72.53 -42.97 64.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 121.241 -0.912 . . . . 0.0 109.475 -177.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -36.92 64.13 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.255 0.222 . . . . 0.0 110.736 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -18.68 60.78 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.733 -0.605 . . . . 0.0 112.411 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 7.62 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.962 2.505 . . . . 0.0 114.934 -172.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.251 1.158 0 O-C-N 119.791 -1.818 . . . . 0.0 113.144 -143.348 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.06 -50.68 35.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.179 0.991 . . . . 0.0 112.485 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.33 -44.51 97.07 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.715 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.96 78.58 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.181 0.901 . . . . 0.0 111.184 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.27 -64.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 72.3 t -67.64 -39.32 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 117.921 -1.512 . . . . 0.0 111.851 -163.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -57.89 0.46 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.999 3.32 . . . . 0.0 114.271 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.63 -37.58 1.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.607 1.094 . . . . 0.0 113.241 164.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 -32.32 15.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.436 1.494 . . . . 0.0 110.201 -163.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.9 m -110.77 -39.15 4.93 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.407 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 pt -51.6 -28.87 9.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 O-C-N 123.121 0.263 . . . . 0.0 111.651 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 t -37.55 -45.66 0.77 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.958 1.703 . . . . 0.0 111.768 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.9 m -110.88 -43.06 3.85 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 122.832 0.453 . . . . 0.0 110.619 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -72.49 -15.47 61.8 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.41 153.13 24.37 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.93 4.25 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.15 1.357 . . . . 0.0 113.664 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.4 -0.8 38.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.913 0.485 . . . . 0.0 112.172 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD21 HG12 ' A' ' 28' ' ' VAL . 1.7 mt 66.28 23.65 10.75 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.134 1.774 . . . . 0.0 111.069 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -6.93 58.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.334 2.654 . . . . 0.0 111.565 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 78.21 1.38 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 118.434 0.561 . . . . 0.0 111.936 166.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.42 -78.27 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.643 0.377 . . . . 0.0 111.363 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.5 t -97.52 2.29 49.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.79 1.636 . . . . 0.0 111.64 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.36 162.09 41.34 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.01 165.23 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.773 1.649 . . . . 0.0 111.33 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.06 117.93 8.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.492 HD11 HD22 ' A' ' 40' ' ' LEU 0.294 2.0 pp -114.07 0.31 8.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.835 175.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -35.15 48.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.727 1.149 . . . . 0.0 112.034 171.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.49 4.43 50.46 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.914 1.286 . . . . 0.0 111.974 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . . . -53.2 -35.13 59.55 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.38 67.11 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.748 1.158 . . . . 0.0 114.526 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.99 -45.6 49.01 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.425 1.113 . . . . 0.0 109.535 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.608 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -136.78 160.43 38.87 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.026 2.131 . . . . 0.0 108.236 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.1 m -95.31 169.26 10.2 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.417 0.287 . . . . 0.0 110.645 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -40.09 76.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.093 -174.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -53.24 -53.17 54.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.705 1.202 . . . . 0.0 111.757 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.18 -50.19 73.62 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.181 0.992 . . . . 0.0 109.528 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.1 -51.77 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.29 -55.01 14.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.105 1.362 . . . . 0.0 109.892 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -44.08 97.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.07 -41.92 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.625 -0.672 . . . . 0.0 110.786 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mt -63.5 -50.08 79.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -38.41 90.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.608 0.363 . . . . 0.0 111.5 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -89.38 -59.18 2.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.048 1.739 . . . . 0.0 111.355 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.28 115.92 3.04 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.879 1.704 . . . . 0.0 109.157 -165.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.13 150.31 10.9 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -26.47 -65.64 0.07 OUTLIER Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.826 1.203 . . . . 0.0 115.989 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.59 22.99 21.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.167 0.983 . . . . 0.0 113.67 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.2 ttt -139.23 121.48 10.24 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.822 1.249 . . . . 0.0 110.554 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.58 140.73 58.01 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 N-CA-C 108.825 -1.259 . . . . 0.0 108.825 171.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.98 -172.26 21.8 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.25 12.67 63.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.64 -30.47 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.785 1.234 . . . . 0.0 109.569 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.46 145.88 45.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 168.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -143.02 161.97 36.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.629 0.771 . . . . 0.0 111.122 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.67 -137.59 26.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.99 -37.6 1.4 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.221 1.409 . . . . 0.0 112.343 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -60.67 -59.18 5.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.014 0.526 . . . . 0.0 109.915 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.17 92.98 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.365 -0.835 . . . . 0.0 110.626 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.98 -52.16 61.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 109.735 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.48 -51.31 67.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.118 0.567 . . . . 0.0 110.313 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.2 -60.76 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.449 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.09 -53.46 42.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 118.53 0.604 . . . . 0.0 110.869 -169.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.54 38.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.102 0.477 . . . . 0.0 110.63 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.596 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 56.9 t90 -62.49 -39.3 93.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.657 0.741 . . . . 0.0 112.229 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.596 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -76.24 -34.03 59.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.731 -1.231 . . . . 0.0 109.268 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.37 -54.07 45.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 161.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.2 -8.25 52.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.104 -0.998 . . . . 0.0 112.161 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -24.28 66.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.558 1.143 . . . . 0.0 110.926 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.767 -1.111 . . . . 0.0 113.043 -156.351 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.87 -51.23 58.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.115 -166.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.95 -42.55 94.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.304 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.8 -44.56 86.4 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.931 1.241 . . . . 0.0 111.055 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -48.94 -60.51 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.649 HG21 ' CZ3' ' A' ' 87' ' ' TRP 0.299 89.5 t -65.19 -42.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.678 -167.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -60.37 0.89 0.15 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.556 3.542 . . . . 0.0 113.997 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.75 -20.07 1.02 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -25.22 11.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.993 1.317 . . . . 0.0 110.855 -173.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.0 m -118.86 -41.08 2.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.474 0.579 . . . . 0.0 111.742 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -49.26 -30.06 3.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 122.681 0.392 . . . . 0.0 111.52 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -36.25 -43.55 0.37 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.298 1.839 . . . . 0.0 111.641 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.79 -44.81 2.91 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 110.934 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -69.17 -16.85 63.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.85 154.52 27.39 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.22 -60.42 2.31 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.366 1.46 . . . . 0.0 114.085 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.64 -3.3 43.29 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 48' ' ' ILE . 1.2 mt 68.29 25.6 7.08 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.495 1.518 . . . . 0.0 110.548 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -78.16 -7.6 57.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 129.032 2.933 . . . . 0.0 111.265 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.19 76.99 1.31 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.447 0.567 . . . . 0.0 112.191 164.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.16 -80.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.748 0.419 . . . . 0.0 111.598 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -92.04 2.23 56.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.022 1.729 . . . . 0.0 112.066 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.69 162.27 39.56 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.67 162.3 32.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.796 1.664 . . . . 0.0 111.39 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.48 115.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.091 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.616 HD11 HD22 ' A' ' 40' ' ' LEU . 2.4 pp -105.06 0.5 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.252 172.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -36.69 37.04 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.226 0.921 . . . . 0.0 111.658 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.67 3.55 55.31 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.176 0.991 . . . . 0.0 112.824 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.53 69.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.076 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.59 66.83 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 121.76 2.073 . . . . 0.0 114.073 171.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.36 -45.91 57.75 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.321 -1.105 . . . . 0.0 109.718 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.26 -37.93 63.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.882 0.473 . . . . 0.0 111.547 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.33 160.57 39.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.434 1.894 . . . . 0.0 108.464 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -94.74 166.67 11.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.274 0.559 . . . . 0.0 110.763 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.58 -44.49 36.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.697 1.199 . . . . 0.0 110.718 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.78 -55.86 17.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.444 1.098 . . . . 0.0 112.007 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.99 -51.54 67.38 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.672 1.189 . . . . 0.0 109.412 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -61.24 -50.39 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -50.77 -55.31 17.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.795 1.238 . . . . 0.0 109.742 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.13 -46.11 89.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.039 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mt -58.55 -40.86 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 O-C-N 121.963 -0.46 . . . . 0.0 110.9 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.55 -50.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.25 -37.2 86.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -92.21 -45.19 8.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.88 1.672 . . . . 0.0 111.962 -170.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.81 113.66 3.03 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.32 1.438 . . . . 0.0 110.075 -168.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -55.34 155.52 5.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 159.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -32.56 -64.53 0.26 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.315 1.436 . . . . 0.0 116.114 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.12 2.73 85.56 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 117.951 0.876 . . . . 0.0 113.484 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.6 ttt -103.43 132.26 21.27 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.286 1.434 . . . . 0.0 110.569 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.45 136.33 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.883 1.722 . . . . 0.0 110.163 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.53 148.54 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.41 79.93 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.6 mm -56.26 -33.52 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.712 1.205 . . . . 0.0 110.259 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.75 149.92 49.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -143.34 157.53 44.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.452 0.644 . . . . 0.0 112.357 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.64 -137.05 31.59 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.91 -37.59 1.34 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.306 1.442 . . . . 0.0 112.519 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.15 -60.6 3.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.467 0.707 . . . . 0.0 109.757 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.66 82.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.498 -0.751 . . . . 0.0 110.764 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.6 -49.74 76.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.211 0.605 . . . . 0.0 110.253 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.63 -49.93 66.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 28' ' ' VAL . 64.7 t -51.42 -60.74 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.202 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.36 -55.58 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.13 0.972 . . . . 0.0 110.982 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.32 69.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.649 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 18.7 t90 -63.59 -57.05 11.35 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.194 0.521 . . . . 0.0 111.481 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -57.23 -36.48 70.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.356 -1.465 . . . . 0.0 109.847 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.25 -58.04 10.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 168.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.32 -12.87 61.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.233 -0.917 . . . . 0.0 111.947 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -23.67 66.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.66 -174.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.2 pttt . . . . . 0 C--O 1.251 1.133 0 C-N-CA 127.337 2.255 . . . . 0.0 113.931 -153.654 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.69 -50.41 68.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.604 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.197 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.6 79.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.888 1.222 . . . . 0.0 111.32 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.3 t -47.23 -63.95 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.767 HG13 ' SG ' ' A' ' 32' ' ' CYS . 77.8 t -67.9 -39.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.99 -165.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -56.63 -3.88 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 129.142 2.977 . . . . 0.0 113.297 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.22 -5.52 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -119.47 -27.92 5.45 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.61 1.164 . . . . 0.0 111.464 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.767 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -114.3 -37.81 4.27 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.251 0.621 . . . . 0.0 111.246 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -51.15 -30.75 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.313 0.245 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 m -37.22 -41.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.326 1.45 . . . . 0.0 113.252 170.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -120.2 -40.86 2.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.086 0.554 . . . . 0.0 110.809 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -75.81 -9.1 58.32 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.416 -0.803 . . . . 0.0 113.052 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.58 154.74 12.84 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 118.954 0.797 . . . . 0.0 111.131 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.6 -56.87 4.08 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.197 1.38 . . . . 0.0 113.66 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -81.44 -1.86 47.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.124 0.569 . . . . 0.0 112.199 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.541 HD21 HG12 ' A' ' 28' ' ' VAL . 3.6 mt 70.46 22.67 5.13 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.02 1.728 . . . . 0.0 110.748 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.32 -7.79 58.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.634 2.774 . . . . 0.0 111.665 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.32 100.19 1.78 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.882 0.753 . . . . 0.0 111.613 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.8 -79.25 0.52 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.704 0.752 . . . . 0.0 110.042 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 m -92.4 1.5 57.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.47 160.73 55.84 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.577 1.951 . . . . 0.0 105.783 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.03 164.72 23.92 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.093 1.862 . . . . 0.0 111.421 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.67 14.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.43 ' O ' HD11 ' A' ' 88' ' ' LEU 0.296 2.2 pp -117.28 0.88 8.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.571 173.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -22.92 18.95 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.861 -1.149 . . . . 0.0 112.778 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 1.25 34.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.995 1.318 . . . . 0.0 112.724 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.69 67.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.481 1.037 . . . . 0.0 111.981 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.0 -30.01 74.25 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.354 1.434 . . . . 0.0 113.576 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.64 -46.11 23.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.113 0.957 . . . . 0.0 111.357 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -72.52 -42.78 64.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.69 173.35 8.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.794 1.637 . . . . 0.0 108.003 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 t -104.53 174.46 5.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.002 0.906 . . . . 0.0 112.548 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -44.01 92.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.03 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.9 -50.64 63.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.45 -51.9 66.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 109.91 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.11 -51.67 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.6 tp -49.27 -56.46 9.33 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.67 -49.28 77.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -56.42 -44.03 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.968 0.507 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mt -63.75 -51.47 69.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 O-C-N 121.776 -0.578 . . . . 0.0 109.908 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.82 -25.27 67.14 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.283 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.4 -62.31 1.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.359 1.864 . . . . 0.0 111.311 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.62 105.68 2.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.687 1.613 . . . . 0.0 110.64 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -57.07 154.07 10.45 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 161.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.76 -62.79 0.65 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.983 1.277 . . . . 0.0 115.191 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.77 22.17 22.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.83 0.815 . . . . 0.0 113.485 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -126.87 132.98 24.55 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 108.408 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.38 -35.88 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.131 1.887 . . . . 0.0 112.393 -171.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.91 161.71 26.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 121.854 0.697 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.06 26.59 61.27 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 122.367 -0.49 . . . . 0.0 111.99 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.2 mt -66.14 -30.47 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.24 1.016 . . . . 0.0 109.533 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.68 145.57 36.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -145.55 156.09 43.48 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.264 0.938 . . . . 0.0 112.593 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.4 -143.66 48.67 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.47 -37.45 1.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.04 1.736 . . . . 0.0 112.455 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -53.96 -64.17 0.91 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.014 1.326 . . . . 0.0 110.208 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.04 92.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.576 -0.702 . . . . 0.0 110.313 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -52.26 -51.78 56.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.436 0.636 . . . . 0.0 109.362 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.4 81.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.767 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.31 -57.78 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-N 118.429 0.559 . . . . 0.0 110.186 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.75 -56.23 13.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.734 0.814 . . . . 0.0 110.784 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.4 -53.34 59.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.663 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.505 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 58.3 t90 -54.52 -54.19 44.42 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.816 0.446 . . . . 0.0 110.899 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.505 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -57.71 -45.7 85.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.179 -0.951 . . . . 0.0 110.316 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.04 65.96 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -88.69 -22.42 23.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.68 1.592 . . . . 0.0 110.829 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -28.44 66.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.412 -0.805 . . . . 0.0 110.064 -164.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 pttt . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.887 1.275 . . . . 0.0 111.763 -146.189 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.84 -53.27 26.63 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.325 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.741 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.59 67.73 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.511 1.05 . . . . 0.0 110.171 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -51.68 -57.42 3.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.503 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 2.3 t -77.55 -1.36 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.128 -174.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 -99.89 1.64 43.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.787 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.27 -26.61 0.76 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -106.01 -14.52 15.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.709 1.204 . . . . 0.0 111.618 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 6.8 m -122.36 -41.49 2.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.845 0.858 . . . . 0.0 111.247 -168.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 28' ' ' VAL . 31.0 pt -49.03 -31.11 3.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -40.27 -39.8 1.02 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.907 1.683 . . . . 0.0 111.461 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.9 m -117.24 -42.15 2.93 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 122.7 0.4 . . . . 0.0 111.088 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -72.15 -15.67 61.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.07 155.03 30.53 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.97 -56.31 4.52 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.162 1.363 . . . . 0.0 113.111 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -82.87 0.66 43.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.775 0.83 . . . . 0.0 112.399 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 48' ' ' ILE . 5.3 mt 64.91 23.96 12.66 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.155 1.382 . . . . 0.0 111.559 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -80.86 -6.05 58.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 128.557 2.743 . . . . 0.0 111.662 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.67 76.82 1.32 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 118.442 0.565 . . . . 0.0 111.91 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 -75.81 0.23 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.393 . . . . 0.0 111.462 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -96.83 1.7 50.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.168 1.787 . . . . 0.0 111.045 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.41 32.96 Favored Pre-proline 0 N--CA 1.452 -0.355 0 C-N-CA 127.081 2.152 . . . . 0.0 105.296 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.97 162.31 26.32 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.574 1.516 . . . . 0.0 110.848 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.72 125.11 23.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.489 ' O ' HD11 ' A' ' 88' ' ' LEU 0.274 2.2 pp -119.72 -3.22 9.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.46 174.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -38.64 -45.8 1.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.817 1.19 . . . . 0.0 111.913 164.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 2.56 51.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.557 1.543 . . . . 0.0 111.992 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.59 -28.71 56.63 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.274 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.06 73.42 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.279 0.945 . . . . 0.0 114.079 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -44.23 32.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.678 0.739 . . . . 0.0 109.483 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -74.61 -43.98 52.85 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.47 164.31 21.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.199 2.2 . . . . 0.0 108.523 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -99.3 163.92 12.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.177 0.591 . . . . 0.0 111.284 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -47.91 -48.05 31.87 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 110.441 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -48.16 -48.53 34.27 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.076 0.95 . . . . 0.0 112.268 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.06 -52.7 46.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.522 0.729 . . . . 0.0 109.679 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.93 -47.12 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.4 tp -48.18 -56.3 8.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.482 1.513 . . . . 0.0 110.174 172.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.4 -50.03 68.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.33 -44.22 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 25.8 mt -63.39 -46.02 96.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 120.433 -1.417 . . . . 0.0 110.08 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.79 -37.26 81.79 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.915 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -93.4 -36.67 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.985 2.114 . . . . 0.0 112.249 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.62 -178.75 27.63 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.955 1.74 . . . . 0.0 110.06 -163.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -137.76 164.27 29.29 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.81 -69.89 0.09 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.738 1.637 . . . . 0.0 114.868 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 31.62 6.02 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.02 0.91 . . . . 0.0 113.348 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.2 ttt -139.6 121.17 9.78 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.652 1.181 . . . . 0.0 111.564 -174.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.36 157.87 55.62 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.03 1.82 . . . . 0.0 110.424 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 148.3 18.7 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -172.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.58 16.3 66.45 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.769 -0.461 . . . . 0.0 112.373 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.62 -41.22 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.911 0.884 . . . . 0.0 108.973 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB3' ' CG2' ' A' ' 64' ' ' ILE . . . -128.89 143.23 50.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -140.68 158.72 43.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 0.0 108.83 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.98 -139.22 29.17 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.07 1.55 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.549 1.54 . . . . 0.0 112.384 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -59.02 6.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.134 0.574 . . . . 0.0 109.541 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.45 85.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.38 -52.65 64.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.265 0.626 . . . . 0.0 110.402 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.86 69.61 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 109.522 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG22 ' CG2' ' A' ' 28' ' ' VAL . 53.2 t -48.4 -63.24 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 O-C-N 123.388 0.43 . . . . 0.0 109.877 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.8 51.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.21 1.004 . . . . 0.0 111.085 -171.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.23 37.63 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.425 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 60.6 t90 -57.74 -38.46 75.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.183 0.593 . . . . 0.0 111.564 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.489 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -72.42 -45.35 60.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.559 0.744 . . . . 0.0 109.469 -178.091 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.07 -33.07 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.733 0.813 . . . . 0.0 111.264 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -21.81 60.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.851 0.86 . . . . 0.0 110.904 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -66.93 8.75 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -161.299 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 pttt . . . . . 0 C--O 1.247 0.962 0 O-C-N 120.9 -1.125 . . . . 0.0 112.969 -131.731 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.31 -49.73 42.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.936 -168.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.74 -45.74 93.13 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.556 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -44.91 82.46 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.482 1.037 . . . . 0.0 110.808 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.91 -62.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.668 HG13 ' SG ' ' A' ' 32' ' ' CYS . 72.1 t -66.69 -39.33 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.203 -168.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -59.08 0.26 0.1 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 129.141 2.976 . . . . 0.0 113.502 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 -15.43 1.57 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.08 -20.98 11.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.818 1.247 . . . . 0.0 111.503 -171.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.668 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.8 m -118.73 -40.98 2.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.989 0.813 . . . . 0.0 112.123 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.7 pt -50.7 -29.85 7.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 111.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -41.27 -39.15 1.3 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.949 1.699 . . . . 0.0 113.048 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -116.66 -43.31 2.91 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.33 0.652 . . . . 0.0 110.575 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.42 -12.94 60.98 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.88 153.28 25.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.11 -53.69 6.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.88 1.229 . . . . 0.0 113.111 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -81.79 -1.53 47.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.27 0.628 . . . . 0.0 112.205 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.46 HD21 HG12 ' A' ' 28' ' ' VAL . 5.6 mt 66.38 21.79 10.86 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.631 1.572 . . . . 0.0 111.26 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -78.98 -6.76 57.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.312 2.645 . . . . 0.0 111.572 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.56 82.92 1.65 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.461 0.573 . . . . 0.0 111.738 168.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.24 -77.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.768 0.427 . . . . 0.0 110.965 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -97.17 2.58 51.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.695 1.598 . . . . 0.0 111.58 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.0 161.28 46.26 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.98 163.19 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.73 1.62 . . . . 0.0 111.163 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 123.08 18.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.288 2.2 pp -119.04 -1.12 8.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.194 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -38.46 -45.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.574 1.079 . . . . 0.0 112.567 163.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.68 2.98 44.88 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.25 1.82 . . . . 0.0 112.59 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.14 -30.53 16.85 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.787 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.96 -30.29 76.75 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.12 0.873 . . . . 0.0 114.806 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.61 -44.15 44.42 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.663 -0.904 . . . . 0.0 109.374 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -73.36 -36.81 66.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.63 157.83 45.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 m -90.61 165.66 13.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.546 0.738 . . . . 0.0 111.806 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -46.72 63.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.474 0.71 . . . . 0.0 110.488 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -49.86 -49.03 50.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.053 . . . . 0.0 111.694 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.75 -49.72 71.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.467 0.651 . . . . 0.0 109.639 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.42 -48.05 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.3 tp -48.63 -53.51 18.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.653 1.181 . . . . 0.0 109.64 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.81 0.63 6.77 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.615 0.766 . . . . 0.0 113.037 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -104.35 -39.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 120.91 -1.119 . . . . 0.0 109.441 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 mt -66.24 -50.58 67.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.133 -0.98 . . . . 0.0 109.961 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.4 -39.8 94.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.469 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.38 -48.56 7.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.087 0.955 . . . . 0.0 112.373 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.12 107.99 3.06 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.641 1.591 . . . . 0.0 109.723 -167.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.48 149.52 16.95 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 163.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -19.18 -71.13 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 C-N-CA 126.286 1.898 . . . . 0.0 116.965 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.03 73.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 117.946 0.873 . . . . 0.0 113.793 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.8 ttt -87.99 127.49 57.44 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 126.095 1.758 . . . . 0.0 109.483 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.12 143.39 84.13 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 N-CA-C 109.237 -1.101 . . . . 0.0 109.237 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.45 166.97 28.39 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.52 18.05 75.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.922 -0.639 . . . . 0.0 112.307 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -54.66 -36.02 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.55 1.14 . . . . 0.0 109.967 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.28 146.38 38.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -143.0 154.76 44.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.395 1.078 . . . . 0.0 110.772 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.58 -136.36 49.59 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.53 -38.63 6.53 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.599 1.16 . . . . 0.0 111.978 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -51.9 -62.13 1.82 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.797 0.839 . . . . 0.0 109.348 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.89 71.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.019 0.527 . . . . 0.0 110.904 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.32 -51.05 71.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 0.0 109.928 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -50.18 71.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.759 -0.638 . . . . 0.0 109.362 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.85 -61.76 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.986 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.1 -54.15 14.18 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 111.195 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -54.63 44.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 110.873 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.578 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 59.3 t90 -57.85 -41.1 81.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 111.749 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.447 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.55 -45.12 66.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 108.938 -177.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.58 -31.96 68.5 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.432 0.693 . . . . 0.0 112.125 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -21.18 60.95 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 110.701 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -68.82 7.67 0.64 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -158.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.5 pttt . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.478 -1.249 . . . . 0.0 113.075 -128.465 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.2 m-20 . . . . . 0 N--CA 1.438 -1.028 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB1' ' CB ' ' A' ' 87' ' ' TRP . . . -101.51 -69.86 0.76 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.78 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -58.51 -41.38 85.29 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.421 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -57.17 -39.15 74.71 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.673 0.67 . . . . 0.0 111.303 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.82 -55.87 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.606 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 3.5 t -66.32 -41.05 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 117.015 -1.874 . . . . 0.0 110.615 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -59.92 0.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 129.844 3.258 . . . . 0.0 114.761 169.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.47 -15.51 0.95 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.6 -23.56 11.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.09 1.356 . . . . 0.0 110.519 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -122.82 -39.09 2.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.018 0.527 . . . . 0.0 111.615 -165.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -49.11 -30.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 C-N-CA 122.797 0.439 . . . . 0.0 111.647 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 m -38.46 -39.67 0.48 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.864 1.665 . . . . 0.0 113.068 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.85 -43.97 2.64 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.943 0.497 . . . . 0.0 110.519 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.93 -16.24 63.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 113.017 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.69 153.44 26.9 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.8 -59.12 2.48 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.189 1.376 . . . . 0.0 113.13 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.98 -2.19 38.98 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.188 0.995 . . . . 0.0 112.378 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD21 HG12 ' A' ' 28' ' ' VAL . 1.7 mt 65.33 24.15 12.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.026 1.73 . . . . 0.0 111.631 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -78.54 -8.33 58.46 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.765 2.826 . . . . 0.0 111.449 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.24 76.51 1.26 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-N 118.408 0.549 . . . . 0.0 111.984 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.59 -82.53 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.792 0.437 . . . . 0.0 111.443 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.72 1.46 56.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.699 1.999 . . . . 0.0 111.97 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.05 162.93 35.55 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.3 165.63 21.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.813 1.676 . . . . 0.0 111.148 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.45 117.2 7.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 40' ' ' LEU 0.265 2.2 pp -114.55 -3.78 11.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.207 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -38.23 -48.27 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.504 1.047 . . . . 0.0 111.996 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -99.95 5.55 45.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.395 1.878 . . . . 0.0 112.08 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -46.96 -44.46 20.05 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.918 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.49 -29.1 16.62 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.964 0.802 . . . . 0.0 114.839 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.08 68.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.413 -1.051 . . . . 0.0 110.497 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.77 -44.0 12.87 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.24 0.616 . . . . 0.0 110.816 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.25 154.85 38.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.817 2.047 . . . . 0.0 107.701 -171.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -95.44 169.82 9.79 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.736 0.415 . . . . 0.0 110.75 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -43.0 64.58 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.713 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -48.74 -52.71 22.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 111.863 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.57 -53.91 50.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.841 0.856 . . . . 0.0 109.684 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.01 -46.97 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -171.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.1 tp -47.31 -56.33 7.04 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.013 1.725 . . . . 0.0 109.95 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.07 -48.4 76.15 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -46.94 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.64 -47.84 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.965 -1.084 . . . . 0.0 109.917 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.5 -27.04 64.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.47 0.708 . . . . 0.0 112.852 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.42 -60.77 1.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.039 -171.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.83 -167.13 24.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.191 2.329 . . . . 0.0 109.469 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -157.97 163.89 37.36 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -15.81 -83.78 0.01 OUTLIER Glycine 0 CA--C 1.542 1.73 0 C-N-CA 126.005 1.764 . . . . 0.0 116.303 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.39 18.82 56.21 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.818 1.309 . . . . 0.0 113.566 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -103.81 127.71 28.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.01 1.324 . . . . 0.0 109.168 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.1 -40.98 24.13 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.569 2.179 . . . . 0.0 112.13 -172.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 161.67 23.09 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 121.851 0.695 . . . . 0.0 111.732 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.61 22.17 65.7 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 122.178 -0.601 . . . . 0.0 111.827 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.46 -29.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.448 1.499 . . . . 0.0 109.835 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.47 143.12 29.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -138.3 166.5 24.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.48 -135.09 41.78 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.9 -36.83 8.01 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.675 1.19 . . . . 0.0 112.027 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -60.63 -55.91 27.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.97 84.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.637 -0.664 . . . . 0.0 111.22 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.69 -54.14 49.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.305 0.502 . . . . 0.0 110.999 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.04 -51.19 62.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.8 t -50.03 -64.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.308 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.61 -51.87 25.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.495 1.118 . . . . 0.0 111.148 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -55.26 34.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 110.77 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 66.3 t90 -59.36 -39.59 83.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.006 0.432 . . . . 0.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -68.95 -41.65 77.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 -178.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.98 -39.08 73.98 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 122.129 -0.357 . . . . 0.0 110.522 168.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.14 -19.05 61.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.99 0.516 . . . . 0.0 111.28 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.71 9.08 0.94 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.953 1.701 . . . . 0.0 114.649 -171.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 C--O 1.25 1.12 0 O-C-N 120.635 -1.29 . . . . 0.0 112.73 -154.428 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.442 -0.835 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.23 -53.05 60.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.555 -167.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.18 -43.59 98.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.088 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.32 78.13 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.168 0.895 . . . . 0.0 111.326 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -46.25 -63.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.732 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 80.2 t -67.97 -37.78 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 117.352 -1.739 . . . . 0.0 112.52 -166.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -60.1 -1.02 0.26 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.203 3.001 . . . . 0.0 113.179 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 -9.67 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 169.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -118.72 -25.19 6.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.188 1.395 . . . . 0.0 112.04 -171.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -117.21 -40.96 3.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.418 0.554 . . . . 0.0 110.499 -172.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -48.33 -32.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 122.942 0.497 . . . . 0.0 111.612 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -38.64 -37.38 0.32 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 113.206 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -120.08 -41.72 2.63 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.786 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.16 -6.33 49.04 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.66 -86.72 0.41 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.408 1.004 . . . . 0.0 112.788 163.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.53 -62.93 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.35 2.59 39.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 111.764 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.85 26.87 7.51 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.31 1.844 . . . . 0.0 111.505 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -72.83 -10.87 60.29 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.43 1.892 . . . . 0.0 111.721 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 104.14 1.8 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.4 -77.11 0.6 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.535 0.734 . . . . 0.0 110.01 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -92.26 2.1 56.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.922 1.289 . . . . 0.0 111.646 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.83 158.61 52.61 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -63.98 164.57 21.63 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.153 1.902 . . . . 0.0 111.105 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.24 123.72 18.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.631 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.415 ' O ' HD11 ' A' ' 88' ' ' LEU 0.253 2.5 pp -119.79 -2.42 8.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.322 -0.847 . . . . 0.0 112.266 172.452 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -42.06 -44.85 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.133 1.333 . . . . 0.0 111.594 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.68 4.14 45.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.608 1.563 . . . . 0.0 112.195 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.4 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -48.9 -36.97 18.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.358 176.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.07 -34.34 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 120.86 1.664 . . . . 0.0 114.379 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -53.27 32.04 Favored 'General case' 0 C--N 1.337 0.056 0 O-C-N 121.446 -1.032 . . . . 0.0 110.276 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -74.31 -37.02 63.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.474 -169.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -132.01 151.53 51.69 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.831 1.652 . . . . 0.0 107.822 -171.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.34 166.95 12.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.665 0.745 . . . . 0.0 110.899 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.37 -47.83 26.02 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.026 1.331 . . . . 0.0 110.498 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.94 -46.34 68.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.853 0.751 . . . . 0.0 111.764 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.99 -53.68 42.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.511 0.724 . . . . 0.0 109.27 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 64' ' ' ILE . 69.6 mt -60.07 -47.6 91.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.0 tp -49.85 -54.47 19.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.13 1.372 . . . . 0.0 110.322 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.38 -49.66 71.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -46.46 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 60' ' ' ILE . 32.1 mt -58.95 -48.84 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 121.245 -0.909 . . . . 0.0 109.635 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.75 -32.63 73.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.485 0.714 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -101.78 -61.55 1.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.015 1.726 . . . . 0.0 111.481 -169.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.09 -173.36 22.71 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 126.776 2.131 . . . . 0.0 110.388 -171.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.92 163.94 38.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 168.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -17.83 -81.97 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.178 1.847 . . . . 0.0 116.102 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.13 25.71 24.35 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.858 1.329 . . . . 0.0 113.441 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -112.46 126.77 27.81 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.948 1.299 . . . . 0.0 108.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.93 -40.88 49.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.101 2.534 . . . . 0.0 112.381 -172.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.67 161.47 25.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-O 121.958 0.755 . . . . 0.0 111.869 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.63 62.12 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.09 -35.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.437 0.695 . . . . 0.0 109.344 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.5 52.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -145.05 152.24 39.8 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.925 0.869 . . . . 0.0 113.233 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.94 -138.86 47.97 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.76 -34.26 11.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.706 1.203 . . . . 0.0 112.034 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.23 -57.01 13.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.086 0.954 . . . . 0.0 109.906 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.77 -39.58 80.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.837 -0.539 . . . . 0.0 110.266 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -55.73 -53.38 57.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.909 0.322 . . . . 0.0 110.151 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.79 39.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.466 0.706 . . . . 0.0 109.643 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.24 -65.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 O-C-N 123.433 0.458 . . . . 0.0 110.21 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.86 -48.85 66.8 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.793 0.837 . . . . 0.0 111.235 -170.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.74 30.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.755 0.422 . . . . 0.0 110.337 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.732 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 31.9 t90 -54.9 -41.8 71.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.362 0.665 . . . . 0.0 111.247 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.88 -49.32 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.821 0.848 . . . . 0.0 110.366 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.07 69.22 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.522 0.729 . . . . 0.0 110.875 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.49 -23.21 60.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.427 1.091 . . . . 0.0 110.985 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -32.17 73.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.263 -0.898 . . . . 0.0 110.472 -166.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.989 1.716 . . . . 0.0 114.502 -145.446 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.64 -49.78 14.02 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.129 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -63.11 -44.03 96.78 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.928 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.43 75.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 120.002 1.273 . . . . 0.0 111.183 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -55.0 -63.52 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.769 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 25.6 t -65.32 -42.61 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.683 -164.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -3.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.025 2.93 . . . . 0.0 112.726 170.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.59 0.55 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mmtt -126.89 -30.51 2.73 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.114 0.966 . . . . 0.0 111.878 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.5 m -110.23 -38.47 5.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.76 0.709 . . . . 0.0 110.687 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.0 pt -51.55 -30.15 10.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -38.66 -39.22 0.47 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.396 1.878 . . . . 0.0 113.154 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -123.02 -38.8 2.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 110.993 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.16 -9.68 59.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.18 155.87 17.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.94 -57.02 3.63 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.257 1.408 . . . . 0.0 113.498 -174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.03 1.29 44.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 112.518 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt 68.42 21.36 8.28 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.051 1.341 . . . . 0.0 111.363 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -6.59 53.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.972 2.509 . . . . 0.0 111.654 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 113.51 2.34 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.64 -77.15 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.771 0.786 . . . . 0.0 109.449 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 m -93.08 1.85 57.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.938 1.295 . . . . 0.0 111.477 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.89 159.23 57.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 127.038 2.135 . . . . 0.0 105.591 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.0 164.66 21.36 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.08 1.854 . . . . 0.0 111.263 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 120.04 11.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.273 2.2 pp -115.14 -0.4 9.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-O 118.272 -0.871 . . . . 0.0 112.063 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -46.23 -41.26 12.65 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.46 1.027 . . . . 0.0 112.157 170.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.93 4.05 51.77 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.329 1.452 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -25.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.598 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.31 -33.03 76.79 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.901 1.228 . . . . 0.0 113.997 171.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.93 -43.21 59.05 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.624 -0.927 . . . . 0.0 109.646 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -74.36 -44.17 53.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.066 0.547 . . . . 0.0 111.109 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.49 164.43 23.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.707 2.003 . . . . 0.0 108.486 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.22 168.49 10.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.521 0.729 . . . . 0.0 111.6 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -44.0 73.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.34 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.158 0.983 . . . . 0.0 112.236 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.88 -49.21 78.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 64' ' ' ILE . 74.2 mt -63.53 -49.87 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -175.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.0 tp -47.39 -57.52 5.2 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.495 1.518 . . . . 0.0 110.121 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.5 -45.17 92.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.2 mt -59.63 -43.17 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.646 -0.659 . . . . 0.0 111.0 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 60' ' ' ILE . 31.0 mt -59.69 -48.4 87.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 O-C-N 120.941 -1.099 . . . . 0.0 109.449 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 mt -65.82 -34.8 79.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.327 0.651 . . . . 0.0 112.21 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -102.97 -53.79 2.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.572 1.549 . . . . 0.0 112.356 -167.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -171.72 20.23 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.411 1.958 . . . . 0.0 110.269 -170.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -166.08 135.83 3.31 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.02 -110.75 0.15 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 120.333 1.424 . . . . 0.0 113.465 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.85 -9.2 68.52 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.157 0.979 . . . . 0.0 114.232 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -63.18 127.52 91.08 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 118.498 1.149 . . . . 0.0 109.122 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -63.79 -37.84 42.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.14 2.56 . . . . 0.0 111.817 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.48 165.41 32.69 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-O 121.987 0.771 . . . . 0.0 111.668 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.24 68.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -65.13 -32.62 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.069 0.948 . . . . 0.0 110.192 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.37 150.41 51.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -144.11 153.26 41.96 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.217 0.917 . . . . 0.0 113.359 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.76 -142.21 47.31 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.6 -36.91 1.52 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.614 1.565 . . . . 0.0 112.437 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -54.27 -61.99 1.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.426 1.09 . . . . 0.0 110.04 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.88 -38.82 87.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.711 -0.618 . . . . 0.0 110.487 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.94 -50.62 72.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 109.851 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.08 73.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.559 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.84 -57.82 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.347 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.14 -54.36 13.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.4 1.08 . . . . 0.0 111.224 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.85 71.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.955 0.407 . . . . 0.0 110.707 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.769 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 64.3 t90 -62.84 -27.24 69.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.578 1.151 . . . . 0.0 112.809 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.607 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -84.73 -43.33 14.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 176.139 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.12 -42.88 73.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.721 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -5.6 41.35 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.27 0.941 . . . . 0.0 112.22 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.0 6.9 1.35 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -163.417 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.989 -124.92 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.443 -0.8 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.94 -51.86 9.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.063 0.945 . . . . 0.0 111.916 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -62.73 -43.95 97.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.603 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.89 82.42 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 119.156 0.889 . . . . 0.0 110.858 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -49.99 -61.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 40.4 t -63.67 -41.99 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 116.803 -1.959 . . . . 0.0 112.697 -170.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -63.18 1.23 0.5 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.411 3.084 . . . . 0.0 113.628 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -134.92 -22.63 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -112.29 -20.42 11.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.719 1.608 . . . . 0.0 111.577 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -121.76 -42.65 2.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.463 0.574 . . . . 0.0 111.25 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.1 pt -48.78 -32.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.696 0.398 . . . . 0.0 111.609 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.24 -36.88 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.067 1.747 . . . . 0.0 113.384 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.0 -42.38 2.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.272 0.629 . . . . 0.0 110.837 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.79 -7.95 54.95 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.41 -84.45 0.37 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.409 1.004 . . . . 0.0 112.813 163.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.25 -64.36 0.02 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.97 3.58 37.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.9 0.88 . . . . 0.0 111.866 173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 67.61 28.1 7.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.583 1.553 . . . . 0.0 111.576 -175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -73.62 -13.07 60.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.036 2.135 . . . . 0.0 111.075 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.38 98.64 1.62 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 172.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.56 -77.47 0.56 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.473 0.709 . . . . 0.0 110.157 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -90.71 1.42 56.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.603 1.161 . . . . 0.0 111.542 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.91 160.2 44.34 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.726 2.011 . . . . 0.0 105.686 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -64.2 164.52 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.25 1.967 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.62 25.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.227 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 88' ' ' LEU 0.274 2.8 pp -119.78 -1.06 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 122.76 0.424 . . . . 0.0 112.131 176.286 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -35.39 64.11 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.009 -1.057 . . . . 0.0 111.426 167.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 4.07 51.91 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.486 1.514 . . . . 0.0 111.677 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.36 -53.87 12.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.92 9.22 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 115.156 0.822 . . . . 0.0 115.156 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.35 -29.65 28.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.023 0.912 . . . . 0.0 110.971 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -92.76 -51.95 4.85 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 124.036 0.934 . . . . 0.0 110.113 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.46 146.13 40.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.518 2.327 . . . . 0.0 108.276 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.4 m -86.87 164.16 16.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.256 0.48 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -45.52 58.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.898 0.479 . . . . 0.0 110.008 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -47.01 -53.31 12.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.371 1.468 . . . . 0.0 112.512 173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.39 -48.6 77.21 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.687 0.795 . . . . 0.0 110.175 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 64' ' ' ILE . 67.1 mt -63.05 -46.73 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -49.85 -55.29 14.84 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.084 1.753 . . . . 0.0 109.786 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.86 73.55 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.89 -37.15 77.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 121.307 -0.87 . . . . 0.0 111.62 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 21.8 mt -65.47 -44.87 94.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.501 -1.374 . . . . 0.0 109.819 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -68.74 -41.42 78.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.081 0.552 . . . . 0.0 111.594 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -91.28 -37.29 13.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.713 1.605 . . . . 0.0 111.62 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.8 -167.17 18.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.308 1.433 . . . . 0.0 110.139 -166.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -149.69 163.03 39.04 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -31.33 -66.66 0.16 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.641 1.591 . . . . 0.0 114.754 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.25 32.35 6.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.708 0.67 . . . . 0.0 113.266 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.7 ttt -139.4 128.76 14.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.399 1.079 . . . . 0.0 111.594 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.2 155.44 68.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.399 2.066 . . . . 0.0 111.312 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.25 142.67 15.57 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.34 24.95 60.08 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.877 0.751 . . . . 0.0 111.432 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.3 mt -51.83 -44.38 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 108.971 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' A' ' 80' ' ' GLU . . . -134.47 140.19 46.04 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.5 2.32 . . . . 0.0 105.302 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -147.25 153.71 40.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 109.189 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.78 -133.89 51.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.86 -46.89 11.03 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.436 1.095 . . . . 0.0 111.804 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.75 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 35.7 mp0 -52.42 -61.4 2.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.898 0.772 . . . . 0.0 110.432 175.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.42 97.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.911 -0.493 . . . . 0.0 110.839 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.46 -58.93 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.197 0.999 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.21 -53.55 49.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.725 1.21 . . . . 0.0 109.618 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -50.38 -61.9 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.045 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.34 -51.66 57.61 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.572 0.749 . . . . 0.0 110.571 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.91 63.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 110.798 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.604 ' CE3' HD12 ' A' ' 88' ' ' LEU . 72.2 t90 -61.86 -31.96 72.28 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.093 0.557 . . . . 0.0 111.665 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.604 HD12 ' CE3' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -75.76 -43.74 45.1 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.032 -1.043 . . . . 0.0 110.166 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.21 -37.71 62.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.599 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.4 -8.5 59.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.165 1.348 . . . . 0.0 113.443 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.472 ' CA ' ' HE2' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -73.21 5.24 3.67 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.053 2.141 . . . . 0.0 116.204 -170.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 pttp . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.534 -1.222 . . . . 0.0 111.192 -126.373 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -52.64 11.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 112.962 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.28 -46.55 89.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.315 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.52 78.56 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.093 0.86 . . . . 0.0 111.218 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.2 -61.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 170.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.888 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 81.9 t -68.92 -40.16 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 120.854 -1.154 . . . . 0.0 112.293 -167.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -58.06 0.61 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 129.136 2.974 . . . . 0.0 113.003 167.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.65 -12.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 13.5 mttt -122.59 -19.09 6.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.708 1.203 . . . . 0.0 112.101 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -116.93 -41.59 3.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.42 1.009 . . . . 0.0 111.699 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -48.83 -32.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 122.47 0.308 . . . . 0.0 111.43 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -36.09 -38.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.22 2.208 . . . . 0.0 113.464 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -117.52 -42.31 2.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.617 0.767 . . . . 0.0 110.699 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -74.25 -8.35 55.93 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.67 -90.38 0.43 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.577 1.084 . . . . 0.0 112.751 164.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.1 -58.67 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.59 3.42 47.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.802 0.841 . . . . 0.0 111.367 172.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 65.68 27.59 11.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.741 1.617 . . . . 0.0 111.149 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -78.38 -5.22 51.64 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.727 2.411 . . . . 0.0 111.667 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 92.47 1.57 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.713 0.688 . . . . 0.0 111.599 166.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.31 -79.78 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.38 0.672 . . . . 0.0 110.617 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.9 t -90.81 1.64 56.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.278 1.031 . . . . 0.0 111.25 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.86 160.13 44.74 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.49 161.47 27.67 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.018 1.812 . . . . 0.0 111.198 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.61 116.7 8.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.989 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.7 pp -106.58 -6.81 10.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.053 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -43.85 -50.87 7.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.779 1.172 . . . . 0.0 111.036 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 1.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.534 -0.728 . . . . 0.0 112.103 -175.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -52.96 -40.45 63.69 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.049 -171.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.67 -26.28 24.18 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 119.028 0.831 . . . . 0.0 114.045 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -45.3 62.13 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.31 -1.112 . . . . 0.0 110.264 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -80.82 -43.13 20.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.165 0.986 . . . . 0.0 111.099 -171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.61 158.96 37.86 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.959 2.103 . . . . 0.0 107.647 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -100.75 171.9 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.249 0.477 . . . . 0.0 112.028 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -40.57 75.11 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.47 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -53.34 -49.79 66.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.507 1.048 . . . . 0.0 111.429 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.56 -48.23 78.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.52 0.728 . . . . 0.0 110.029 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 64' ' ' ILE . 82.2 mt -64.33 -47.58 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -49.24 -57.24 7.12 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.667 1.587 . . . . 0.0 110.365 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -46.28 82.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.97 -43.7 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.526 -0.734 . . . . 0.0 111.268 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 60' ' ' ILE . 30.9 mt -60.18 -47.4 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.104 -0.997 . . . . 0.0 109.536 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.36 -42.59 92.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -91.28 -51.8 5.12 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.368 1.467 . . . . 0.0 111.473 -166.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -166.94 17.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -164.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.79 167.21 28.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 175.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.63 72.32 0.02 OUTLIER Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.84 1.2 . . . . 0.0 113.118 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.11 -15.6 3.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.374 1.94 . . . . 0.0 112.585 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.7 ttt -112.37 132.14 22.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.776 1.288 . . . . 0.0 108.459 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.93 -38.09 7.89 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.224 2.616 . . . . 0.0 113.528 -169.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.44 173.18 48.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-O 122.003 0.78 . . . . 0.0 112.218 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 -1.73 62.3 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.267 0.937 . . . . 0.0 112.629 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.09 -31.61 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.171 2.188 . . . . 0.0 111.036 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.87 139.65 38.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -141.79 155.17 45.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.468 1.507 . . . . 0.0 108.675 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.56 -136.49 43.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.15 -41.53 3.74 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.036 1.334 . . . . 0.0 111.796 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.92 -64.12 0.92 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.516 0.726 . . . . 0.0 109.377 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.94 96.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.995 -0.44 . . . . 0.0 110.918 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.06 -58.02 9.67 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.822 0.849 . . . . 0.0 110.077 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.41 -50.91 66.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.128 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 28' ' ' VAL . 61.3 t -49.15 -63.03 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 123.577 0.548 . . . . 0.0 110.365 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.19 62.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.159 0.984 . . . . 0.0 111.095 -171.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.06 -55.52 33.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.279 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.888 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 35.4 t90 -52.31 -39.41 60.54 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.361 0.664 . . . . 0.0 110.771 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.859 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.35 -41.52 73.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -27.92 62.91 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.142 -0.349 . . . . 0.0 110.877 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -88.82 -12.36 42.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.041 0.937 . . . . 0.0 112.977 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -83.35 -0.56 50.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 110.45 -174.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 O-C-N 119.867 -1.771 . . . . 0.0 112.407 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.56 -50.89 40.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.081 0.952 . . . . 0.0 112.485 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.37 -41.42 93.7 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.537 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.02 94.54 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.93 1.241 . . . . 0.0 111.216 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.9 -63.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 166.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.82 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 85.8 t -63.79 -41.27 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.517 -166.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -60.48 -1.98 0.44 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.227 3.011 . . . . 0.0 112.89 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -11.62 2.26 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 168.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -119.74 -23.86 6.36 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.87 1.268 . . . . 0.0 112.793 -169.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.677 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.1 m -122.47 -41.32 2.4 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.812 0.733 . . . . 0.0 111.589 -172.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.3 pt -50.39 -30.04 7.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 122.408 0.283 . . . . 0.0 111.066 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -35.93 -41.06 0.22 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.57 2.348 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.44 -40.37 2.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.295 0.638 . . . . 0.0 110.848 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -78.14 -8.73 58.64 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.33 157.96 16.31 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.148 0.886 . . . . 0.0 112.038 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -36.34 -62.12 0.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.337 1.922 . . . . 0.0 115.952 -168.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -92.86 4.62 53.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.424 1.112 . . . . 0.0 111.988 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 77.39 28.29 0.6 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.671 1.988 . . . . 0.0 110.953 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.2 -10.7 59.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.234 2.214 . . . . 0.0 112.505 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.39 100.26 1.52 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.958 0.79 . . . . 0.0 111.562 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.56 -76.75 0.58 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.732 0.766 . . . . 0.0 110.188 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -94.86 2.24 55.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 111.654 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.02 160.97 50.81 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 127.121 2.169 . . . . 0.0 105.238 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.74 165.03 24.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.903 1.735 . . . . 0.0 111.103 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 115.7 4.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.4 pp -112.56 -0.96 9.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.492 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -44.48 -45.73 9.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.672 1.124 . . . . 0.0 112.049 168.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -90.65 3.84 53.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.249 1.42 . . . . 0.0 111.156 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.15 -31.58 65.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.774 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.76 -30.23 76.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 120.518 1.508 . . . . 0.0 113.195 170.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.44 54.38 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.016 -1.285 . . . . 0.0 110.487 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -74.21 -38.6 63.52 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.286 0.234 . . . . 0.0 111.302 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -135.31 175.64 9.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.253 2.221 . . . . 0.0 108.033 -172.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -112.18 167.74 10.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.247 0.619 . . . . 0.0 110.483 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -50.57 -41.28 54.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 111.531 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -57.01 -51.69 68.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.176 1.353 . . . . 0.0 111.959 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.34 -51.22 69.07 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.141 0.976 . . . . 0.0 109.261 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.49 -49.92 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.834 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.3 tp -48.81 -56.33 9.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.314 1.446 . . . . 0.0 110.333 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.43 -44.76 95.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.931 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.7 mt -59.93 -41.96 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 121.838 -0.539 . . . . 0.0 110.696 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.04 -50.04 81.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.138 -0.976 . . . . 0.0 109.659 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.83 -30.9 71.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.477 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -105.16 -57.31 2.05 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.441 1.497 . . . . 0.0 112.244 -168.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.57 -173.47 21.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.068 1.794 . . . . 0.0 110.554 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -165.48 125.02 1.75 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.88 -113.53 1.06 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.974 1.261 . . . . 0.0 112.779 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.26 82.61 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.207 1.004 . . . . 0.0 113.965 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.5 ttt -66.36 126.85 92.79 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.46 1.13 . . . . 0.0 109.468 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.25 -39.16 39.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.751 2.3 . . . . 0.0 112.082 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.18 163.74 28.78 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 121.956 0.753 . . . . 0.0 111.707 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.84 21.64 65.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.14 -35.3 73.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.286 1.434 . . . . 0.0 109.759 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.54 146.77 49.99 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -139.93 155.09 47.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.235 0.925 . . . . 0.0 112.903 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.84 -139.32 45.87 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.4 -37.21 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.366 1.467 . . . . 0.0 112.068 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.03 -61.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.2 -39.69 89.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.792 -0.568 . . . . 0.0 110.452 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -58.11 -50.9 71.88 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.048 0.539 . . . . 0.0 110.023 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.94 65.39 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.44 0.696 . . . . 0.0 109.687 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.13 -57.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.321 0 O-C-N 123.237 0.335 . . . . 0.0 110.179 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.7 -55.38 19.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.064 0.545 . . . . 0.0 111.279 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.39 58.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 110.783 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.82 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 21.0 t90 -51.13 -44.14 61.31 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.488 0.715 . . . . 0.0 111.187 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.818 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -76.2 -37.29 57.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.384 -0.823 . . . . 0.0 112.154 -173.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 109.462 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -76.22 -22.16 55.56 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.397 1.079 . . . . 0.0 113.256 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -18.71 55.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.435 -1.415 . . . . 0.0 112.789 -168.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.955 1.702 . . . . 0.0 113.121 -156.055 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.39 -53.06 59.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.2 -161.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -61.94 -40.18 94.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.492 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.8 91.1 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.792 0.724 . . . . 0.0 111.315 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.7 t -48.02 -65.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.717 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 58.4 t -64.63 -41.37 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.526 -165.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.91 0.65 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.985 2.914 . . . . 0.0 113.382 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -126.56 -33.42 2.55 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.135 0.974 . . . . 0.0 113.257 167.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -107.62 -19.68 13.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.924 1.69 . . . . 0.0 112.675 -160.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.6 m -123.37 -40.07 2.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.316 0.507 . . . . 0.0 110.862 -171.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.65 -28.55 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.558 0.343 . . . . 0.0 111.422 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -36.75 -43.7 0.44 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.962 2.105 . . . . 0.0 112.913 170.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.28 -37.68 3.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.56 0.744 . . . . 0.0 110.681 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -77.75 -9.42 59.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.4 153.19 10.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.8 -60.54 2.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.175 1.369 . . . . 0.0 113.314 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -3.23 39.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.513 1.125 . . . . 0.0 112.456 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD21 HG12 ' A' ' 28' ' ' VAL . 7.6 mt 71.06 24.38 3.95 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.138 1.775 . . . . 0.0 111.124 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -79.51 -6.03 56.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.397 2.279 . . . . 0.0 112.036 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.59 112.64 2.26 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.07 -73.23 0.67 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.148 0.974 . . . . 0.0 109.986 175.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -98.3 2.2 47.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.55 56.54 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 127.356 2.262 . . . . 0.0 105.394 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.11 165.14 25.12 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.818 1.679 . . . . 0.0 110.751 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.98 122.49 15.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.316 2.2 pp -116.57 1.93 7.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.54 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -42.34 -48.81 5.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.662 1.119 . . . . 0.0 112.151 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -90.28 4.84 49.5 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.916 1.286 . . . . 0.0 112.02 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.24 -44.83 53.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.826 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.02 -33.52 44.54 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 120.862 1.665 . . . . 0.0 114.038 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.74 -35.77 77.54 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.375 -1.074 . . . . 0.0 110.891 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -89.78 -34.39 16.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.668 0.787 . . . . 0.0 111.166 -171.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -138.65 142.47 39.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.109 1.363 . . . . 0.0 108.035 -167.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 p -80.49 165.3 22.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.649 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -49.36 -49.56 43.89 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.367 1.067 . . . . 0.0 110.019 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -47.09 -52.6 14.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.646 1.179 . . . . 0.0 112.676 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.98 -49.01 77.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.515 -0.741 . . . . 0.0 110.336 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.98 -47.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.0 tp -50.29 -55.36 15.76 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.82 1.648 . . . . 0.0 109.943 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.76 -48.17 80.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -57.98 -43.46 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.56 0.344 . . . . 0.0 110.377 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.4 -50.42 80.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.08 -28.65 68.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -103.46 -60.95 1.48 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.137 1.775 . . . . 0.0 111.495 -171.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.8 -175.75 21.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.405 1.955 . . . . 0.0 110.365 -170.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.62 164.02 37.81 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.88 -91.97 0.0 OUTLIER Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.921 2.2 . . . . 0.0 116.2 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.36 37.27 3.59 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 118.571 1.186 . . . . 0.0 112.471 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.3 ttt -117.93 122.84 30.12 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 125.547 1.539 . . . . 0.0 108.617 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -61.92 -38.54 57.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.873 2.382 . . . . 0.0 112.688 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.49 163.57 29.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 122.003 0.779 . . . . 0.0 111.849 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.73 22.28 63.99 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.408 0.527 . . . . 0.0 111.872 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mt -64.39 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.168 1.387 . . . . 0.0 109.748 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.95 144.28 38.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -138.78 158.34 44.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.261 0.937 . . . . 0.0 112.931 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.93 -136.27 41.93 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.263 0.935 . . . . 0.0 110.89 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.15 -37.72 3.29 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.259 1.424 . . . . 0.0 112.172 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -59.01 -56.35 23.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.704 0.801 . . . . 0.0 110.214 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.36 88.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.671 -0.643 . . . . 0.0 110.266 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.26 -53.1 58.2 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.311 0.644 . . . . 0.0 109.968 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.14 41.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.609 0.763 . . . . 0.0 109.888 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.9 t -50.72 -58.2 2.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 117.897 0.317 . . . . 0.0 110.36 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.72 -54.16 41.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.02 0.528 . . . . 0.0 110.771 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.18 59.47 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.083 0.468 . . . . 0.0 110.545 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.796 ' CH2' HD23 ' A' ' 88' ' ' LEU . 14.0 t90 -58.33 -47.73 82.8 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.892 0.477 . . . . 0.0 111.69 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.796 HD23 ' CH2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -75.19 -29.75 60.45 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.861 -1.149 . . . . 0.0 110.736 -172.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.04 -56.24 21.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 160.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.69 -8.45 52.11 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.767 -1.208 . . . . 0.0 112.037 -172.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -27.4 61.07 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.289 -0.882 . . . . 0.0 110.11 -176.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.7 pttp . . . . . 0 C--O 1.252 1.223 0 C-N-CA 124.941 1.296 . . . . 0.0 113.702 -150.393 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 t0 . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.29 76.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.575 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -70.62 -41.38 72.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -175.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.25 58.93 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.259 0.936 . . . . 0.0 110.919 174.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 31' ' ' LYS . 59.0 t -49.77 -59.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.554 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 33.1 t -71.11 -11.99 15.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 119.937 1.244 . . . . 0.0 114.071 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -93.51 0.36 56.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.126 2.17 . . . . 0.0 110.86 174.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -6.59 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.487 ' HG3' HG13 ' A' ' 27' ' ' VAL . 53.9 mmtt -112.25 -49.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.67 1.188 . . . . 0.0 109.947 -177.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -88.73 -37.93 15.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.124 0.569 . . . . 0.0 110.978 -170.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 28' ' ' VAL . 23.0 pt -46.89 -36.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.069 0.948 . . . . 0.0 111.317 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 m -37.9 -36.71 0.21 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.326 2.25 . . . . 0.0 112.884 174.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.53 -43.42 2.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.723 . . . . 0.0 111.189 173.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -74.46 -7.12 51.95 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.94 -71.77 0.26 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.088 0.851 . . . . 0.0 113.198 163.035 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.53 -77.46 0.06 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 5.5 5.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.984 1.313 . . . . 0.0 112.367 169.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 69.09 24.71 6.05 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.507 1.523 . . . . 0.0 110.965 176.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.7 p -70.73 -15.0 62.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.056 1.343 . . . . 0.0 111.153 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 97.79 1.9 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -99.0 -80.21 0.47 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.252 0.621 . . . . 0.0 109.831 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 1.94 55.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.228 1.411 . . . . 0.0 111.705 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.92 54.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 127.295 2.238 . . . . 0.0 105.347 -176.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.59 164.31 29.43 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.91 123.36 17.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.03 -5.49 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.746 170.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -41.28 -46.22 3.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.739 1.154 . . . . 0.0 111.336 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 0.73 54.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.106 0.962 . . . . 0.0 110.927 -172.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.9 -41.61 62.08 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 121.376 -0.827 . . . . 0.0 112.056 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.7 -24.75 8.23 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.629 0.633 . . . . 0.0 114.679 177.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.07 -30.34 31.36 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.815 0.807 . . . . 0.0 111.52 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -89.56 -44.57 10.0 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.857 0.863 . . . . 0.0 110.513 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -126.58 149.86 49.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.106 1.763 . . . . 0.0 107.876 -171.34 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.3 m -88.05 162.8 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.787 0.435 . . . . 0.0 111.113 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -42.6 -52.41 4.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.554 1.142 . . . . 0.0 110.32 175.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -48.03 -55.59 9.76 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.12 -49.51 76.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.721 0.772 . . . . 0.0 109.96 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 64' ' ' ILE . 67.2 mt -64.03 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.3 tp -49.41 -55.78 11.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.114 1.366 . . . . 0.0 110.185 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -44.19 90.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -61.69 -40.76 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.335 -0.853 . . . . 0.0 111.356 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 60' ' ' ILE . 26.1 mt -61.03 -47.59 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 120.905 -1.122 . . . . 0.0 109.464 177.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.51 -40.03 88.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.486 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.34 -50.88 5.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.46 1.504 . . . . 0.0 112.318 -169.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.1 -170.83 15.11 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.092 1.806 . . . . 0.0 111.211 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.431 ' H ' ' HB3' ' A' ' 71' ' ' MET . 1.0 OUTLIER -163.93 116.27 1.4 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 127.056 2.142 . . . . 0.0 105.495 168.781 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.9 -109.93 0.64 Allowed Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.062 1.301 . . . . 0.0 113.157 172.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -26.18 73.37 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 118.011 0.905 . . . . 0.0 113.061 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.431 ' HB3' ' H ' ' A' ' 68' ' ' GLN . 22.1 ttt -72.74 118.85 71.57 Favored Pre-proline 0 N--CA 1.454 -0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 109.911 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.32 -34.11 28.18 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.594 2.863 . . . . 0.0 112.582 -173.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.48 165.64 40.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -176.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.32 12.65 66.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.754 0.692 . . . . 0.0 112.278 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.78 -34.65 52.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.845 1.658 . . . . 0.0 110.36 177.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.53 149.46 49.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -145.85 155.66 43.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 179.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.68 -136.93 49.15 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -175.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.17 -37.44 4.46 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.795 1.238 . . . . 0.0 112.186 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -54.29 -61.4 2.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.237 1.015 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.91 74.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.725 -0.61 . . . . 0.0 111.145 -175.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.24 -52.86 63.87 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.441 0.564 . . . . 0.0 109.873 175.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.44 -52.47 53.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.98 -62.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 123.176 0.298 . . . . 0.0 110.786 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.97 69.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 111.285 -171.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.97 -53.37 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.317 0.58 . . . . 0.0 110.662 177.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.554 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 20.3 t90 -60.11 -31.31 69.93 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.786 0.834 . . . . 0.0 112.001 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -43.41 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 172.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.39 77.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.067 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.99 -16.41 58.15 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 13.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.877 3.271 . . . . 0.0 114.953 -177.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.095 0 O-C-N 119.981 -1.7 . . . . 0.0 112.88 -151.19 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.47 66.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.561 -169.265 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.84 -42.14 88.59 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.638 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.45 93.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.543 0.61 . . . . 0.0 109.881 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.03 -60.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.636 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.267 87.1 t -65.19 -43.25 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.726 -168.871 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.72 0.72 0.74 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.354 2.261 . . . . 0.0 114.032 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -138.29 -12.13 1.41 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 172.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -128.42 -20.51 3.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.152 1.381 . . . . 0.0 112.067 -171.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 18.4 m -110.93 -43.6 3.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.138 0.881 . . . . 0.0 110.671 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -49.42 -29.21 3.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.185 0.594 . . . . 0.0 111.845 176.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -38.06 -43.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.868 1.667 . . . . 0.0 112.007 174.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.7 m -114.11 -41.65 3.48 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 117.888 0.313 . . . . 0.0 110.644 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.78 -16.5 62.75 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.401 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.9 25.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.7 -61.51 1.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.581 1.563 . . . . 0.0 113.753 -173.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.24 -5.61 47.67 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.215 1.006 . . . . 0.0 112.419 -177.207 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 48' ' ' ILE . 4.2 mt 69.65 23.68 5.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.085 1.754 . . . . 0.0 111.096 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -78.79 -6.49 56.09 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.552 2.341 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 77.17 1.32 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-N 118.595 0.634 . . . . 0.0 112.064 167.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 -76.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.681 0.392 . . . . 0.0 111.458 177.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -99.52 2.73 45.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.827 1.651 . . . . 0.0 111.552 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.53 162.45 39.17 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.42 166.36 21.9 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.806 1.67 . . . . 0.0 111.299 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.69 122.27 16.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.33 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 40' ' ' LEU 0.311 2.1 pp -117.24 -0.97 8.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.401 173.166 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -34.61 -47.13 0.31 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 112.087 159.353 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -102.65 6.33 39.57 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.984 1.314 . . . . 0.0 112.765 -175.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.31 57.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.102 0.865 . . . . 0.0 111.691 177.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.88 -32.6 75.42 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 119.84 1.2 . . . . 0.0 113.229 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.49 27.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.9 1.35 . . . . 0.0 110.455 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.41 -39.57 62.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.281 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -123.11 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 128.009 2.524 . . . . 0.0 107.606 -173.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.4 m -135.88 171.28 14.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.835 -1.165 . . . . 0.0 109.999 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -39.37 68.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.107 0.563 . . . . 0.0 110.795 -166.168 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.55 -53.14 61.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -57.99 -50.35 73.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.935 0.894 . . . . 0.0 109.383 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.41 -49.67 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.91 -57.27 6.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.872 1.269 . . . . 0.0 109.921 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.85 -43.55 94.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.049 -176.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.03 -41.22 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.736 -0.602 . . . . 0.0 111.14 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.3 mt -59.25 -50.57 79.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 O-C-N 120.899 -1.126 . . . . 0.0 109.408 175.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.82 -36.31 83.47 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.651 -177.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.65 -51.62 3.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.158 1.383 . . . . 0.0 112.12 -168.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.34 -171.67 18.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.857 1.694 . . . . 0.0 110.33 -171.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -165.06 127.9 2.24 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.42 -112.18 0.61 Allowed Glycine 0 CA--C 1.538 1.479 0 CA-C-N 120.098 1.317 . . . . 0.0 112.876 176.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.17 -12.68 75.87 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 118.161 0.981 . . . . 0.0 113.996 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.2 ttt -64.34 125.11 87.69 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 118.46 1.13 . . . . 0.0 109.175 178.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.41 -36.55 54.57 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -172.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.2 165.19 31.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.48 27.49 68.01 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.3 -32.26 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.151 0.98 . . . . 0.0 109.373 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.44 46.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.751 1.621 . . . . 0.0 106.755 173.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -145.32 154.64 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.02 -140.57 48.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -40.52 -37.33 0.69 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.709 1.604 . . . . 0.0 112.557 176.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.32 -61.98 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.308 1.043 . . . . 0.0 110.319 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.67 87.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.748 -0.595 . . . . 0.0 110.29 -177.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.23 -48.38 78.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.649 0.78 . . . . 0.0 110.002 178.236 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.41 82.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.897 176.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.28 -48.95 75.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.707 174.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.63 -55.14 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.162 0.892 . . . . 0.0 110.195 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.02 -58.05 10.13 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.771 0.428 . . . . 0.0 111.475 178.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.636 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 54.9 t90 -57.14 -45.68 83.34 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.078 0.951 . . . . 0.0 111.482 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.485 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -70.78 -42.54 70.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.18 -175.709 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.65 66.86 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.021 -0.424 . . . . 0.0 110.651 169.231 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -74.04 -14.36 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.681 0.792 . . . . 0.0 112.438 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 -15.22 48.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.696 -1.253 . . . . 0.0 113.082 -166.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.923 1.289 . . . . 0.0 112.961 -153.716 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.84 -52.27 43.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.537 -167.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.34 -44.76 96.65 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.366 178.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.38 59.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 120.081 1.31 . . . . 0.0 110.849 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -46.99 -62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.557 HG13 ' SG ' ' A' ' 32' ' ' CYS . 40.2 t -77.78 2.42 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.363 -1.46 . . . . 0.0 113.239 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.28 0.9 38.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.569 2.348 . . . . 0.0 110.063 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -142.35 -13.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -106.93 -55.82 2.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.456 1.503 . . . . 0.0 109.574 -175.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' HG13 ' A' ' 28' ' ' VAL . 2.9 m -82.59 -37.2 25.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.475 0.31 . . . . 0.0 110.663 -171.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 28' ' ' VAL . 14.1 pt -48.31 -32.73 3.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 123.383 0.673 . . . . 0.0 111.284 178.167 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -45.14 -29.52 0.94 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 112.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -127.2 -44.41 1.59 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.439 0.696 . . . . 0.0 111.311 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -71.86 -14.62 62.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.307 -0.87 . . . . 0.0 113.283 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.86 154.95 28.12 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.804 0.716 . . . . 0.0 111.562 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.76 -49.89 8.75 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.215 1.388 . . . . 0.0 113.274 -175.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -84.15 -8.42 59.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.787 0.835 . . . . 0.0 111.857 -176.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.419 HD21 HG12 ' A' ' 28' ' ' VAL . 3.7 mt 69.68 21.45 6.56 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.642 1.577 . . . . 0.0 111.181 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -77.66 -8.23 57.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 128.223 2.609 . . . . 0.0 111.431 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.54 87.0 1.74 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.46 -81.16 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.843 0.457 . . . . 0.0 110.524 175.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -90.45 2.01 56.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.343 1.457 . . . . 0.0 112.138 177.745 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.75 43.55 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.6 166.08 21.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.797 1.665 . . . . 0.0 111.441 -178.002 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.1 117.59 7.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 88' ' ' LEU 0.281 2.5 pp -112.7 -3.32 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.067 176.509 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -38.03 -46.49 1.01 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.644 1.111 . . . . 0.0 113.152 163.437 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -98.15 4.75 49.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.076 1.75 . . . . 0.0 112.116 -177.541 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.07 -38.58 62.61 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.767 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.35 -27.33 65.39 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.619 1.1 . . . . 0.0 113.463 173.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.38 -48.25 20.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.8 -0.824 . . . . 0.0 109.701 177.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -74.08 -45.21 50.69 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 122.634 0.373 . . . . 0.0 111.684 -174.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -122.55 157.36 32.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.284 1.834 . . . . 0.0 109.265 -169.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -89.11 167.18 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.39 0.614 . . . . 0.0 110.813 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.73 -45.59 49.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.078 0.951 . . . . 0.0 109.858 174.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -54.5 -49.56 69.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.593 0.633 . . . . 0.0 112.521 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.7 -51.22 70.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.697 0.761 . . . . 0.0 109.791 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.54 -50.1 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -174.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -47.14 -58.12 4.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.183 1.393 . . . . 0.0 110.271 172.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.14 -47.69 80.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -175.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.74 -44.31 89.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 122.329 0.252 . . . . 0.0 110.673 -178.304 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.7 mt -60.97 -50.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 121.79 -0.569 . . . . 0.0 110.045 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.48 -36.43 84.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.778 -178.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.11 -59.3 2.0 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.1 1.76 . . . . 0.0 111.565 -169.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.36 106.79 2.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.45 1.5 . . . . 0.0 110.595 -168.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -55.19 155.29 4.96 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 160.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.78 -61.64 0.73 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.028 1.299 . . . . 0.0 115.469 -175.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.88 17.49 52.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 117.902 0.851 . . . . 0.0 113.386 -177.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.0 ttt -119.41 136.97 24.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.846 1.658 . . . . 0.0 108.396 -176.044 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.76 -36.91 17.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.104 1.87 . . . . 0.0 112.034 -172.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 163.69 27.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.4 23.52 62.56 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.01 -32.58 58.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 123.57 0.748 . . . . 0.0 109.976 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.49 48.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -144.97 153.21 41.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -137.67 49.51 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.3 -35.99 1.68 Allowed 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 112.352 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.25 -60.37 3.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 110.237 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.01 88.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.556 -0.715 . . . . 0.0 110.52 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.38 -48.33 82.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.307 0.643 . . . . 0.0 110.13 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.59 -49.57 70.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.317 0.647 . . . . 0.0 109.478 175.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 28' ' ' VAL . 61.9 t -52.44 -58.77 2.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.2 173.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.73 -55.12 6.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.932 0.893 . . . . 0.0 111.147 -172.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.87 29.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 110.965 178.222 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.544 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 65.3 t90 -58.99 -41.37 87.46 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.742 0.417 . . . . 0.0 111.515 -175.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.5 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -69.05 -46.02 68.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.293 1.037 . . . . 0.0 109.976 -179.622 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.35 59.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.871 0.468 . . . . 0.0 110.931 171.103 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.42 -17.93 60.72 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.866 1.267 . . . . 0.0 112.536 178.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 2.05 44.16 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.429 -1.419 . . . . 0.0 113.536 -164.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.305 1.442 . . . . 0.0 114.815 -148.444 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -49.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.27 -167.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.39 -39.65 91.47 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.544 178.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.46 96.65 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 120.274 1.397 . . . . 0.0 111.028 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -49.36 -65.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 167.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.806 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 48.1 t -58.97 -48.0 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.488 -167.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -56.58 -6.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.363 3.065 . . . . 0.0 113.268 174.267 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -132.75 2.22 3.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.992 0.917 . . . . 0.0 113.001 173.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -129.16 -59.85 1.09 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.124 0.97 . . . . 0.0 109.831 -169.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.644 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.3 m -86.9 -40.57 14.72 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.679 0.391 . . . . 0.0 110.284 -171.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.15 -26.78 8.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.77 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -46.73 -37.36 8.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.844 1.258 . . . . 0.0 111.549 176.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.5 m -116.02 -38.96 3.52 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 122.934 0.494 . . . . 0.0 111.301 174.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -76.16 -13.01 60.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.93 151.99 23.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -54.03 5.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.254 1.407 . . . . 0.0 112.902 -177.07 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 -7.56 58.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.82 1.648 . . . . 0.0 111.971 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.578 HD22 HD11 ' A' ' 48' ' ' ILE . 1.6 mt 69.08 21.35 7.35 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.808 1.643 . . . . 0.0 110.948 178.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 p -79.34 -5.54 54.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.011 2.524 . . . . 0.0 111.537 178.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.44 83.9 1.65 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 118.53 0.605 . . . . 0.0 111.701 167.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.12 -71.17 0.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.746 0.418 . . . . 0.0 110.853 177.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t -100.17 1.74 42.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.623 1.569 . . . . 0.0 110.839 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.23 163.9 29.79 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 126.273 1.829 . . . . 0.0 106.082 -173.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -63.26 160.64 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.633 1.555 . . . . 0.0 111.231 174.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 113.65 3.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.172 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 88' ' ' LEU . 2.1 pp -100.08 -5.86 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.748 173.279 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -37.89 6.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.839 1.199 . . . . 0.0 112.079 176.057 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -105.46 4.83 31.04 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.393 1.877 . . . . 0.0 112.371 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.9 -35.18 22.68 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 118.688 0.676 . . . . 0.0 110.882 176.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.11 -30.23 54.03 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.961 0.801 . . . . 0.0 114.588 174.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.51 -45.33 38.81 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 121.633 -0.922 . . . . 0.0 109.845 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -73.78 -38.41 64.66 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 122.869 0.467 . . . . 0.0 111.575 -171.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -135.85 154.23 51.24 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.322 1.849 . . . . 0.0 107.721 -171.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -89.46 168.23 12.37 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.161 -0.337 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.84 -43.39 65.99 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.928 0.491 . . . . 0.0 110.952 -175.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.58 -55.85 12.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.104 1.361 . . . . 0.0 112.713 174.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -53.88 -48.54 69.96 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.46 1.104 . . . . 0.0 109.854 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.48 -50.17 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -50.74 -55.58 15.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.872 1.269 . . . . 0.0 110.008 177.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -45.65 91.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.76 -41.25 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 121.378 -0.826 . . . . 0.0 111.25 -178.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.11 -52.3 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.849 0.75 . . . . 0.0 109.839 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.23 -36.92 84.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -174.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -90.28 -53.05 4.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.271 1.828 . . . . 0.0 111.508 -171.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 111.76 3.61 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -169.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -57.17 154.56 9.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 117.8 0.8 . . . . 0.0 108.846 167.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.59 86.8 0.03 OUTLIER Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.062 -1.024 . . . . 0.0 112.516 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.57 -12.38 4.29 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.161 2.315 . . . . 0.0 112.311 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.0 ttt -116.62 129.21 25.44 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 127.081 2.153 . . . . 0.0 108.783 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.45 136.18 33.14 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.306 1.337 . . . . 0.0 108.699 170.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.02 39.5 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.47 13.5 65.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.919 0.771 . . . . 0.0 112.339 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.45 -30.9 45.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.99 1.316 . . . . 0.0 110.204 175.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.47 148.42 42.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.146 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -139.92 156.11 46.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.271 0.941 . . . . 0.0 113.383 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.13 -139.02 41.85 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.42 -37.43 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.744 1.618 . . . . 0.0 112.714 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.53 -62.06 1.9 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.38 1.072 . . . . 0.0 109.675 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.38 82.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.65 -0.656 . . . . 0.0 110.761 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.16 -49.25 77.67 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.262 0.625 . . . . 0.0 109.994 178.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.81 76.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.57 -53.93 14.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.365 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.15 -56.34 8.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.588 0.755 . . . . 0.0 110.777 -174.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -54.49 45.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.806 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 7.6 t90 -60.29 -47.63 85.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.96 0.504 . . . . 0.0 112.151 -175.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -63.61 -43.05 98.02 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.367 -0.833 . . . . 0.0 108.957 -179.701 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.8 -44.02 73.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.315 -0.241 . . . . 0.0 110.866 171.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -73.82 -11.17 60.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.482 1.113 . . . . 0.0 111.927 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.13 60.17 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.028 -1.045 . . . . 0.0 110.277 -177.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.171 -158.982 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.84 -51.72 59.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.617 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.41 -43.73 98.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 118.194 -0.907 . . . . 0.0 109.142 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.18 81.57 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.558 1.072 . . . . 0.0 111.302 -176.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -45.8 -62.63 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.798 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.257 52.1 t -65.11 -40.65 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 118.564 -1.254 . . . . 0.0 113.262 -167.527 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.15 0.37 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.091 3.356 . . . . 0.0 113.196 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -137.37 -12.19 1.61 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -119.38 -25.77 5.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.132 1.373 . . . . 0.0 111.949 -168.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.649 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.7 m -114.12 -39.75 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.992 0.814 . . . . 0.0 111.004 -177.233 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -48.41 -32.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 122.545 0.338 . . . . 0.0 111.416 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -44.17 -30.67 0.81 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.222 1.409 . . . . 0.0 113.024 175.396 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -122.61 -43.98 2.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.689 0.796 . . . . 0.0 110.576 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -71.96 -10.06 59.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.49 -85.0 0.38 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.186 0.898 . . . . 0.0 112.746 163.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.59 -63.54 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -174.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.407 ' C ' HD22 ' A' ' 40' ' ' LEU . 4.7 m-20 -82.59 3.26 29.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 111.86 173.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 39' ' ' ASP . 1.2 mm? 65.29 25.8 12.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.873 1.669 . . . . 0.0 111.453 -172.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.6 -11.91 60.32 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.034 2.134 . . . . 0.0 111.42 177.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.43 89.44 1.82 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 168.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.18 -77.66 0.45 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.274 0.629 . . . . 0.0 110.616 177.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -92.96 2.34 56.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.071 1.349 . . . . 0.0 111.482 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 158.92 50.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -62.58 162.54 24.14 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.985 1.79 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 126.11 26.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.763 177.399 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.438 ' O ' HD11 ' A' ' 88' ' ' LEU 0.272 2.7 pp -116.78 -2.29 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.672 171.738 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -43.7 -45.69 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.499 1.045 . . . . 0.0 112.134 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -94.55 4.23 54.11 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.466 1.106 . . . . 0.0 112.463 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.68 -34.15 37.14 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.572 177.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.72 73.46 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.134 1.334 . . . . 0.0 114.018 173.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.26 -44.83 43.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.503 1.151 . . . . 0.0 110.037 170.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -73.31 -40.95 64.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.509 0.195 . . . . 0.0 111.269 -171.186 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -131.98 169.21 16.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.973 2.109 . . . . 0.0 107.194 -169.688 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 m -108.34 167.45 10.02 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.248 0.477 . . . . 0.0 109.764 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -50.57 -42.15 55.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.249 -176.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.3 -50.83 58.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.12 1.327 . . . . 0.0 112.035 177.362 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -61.87 -52.47 63.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 122.247 1.022 . . . . 0.0 109.252 -176.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 64' ' ' ILE . 37.2 mt -62.57 -47.17 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.21 -53.76 32.08 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.929 1.292 . . . . 0.0 110.047 176.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -56.66 -48.22 78.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.31 -45.7 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.367 -0.833 . . . . 0.0 111.251 -178.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 60' ' ' ILE . 29.5 mt -59.1 -48.0 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.094 -1.003 . . . . 0.0 109.59 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.1 -25.88 62.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.7 0.8 . . . . 0.0 113.104 -177.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.55 -60.29 1.65 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.508 1.523 . . . . 0.0 111.02 -171.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.31 -174.63 21.39 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.648 2.07 . . . . 0.0 109.884 -170.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -152.79 163.58 39.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -1.19 -91.78 0.0 OUTLIER Glycine 0 CA--C 1.543 1.814 0 C-N-CA 126.382 1.944 . . . . 0.0 116.622 175.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.98 12.29 67.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.501 1.151 . . . . 0.0 113.7 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.2 ttt -96.19 120.1 63.25 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.715 1.606 . . . . 0.0 109.023 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.96 -37.31 54.66 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.807 2.338 . . . . 0.0 112.176 -171.411 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.21 164.62 28.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-O 122.111 0.84 . . . . 0.0 111.743 177.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.51 17.14 61.79 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 122.407 -0.466 . . . . 0.0 112.159 -173.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.76 -31.28 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.441 1.496 . . . . 0.0 109.628 173.319 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.58 140.31 35.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -139.5 162.79 34.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.22 1.008 . . . . 0.0 111.768 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.73 -138.59 44.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.83 -37.48 2.81 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.98 1.312 . . . . 0.0 112.002 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.26 -58.37 8.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.836 0.454 . . . . 0.0 110.048 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.49 93.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.753 -0.592 . . . . 0.0 110.507 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.16 -54.07 47.94 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.157 0.583 . . . . 0.0 110.03 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.07 -54.44 30.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.377 0.671 . . . . 0.0 109.626 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.37 -66.99 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 123.432 0.458 . . . . 0.0 110.078 176.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.7 -46.78 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.241 0.617 . . . . 0.0 111.455 -170.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -58.72 7.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.367 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.948 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 9.6 t90 -53.14 -43.38 66.94 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.399 0.68 . . . . 0.0 110.793 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.948 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.62 -39.4 73.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.998 -1.064 . . . . 0.0 110.657 -175.784 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.56 72.39 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.889 -0.507 . . . . 0.0 110.978 166.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -16.25 60.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.648 0.779 . . . . 0.0 112.813 179.023 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -20.14 57.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.822 1.249 . . . . 0.0 111.472 -166.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -156.055 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.38 -52.66 7.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.495 1.118 . . . . 0.0 113.169 -170.281 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.27 -39.84 95.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.286 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.94 76.59 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 119.981 1.264 . . . . 0.0 110.381 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.9 t -52.31 -59.94 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.726 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 29.8 t -79.35 3.85 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -171.682 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -104.96 3.6 30.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.521 1.928 . . . . 0.0 110.465 170.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -128.79 -43.49 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.89 -14.28 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.247 1.419 . . . . 0.0 112.024 -159.65 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 4.5 m -120.91 -37.47 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.615 1.166 . . . . 0.0 111.026 -170.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 pt -50.97 -30.97 9.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.474 0.71 . . . . 0.0 111.659 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -38.18 -42.4 0.68 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.699 2.0 . . . . 0.0 112.737 173.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.3 m -121.3 -38.39 2.8 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.215 0.606 . . . . 0.0 110.799 -177.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -79.79 -8.05 59.03 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.517 -0.74 . . . . 0.0 112.851 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.61 156.21 19.3 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.16 -58.91 3.62 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.633 1.111 . . . . 0.0 112.534 -176.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.94 -4.52 47.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.622 1.169 . . . . 0.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt 72.0 20.43 4.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.764 1.626 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 p -80.23 -2.79 46.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.822 2.449 . . . . 0.0 112.112 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.18 102.36 1.56 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.916 0.77 . . . . 0.0 111.472 168.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.39 -70.66 0.75 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.924 0.862 . . . . 0.0 110.128 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -99.62 2.69 44.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.464 1.506 . . . . 0.0 111.109 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.84 161.79 44.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -175.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.36 163.4 29.65 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.781 1.654 . . . . 0.0 110.828 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.28 113.62 3.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.591 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.305 2.1 pp -105.2 0.69 10.21 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.009 172.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -41.42 14.57 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.239 -0.913 . . . . 0.0 112.801 170.253 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -97.88 4.99 49.54 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.656 1.183 . . . . 0.0 112.106 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.27 32.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.451 -1.261 . . . . 0.0 112.398 -178.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.73 -32.04 68.85 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 120.893 1.679 . . . . 0.0 113.881 174.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.17 -41.55 57.83 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.407 -1.055 . . . . 0.0 109.83 174.068 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -73.56 -35.17 65.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.828 -172.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -142.24 152.89 43.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.847 1.659 . . . . 0.0 108.674 -170.007 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.6 t -80.75 163.81 23.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.823 -0.548 . . . . 0.0 110.621 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.11 -44.92 68.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.24 -0.41 . . . . 0.0 109.951 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.53 -44.55 72.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.372 0.669 . . . . 0.0 112.494 178.221 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.9 -50.49 70.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.582 0.706 . . . . 0.0 109.833 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.53 -48.3 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.118 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 tp -48.38 -56.75 7.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.642 1.577 . . . . 0.0 109.97 175.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -56.54 -48.94 76.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -59.27 -43.73 90.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 122.248 -0.282 . . . . 0.0 110.454 -175.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.46 -50.38 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.525 -0.735 . . . . 0.0 109.559 177.119 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.23 -35.45 78.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.453 -179.165 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -102.48 -65.46 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.765 2.026 . . . . 0.0 112.527 -167.11 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.76 -176.96 22.82 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.952 1.739 . . . . 0.0 111.619 -170.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -157.07 170.44 22.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.875 3.27 . . . . 0.0 103.701 169.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -9.53 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 126.953 2.216 . . . . 0.0 116.343 175.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.88 42.01 2.0 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 118.599 1.199 . . . . 0.0 110.949 171.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.7 tpt -116.55 107.5 46.7 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -177.639 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.33 -36.22 88.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.499 2.8 . . . . 0.0 112.617 -162.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.17 161.49 17.66 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 122.264 0.924 . . . . 0.0 111.484 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.76 14.31 57.97 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 122.051 -0.676 . . . . 0.0 113.154 -177.228 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 -32.46 50.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.616 175.156 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.41 141.49 46.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -139.35 154.08 47.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 107.154 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.68 -139.54 35.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.86 -41.07 1.09 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.205 1.802 . . . . 0.0 112.418 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -57.17 -55.85 29.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.431 0.692 . . . . 0.0 110.032 178.728 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.84 78.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -178.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.87 -56.28 19.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.622 0.769 . . . . 0.0 109.879 177.098 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.53 -53.05 59.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.039 0.936 . . . . 0.0 109.762 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 80' ' ' GLU . 87.7 t -48.64 -63.09 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 O-C-N 123.641 0.588 . . . . 0.0 109.805 176.564 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.55 -55.16 17.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.528 0.731 . . . . 0.0 111.76 -171.526 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.17 -53.22 60.73 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.467 0.651 . . . . 0.0 110.793 -177.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.726 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 21.8 t90 -54.23 -45.81 72.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.287 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.718 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -62.97 -45.63 91.52 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.732 -1.23 . . . . 0.0 111.502 -177.877 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.6 51.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.672 0.789 . . . . 0.0 111.606 172.218 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.0 -26.91 33.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.241 1.016 . . . . 0.0 112.056 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -32.58 65.57 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.976 1.311 . . . . 0.0 110.91 -165.834 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 128.512 2.725 . . . . 0.0 112.822 -162.63 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.17 -53.01 56.78 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.311 -170.293 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.97 -43.76 97.92 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.446 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.48 76.14 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 119.904 1.229 . . . . 0.0 111.117 -177.485 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -46.68 -62.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 167.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG13 ' SG ' ' A' ' 32' ' ' CYS 0.28 73.7 t -70.82 -33.08 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.463 -161.313 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -63.1 -0.78 0.8 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 130.249 3.419 . . . . 0.0 113.315 169.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.24 -22.73 0.91 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 173.137 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -104.43 -23.75 13.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.29 1.836 . . . . 0.0 110.778 -171.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' HG13 ' A' ' 28' ' ' VAL . 2.3 m -117.57 -40.37 3.05 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.653 0.661 . . . . 0.0 111.781 -174.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 pt -49.74 -31.11 6.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 117.941 0.337 . . . . 0.0 111.397 178.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -37.11 -43.4 0.49 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.313 1.845 . . . . 0.0 111.904 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -114.25 -44.09 3.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.145 0.578 . . . . 0.0 110.853 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -73.67 -14.65 61.19 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.0 152.85 23.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.032 0.833 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.17 -63.46 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.033 1.778 . . . . 0.0 113.895 -173.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.79 -7.89 54.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.144 1.377 . . . . 0.0 112.658 -176.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mt 72.41 25.1 2.82 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.996 2.118 . . . . 0.0 110.672 -178.359 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -78.65 -6.01 54.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.355 2.662 . . . . 0.0 112.131 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 80.73 1.52 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 118.593 0.633 . . . . 0.0 112.033 168.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.59 -79.41 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.858 0.463 . . . . 0.0 111.135 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -94.78 2.08 55.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.521 1.528 . . . . 0.0 111.833 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.17 162.79 35.9 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 127.577 2.351 . . . . 0.0 104.677 -177.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.96 166.19 19.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.035 1.823 . . . . 0.0 111.656 -178.187 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.02 114.35 6.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.457 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 88' ' ' LEU 0.261 2.2 pp -108.78 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.652 177.394 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -37.16 -48.31 0.83 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.651 1.114 . . . . 0.0 112.846 165.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -97.71 4.82 49.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.689 1.996 . . . . 0.0 111.545 -174.555 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.25 -32.74 25.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.08 171.449 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.67 72.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.665 1.12 . . . . 0.0 114.203 173.374 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.38 -47.18 18.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.45 1.125 . . . . 0.0 109.865 171.002 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -74.06 -42.96 59.42 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.938 0.495 . . . . 0.0 111.047 -168.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.26 -179.87 4.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.473 2.309 . . . . 0.0 107.964 -176.257 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m -119.21 170.16 9.33 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.567 0.747 . . . . 0.0 110.219 -178.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -40.8 72.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.556 -174.05 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -53.47 -53.81 46.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.48 1.112 . . . . 0.0 111.714 176.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -59.13 -49.59 77.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.188 0.995 . . . . 0.0 109.33 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.31 -52.24 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.8 tp -48.61 -57.0 6.89 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.081 1.352 . . . . 0.0 109.858 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.95 -41.84 98.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -59.98 -41.82 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 121.586 -0.696 . . . . 0.0 111.283 177.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.39 -50.94 78.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 109.521 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.71 -38.45 91.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.376 -176.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.77 -53.79 4.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.657 1.583 . . . . 0.0 111.903 -171.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.87 110.11 3.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.389 1.471 . . . . 0.0 110.208 -167.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.3 151.61 5.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 157.325 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.46 -58.52 1.09 Allowed Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.924 1.249 . . . . 0.0 115.477 -172.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.57 12.64 62.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.951 0.876 . . . . 0.0 113.775 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -120.47 132.2 24.21 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 126.12 1.768 . . . . 0.0 107.923 -174.392 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 -36.83 42.64 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.964 1.776 . . . . 0.0 112.793 -169.8 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.09 163.21 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.804 0.669 . . . . 0.0 111.691 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.01 17.81 61.51 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.93 -38.17 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.117 1.367 . . . . 0.0 108.961 179.136 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.38 147.28 48.99 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.393 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -141.3 152.23 44.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.486 0.66 . . . . 0.0 111.8 -175.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.5 -142.61 46.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.75 -33.36 1.24 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.83 1.652 . . . . 0.0 112.926 -179.388 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -53.98 -66.79 0.33 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 109.946 171.539 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.53 87.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.263 0.625 . . . . 0.0 110.554 -176.45 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -55.97 -50.17 71.55 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.98 0.512 . . . . 0.0 109.695 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.3 85.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.315 177.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.448 HG22 ' CG2' ' A' ' 28' ' ' VAL . 59.2 t -50.56 -58.16 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.011 173.751 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.48 -58.71 2.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.868 0.867 . . . . 0.0 111.549 -174.365 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.06 -54.43 46.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.165 -179.082 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.491 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 47.8 t90 -56.87 -45.78 82.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 111.07 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.491 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.21 -45.61 84.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.296 1.038 . . . . 0.0 109.72 -178.378 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.46 63.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.791 0.436 . . . . 0.0 111.171 171.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.9 -16.75 60.65 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.184 1.393 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 -4.81 58.41 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.842 -1.161 . . . . 0.0 113.203 -167.925 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.752 1.621 . . . . 0.0 114.059 -157.053 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.91 -49.52 73.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.239 -165.167 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.35 -41.69 94.18 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.384 177.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.61 -46.9 87.87 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.31 0.959 . . . . 0.0 111.004 -176.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -46.57 -62.27 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.768 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 43.0 t -62.46 -41.96 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.782 -167.288 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.85 1.44 1.36 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.44 3.096 . . . . 0.0 113.306 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.31 -23.42 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.282 0.946 . . . . 0.0 113.457 168.49 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -116.74 -18.79 10.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.757 1.223 . . . . 0.0 112.762 -166.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.5 m -113.31 -43.27 3.37 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.489 1.041 . . . . 0.0 111.246 179.171 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 pt -51.99 -30.03 12.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -37.05 -40.5 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.016 1.327 . . . . 0.0 113.053 170.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.3 m -115.81 -42.15 3.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.932 0.493 . . . . 0.0 110.623 174.72 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -70.74 -17.34 62.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.56 -89.22 0.33 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.361 0.981 . . . . 0.0 112.465 165.309 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.98 -65.36 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.54 2.49 13.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.054 0.942 . . . . 0.0 111.792 170.068 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.481 HD21 HG12 ' A' ' 28' ' ' VAL . 4.1 mt 71.21 20.45 5.09 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.992 1.317 . . . . 0.0 110.353 177.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -76.48 -8.54 57.38 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.582 2.353 . . . . 0.0 111.722 -177.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.17 74.5 1.08 Allowed Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.446 0.567 . . . . 0.0 111.889 164.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.66 -77.38 0.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.541 0.336 . . . . 0.0 111.427 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 t -96.58 2.39 52.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.025 1.33 . . . . 0.0 111.419 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.34 162.01 39.0 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -176.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.2 164.56 24.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.876 1.717 . . . . 0.0 111.167 179.174 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.14 114.18 6.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.512 -177.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.444 ' O ' HD21 ' A' ' 88' ' ' LEU 0.291 2.7 pp -106.56 -2.26 9.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.515 173.829 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -33.23 -48.13 0.22 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.022 1.729 . . . . 0.0 112.51 163.026 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 4.84 28.74 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.705 2.002 . . . . 0.0 111.274 -171.324 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.25 -37.62 16.58 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.381 -175.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.06 -32.52 59.79 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 119.173 0.897 . . . . 0.0 114.592 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.01 54.74 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.529 -0.983 . . . . 0.0 110.32 174.343 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.3 -36.03 63.73 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.52 150.45 46.4 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.348 1.459 . . . . 0.0 108.956 -167.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 m -86.79 158.52 19.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.128 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -44.65 60.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.919 0.488 . . . . 0.0 110.79 -174.064 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -50.62 -48.13 58.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 112.95 174.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.42 -47.49 81.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.699 0.761 . . . . 0.0 109.32 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.2 -49.96 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.394 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -47.68 -57.51 5.42 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.9 1.68 . . . . 0.0 110.234 174.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.46 -46.3 83.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.201 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -61.44 -42.13 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 122.025 -0.422 . . . . 0.0 110.827 -177.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -58.43 -50.44 78.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.32 -37.82 88.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.699 0.399 . . . . 0.0 111.716 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -96.8 -56.63 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.459 1.504 . . . . 0.0 111.957 -168.172 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.76 -173.15 21.04 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.911 1.72 . . . . 0.0 110.585 -171.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -165.01 123.5 1.7 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.243 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.17 -113.42 1.08 Allowed Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.797 1.181 . . . . 0.0 112.811 175.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.11 -16.63 79.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.208 1.004 . . . . 0.0 113.695 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.4 ttt -65.92 122.21 79.81 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.219 1.009 . . . . 0.0 109.164 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.15 -34.58 56.7 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.985 2.457 . . . . 0.0 111.555 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.92 168.1 36.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 122.604 1.113 . . . . 0.0 111.507 177.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.88 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.142 -178.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -67.54 -32.45 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 127.531 2.333 . . . . 0.0 110.172 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.71 153.09 51.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 172.366 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 164.17 33.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.183 0.593 . . . . 0.0 112.388 178.231 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.15 -137.86 22.93 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.08 -38.33 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.411 1.484 . . . . 0.0 112.815 178.123 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -62.09 -58.67 6.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.92 85.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.735 -0.603 . . . . 0.0 110.744 -177.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -58.1 -52.66 64.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.005 0.922 . . . . 0.0 110.141 174.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.32 -50.21 67.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.81 -55.24 12.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.371 174.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.47 24.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.82 0.736 . . . . 0.0 110.604 -174.009 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.6 -58.07 9.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.962 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.768 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 2.5 t90 -54.95 -50.75 68.12 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.851 0.461 . . . . 0.0 110.936 -178.223 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.537 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.146 -0.971 . . . . 0.0 108.724 -175.046 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.28 -38.99 69.31 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 122.132 -0.355 . . . . 0.0 111.223 172.217 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -22.0 60.8 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.713 -0.617 . . . . 0.0 111.15 178.016 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.4 9.74 0.74 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.282 2.233 . . . . 0.0 114.637 -172.226 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.252 1.197 0 O-C-N 120.504 -1.373 . . . . 0.0 112.193 -162.75 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.66 46.25 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -160.08 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -62.73 -46.23 89.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.58 177.527 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -41.57 72.63 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 118.744 0.702 . . . . 0.0 110.954 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -50.59 -64.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 167.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.642 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 92.6 t -66.86 -38.45 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 120.761 1.619 . . . . 0.0 112.211 -166.864 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -59.97 0.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.04 2.936 . . . . 0.0 113.331 170.059 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -125.4 -37.38 2.38 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.764 1.226 . . . . 0.0 112.404 168.169 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -102.42 -24.06 13.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.421 1.488 . . . . 0.0 111.577 -159.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.566 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.3 m -120.43 -40.59 2.67 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.289 0.636 . . . . 0.0 111.172 -169.063 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -49.68 -30.84 5.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 122.283 0.233 . . . . 0.0 111.462 178.03 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -34.73 -41.48 0.13 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.367 2.267 . . . . 0.0 113.164 170.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 m -119.91 -36.33 3.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.445 0.698 . . . . 0.0 111.118 176.241 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -80.84 -2.54 47.74 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.55 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.89 -85.52 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 123.811 0.72 . . . . 0.0 112.464 164.372 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.68 -66.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -173.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.11 2.21 24.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.312 -0.522 . . . . 0.0 111.733 173.33 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 70.1 22.25 5.73 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.393 1.877 . . . . 0.0 111.389 -172.239 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -5.56 37.75 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.994 2.118 . . . . 0.0 112.063 173.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.44 147.03 21.91 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 174.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.76 -82.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.913 0.885 . . . . 0.0 109.992 174.091 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 m -92.13 -0.15 57.45 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.021 0.928 . . . . 0.0 111.047 171.991 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.33 157.18 63.53 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 105.635 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.33 167.06 19.46 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.688 2.258 . . . . 0.0 111.645 -175.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 113.56 3.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.028 175.05 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp -108.02 -1.89 9.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.411 172.679 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -34.95 -50.45 0.48 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.285 1.434 . . . . 0.0 111.648 162.731 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -92.37 0.9 57.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.075 1.35 . . . . 0.0 110.74 -171.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.3 70.63 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.032 -1.043 . . . . 0.0 111.777 -174.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.12 -32.58 76.48 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 119.818 1.19 . . . . 0.0 112.557 174.227 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.34 -38.05 36.06 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.305 -1.115 . . . . 0.0 111.607 175.647 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -74.2 -38.94 63.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.307 0.503 . . . . 0.0 111.81 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -133.63 170.86 14.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.973 1.709 . . . . 0.0 108.292 -167.622 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.3 t -105.86 169.38 8.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.068 0.547 . . . . 0.0 110.38 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -51.39 64.55 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.137 0.575 . . . . 0.0 109.778 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -42.94 -55.79 3.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.678 1.591 . . . . 0.0 113.165 173.115 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -56.72 -52.25 65.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.04 0.936 . . . . 0.0 109.844 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.01 -48.35 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -173.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.7 tp -49.9 -56.04 12.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.448 1.899 . . . . 0.0 109.997 175.042 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.56 -47.82 81.03 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -58.83 -42.5 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 122.111 -0.368 . . . . 0.0 110.451 -177.034 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.45 -50.03 82.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 121.26 -0.9 . . . . 0.0 109.764 176.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.76 -32.66 74.23 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.027 0.531 . . . . 0.0 112.193 -178.444 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -103.39 -59.19 1.75 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.043 1.737 . . . . 0.0 112.01 -168.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.47 -175.61 21.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.207 1.861 . . . . 0.0 110.74 -173.126 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -150.64 164.63 35.62 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 166.464 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 3.14 -94.88 0.01 OUTLIER Glycine 0 CA--C 1.541 1.682 0 C-N-CA 126.887 2.184 . . . . 0.0 116.403 173.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.92 26.01 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 118.494 1.147 . . . . 0.0 112.928 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -104.05 121.11 48.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.952 1.701 . . . . 0.0 108.178 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.65 -36.5 63.4 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.088 2.525 . . . . 0.0 112.545 -169.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.81 165.71 34.03 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 122.158 0.866 . . . . 0.0 111.694 178.073 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.97 25.48 67.97 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -173.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.08 -26.72 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.079 1.351 . . . . 0.0 110.182 -177.038 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.54 146.68 32.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -139.07 164.16 30.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.24 0.927 . . . . 0.0 111.338 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.91 -134.66 16.53 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.366 0.984 . . . . 0.0 110.658 -175.744 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.21 -38.48 3.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.958 1.303 . . . . 0.0 112.26 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.79 -54.24 47.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.2 86.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.649 -0.657 . . . . 0.0 111.138 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.43 -52.73 62.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.295 0.638 . . . . 0.0 110.113 177.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.65 -52.9 53.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.867 0.867 . . . . 0.0 109.833 178.244 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 28' ' ' VAL . 77.4 t -50.19 -63.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 123.341 0.4 . . . . 0.0 110.226 174.392 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.96 -49.69 49.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.86 0.864 . . . . 0.0 110.978 -171.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.87 -59.8 4.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 177.082 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.642 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 47.0 t90 -55.93 -35.7 66.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.058 0.943 . . . . 0.0 112.085 -177.384 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.41 -44.73 50.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.39 -0.819 . . . . 0.0 110.554 178.3 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.89 -22.37 66.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.604 -0.685 . . . . 0.0 112.169 174.253 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.48 -26.93 58.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.187 1.395 . . . . 0.0 111.652 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -9.87 56.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -149.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.4 pttt . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.933 -1.032 . . . . 0.0 113.016 -107.281 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -55.56 9.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.587 -170.101 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.15 -41.34 83.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.204 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.78 81.96 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.151 0.887 . . . . 0.0 110.499 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.62 -58.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 168.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 2.0 t -68.85 -39.48 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 116.898 -1.921 . . . . 0.0 110.406 -165.348 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -62.31 -0.2 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.971 3.308 . . . . 0.0 114.079 170.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.93 -11.54 0.98 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 171.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.04 -18.47 11.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.888 1.275 . . . . 0.0 111.022 -176.169 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.3 m -127.25 -46.15 1.51 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.602 0.637 . . . . 0.0 111.762 -167.564 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.6 pt -53.91 -24.66 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.082 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -49.24 -27.38 3.66 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.911 0.884 . . . . 0.0 112.301 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.13 -42.77 3.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.212 0.605 . . . . 0.0 110.868 167.475 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.86 -9.95 58.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.28 -88.36 0.4 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.18 1.371 . . . . 0.0 112.564 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.82 -60.49 0.02 OUTLIER Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -176.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.9 4.0 39.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.713 0.805 . . . . 0.0 111.735 172.925 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 28' ' ' VAL . 1.2 mt 74.85 20.86 2.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.134 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -76.49 -12.46 60.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.401 2.68 . . . . 0.0 111.321 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.32 83.4 1.71 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 169.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.1 -76.87 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.935 0.494 . . . . 0.0 110.663 177.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -94.62 2.06 55.61 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.405 1.082 . . . . 0.0 111.408 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.98 38.02 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 127.5 2.32 . . . . 0.0 105.414 -176.24 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.68 164.47 26.49 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.03 1.82 . . . . 0.0 111.68 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.18 13.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.959 0.904 . . . . 0.0 109.717 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.291 2.5 pp -112.1 -3.03 10.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 173.41 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -32.97 9.37 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.123 -0.985 . . . . 0.0 112.295 165.547 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.0 3.12 38.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.337 1.055 . . . . 0.0 112.629 177.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.33 -38.2 68.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 117.402 -1.285 . . . . 0.0 111.094 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.58 -26.69 60.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.841 1.655 . . . . 0.0 114.328 174.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.47 -47.08 16.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.958 0.879 . . . . 0.0 109.878 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -74.66 -44.82 48.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 122.501 0.32 . . . . 0.0 111.854 -173.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -123.3 157.2 33.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.658 1.983 . . . . 0.0 109.504 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -89.46 163.89 15.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 0.0 110.964 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -44.17 68.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.895 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -49.64 -53.12 26.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.861 1.665 . . . . 0.0 112.169 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.9 -48.91 79.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.491 0.717 . . . . 0.0 109.834 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.33 -52.24 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -48.9 -56.26 9.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.509 1.524 . . . . 0.0 110.076 177.041 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.14 -46.59 85.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.215 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -59.78 -38.86 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.904 -0.498 . . . . 0.0 111.387 -179.037 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -51.84 66.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 119.469 1.032 . . . . 0.0 109.755 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.15 -33.4 75.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.433 -175.16 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.7 -43.39 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.21 1.804 . . . . 0.0 112.238 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.07 111.4 2.65 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.163 1.363 . . . . 0.0 110.133 -169.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -55.19 145.88 20.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 161.594 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -13.48 -74.73 0.01 OUTLIER Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.902 2.191 . . . . 0.0 117.235 -175.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 -12.42 73.8 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.804 0.802 . . . . 0.0 113.775 -175.241 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.5 ttt -88.14 135.65 32.96 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 126.16 1.784 . . . . 0.0 109.518 -175.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.0 157.95 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.41 1.407 . . . . 0.0 110.959 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.89 146.99 18.67 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -175.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.32 71.7 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.44 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.5 mt -55.59 -35.42 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.549 1.14 . . . . 0.0 109.366 172.477 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.65 152.29 46.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.019 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -143.15 162.61 35.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.977 0.808 . . . . 0.0 111.413 177.485 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.91 -136.34 41.76 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.38 -36.26 4.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.582 1.153 . . . . 0.0 112.064 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.52 -55.79 24.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.17 85.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.553 -0.717 . . . . 0.0 110.408 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.66 -47.75 81.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.128 0.571 . . . . 0.0 110.998 177.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.82 62.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.16 -57.38 8.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.937 173.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.36 -55.99 5.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.12 0.873 . . . . 0.0 110.644 -175.388 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.04 -54.0 52.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.89 0.476 . . . . 0.0 111.306 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.66 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 57.3 t90 -62.3 -54.7 36.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.286 -176.27 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -40.54 79.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.872 -1.143 . . . . 0.0 110.083 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.15 -50.37 71.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.782 0.264 . . . . 0.0 111.028 170.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.28 -8.88 57.72 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.808 0.731 . . . . 0.0 112.264 -177.005 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -16.76 64.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.652 1.181 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.789 1.236 . . . . 0.0 113.055 -162.987 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -68.81 105.51 2.36 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.7 -46.77 81.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.607 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.2 -44.33 84.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -49.19 75.52 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 119.089 0.858 . . . . 0.0 111.436 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.7 t -49.03 -55.82 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.543 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.278 94.6 t -66.02 -43.18 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.512 -169.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.37 1.33 0.35 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.455 3.102 . . . . 0.0 114.115 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.73 -8.13 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -116.02 -26.01 7.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.853 1.261 . . . . 0.0 110.606 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -114.35 -42.06 3.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.489 0.586 . . . . 0.0 111.199 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -49.66 -30.91 5.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 111.563 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.1 m -39.4 -38.52 0.56 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.57 1.548 . . . . 0.0 112.968 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.67 -43.95 2.77 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.758 0.423 . . . . 0.0 110.603 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -68.04 -17.24 64.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.82 155.45 31.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.13 -56.21 5.4 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.826 1.203 . . . . 0.0 113.97 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.61 0.33 43.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.254 0.621 . . . . 0.0 112.416 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.615 HD22 HD11 ' A' ' 48' ' ' ILE . 1.0 OUTLIER 62.58 27.73 16.35 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.962 1.305 . . . . 0.0 110.932 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 p -78.56 -8.81 58.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 128.778 2.831 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.84 76.75 1.23 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 118.293 0.497 . . . . 0.0 111.991 165.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.49 -85.31 0.1 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.897 0.479 . . . . 0.0 111.441 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.9 m -89.05 2.39 54.13 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 112.157 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.61 162.64 38.06 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.48 164.94 28.88 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.231 1.954 . . . . 0.0 111.128 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.93 119.31 10.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.389 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 40' ' ' LEU . 2.8 pp -113.77 -0.61 9.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.132 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -31.28 45.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.382 1.446 . . . . 0.0 112.147 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' NZ ' ' OXT' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -103.93 5.97 36.0 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.016 1.726 . . . . 0.0 112.552 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB3' HD22 ' A' ' 88' ' ' LEU . . . -54.37 -31.15 54.03 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.318 -1.489 . . . . 0.0 111.754 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.73 -27.61 68.61 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 120.324 1.42 . . . . 0.0 114.423 171.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.48 34.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.886 . . . . 0.0 109.03 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -73.86 -45.82 48.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.36 162.17 26.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.523 1.929 . . . . 0.0 109.262 -170.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 m -93.99 162.09 14.03 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.429 0.692 . . . . 0.0 110.331 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -50.56 -41.96 54.82 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.141 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.49 -58.24 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.099 0.863 . . . . 0.0 112.336 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.93 -51.1 67.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 110.085 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.596 HG23 HMA1 ' A' ' 93' ' ' HEC . 61.1 mt -64.61 -48.04 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -50.41 -55.42 15.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.47 1.908 . . . . 0.0 109.872 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -45.76 86.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.77 -41.77 86.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.085 -1.009 . . . . 0.0 111.269 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 60' ' ' ILE . 19.6 mt -60.75 -47.72 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.046 -1.034 . . . . 0.0 109.544 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.275 0.63 . . . . 0.0 111.954 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -97.64 -54.26 3.18 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 111.636 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.75 -169.63 19.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.317 1.913 . . . . 0.0 110.301 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -170.59 122.16 0.61 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 127.431 2.293 . . . . 0.0 105.109 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.19 -113.83 1.03 Allowed Glycine 0 CA--C 1.538 1.52 0 CA-C-N 120.146 1.339 . . . . 0.0 113.027 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.52 -14.65 82.23 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 118.235 1.018 . . . . 0.0 114.069 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.428 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.6 ttt -66.82 129.96 94.02 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.193 0.997 . . . . 0.0 109.966 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.484 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 51.9 Cg_endo -65.19 -40.01 21.28 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.08 2.52 . . . . 0.0 111.77 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.69 162.7 28.04 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.007 0.782 . . . . 0.0 111.774 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 17.65 66.27 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.737 0.684 . . . . 0.0 112.158 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 mm -61.16 -33.38 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.61 1.964 . . . . 0.0 110.391 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB1' ' HB3' ' A' ' 80' ' ' GLU . . . -134.75 144.34 47.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 157.99 43.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.437 0.695 . . . . 0.0 111.392 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.01 -137.34 32.65 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.08 -40.08 6.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.405 1.082 . . . . 0.0 112.726 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.7 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -53.0 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.531 0.605 . . . . 0.0 110.178 173.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.77 83.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.965 -0.46 . . . . 0.0 111.155 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.57 -55.15 38.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.411 0.684 . . . . 0.0 109.317 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.59 72.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.66 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG22 HG23 ' A' ' 28' ' ' VAL . 55.8 t -45.34 -66.94 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.79 70.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 111.601 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.38 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 110.769 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.525 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 7.2 t90 -55.14 -43.16 73.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.096 0.558 . . . . 0.0 110.755 176.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.525 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.55 -49.76 75.37 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.508 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.93 -40.64 63.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.451 0.7 . . . . 0.0 110.667 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -73.91 -18.66 60.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.96 0.904 . . . . 0.0 112.331 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -13.12 61.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.776 1.23 . . . . 0.0 111.482 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' OXT' ' NZ ' ' A' ' 50' ' ' LYS . 8.4 pttt . . . . . 0 C--O 1.247 0.93 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -157.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.777 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -97.28 113.37 24.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -138.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.37 -53.23 23.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -156.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.63 -43.29 99.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.491 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.35 79.67 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.918 0.887 . . . . 0.0 110.983 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -51.43 -63.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.704 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 67.6 t -64.68 -40.43 89.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 121.066 -1.021 . . . . 0.0 112.498 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -61.23 0.76 0.23 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.808 2.843 . . . . 0.0 113.468 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.75 -25.6 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 165.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -104.5 -28.36 11.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.663 1.185 . . . . 0.0 111.452 -165.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.613 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.2 m -120.2 -39.79 2.77 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.248 0.619 . . . . 0.0 111.579 -167.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -48.62 -31.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 122.634 0.374 . . . . 0.0 111.143 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -36.75 -41.97 0.35 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.542 2.337 . . . . 0.0 113.38 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.9 -42.9 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.101 0.561 . . . . 0.0 110.649 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.84 -17.64 62.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.15 152.4 28.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.9 -53.91 7.12 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.037 1.303 . . . . 0.0 113.567 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.25 1.42 50.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.772 0.829 . . . . 0.0 112.056 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.69 HD22 HD11 ' A' ' 48' ' ' ILE . 9.7 mt 66.28 25.16 10.56 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.895 0.878 . . . . 0.0 110.961 171.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -84.61 -4.41 58.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.969 2.908 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.63 77.12 1.32 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.399 0.545 . . . . 0.0 112.248 164.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.96 -78.43 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.067 0.434 . . . . 0.0 111.356 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -97.74 1.75 48.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.731 1.612 . . . . 0.0 111.965 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.92 162.7 39.65 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.54 164.75 31.69 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.839 1.692 . . . . 0.0 111.608 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.54 114.68 5.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.112 0.965 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.753 HD13 HD11 ' A' ' 88' ' ' LEU . 2.5 pp -102.52 -0.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 122.771 0.428 . . . . 0.0 111.845 173.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.06 -42.52 1.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.98 0.912 . . . . 0.0 111.986 162.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -99.81 5.09 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.058 1.343 . . . . 0.0 113.032 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.58 -42.65 34.42 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.634 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.72 68.28 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.604 1.093 . . . . 0.0 114.664 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.41 -47.66 26.35 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.12 0.96 . . . . 0.0 109.255 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.55 -39.3 62.39 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.236 0.615 . . . . 0.0 111.327 -170.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.74 161.58 34.3 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.02 2.128 . . . . 0.0 108.04 -171.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -99.6 156.51 17.03 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.062 0.945 . . . . 0.0 110.378 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.26 -51.1 6.37 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.893 0.877 . . . . 0.0 111.316 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -40.87 -52.77 3.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.753 1.621 . . . . 0.0 113.839 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.09 -47.89 75.63 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.355 -0.841 . . . . 0.0 109.842 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.53 HG23 HMA1 ' A' ' 93' ' ' HEC . 56.5 mt -61.77 -48.34 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -48.84 -56.28 9.18 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 126.748 2.019 . . . . 0.0 109.946 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.16 -48.29 76.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.7 mt -59.95 -42.24 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 122.028 -0.42 . . . . 0.0 110.749 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.39 -50.97 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.94 -36.86 85.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.962 0.505 . . . . 0.0 111.838 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -96.82 -58.39 2.05 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.572 1.549 . . . . 0.0 111.36 -169.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.29 -176.74 20.11 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.377 1.941 . . . . 0.0 110.354 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -145.33 163.21 35.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 103.298 -2.853 . . . . 0.0 103.298 166.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -23.63 -77.47 0.01 OUTLIER Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.704 1.621 . . . . 0.0 115.676 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 32.2 6.39 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.5 1.15 . . . . 0.0 113.506 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -124.32 124.72 25.78 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.197 1.399 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.97 -38.73 55.8 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.866 2.378 . . . . 0.0 113.173 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.45 163.33 32.85 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 121.802 0.668 . . . . 0.0 112.237 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.48 66.9 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mt -69.13 -29.07 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.177 1.391 . . . . 0.0 110.139 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.24 41.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -140.51 152.18 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.665 1.121 . . . . 0.0 113.267 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.06 -137.16 50.63 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.47 -38.68 4.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.236 1.414 . . . . 0.0 112.031 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -54.74 -57.37 11.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.826 1.25 . . . . 0.0 109.859 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.28 87.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 110.649 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.46 -53.36 55.21 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.332 0.653 . . . . 0.0 109.849 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.98 -55.12 25.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.99 0.916 . . . . 0.0 109.848 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.7 t -51.07 -54.41 10.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 122.922 0.139 . . . . 0.0 110.971 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.3 -52.34 65.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.092 0.557 . . . . 0.0 110.777 -172.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.23 -54.3 38.13 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.55 0.69 . . . . 0.0 109.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.704 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 51.6 t90 -57.6 -40.72 79.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.485 0.714 . . . . 0.0 112.14 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.753 HD11 HD13 ' A' ' 48' ' ' ILE 0.305 3.7 mt -68.05 -39.66 82.96 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.618 -1.301 . . . . 0.0 112.887 175.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.12 72.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.307 0.503 . . . . 0.0 111.108 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -73.24 -28.84 62.37 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.316 1.046 . . . . 0.0 111.211 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -20.72 66.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.548 1.139 . . . . 0.0 113.68 -169.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 pttt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -151.267 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.736 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 103.101 -2.926 . . . . 0.0 103.101 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.13 110.62 4.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.35 86.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.613 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.61 -43.31 73.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 -49.59 68.54 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.002 0.819 . . . . 0.0 111.246 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -47.99 -59.15 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.566 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.261 87.8 t -68.93 -38.47 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.37 -166.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.04 0.19 0.25 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 129.186 2.994 . . . . 0.0 113.947 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 -13.48 1.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.1 -26.63 8.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.93 1.292 . . . . 0.0 110.817 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.8 m -115.01 -40.72 3.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.706 0.684 . . . . 0.0 111.976 -172.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.6 pt -49.34 -30.14 4.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 122.619 0.368 . . . . 0.0 111.706 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.9 t -38.66 -42.24 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.067 1.747 . . . . 0.0 111.653 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -116.2 -42.65 3.02 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.267 0.627 . . . . 0.0 111.002 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -71.71 -13.21 61.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.24 153.0 21.71 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.01 -60.52 2.21 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.281 1.419 . . . . 0.0 113.53 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.55 -2.28 34.82 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.577 0.751 . . . . 0.0 112.571 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 28' ' ' VAL . 1.4 mt 66.84 26.53 9.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.23 1.812 . . . . 0.0 111.007 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -79.29 -7.99 58.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.701 2.8 . . . . 0.0 111.563 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.86 83.62 1.69 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 168.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.68 -84.09 0.18 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.011 0.524 . . . . 0.0 110.549 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -88.97 2.1 54.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.263 1.425 . . . . 0.0 111.89 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.79 41.32 Favored Pre-proline 0 N--CA 1.452 -0.36 0 C-N-CA 126.925 2.09 . . . . 0.0 105.413 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.47 164.37 23.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.922 1.748 . . . . 0.0 111.007 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.59 122.88 18.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.467 HD11 HD22 ' A' ' 40' ' ' LEU 0.296 1.9 pp -119.42 0.5 7.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.968 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -41.41 -43.95 2.7 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.783 1.174 . . . . 0.0 112.133 164.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -101.92 6.17 41.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.429 1.892 . . . . 0.0 112.12 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -33.02 42.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.02 -0.991 . . . . 0.0 111.552 172.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.1 -31.98 78.73 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.768 1.622 . . . . 0.0 113.647 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.0 -49.42 37.15 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.147 0.974 . . . . 0.0 109.746 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.79 -42.22 50.67 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.324 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -118.37 179.76 4.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.889 1.676 . . . . 0.0 107.639 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.2 m -120.14 163.37 17.81 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.577 -0.702 . . . . 0.0 109.987 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -52.51 19.45 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.471 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -35.69 -61.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.719 1.208 . . . . 0.0 113.421 168.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -55.77 30.81 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 121.855 0.835 . . . . 0.0 109.769 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.645 HG23 HMA1 ' A' ' 93' ' ' HEC . 64.5 mt -60.12 -47.06 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -171.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.9 -53.81 29.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.976 1.71 . . . . 0.0 109.99 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.11 -49.8 68.31 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.42 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.461 -0.775 . . . . 0.0 110.88 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 60' ' ' ILE . 22.0 mt -59.65 -49.11 84.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 120.813 -1.179 . . . . 0.0 109.638 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.3 -37.19 82.99 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.743 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -94.9 -58.15 2.25 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.211 1.404 . . . . 0.0 111.458 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.5 -171.03 21.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.177 2.322 . . . . 0.0 109.675 -168.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -156.73 163.73 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.48 -90.05 0.0 OUTLIER Glycine 0 CA--C 1.544 1.863 0 C-N-CA 126.27 1.89 . . . . 0.0 116.57 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.66 13.83 66.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.859 1.329 . . . . 0.0 114.202 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.432 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 21.6 ttt -99.12 126.14 39.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.547 . . . . 0.0 109.073 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.63 -40.65 22.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.698 2.266 . . . . 0.0 112.348 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.27 163.71 31.26 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.716 0.62 . . . . 0.0 112.161 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.44 20.11 65.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mt -66.97 -32.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 125.426 1.49 . . . . 0.0 109.619 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.02 146.49 47.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -146.73 162.83 37.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.2 -139.78 40.63 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.09 -38.56 1.06 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.546 1.539 . . . . 0.0 112.467 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -55.54 -61.09 2.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.405 1.082 . . . . 0.0 110.015 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.69 -38.01 80.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.699 -0.626 . . . . 0.0 110.788 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -55.49 -54.29 45.73 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.38 62.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.58 0.752 . . . . 0.0 109.663 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 HG23 ' A' ' 28' ' ' VAL . 58.6 t -46.82 -66.03 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 O-C-N 123.363 0.414 . . . . 0.0 110.256 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.24 -47.43 75.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.063 0.945 . . . . 0.0 110.616 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -56.31 23.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.385 0.274 . . . . 0.0 110.373 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.453 ' HZ3' HG11 ' A' ' 28' ' ' VAL . 45.5 t90 -55.31 -43.04 74.5 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.568 0.747 . . . . 0.0 110.946 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.04 -51.48 63.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.679 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.25 68.28 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.035 0.534 . . . . 0.0 110.959 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.79 -20.5 61.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.244 0.618 . . . . 0.0 110.764 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.155 -0.966 . . . . 0.0 111.121 -165.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.788 2.435 . . . . 0.0 114.081 -151.575 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.758 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.34 102.72 2.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.27 1.428 . . . . 0.0 107.526 -164.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.42 -52.17 40.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.019 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -60.53 -40.75 92.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.815 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.79 -44.61 90.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.023 0.829 . . . . 0.0 110.659 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.5 -60.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.555 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.258 17.3 t -65.01 -41.16 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 116.462 -2.095 . . . . 0.0 111.968 -168.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -61.29 0.4 0.28 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.074 2.95 . . . . 0.0 114.28 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.81 -13.43 0.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -114.65 -21.38 10.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.434 1.494 . . . . 0.0 111.427 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.6 m -123.26 -40.13 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.377 0.535 . . . . 0.0 111.183 -168.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -48.59 -30.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 122.96 0.504 . . . . 0.0 111.746 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 m -40.82 -37.06 0.71 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.089 1.755 . . . . 0.0 112.885 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 m -119.66 -43.5 2.58 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 122.859 0.464 . . . . 0.0 110.739 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.4 -14.9 62.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.05 153.4 25.84 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.09 4.55 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.224 1.393 . . . . 0.0 113.564 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.52 -0.27 41.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.06 0.544 . . . . 0.0 112.136 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 HG12 ' A' ' 28' ' ' VAL . 4.8 mt 64.71 25.85 13.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.59 1.556 . . . . 0.0 111.003 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -81.38 -8.31 59.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 128.901 2.88 . . . . 0.0 111.407 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.52 79.27 1.45 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 118.332 0.515 . . . . 0.0 112.21 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.57 -81.74 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.708 0.403 . . . . 0.0 111.226 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -91.64 1.97 56.78 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.548 1.539 . . . . 0.0 112.015 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.15 162.03 45.08 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.96 164.15 25.82 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.845 1.697 . . . . 0.0 111.088 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.47 122.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 40' ' ' LEU 0.323 2.4 pp -116.5 1.07 8.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.877 174.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -35.26 18.74 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.143 1.338 . . . . 0.0 112.344 168.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -99.16 4.31 46.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.172 1.389 . . . . 0.0 112.309 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -33.05 52.95 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 120.92 -1.113 . . . . 0.0 111.168 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.95 -31.15 79.62 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.45 1.023 . . . . 0.0 114.41 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -43.9 38.09 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.818 -0.813 . . . . 0.0 110.076 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -74.16 -39.92 62.93 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.678 0.391 . . . . 0.0 111.538 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -131.6 156.35 45.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.114 1.766 . . . . 0.0 108.054 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -92.88 162.56 14.04 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.753 -0.592 . . . . 0.0 110.506 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -46.56 -46.59 19.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.224 0.609 . . . . 0.0 110.772 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.39 -57.38 4.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.822 1.249 . . . . 0.0 112.899 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 -50.94 71.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.046 0.927 . . . . 0.0 110.073 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.588 HG23 HMA1 ' A' ' 93' ' ' HEC . 59.9 mt -63.42 -47.26 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.1 tp -50.29 -54.89 18.08 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.745 1.618 . . . . 0.0 109.988 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.14 -49.8 70.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.29 -43.23 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.568 -0.708 . . . . 0.0 111.082 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 60' ' ' ILE . 28.7 mt -60.88 -51.05 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.03 -29.9 69.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.551 0.741 . . . . 0.0 112.542 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.5 -60.17 1.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.27 1.828 . . . . 0.0 111.268 -170.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.23 -173.18 21.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.558 2.028 . . . . 0.0 110.655 -168.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -152.62 161.04 43.11 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 102.741 -3.059 . . . . 0.0 102.741 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.32 -71.09 0.07 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 120.489 1.495 . . . . 0.0 115.427 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.47 23.37 28.14 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 118.058 0.929 . . . . 0.0 113.763 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -117.94 131.97 23.9 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.075 1.35 . . . . 0.0 109.34 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.503 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 43.7 Cg_endo -65.26 -40.72 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.661 2.241 . . . . 0.0 112.187 -172.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.22 157.57 17.99 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 121.699 0.611 . . . . 0.0 112.426 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 17.84 61.39 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mm -58.76 -37.2 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.529 1.132 . . . . 0.0 109.587 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.82 146.35 52.24 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -144.22 154.6 43.28 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.67 -139.21 48.1 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.6 -37.16 5.29 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.017 1.327 . . . . 0.0 111.738 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -53.74 -60.99 2.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.478 1.111 . . . . 0.0 110.061 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.35 79.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.814 -0.554 . . . . 0.0 110.667 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.94 -52.92 63.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.02 0.438 . . . . 0.0 109.913 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.03 -52.52 60.59 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.829 0.851 . . . . 0.0 109.607 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -48.24 -65.2 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 119.172 -0.442 . . . . 0.0 109.87 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.05 -49.93 49.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.429 1.091 . . . . 0.0 111.453 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.65 -57.08 14.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.999 0.428 . . . . 0.0 110.566 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.524 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 68.7 t90 -56.36 -34.47 66.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.569 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.74 -43.85 52.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.16 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.13 -32.74 66.66 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.74 -0.6 . . . . 0.0 111.008 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.09 -23.14 59.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.079 0.952 . . . . 0.0 111.924 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.51 4.09 0.42 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.519 2.328 . . . . 0.0 115.671 -165.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.103 0 O-C-N 119.993 -1.692 . . . . 0.0 113.457 -125.594 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.766 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.61 97.71 0.82 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 123.024 1.392 . . . . 0.0 107.727 -163.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.22 82.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.744 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -56.89 -45.32 82.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.942 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.58 96.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.687 0.676 . . . . 0.0 110.681 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -51.48 -65.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 32' ' ' CYS . 73.7 t -63.1 -42.03 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 120.088 1.313 . . . . 0.0 110.793 -165.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -1.44 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.59 2.756 . . . . 0.0 113.261 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.78 0.96 2.05 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 169.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.01 -54.61 1.61 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.319 1.048 . . . . 0.0 109.986 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.794 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.9 m -90.0 -41.82 11.5 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.769 0.428 . . . . 0.0 110.248 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 pt -52.74 -27.21 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.038 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -47.51 -29.33 2.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.923 1.289 . . . . 0.0 112.363 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 m -122.9 -41.58 2.34 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.542 0.61 . . . . 0.0 110.864 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -70.7 -17.35 62.83 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.81 150.15 18.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.46 -59.88 1.5 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.703 1.62 . . . . 0.0 113.969 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.01 -15.42 61.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.767 1.227 . . . . 0.0 112.77 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.589 HD22 HD11 ' A' ' 48' ' ' ILE . 1.4 mt 77.06 23.87 0.9 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.704 2.402 . . . . 0.0 111.098 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 p -75.73 -9.17 58.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 111.961 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.19 81.07 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.671 . . . . 0.0 111.797 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.66 -78.92 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.797 0.439 . . . . 0.0 111.1 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -93.98 2.6 56.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.609 1.563 . . . . 0.0 111.502 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.36 163.05 34.25 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.97 165.48 21.35 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.792 1.661 . . . . 0.0 111.189 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 119.7 11.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 40' ' ' LEU 0.319 2.1 pp -115.65 1.3 8.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.734 174.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.52 -40.31 18.39 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.519 1.054 . . . . 0.0 111.606 167.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -93.12 2.8 56.55 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 125.699 1.599 . . . . 0.0 111.315 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.13 -34.92 66.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.184 0.902 . . . . 0.0 111.183 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.47 -31.75 78.62 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.479 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.42 -46.23 28.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.514 1.157 . . . . 0.0 110.455 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -74.37 -40.67 61.95 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 111.264 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -124.91 -177.94 4.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.52 2.328 . . . . 0.0 107.893 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -122.92 169.47 11.11 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.607 -0.683 . . . . 0.0 110.32 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -42.73 67.29 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.436 0.694 . . . . 0.0 110.374 -171.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -51.12 -56.26 13.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 112.913 175.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 31.5 mm-40 -56.55 -49.35 75.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.185 1.394 . . . . 0.0 109.176 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.89 -51.22 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.75 -56.15 11.32 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.253 1.021 . . . . 0.0 109.912 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.67 -41.12 97.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.705 -0.798 . . . . 0.0 108.904 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.8 mt -62.72 -39.98 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.817 -0.552 . . . . 0.0 111.325 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.413 HD11 HMB2 ' A' ' 93' ' ' HEC . 94.5 mt -59.47 -51.09 76.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 O-C-N 120.719 -1.238 . . . . 0.0 109.571 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.87 -42.1 99.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -91.82 -50.6 5.64 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 112.323 -168.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.33 -167.66 14.84 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.976 1.75 . . . . 0.0 110.112 -168.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -169.37 131.02 1.14 Allowed 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.13 -112.38 0.5 Allowed Glycine 0 CA--C 1.539 1.559 0 CA-C-N 120.486 1.494 . . . . 0.0 113.078 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 -10.31 76.11 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.363 1.082 . . . . 0.0 114.263 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.408 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.5 ttt -64.46 126.43 90.58 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 118.549 1.175 . . . . 0.0 109.405 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.88 -34.82 37.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.007 2.471 . . . . 0.0 112.621 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.57 164.32 36.4 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.55 19.4 68.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.667 0.651 . . . . 0.0 112.077 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.09 -29.77 48.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.698 1.199 . . . . 0.0 110.445 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.61 153.21 42.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -146.87 162.12 39.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.39 -138.53 45.91 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.1 -6.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.176 1.791 . . . . 0.0 114.909 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.59 -67.19 0.79 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.243 1.817 . . . . 0.0 108.223 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.44 90.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.454 -0.779 . . . . 0.0 111.004 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.23 -48.58 76.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.66 91.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.694 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.1 t -53.05 -49.45 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.47 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.59 -56.58 6.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.096 0.862 . . . . 0.0 110.391 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.87 -55.67 30.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.745 0.418 . . . . 0.0 111.611 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.62 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 55.8 t90 -58.05 -49.9 75.3 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.023 0.916 . . . . 0.0 111.351 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.495 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -64.37 -43.27 95.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.182 0.993 . . . . 0.0 109.6 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.71 -41.81 67.4 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 170.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.99 -13.61 60.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.035 0.934 . . . . 0.0 112.459 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -15.56 56.33 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.704 -1.247 . . . . 0.0 113.242 -169.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.596 1.158 . . . . 0.0 113.765 -150.146 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.742 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.56 1.41 Allowed 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 125.509 1.524 . . . . 0.0 107.928 -160.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.35 63.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.901 -166.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -62.2 -43.08 99.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.283 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.31 85.9 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 119.452 1.024 . . . . 0.0 110.984 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -47.09 -64.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 32' ' ' CYS . 69.3 t -64.41 -43.46 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 117.711 -1.596 . . . . 0.0 112.244 -167.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -56.02 -2.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.564 3.145 . . . . 0.0 112.984 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.66 2.59 2.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.286 0.948 . . . . 0.0 113.507 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -129.33 -53.06 1.18 Allowed 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.141 0.977 . . . . 0.0 110.541 -168.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.691 ' HB2' HG13 ' A' ' 28' ' ' VAL . 1.9 m -95.62 -40.3 9.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.934 0.494 . . . . 0.0 109.756 -171.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 pt -52.45 -28.02 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.054 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.17 -30.26 2.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.115 1.366 . . . . 0.0 112.571 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 m -126.28 -37.25 2.24 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.409 0.683 . . . . 0.0 111.316 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -78.71 -10.56 59.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.27 153.11 22.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.121 0.867 . . . . 0.0 110.946 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -47.5 5.99 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.424 1.488 . . . . 0.0 113.665 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -85.14 -10.3 56.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.824 1.25 . . . . 0.0 112.224 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 48' ' ' ILE . 1.4 mt 70.18 23.05 5.32 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.855 2.062 . . . . 0.0 111.709 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -76.2 -7.37 54.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.722 2.409 . . . . 0.0 111.89 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.86 112.47 2.08 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.56 -72.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.469 0.708 . . . . 0.0 109.475 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -93.99 2.05 56.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.628 1.171 . . . . 0.0 110.737 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.63 162.06 38.01 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.579 1.951 . . . . 0.0 106.034 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.41 163.91 22.17 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.862 1.708 . . . . 0.0 110.622 174.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 121.55 14.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.595 HD11 HD22 ' A' ' 40' ' ' LEU 0.25 2.0 pp -115.62 -1.59 9.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.972 174.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -38.69 -46.82 1.28 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.359 0.982 . . . . 0.0 112.216 165.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -98.32 3.93 48.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.814 2.046 . . . . 0.0 111.177 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.25 -32.66 56.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.174 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.78 -30.42 72.69 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.886 1.221 . . . . 0.0 113.68 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.33 -45.55 38.8 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.281 1.04 . . . . 0.0 109.359 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -73.67 -41.16 63.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -130.4 165.01 23.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 127.186 2.194 . . . . 0.0 107.766 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 m -103.77 167.92 9.47 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.931 -0.481 . . . . 0.0 110.691 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -38.63 68.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.322 -173.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -53.87 -48.04 70.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.598 0.636 . . . . 0.0 112.449 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -66.17 -47.71 73.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.504 1.145 . . . . 0.0 108.503 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.72 -47.14 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.3 tp -51.81 -55.49 19.58 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 110.623 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.66 -54.57 11.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -63.8 -39.95 87.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.579 -171.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.83 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 121.294 -0.878 . . . . 0.0 109.396 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.46 -35.17 80.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -100.71 -55.79 2.5 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.376 1.471 . . . . 0.0 112.303 -168.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.12 -168.09 22.16 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.903 1.716 . . . . 0.0 110.383 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -164.06 160.99 22.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.16 2.984 . . . . 0.0 103.392 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 9.56 -99.41 0.01 OUTLIER Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.382 1.944 . . . . 0.0 116.302 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.55 17.79 57.13 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 118.491 1.146 . . . . 0.0 113.584 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.1 ttt -89.05 129.62 47.46 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 125.313 1.445 . . . . 0.0 108.464 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.509 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 36.3 Cg_endo -62.48 -41.22 33.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.833 2.356 . . . . 0.0 112.048 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 159.38 17.23 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.14 20.56 62.92 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 122.165 -0.609 . . . . 0.0 111.614 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.5 mm -63.5 -29.12 46.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 124.518 1.127 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 149.15 45.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -142.19 157.77 44.49 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.294 0.952 . . . . 0.0 113.248 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.84 -141.51 44.86 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.05 -35.71 2.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.197 1.399 . . . . 0.0 112.563 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.36 -62.55 1.58 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.607 1.163 . . . . 0.0 110.179 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.16 80.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.173 0.589 . . . . 0.0 110.715 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.66 -50.36 74.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.544 0.687 . . . . 0.0 109.634 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.52 -48.09 81.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.027 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 28' ' ' VAL . 78.0 t -49.95 -55.9 4.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.263 172.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.3 17.51 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.051 0.841 . . . . 0.0 110.556 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.85 78.96 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.005 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.616 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 71.7 t90 -61.13 -46.06 92.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.033 0.533 . . . . 0.0 111.72 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -66.56 -43.83 83.97 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.64 -47.81 58.33 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.11 -10.17 59.41 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.341 -0.85 . . . . 0.0 112.172 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 -5.45 59.24 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.871 -1.143 . . . . 0.0 112.079 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 C--O 1.247 0.948 0 C-N-CA 125.957 1.703 . . . . 0.0 114.194 -164.953 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.774 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.5 98.15 2.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.414 1.085 . . . . 0.0 108.715 -161.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.9 58.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.97 -1.013 . . . . 0.0 113.06 -165.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.18 -44.24 97.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.208 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.11 77.25 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.557 0.617 . . . . 0.0 110.852 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.03 -60.89 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 170.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.708 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.25 63.2 t -66.85 -40.76 86.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 121.078 -1.014 . . . . 0.0 112.047 -168.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -60.34 1.05 0.14 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.04 2.936 . . . . 0.0 113.746 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.31 -22.64 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 168.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -15.96 11.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 111.999 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.9 m -121.55 -41.39 2.49 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.58 0.627 . . . . 0.0 111.283 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.0 pt -48.68 -29.81 2.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 122.974 0.51 . . . . 0.0 111.561 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -38.1 -44.94 0.87 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.918 1.687 . . . . 0.0 112.02 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -113.19 -41.66 3.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.873 0.469 . . . . 0.0 110.73 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -71.27 -15.31 62.42 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.55 152.04 24.28 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -56.99 3.88 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.029 1.3 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 -5.86 49.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.956 1.302 . . . . 0.0 112.046 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 mt 66.53 20.38 10.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.099 1.759 . . . . 0.0 111.89 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 p -81.31 1.15 33.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.91 2.084 . . . . 0.0 111.647 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 79.21 1.44 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.596 0.635 . . . . 0.0 112.441 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.08 -80.37 0.13 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.973 0.387 . . . . 0.0 111.135 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m -94.51 1.94 55.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.442 1.497 . . . . 0.0 112.068 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.1 46.9 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.85 164.58 21.24 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.661 1.574 . . . . 0.0 110.992 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.85 113.22 6.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.861 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.437 ' O ' HD11 ' A' ' 88' ' ' LEU 0.262 2.3 pp -107.96 -2.02 10.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.604 178.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -32.92 -54.53 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.112 1.365 . . . . 0.0 112.261 163.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 3.14 54.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.923 2.089 . . . . 0.0 111.429 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.65 -37.76 42.57 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.196 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.97 -27.54 59.74 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.916 0.78 . . . . 0.0 115.001 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -44.5 55.67 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.266 1.033 . . . . 0.0 110.212 171.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -74.05 -38.45 63.98 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.66 0.384 . . . . 0.0 111.258 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -140.47 160.41 40.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 108.348 -167.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -94.59 165.84 12.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.541 0.736 . . . . 0.0 111.127 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.18 -45.87 53.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.42 0.688 . . . . 0.0 110.387 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.26 -49.84 31.93 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 112.573 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.48 -51.38 60.51 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.034 0.934 . . . . 0.0 110.276 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.24 -47.48 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.2 tp -48.02 -56.74 6.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.306 1.842 . . . . 0.0 110.12 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.34 -47.81 78.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.1 -44.18 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 122.277 -0.264 . . . . 0.0 110.762 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.2 mt -61.14 -50.65 79.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.115 -0.99 . . . . 0.0 109.724 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -39.74 89.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.562 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -94.81 -61.24 1.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.587 1.955 . . . . 0.0 111.59 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.33 -175.86 21.14 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.571 2.034 . . . . 0.0 110.202 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -150.97 164.46 36.32 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 167.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -4.97 -91.75 0.0 OUTLIER Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.965 2.221 . . . . 0.0 116.272 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.53 34.72 5.34 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.558 1.179 . . . . 0.0 112.58 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.413 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.7 ttt -114.49 123.97 31.43 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 125.592 1.557 . . . . 0.0 108.671 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.64 -38.67 59.83 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.869 2.38 . . . . 0.0 112.621 -170.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 162.61 27.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 122.077 0.82 . . . . 0.0 111.857 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.98 21.22 65.46 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 mt -64.55 -30.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.838 1.255 . . . . 0.0 109.559 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.48 149.48 44.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -143.83 164.5 30.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.231 0.923 . . . . 0.0 111.681 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.64 -140.85 43.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.38 -35.21 5.25 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.939 1.295 . . . . 0.0 112.095 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.04 -56.14 26.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.866 0.466 . . . . 0.0 109.921 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.32 81.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.643 -0.661 . . . . 0.0 110.72 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.53 -53.04 62.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.144 0.429 . . . . 0.0 110.214 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.01 57.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.402 0.681 . . . . 0.0 109.932 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.2 -61.96 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.28 -51.96 49.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.702 0.801 . . . . 0.0 111.374 -170.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.35 -56.18 25.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 110.656 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.964 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 20.4 t90 -54.09 -41.0 67.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.439 0.696 . . . . 0.0 111.467 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.964 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -79.02 -28.63 43.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.856 -1.153 . . . . 0.0 111.291 -175.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.88 67.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.576 0.75 . . . . 0.0 111.375 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.79 62.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.332 1.053 . . . . 0.0 110.75 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.504 ' HA ' ' CE ' ' A' ' 91' ' ' LYS 0.33 0.0 OUTLIER -62.64 9.4 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 118.924 2.935 . . . . 0.0 118.924 -163.102 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--O 1.251 1.166 0 O-C-N 120.77 -1.206 . . . . 0.0 113.26 -149.811 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.735 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.487 HG11 ' HG3' ' A' ' 80' ' ' GLU . 99.1 t . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -72.09 102.73 3.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -168.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.99 -49.6 20.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.445 1.098 . . . . 0.0 112.339 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.15 -44.77 96.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.751 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.1 82.92 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.414 1.006 . . . . 0.0 111.476 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -51.57 -63.2 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.678 HG22 ' SG ' ' A' ' 32' ' ' CYS 0.258 34.1 t -67.05 -39.54 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.696 -164.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.93 0.86 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.174 2.99 . . . . 0.0 112.987 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.45 -25.36 3.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.736 1.153 . . . . 0.0 113.996 165.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -117.85 -17.92 9.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.625 1.17 . . . . 0.0 113.041 -163.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.678 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.6 m -113.58 -39.72 3.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.679 1.127 . . . . 0.0 111.275 176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -50.3 -29.29 5.91 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.6 -29.58 3.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.812 1.245 . . . . 0.0 112.813 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -123.61 -41.52 2.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.696 0.799 . . . . 0.0 110.624 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -74.63 -10.63 59.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.81 152.3 13.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.56 -57.97 2.64 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.476 1.512 . . . . 0.0 113.452 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -5.84 53.3 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.856 1.662 . . . . 0.0 112.523 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD21 HG12 ' A' ' 28' ' ' VAL . 8.0 mt 69.96 21.58 6.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.256 1.822 . . . . 0.0 111.485 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -75.28 -8.09 55.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.406 2.283 . . . . 0.0 111.766 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 99.29 1.49 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 -76.5 0.56 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.471 0.635 . . . . 0.0 109.811 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 m -93.98 2.06 56.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.506 1.523 . . . . 0.0 111.691 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.12 161.3 45.85 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 127.207 2.203 . . . . 0.0 105.303 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.7 165.67 22.48 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.33 2.02 . . . . 0.0 111.094 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 120.76 13.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.893 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 2.0 pp -117.23 0.54 8.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.063 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.26 -43.63 10.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.257 0.935 . . . . 0.0 111.207 164.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -96.53 3.89 52.39 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.561 1.544 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -52.81 -34.58 54.35 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.633 -0.667 . . . . 0.0 111.131 173.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.06 -30.47 75.68 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.045 0.839 . . . . 0.0 113.567 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.49 -47.24 17.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.987 0.893 . . . . 0.0 110.199 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.64 -44.58 49.73 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.704 0.402 . . . . 0.0 111.591 -171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.22 -178.28 3.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.833 2.053 . . . . 0.0 107.288 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.8 t -123.64 171.92 9.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 0.566 . . . . 0.0 110.294 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.79 -44.12 73.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.338 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -52.37 -48.19 65.73 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.959 0.8 . . . . 0.0 111.567 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.0 -50.38 64.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.512 0.672 . . . . 0.0 109.69 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.24 -47.16 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.4 tp -49.88 -55.48 14.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.76 -48.27 72.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.471 HG21 ' C3A' ' A' ' 93' ' ' HEC . 1.0 OUTLIER -58.74 -47.43 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.144 -0.348 . . . . 0.0 110.26 -179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.49 -48.32 87.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 120.835 -1.165 . . . . 0.0 110.022 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.7 -43.18 89.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -86.5 -56.42 3.43 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.19 1.396 . . . . 0.0 110.934 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.1 -160.69 21.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 126.841 2.162 . . . . 0.0 108.737 -166.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 0.0 OUTLIER -158.38 162.71 37.66 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 101.811 -3.403 . . . . 0.0 101.811 174.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.16 -54.56 1.23 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.865 1.221 . . . . 0.0 113.983 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -105.74 30.64 9.45 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 117.478 0.639 . . . . 0.0 113.264 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.6 ttt -137.8 129.52 16.22 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 118.664 1.232 . . . . 0.0 109.449 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.55 -41.98 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.103 2.535 . . . . 0.0 113.058 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.23 166.55 39.94 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-O 121.841 0.69 . . . . 0.0 112.18 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.47 19.48 68.82 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.3 -35.11 70.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 125.757 1.623 . . . . 0.0 109.63 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.49 146.12 41.64 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 165.3 30.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.066 0.546 . . . . 0.0 112.436 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.47 -141.36 35.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -173.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.84 -38.94 0.73 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.746 1.619 . . . . 0.0 112.395 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.487 ' HG3' HG11 ' A' ' 22' ' ' VAL . 29.0 tt0 -59.38 -58.83 6.9 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.925 0.49 . . . . 0.0 110.191 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.0 90.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.22 -51.95 55.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.471 0.708 . . . . 0.0 109.77 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.49 69.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.36 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -48.84 -61.3 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 118.396 0.543 . . . . 0.0 110.026 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.42 -55.79 9.9 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.168 0.987 . . . . 0.0 111.805 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.94 -53.49 57.36 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.707 0.765 . . . . 0.0 110.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.652 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 57.8 t90 -57.41 -37.36 72.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.203 0.525 . . . . 0.0 111.625 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.527 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -72.53 -42.97 64.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 121.241 -0.912 . . . . 0.0 109.475 -177.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -36.92 64.13 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.255 0.222 . . . . 0.0 110.736 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -18.68 60.78 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.733 -0.605 . . . . 0.0 112.411 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 7.62 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.962 2.505 . . . . 0.0 114.934 -172.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.251 1.158 0 O-C-N 119.791 -1.818 . . . . 0.0 113.144 -143.348 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.675 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.25 100.55 2.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.11 1.364 . . . . 0.0 107.591 -163.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.06 -50.68 35.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.179 0.991 . . . . 0.0 112.485 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.33 -44.51 97.07 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.715 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.96 78.58 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.181 0.901 . . . . 0.0 111.184 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.27 -64.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 72.3 t -67.64 -39.32 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 117.921 -1.512 . . . . 0.0 111.851 -163.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -57.89 0.46 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.999 3.32 . . . . 0.0 114.271 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.63 -37.58 1.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.607 1.094 . . . . 0.0 113.241 164.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 -32.32 15.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.436 1.494 . . . . 0.0 110.201 -163.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.9 m -110.77 -39.15 4.93 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.407 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 pt -51.6 -28.87 9.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 O-C-N 123.121 0.263 . . . . 0.0 111.651 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 t -37.55 -45.66 0.77 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.958 1.703 . . . . 0.0 111.768 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.9 m -110.88 -43.06 3.85 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 122.832 0.453 . . . . 0.0 110.619 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -72.49 -15.47 61.8 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.41 153.13 24.37 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.93 4.25 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.15 1.357 . . . . 0.0 113.664 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.4 -0.8 38.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.913 0.485 . . . . 0.0 112.172 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD21 HG12 ' A' ' 28' ' ' VAL . 1.7 mt 66.28 23.65 10.75 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.134 1.774 . . . . 0.0 111.069 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -6.93 58.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.334 2.654 . . . . 0.0 111.565 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 78.21 1.38 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 118.434 0.561 . . . . 0.0 111.936 166.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.42 -78.27 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.643 0.377 . . . . 0.0 111.363 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.5 t -97.52 2.29 49.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.79 1.636 . . . . 0.0 111.64 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.36 162.09 41.34 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.01 165.23 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.773 1.649 . . . . 0.0 111.33 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.06 117.93 8.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.492 HD11 HD22 ' A' ' 40' ' ' LEU 0.294 2.0 pp -114.07 0.31 8.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.835 175.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -35.15 48.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.727 1.149 . . . . 0.0 112.034 171.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.49 4.43 50.46 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.914 1.286 . . . . 0.0 111.974 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . . . -53.2 -35.13 59.55 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.38 67.11 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.748 1.158 . . . . 0.0 114.526 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.99 -45.6 49.01 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.425 1.113 . . . . 0.0 109.535 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.608 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -136.78 160.43 38.87 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.026 2.131 . . . . 0.0 108.236 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.1 m -95.31 169.26 10.2 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.417 0.287 . . . . 0.0 110.645 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -40.09 76.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.093 -174.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -53.24 -53.17 54.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.705 1.202 . . . . 0.0 111.757 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.18 -50.19 73.62 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.181 0.992 . . . . 0.0 109.528 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.1 -51.77 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.29 -55.01 14.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.105 1.362 . . . . 0.0 109.892 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -44.08 97.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.07 -41.92 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.625 -0.672 . . . . 0.0 110.786 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mt -63.5 -50.08 79.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -38.41 90.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.608 0.363 . . . . 0.0 111.5 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -89.38 -59.18 2.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.048 1.739 . . . . 0.0 111.355 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.28 115.92 3.04 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.879 1.704 . . . . 0.0 109.157 -165.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.13 150.31 10.9 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -26.47 -65.64 0.07 OUTLIER Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.826 1.203 . . . . 0.0 115.989 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.59 22.99 21.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.167 0.983 . . . . 0.0 113.67 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.2 ttt -139.23 121.48 10.24 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.822 1.249 . . . . 0.0 110.554 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.58 140.73 58.01 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 N-CA-C 108.825 -1.259 . . . . 0.0 108.825 171.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.98 -172.26 21.8 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.25 12.67 63.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.64 -30.47 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.785 1.234 . . . . 0.0 109.569 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.46 145.88 45.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 168.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -143.02 161.97 36.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.629 0.771 . . . . 0.0 111.122 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.67 -137.59 26.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.99 -37.6 1.4 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.221 1.409 . . . . 0.0 112.343 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -60.67 -59.18 5.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.014 0.526 . . . . 0.0 109.915 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.17 92.98 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.365 -0.835 . . . . 0.0 110.626 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.98 -52.16 61.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 109.735 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.48 -51.31 67.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.118 0.567 . . . . 0.0 110.313 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.2 -60.76 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.449 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.09 -53.46 42.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 118.53 0.604 . . . . 0.0 110.869 -169.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.54 38.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.102 0.477 . . . . 0.0 110.63 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.596 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 56.9 t90 -62.49 -39.3 93.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.657 0.741 . . . . 0.0 112.229 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.596 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -76.24 -34.03 59.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.731 -1.231 . . . . 0.0 109.268 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.37 -54.07 45.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 161.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.2 -8.25 52.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.104 -0.998 . . . . 0.0 112.161 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -24.28 66.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.558 1.143 . . . . 0.0 110.926 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.767 -1.111 . . . . 0.0 113.043 -156.351 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.758 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.29 101.65 1.95 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 125.614 1.566 . . . . 0.0 107.274 -162.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.87 -51.23 58.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.115 -166.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.95 -42.55 94.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.304 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.8 -44.56 86.4 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.931 1.241 . . . . 0.0 111.055 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -48.94 -60.51 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.649 HG21 ' CZ3' ' A' ' 87' ' ' TRP 0.299 89.5 t -65.19 -42.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.678 -167.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -60.37 0.89 0.15 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.556 3.542 . . . . 0.0 113.997 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.75 -20.07 1.02 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -25.22 11.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.993 1.317 . . . . 0.0 110.855 -173.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.0 m -118.86 -41.08 2.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.474 0.579 . . . . 0.0 111.742 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -49.26 -30.06 3.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 122.681 0.392 . . . . 0.0 111.52 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -36.25 -43.55 0.37 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.298 1.839 . . . . 0.0 111.641 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.79 -44.81 2.91 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 110.934 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -69.17 -16.85 63.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.85 154.52 27.39 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.22 -60.42 2.31 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.366 1.46 . . . . 0.0 114.085 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.64 -3.3 43.29 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 48' ' ' ILE . 1.2 mt 68.29 25.6 7.08 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.495 1.518 . . . . 0.0 110.548 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -78.16 -7.6 57.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 129.032 2.933 . . . . 0.0 111.265 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.19 76.99 1.31 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.447 0.567 . . . . 0.0 112.191 164.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.16 -80.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.748 0.419 . . . . 0.0 111.598 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -92.04 2.23 56.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.022 1.729 . . . . 0.0 112.066 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.69 162.27 39.56 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.67 162.3 32.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.796 1.664 . . . . 0.0 111.39 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.48 115.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.091 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.616 HD11 HD22 ' A' ' 40' ' ' LEU . 2.4 pp -105.06 0.5 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.252 172.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -36.69 37.04 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.226 0.921 . . . . 0.0 111.658 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.67 3.55 55.31 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.176 0.991 . . . . 0.0 112.824 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.53 69.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.076 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.59 66.83 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 121.76 2.073 . . . . 0.0 114.073 171.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.36 -45.91 57.75 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.321 -1.105 . . . . 0.0 109.718 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.26 -37.93 63.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.882 0.473 . . . . 0.0 111.547 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.33 160.57 39.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.434 1.894 . . . . 0.0 108.464 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -94.74 166.67 11.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.274 0.559 . . . . 0.0 110.763 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.58 -44.49 36.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.697 1.199 . . . . 0.0 110.718 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.78 -55.86 17.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.444 1.098 . . . . 0.0 112.007 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.99 -51.54 67.38 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.672 1.189 . . . . 0.0 109.412 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -61.24 -50.39 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -50.77 -55.31 17.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.795 1.238 . . . . 0.0 109.742 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.13 -46.11 89.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.039 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mt -58.55 -40.86 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 O-C-N 121.963 -0.46 . . . . 0.0 110.9 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.55 -50.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.25 -37.2 86.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -92.21 -45.19 8.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.88 1.672 . . . . 0.0 111.962 -170.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.81 113.66 3.03 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.32 1.438 . . . . 0.0 110.075 -168.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.448 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 3.4 tp60 -55.34 155.52 5.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 159.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -32.56 -64.53 0.26 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.315 1.436 . . . . 0.0 116.114 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.12 2.73 85.56 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 117.951 0.876 . . . . 0.0 113.484 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.6 ttt -103.43 132.26 21.27 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.286 1.434 . . . . 0.0 110.569 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.45 136.33 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.883 1.722 . . . . 0.0 110.163 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.53 148.54 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.41 79.93 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.6 mm -56.26 -33.52 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.712 1.205 . . . . 0.0 110.259 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.75 149.92 49.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -143.34 157.53 44.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.452 0.644 . . . . 0.0 112.357 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.64 -137.05 31.59 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.91 -37.59 1.34 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.306 1.442 . . . . 0.0 112.519 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.15 -60.6 3.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.467 0.707 . . . . 0.0 109.757 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.66 82.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.498 -0.751 . . . . 0.0 110.764 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.6 -49.74 76.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.211 0.605 . . . . 0.0 110.253 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.63 -49.93 66.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 28' ' ' VAL . 64.7 t -51.42 -60.74 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.202 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.36 -55.58 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.13 0.972 . . . . 0.0 110.982 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.32 69.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.649 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 18.7 t90 -63.59 -57.05 11.35 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.194 0.521 . . . . 0.0 111.481 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -57.23 -36.48 70.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.356 -1.465 . . . . 0.0 109.847 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.25 -58.04 10.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 168.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.32 -12.87 61.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.233 -0.917 . . . . 0.0 111.947 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -23.67 66.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.66 -174.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.2 pttt . . . . . 0 C--O 1.251 1.133 0 C-N-CA 127.337 2.255 . . . . 0.0 113.931 -153.654 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.744 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.19 97.62 1.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 125.157 1.383 . . . . 0.0 107.678 -160.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.69 -50.41 68.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.604 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.197 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.6 79.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.888 1.222 . . . . 0.0 111.32 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.3 t -47.23 -63.95 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.767 HG13 ' SG ' ' A' ' 32' ' ' CYS . 77.8 t -67.9 -39.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.99 -165.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -56.63 -3.88 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 129.142 2.977 . . . . 0.0 113.297 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.22 -5.52 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -119.47 -27.92 5.45 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.61 1.164 . . . . 0.0 111.464 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.767 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -114.3 -37.81 4.27 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.251 0.621 . . . . 0.0 111.246 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -51.15 -30.75 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.313 0.245 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 m -37.22 -41.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.326 1.45 . . . . 0.0 113.252 170.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -120.2 -40.86 2.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.086 0.554 . . . . 0.0 110.809 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -75.81 -9.1 58.32 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.416 -0.803 . . . . 0.0 113.052 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.58 154.74 12.84 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 118.954 0.797 . . . . 0.0 111.131 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.6 -56.87 4.08 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.197 1.38 . . . . 0.0 113.66 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -81.44 -1.86 47.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.124 0.569 . . . . 0.0 112.199 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.541 HD21 HG12 ' A' ' 28' ' ' VAL . 3.6 mt 70.46 22.67 5.13 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.02 1.728 . . . . 0.0 110.748 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.32 -7.79 58.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.634 2.774 . . . . 0.0 111.665 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.32 100.19 1.78 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.882 0.753 . . . . 0.0 111.613 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.8 -79.25 0.52 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.704 0.752 . . . . 0.0 110.042 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 m -92.4 1.5 57.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.47 160.73 55.84 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.577 1.951 . . . . 0.0 105.783 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.03 164.72 23.92 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.093 1.862 . . . . 0.0 111.421 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.67 14.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.43 ' O ' HD11 ' A' ' 88' ' ' LEU 0.296 2.2 pp -117.28 0.88 8.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.571 173.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -22.92 18.95 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.861 -1.149 . . . . 0.0 112.778 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 1.25 34.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.995 1.318 . . . . 0.0 112.724 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.69 67.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.481 1.037 . . . . 0.0 111.981 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.0 -30.01 74.25 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.354 1.434 . . . . 0.0 113.576 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.64 -46.11 23.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.113 0.957 . . . . 0.0 111.357 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -72.52 -42.78 64.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.69 173.35 8.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.794 1.637 . . . . 0.0 108.003 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 t -104.53 174.46 5.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.002 0.906 . . . . 0.0 112.548 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -44.01 92.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.03 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.9 -50.64 63.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.45 -51.9 66.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 109.91 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.11 -51.67 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.6 tp -49.27 -56.46 9.33 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.67 -49.28 77.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -56.42 -44.03 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.968 0.507 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mt -63.75 -51.47 69.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 O-C-N 121.776 -0.578 . . . . 0.0 109.908 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.82 -25.27 67.14 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.283 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.4 -62.31 1.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.359 1.864 . . . . 0.0 111.311 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.62 105.68 2.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.687 1.613 . . . . 0.0 110.64 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 3.5 tp60 -57.07 154.07 10.45 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 161.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.76 -62.79 0.65 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.983 1.277 . . . . 0.0 115.191 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.77 22.17 22.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.83 0.815 . . . . 0.0 113.485 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -126.87 132.98 24.55 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 108.408 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.38 -35.88 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.131 1.887 . . . . 0.0 112.393 -171.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.91 161.71 26.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 121.854 0.697 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.06 26.59 61.27 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 122.367 -0.49 . . . . 0.0 111.99 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.2 mt -66.14 -30.47 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.24 1.016 . . . . 0.0 109.533 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.68 145.57 36.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -145.55 156.09 43.48 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.264 0.938 . . . . 0.0 112.593 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.4 -143.66 48.67 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.47 -37.45 1.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.04 1.736 . . . . 0.0 112.455 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -53.96 -64.17 0.91 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.014 1.326 . . . . 0.0 110.208 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.04 92.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.576 -0.702 . . . . 0.0 110.313 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -52.26 -51.78 56.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.436 0.636 . . . . 0.0 109.362 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.4 81.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.767 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.31 -57.78 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-N 118.429 0.559 . . . . 0.0 110.186 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.75 -56.23 13.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.734 0.814 . . . . 0.0 110.784 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.4 -53.34 59.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.663 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.505 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 58.3 t90 -54.52 -54.19 44.42 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.816 0.446 . . . . 0.0 110.899 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.505 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -57.71 -45.7 85.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.179 -0.951 . . . . 0.0 110.316 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.04 65.96 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -88.69 -22.42 23.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.68 1.592 . . . . 0.0 110.829 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -28.44 66.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.412 -0.805 . . . . 0.0 110.064 -164.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 pttt . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.887 1.275 . . . . 0.0 111.763 -146.189 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.707 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.513 -0.477 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.39 98.36 1.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.84 -53.27 26.63 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.325 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.741 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.59 67.73 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.511 1.05 . . . . 0.0 110.171 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -51.68 -57.42 3.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.503 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 2.3 t -77.55 -1.36 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.128 -174.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 -99.89 1.64 43.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.787 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.27 -26.61 0.76 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -106.01 -14.52 15.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.709 1.204 . . . . 0.0 111.618 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 6.8 m -122.36 -41.49 2.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.845 0.858 . . . . 0.0 111.247 -168.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 28' ' ' VAL . 31.0 pt -49.03 -31.11 3.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -40.27 -39.8 1.02 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.907 1.683 . . . . 0.0 111.461 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.9 m -117.24 -42.15 2.93 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 122.7 0.4 . . . . 0.0 111.088 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -72.15 -15.67 61.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.07 155.03 30.53 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.97 -56.31 4.52 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.162 1.363 . . . . 0.0 113.111 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -82.87 0.66 43.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.775 0.83 . . . . 0.0 112.399 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 48' ' ' ILE . 5.3 mt 64.91 23.96 12.66 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.155 1.382 . . . . 0.0 111.559 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -80.86 -6.05 58.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 128.557 2.743 . . . . 0.0 111.662 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.67 76.82 1.32 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 118.442 0.565 . . . . 0.0 111.91 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 -75.81 0.23 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.393 . . . . 0.0 111.462 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -96.83 1.7 50.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.168 1.787 . . . . 0.0 111.045 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.41 32.96 Favored Pre-proline 0 N--CA 1.452 -0.355 0 C-N-CA 127.081 2.152 . . . . 0.0 105.296 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.97 162.31 26.32 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.574 1.516 . . . . 0.0 110.848 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.72 125.11 23.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.489 ' O ' HD11 ' A' ' 88' ' ' LEU 0.274 2.2 pp -119.72 -3.22 9.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.46 174.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -38.64 -45.8 1.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.817 1.19 . . . . 0.0 111.913 164.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 2.56 51.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.557 1.543 . . . . 0.0 111.992 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.59 -28.71 56.63 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.274 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.06 73.42 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.279 0.945 . . . . 0.0 114.079 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -44.23 32.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.678 0.739 . . . . 0.0 109.483 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -74.61 -43.98 52.85 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.47 164.31 21.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.199 2.2 . . . . 0.0 108.523 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -99.3 163.92 12.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.177 0.591 . . . . 0.0 111.284 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -47.91 -48.05 31.87 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 110.441 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -48.16 -48.53 34.27 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.076 0.95 . . . . 0.0 112.268 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.06 -52.7 46.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.522 0.729 . . . . 0.0 109.679 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.554 HG23 HMA1 ' A' ' 93' ' ' HEC . 62.9 mt -59.93 -47.12 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.4 tp -48.18 -56.3 8.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.482 1.513 . . . . 0.0 110.174 172.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.4 -50.03 68.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG21 ' C3A' ' A' ' 93' ' ' HEC . 1.1 mp -57.33 -44.22 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 25.8 mt -63.39 -46.02 96.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 120.433 -1.417 . . . . 0.0 110.08 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.79 -37.26 81.79 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.915 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -93.4 -36.67 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.985 2.114 . . . . 0.0 112.249 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.62 -178.75 27.63 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.955 1.74 . . . . 0.0 110.06 -163.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 6.0 tp-100 -137.76 164.27 29.29 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.81 -69.89 0.09 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.738 1.637 . . . . 0.0 114.868 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 31.62 6.02 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.02 0.91 . . . . 0.0 113.348 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.462 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.2 ttt -139.6 121.17 9.78 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.652 1.181 . . . . 0.0 111.564 -174.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.36 157.87 55.62 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.03 1.82 . . . . 0.0 110.424 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 148.3 18.7 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -172.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.58 16.3 66.45 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.769 -0.461 . . . . 0.0 112.373 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.62 -41.22 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.911 0.884 . . . . 0.0 108.973 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB3' ' CG2' ' A' ' 64' ' ' ILE . . . -128.89 143.23 50.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -140.68 158.72 43.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 0.0 108.83 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.98 -139.22 29.17 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.07 1.55 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.549 1.54 . . . . 0.0 112.384 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -59.02 6.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.134 0.574 . . . . 0.0 109.541 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.45 85.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.38 -52.65 64.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.265 0.626 . . . . 0.0 110.402 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.86 69.61 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 109.522 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG22 ' CG2' ' A' ' 28' ' ' VAL . 53.2 t -48.4 -63.24 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 O-C-N 123.388 0.43 . . . . 0.0 109.877 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.8 51.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.21 1.004 . . . . 0.0 111.085 -171.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.23 37.63 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.425 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 60.6 t90 -57.74 -38.46 75.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.183 0.593 . . . . 0.0 111.564 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.489 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -72.42 -45.35 60.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.559 0.744 . . . . 0.0 109.469 -178.091 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.07 -33.07 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.733 0.813 . . . . 0.0 111.264 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -21.81 60.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.851 0.86 . . . . 0.0 110.904 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -66.93 8.75 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -161.299 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 pttt . . . . . 0 C--O 1.247 0.962 0 O-C-N 120.9 -1.125 . . . . 0.0 112.969 -131.731 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.72 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.55 98.04 1.41 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 107.137 -162.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.31 -49.73 42.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.936 -168.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.74 -45.74 93.13 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.556 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -44.91 82.46 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.482 1.037 . . . . 0.0 110.808 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.91 -62.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.668 HG13 ' SG ' ' A' ' 32' ' ' CYS . 72.1 t -66.69 -39.33 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.203 -168.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -59.08 0.26 0.1 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 129.141 2.976 . . . . 0.0 113.502 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 -15.43 1.57 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.08 -20.98 11.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.818 1.247 . . . . 0.0 111.503 -171.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.668 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.8 m -118.73 -40.98 2.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.989 0.813 . . . . 0.0 112.123 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.7 pt -50.7 -29.85 7.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 111.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -41.27 -39.15 1.3 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.949 1.699 . . . . 0.0 113.048 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -116.66 -43.31 2.91 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.33 0.652 . . . . 0.0 110.575 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.42 -12.94 60.98 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.88 153.28 25.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.11 -53.69 6.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.88 1.229 . . . . 0.0 113.111 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -81.79 -1.53 47.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.27 0.628 . . . . 0.0 112.205 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.46 HD21 HG12 ' A' ' 28' ' ' VAL . 5.6 mt 66.38 21.79 10.86 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.631 1.572 . . . . 0.0 111.26 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -78.98 -6.76 57.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.312 2.645 . . . . 0.0 111.572 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.56 82.92 1.65 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.461 0.573 . . . . 0.0 111.738 168.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.24 -77.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.768 0.427 . . . . 0.0 110.965 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -97.17 2.58 51.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.695 1.598 . . . . 0.0 111.58 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.0 161.28 46.26 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.98 163.19 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.73 1.62 . . . . 0.0 111.163 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 123.08 18.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.288 2.2 pp -119.04 -1.12 8.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.194 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -38.46 -45.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.574 1.079 . . . . 0.0 112.567 163.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.68 2.98 44.88 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.25 1.82 . . . . 0.0 112.59 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.14 -30.53 16.85 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.787 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.96 -30.29 76.75 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.12 0.873 . . . . 0.0 114.806 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.61 -44.15 44.42 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.663 -0.904 . . . . 0.0 109.374 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -73.36 -36.81 66.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.63 157.83 45.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 m -90.61 165.66 13.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.546 0.738 . . . . 0.0 111.806 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -46.72 63.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.474 0.71 . . . . 0.0 110.488 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -49.86 -49.03 50.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.053 . . . . 0.0 111.694 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.75 -49.72 71.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.467 0.651 . . . . 0.0 109.639 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.42 -48.05 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.3 tp -48.63 -53.51 18.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.653 1.181 . . . . 0.0 109.64 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.81 0.63 6.77 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.615 0.766 . . . . 0.0 113.037 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -104.35 -39.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 120.91 -1.119 . . . . 0.0 109.441 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 mt -66.24 -50.58 67.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.133 -0.98 . . . . 0.0 109.961 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.4 -39.8 94.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.469 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.38 -48.56 7.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.087 0.955 . . . . 0.0 112.373 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.12 107.99 3.06 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.641 1.591 . . . . 0.0 109.723 -167.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.48 149.52 16.95 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 163.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -19.18 -71.13 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 C-N-CA 126.286 1.898 . . . . 0.0 116.965 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.03 73.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 117.946 0.873 . . . . 0.0 113.793 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.8 ttt -87.99 127.49 57.44 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 126.095 1.758 . . . . 0.0 109.483 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.12 143.39 84.13 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 N-CA-C 109.237 -1.101 . . . . 0.0 109.237 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.45 166.97 28.39 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.52 18.05 75.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.922 -0.639 . . . . 0.0 112.307 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -54.66 -36.02 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.55 1.14 . . . . 0.0 109.967 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.28 146.38 38.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -143.0 154.76 44.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.395 1.078 . . . . 0.0 110.772 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.58 -136.36 49.59 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.53 -38.63 6.53 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.599 1.16 . . . . 0.0 111.978 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -51.9 -62.13 1.82 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.797 0.839 . . . . 0.0 109.348 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.89 71.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.019 0.527 . . . . 0.0 110.904 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.32 -51.05 71.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 0.0 109.928 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -50.18 71.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.759 -0.638 . . . . 0.0 109.362 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.85 -61.76 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.986 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.1 -54.15 14.18 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 111.195 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -54.63 44.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 110.873 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.578 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 59.3 t90 -57.85 -41.1 81.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 111.749 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.447 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.55 -45.12 66.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 108.938 -177.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.58 -31.96 68.5 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.432 0.693 . . . . 0.0 112.125 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -21.18 60.95 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 110.701 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -68.82 7.67 0.64 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -158.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.5 pttt . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.478 -1.249 . . . . 0.0 113.075 -128.465 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.799 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.2 m-20 -72.36 162.42 29.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 127.16 2.184 . . . . 0.0 107.026 -172.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB1' ' CB ' ' A' ' 87' ' ' TRP . . . -101.51 -69.86 0.76 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.78 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -58.51 -41.38 85.29 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.421 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -57.17 -39.15 74.71 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.673 0.67 . . . . 0.0 111.303 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.82 -55.87 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.606 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 3.5 t -66.32 -41.05 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 117.015 -1.874 . . . . 0.0 110.615 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -59.92 0.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 129.844 3.258 . . . . 0.0 114.761 169.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.47 -15.51 0.95 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.6 -23.56 11.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.09 1.356 . . . . 0.0 110.519 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -122.82 -39.09 2.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.018 0.527 . . . . 0.0 111.615 -165.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -49.11 -30.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 C-N-CA 122.797 0.439 . . . . 0.0 111.647 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 m -38.46 -39.67 0.48 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.864 1.665 . . . . 0.0 113.068 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.85 -43.97 2.64 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.943 0.497 . . . . 0.0 110.519 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.93 -16.24 63.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 113.017 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.69 153.44 26.9 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.8 -59.12 2.48 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.189 1.376 . . . . 0.0 113.13 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.98 -2.19 38.98 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.188 0.995 . . . . 0.0 112.378 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD21 HG12 ' A' ' 28' ' ' VAL . 1.7 mt 65.33 24.15 12.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.026 1.73 . . . . 0.0 111.631 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -78.54 -8.33 58.46 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.765 2.826 . . . . 0.0 111.449 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.24 76.51 1.26 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-N 118.408 0.549 . . . . 0.0 111.984 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.59 -82.53 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.792 0.437 . . . . 0.0 111.443 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.72 1.46 56.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.699 1.999 . . . . 0.0 111.97 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.05 162.93 35.55 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.3 165.63 21.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.813 1.676 . . . . 0.0 111.148 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.45 117.2 7.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 40' ' ' LEU 0.265 2.2 pp -114.55 -3.78 11.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.207 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -38.23 -48.27 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.504 1.047 . . . . 0.0 111.996 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -99.95 5.55 45.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.395 1.878 . . . . 0.0 112.08 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -46.96 -44.46 20.05 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.918 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.49 -29.1 16.62 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.964 0.802 . . . . 0.0 114.839 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.08 68.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.413 -1.051 . . . . 0.0 110.497 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.77 -44.0 12.87 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.24 0.616 . . . . 0.0 110.816 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.25 154.85 38.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.817 2.047 . . . . 0.0 107.701 -171.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -95.44 169.82 9.79 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.736 0.415 . . . . 0.0 110.75 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -43.0 64.58 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.713 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -48.74 -52.71 22.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 111.863 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.57 -53.91 50.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.841 0.856 . . . . 0.0 109.684 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.01 -46.97 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -171.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.1 tp -47.31 -56.33 7.04 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.013 1.725 . . . . 0.0 109.95 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.07 -48.4 76.15 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -46.94 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.64 -47.84 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.965 -1.084 . . . . 0.0 109.917 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.5 -27.04 64.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.47 0.708 . . . . 0.0 112.852 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.42 -60.77 1.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.039 -171.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.83 -167.13 24.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.191 2.329 . . . . 0.0 109.469 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -157.97 163.89 37.36 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -15.81 -83.78 0.01 OUTLIER Glycine 0 CA--C 1.542 1.73 0 C-N-CA 126.005 1.764 . . . . 0.0 116.303 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.39 18.82 56.21 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.818 1.309 . . . . 0.0 113.566 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -103.81 127.71 28.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.01 1.324 . . . . 0.0 109.168 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.53 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 38.2 Cg_endo -64.1 -40.98 24.13 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.569 2.179 . . . . 0.0 112.13 -172.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 161.67 23.09 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 121.851 0.695 . . . . 0.0 111.732 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.61 22.17 65.7 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 122.178 -0.601 . . . . 0.0 111.827 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' CHC' ' A' ' 93' ' ' HEC . 7.9 mt -64.46 -29.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.448 1.499 . . . . 0.0 109.835 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.47 143.12 29.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -138.3 166.5 24.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.48 -135.09 41.78 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.9 -36.83 8.01 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.675 1.19 . . . . 0.0 112.027 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -60.63 -55.91 27.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.97 84.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.637 -0.664 . . . . 0.0 111.22 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.69 -54.14 49.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.305 0.502 . . . . 0.0 110.999 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.04 -51.19 62.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.8 t -50.03 -64.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.308 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.61 -51.87 25.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.495 1.118 . . . . 0.0 111.148 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -55.26 34.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 110.77 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 66.3 t90 -59.36 -39.59 83.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.006 0.432 . . . . 0.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -68.95 -41.65 77.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 -178.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.98 -39.08 73.98 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 122.129 -0.357 . . . . 0.0 110.522 168.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.14 -19.05 61.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.99 0.516 . . . . 0.0 111.28 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.71 9.08 0.94 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.953 1.701 . . . . 0.0 114.649 -171.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 C--O 1.25 1.12 0 O-C-N 120.635 -1.29 . . . . 0.0 112.73 -154.428 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.744 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 CA--C 1.514 -0.433 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 97.73 2.31 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.063 1.345 . . . . 0.0 108.093 -163.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.23 -53.05 60.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.555 -167.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.18 -43.59 98.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.088 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.32 78.13 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.168 0.895 . . . . 0.0 111.326 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -46.25 -63.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.732 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 80.2 t -67.97 -37.78 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 117.352 -1.739 . . . . 0.0 112.52 -166.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -60.1 -1.02 0.26 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.203 3.001 . . . . 0.0 113.179 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 -9.67 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 169.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -118.72 -25.19 6.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.188 1.395 . . . . 0.0 112.04 -171.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -117.21 -40.96 3.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.418 0.554 . . . . 0.0 110.499 -172.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -48.33 -32.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 122.942 0.497 . . . . 0.0 111.612 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -38.64 -37.38 0.32 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 113.206 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -120.08 -41.72 2.63 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.786 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.16 -6.33 49.04 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.66 -86.72 0.41 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.408 1.004 . . . . 0.0 112.788 163.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.53 -62.93 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.35 2.59 39.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 111.764 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.85 26.87 7.51 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.31 1.844 . . . . 0.0 111.505 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -72.83 -10.87 60.29 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.43 1.892 . . . . 0.0 111.721 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 104.14 1.8 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.4 -77.11 0.6 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.535 0.734 . . . . 0.0 110.01 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -92.26 2.1 56.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.922 1.289 . . . . 0.0 111.646 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.83 158.61 52.61 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -63.98 164.57 21.63 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.153 1.902 . . . . 0.0 111.105 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.24 123.72 18.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.631 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.415 ' O ' HD11 ' A' ' 88' ' ' LEU 0.253 2.5 pp -119.79 -2.42 8.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.322 -0.847 . . . . 0.0 112.266 172.452 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -42.06 -44.85 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.133 1.333 . . . . 0.0 111.594 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.68 4.14 45.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.608 1.563 . . . . 0.0 112.195 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.4 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -48.9 -36.97 18.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.358 176.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.07 -34.34 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 120.86 1.664 . . . . 0.0 114.379 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -53.27 32.04 Favored 'General case' 0 C--N 1.337 0.056 0 O-C-N 121.446 -1.032 . . . . 0.0 110.276 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -74.31 -37.02 63.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.474 -169.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -132.01 151.53 51.69 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.831 1.652 . . . . 0.0 107.822 -171.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.34 166.95 12.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.665 0.745 . . . . 0.0 110.899 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.37 -47.83 26.02 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.026 1.331 . . . . 0.0 110.498 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.94 -46.34 68.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.853 0.751 . . . . 0.0 111.764 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.99 -53.68 42.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.511 0.724 . . . . 0.0 109.27 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.517 HG23 HMA1 ' A' ' 93' ' ' HEC . 69.6 mt -60.07 -47.6 91.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.0 tp -49.85 -54.47 19.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.13 1.372 . . . . 0.0 110.322 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.38 -49.66 71.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -46.46 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 60' ' ' ILE . 32.1 mt -58.95 -48.84 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 121.245 -0.909 . . . . 0.0 109.635 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.75 -32.63 73.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.485 0.714 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -101.78 -61.55 1.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.015 1.726 . . . . 0.0 111.481 -169.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.09 -173.36 22.71 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 126.776 2.131 . . . . 0.0 110.388 -171.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.92 163.94 38.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 168.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -17.83 -81.97 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.178 1.847 . . . . 0.0 116.102 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.13 25.71 24.35 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.858 1.329 . . . . 0.0 113.441 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -112.46 126.77 27.81 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.948 1.299 . . . . 0.0 108.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.93 -40.88 49.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.101 2.534 . . . . 0.0 112.381 -172.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.67 161.47 25.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-O 121.958 0.755 . . . . 0.0 111.869 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.63 62.12 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.09 -35.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.437 0.695 . . . . 0.0 109.344 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.5 52.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -145.05 152.24 39.8 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.925 0.869 . . . . 0.0 113.233 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.94 -138.86 47.97 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.76 -34.26 11.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.706 1.203 . . . . 0.0 112.034 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.23 -57.01 13.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.086 0.954 . . . . 0.0 109.906 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.77 -39.58 80.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.837 -0.539 . . . . 0.0 110.266 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -55.73 -53.38 57.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.909 0.322 . . . . 0.0 110.151 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.79 39.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.466 0.706 . . . . 0.0 109.643 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.24 -65.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 O-C-N 123.433 0.458 . . . . 0.0 110.21 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.86 -48.85 66.8 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.793 0.837 . . . . 0.0 111.235 -170.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.74 30.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.755 0.422 . . . . 0.0 110.337 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.732 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 31.9 t90 -54.9 -41.8 71.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.362 0.665 . . . . 0.0 111.247 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.88 -49.32 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.821 0.848 . . . . 0.0 110.366 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.07 69.22 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.522 0.729 . . . . 0.0 110.875 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.49 -23.21 60.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.427 1.091 . . . . 0.0 110.985 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -32.17 73.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.263 -0.898 . . . . 0.0 110.472 -166.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.989 1.716 . . . . 0.0 114.502 -145.446 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.754 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.14 98.63 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -169.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.64 -49.78 14.02 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.129 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -63.11 -44.03 96.78 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.928 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.43 75.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 120.002 1.273 . . . . 0.0 111.183 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -55.0 -63.52 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.769 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 25.6 t -65.32 -42.61 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.683 -164.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -3.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.025 2.93 . . . . 0.0 112.726 170.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.59 0.55 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mmtt -126.89 -30.51 2.73 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.114 0.966 . . . . 0.0 111.878 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.5 m -110.23 -38.47 5.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.76 0.709 . . . . 0.0 110.687 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.0 pt -51.55 -30.15 10.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -38.66 -39.22 0.47 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.396 1.878 . . . . 0.0 113.154 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -123.02 -38.8 2.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 110.993 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.16 -9.68 59.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.18 155.87 17.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.94 -57.02 3.63 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.257 1.408 . . . . 0.0 113.498 -174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.03 1.29 44.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 112.518 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt 68.42 21.36 8.28 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.051 1.341 . . . . 0.0 111.363 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -6.59 53.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.972 2.509 . . . . 0.0 111.654 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 113.51 2.34 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.64 -77.15 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.771 0.786 . . . . 0.0 109.449 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 m -93.08 1.85 57.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.938 1.295 . . . . 0.0 111.477 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.89 159.23 57.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 127.038 2.135 . . . . 0.0 105.591 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.0 164.66 21.36 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.08 1.854 . . . . 0.0 111.263 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 120.04 11.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.273 2.2 pp -115.14 -0.4 9.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-O 118.272 -0.871 . . . . 0.0 112.063 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -46.23 -41.26 12.65 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.46 1.027 . . . . 0.0 112.157 170.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.93 4.05 51.77 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.329 1.452 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -25.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.598 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.31 -33.03 76.79 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.901 1.228 . . . . 0.0 113.997 171.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.93 -43.21 59.05 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.624 -0.927 . . . . 0.0 109.646 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -74.36 -44.17 53.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.066 0.547 . . . . 0.0 111.109 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.49 164.43 23.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.707 2.003 . . . . 0.0 108.486 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.22 168.49 10.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.521 0.729 . . . . 0.0 111.6 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -44.0 73.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.34 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.158 0.983 . . . . 0.0 112.236 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.88 -49.21 78.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 64' ' ' ILE . 74.2 mt -63.53 -49.87 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -175.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.0 tp -47.39 -57.52 5.2 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.495 1.518 . . . . 0.0 110.121 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.5 -45.17 92.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.2 mt -59.63 -43.17 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.646 -0.659 . . . . 0.0 111.0 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 60' ' ' ILE . 31.0 mt -59.69 -48.4 87.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 O-C-N 120.941 -1.099 . . . . 0.0 109.449 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 mt -65.82 -34.8 79.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.327 0.651 . . . . 0.0 112.21 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -102.97 -53.79 2.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.572 1.549 . . . . 0.0 112.356 -167.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -171.72 20.23 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.411 1.958 . . . . 0.0 110.269 -170.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -166.08 135.83 3.31 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.02 -110.75 0.15 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 120.333 1.424 . . . . 0.0 113.465 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.85 -9.2 68.52 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.157 0.979 . . . . 0.0 114.232 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -63.18 127.52 91.08 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 118.498 1.149 . . . . 0.0 109.122 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -63.79 -37.84 42.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.14 2.56 . . . . 0.0 111.817 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.48 165.41 32.69 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-O 121.987 0.771 . . . . 0.0 111.668 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.24 68.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -65.13 -32.62 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.069 0.948 . . . . 0.0 110.192 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.37 150.41 51.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -144.11 153.26 41.96 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.217 0.917 . . . . 0.0 113.359 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.76 -142.21 47.31 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.6 -36.91 1.52 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.614 1.565 . . . . 0.0 112.437 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -54.27 -61.99 1.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.426 1.09 . . . . 0.0 110.04 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.88 -38.82 87.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.711 -0.618 . . . . 0.0 110.487 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.94 -50.62 72.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 109.851 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.08 73.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.559 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.84 -57.82 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.347 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.14 -54.36 13.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.4 1.08 . . . . 0.0 111.224 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.85 71.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.955 0.407 . . . . 0.0 110.707 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.769 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 64.3 t90 -62.84 -27.24 69.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.578 1.151 . . . . 0.0 112.809 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.607 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -84.73 -43.33 14.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 176.139 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.12 -42.88 73.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.721 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -5.6 41.35 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.27 0.941 . . . . 0.0 112.22 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.0 6.9 1.35 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -163.417 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.989 -124.92 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.745 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.97 102.75 5.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -170.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.94 -51.86 9.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.063 0.945 . . . . 0.0 111.916 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -62.73 -43.95 97.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.603 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.89 82.42 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 119.156 0.889 . . . . 0.0 110.858 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -49.99 -61.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 40.4 t -63.67 -41.99 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 116.803 -1.959 . . . . 0.0 112.697 -170.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -63.18 1.23 0.5 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.411 3.084 . . . . 0.0 113.628 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -134.92 -22.63 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -112.29 -20.42 11.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.719 1.608 . . . . 0.0 111.577 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -121.76 -42.65 2.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.463 0.574 . . . . 0.0 111.25 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.1 pt -48.78 -32.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.696 0.398 . . . . 0.0 111.609 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.24 -36.88 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.067 1.747 . . . . 0.0 113.384 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.0 -42.38 2.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.272 0.629 . . . . 0.0 110.837 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.79 -7.95 54.95 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.41 -84.45 0.37 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.409 1.004 . . . . 0.0 112.813 163.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.25 -64.36 0.02 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.97 3.58 37.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.9 0.88 . . . . 0.0 111.866 173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 67.61 28.1 7.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.583 1.553 . . . . 0.0 111.576 -175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -73.62 -13.07 60.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.036 2.135 . . . . 0.0 111.075 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.38 98.64 1.62 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 172.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.56 -77.47 0.56 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.473 0.709 . . . . 0.0 110.157 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -90.71 1.42 56.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.603 1.161 . . . . 0.0 111.542 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.91 160.2 44.34 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.726 2.011 . . . . 0.0 105.686 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -64.2 164.52 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.25 1.967 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.62 25.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.227 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 88' ' ' LEU 0.274 2.8 pp -119.78 -1.06 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 122.76 0.424 . . . . 0.0 112.131 176.286 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -35.39 64.11 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.009 -1.057 . . . . 0.0 111.426 167.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 4.07 51.91 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.486 1.514 . . . . 0.0 111.677 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.36 -53.87 12.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.92 9.22 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 115.156 0.822 . . . . 0.0 115.156 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.35 -29.65 28.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.023 0.912 . . . . 0.0 110.971 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -92.76 -51.95 4.85 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 124.036 0.934 . . . . 0.0 110.113 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.46 146.13 40.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.518 2.327 . . . . 0.0 108.276 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.4 m -86.87 164.16 16.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.256 0.48 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -45.52 58.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.898 0.479 . . . . 0.0 110.008 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -47.01 -53.31 12.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.371 1.468 . . . . 0.0 112.512 173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.39 -48.6 77.21 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.687 0.795 . . . . 0.0 110.175 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.557 HG23 HMA1 ' A' ' 93' ' ' HEC . 67.1 mt -63.05 -46.73 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -49.85 -55.29 14.84 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.084 1.753 . . . . 0.0 109.786 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.86 73.55 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.89 -37.15 77.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 121.307 -0.87 . . . . 0.0 111.62 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 21.8 mt -65.47 -44.87 94.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.501 -1.374 . . . . 0.0 109.819 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -68.74 -41.42 78.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.081 0.552 . . . . 0.0 111.594 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -91.28 -37.29 13.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.713 1.605 . . . . 0.0 111.62 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.8 -167.17 18.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.308 1.433 . . . . 0.0 110.139 -166.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.465 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 5.2 tp-100 -149.69 163.03 39.04 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 173.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -31.33 -66.66 0.16 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.641 1.591 . . . . 0.0 114.754 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.25 32.35 6.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.708 0.67 . . . . 0.0 113.266 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.408 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.7 ttt -139.4 128.76 14.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.399 1.079 . . . . 0.0 111.594 -175.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.2 155.44 68.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.399 2.066 . . . . 0.0 111.312 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.25 142.67 15.57 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.34 24.95 60.08 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.877 0.751 . . . . 0.0 111.432 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.3 mt -51.83 -44.38 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 108.971 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' A' ' 80' ' ' GLU . . . -134.47 140.19 46.04 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.5 2.32 . . . . 0.0 105.302 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -147.25 153.71 40.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 109.189 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.78 -133.89 51.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.86 -46.89 11.03 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.436 1.095 . . . . 0.0 111.804 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.75 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 35.7 mp0 -52.42 -61.4 2.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.898 0.772 . . . . 0.0 110.432 175.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.42 97.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.911 -0.493 . . . . 0.0 110.839 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.46 -58.93 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.197 0.999 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.21 -53.55 49.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.725 1.21 . . . . 0.0 109.618 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -50.38 -61.9 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.045 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.34 -51.66 57.61 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.572 0.749 . . . . 0.0 110.571 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.91 63.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 110.798 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.604 ' CE3' HD12 ' A' ' 88' ' ' LEU . 72.2 t90 -61.86 -31.96 72.28 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.093 0.557 . . . . 0.0 111.665 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.604 HD12 ' CE3' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -75.76 -43.74 45.1 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.032 -1.043 . . . . 0.0 110.166 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.21 -37.71 62.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.599 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.4 -8.5 59.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.165 1.348 . . . . 0.0 113.443 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' CA ' ' HE2' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -73.21 5.24 3.67 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.053 2.141 . . . . 0.0 116.204 -170.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 pttp . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.534 -1.222 . . . . 0.0 111.192 -126.373 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.719 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 101.29 9.55 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -158.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -52.64 11.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 112.962 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.28 -46.55 89.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.315 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.52 78.56 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.093 0.86 . . . . 0.0 111.218 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.2 -61.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 170.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.888 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 81.9 t -68.92 -40.16 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 120.854 -1.154 . . . . 0.0 112.293 -167.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -58.06 0.61 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 129.136 2.974 . . . . 0.0 113.003 167.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.65 -12.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 13.5 mttt -122.59 -19.09 6.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.708 1.203 . . . . 0.0 112.101 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -116.93 -41.59 3.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.42 1.009 . . . . 0.0 111.699 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -48.83 -32.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 122.47 0.308 . . . . 0.0 111.43 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -36.09 -38.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.22 2.208 . . . . 0.0 113.464 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -117.52 -42.31 2.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.617 0.767 . . . . 0.0 110.699 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -74.25 -8.35 55.93 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.67 -90.38 0.43 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.577 1.084 . . . . 0.0 112.751 164.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.1 -58.67 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.59 3.42 47.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.802 0.841 . . . . 0.0 111.367 172.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 65.68 27.59 11.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.741 1.617 . . . . 0.0 111.149 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -78.38 -5.22 51.64 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.727 2.411 . . . . 0.0 111.667 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 92.47 1.57 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.713 0.688 . . . . 0.0 111.599 166.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.31 -79.78 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.38 0.672 . . . . 0.0 110.617 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.9 t -90.81 1.64 56.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.278 1.031 . . . . 0.0 111.25 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.86 160.13 44.74 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.49 161.47 27.67 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.018 1.812 . . . . 0.0 111.198 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.61 116.7 8.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.989 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.7 pp -106.58 -6.81 10.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.053 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -43.85 -50.87 7.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.779 1.172 . . . . 0.0 111.036 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 1.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.534 -0.728 . . . . 0.0 112.103 -175.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -52.96 -40.45 63.69 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.049 -171.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.67 -26.28 24.18 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 119.028 0.831 . . . . 0.0 114.045 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -45.3 62.13 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.31 -1.112 . . . . 0.0 110.264 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -80.82 -43.13 20.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.165 0.986 . . . . 0.0 111.099 -171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.61 158.96 37.86 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.959 2.103 . . . . 0.0 107.647 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -100.75 171.9 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.249 0.477 . . . . 0.0 112.028 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -40.57 75.11 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.47 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -53.34 -49.79 66.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.507 1.048 . . . . 0.0 111.429 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.56 -48.23 78.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.52 0.728 . . . . 0.0 110.029 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 64' ' ' ILE . 82.2 mt -64.33 -47.58 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -49.24 -57.24 7.12 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.667 1.587 . . . . 0.0 110.365 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -46.28 82.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.97 -43.7 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.526 -0.734 . . . . 0.0 111.268 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 60' ' ' ILE . 30.9 mt -60.18 -47.4 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.104 -0.997 . . . . 0.0 109.536 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.36 -42.59 92.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -91.28 -51.8 5.12 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.368 1.467 . . . . 0.0 111.473 -166.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -166.94 17.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -164.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.438 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 0.0 OUTLIER -150.79 167.21 28.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 175.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.63 72.32 0.02 OUTLIER Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.84 1.2 . . . . 0.0 113.118 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.11 -15.6 3.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.374 1.94 . . . . 0.0 112.585 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.7 ttt -112.37 132.14 22.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.776 1.288 . . . . 0.0 108.459 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.93 -38.09 7.89 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.224 2.616 . . . . 0.0 113.528 -169.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.44 173.18 48.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-O 122.003 0.78 . . . . 0.0 112.218 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 -1.73 62.3 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.267 0.937 . . . . 0.0 112.629 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.09 -31.61 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.171 2.188 . . . . 0.0 111.036 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.87 139.65 38.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -141.79 155.17 45.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.468 1.507 . . . . 0.0 108.675 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.56 -136.49 43.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.15 -41.53 3.74 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.036 1.334 . . . . 0.0 111.796 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.92 -64.12 0.92 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.516 0.726 . . . . 0.0 109.377 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.94 96.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.995 -0.44 . . . . 0.0 110.918 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.06 -58.02 9.67 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.822 0.849 . . . . 0.0 110.077 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.41 -50.91 66.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.128 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 28' ' ' VAL . 61.3 t -49.15 -63.03 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 123.577 0.548 . . . . 0.0 110.365 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.19 62.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.159 0.984 . . . . 0.0 111.095 -171.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.06 -55.52 33.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.279 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.888 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 35.4 t90 -52.31 -39.41 60.54 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.361 0.664 . . . . 0.0 110.771 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.859 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.35 -41.52 73.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -27.92 62.91 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.142 -0.349 . . . . 0.0 110.877 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -88.82 -12.36 42.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.041 0.937 . . . . 0.0 112.977 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -83.35 -0.56 50.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 110.45 -174.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 O-C-N 119.867 -1.771 . . . . 0.0 112.407 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.776 ' CGD' HMD1 ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.59 104.29 5.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.316 1.447 . . . . 0.0 107.413 -167.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.56 -50.89 40.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.081 0.952 . . . . 0.0 112.485 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.37 -41.42 93.7 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.537 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.02 94.54 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.93 1.241 . . . . 0.0 111.216 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.9 -63.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 166.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.82 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 85.8 t -63.79 -41.27 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.517 -166.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -60.48 -1.98 0.44 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.227 3.011 . . . . 0.0 112.89 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -11.62 2.26 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 168.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -119.74 -23.86 6.36 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.87 1.268 . . . . 0.0 112.793 -169.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.677 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.1 m -122.47 -41.32 2.4 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.812 0.733 . . . . 0.0 111.589 -172.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.3 pt -50.39 -30.04 7.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 122.408 0.283 . . . . 0.0 111.066 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -35.93 -41.06 0.22 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.57 2.348 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.44 -40.37 2.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.295 0.638 . . . . 0.0 110.848 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -78.14 -8.73 58.64 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.33 157.96 16.31 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.148 0.886 . . . . 0.0 112.038 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -36.34 -62.12 0.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.337 1.922 . . . . 0.0 115.952 -168.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -92.86 4.62 53.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.424 1.112 . . . . 0.0 111.988 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 77.39 28.29 0.6 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.671 1.988 . . . . 0.0 110.953 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.2 -10.7 59.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.234 2.214 . . . . 0.0 112.505 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.39 100.26 1.52 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.958 0.79 . . . . 0.0 111.562 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.56 -76.75 0.58 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.732 0.766 . . . . 0.0 110.188 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -94.86 2.24 55.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 111.654 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.02 160.97 50.81 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 127.121 2.169 . . . . 0.0 105.238 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.74 165.03 24.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.903 1.735 . . . . 0.0 111.103 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 115.7 4.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.4 pp -112.56 -0.96 9.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.492 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -44.48 -45.73 9.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.672 1.124 . . . . 0.0 112.049 168.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -90.65 3.84 53.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.249 1.42 . . . . 0.0 111.156 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.15 -31.58 65.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.774 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.76 -30.23 76.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 120.518 1.508 . . . . 0.0 113.195 170.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.44 54.38 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.016 -1.285 . . . . 0.0 110.487 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -74.21 -38.6 63.52 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.286 0.234 . . . . 0.0 111.302 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -135.31 175.64 9.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.253 2.221 . . . . 0.0 108.033 -172.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -112.18 167.74 10.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.247 0.619 . . . . 0.0 110.483 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -50.57 -41.28 54.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 111.531 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -57.01 -51.69 68.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.176 1.353 . . . . 0.0 111.959 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.34 -51.22 69.07 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.141 0.976 . . . . 0.0 109.261 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.49 -49.92 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.834 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.3 tp -48.81 -56.33 9.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.314 1.446 . . . . 0.0 110.333 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.43 -44.76 95.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.931 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.7 mt -59.93 -41.96 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 121.838 -0.539 . . . . 0.0 110.696 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.04 -50.04 81.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.138 -0.976 . . . . 0.0 109.659 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.83 -30.9 71.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.477 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -105.16 -57.31 2.05 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.441 1.497 . . . . 0.0 112.244 -168.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.57 -173.47 21.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.068 1.794 . . . . 0.0 110.554 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -165.48 125.02 1.75 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.88 -113.53 1.06 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.974 1.261 . . . . 0.0 112.779 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.26 82.61 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.207 1.004 . . . . 0.0 113.965 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.5 ttt -66.36 126.85 92.79 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.46 1.13 . . . . 0.0 109.468 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.25 -39.16 39.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.751 2.3 . . . . 0.0 112.082 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.18 163.74 28.78 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 121.956 0.753 . . . . 0.0 111.707 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.84 21.64 65.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.14 -35.3 73.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.286 1.434 . . . . 0.0 109.759 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.54 146.77 49.99 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -139.93 155.09 47.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.235 0.925 . . . . 0.0 112.903 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.84 -139.32 45.87 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.4 -37.21 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.366 1.467 . . . . 0.0 112.068 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.03 -61.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.2 -39.69 89.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.792 -0.568 . . . . 0.0 110.452 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -58.11 -50.9 71.88 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.048 0.539 . . . . 0.0 110.023 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.94 65.39 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.44 0.696 . . . . 0.0 109.687 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.13 -57.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.321 0 O-C-N 123.237 0.335 . . . . 0.0 110.179 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.7 -55.38 19.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.064 0.545 . . . . 0.0 111.279 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.39 58.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 110.783 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.82 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 21.0 t90 -51.13 -44.14 61.31 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.488 0.715 . . . . 0.0 111.187 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.818 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -76.2 -37.29 57.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.384 -0.823 . . . . 0.0 112.154 -173.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 109.462 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -76.22 -22.16 55.56 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.397 1.079 . . . . 0.0 113.256 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -18.71 55.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.435 -1.415 . . . . 0.0 112.789 -168.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.955 1.702 . . . . 0.0 113.121 -156.055 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.744 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.7 109.98 8.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.795 1.238 . . . . 0.0 109.011 -155.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.39 -53.06 59.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.2 -161.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -61.94 -40.18 94.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.492 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.8 91.1 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.792 0.724 . . . . 0.0 111.315 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.7 t -48.02 -65.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.717 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 58.4 t -64.63 -41.37 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.526 -165.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.91 0.65 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.985 2.914 . . . . 0.0 113.382 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -126.56 -33.42 2.55 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.135 0.974 . . . . 0.0 113.257 167.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -107.62 -19.68 13.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.924 1.69 . . . . 0.0 112.675 -160.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.6 m -123.37 -40.07 2.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.316 0.507 . . . . 0.0 110.862 -171.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.65 -28.55 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.558 0.343 . . . . 0.0 111.422 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -36.75 -43.7 0.44 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.962 2.105 . . . . 0.0 112.913 170.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.28 -37.68 3.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.56 0.744 . . . . 0.0 110.681 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -77.75 -9.42 59.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.4 153.19 10.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.8 -60.54 2.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.175 1.369 . . . . 0.0 113.314 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -3.23 39.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.513 1.125 . . . . 0.0 112.456 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD21 HG12 ' A' ' 28' ' ' VAL . 7.6 mt 71.06 24.38 3.95 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.138 1.775 . . . . 0.0 111.124 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -79.51 -6.03 56.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.397 2.279 . . . . 0.0 112.036 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.59 112.64 2.26 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.07 -73.23 0.67 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.148 0.974 . . . . 0.0 109.986 175.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -98.3 2.2 47.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HA ' HMD3 ' A' ' 93' ' ' HEC . . . -141.46 160.55 56.54 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 127.356 2.262 . . . . 0.0 105.394 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.11 165.14 25.12 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.818 1.679 . . . . 0.0 110.751 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.98 122.49 15.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.316 2.2 pp -116.57 1.93 7.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.54 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -42.34 -48.81 5.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.662 1.119 . . . . 0.0 112.151 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -90.28 4.84 49.5 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.916 1.286 . . . . 0.0 112.02 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.24 -44.83 53.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.826 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.02 -33.52 44.54 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 120.862 1.665 . . . . 0.0 114.038 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.74 -35.77 77.54 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.375 -1.074 . . . . 0.0 110.891 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -89.78 -34.39 16.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.668 0.787 . . . . 0.0 111.166 -171.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -138.65 142.47 39.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.109 1.363 . . . . 0.0 108.035 -167.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 p -80.49 165.3 22.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.649 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -49.36 -49.56 43.89 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.367 1.067 . . . . 0.0 110.019 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -47.09 -52.6 14.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.646 1.179 . . . . 0.0 112.676 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.98 -49.01 77.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.515 -0.741 . . . . 0.0 110.336 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.98 -47.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.0 tp -50.29 -55.36 15.76 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.82 1.648 . . . . 0.0 109.943 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.76 -48.17 80.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -57.98 -43.46 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.56 0.344 . . . . 0.0 110.377 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.4 -50.42 80.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.08 -28.65 68.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -103.46 -60.95 1.48 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.137 1.775 . . . . 0.0 111.495 -171.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.8 -175.75 21.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.405 1.955 . . . . 0.0 110.365 -170.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.62 164.02 37.81 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.88 -91.97 0.0 OUTLIER Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.921 2.2 . . . . 0.0 116.2 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.36 37.27 3.59 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 118.571 1.186 . . . . 0.0 112.471 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.411 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.3 ttt -117.93 122.84 30.12 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 125.547 1.539 . . . . 0.0 108.617 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -61.92 -38.54 57.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.873 2.382 . . . . 0.0 112.688 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.49 163.57 29.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 122.003 0.779 . . . . 0.0 111.849 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.73 22.28 63.99 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.408 0.527 . . . . 0.0 111.872 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mt -64.39 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.168 1.387 . . . . 0.0 109.748 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.95 144.28 38.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -138.78 158.34 44.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.261 0.937 . . . . 0.0 112.931 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.93 -136.27 41.93 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.263 0.935 . . . . 0.0 110.89 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.15 -37.72 3.29 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.259 1.424 . . . . 0.0 112.172 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -59.01 -56.35 23.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.704 0.801 . . . . 0.0 110.214 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.36 88.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.671 -0.643 . . . . 0.0 110.266 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.26 -53.1 58.2 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.311 0.644 . . . . 0.0 109.968 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.14 41.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.609 0.763 . . . . 0.0 109.888 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.9 t -50.72 -58.2 2.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 117.897 0.317 . . . . 0.0 110.36 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.72 -54.16 41.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.02 0.528 . . . . 0.0 110.771 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.18 59.47 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.083 0.468 . . . . 0.0 110.545 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.796 ' CH2' HD23 ' A' ' 88' ' ' LEU . 14.0 t90 -58.33 -47.73 82.8 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.892 0.477 . . . . 0.0 111.69 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.796 HD23 ' CH2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -75.19 -29.75 60.45 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.861 -1.149 . . . . 0.0 110.736 -172.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.04 -56.24 21.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 160.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.69 -8.45 52.11 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.767 -1.208 . . . . 0.0 112.037 -172.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -27.4 61.07 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.289 -0.882 . . . . 0.0 110.11 -176.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.7 pttp . . . . . 0 C--O 1.252 1.223 0 C-N-CA 124.941 1.296 . . . . 0.0 113.702 -150.393 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.748 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -70.17 108.04 3.96 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.29 76.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.575 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -70.62 -41.38 72.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -175.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.25 58.93 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.259 0.936 . . . . 0.0 110.919 174.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 31' ' ' LYS . 59.0 t -49.77 -59.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.554 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 33.1 t -71.11 -11.99 15.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 119.937 1.244 . . . . 0.0 114.071 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -93.51 0.36 56.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.126 2.17 . . . . 0.0 110.86 174.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -6.59 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' HG3' HG13 ' A' ' 27' ' ' VAL . 53.9 mmtt -112.25 -49.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.67 1.188 . . . . 0.0 109.947 -177.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -88.73 -37.93 15.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.124 0.569 . . . . 0.0 110.978 -170.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 28' ' ' VAL . 23.0 pt -46.89 -36.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.069 0.948 . . . . 0.0 111.317 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 m -37.9 -36.71 0.21 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.326 2.25 . . . . 0.0 112.884 174.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.53 -43.42 2.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.723 . . . . 0.0 111.189 173.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -74.46 -7.12 51.95 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.94 -71.77 0.26 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.088 0.851 . . . . 0.0 113.198 163.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.53 -77.46 0.06 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 5.5 5.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.984 1.313 . . . . 0.0 112.367 169.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 69.09 24.71 6.05 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.507 1.523 . . . . 0.0 110.965 176.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.7 p -70.73 -15.0 62.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.056 1.343 . . . . 0.0 111.153 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 97.79 1.9 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -99.0 -80.21 0.47 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.252 0.621 . . . . 0.0 109.831 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 1.94 55.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.228 1.411 . . . . 0.0 111.705 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HA ' HMD3 ' A' ' 93' ' ' HEC . . . -145.1 156.92 54.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 127.295 2.238 . . . . 0.0 105.347 -176.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.59 164.31 29.43 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.91 123.36 17.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.03 -5.49 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.746 170.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -41.28 -46.22 3.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.739 1.154 . . . . 0.0 111.336 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 0.73 54.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.106 0.962 . . . . 0.0 110.927 -172.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.9 -41.61 62.08 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 121.376 -0.827 . . . . 0.0 112.056 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.7 -24.75 8.23 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.629 0.633 . . . . 0.0 114.679 177.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.07 -30.34 31.36 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.815 0.807 . . . . 0.0 111.52 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -89.56 -44.57 10.0 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.857 0.863 . . . . 0.0 110.513 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -126.58 149.86 49.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.106 1.763 . . . . 0.0 107.876 -171.34 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.3 m -88.05 162.8 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.787 0.435 . . . . 0.0 111.113 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -42.6 -52.41 4.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.554 1.142 . . . . 0.0 110.32 175.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -48.03 -55.59 9.76 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.12 -49.51 76.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.721 0.772 . . . . 0.0 109.96 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.579 HG23 HMA1 ' A' ' 93' ' ' HEC . 67.2 mt -64.03 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.3 tp -49.41 -55.78 11.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.114 1.366 . . . . 0.0 110.185 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -44.19 90.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -61.69 -40.76 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.335 -0.853 . . . . 0.0 111.356 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 60' ' ' ILE . 26.1 mt -61.03 -47.59 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 120.905 -1.122 . . . . 0.0 109.464 177.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.51 -40.03 88.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.486 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.34 -50.88 5.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.46 1.504 . . . . 0.0 112.318 -169.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.1 -170.83 15.11 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.092 1.806 . . . . 0.0 111.211 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.431 ' H ' ' HB3' ' A' ' 71' ' ' MET . 1.0 OUTLIER -163.93 116.27 1.4 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 127.056 2.142 . . . . 0.0 105.495 168.781 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.9 -109.93 0.64 Allowed Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.062 1.301 . . . . 0.0 113.157 172.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -26.18 73.37 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 118.011 0.905 . . . . 0.0 113.061 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.526 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 22.1 ttt -72.74 118.85 71.57 Favored Pre-proline 0 N--CA 1.454 -0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 109.911 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.32 -34.11 28.18 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.594 2.863 . . . . 0.0 112.582 -173.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.48 165.64 40.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -176.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.32 12.65 66.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.754 0.692 . . . . 0.0 112.278 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.78 -34.65 52.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.845 1.658 . . . . 0.0 110.36 177.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.53 149.46 49.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -145.85 155.66 43.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 179.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.68 -136.93 49.15 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -175.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.17 -37.44 4.46 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.795 1.238 . . . . 0.0 112.186 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -54.29 -61.4 2.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.237 1.015 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.91 74.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.725 -0.61 . . . . 0.0 111.145 -175.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.24 -52.86 63.87 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.441 0.564 . . . . 0.0 109.873 175.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.44 -52.47 53.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.98 -62.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 123.176 0.298 . . . . 0.0 110.786 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.97 69.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 111.285 -171.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.97 -53.37 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.317 0.58 . . . . 0.0 110.662 177.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.554 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 20.3 t90 -60.11 -31.31 69.93 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.786 0.834 . . . . 0.0 112.001 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -43.41 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 172.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.39 77.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.067 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.99 -16.41 58.15 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 13.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.877 3.271 . . . . 0.0 114.953 -177.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.095 0 O-C-N 119.981 -1.7 . . . . 0.0 112.88 -151.19 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.763 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 CA--C 1.513 -0.443 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.95 97.14 1.8 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.47 66.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.561 -169.265 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.84 -42.14 88.59 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.638 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.45 93.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.543 0.61 . . . . 0.0 109.881 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.03 -60.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.636 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.267 87.1 t -65.19 -43.25 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.726 -168.871 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.72 0.72 0.74 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.354 2.261 . . . . 0.0 114.032 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -138.29 -12.13 1.41 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 172.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -128.42 -20.51 3.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.152 1.381 . . . . 0.0 112.067 -171.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 18.4 m -110.93 -43.6 3.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.138 0.881 . . . . 0.0 110.671 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -49.42 -29.21 3.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.185 0.594 . . . . 0.0 111.845 176.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -38.06 -43.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.868 1.667 . . . . 0.0 112.007 174.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.7 m -114.11 -41.65 3.48 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 117.888 0.313 . . . . 0.0 110.644 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.78 -16.5 62.75 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.9 25.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.7 -61.51 1.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.581 1.563 . . . . 0.0 113.753 -173.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.24 -5.61 47.67 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.215 1.006 . . . . 0.0 112.419 -177.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 48' ' ' ILE . 4.2 mt 69.65 23.68 5.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.085 1.754 . . . . 0.0 111.096 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -78.79 -6.49 56.09 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.552 2.341 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 77.17 1.32 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-N 118.595 0.634 . . . . 0.0 112.064 167.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 -76.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.681 0.392 . . . . 0.0 111.458 177.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -99.52 2.73 45.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.827 1.651 . . . . 0.0 111.552 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.53 162.45 39.17 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.42 166.36 21.9 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.806 1.67 . . . . 0.0 111.299 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.69 122.27 16.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.33 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 40' ' ' LEU 0.311 2.1 pp -117.24 -0.97 8.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.401 173.166 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -34.61 -47.13 0.31 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 112.087 159.353 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -102.65 6.33 39.57 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.984 1.314 . . . . 0.0 112.765 -175.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.31 57.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.102 0.865 . . . . 0.0 111.691 177.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.88 -32.6 75.42 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 119.84 1.2 . . . . 0.0 113.229 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.49 27.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.9 1.35 . . . . 0.0 110.455 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.41 -39.57 62.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.281 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -123.11 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 128.009 2.524 . . . . 0.0 107.606 -173.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.4 m -135.88 171.28 14.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.835 -1.165 . . . . 0.0 109.999 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -39.37 68.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.107 0.563 . . . . 0.0 110.795 -166.168 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.55 -53.14 61.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -57.99 -50.35 73.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.935 0.894 . . . . 0.0 109.383 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.41 -49.67 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.91 -57.27 6.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.872 1.269 . . . . 0.0 109.921 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.85 -43.55 94.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.049 -176.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.03 -41.22 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.736 -0.602 . . . . 0.0 111.14 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.3 mt -59.25 -50.57 79.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 O-C-N 120.899 -1.126 . . . . 0.0 109.408 175.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.82 -36.31 83.47 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.651 -177.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.65 -51.62 3.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.158 1.383 . . . . 0.0 112.12 -168.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.34 -171.67 18.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.857 1.694 . . . . 0.0 110.33 -171.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -165.06 127.9 2.24 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.42 -112.18 0.61 Allowed Glycine 0 CA--C 1.538 1.479 0 CA-C-N 120.098 1.317 . . . . 0.0 112.876 176.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.17 -12.68 75.87 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 118.161 0.981 . . . . 0.0 113.996 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.409 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 16.2 ttt -64.34 125.11 87.69 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 118.46 1.13 . . . . 0.0 109.175 178.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.41 -36.55 54.57 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -172.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.2 165.19 31.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.48 27.49 68.01 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.3 -32.26 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.151 0.98 . . . . 0.0 109.373 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.44 46.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.751 1.621 . . . . 0.0 106.755 173.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -145.32 154.64 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.02 -140.57 48.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -40.52 -37.33 0.69 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.709 1.604 . . . . 0.0 112.557 176.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.32 -61.98 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.308 1.043 . . . . 0.0 110.319 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.67 87.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.748 -0.595 . . . . 0.0 110.29 -177.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.23 -48.38 78.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.649 0.78 . . . . 0.0 110.002 178.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.41 82.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.897 176.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.28 -48.95 75.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.707 174.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.63 -55.14 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.162 0.892 . . . . 0.0 110.195 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.02 -58.05 10.13 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.771 0.428 . . . . 0.0 111.475 178.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.636 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 54.9 t90 -57.14 -45.68 83.34 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.078 0.951 . . . . 0.0 111.482 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.485 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -70.78 -42.54 70.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.18 -175.709 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.65 66.86 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.021 -0.424 . . . . 0.0 110.651 169.231 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -74.04 -14.36 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.681 0.792 . . . . 0.0 112.438 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 -15.22 48.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.696 -1.253 . . . . 0.0 113.082 -166.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.923 1.289 . . . . 0.0 112.961 -153.716 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.746 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 CA--C 1.513 -0.48 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.72 99.94 1.79 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 126.044 1.737 . . . . 0.0 107.641 -163.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.84 -52.27 43.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.537 -167.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.34 -44.76 96.65 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.366 178.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.38 59.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 120.081 1.31 . . . . 0.0 110.849 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -46.99 -62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.557 HG13 ' SG ' ' A' ' 32' ' ' CYS . 40.2 t -77.78 2.42 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.363 -1.46 . . . . 0.0 113.239 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.28 0.9 38.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.569 2.348 . . . . 0.0 110.063 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -142.35 -13.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -106.93 -55.82 2.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.456 1.503 . . . . 0.0 109.574 -175.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' HG13 ' A' ' 28' ' ' VAL . 2.9 m -82.59 -37.2 25.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.475 0.31 . . . . 0.0 110.663 -171.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 28' ' ' VAL . 14.1 pt -48.31 -32.73 3.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 123.383 0.673 . . . . 0.0 111.284 178.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -45.14 -29.52 0.94 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 112.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -127.2 -44.41 1.59 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.439 0.696 . . . . 0.0 111.311 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -71.86 -14.62 62.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.307 -0.87 . . . . 0.0 113.283 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.86 154.95 28.12 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.804 0.716 . . . . 0.0 111.562 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.76 -49.89 8.75 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.215 1.388 . . . . 0.0 113.274 -175.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -84.15 -8.42 59.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.787 0.835 . . . . 0.0 111.857 -176.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.419 HD21 HG12 ' A' ' 28' ' ' VAL . 3.7 mt 69.68 21.45 6.56 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.642 1.577 . . . . 0.0 111.181 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -77.66 -8.23 57.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 128.223 2.609 . . . . 0.0 111.431 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.54 87.0 1.74 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.46 -81.16 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.843 0.457 . . . . 0.0 110.524 175.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -90.45 2.01 56.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.343 1.457 . . . . 0.0 112.138 177.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.75 43.55 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.6 166.08 21.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.797 1.665 . . . . 0.0 111.441 -178.002 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.1 117.59 7.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 88' ' ' LEU 0.281 2.5 pp -112.7 -3.32 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.067 176.509 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -38.03 -46.49 1.01 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.644 1.111 . . . . 0.0 113.152 163.437 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -98.15 4.75 49.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.076 1.75 . . . . 0.0 112.116 -177.541 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.07 -38.58 62.61 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.767 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.35 -27.33 65.39 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.619 1.1 . . . . 0.0 113.463 173.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.38 -48.25 20.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.8 -0.824 . . . . 0.0 109.701 177.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -74.08 -45.21 50.69 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 122.634 0.373 . . . . 0.0 111.684 -174.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -122.55 157.36 32.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.284 1.834 . . . . 0.0 109.265 -169.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -89.11 167.18 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.39 0.614 . . . . 0.0 110.813 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.73 -45.59 49.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.078 0.951 . . . . 0.0 109.858 174.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -54.5 -49.56 69.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.593 0.633 . . . . 0.0 112.521 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.7 -51.22 70.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.697 0.761 . . . . 0.0 109.791 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.54 -50.1 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -174.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -47.14 -58.12 4.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.183 1.393 . . . . 0.0 110.271 172.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.14 -47.69 80.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -175.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.74 -44.31 89.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 122.329 0.252 . . . . 0.0 110.673 -178.304 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.646 HD11 HMB2 ' A' ' 93' ' ' HEC . 66.7 mt -60.97 -50.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 121.79 -0.569 . . . . 0.0 110.045 177.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.48 -36.43 84.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.778 -178.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.11 -59.3 2.0 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.1 1.76 . . . . 0.0 111.565 -169.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.36 106.79 2.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.45 1.5 . . . . 0.0 110.595 -168.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -55.19 155.29 4.96 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 160.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.78 -61.64 0.73 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.028 1.299 . . . . 0.0 115.469 -175.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.88 17.49 52.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 117.902 0.851 . . . . 0.0 113.386 -177.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.0 ttt -119.41 136.97 24.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.846 1.658 . . . . 0.0 108.396 -176.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.524 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 54.7 Cg_endo -67.76 -36.91 17.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.104 1.87 . . . . 0.0 112.034 -172.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 163.69 27.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.4 23.52 62.56 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.01 -32.58 58.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 123.57 0.748 . . . . 0.0 109.976 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.49 48.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -144.97 153.21 41.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -137.67 49.51 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.3 -35.99 1.68 Allowed 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 112.352 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.25 -60.37 3.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 110.237 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.01 88.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.556 -0.715 . . . . 0.0 110.52 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.38 -48.33 82.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.307 0.643 . . . . 0.0 110.13 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.59 -49.57 70.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.317 0.647 . . . . 0.0 109.478 175.109 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 28' ' ' VAL . 61.9 t -52.44 -58.77 2.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.2 173.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.73 -55.12 6.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.932 0.893 . . . . 0.0 111.147 -172.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.87 29.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 110.965 178.222 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.544 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 65.3 t90 -58.99 -41.37 87.46 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.742 0.417 . . . . 0.0 111.515 -175.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.5 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -69.05 -46.02 68.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.293 1.037 . . . . 0.0 109.976 -179.622 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.35 59.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.871 0.468 . . . . 0.0 110.931 171.103 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.42 -17.93 60.72 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.866 1.267 . . . . 0.0 112.536 178.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 2.05 44.16 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.429 -1.419 . . . . 0.0 113.536 -164.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.305 1.442 . . . . 0.0 114.815 -148.444 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.743 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.56 99.13 2.0 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.154 1.382 . . . . 0.0 107.582 -164.118 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -49.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.27 -167.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.39 -39.65 91.47 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.544 178.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.46 96.65 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 120.274 1.397 . . . . 0.0 111.028 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -49.36 -65.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 167.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.806 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 48.1 t -58.97 -48.0 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.488 -167.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -56.58 -6.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.363 3.065 . . . . 0.0 113.268 174.267 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -132.75 2.22 3.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.992 0.917 . . . . 0.0 113.001 173.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -129.16 -59.85 1.09 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.124 0.97 . . . . 0.0 109.831 -169.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.644 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.3 m -86.9 -40.57 14.72 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.679 0.391 . . . . 0.0 110.284 -171.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.15 -26.78 8.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.77 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -46.73 -37.36 8.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.844 1.258 . . . . 0.0 111.549 176.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.5 m -116.02 -38.96 3.52 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 122.934 0.494 . . . . 0.0 111.301 174.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -76.16 -13.01 60.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.93 151.99 23.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -54.03 5.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.254 1.407 . . . . 0.0 112.902 -177.07 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 -7.56 58.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.82 1.648 . . . . 0.0 111.971 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.578 HD22 HD11 ' A' ' 48' ' ' ILE . 1.6 mt 69.08 21.35 7.35 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.808 1.643 . . . . 0.0 110.948 178.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 p -79.34 -5.54 54.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.011 2.524 . . . . 0.0 111.537 178.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.44 83.9 1.65 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 118.53 0.605 . . . . 0.0 111.701 167.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.12 -71.17 0.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.746 0.418 . . . . 0.0 110.853 177.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t -100.17 1.74 42.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.623 1.569 . . . . 0.0 110.839 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.23 163.9 29.79 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 126.273 1.829 . . . . 0.0 106.082 -173.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -63.26 160.64 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.633 1.555 . . . . 0.0 111.231 174.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 113.65 3.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.172 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 88' ' ' LEU . 2.1 pp -100.08 -5.86 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.748 173.279 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -37.89 6.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.839 1.199 . . . . 0.0 112.079 176.057 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -105.46 4.83 31.04 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.393 1.877 . . . . 0.0 112.371 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.9 -35.18 22.68 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 118.688 0.676 . . . . 0.0 110.882 176.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.11 -30.23 54.03 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.961 0.801 . . . . 0.0 114.588 174.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.51 -45.33 38.81 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 121.633 -0.922 . . . . 0.0 109.845 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -73.78 -38.41 64.66 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 122.869 0.467 . . . . 0.0 111.575 -171.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -135.85 154.23 51.24 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.322 1.849 . . . . 0.0 107.721 -171.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -89.46 168.23 12.37 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.161 -0.337 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.84 -43.39 65.99 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.928 0.491 . . . . 0.0 110.952 -175.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.58 -55.85 12.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.104 1.361 . . . . 0.0 112.713 174.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -53.88 -48.54 69.96 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.46 1.104 . . . . 0.0 109.854 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.48 -50.17 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -50.74 -55.58 15.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.872 1.269 . . . . 0.0 110.008 177.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -45.65 91.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.76 -41.25 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 121.378 -0.826 . . . . 0.0 111.25 -178.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HMB2 ' A' ' 93' ' ' HEC . 88.8 mt -60.11 -52.3 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.849 0.75 . . . . 0.0 109.839 175.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.23 -36.92 84.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -174.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -90.28 -53.05 4.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.271 1.828 . . . . 0.0 111.508 -171.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 111.76 3.61 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -169.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.406 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 3.3 tp60 -57.17 154.56 9.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 117.8 0.8 . . . . 0.0 108.846 167.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.59 86.8 0.03 OUTLIER Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.062 -1.024 . . . . 0.0 112.516 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.57 -12.38 4.29 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.161 2.315 . . . . 0.0 112.311 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.0 ttt -116.62 129.21 25.44 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 127.081 2.153 . . . . 0.0 108.783 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.45 136.18 33.14 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.306 1.337 . . . . 0.0 108.699 170.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.02 39.5 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.47 13.5 65.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.919 0.771 . . . . 0.0 112.339 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.455 HD13 HMC2 ' A' ' 93' ' ' HEC . 61.4 mt -59.45 -30.9 45.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.99 1.316 . . . . 0.0 110.204 175.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.47 148.42 42.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.146 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -139.92 156.11 46.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.271 0.941 . . . . 0.0 113.383 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.13 -139.02 41.85 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.42 -37.43 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.744 1.618 . . . . 0.0 112.714 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.53 -62.06 1.9 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.38 1.072 . . . . 0.0 109.675 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.38 82.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.65 -0.656 . . . . 0.0 110.761 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.16 -49.25 77.67 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.262 0.625 . . . . 0.0 109.994 178.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.81 76.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.57 -53.93 14.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.365 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.15 -56.34 8.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.588 0.755 . . . . 0.0 110.777 -174.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -54.49 45.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.806 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 7.6 t90 -60.29 -47.63 85.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.96 0.504 . . . . 0.0 112.151 -175.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -63.61 -43.05 98.02 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.367 -0.833 . . . . 0.0 108.957 -179.701 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.8 -44.02 73.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.315 -0.241 . . . . 0.0 110.866 171.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -73.82 -11.17 60.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.482 1.113 . . . . 0.0 111.927 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.13 60.17 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.028 -1.045 . . . . 0.0 110.277 -177.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.171 -158.982 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.76 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.59 102.79 3.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.967 1.707 . . . . 0.0 108.187 -163.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.84 -51.72 59.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.617 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.41 -43.73 98.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 118.194 -0.907 . . . . 0.0 109.142 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.18 81.57 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.558 1.072 . . . . 0.0 111.302 -176.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -45.8 -62.63 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.798 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.257 52.1 t -65.11 -40.65 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 118.564 -1.254 . . . . 0.0 113.262 -167.527 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.15 0.37 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.091 3.356 . . . . 0.0 113.196 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -137.37 -12.19 1.61 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -119.38 -25.77 5.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.132 1.373 . . . . 0.0 111.949 -168.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.649 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.7 m -114.12 -39.75 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.992 0.814 . . . . 0.0 111.004 -177.233 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -48.41 -32.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 122.545 0.338 . . . . 0.0 111.416 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -44.17 -30.67 0.81 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.222 1.409 . . . . 0.0 113.024 175.396 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -122.61 -43.98 2.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.689 0.796 . . . . 0.0 110.576 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -71.96 -10.06 59.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.49 -85.0 0.38 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.186 0.898 . . . . 0.0 112.746 163.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.59 -63.54 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -174.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.407 ' C ' HD22 ' A' ' 40' ' ' LEU . 4.7 m-20 -82.59 3.26 29.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 111.86 173.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 39' ' ' ASP . 1.2 mm? 65.29 25.8 12.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.873 1.669 . . . . 0.0 111.453 -172.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.6 -11.91 60.32 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.034 2.134 . . . . 0.0 111.42 177.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.43 89.44 1.82 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 168.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.18 -77.66 0.45 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.274 0.629 . . . . 0.0 110.616 177.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -92.96 2.34 56.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.071 1.349 . . . . 0.0 111.482 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 158.92 50.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -62.58 162.54 24.14 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.985 1.79 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 126.11 26.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.763 177.399 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.438 ' O ' HD11 ' A' ' 88' ' ' LEU 0.272 2.7 pp -116.78 -2.29 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.672 171.738 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -43.7 -45.69 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.499 1.045 . . . . 0.0 112.134 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -94.55 4.23 54.11 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.466 1.106 . . . . 0.0 112.463 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.68 -34.15 37.14 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.572 177.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.72 73.46 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.134 1.334 . . . . 0.0 114.018 173.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.26 -44.83 43.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.503 1.151 . . . . 0.0 110.037 170.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -73.31 -40.95 64.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.509 0.195 . . . . 0.0 111.269 -171.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -131.98 169.21 16.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.973 2.109 . . . . 0.0 107.194 -169.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 m -108.34 167.45 10.02 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.248 0.477 . . . . 0.0 109.764 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -50.57 -42.15 55.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.249 -176.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.3 -50.83 58.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.12 1.327 . . . . 0.0 112.035 177.362 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -61.87 -52.47 63.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 122.247 1.022 . . . . 0.0 109.252 -176.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.55 HG23 HMA1 ' A' ' 93' ' ' HEC . 37.2 mt -62.57 -47.17 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.21 -53.76 32.08 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.929 1.292 . . . . 0.0 110.047 176.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -56.66 -48.22 78.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.31 -45.7 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.367 -0.833 . . . . 0.0 111.251 -178.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 60' ' ' ILE . 29.5 mt -59.1 -48.0 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.094 -1.003 . . . . 0.0 109.59 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.1 -25.88 62.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.7 0.8 . . . . 0.0 113.104 -177.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.55 -60.29 1.65 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.508 1.523 . . . . 0.0 111.02 -171.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.31 -174.63 21.39 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.648 2.07 . . . . 0.0 109.884 -170.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -152.79 163.58 39.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -1.19 -91.78 0.0 OUTLIER Glycine 0 CA--C 1.543 1.814 0 C-N-CA 126.382 1.944 . . . . 0.0 116.622 175.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.98 12.29 67.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.501 1.151 . . . . 0.0 113.7 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.443 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.2 ttt -96.19 120.1 63.25 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.715 1.606 . . . . 0.0 109.023 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.96 -37.31 54.66 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.807 2.338 . . . . 0.0 112.176 -171.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.21 164.62 28.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-O 122.111 0.84 . . . . 0.0 111.743 177.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.51 17.14 61.79 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 122.407 -0.466 . . . . 0.0 112.159 -173.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.76 -31.28 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.441 1.496 . . . . 0.0 109.628 173.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.58 140.31 35.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -139.5 162.79 34.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.22 1.008 . . . . 0.0 111.768 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.73 -138.59 44.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.83 -37.48 2.81 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.98 1.312 . . . . 0.0 112.002 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.26 -58.37 8.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.836 0.454 . . . . 0.0 110.048 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.49 93.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.753 -0.592 . . . . 0.0 110.507 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.16 -54.07 47.94 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.157 0.583 . . . . 0.0 110.03 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.07 -54.44 30.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.377 0.671 . . . . 0.0 109.626 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.37 -66.99 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 123.432 0.458 . . . . 0.0 110.078 176.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.7 -46.78 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.241 0.617 . . . . 0.0 111.455 -170.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -58.72 7.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.367 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.948 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 9.6 t90 -53.14 -43.38 66.94 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.399 0.68 . . . . 0.0 110.793 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.948 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.62 -39.4 73.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.998 -1.064 . . . . 0.0 110.657 -175.784 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.56 72.39 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.889 -0.507 . . . . 0.0 110.978 166.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -16.25 60.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.648 0.779 . . . . 0.0 112.813 179.023 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -20.14 57.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.822 1.249 . . . . 0.0 111.472 -166.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -156.055 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.761 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.88 100.18 4.01 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.787 1.635 . . . . 0.0 107.847 -167.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.38 -52.66 7.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.495 1.118 . . . . 0.0 113.169 -170.281 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.27 -39.84 95.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.286 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.94 76.59 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 119.981 1.264 . . . . 0.0 110.381 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.9 t -52.31 -59.94 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.726 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 29.8 t -79.35 3.85 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -171.682 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -104.96 3.6 30.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.521 1.928 . . . . 0.0 110.465 170.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -128.79 -43.49 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.89 -14.28 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.247 1.419 . . . . 0.0 112.024 -159.65 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 4.5 m -120.91 -37.47 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.615 1.166 . . . . 0.0 111.026 -170.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 pt -50.97 -30.97 9.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.474 0.71 . . . . 0.0 111.659 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -38.18 -42.4 0.68 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.699 2.0 . . . . 0.0 112.737 173.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.3 m -121.3 -38.39 2.8 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.215 0.606 . . . . 0.0 110.799 -177.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -79.79 -8.05 59.03 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.517 -0.74 . . . . 0.0 112.851 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.61 156.21 19.3 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.16 -58.91 3.62 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.633 1.111 . . . . 0.0 112.534 -176.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.94 -4.52 47.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.622 1.169 . . . . 0.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt 72.0 20.43 4.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.764 1.626 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 p -80.23 -2.79 46.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.822 2.449 . . . . 0.0 112.112 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.18 102.36 1.56 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.916 0.77 . . . . 0.0 111.472 168.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.39 -70.66 0.75 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.924 0.862 . . . . 0.0 110.128 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -99.62 2.69 44.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.464 1.506 . . . . 0.0 111.109 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.84 161.79 44.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -175.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.36 163.4 29.65 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.781 1.654 . . . . 0.0 110.828 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.28 113.62 3.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.591 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.305 2.1 pp -105.2 0.69 10.21 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.009 172.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -41.42 14.57 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.239 -0.913 . . . . 0.0 112.801 170.253 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -97.88 4.99 49.54 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.656 1.183 . . . . 0.0 112.106 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.27 32.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.451 -1.261 . . . . 0.0 112.398 -178.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.73 -32.04 68.85 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 120.893 1.679 . . . . 0.0 113.881 174.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.17 -41.55 57.83 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.407 -1.055 . . . . 0.0 109.83 174.068 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -73.56 -35.17 65.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.828 -172.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -142.24 152.89 43.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.847 1.659 . . . . 0.0 108.674 -170.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.6 t -80.75 163.81 23.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.823 -0.548 . . . . 0.0 110.621 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.11 -44.92 68.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.24 -0.41 . . . . 0.0 109.951 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.53 -44.55 72.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.372 0.669 . . . . 0.0 112.494 178.221 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.9 -50.49 70.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.582 0.706 . . . . 0.0 109.833 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG23 HMA1 ' A' ' 93' ' ' HEC . 63.7 mt -62.53 -48.3 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.118 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 tp -48.38 -56.75 7.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.642 1.577 . . . . 0.0 109.97 175.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -56.54 -48.94 76.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -59.27 -43.73 90.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 122.248 -0.282 . . . . 0.0 110.454 -175.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.46 -50.38 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.525 -0.735 . . . . 0.0 109.559 177.119 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.23 -35.45 78.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.453 -179.165 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -102.48 -65.46 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.765 2.026 . . . . 0.0 112.527 -167.11 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.76 -176.96 22.82 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.952 1.739 . . . . 0.0 111.619 -170.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -157.07 170.44 22.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.875 3.27 . . . . 0.0 103.701 169.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -9.53 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 126.953 2.216 . . . . 0.0 116.343 175.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.88 42.01 2.0 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 118.599 1.199 . . . . 0.0 110.949 171.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.495 ' HB2' ' C4D' ' A' ' 93' ' ' HEC . 7.7 tpt -116.55 107.5 46.7 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -177.639 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.33 -36.22 88.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.499 2.8 . . . . 0.0 112.617 -162.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.17 161.49 17.66 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 122.264 0.924 . . . . 0.0 111.484 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.76 14.31 57.97 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 122.051 -0.676 . . . . 0.0 113.154 -177.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 -32.46 50.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.616 175.156 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.41 141.49 46.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -139.35 154.08 47.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 107.154 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.68 -139.54 35.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.86 -41.07 1.09 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.205 1.802 . . . . 0.0 112.418 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -57.17 -55.85 29.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.431 0.692 . . . . 0.0 110.032 178.728 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.84 78.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -178.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.87 -56.28 19.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.622 0.769 . . . . 0.0 109.879 177.098 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.53 -53.05 59.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.039 0.936 . . . . 0.0 109.762 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 80' ' ' GLU . 87.7 t -48.64 -63.09 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 O-C-N 123.641 0.588 . . . . 0.0 109.805 176.564 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.55 -55.16 17.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.528 0.731 . . . . 0.0 111.76 -171.526 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.17 -53.22 60.73 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.467 0.651 . . . . 0.0 110.793 -177.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.726 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 21.8 t90 -54.23 -45.81 72.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.287 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.718 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -62.97 -45.63 91.52 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.732 -1.23 . . . . 0.0 111.502 -177.877 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.6 51.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.672 0.789 . . . . 0.0 111.606 172.218 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.0 -26.91 33.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.241 1.016 . . . . 0.0 112.056 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -32.58 65.57 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.976 1.311 . . . . 0.0 110.91 -165.834 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 128.512 2.725 . . . . 0.0 112.822 -162.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.766 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.42 97.65 1.31 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -169.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.17 -53.01 56.78 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.311 -170.293 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.97 -43.76 97.92 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.446 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.48 76.14 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 119.904 1.229 . . . . 0.0 111.117 -177.485 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -46.68 -62.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 167.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG13 ' SG ' ' A' ' 32' ' ' CYS 0.28 73.7 t -70.82 -33.08 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.463 -161.313 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -63.1 -0.78 0.8 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 130.249 3.419 . . . . 0.0 113.315 169.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.24 -22.73 0.91 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 173.137 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -104.43 -23.75 13.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.29 1.836 . . . . 0.0 110.778 -171.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' HG13 ' A' ' 28' ' ' VAL . 2.3 m -117.57 -40.37 3.05 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.653 0.661 . . . . 0.0 111.781 -174.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 pt -49.74 -31.11 6.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 117.941 0.337 . . . . 0.0 111.397 178.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -37.11 -43.4 0.49 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.313 1.845 . . . . 0.0 111.904 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -114.25 -44.09 3.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.145 0.578 . . . . 0.0 110.853 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -73.67 -14.65 61.19 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.0 152.85 23.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.032 0.833 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.17 -63.46 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.033 1.778 . . . . 0.0 113.895 -173.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.79 -7.89 54.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.144 1.377 . . . . 0.0 112.658 -176.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mt 72.41 25.1 2.82 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.996 2.118 . . . . 0.0 110.672 -178.359 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -78.65 -6.01 54.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.355 2.662 . . . . 0.0 112.131 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 80.73 1.52 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 118.593 0.633 . . . . 0.0 112.033 168.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.59 -79.41 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.858 0.463 . . . . 0.0 111.135 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -94.78 2.08 55.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.521 1.528 . . . . 0.0 111.833 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.17 162.79 35.9 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 127.577 2.351 . . . . 0.0 104.677 -177.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.96 166.19 19.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.035 1.823 . . . . 0.0 111.656 -178.187 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.02 114.35 6.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.457 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 88' ' ' LEU 0.261 2.2 pp -108.78 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.652 177.394 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -37.16 -48.31 0.83 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.651 1.114 . . . . 0.0 112.846 165.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -97.71 4.82 49.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.689 1.996 . . . . 0.0 111.545 -174.555 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.25 -32.74 25.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.08 171.449 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.67 72.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.665 1.12 . . . . 0.0 114.203 173.374 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.38 -47.18 18.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.45 1.125 . . . . 0.0 109.865 171.002 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -74.06 -42.96 59.42 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.938 0.495 . . . . 0.0 111.047 -168.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.26 -179.87 4.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.473 2.309 . . . . 0.0 107.964 -176.257 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m -119.21 170.16 9.33 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.567 0.747 . . . . 0.0 110.219 -178.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -40.8 72.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.556 -174.05 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -53.47 -53.81 46.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.48 1.112 . . . . 0.0 111.714 176.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -59.13 -49.59 77.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.188 0.995 . . . . 0.0 109.33 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.31 -52.24 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.8 tp -48.61 -57.0 6.89 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.081 1.352 . . . . 0.0 109.858 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.95 -41.84 98.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -59.98 -41.82 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 121.586 -0.696 . . . . 0.0 111.283 177.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.39 -50.94 78.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 109.521 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.71 -38.45 91.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.376 -176.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.77 -53.79 4.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.657 1.583 . . . . 0.0 111.903 -171.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.87 110.11 3.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.389 1.471 . . . . 0.0 110.208 -167.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 3.1 tp60 -53.3 151.61 5.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 157.325 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.46 -58.52 1.09 Allowed Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.924 1.249 . . . . 0.0 115.477 -172.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.57 12.64 62.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.951 0.876 . . . . 0.0 113.775 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -120.47 132.2 24.21 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 126.12 1.768 . . . . 0.0 107.923 -174.392 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 -36.83 42.64 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.964 1.776 . . . . 0.0 112.793 -169.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.09 163.21 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.804 0.669 . . . . 0.0 111.691 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.01 17.81 61.51 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.93 -38.17 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.117 1.367 . . . . 0.0 108.961 179.136 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.38 147.28 48.99 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.393 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -141.3 152.23 44.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.486 0.66 . . . . 0.0 111.8 -175.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.5 -142.61 46.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.75 -33.36 1.24 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.83 1.652 . . . . 0.0 112.926 -179.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -53.98 -66.79 0.33 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 109.946 171.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.53 87.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.263 0.625 . . . . 0.0 110.554 -176.45 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -55.97 -50.17 71.55 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.98 0.512 . . . . 0.0 109.695 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.3 85.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.315 177.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.448 HG22 ' CG2' ' A' ' 28' ' ' VAL . 59.2 t -50.56 -58.16 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.011 173.751 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.48 -58.71 2.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.868 0.867 . . . . 0.0 111.549 -174.365 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.06 -54.43 46.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.165 -179.082 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.491 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 47.8 t90 -56.87 -45.78 82.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 111.07 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.491 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.21 -45.61 84.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.296 1.038 . . . . 0.0 109.72 -178.378 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.46 63.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.791 0.436 . . . . 0.0 111.171 171.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.9 -16.75 60.65 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.184 1.393 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 -4.81 58.41 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.842 -1.161 . . . . 0.0 113.203 -167.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.752 1.621 . . . . 0.0 114.059 -157.053 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.737 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.4 110.32 7.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.38 1.072 . . . . 0.0 108.473 -160.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.91 -49.52 73.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.239 -165.167 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.35 -41.69 94.18 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.384 177.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.61 -46.9 87.87 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.31 0.959 . . . . 0.0 111.004 -176.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -46.57 -62.27 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.768 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 43.0 t -62.46 -41.96 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.782 -167.288 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.85 1.44 1.36 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.44 3.096 . . . . 0.0 113.306 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.31 -23.42 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.282 0.946 . . . . 0.0 113.457 168.49 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -116.74 -18.79 10.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.757 1.223 . . . . 0.0 112.762 -166.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.5 m -113.31 -43.27 3.37 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.489 1.041 . . . . 0.0 111.246 179.171 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 pt -51.99 -30.03 12.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -37.05 -40.5 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.016 1.327 . . . . 0.0 113.053 170.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.3 m -115.81 -42.15 3.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.932 0.493 . . . . 0.0 110.623 174.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -70.74 -17.34 62.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.56 -89.22 0.33 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.361 0.981 . . . . 0.0 112.465 165.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.98 -65.36 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.54 2.49 13.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.054 0.942 . . . . 0.0 111.792 170.068 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.481 HD21 HG12 ' A' ' 28' ' ' VAL . 4.1 mt 71.21 20.45 5.09 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.992 1.317 . . . . 0.0 110.353 177.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -76.48 -8.54 57.38 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.582 2.353 . . . . 0.0 111.722 -177.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.17 74.5 1.08 Allowed Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.446 0.567 . . . . 0.0 111.889 164.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.66 -77.38 0.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.541 0.336 . . . . 0.0 111.427 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 t -96.58 2.39 52.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.025 1.33 . . . . 0.0 111.419 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.34 162.01 39.0 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -176.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.2 164.56 24.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.876 1.717 . . . . 0.0 111.167 179.174 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.14 114.18 6.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.512 -177.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.444 ' O ' HD21 ' A' ' 88' ' ' LEU 0.291 2.7 pp -106.56 -2.26 9.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.515 173.829 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -33.23 -48.13 0.22 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.022 1.729 . . . . 0.0 112.51 163.026 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 4.84 28.74 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.705 2.002 . . . . 0.0 111.274 -171.324 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.25 -37.62 16.58 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.381 -175.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.06 -32.52 59.79 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 119.173 0.897 . . . . 0.0 114.592 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.01 54.74 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.529 -0.983 . . . . 0.0 110.32 174.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.3 -36.03 63.73 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.52 150.45 46.4 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.348 1.459 . . . . 0.0 108.956 -167.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 m -86.79 158.52 19.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.128 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -44.65 60.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.919 0.488 . . . . 0.0 110.79 -174.064 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -50.62 -48.13 58.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 112.95 174.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.42 -47.49 81.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.699 0.761 . . . . 0.0 109.32 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.2 -49.96 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.394 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -47.68 -57.51 5.42 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.9 1.68 . . . . 0.0 110.234 174.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.46 -46.3 83.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.201 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -61.44 -42.13 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 122.025 -0.422 . . . . 0.0 110.827 -177.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -58.43 -50.44 78.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.32 -37.82 88.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.699 0.399 . . . . 0.0 111.716 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -96.8 -56.63 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.459 1.504 . . . . 0.0 111.957 -168.172 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.76 -173.15 21.04 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.911 1.72 . . . . 0.0 110.585 -171.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -165.01 123.5 1.7 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.243 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.17 -113.42 1.08 Allowed Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.797 1.181 . . . . 0.0 112.811 175.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.11 -16.63 79.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.208 1.004 . . . . 0.0 113.695 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.418 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.4 ttt -65.92 122.21 79.81 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.219 1.009 . . . . 0.0 109.164 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.15 -34.58 56.7 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.985 2.457 . . . . 0.0 111.555 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.92 168.1 36.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 122.604 1.113 . . . . 0.0 111.507 177.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.88 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.142 -178.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -67.54 -32.45 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 127.531 2.333 . . . . 0.0 110.172 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.71 153.09 51.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 172.366 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 164.17 33.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.183 0.593 . . . . 0.0 112.388 178.231 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.15 -137.86 22.93 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.08 -38.33 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.411 1.484 . . . . 0.0 112.815 178.123 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -62.09 -58.67 6.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.92 85.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.735 -0.603 . . . . 0.0 110.744 -177.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -58.1 -52.66 64.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.005 0.922 . . . . 0.0 110.141 174.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.32 -50.21 67.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.81 -55.24 12.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.371 174.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.47 24.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.82 0.736 . . . . 0.0 110.604 -174.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.6 -58.07 9.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.962 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.768 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 2.5 t90 -54.95 -50.75 68.12 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.851 0.461 . . . . 0.0 110.936 -178.223 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.537 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.146 -0.971 . . . . 0.0 108.724 -175.046 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.28 -38.99 69.31 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 122.132 -0.355 . . . . 0.0 111.223 172.217 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -22.0 60.8 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.713 -0.617 . . . . 0.0 111.15 178.016 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.4 9.74 0.74 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.282 2.233 . . . . 0.0 114.637 -172.226 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.252 1.197 0 O-C-N 120.504 -1.373 . . . . 0.0 112.193 -162.75 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.757 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.62 99.36 8.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -146.421 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.66 46.25 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -160.08 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -62.73 -46.23 89.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.58 177.527 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -41.57 72.63 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 118.744 0.702 . . . . 0.0 110.954 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -50.59 -64.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 167.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.642 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 92.6 t -66.86 -38.45 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 120.761 1.619 . . . . 0.0 112.211 -166.864 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -59.97 0.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.04 2.936 . . . . 0.0 113.331 170.059 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -125.4 -37.38 2.38 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.764 1.226 . . . . 0.0 112.404 168.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -102.42 -24.06 13.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.421 1.488 . . . . 0.0 111.577 -159.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.566 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.3 m -120.43 -40.59 2.67 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.289 0.636 . . . . 0.0 111.172 -169.063 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -49.68 -30.84 5.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 122.283 0.233 . . . . 0.0 111.462 178.03 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -34.73 -41.48 0.13 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.367 2.267 . . . . 0.0 113.164 170.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 m -119.91 -36.33 3.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.445 0.698 . . . . 0.0 111.118 176.241 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -80.84 -2.54 47.74 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.55 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.89 -85.52 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 123.811 0.72 . . . . 0.0 112.464 164.372 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.68 -66.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -173.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.11 2.21 24.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.312 -0.522 . . . . 0.0 111.733 173.33 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 70.1 22.25 5.73 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.393 1.877 . . . . 0.0 111.389 -172.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -5.56 37.75 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.994 2.118 . . . . 0.0 112.063 173.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.44 147.03 21.91 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 174.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.76 -82.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.913 0.885 . . . . 0.0 109.992 174.091 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 m -92.13 -0.15 57.45 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.021 0.928 . . . . 0.0 111.047 171.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.33 157.18 63.53 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 105.635 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.33 167.06 19.46 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.688 2.258 . . . . 0.0 111.645 -175.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 113.56 3.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.028 175.05 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp -108.02 -1.89 9.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.411 172.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -34.95 -50.45 0.48 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.285 1.434 . . . . 0.0 111.648 162.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -92.37 0.9 57.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.075 1.35 . . . . 0.0 110.74 -171.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.3 70.63 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.032 -1.043 . . . . 0.0 111.777 -174.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.12 -32.58 76.48 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 119.818 1.19 . . . . 0.0 112.557 174.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.34 -38.05 36.06 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.305 -1.115 . . . . 0.0 111.607 175.647 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -74.2 -38.94 63.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.307 0.503 . . . . 0.0 111.81 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -133.63 170.86 14.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.973 1.709 . . . . 0.0 108.292 -167.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.3 t -105.86 169.38 8.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.068 0.547 . . . . 0.0 110.38 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -51.39 64.55 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.137 0.575 . . . . 0.0 109.778 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -42.94 -55.79 3.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.678 1.591 . . . . 0.0 113.165 173.115 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -56.72 -52.25 65.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.04 0.936 . . . . 0.0 109.844 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.01 -48.35 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -173.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.7 tp -49.9 -56.04 12.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.448 1.899 . . . . 0.0 109.997 175.042 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.56 -47.82 81.03 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -58.83 -42.5 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 122.111 -0.368 . . . . 0.0 110.451 -177.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.45 -50.03 82.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 121.26 -0.9 . . . . 0.0 109.764 176.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.76 -32.66 74.23 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.027 0.531 . . . . 0.0 112.193 -178.444 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -103.39 -59.19 1.75 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.043 1.737 . . . . 0.0 112.01 -168.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.47 -175.61 21.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.207 1.861 . . . . 0.0 110.74 -173.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -150.64 164.63 35.62 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 166.464 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 3.14 -94.88 0.01 OUTLIER Glycine 0 CA--C 1.541 1.682 0 C-N-CA 126.887 2.184 . . . . 0.0 116.403 173.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.92 26.01 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 118.494 1.147 . . . . 0.0 112.928 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.414 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.6 ttt -104.05 121.11 48.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.952 1.701 . . . . 0.0 108.178 177.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.65 -36.5 63.4 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.088 2.525 . . . . 0.0 112.545 -169.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.81 165.71 34.03 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 122.158 0.866 . . . . 0.0 111.694 178.073 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.97 25.48 67.97 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -173.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.08 -26.72 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.079 1.351 . . . . 0.0 110.182 -177.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.54 146.68 32.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -139.07 164.16 30.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.24 0.927 . . . . 0.0 111.338 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.91 -134.66 16.53 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.366 0.984 . . . . 0.0 110.658 -175.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.21 -38.48 3.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.958 1.303 . . . . 0.0 112.26 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.79 -54.24 47.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.2 86.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.649 -0.657 . . . . 0.0 111.138 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.43 -52.73 62.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.295 0.638 . . . . 0.0 110.113 177.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.65 -52.9 53.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.867 0.867 . . . . 0.0 109.833 178.244 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 28' ' ' VAL . 77.4 t -50.19 -63.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 123.341 0.4 . . . . 0.0 110.226 174.392 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.96 -49.69 49.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.86 0.864 . . . . 0.0 110.978 -171.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.87 -59.8 4.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 177.082 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.642 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 47.0 t90 -55.93 -35.7 66.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.058 0.943 . . . . 0.0 112.085 -177.384 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.41 -44.73 50.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.39 -0.819 . . . . 0.0 110.554 178.3 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.89 -22.37 66.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.604 -0.685 . . . . 0.0 112.169 174.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.48 -26.93 58.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.187 1.395 . . . . 0.0 111.652 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -9.87 56.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -149.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.4 pttt . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.933 -1.032 . . . . 0.0 113.016 -107.281 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.741 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.8 103.66 3.74 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.497 1.519 . . . . 0.0 107.066 -170.171 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -55.56 9.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.587 -170.101 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.15 -41.34 83.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.204 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.78 81.96 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.151 0.887 . . . . 0.0 110.499 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.62 -58.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 168.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 2.0 t -68.85 -39.48 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 116.898 -1.921 . . . . 0.0 110.406 -165.348 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -62.31 -0.2 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.971 3.308 . . . . 0.0 114.079 170.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.93 -11.54 0.98 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 171.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.04 -18.47 11.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.888 1.275 . . . . 0.0 111.022 -176.169 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.3 m -127.25 -46.15 1.51 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.602 0.637 . . . . 0.0 111.762 -167.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.6 pt -53.91 -24.66 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.082 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -49.24 -27.38 3.66 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.911 0.884 . . . . 0.0 112.301 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.13 -42.77 3.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.212 0.605 . . . . 0.0 110.868 167.475 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.86 -9.95 58.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.28 -88.36 0.4 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.18 1.371 . . . . 0.0 112.564 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.82 -60.49 0.02 OUTLIER Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -176.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.9 4.0 39.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.713 0.805 . . . . 0.0 111.735 172.925 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 28' ' ' VAL . 1.2 mt 74.85 20.86 2.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.134 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -76.49 -12.46 60.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.401 2.68 . . . . 0.0 111.321 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.32 83.4 1.71 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 169.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.1 -76.87 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.935 0.494 . . . . 0.0 110.663 177.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -94.62 2.06 55.61 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.405 1.082 . . . . 0.0 111.408 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.98 38.02 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 127.5 2.32 . . . . 0.0 105.414 -176.24 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.68 164.47 26.49 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.03 1.82 . . . . 0.0 111.68 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.18 13.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.959 0.904 . . . . 0.0 109.717 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.291 2.5 pp -112.1 -3.03 10.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 173.41 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -32.97 9.37 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.123 -0.985 . . . . 0.0 112.295 165.547 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.0 3.12 38.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.337 1.055 . . . . 0.0 112.629 177.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.33 -38.2 68.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 117.402 -1.285 . . . . 0.0 111.094 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.58 -26.69 60.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.841 1.655 . . . . 0.0 114.328 174.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.47 -47.08 16.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.958 0.879 . . . . 0.0 109.878 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -74.66 -44.82 48.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 122.501 0.32 . . . . 0.0 111.854 -173.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -123.3 157.2 33.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.658 1.983 . . . . 0.0 109.504 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -89.46 163.89 15.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 0.0 110.964 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -44.17 68.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.895 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -49.64 -53.12 26.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.861 1.665 . . . . 0.0 112.169 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.9 -48.91 79.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.491 0.717 . . . . 0.0 109.834 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.33 -52.24 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -48.9 -56.26 9.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.509 1.524 . . . . 0.0 110.076 177.041 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.14 -46.59 85.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.215 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -59.78 -38.86 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.904 -0.498 . . . . 0.0 111.387 -179.037 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -51.84 66.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 119.469 1.032 . . . . 0.0 109.755 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.15 -33.4 75.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.433 -175.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.7 -43.39 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.21 1.804 . . . . 0.0 112.238 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.07 111.4 2.65 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.163 1.363 . . . . 0.0 110.133 -169.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -55.19 145.88 20.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 161.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -13.48 -74.73 0.01 OUTLIER Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.902 2.191 . . . . 0.0 117.235 -175.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 -12.42 73.8 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.804 0.802 . . . . 0.0 113.775 -175.241 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.5 ttt -88.14 135.65 32.96 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 126.16 1.784 . . . . 0.0 109.518 -175.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.0 157.95 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.41 1.407 . . . . 0.0 110.959 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.89 146.99 18.67 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -175.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.32 71.7 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.44 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.5 mt -55.59 -35.42 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.549 1.14 . . . . 0.0 109.366 172.477 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.65 152.29 46.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.019 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -143.15 162.61 35.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.977 0.808 . . . . 0.0 111.413 177.485 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.91 -136.34 41.76 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.38 -36.26 4.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.582 1.153 . . . . 0.0 112.064 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.52 -55.79 24.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.17 85.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.553 -0.717 . . . . 0.0 110.408 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.66 -47.75 81.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.128 0.571 . . . . 0.0 110.998 177.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.82 62.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.16 -57.38 8.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.937 173.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.36 -55.99 5.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.12 0.873 . . . . 0.0 110.644 -175.388 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.04 -54.0 52.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.89 0.476 . . . . 0.0 111.306 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.66 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 57.3 t90 -62.3 -54.7 36.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.286 -176.27 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -40.54 79.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.872 -1.143 . . . . 0.0 110.083 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.15 -50.37 71.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.782 0.264 . . . . 0.0 111.028 170.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.28 -8.88 57.72 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.808 0.731 . . . . 0.0 112.264 -177.005 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -16.76 64.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.652 1.181 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.789 1.236 . . . . 0.0 113.055 -162.987 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.811 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t0 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.7 -46.77 81.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.607 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.2 -44.33 84.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -49.19 75.52 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 119.089 0.858 . . . . 0.0 111.436 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.7 t -49.03 -55.82 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.543 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.278 94.6 t -66.02 -43.18 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.512 -169.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.37 1.33 0.35 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.455 3.102 . . . . 0.0 114.115 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.73 -8.13 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -116.02 -26.01 7.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.853 1.261 . . . . 0.0 110.606 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -114.35 -42.06 3.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.489 0.586 . . . . 0.0 111.199 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -49.66 -30.91 5.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 111.563 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.1 m -39.4 -38.52 0.56 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.57 1.548 . . . . 0.0 112.968 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.67 -43.95 2.77 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.758 0.423 . . . . 0.0 110.603 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -68.04 -17.24 64.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.82 155.45 31.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.13 -56.21 5.4 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.826 1.203 . . . . 0.0 113.97 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.61 0.33 43.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.254 0.621 . . . . 0.0 112.416 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.615 HD22 HD11 ' A' ' 48' ' ' ILE . 1.0 OUTLIER 62.58 27.73 16.35 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.962 1.305 . . . . 0.0 110.932 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 p -78.56 -8.81 58.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 128.778 2.831 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.84 76.75 1.23 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 118.293 0.497 . . . . 0.0 111.991 165.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.49 -85.31 0.1 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.897 0.479 . . . . 0.0 111.441 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.9 m -89.05 2.39 54.13 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 112.157 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.61 162.64 38.06 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.48 164.94 28.88 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.231 1.954 . . . . 0.0 111.128 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.93 119.31 10.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.389 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 40' ' ' LEU . 2.8 pp -113.77 -0.61 9.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.132 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -31.28 45.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.382 1.446 . . . . 0.0 112.147 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.418 ' NZ ' ' OXT' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -103.93 5.97 36.0 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.016 1.726 . . . . 0.0 112.552 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB3' HD22 ' A' ' 88' ' ' LEU . . . -54.37 -31.15 54.03 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.318 -1.489 . . . . 0.0 111.754 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.73 -27.61 68.61 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 120.324 1.42 . . . . 0.0 114.423 171.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.48 34.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.886 . . . . 0.0 109.03 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -73.86 -45.82 48.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.36 162.17 26.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.523 1.929 . . . . 0.0 109.262 -170.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 m -93.99 162.09 14.03 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.429 0.692 . . . . 0.0 110.331 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -50.56 -41.96 54.82 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.141 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.49 -58.24 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.099 0.863 . . . . 0.0 112.336 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.93 -51.1 67.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 110.085 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.492 HG22 HD11 ' A' ' 64' ' ' ILE . 61.1 mt -64.61 -48.04 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -50.41 -55.42 15.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.47 1.908 . . . . 0.0 109.872 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -45.76 86.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.77 -41.77 86.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.085 -1.009 . . . . 0.0 111.269 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 60' ' ' ILE . 19.6 mt -60.75 -47.72 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.046 -1.034 . . . . 0.0 109.544 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.275 0.63 . . . . 0.0 111.954 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -97.64 -54.26 3.18 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 111.636 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.75 -169.63 19.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.317 1.913 . . . . 0.0 110.301 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -170.59 122.16 0.61 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 127.431 2.293 . . . . 0.0 105.109 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.19 -113.83 1.03 Allowed Glycine 0 CA--C 1.538 1.52 0 CA-C-N 120.146 1.339 . . . . 0.0 113.027 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.52 -14.65 82.23 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 118.235 1.018 . . . . 0.0 114.069 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -66.82 129.96 94.02 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.193 0.997 . . . . 0.0 109.966 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -65.19 -40.01 21.28 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.08 2.52 . . . . 0.0 111.77 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.69 162.7 28.04 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.007 0.782 . . . . 0.0 111.774 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 17.65 66.27 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.737 0.684 . . . . 0.0 112.158 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 mm -61.16 -33.38 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.61 1.964 . . . . 0.0 110.391 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB1' ' HB3' ' A' ' 80' ' ' GLU . . . -134.75 144.34 47.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 157.99 43.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.437 0.695 . . . . 0.0 111.392 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.01 -137.34 32.65 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.08 -40.08 6.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.405 1.082 . . . . 0.0 112.726 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.7 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -53.0 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.531 0.605 . . . . 0.0 110.178 173.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.77 83.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.965 -0.46 . . . . 0.0 111.155 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.57 -55.15 38.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.411 0.684 . . . . 0.0 109.317 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.59 72.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.66 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG22 HG23 ' A' ' 28' ' ' VAL . 55.8 t -45.34 -66.94 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.79 70.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 111.601 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.38 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 110.769 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.525 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 7.2 t90 -55.14 -43.16 73.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.096 0.558 . . . . 0.0 110.755 176.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.525 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.55 -49.76 75.37 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.508 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.93 -40.64 63.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.451 0.7 . . . . 0.0 110.667 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -73.91 -18.66 60.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.96 0.904 . . . . 0.0 112.331 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -13.12 61.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.776 1.23 . . . . 0.0 111.482 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.418 ' OXT' ' NZ ' ' A' ' 50' ' ' LYS . 8.4 pttt . . . . . 0 C--O 1.247 0.93 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -157.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.37 -53.23 23.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -156.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.63 -43.29 99.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.491 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.35 79.67 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.918 0.887 . . . . 0.0 110.983 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -51.43 -63.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.704 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 67.6 t -64.68 -40.43 89.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 121.066 -1.021 . . . . 0.0 112.498 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -61.23 0.76 0.23 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.808 2.843 . . . . 0.0 113.468 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.75 -25.6 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 165.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -104.5 -28.36 11.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.663 1.185 . . . . 0.0 111.452 -165.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.613 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.2 m -120.2 -39.79 2.77 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.248 0.619 . . . . 0.0 111.579 -167.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -48.62 -31.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 122.634 0.374 . . . . 0.0 111.143 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -36.75 -41.97 0.35 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.542 2.337 . . . . 0.0 113.38 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.9 -42.9 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.101 0.561 . . . . 0.0 110.649 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.84 -17.64 62.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.15 152.4 28.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.9 -53.91 7.12 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.037 1.303 . . . . 0.0 113.567 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.25 1.42 50.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.772 0.829 . . . . 0.0 112.056 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.69 HD22 HD11 ' A' ' 48' ' ' ILE . 9.7 mt 66.28 25.16 10.56 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.895 0.878 . . . . 0.0 110.961 171.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -84.61 -4.41 58.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.969 2.908 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.63 77.12 1.32 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.399 0.545 . . . . 0.0 112.248 164.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.96 -78.43 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.067 0.434 . . . . 0.0 111.356 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -97.74 1.75 48.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.731 1.612 . . . . 0.0 111.965 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.92 162.7 39.65 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.54 164.75 31.69 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.839 1.692 . . . . 0.0 111.608 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.54 114.68 5.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.112 0.965 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.753 HD13 HD11 ' A' ' 88' ' ' LEU . 2.5 pp -102.52 -0.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 122.771 0.428 . . . . 0.0 111.845 173.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.06 -42.52 1.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.98 0.912 . . . . 0.0 111.986 162.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -99.81 5.09 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.058 1.343 . . . . 0.0 113.032 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.58 -42.65 34.42 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.634 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.72 68.28 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.604 1.093 . . . . 0.0 114.664 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.41 -47.66 26.35 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.12 0.96 . . . . 0.0 109.255 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.55 -39.3 62.39 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.236 0.615 . . . . 0.0 111.327 -170.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.74 161.58 34.3 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.02 2.128 . . . . 0.0 108.04 -171.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -99.6 156.51 17.03 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.062 0.945 . . . . 0.0 110.378 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.26 -51.1 6.37 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.893 0.877 . . . . 0.0 111.316 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -40.87 -52.77 3.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.753 1.621 . . . . 0.0 113.839 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.09 -47.89 75.63 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.355 -0.841 . . . . 0.0 109.842 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.5 mt -61.77 -48.34 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -48.84 -56.28 9.18 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 126.748 2.019 . . . . 0.0 109.946 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.16 -48.29 76.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.7 mt -59.95 -42.24 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 122.028 -0.42 . . . . 0.0 110.749 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.39 -50.97 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.94 -36.86 85.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.962 0.505 . . . . 0.0 111.838 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -96.82 -58.39 2.05 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.572 1.549 . . . . 0.0 111.36 -169.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.29 -176.74 20.11 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.377 1.941 . . . . 0.0 110.354 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -145.33 163.21 35.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 103.298 -2.853 . . . . 0.0 103.298 166.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -23.63 -77.47 0.01 OUTLIER Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.704 1.621 . . . . 0.0 115.676 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 32.2 6.39 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.5 1.15 . . . . 0.0 113.506 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -124.32 124.72 25.78 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.197 1.399 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.97 -38.73 55.8 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.866 2.378 . . . . 0.0 113.173 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.45 163.33 32.85 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 121.802 0.668 . . . . 0.0 112.237 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.48 66.9 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mt -69.13 -29.07 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.177 1.391 . . . . 0.0 110.139 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.24 41.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -140.51 152.18 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.665 1.121 . . . . 0.0 113.267 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.06 -137.16 50.63 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.47 -38.68 4.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.236 1.414 . . . . 0.0 112.031 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -54.74 -57.37 11.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.826 1.25 . . . . 0.0 109.859 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.28 87.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 110.649 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.46 -53.36 55.21 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.332 0.653 . . . . 0.0 109.849 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.98 -55.12 25.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.99 0.916 . . . . 0.0 109.848 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.7 t -51.07 -54.41 10.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 122.922 0.139 . . . . 0.0 110.971 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.3 -52.34 65.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.092 0.557 . . . . 0.0 110.777 -172.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.23 -54.3 38.13 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.55 0.69 . . . . 0.0 109.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.704 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 51.6 t90 -57.6 -40.72 79.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.485 0.714 . . . . 0.0 112.14 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.753 HD11 HD13 ' A' ' 48' ' ' ILE 0.305 3.7 mt -68.05 -39.66 82.96 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.618 -1.301 . . . . 0.0 112.887 175.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.12 72.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.307 0.503 . . . . 0.0 111.108 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -73.24 -28.84 62.37 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.316 1.046 . . . . 0.0 111.211 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -20.72 66.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.548 1.139 . . . . 0.0 113.68 -169.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 pttt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -151.267 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.35 86.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.613 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.61 -43.31 73.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 -49.59 68.54 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.002 0.819 . . . . 0.0 111.246 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -47.99 -59.15 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.566 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.261 87.8 t -68.93 -38.47 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.37 -166.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.04 0.19 0.25 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 129.186 2.994 . . . . 0.0 113.947 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 -13.48 1.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.1 -26.63 8.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.93 1.292 . . . . 0.0 110.817 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.8 m -115.01 -40.72 3.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.706 0.684 . . . . 0.0 111.976 -172.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.6 pt -49.34 -30.14 4.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 122.619 0.368 . . . . 0.0 111.706 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.9 t -38.66 -42.24 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.067 1.747 . . . . 0.0 111.653 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -116.2 -42.65 3.02 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.267 0.627 . . . . 0.0 111.002 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -71.71 -13.21 61.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.24 153.0 21.71 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.01 -60.52 2.21 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.281 1.419 . . . . 0.0 113.53 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.55 -2.28 34.82 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.577 0.751 . . . . 0.0 112.571 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 28' ' ' VAL . 1.4 mt 66.84 26.53 9.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.23 1.812 . . . . 0.0 111.007 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -79.29 -7.99 58.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.701 2.8 . . . . 0.0 111.563 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.86 83.62 1.69 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 168.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.68 -84.09 0.18 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.011 0.524 . . . . 0.0 110.549 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -88.97 2.1 54.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.263 1.425 . . . . 0.0 111.89 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.79 41.32 Favored Pre-proline 0 N--CA 1.452 -0.36 0 C-N-CA 126.925 2.09 . . . . 0.0 105.413 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.47 164.37 23.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.922 1.748 . . . . 0.0 111.007 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.59 122.88 18.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.467 HD11 HD22 ' A' ' 40' ' ' LEU 0.296 1.9 pp -119.42 0.5 7.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.968 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -41.41 -43.95 2.7 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.783 1.174 . . . . 0.0 112.133 164.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -101.92 6.17 41.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.429 1.892 . . . . 0.0 112.12 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -33.02 42.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.02 -0.991 . . . . 0.0 111.552 172.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.1 -31.98 78.73 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.768 1.622 . . . . 0.0 113.647 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.0 -49.42 37.15 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.147 0.974 . . . . 0.0 109.746 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.79 -42.22 50.67 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.324 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -118.37 179.76 4.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.889 1.676 . . . . 0.0 107.639 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.2 m -120.14 163.37 17.81 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.577 -0.702 . . . . 0.0 109.987 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -52.51 19.45 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.471 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -35.69 -61.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.719 1.208 . . . . 0.0 113.421 168.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -55.77 30.81 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 121.855 0.835 . . . . 0.0 109.769 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.486 HG22 HD11 ' A' ' 64' ' ' ILE . 64.5 mt -60.12 -47.06 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -171.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.9 -53.81 29.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.976 1.71 . . . . 0.0 109.99 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.11 -49.8 68.31 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.42 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.461 -0.775 . . . . 0.0 110.88 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 60' ' ' ILE . 22.0 mt -59.65 -49.11 84.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 120.813 -1.179 . . . . 0.0 109.638 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.3 -37.19 82.99 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.743 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -94.9 -58.15 2.25 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.211 1.404 . . . . 0.0 111.458 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.5 -171.03 21.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.177 2.322 . . . . 0.0 109.675 -168.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -156.73 163.73 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.48 -90.05 0.0 OUTLIER Glycine 0 CA--C 1.544 1.863 0 C-N-CA 126.27 1.89 . . . . 0.0 116.57 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.66 13.83 66.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.859 1.329 . . . . 0.0 114.202 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.6 ttt -99.12 126.14 39.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.547 . . . . 0.0 109.073 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.63 -40.65 22.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.698 2.266 . . . . 0.0 112.348 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.27 163.71 31.26 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.716 0.62 . . . . 0.0 112.161 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.44 20.11 65.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mt -66.97 -32.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 125.426 1.49 . . . . 0.0 109.619 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.02 146.49 47.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -146.73 162.83 37.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.2 -139.78 40.63 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.09 -38.56 1.06 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.546 1.539 . . . . 0.0 112.467 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -55.54 -61.09 2.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.405 1.082 . . . . 0.0 110.015 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.69 -38.01 80.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.699 -0.626 . . . . 0.0 110.788 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -55.49 -54.29 45.73 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.38 62.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.58 0.752 . . . . 0.0 109.663 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 HG23 ' A' ' 28' ' ' VAL . 58.6 t -46.82 -66.03 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 O-C-N 123.363 0.414 . . . . 0.0 110.256 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.24 -47.43 75.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.063 0.945 . . . . 0.0 110.616 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -56.31 23.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.385 0.274 . . . . 0.0 110.373 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.453 ' HZ3' HG11 ' A' ' 28' ' ' VAL . 45.5 t90 -55.31 -43.04 74.5 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.568 0.747 . . . . 0.0 110.946 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.04 -51.48 63.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.679 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.25 68.28 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.035 0.534 . . . . 0.0 110.959 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.79 -20.5 61.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.244 0.618 . . . . 0.0 110.764 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.155 -0.966 . . . . 0.0 111.121 -165.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.788 2.435 . . . . 0.0 114.081 -151.575 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.42 -52.17 40.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.019 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -60.53 -40.75 92.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.815 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.79 -44.61 90.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.023 0.829 . . . . 0.0 110.659 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.5 -60.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.555 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.258 17.3 t -65.01 -41.16 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 116.462 -2.095 . . . . 0.0 111.968 -168.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -61.29 0.4 0.28 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.074 2.95 . . . . 0.0 114.28 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.81 -13.43 0.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -114.65 -21.38 10.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.434 1.494 . . . . 0.0 111.427 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.6 m -123.26 -40.13 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.377 0.535 . . . . 0.0 111.183 -168.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -48.59 -30.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 122.96 0.504 . . . . 0.0 111.746 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 m -40.82 -37.06 0.71 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.089 1.755 . . . . 0.0 112.885 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 m -119.66 -43.5 2.58 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 122.859 0.464 . . . . 0.0 110.739 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.4 -14.9 62.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.05 153.4 25.84 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.09 4.55 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.224 1.393 . . . . 0.0 113.564 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.52 -0.27 41.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.06 0.544 . . . . 0.0 112.136 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 HG12 ' A' ' 28' ' ' VAL . 4.8 mt 64.71 25.85 13.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.59 1.556 . . . . 0.0 111.003 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -81.38 -8.31 59.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 128.901 2.88 . . . . 0.0 111.407 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.52 79.27 1.45 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 118.332 0.515 . . . . 0.0 112.21 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.57 -81.74 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.708 0.403 . . . . 0.0 111.226 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -91.64 1.97 56.78 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.548 1.539 . . . . 0.0 112.015 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.15 162.03 45.08 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.96 164.15 25.82 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.845 1.697 . . . . 0.0 111.088 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.47 122.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 40' ' ' LEU 0.323 2.4 pp -116.5 1.07 8.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.877 174.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -35.26 18.74 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.143 1.338 . . . . 0.0 112.344 168.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -99.16 4.31 46.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.172 1.389 . . . . 0.0 112.309 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -33.05 52.95 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 120.92 -1.113 . . . . 0.0 111.168 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.95 -31.15 79.62 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.45 1.023 . . . . 0.0 114.41 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -43.9 38.09 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.818 -0.813 . . . . 0.0 110.076 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -74.16 -39.92 62.93 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.678 0.391 . . . . 0.0 111.538 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -131.6 156.35 45.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.114 1.766 . . . . 0.0 108.054 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -92.88 162.56 14.04 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.753 -0.592 . . . . 0.0 110.506 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -46.56 -46.59 19.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.224 0.609 . . . . 0.0 110.772 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.39 -57.38 4.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.822 1.249 . . . . 0.0 112.899 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 -50.94 71.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.046 0.927 . . . . 0.0 110.073 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 64' ' ' ILE . 59.9 mt -63.42 -47.26 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.1 tp -50.29 -54.89 18.08 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.745 1.618 . . . . 0.0 109.988 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.14 -49.8 70.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.29 -43.23 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.568 -0.708 . . . . 0.0 111.082 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 60' ' ' ILE . 28.7 mt -60.88 -51.05 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.03 -29.9 69.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.551 0.741 . . . . 0.0 112.542 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.5 -60.17 1.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.27 1.828 . . . . 0.0 111.268 -170.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.23 -173.18 21.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.558 2.028 . . . . 0.0 110.655 -168.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -152.62 161.04 43.11 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 102.741 -3.059 . . . . 0.0 102.741 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.32 -71.09 0.07 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 120.489 1.495 . . . . 0.0 115.427 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.47 23.37 28.14 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 118.058 0.929 . . . . 0.0 113.763 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -117.94 131.97 23.9 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.075 1.35 . . . . 0.0 109.34 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.26 -40.72 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.661 2.241 . . . . 0.0 112.187 -172.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.22 157.57 17.99 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 121.699 0.611 . . . . 0.0 112.426 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 17.84 61.39 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mm -58.76 -37.2 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.529 1.132 . . . . 0.0 109.587 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.82 146.35 52.24 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -144.22 154.6 43.28 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.67 -139.21 48.1 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.6 -37.16 5.29 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.017 1.327 . . . . 0.0 111.738 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -53.74 -60.99 2.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.478 1.111 . . . . 0.0 110.061 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.35 79.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.814 -0.554 . . . . 0.0 110.667 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.94 -52.92 63.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.02 0.438 . . . . 0.0 109.913 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.03 -52.52 60.59 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.829 0.851 . . . . 0.0 109.607 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -48.24 -65.2 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 119.172 -0.442 . . . . 0.0 109.87 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.05 -49.93 49.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.429 1.091 . . . . 0.0 111.453 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.65 -57.08 14.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.999 0.428 . . . . 0.0 110.566 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.524 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 68.7 t90 -56.36 -34.47 66.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.569 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.74 -43.85 52.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.16 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.13 -32.74 66.66 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.74 -0.6 . . . . 0.0 111.008 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.09 -23.14 59.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.079 0.952 . . . . 0.0 111.924 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.51 4.09 0.42 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.519 2.328 . . . . 0.0 115.671 -165.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.103 0 O-C-N 119.993 -1.692 . . . . 0.0 113.457 -125.594 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 123.024 1.392 . . . . 0.0 107.727 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.22 82.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.744 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -56.89 -45.32 82.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.942 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.58 96.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.687 0.676 . . . . 0.0 110.681 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -51.48 -65.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 32' ' ' CYS . 73.7 t -63.1 -42.03 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 120.088 1.313 . . . . 0.0 110.793 -165.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -1.44 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.59 2.756 . . . . 0.0 113.261 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.78 0.96 2.05 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 169.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.01 -54.61 1.61 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.319 1.048 . . . . 0.0 109.986 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.794 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.9 m -90.0 -41.82 11.5 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.769 0.428 . . . . 0.0 110.248 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 pt -52.74 -27.21 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.038 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -47.51 -29.33 2.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.923 1.289 . . . . 0.0 112.363 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 m -122.9 -41.58 2.34 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.542 0.61 . . . . 0.0 110.864 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -70.7 -17.35 62.83 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.81 150.15 18.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.46 -59.88 1.5 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.703 1.62 . . . . 0.0 113.969 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.01 -15.42 61.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.767 1.227 . . . . 0.0 112.77 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.589 HD22 HD11 ' A' ' 48' ' ' ILE . 1.4 mt 77.06 23.87 0.9 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.704 2.402 . . . . 0.0 111.098 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 p -75.73 -9.17 58.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 111.961 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.19 81.07 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.671 . . . . 0.0 111.797 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.66 -78.92 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.797 0.439 . . . . 0.0 111.1 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -93.98 2.6 56.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.609 1.563 . . . . 0.0 111.502 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.36 163.05 34.25 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.97 165.48 21.35 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.792 1.661 . . . . 0.0 111.189 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 119.7 11.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 40' ' ' LEU 0.319 2.1 pp -115.65 1.3 8.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.734 174.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.52 -40.31 18.39 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.519 1.054 . . . . 0.0 111.606 167.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -93.12 2.8 56.55 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 125.699 1.599 . . . . 0.0 111.315 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.13 -34.92 66.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.184 0.902 . . . . 0.0 111.183 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.47 -31.75 78.62 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.479 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.42 -46.23 28.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.514 1.157 . . . . 0.0 110.455 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -74.37 -40.67 61.95 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 111.264 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -124.91 -177.94 4.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.52 2.328 . . . . 0.0 107.893 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -122.92 169.47 11.11 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.607 -0.683 . . . . 0.0 110.32 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -42.73 67.29 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.436 0.694 . . . . 0.0 110.374 -171.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -51.12 -56.26 13.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 112.913 175.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 31.5 mm-40 -56.55 -49.35 75.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.185 1.394 . . . . 0.0 109.176 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.89 -51.22 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.75 -56.15 11.32 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.253 1.021 . . . . 0.0 109.912 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.67 -41.12 97.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.705 -0.798 . . . . 0.0 108.904 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.8 mt -62.72 -39.98 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.817 -0.552 . . . . 0.0 111.325 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.47 -51.09 76.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 O-C-N 120.719 -1.238 . . . . 0.0 109.571 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.87 -42.1 99.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -91.82 -50.6 5.64 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 112.323 -168.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.33 -167.66 14.84 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.976 1.75 . . . . 0.0 110.112 -168.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -169.37 131.02 1.14 Allowed 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.13 -112.38 0.5 Allowed Glycine 0 CA--C 1.539 1.559 0 CA-C-N 120.486 1.494 . . . . 0.0 113.078 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 -10.31 76.11 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.363 1.082 . . . . 0.0 114.263 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.5 ttt -64.46 126.43 90.58 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 118.549 1.175 . . . . 0.0 109.405 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.88 -34.82 37.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.007 2.471 . . . . 0.0 112.621 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.57 164.32 36.4 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.55 19.4 68.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.667 0.651 . . . . 0.0 112.077 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.09 -29.77 48.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.698 1.199 . . . . 0.0 110.445 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.61 153.21 42.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -146.87 162.12 39.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.39 -138.53 45.91 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.1 -6.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.176 1.791 . . . . 0.0 114.909 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.59 -67.19 0.79 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.243 1.817 . . . . 0.0 108.223 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.44 90.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.454 -0.779 . . . . 0.0 111.004 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.23 -48.58 76.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.66 91.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.694 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.1 t -53.05 -49.45 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.47 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.59 -56.58 6.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.096 0.862 . . . . 0.0 110.391 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.87 -55.67 30.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.745 0.418 . . . . 0.0 111.611 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.62 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 55.8 t90 -58.05 -49.9 75.3 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.023 0.916 . . . . 0.0 111.351 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.495 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -64.37 -43.27 95.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.182 0.993 . . . . 0.0 109.6 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.71 -41.81 67.4 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 170.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.99 -13.61 60.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.035 0.934 . . . . 0.0 112.459 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -15.56 56.33 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.704 -1.247 . . . . 0.0 113.242 -169.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.596 1.158 . . . . 0.0 113.765 -150.146 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.35 63.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.901 -166.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -62.2 -43.08 99.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.283 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.31 85.9 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 119.452 1.024 . . . . 0.0 110.984 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -47.09 -64.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 32' ' ' CYS . 69.3 t -64.41 -43.46 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 117.711 -1.596 . . . . 0.0 112.244 -167.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -56.02 -2.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.564 3.145 . . . . 0.0 112.984 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.66 2.59 2.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.286 0.948 . . . . 0.0 113.507 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -129.33 -53.06 1.18 Allowed 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.141 0.977 . . . . 0.0 110.541 -168.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.691 ' HB2' HG13 ' A' ' 28' ' ' VAL . 1.9 m -95.62 -40.3 9.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.934 0.494 . . . . 0.0 109.756 -171.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 pt -52.45 -28.02 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.054 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.17 -30.26 2.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.115 1.366 . . . . 0.0 112.571 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 m -126.28 -37.25 2.24 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.409 0.683 . . . . 0.0 111.316 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -78.71 -10.56 59.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.27 153.11 22.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.121 0.867 . . . . 0.0 110.946 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -47.5 5.99 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.424 1.488 . . . . 0.0 113.665 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -85.14 -10.3 56.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.824 1.25 . . . . 0.0 112.224 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 48' ' ' ILE . 1.4 mt 70.18 23.05 5.32 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.855 2.062 . . . . 0.0 111.709 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -76.2 -7.37 54.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.722 2.409 . . . . 0.0 111.89 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.86 112.47 2.08 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.56 -72.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.469 0.708 . . . . 0.0 109.475 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -93.99 2.05 56.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.628 1.171 . . . . 0.0 110.737 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.63 162.06 38.01 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.579 1.951 . . . . 0.0 106.034 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.41 163.91 22.17 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.862 1.708 . . . . 0.0 110.622 174.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 121.55 14.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.595 HD11 HD22 ' A' ' 40' ' ' LEU 0.25 2.0 pp -115.62 -1.59 9.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.972 174.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -38.69 -46.82 1.28 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.359 0.982 . . . . 0.0 112.216 165.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -98.32 3.93 48.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.814 2.046 . . . . 0.0 111.177 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.25 -32.66 56.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.174 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.78 -30.42 72.69 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.886 1.221 . . . . 0.0 113.68 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.33 -45.55 38.8 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.281 1.04 . . . . 0.0 109.359 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -73.67 -41.16 63.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -130.4 165.01 23.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 127.186 2.194 . . . . 0.0 107.766 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 m -103.77 167.92 9.47 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.931 -0.481 . . . . 0.0 110.691 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -38.63 68.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.322 -173.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -53.87 -48.04 70.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.598 0.636 . . . . 0.0 112.449 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -66.17 -47.71 73.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.504 1.145 . . . . 0.0 108.503 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.72 -47.14 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.3 tp -51.81 -55.49 19.58 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 110.623 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.66 -54.57 11.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -63.8 -39.95 87.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.579 -171.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.83 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 121.294 -0.878 . . . . 0.0 109.396 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.46 -35.17 80.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -100.71 -55.79 2.5 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.376 1.471 . . . . 0.0 112.303 -168.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.12 -168.09 22.16 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.903 1.716 . . . . 0.0 110.383 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -164.06 160.99 22.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.16 2.984 . . . . 0.0 103.392 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 9.56 -99.41 0.01 OUTLIER Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.382 1.944 . . . . 0.0 116.302 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.55 17.79 57.13 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 118.491 1.146 . . . . 0.0 113.584 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.1 ttt -89.05 129.62 47.46 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 125.313 1.445 . . . . 0.0 108.464 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.48 -41.22 33.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.833 2.356 . . . . 0.0 112.048 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 159.38 17.23 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.14 20.56 62.92 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 122.165 -0.609 . . . . 0.0 111.614 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.5 mm -63.5 -29.12 46.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 124.518 1.127 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 149.15 45.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -142.19 157.77 44.49 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.294 0.952 . . . . 0.0 113.248 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.84 -141.51 44.86 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.05 -35.71 2.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.197 1.399 . . . . 0.0 112.563 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.36 -62.55 1.58 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.607 1.163 . . . . 0.0 110.179 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.16 80.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.173 0.589 . . . . 0.0 110.715 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.66 -50.36 74.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.544 0.687 . . . . 0.0 109.634 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.52 -48.09 81.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.027 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 28' ' ' VAL . 78.0 t -49.95 -55.9 4.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.263 172.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.3 17.51 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.051 0.841 . . . . 0.0 110.556 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.85 78.96 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.005 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.616 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 71.7 t90 -61.13 -46.06 92.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.033 0.533 . . . . 0.0 111.72 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -66.56 -43.83 83.97 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.64 -47.81 58.33 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.11 -10.17 59.41 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.341 -0.85 . . . . 0.0 112.172 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 -5.45 59.24 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.871 -1.143 . . . . 0.0 112.079 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 C--O 1.247 0.948 0 C-N-CA 125.957 1.703 . . . . 0.0 114.194 -164.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.9 58.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.97 -1.013 . . . . 0.0 113.06 -165.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.18 -44.24 97.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.208 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.11 77.25 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.557 0.617 . . . . 0.0 110.852 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.03 -60.89 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 170.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.708 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.25 63.2 t -66.85 -40.76 86.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 121.078 -1.014 . . . . 0.0 112.047 -168.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -60.34 1.05 0.14 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.04 2.936 . . . . 0.0 113.746 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.31 -22.64 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 168.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -15.96 11.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 111.999 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.9 m -121.55 -41.39 2.49 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.58 0.627 . . . . 0.0 111.283 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.0 pt -48.68 -29.81 2.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 122.974 0.51 . . . . 0.0 111.561 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -38.1 -44.94 0.87 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.918 1.687 . . . . 0.0 112.02 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -113.19 -41.66 3.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.873 0.469 . . . . 0.0 110.73 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -71.27 -15.31 62.42 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.55 152.04 24.28 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -56.99 3.88 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.029 1.3 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 -5.86 49.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.956 1.302 . . . . 0.0 112.046 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 mt 66.53 20.38 10.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.099 1.759 . . . . 0.0 111.89 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 p -81.31 1.15 33.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.91 2.084 . . . . 0.0 111.647 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 79.21 1.44 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.596 0.635 . . . . 0.0 112.441 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.08 -80.37 0.13 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.973 0.387 . . . . 0.0 111.135 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m -94.51 1.94 55.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.442 1.497 . . . . 0.0 112.068 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.1 46.9 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.85 164.58 21.24 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.661 1.574 . . . . 0.0 110.992 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.85 113.22 6.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.861 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.437 ' O ' HD11 ' A' ' 88' ' ' LEU 0.262 2.3 pp -107.96 -2.02 10.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.604 178.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -32.92 -54.53 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.112 1.365 . . . . 0.0 112.261 163.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 3.14 54.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.923 2.089 . . . . 0.0 111.429 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.65 -37.76 42.57 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.196 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.97 -27.54 59.74 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.916 0.78 . . . . 0.0 115.001 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -44.5 55.67 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.266 1.033 . . . . 0.0 110.212 171.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -74.05 -38.45 63.98 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.66 0.384 . . . . 0.0 111.258 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -140.47 160.41 40.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 108.348 -167.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -94.59 165.84 12.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.541 0.736 . . . . 0.0 111.127 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.18 -45.87 53.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.42 0.688 . . . . 0.0 110.387 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.26 -49.84 31.93 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 112.573 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.48 -51.38 60.51 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.034 0.934 . . . . 0.0 110.276 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.24 -47.48 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.2 tp -48.02 -56.74 6.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.306 1.842 . . . . 0.0 110.12 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.34 -47.81 78.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.1 -44.18 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 122.277 -0.264 . . . . 0.0 110.762 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.2 mt -61.14 -50.65 79.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.115 -0.99 . . . . 0.0 109.724 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -39.74 89.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.562 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -94.81 -61.24 1.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.587 1.955 . . . . 0.0 111.59 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.33 -175.86 21.14 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.571 2.034 . . . . 0.0 110.202 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -150.97 164.46 36.32 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 167.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -4.97 -91.75 0.0 OUTLIER Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.965 2.221 . . . . 0.0 116.272 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.53 34.72 5.34 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.558 1.179 . . . . 0.0 112.58 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 ttt -114.49 123.97 31.43 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 125.592 1.557 . . . . 0.0 108.671 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.64 -38.67 59.83 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.869 2.38 . . . . 0.0 112.621 -170.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 162.61 27.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 122.077 0.82 . . . . 0.0 111.857 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.98 21.22 65.46 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 mt -64.55 -30.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.838 1.255 . . . . 0.0 109.559 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.48 149.48 44.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -143.83 164.5 30.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.231 0.923 . . . . 0.0 111.681 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.64 -140.85 43.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.38 -35.21 5.25 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.939 1.295 . . . . 0.0 112.095 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.04 -56.14 26.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.866 0.466 . . . . 0.0 109.921 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.32 81.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.643 -0.661 . . . . 0.0 110.72 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.53 -53.04 62.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.144 0.429 . . . . 0.0 110.214 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.01 57.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.402 0.681 . . . . 0.0 109.932 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.2 -61.96 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.28 -51.96 49.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.702 0.801 . . . . 0.0 111.374 -170.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.35 -56.18 25.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 110.656 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.964 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 20.4 t90 -54.09 -41.0 67.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.439 0.696 . . . . 0.0 111.467 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.964 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -79.02 -28.63 43.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.856 -1.153 . . . . 0.0 111.291 -175.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.88 67.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.576 0.75 . . . . 0.0 111.375 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.79 62.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.332 1.053 . . . . 0.0 110.75 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.504 ' HA ' ' CE ' ' A' ' 91' ' ' LYS 0.33 0.0 OUTLIER -62.64 9.4 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 118.924 2.935 . . . . 0.0 118.924 -163.102 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--O 1.251 1.166 0 O-C-N 120.77 -1.206 . . . . 0.0 113.26 -149.811 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.99 -49.6 20.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.445 1.098 . . . . 0.0 112.339 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.15 -44.77 96.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.751 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.1 82.92 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.414 1.006 . . . . 0.0 111.476 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -51.57 -63.2 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.678 HG22 ' SG ' ' A' ' 32' ' ' CYS 0.258 34.1 t -67.05 -39.54 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.696 -164.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.93 0.86 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.174 2.99 . . . . 0.0 112.987 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.45 -25.36 3.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.736 1.153 . . . . 0.0 113.996 165.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -117.85 -17.92 9.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.625 1.17 . . . . 0.0 113.041 -163.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.678 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.6 m -113.58 -39.72 3.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.679 1.127 . . . . 0.0 111.275 176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -50.3 -29.29 5.91 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.6 -29.58 3.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.812 1.245 . . . . 0.0 112.813 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -123.61 -41.52 2.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.696 0.799 . . . . 0.0 110.624 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -74.63 -10.63 59.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.81 152.3 13.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.56 -57.97 2.64 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.476 1.512 . . . . 0.0 113.452 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -5.84 53.3 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.856 1.662 . . . . 0.0 112.523 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD21 HG12 ' A' ' 28' ' ' VAL . 8.0 mt 69.96 21.58 6.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.256 1.822 . . . . 0.0 111.485 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -75.28 -8.09 55.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.406 2.283 . . . . 0.0 111.766 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 99.29 1.49 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 -76.5 0.56 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.471 0.635 . . . . 0.0 109.811 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 m -93.98 2.06 56.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.506 1.523 . . . . 0.0 111.691 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.12 161.3 45.85 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 127.207 2.203 . . . . 0.0 105.303 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.7 165.67 22.48 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.33 2.02 . . . . 0.0 111.094 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 120.76 13.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.893 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 2.0 pp -117.23 0.54 8.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.063 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.26 -43.63 10.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.257 0.935 . . . . 0.0 111.207 164.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -96.53 3.89 52.39 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.561 1.544 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -52.81 -34.58 54.35 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.633 -0.667 . . . . 0.0 111.131 173.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.06 -30.47 75.68 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.045 0.839 . . . . 0.0 113.567 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.49 -47.24 17.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.987 0.893 . . . . 0.0 110.199 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.64 -44.58 49.73 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.704 0.402 . . . . 0.0 111.591 -171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.22 -178.28 3.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.833 2.053 . . . . 0.0 107.288 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.8 t -123.64 171.92 9.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 0.566 . . . . 0.0 110.294 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.79 -44.12 73.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.338 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -52.37 -48.19 65.73 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.959 0.8 . . . . 0.0 111.567 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.0 -50.38 64.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.512 0.672 . . . . 0.0 109.69 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.24 -47.16 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.4 tp -49.88 -55.48 14.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.76 -48.27 72.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -47.43 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.144 -0.348 . . . . 0.0 110.26 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.49 -48.32 87.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 120.835 -1.165 . . . . 0.0 110.022 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.7 -43.18 89.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -86.5 -56.42 3.43 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.19 1.396 . . . . 0.0 110.934 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.1 -160.69 21.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 126.841 2.162 . . . . 0.0 108.737 -166.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.38 162.71 37.66 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 101.811 -3.403 . . . . 0.0 101.811 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.16 -54.56 1.23 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.865 1.221 . . . . 0.0 113.983 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -105.74 30.64 9.45 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 117.478 0.639 . . . . 0.0 113.264 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.6 ttt -137.8 129.52 16.22 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 118.664 1.232 . . . . 0.0 109.449 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.55 -41.98 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.103 2.535 . . . . 0.0 113.058 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.23 166.55 39.94 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-O 121.841 0.69 . . . . 0.0 112.18 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.47 19.48 68.82 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.3 -35.11 70.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 125.757 1.623 . . . . 0.0 109.63 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.49 146.12 41.64 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 165.3 30.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.066 0.546 . . . . 0.0 112.436 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.47 -141.36 35.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -173.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.84 -38.94 0.73 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.746 1.619 . . . . 0.0 112.395 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.38 -58.83 6.9 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.925 0.49 . . . . 0.0 110.191 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.0 90.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.22 -51.95 55.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.471 0.708 . . . . 0.0 109.77 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.49 69.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.36 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -48.84 -61.3 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 118.396 0.543 . . . . 0.0 110.026 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.42 -55.79 9.9 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.168 0.987 . . . . 0.0 111.805 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.94 -53.49 57.36 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.707 0.765 . . . . 0.0 110.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.652 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 57.8 t90 -57.41 -37.36 72.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.203 0.525 . . . . 0.0 111.625 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.527 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -72.53 -42.97 64.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 121.241 -0.912 . . . . 0.0 109.475 -177.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -36.92 64.13 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.255 0.222 . . . . 0.0 110.736 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -18.68 60.78 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.733 -0.605 . . . . 0.0 112.411 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 7.62 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.962 2.505 . . . . 0.0 114.934 -172.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.251 1.158 0 O-C-N 119.791 -1.818 . . . . 0.0 113.144 -143.348 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.06 -50.68 35.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.179 0.991 . . . . 0.0 112.485 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.33 -44.51 97.07 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.715 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.96 78.58 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.181 0.901 . . . . 0.0 111.184 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.27 -64.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 72.3 t -67.64 -39.32 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 117.921 -1.512 . . . . 0.0 111.851 -163.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -57.89 0.46 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.999 3.32 . . . . 0.0 114.271 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.63 -37.58 1.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.607 1.094 . . . . 0.0 113.241 164.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 -32.32 15.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.436 1.494 . . . . 0.0 110.201 -163.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.9 m -110.77 -39.15 4.93 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.407 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 pt -51.6 -28.87 9.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 O-C-N 123.121 0.263 . . . . 0.0 111.651 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 t -37.55 -45.66 0.77 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.958 1.703 . . . . 0.0 111.768 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.9 m -110.88 -43.06 3.85 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 122.832 0.453 . . . . 0.0 110.619 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -72.49 -15.47 61.8 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.41 153.13 24.37 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.93 4.25 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.15 1.357 . . . . 0.0 113.664 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.4 -0.8 38.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.913 0.485 . . . . 0.0 112.172 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD21 HG12 ' A' ' 28' ' ' VAL . 1.7 mt 66.28 23.65 10.75 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.134 1.774 . . . . 0.0 111.069 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -6.93 58.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.334 2.654 . . . . 0.0 111.565 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 78.21 1.38 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 118.434 0.561 . . . . 0.0 111.936 166.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.42 -78.27 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.643 0.377 . . . . 0.0 111.363 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.5 t -97.52 2.29 49.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.79 1.636 . . . . 0.0 111.64 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.36 162.09 41.34 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.01 165.23 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.773 1.649 . . . . 0.0 111.33 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.06 117.93 8.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.492 HD11 HD22 ' A' ' 40' ' ' LEU 0.294 2.0 pp -114.07 0.31 8.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.835 175.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -35.15 48.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.727 1.149 . . . . 0.0 112.034 171.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.49 4.43 50.46 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.914 1.286 . . . . 0.0 111.974 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . . . -53.2 -35.13 59.55 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.38 67.11 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.748 1.158 . . . . 0.0 114.526 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.99 -45.6 49.01 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.425 1.113 . . . . 0.0 109.535 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.608 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -136.78 160.43 38.87 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.026 2.131 . . . . 0.0 108.236 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.1 m -95.31 169.26 10.2 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.417 0.287 . . . . 0.0 110.645 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -40.09 76.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.093 -174.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -53.24 -53.17 54.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.705 1.202 . . . . 0.0 111.757 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.18 -50.19 73.62 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.181 0.992 . . . . 0.0 109.528 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.1 -51.77 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.29 -55.01 14.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.105 1.362 . . . . 0.0 109.892 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -44.08 97.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.07 -41.92 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.625 -0.672 . . . . 0.0 110.786 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mt -63.5 -50.08 79.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -38.41 90.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.608 0.363 . . . . 0.0 111.5 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -89.38 -59.18 2.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.048 1.739 . . . . 0.0 111.355 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.28 115.92 3.04 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.879 1.704 . . . . 0.0 109.157 -165.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.13 150.31 10.9 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -26.47 -65.64 0.07 OUTLIER Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.826 1.203 . . . . 0.0 115.989 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.59 22.99 21.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.167 0.983 . . . . 0.0 113.67 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.2 ttt -139.23 121.48 10.24 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.822 1.249 . . . . 0.0 110.554 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.58 140.73 58.01 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 N-CA-C 108.825 -1.259 . . . . 0.0 108.825 171.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.98 -172.26 21.8 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.25 12.67 63.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.64 -30.47 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.785 1.234 . . . . 0.0 109.569 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.46 145.88 45.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 168.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -143.02 161.97 36.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.629 0.771 . . . . 0.0 111.122 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.67 -137.59 26.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.99 -37.6 1.4 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.221 1.409 . . . . 0.0 112.343 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -60.67 -59.18 5.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.014 0.526 . . . . 0.0 109.915 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.17 92.98 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.365 -0.835 . . . . 0.0 110.626 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.98 -52.16 61.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 109.735 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.48 -51.31 67.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.118 0.567 . . . . 0.0 110.313 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.2 -60.76 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.449 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.09 -53.46 42.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 118.53 0.604 . . . . 0.0 110.869 -169.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.54 38.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.102 0.477 . . . . 0.0 110.63 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.596 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 56.9 t90 -62.49 -39.3 93.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.657 0.741 . . . . 0.0 112.229 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.596 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -76.24 -34.03 59.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.731 -1.231 . . . . 0.0 109.268 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.37 -54.07 45.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 161.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.2 -8.25 52.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.104 -0.998 . . . . 0.0 112.161 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -24.28 66.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.558 1.143 . . . . 0.0 110.926 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.767 -1.111 . . . . 0.0 113.043 -156.351 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.87 -51.23 58.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.115 -166.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.95 -42.55 94.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.304 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.8 -44.56 86.4 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.931 1.241 . . . . 0.0 111.055 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -48.94 -60.51 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.649 HG21 ' CZ3' ' A' ' 87' ' ' TRP 0.299 89.5 t -65.19 -42.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.678 -167.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -60.37 0.89 0.15 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.556 3.542 . . . . 0.0 113.997 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.75 -20.07 1.02 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -25.22 11.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.993 1.317 . . . . 0.0 110.855 -173.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.0 m -118.86 -41.08 2.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.474 0.579 . . . . 0.0 111.742 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -49.26 -30.06 3.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 122.681 0.392 . . . . 0.0 111.52 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -36.25 -43.55 0.37 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.298 1.839 . . . . 0.0 111.641 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.79 -44.81 2.91 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 110.934 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -69.17 -16.85 63.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.85 154.52 27.39 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.22 -60.42 2.31 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.366 1.46 . . . . 0.0 114.085 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.64 -3.3 43.29 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 48' ' ' ILE . 1.2 mt 68.29 25.6 7.08 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.495 1.518 . . . . 0.0 110.548 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -78.16 -7.6 57.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 129.032 2.933 . . . . 0.0 111.265 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.19 76.99 1.31 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.447 0.567 . . . . 0.0 112.191 164.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.16 -80.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.748 0.419 . . . . 0.0 111.598 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -92.04 2.23 56.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.022 1.729 . . . . 0.0 112.066 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.69 162.27 39.56 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.67 162.3 32.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.796 1.664 . . . . 0.0 111.39 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.48 115.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.091 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.616 HD11 HD22 ' A' ' 40' ' ' LEU . 2.4 pp -105.06 0.5 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.252 172.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -36.69 37.04 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.226 0.921 . . . . 0.0 111.658 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.67 3.55 55.31 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.176 0.991 . . . . 0.0 112.824 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.53 69.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.076 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.59 66.83 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 121.76 2.073 . . . . 0.0 114.073 171.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.36 -45.91 57.75 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.321 -1.105 . . . . 0.0 109.718 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.26 -37.93 63.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.882 0.473 . . . . 0.0 111.547 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.33 160.57 39.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.434 1.894 . . . . 0.0 108.464 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -94.74 166.67 11.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.274 0.559 . . . . 0.0 110.763 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.58 -44.49 36.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.697 1.199 . . . . 0.0 110.718 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.78 -55.86 17.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.444 1.098 . . . . 0.0 112.007 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.99 -51.54 67.38 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.672 1.189 . . . . 0.0 109.412 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -61.24 -50.39 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -50.77 -55.31 17.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.795 1.238 . . . . 0.0 109.742 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.13 -46.11 89.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.039 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mt -58.55 -40.86 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 O-C-N 121.963 -0.46 . . . . 0.0 110.9 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.55 -50.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.25 -37.2 86.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -92.21 -45.19 8.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.88 1.672 . . . . 0.0 111.962 -170.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.81 113.66 3.03 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.32 1.438 . . . . 0.0 110.075 -168.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -55.34 155.52 5.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 159.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -32.56 -64.53 0.26 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.315 1.436 . . . . 0.0 116.114 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.12 2.73 85.56 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 117.951 0.876 . . . . 0.0 113.484 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.6 ttt -103.43 132.26 21.27 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.286 1.434 . . . . 0.0 110.569 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.45 136.33 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.883 1.722 . . . . 0.0 110.163 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.53 148.54 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.41 79.93 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.6 mm -56.26 -33.52 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.712 1.205 . . . . 0.0 110.259 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.75 149.92 49.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -143.34 157.53 44.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.452 0.644 . . . . 0.0 112.357 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.64 -137.05 31.59 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.91 -37.59 1.34 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.306 1.442 . . . . 0.0 112.519 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.15 -60.6 3.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.467 0.707 . . . . 0.0 109.757 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.66 82.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.498 -0.751 . . . . 0.0 110.764 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.6 -49.74 76.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.211 0.605 . . . . 0.0 110.253 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.63 -49.93 66.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 28' ' ' VAL . 64.7 t -51.42 -60.74 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.202 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.36 -55.58 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.13 0.972 . . . . 0.0 110.982 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.32 69.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.649 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 18.7 t90 -63.59 -57.05 11.35 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.194 0.521 . . . . 0.0 111.481 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -57.23 -36.48 70.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.356 -1.465 . . . . 0.0 109.847 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.25 -58.04 10.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 168.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.32 -12.87 61.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.233 -0.917 . . . . 0.0 111.947 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -23.67 66.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.66 -174.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.2 pttt . . . . . 0 C--O 1.251 1.133 0 C-N-CA 127.337 2.255 . . . . 0.0 113.931 -153.654 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.69 -50.41 68.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.604 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.197 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.6 79.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.888 1.222 . . . . 0.0 111.32 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.3 t -47.23 -63.95 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.767 HG13 ' SG ' ' A' ' 32' ' ' CYS . 77.8 t -67.9 -39.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.99 -165.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -56.63 -3.88 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 129.142 2.977 . . . . 0.0 113.297 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.22 -5.52 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -119.47 -27.92 5.45 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.61 1.164 . . . . 0.0 111.464 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.767 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -114.3 -37.81 4.27 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.251 0.621 . . . . 0.0 111.246 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -51.15 -30.75 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.313 0.245 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 m -37.22 -41.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.326 1.45 . . . . 0.0 113.252 170.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -120.2 -40.86 2.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.086 0.554 . . . . 0.0 110.809 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -75.81 -9.1 58.32 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.416 -0.803 . . . . 0.0 113.052 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.58 154.74 12.84 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 118.954 0.797 . . . . 0.0 111.131 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.6 -56.87 4.08 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.197 1.38 . . . . 0.0 113.66 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -81.44 -1.86 47.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.124 0.569 . . . . 0.0 112.199 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.541 HD21 HG12 ' A' ' 28' ' ' VAL . 3.6 mt 70.46 22.67 5.13 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.02 1.728 . . . . 0.0 110.748 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.32 -7.79 58.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.634 2.774 . . . . 0.0 111.665 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.32 100.19 1.78 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.882 0.753 . . . . 0.0 111.613 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.8 -79.25 0.52 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.704 0.752 . . . . 0.0 110.042 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 m -92.4 1.5 57.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.47 160.73 55.84 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.577 1.951 . . . . 0.0 105.783 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.03 164.72 23.92 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.093 1.862 . . . . 0.0 111.421 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.67 14.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.43 ' O ' HD11 ' A' ' 88' ' ' LEU 0.296 2.2 pp -117.28 0.88 8.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.571 173.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -22.92 18.95 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.861 -1.149 . . . . 0.0 112.778 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 1.25 34.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.995 1.318 . . . . 0.0 112.724 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.69 67.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.481 1.037 . . . . 0.0 111.981 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.0 -30.01 74.25 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.354 1.434 . . . . 0.0 113.576 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.64 -46.11 23.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.113 0.957 . . . . 0.0 111.357 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -72.52 -42.78 64.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.69 173.35 8.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.794 1.637 . . . . 0.0 108.003 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 t -104.53 174.46 5.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.002 0.906 . . . . 0.0 112.548 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -44.01 92.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.03 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.9 -50.64 63.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.45 -51.9 66.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 109.91 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.11 -51.67 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.6 tp -49.27 -56.46 9.33 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.67 -49.28 77.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -56.42 -44.03 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.968 0.507 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mt -63.75 -51.47 69.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 O-C-N 121.776 -0.578 . . . . 0.0 109.908 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.82 -25.27 67.14 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.283 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.4 -62.31 1.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.359 1.864 . . . . 0.0 111.311 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.62 105.68 2.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.687 1.613 . . . . 0.0 110.64 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -57.07 154.07 10.45 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 161.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.76 -62.79 0.65 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.983 1.277 . . . . 0.0 115.191 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.77 22.17 22.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.83 0.815 . . . . 0.0 113.485 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -126.87 132.98 24.55 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 108.408 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.38 -35.88 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.131 1.887 . . . . 0.0 112.393 -171.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.91 161.71 26.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 121.854 0.697 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.06 26.59 61.27 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 122.367 -0.49 . . . . 0.0 111.99 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.2 mt -66.14 -30.47 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.24 1.016 . . . . 0.0 109.533 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.68 145.57 36.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -145.55 156.09 43.48 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.264 0.938 . . . . 0.0 112.593 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.4 -143.66 48.67 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.47 -37.45 1.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.04 1.736 . . . . 0.0 112.455 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -53.96 -64.17 0.91 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.014 1.326 . . . . 0.0 110.208 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.04 92.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.576 -0.702 . . . . 0.0 110.313 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -52.26 -51.78 56.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.436 0.636 . . . . 0.0 109.362 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.4 81.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.767 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.31 -57.78 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-N 118.429 0.559 . . . . 0.0 110.186 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.75 -56.23 13.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.734 0.814 . . . . 0.0 110.784 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.4 -53.34 59.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.663 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.505 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 58.3 t90 -54.52 -54.19 44.42 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.816 0.446 . . . . 0.0 110.899 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.505 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -57.71 -45.7 85.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.179 -0.951 . . . . 0.0 110.316 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.04 65.96 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -88.69 -22.42 23.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.68 1.592 . . . . 0.0 110.829 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -28.44 66.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.412 -0.805 . . . . 0.0 110.064 -164.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 pttt . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.887 1.275 . . . . 0.0 111.763 -146.189 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.84 -53.27 26.63 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.325 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.741 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.59 67.73 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.511 1.05 . . . . 0.0 110.171 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -51.68 -57.42 3.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.503 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 2.3 t -77.55 -1.36 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.128 -174.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 -99.89 1.64 43.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.787 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.27 -26.61 0.76 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -106.01 -14.52 15.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.709 1.204 . . . . 0.0 111.618 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 6.8 m -122.36 -41.49 2.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.845 0.858 . . . . 0.0 111.247 -168.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 28' ' ' VAL . 31.0 pt -49.03 -31.11 3.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -40.27 -39.8 1.02 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.907 1.683 . . . . 0.0 111.461 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.9 m -117.24 -42.15 2.93 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 122.7 0.4 . . . . 0.0 111.088 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -72.15 -15.67 61.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.07 155.03 30.53 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.97 -56.31 4.52 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.162 1.363 . . . . 0.0 113.111 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -82.87 0.66 43.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.775 0.83 . . . . 0.0 112.399 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 48' ' ' ILE . 5.3 mt 64.91 23.96 12.66 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.155 1.382 . . . . 0.0 111.559 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -80.86 -6.05 58.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 128.557 2.743 . . . . 0.0 111.662 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.67 76.82 1.32 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 118.442 0.565 . . . . 0.0 111.91 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 -75.81 0.23 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.393 . . . . 0.0 111.462 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -96.83 1.7 50.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.168 1.787 . . . . 0.0 111.045 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.41 32.96 Favored Pre-proline 0 N--CA 1.452 -0.355 0 C-N-CA 127.081 2.152 . . . . 0.0 105.296 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.97 162.31 26.32 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.574 1.516 . . . . 0.0 110.848 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.72 125.11 23.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.489 ' O ' HD11 ' A' ' 88' ' ' LEU 0.274 2.2 pp -119.72 -3.22 9.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.46 174.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -38.64 -45.8 1.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.817 1.19 . . . . 0.0 111.913 164.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 2.56 51.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.557 1.543 . . . . 0.0 111.992 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.59 -28.71 56.63 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.274 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.06 73.42 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.279 0.945 . . . . 0.0 114.079 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -44.23 32.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.678 0.739 . . . . 0.0 109.483 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -74.61 -43.98 52.85 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.47 164.31 21.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.199 2.2 . . . . 0.0 108.523 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -99.3 163.92 12.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.177 0.591 . . . . 0.0 111.284 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -47.91 -48.05 31.87 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 110.441 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -48.16 -48.53 34.27 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.076 0.95 . . . . 0.0 112.268 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.06 -52.7 46.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.522 0.729 . . . . 0.0 109.679 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.9 mt -59.93 -47.12 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.4 tp -48.18 -56.3 8.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.482 1.513 . . . . 0.0 110.174 172.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.4 -50.03 68.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.33 -44.22 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 25.8 mt -63.39 -46.02 96.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 120.433 -1.417 . . . . 0.0 110.08 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.79 -37.26 81.79 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.915 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -93.4 -36.67 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.985 2.114 . . . . 0.0 112.249 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.62 -178.75 27.63 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.955 1.74 . . . . 0.0 110.06 -163.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -137.76 164.27 29.29 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.81 -69.89 0.09 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.738 1.637 . . . . 0.0 114.868 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 31.62 6.02 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.02 0.91 . . . . 0.0 113.348 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.2 ttt -139.6 121.17 9.78 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.652 1.181 . . . . 0.0 111.564 -174.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.36 157.87 55.62 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.03 1.82 . . . . 0.0 110.424 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 148.3 18.7 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -172.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.58 16.3 66.45 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.769 -0.461 . . . . 0.0 112.373 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.62 -41.22 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.911 0.884 . . . . 0.0 108.973 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB3' ' CG2' ' A' ' 64' ' ' ILE . . . -128.89 143.23 50.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -140.68 158.72 43.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 0.0 108.83 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.98 -139.22 29.17 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.07 1.55 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.549 1.54 . . . . 0.0 112.384 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -59.02 6.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.134 0.574 . . . . 0.0 109.541 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.45 85.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.38 -52.65 64.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.265 0.626 . . . . 0.0 110.402 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.86 69.61 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 109.522 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG22 ' CG2' ' A' ' 28' ' ' VAL . 53.2 t -48.4 -63.24 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 O-C-N 123.388 0.43 . . . . 0.0 109.877 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.8 51.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.21 1.004 . . . . 0.0 111.085 -171.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.23 37.63 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.425 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 60.6 t90 -57.74 -38.46 75.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.183 0.593 . . . . 0.0 111.564 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.489 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -72.42 -45.35 60.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.559 0.744 . . . . 0.0 109.469 -178.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.07 -33.07 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.733 0.813 . . . . 0.0 111.264 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -21.81 60.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.851 0.86 . . . . 0.0 110.904 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -66.93 8.75 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -161.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 pttt . . . . . 0 C--O 1.247 0.962 0 O-C-N 120.9 -1.125 . . . . 0.0 112.969 -131.731 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.31 -49.73 42.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.936 -168.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.74 -45.74 93.13 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.556 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -44.91 82.46 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.482 1.037 . . . . 0.0 110.808 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.91 -62.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.668 HG13 ' SG ' ' A' ' 32' ' ' CYS . 72.1 t -66.69 -39.33 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.203 -168.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -59.08 0.26 0.1 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 129.141 2.976 . . . . 0.0 113.502 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 -15.43 1.57 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.08 -20.98 11.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.818 1.247 . . . . 0.0 111.503 -171.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.668 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.8 m -118.73 -40.98 2.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.989 0.813 . . . . 0.0 112.123 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.7 pt -50.7 -29.85 7.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 111.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -41.27 -39.15 1.3 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.949 1.699 . . . . 0.0 113.048 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -116.66 -43.31 2.91 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.33 0.652 . . . . 0.0 110.575 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.42 -12.94 60.98 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.88 153.28 25.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.11 -53.69 6.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.88 1.229 . . . . 0.0 113.111 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -81.79 -1.53 47.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.27 0.628 . . . . 0.0 112.205 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.46 HD21 HG12 ' A' ' 28' ' ' VAL . 5.6 mt 66.38 21.79 10.86 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.631 1.572 . . . . 0.0 111.26 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -78.98 -6.76 57.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.312 2.645 . . . . 0.0 111.572 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.56 82.92 1.65 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.461 0.573 . . . . 0.0 111.738 168.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.24 -77.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.768 0.427 . . . . 0.0 110.965 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -97.17 2.58 51.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.695 1.598 . . . . 0.0 111.58 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.0 161.28 46.26 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.98 163.19 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.73 1.62 . . . . 0.0 111.163 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 123.08 18.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.288 2.2 pp -119.04 -1.12 8.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.194 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -38.46 -45.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.574 1.079 . . . . 0.0 112.567 163.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.68 2.98 44.88 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.25 1.82 . . . . 0.0 112.59 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.14 -30.53 16.85 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.787 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.96 -30.29 76.75 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.12 0.873 . . . . 0.0 114.806 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.61 -44.15 44.42 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.663 -0.904 . . . . 0.0 109.374 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -73.36 -36.81 66.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.63 157.83 45.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 m -90.61 165.66 13.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.546 0.738 . . . . 0.0 111.806 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -46.72 63.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.474 0.71 . . . . 0.0 110.488 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -49.86 -49.03 50.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.053 . . . . 0.0 111.694 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.75 -49.72 71.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.467 0.651 . . . . 0.0 109.639 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.42 -48.05 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.3 tp -48.63 -53.51 18.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.653 1.181 . . . . 0.0 109.64 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.81 0.63 6.77 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.615 0.766 . . . . 0.0 113.037 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -104.35 -39.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 120.91 -1.119 . . . . 0.0 109.441 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 mt -66.24 -50.58 67.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.133 -0.98 . . . . 0.0 109.961 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.4 -39.8 94.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.469 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.38 -48.56 7.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.087 0.955 . . . . 0.0 112.373 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.12 107.99 3.06 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.641 1.591 . . . . 0.0 109.723 -167.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.48 149.52 16.95 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 163.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -19.18 -71.13 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 C-N-CA 126.286 1.898 . . . . 0.0 116.965 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.03 73.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 117.946 0.873 . . . . 0.0 113.793 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.8 ttt -87.99 127.49 57.44 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 126.095 1.758 . . . . 0.0 109.483 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.12 143.39 84.13 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 N-CA-C 109.237 -1.101 . . . . 0.0 109.237 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.45 166.97 28.39 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.52 18.05 75.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.922 -0.639 . . . . 0.0 112.307 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -54.66 -36.02 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.55 1.14 . . . . 0.0 109.967 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.28 146.38 38.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -143.0 154.76 44.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.395 1.078 . . . . 0.0 110.772 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.58 -136.36 49.59 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.53 -38.63 6.53 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.599 1.16 . . . . 0.0 111.978 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -51.9 -62.13 1.82 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.797 0.839 . . . . 0.0 109.348 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.89 71.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.019 0.527 . . . . 0.0 110.904 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.32 -51.05 71.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 0.0 109.928 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -50.18 71.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.759 -0.638 . . . . 0.0 109.362 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.85 -61.76 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.986 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.1 -54.15 14.18 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 111.195 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -54.63 44.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 110.873 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.578 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 59.3 t90 -57.85 -41.1 81.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 111.749 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.447 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.55 -45.12 66.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 108.938 -177.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.58 -31.96 68.5 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.432 0.693 . . . . 0.0 112.125 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -21.18 60.95 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 110.701 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -68.82 7.67 0.64 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -158.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.5 pttt . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.478 -1.249 . . . . 0.0 113.075 -128.465 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.2 m-20 . . . . . 0 N--CA 1.438 -1.028 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB1' ' CB ' ' A' ' 87' ' ' TRP . . . -101.51 -69.86 0.76 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.78 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -58.51 -41.38 85.29 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.421 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -57.17 -39.15 74.71 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.673 0.67 . . . . 0.0 111.303 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.82 -55.87 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.606 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 3.5 t -66.32 -41.05 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 117.015 -1.874 . . . . 0.0 110.615 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -59.92 0.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 129.844 3.258 . . . . 0.0 114.761 169.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.47 -15.51 0.95 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.6 -23.56 11.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.09 1.356 . . . . 0.0 110.519 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -122.82 -39.09 2.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.018 0.527 . . . . 0.0 111.615 -165.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -49.11 -30.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 C-N-CA 122.797 0.439 . . . . 0.0 111.647 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 m -38.46 -39.67 0.48 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.864 1.665 . . . . 0.0 113.068 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.85 -43.97 2.64 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.943 0.497 . . . . 0.0 110.519 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.93 -16.24 63.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 113.017 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.69 153.44 26.9 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.8 -59.12 2.48 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.189 1.376 . . . . 0.0 113.13 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.98 -2.19 38.98 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.188 0.995 . . . . 0.0 112.378 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD21 HG12 ' A' ' 28' ' ' VAL . 1.7 mt 65.33 24.15 12.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.026 1.73 . . . . 0.0 111.631 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -78.54 -8.33 58.46 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.765 2.826 . . . . 0.0 111.449 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.24 76.51 1.26 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-N 118.408 0.549 . . . . 0.0 111.984 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.59 -82.53 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.792 0.437 . . . . 0.0 111.443 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.72 1.46 56.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.699 1.999 . . . . 0.0 111.97 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.05 162.93 35.55 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.3 165.63 21.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.813 1.676 . . . . 0.0 111.148 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.45 117.2 7.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 40' ' ' LEU 0.265 2.2 pp -114.55 -3.78 11.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.207 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -38.23 -48.27 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.504 1.047 . . . . 0.0 111.996 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -99.95 5.55 45.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.395 1.878 . . . . 0.0 112.08 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -46.96 -44.46 20.05 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.918 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.49 -29.1 16.62 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.964 0.802 . . . . 0.0 114.839 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.08 68.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.413 -1.051 . . . . 0.0 110.497 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.77 -44.0 12.87 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.24 0.616 . . . . 0.0 110.816 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.25 154.85 38.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.817 2.047 . . . . 0.0 107.701 -171.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -95.44 169.82 9.79 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.736 0.415 . . . . 0.0 110.75 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -43.0 64.58 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.713 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -48.74 -52.71 22.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 111.863 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.57 -53.91 50.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.841 0.856 . . . . 0.0 109.684 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.01 -46.97 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -171.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.1 tp -47.31 -56.33 7.04 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.013 1.725 . . . . 0.0 109.95 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.07 -48.4 76.15 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -46.94 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.64 -47.84 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.965 -1.084 . . . . 0.0 109.917 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.5 -27.04 64.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.47 0.708 . . . . 0.0 112.852 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.42 -60.77 1.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.039 -171.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.83 -167.13 24.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.191 2.329 . . . . 0.0 109.469 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -157.97 163.89 37.36 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -15.81 -83.78 0.01 OUTLIER Glycine 0 CA--C 1.542 1.73 0 C-N-CA 126.005 1.764 . . . . 0.0 116.303 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.39 18.82 56.21 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.818 1.309 . . . . 0.0 113.566 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -103.81 127.71 28.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.01 1.324 . . . . 0.0 109.168 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.1 -40.98 24.13 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.569 2.179 . . . . 0.0 112.13 -172.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 161.67 23.09 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 121.851 0.695 . . . . 0.0 111.732 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.61 22.17 65.7 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 122.178 -0.601 . . . . 0.0 111.827 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.46 -29.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.448 1.499 . . . . 0.0 109.835 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.47 143.12 29.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -138.3 166.5 24.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.48 -135.09 41.78 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.9 -36.83 8.01 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.675 1.19 . . . . 0.0 112.027 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -60.63 -55.91 27.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.97 84.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.637 -0.664 . . . . 0.0 111.22 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.69 -54.14 49.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.305 0.502 . . . . 0.0 110.999 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.04 -51.19 62.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.8 t -50.03 -64.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.308 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.61 -51.87 25.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.495 1.118 . . . . 0.0 111.148 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -55.26 34.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 110.77 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 66.3 t90 -59.36 -39.59 83.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.006 0.432 . . . . 0.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -68.95 -41.65 77.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 -178.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.98 -39.08 73.98 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 122.129 -0.357 . . . . 0.0 110.522 168.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.14 -19.05 61.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.99 0.516 . . . . 0.0 111.28 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.71 9.08 0.94 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.953 1.701 . . . . 0.0 114.649 -171.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 C--O 1.25 1.12 0 O-C-N 120.635 -1.29 . . . . 0.0 112.73 -154.428 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.442 -0.835 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.23 -53.05 60.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.555 -167.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.18 -43.59 98.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.088 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.32 78.13 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.168 0.895 . . . . 0.0 111.326 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -46.25 -63.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.732 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 80.2 t -67.97 -37.78 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 117.352 -1.739 . . . . 0.0 112.52 -166.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -60.1 -1.02 0.26 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.203 3.001 . . . . 0.0 113.179 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 -9.67 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 169.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -118.72 -25.19 6.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.188 1.395 . . . . 0.0 112.04 -171.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -117.21 -40.96 3.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.418 0.554 . . . . 0.0 110.499 -172.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -48.33 -32.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 122.942 0.497 . . . . 0.0 111.612 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -38.64 -37.38 0.32 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 113.206 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -120.08 -41.72 2.63 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.786 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.16 -6.33 49.04 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.66 -86.72 0.41 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.408 1.004 . . . . 0.0 112.788 163.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.53 -62.93 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.35 2.59 39.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 111.764 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.85 26.87 7.51 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.31 1.844 . . . . 0.0 111.505 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -72.83 -10.87 60.29 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.43 1.892 . . . . 0.0 111.721 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 104.14 1.8 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.4 -77.11 0.6 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.535 0.734 . . . . 0.0 110.01 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -92.26 2.1 56.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.922 1.289 . . . . 0.0 111.646 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.83 158.61 52.61 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -63.98 164.57 21.63 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.153 1.902 . . . . 0.0 111.105 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.24 123.72 18.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.631 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.415 ' O ' HD11 ' A' ' 88' ' ' LEU 0.253 2.5 pp -119.79 -2.42 8.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.322 -0.847 . . . . 0.0 112.266 172.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -42.06 -44.85 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.133 1.333 . . . . 0.0 111.594 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.68 4.14 45.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.608 1.563 . . . . 0.0 112.195 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.4 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -48.9 -36.97 18.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.358 176.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.07 -34.34 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 120.86 1.664 . . . . 0.0 114.379 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -53.27 32.04 Favored 'General case' 0 C--N 1.337 0.056 0 O-C-N 121.446 -1.032 . . . . 0.0 110.276 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -74.31 -37.02 63.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.474 -169.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -132.01 151.53 51.69 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.831 1.652 . . . . 0.0 107.822 -171.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.34 166.95 12.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.665 0.745 . . . . 0.0 110.899 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.37 -47.83 26.02 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.026 1.331 . . . . 0.0 110.498 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.94 -46.34 68.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.853 0.751 . . . . 0.0 111.764 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.99 -53.68 42.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.511 0.724 . . . . 0.0 109.27 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 64' ' ' ILE . 69.6 mt -60.07 -47.6 91.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.0 tp -49.85 -54.47 19.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.13 1.372 . . . . 0.0 110.322 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.38 -49.66 71.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -46.46 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 60' ' ' ILE . 32.1 mt -58.95 -48.84 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 121.245 -0.909 . . . . 0.0 109.635 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.75 -32.63 73.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.485 0.714 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -101.78 -61.55 1.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.015 1.726 . . . . 0.0 111.481 -169.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.09 -173.36 22.71 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 126.776 2.131 . . . . 0.0 110.388 -171.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.92 163.94 38.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 168.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -17.83 -81.97 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.178 1.847 . . . . 0.0 116.102 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.13 25.71 24.35 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.858 1.329 . . . . 0.0 113.441 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -112.46 126.77 27.81 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.948 1.299 . . . . 0.0 108.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.93 -40.88 49.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.101 2.534 . . . . 0.0 112.381 -172.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.67 161.47 25.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-O 121.958 0.755 . . . . 0.0 111.869 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.63 62.12 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.09 -35.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.437 0.695 . . . . 0.0 109.344 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.5 52.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -145.05 152.24 39.8 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.925 0.869 . . . . 0.0 113.233 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.94 -138.86 47.97 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.76 -34.26 11.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.706 1.203 . . . . 0.0 112.034 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.23 -57.01 13.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.086 0.954 . . . . 0.0 109.906 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.77 -39.58 80.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.837 -0.539 . . . . 0.0 110.266 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -55.73 -53.38 57.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.909 0.322 . . . . 0.0 110.151 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.79 39.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.466 0.706 . . . . 0.0 109.643 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.24 -65.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 O-C-N 123.433 0.458 . . . . 0.0 110.21 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.86 -48.85 66.8 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.793 0.837 . . . . 0.0 111.235 -170.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.74 30.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.755 0.422 . . . . 0.0 110.337 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.732 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 31.9 t90 -54.9 -41.8 71.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.362 0.665 . . . . 0.0 111.247 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.88 -49.32 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.821 0.848 . . . . 0.0 110.366 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.07 69.22 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.522 0.729 . . . . 0.0 110.875 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.49 -23.21 60.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.427 1.091 . . . . 0.0 110.985 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -32.17 73.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.263 -0.898 . . . . 0.0 110.472 -166.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.989 1.716 . . . . 0.0 114.502 -145.446 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.64 -49.78 14.02 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.129 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -63.11 -44.03 96.78 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.928 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.43 75.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 120.002 1.273 . . . . 0.0 111.183 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -55.0 -63.52 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.769 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 25.6 t -65.32 -42.61 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.683 -164.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -3.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.025 2.93 . . . . 0.0 112.726 170.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.59 0.55 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mmtt -126.89 -30.51 2.73 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.114 0.966 . . . . 0.0 111.878 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.5 m -110.23 -38.47 5.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.76 0.709 . . . . 0.0 110.687 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.0 pt -51.55 -30.15 10.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -38.66 -39.22 0.47 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.396 1.878 . . . . 0.0 113.154 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -123.02 -38.8 2.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 110.993 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.16 -9.68 59.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.18 155.87 17.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.94 -57.02 3.63 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.257 1.408 . . . . 0.0 113.498 -174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.03 1.29 44.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 112.518 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt 68.42 21.36 8.28 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.051 1.341 . . . . 0.0 111.363 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -6.59 53.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.972 2.509 . . . . 0.0 111.654 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 113.51 2.34 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.64 -77.15 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.771 0.786 . . . . 0.0 109.449 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 m -93.08 1.85 57.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.938 1.295 . . . . 0.0 111.477 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.89 159.23 57.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 127.038 2.135 . . . . 0.0 105.591 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.0 164.66 21.36 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.08 1.854 . . . . 0.0 111.263 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 120.04 11.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.273 2.2 pp -115.14 -0.4 9.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-O 118.272 -0.871 . . . . 0.0 112.063 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -46.23 -41.26 12.65 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.46 1.027 . . . . 0.0 112.157 170.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.93 4.05 51.77 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.329 1.452 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -25.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.598 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.31 -33.03 76.79 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.901 1.228 . . . . 0.0 113.997 171.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.93 -43.21 59.05 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.624 -0.927 . . . . 0.0 109.646 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -74.36 -44.17 53.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.066 0.547 . . . . 0.0 111.109 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.49 164.43 23.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.707 2.003 . . . . 0.0 108.486 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.22 168.49 10.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.521 0.729 . . . . 0.0 111.6 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -44.0 73.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.34 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.158 0.983 . . . . 0.0 112.236 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.88 -49.21 78.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 64' ' ' ILE . 74.2 mt -63.53 -49.87 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -175.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.0 tp -47.39 -57.52 5.2 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.495 1.518 . . . . 0.0 110.121 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.5 -45.17 92.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.2 mt -59.63 -43.17 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.646 -0.659 . . . . 0.0 111.0 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 60' ' ' ILE . 31.0 mt -59.69 -48.4 87.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 O-C-N 120.941 -1.099 . . . . 0.0 109.449 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 mt -65.82 -34.8 79.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.327 0.651 . . . . 0.0 112.21 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -102.97 -53.79 2.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.572 1.549 . . . . 0.0 112.356 -167.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -171.72 20.23 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.411 1.958 . . . . 0.0 110.269 -170.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -166.08 135.83 3.31 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.02 -110.75 0.15 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 120.333 1.424 . . . . 0.0 113.465 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.85 -9.2 68.52 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.157 0.979 . . . . 0.0 114.232 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -63.18 127.52 91.08 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 118.498 1.149 . . . . 0.0 109.122 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -63.79 -37.84 42.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.14 2.56 . . . . 0.0 111.817 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.48 165.41 32.69 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-O 121.987 0.771 . . . . 0.0 111.668 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.24 68.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -65.13 -32.62 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.069 0.948 . . . . 0.0 110.192 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.37 150.41 51.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -144.11 153.26 41.96 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.217 0.917 . . . . 0.0 113.359 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.76 -142.21 47.31 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.6 -36.91 1.52 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.614 1.565 . . . . 0.0 112.437 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -54.27 -61.99 1.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.426 1.09 . . . . 0.0 110.04 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.88 -38.82 87.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.711 -0.618 . . . . 0.0 110.487 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.94 -50.62 72.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 109.851 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.08 73.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.559 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.84 -57.82 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.347 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.14 -54.36 13.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.4 1.08 . . . . 0.0 111.224 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.85 71.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.955 0.407 . . . . 0.0 110.707 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.769 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 64.3 t90 -62.84 -27.24 69.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.578 1.151 . . . . 0.0 112.809 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.607 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -84.73 -43.33 14.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 176.139 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.12 -42.88 73.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.721 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -5.6 41.35 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.27 0.941 . . . . 0.0 112.22 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.0 6.9 1.35 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -163.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.989 -124.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.443 -0.8 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.94 -51.86 9.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.063 0.945 . . . . 0.0 111.916 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -62.73 -43.95 97.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.603 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.89 82.42 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 119.156 0.889 . . . . 0.0 110.858 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -49.99 -61.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 40.4 t -63.67 -41.99 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 116.803 -1.959 . . . . 0.0 112.697 -170.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -63.18 1.23 0.5 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.411 3.084 . . . . 0.0 113.628 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -134.92 -22.63 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -112.29 -20.42 11.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.719 1.608 . . . . 0.0 111.577 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -121.76 -42.65 2.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.463 0.574 . . . . 0.0 111.25 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.1 pt -48.78 -32.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.696 0.398 . . . . 0.0 111.609 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.24 -36.88 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.067 1.747 . . . . 0.0 113.384 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.0 -42.38 2.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.272 0.629 . . . . 0.0 110.837 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.79 -7.95 54.95 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.41 -84.45 0.37 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.409 1.004 . . . . 0.0 112.813 163.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.25 -64.36 0.02 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.97 3.58 37.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.9 0.88 . . . . 0.0 111.866 173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 67.61 28.1 7.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.583 1.553 . . . . 0.0 111.576 -175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -73.62 -13.07 60.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.036 2.135 . . . . 0.0 111.075 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.38 98.64 1.62 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 172.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.56 -77.47 0.56 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.473 0.709 . . . . 0.0 110.157 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -90.71 1.42 56.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.603 1.161 . . . . 0.0 111.542 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.91 160.2 44.34 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.726 2.011 . . . . 0.0 105.686 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -64.2 164.52 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.25 1.967 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.62 25.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.227 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 88' ' ' LEU 0.274 2.8 pp -119.78 -1.06 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 122.76 0.424 . . . . 0.0 112.131 176.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -35.39 64.11 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.009 -1.057 . . . . 0.0 111.426 167.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 4.07 51.91 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.486 1.514 . . . . 0.0 111.677 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.36 -53.87 12.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.92 9.22 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 115.156 0.822 . . . . 0.0 115.156 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.35 -29.65 28.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.023 0.912 . . . . 0.0 110.971 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -92.76 -51.95 4.85 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 124.036 0.934 . . . . 0.0 110.113 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.46 146.13 40.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.518 2.327 . . . . 0.0 108.276 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.4 m -86.87 164.16 16.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.256 0.48 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -45.52 58.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.898 0.479 . . . . 0.0 110.008 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -47.01 -53.31 12.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.371 1.468 . . . . 0.0 112.512 173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.39 -48.6 77.21 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.687 0.795 . . . . 0.0 110.175 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 64' ' ' ILE . 67.1 mt -63.05 -46.73 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -49.85 -55.29 14.84 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.084 1.753 . . . . 0.0 109.786 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.86 73.55 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.89 -37.15 77.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 121.307 -0.87 . . . . 0.0 111.62 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 21.8 mt -65.47 -44.87 94.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.501 -1.374 . . . . 0.0 109.819 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -68.74 -41.42 78.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.081 0.552 . . . . 0.0 111.594 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -91.28 -37.29 13.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.713 1.605 . . . . 0.0 111.62 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.8 -167.17 18.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.308 1.433 . . . . 0.0 110.139 -166.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -149.69 163.03 39.04 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -31.33 -66.66 0.16 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.641 1.591 . . . . 0.0 114.754 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.25 32.35 6.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.708 0.67 . . . . 0.0 113.266 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.7 ttt -139.4 128.76 14.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.399 1.079 . . . . 0.0 111.594 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.2 155.44 68.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.399 2.066 . . . . 0.0 111.312 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.25 142.67 15.57 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.34 24.95 60.08 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.877 0.751 . . . . 0.0 111.432 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.3 mt -51.83 -44.38 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 108.971 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' A' ' 80' ' ' GLU . . . -134.47 140.19 46.04 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.5 2.32 . . . . 0.0 105.302 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -147.25 153.71 40.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 109.189 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.78 -133.89 51.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.86 -46.89 11.03 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.436 1.095 . . . . 0.0 111.804 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.75 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 35.7 mp0 -52.42 -61.4 2.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.898 0.772 . . . . 0.0 110.432 175.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.42 97.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.911 -0.493 . . . . 0.0 110.839 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.46 -58.93 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.197 0.999 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.21 -53.55 49.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.725 1.21 . . . . 0.0 109.618 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -50.38 -61.9 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.045 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.34 -51.66 57.61 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.572 0.749 . . . . 0.0 110.571 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.91 63.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 110.798 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.604 ' CE3' HD12 ' A' ' 88' ' ' LEU . 72.2 t90 -61.86 -31.96 72.28 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.093 0.557 . . . . 0.0 111.665 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.604 HD12 ' CE3' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -75.76 -43.74 45.1 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.032 -1.043 . . . . 0.0 110.166 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.21 -37.71 62.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.599 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.4 -8.5 59.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.165 1.348 . . . . 0.0 113.443 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.472 ' CA ' ' HE2' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -73.21 5.24 3.67 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.053 2.141 . . . . 0.0 116.204 -170.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 pttp . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.534 -1.222 . . . . 0.0 111.192 -126.373 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -52.64 11.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 112.962 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.28 -46.55 89.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.315 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.52 78.56 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.093 0.86 . . . . 0.0 111.218 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.2 -61.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 170.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.888 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 81.9 t -68.92 -40.16 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 120.854 -1.154 . . . . 0.0 112.293 -167.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -58.06 0.61 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 129.136 2.974 . . . . 0.0 113.003 167.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.65 -12.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 13.5 mttt -122.59 -19.09 6.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.708 1.203 . . . . 0.0 112.101 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -116.93 -41.59 3.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.42 1.009 . . . . 0.0 111.699 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -48.83 -32.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 122.47 0.308 . . . . 0.0 111.43 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -36.09 -38.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.22 2.208 . . . . 0.0 113.464 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -117.52 -42.31 2.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.617 0.767 . . . . 0.0 110.699 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -74.25 -8.35 55.93 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.67 -90.38 0.43 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.577 1.084 . . . . 0.0 112.751 164.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.1 -58.67 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.59 3.42 47.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.802 0.841 . . . . 0.0 111.367 172.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 65.68 27.59 11.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.741 1.617 . . . . 0.0 111.149 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -78.38 -5.22 51.64 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.727 2.411 . . . . 0.0 111.667 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 92.47 1.57 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.713 0.688 . . . . 0.0 111.599 166.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.31 -79.78 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.38 0.672 . . . . 0.0 110.617 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.9 t -90.81 1.64 56.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.278 1.031 . . . . 0.0 111.25 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.86 160.13 44.74 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.49 161.47 27.67 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.018 1.812 . . . . 0.0 111.198 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.61 116.7 8.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.989 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.7 pp -106.58 -6.81 10.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.053 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -43.85 -50.87 7.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.779 1.172 . . . . 0.0 111.036 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 1.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.534 -0.728 . . . . 0.0 112.103 -175.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -52.96 -40.45 63.69 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.049 -171.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.67 -26.28 24.18 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 119.028 0.831 . . . . 0.0 114.045 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -45.3 62.13 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.31 -1.112 . . . . 0.0 110.264 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -80.82 -43.13 20.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.165 0.986 . . . . 0.0 111.099 -171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.61 158.96 37.86 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.959 2.103 . . . . 0.0 107.647 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -100.75 171.9 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.249 0.477 . . . . 0.0 112.028 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -40.57 75.11 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.47 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -53.34 -49.79 66.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.507 1.048 . . . . 0.0 111.429 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.56 -48.23 78.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.52 0.728 . . . . 0.0 110.029 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 64' ' ' ILE . 82.2 mt -64.33 -47.58 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -49.24 -57.24 7.12 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.667 1.587 . . . . 0.0 110.365 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -46.28 82.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.97 -43.7 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.526 -0.734 . . . . 0.0 111.268 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 60' ' ' ILE . 30.9 mt -60.18 -47.4 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.104 -0.997 . . . . 0.0 109.536 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.36 -42.59 92.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -91.28 -51.8 5.12 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.368 1.467 . . . . 0.0 111.473 -166.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -166.94 17.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -164.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.79 167.21 28.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 175.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.63 72.32 0.02 OUTLIER Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.84 1.2 . . . . 0.0 113.118 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.11 -15.6 3.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.374 1.94 . . . . 0.0 112.585 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.7 ttt -112.37 132.14 22.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.776 1.288 . . . . 0.0 108.459 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.93 -38.09 7.89 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.224 2.616 . . . . 0.0 113.528 -169.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.44 173.18 48.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-O 122.003 0.78 . . . . 0.0 112.218 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 -1.73 62.3 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.267 0.937 . . . . 0.0 112.629 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.09 -31.61 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.171 2.188 . . . . 0.0 111.036 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.87 139.65 38.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -141.79 155.17 45.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.468 1.507 . . . . 0.0 108.675 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.56 -136.49 43.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.15 -41.53 3.74 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.036 1.334 . . . . 0.0 111.796 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.92 -64.12 0.92 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.516 0.726 . . . . 0.0 109.377 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.94 96.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.995 -0.44 . . . . 0.0 110.918 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.06 -58.02 9.67 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.822 0.849 . . . . 0.0 110.077 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.41 -50.91 66.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.128 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 28' ' ' VAL . 61.3 t -49.15 -63.03 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 123.577 0.548 . . . . 0.0 110.365 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.19 62.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.159 0.984 . . . . 0.0 111.095 -171.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.06 -55.52 33.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.279 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.888 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 35.4 t90 -52.31 -39.41 60.54 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.361 0.664 . . . . 0.0 110.771 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.859 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.35 -41.52 73.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -27.92 62.91 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.142 -0.349 . . . . 0.0 110.877 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -88.82 -12.36 42.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.041 0.937 . . . . 0.0 112.977 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -83.35 -0.56 50.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 110.45 -174.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 O-C-N 119.867 -1.771 . . . . 0.0 112.407 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.56 -50.89 40.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.081 0.952 . . . . 0.0 112.485 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.37 -41.42 93.7 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.537 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.02 94.54 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.93 1.241 . . . . 0.0 111.216 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.9 -63.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 166.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.82 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 85.8 t -63.79 -41.27 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.517 -166.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -60.48 -1.98 0.44 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.227 3.011 . . . . 0.0 112.89 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -11.62 2.26 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 168.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -119.74 -23.86 6.36 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.87 1.268 . . . . 0.0 112.793 -169.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.677 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.1 m -122.47 -41.32 2.4 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.812 0.733 . . . . 0.0 111.589 -172.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.3 pt -50.39 -30.04 7.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 122.408 0.283 . . . . 0.0 111.066 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -35.93 -41.06 0.22 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.57 2.348 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.44 -40.37 2.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.295 0.638 . . . . 0.0 110.848 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -78.14 -8.73 58.64 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.33 157.96 16.31 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.148 0.886 . . . . 0.0 112.038 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -36.34 -62.12 0.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.337 1.922 . . . . 0.0 115.952 -168.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -92.86 4.62 53.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.424 1.112 . . . . 0.0 111.988 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 77.39 28.29 0.6 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.671 1.988 . . . . 0.0 110.953 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.2 -10.7 59.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.234 2.214 . . . . 0.0 112.505 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.39 100.26 1.52 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.958 0.79 . . . . 0.0 111.562 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.56 -76.75 0.58 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.732 0.766 . . . . 0.0 110.188 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -94.86 2.24 55.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 111.654 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.02 160.97 50.81 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 127.121 2.169 . . . . 0.0 105.238 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.74 165.03 24.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.903 1.735 . . . . 0.0 111.103 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 115.7 4.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.4 pp -112.56 -0.96 9.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.492 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -44.48 -45.73 9.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.672 1.124 . . . . 0.0 112.049 168.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -90.65 3.84 53.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.249 1.42 . . . . 0.0 111.156 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.15 -31.58 65.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.774 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.76 -30.23 76.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 120.518 1.508 . . . . 0.0 113.195 170.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.44 54.38 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.016 -1.285 . . . . 0.0 110.487 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -74.21 -38.6 63.52 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.286 0.234 . . . . 0.0 111.302 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -135.31 175.64 9.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.253 2.221 . . . . 0.0 108.033 -172.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -112.18 167.74 10.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.247 0.619 . . . . 0.0 110.483 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -50.57 -41.28 54.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 111.531 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -57.01 -51.69 68.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.176 1.353 . . . . 0.0 111.959 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.34 -51.22 69.07 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.141 0.976 . . . . 0.0 109.261 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.49 -49.92 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.834 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.3 tp -48.81 -56.33 9.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.314 1.446 . . . . 0.0 110.333 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.43 -44.76 95.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.931 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.7 mt -59.93 -41.96 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 121.838 -0.539 . . . . 0.0 110.696 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.04 -50.04 81.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.138 -0.976 . . . . 0.0 109.659 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.83 -30.9 71.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.477 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -105.16 -57.31 2.05 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.441 1.497 . . . . 0.0 112.244 -168.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.57 -173.47 21.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.068 1.794 . . . . 0.0 110.554 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -165.48 125.02 1.75 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.88 -113.53 1.06 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.974 1.261 . . . . 0.0 112.779 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.26 82.61 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.207 1.004 . . . . 0.0 113.965 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.5 ttt -66.36 126.85 92.79 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.46 1.13 . . . . 0.0 109.468 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.25 -39.16 39.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.751 2.3 . . . . 0.0 112.082 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.18 163.74 28.78 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 121.956 0.753 . . . . 0.0 111.707 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.84 21.64 65.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.14 -35.3 73.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.286 1.434 . . . . 0.0 109.759 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.54 146.77 49.99 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -139.93 155.09 47.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.235 0.925 . . . . 0.0 112.903 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.84 -139.32 45.87 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.4 -37.21 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.366 1.467 . . . . 0.0 112.068 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.03 -61.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.2 -39.69 89.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.792 -0.568 . . . . 0.0 110.452 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -58.11 -50.9 71.88 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.048 0.539 . . . . 0.0 110.023 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.94 65.39 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.44 0.696 . . . . 0.0 109.687 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.13 -57.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.321 0 O-C-N 123.237 0.335 . . . . 0.0 110.179 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.7 -55.38 19.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.064 0.545 . . . . 0.0 111.279 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.39 58.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 110.783 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.82 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 21.0 t90 -51.13 -44.14 61.31 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.488 0.715 . . . . 0.0 111.187 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.818 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -76.2 -37.29 57.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.384 -0.823 . . . . 0.0 112.154 -173.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 109.462 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -76.22 -22.16 55.56 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.397 1.079 . . . . 0.0 113.256 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -18.71 55.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.435 -1.415 . . . . 0.0 112.789 -168.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.955 1.702 . . . . 0.0 113.121 -156.055 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.743 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.39 -53.06 59.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.2 -161.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -61.94 -40.18 94.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.492 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.8 91.1 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.792 0.724 . . . . 0.0 111.315 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.7 t -48.02 -65.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.717 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 58.4 t -64.63 -41.37 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.526 -165.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.91 0.65 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.985 2.914 . . . . 0.0 113.382 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -126.56 -33.42 2.55 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.135 0.974 . . . . 0.0 113.257 167.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -107.62 -19.68 13.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.924 1.69 . . . . 0.0 112.675 -160.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.6 m -123.37 -40.07 2.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.316 0.507 . . . . 0.0 110.862 -171.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.65 -28.55 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.558 0.343 . . . . 0.0 111.422 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -36.75 -43.7 0.44 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.962 2.105 . . . . 0.0 112.913 170.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.28 -37.68 3.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.56 0.744 . . . . 0.0 110.681 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -77.75 -9.42 59.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.4 153.19 10.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.8 -60.54 2.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.175 1.369 . . . . 0.0 113.314 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -3.23 39.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.513 1.125 . . . . 0.0 112.456 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD21 HG12 ' A' ' 28' ' ' VAL . 7.6 mt 71.06 24.38 3.95 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.138 1.775 . . . . 0.0 111.124 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -79.51 -6.03 56.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.397 2.279 . . . . 0.0 112.036 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.59 112.64 2.26 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.07 -73.23 0.67 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.148 0.974 . . . . 0.0 109.986 175.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -98.3 2.2 47.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.46 160.55 56.54 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 127.356 2.262 . . . . 0.0 105.394 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.11 165.14 25.12 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.818 1.679 . . . . 0.0 110.751 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.98 122.49 15.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.316 2.2 pp -116.57 1.93 7.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.54 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -42.34 -48.81 5.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.662 1.119 . . . . 0.0 112.151 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -90.28 4.84 49.5 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.916 1.286 . . . . 0.0 112.02 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.24 -44.83 53.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.826 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.02 -33.52 44.54 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 120.862 1.665 . . . . 0.0 114.038 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.74 -35.77 77.54 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.375 -1.074 . . . . 0.0 110.891 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -89.78 -34.39 16.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.668 0.787 . . . . 0.0 111.166 -171.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -138.65 142.47 39.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.109 1.363 . . . . 0.0 108.035 -167.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 p -80.49 165.3 22.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.649 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -49.36 -49.56 43.89 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.367 1.067 . . . . 0.0 110.019 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -47.09 -52.6 14.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.646 1.179 . . . . 0.0 112.676 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.98 -49.01 77.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.515 -0.741 . . . . 0.0 110.336 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.98 -47.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.0 tp -50.29 -55.36 15.76 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.82 1.648 . . . . 0.0 109.943 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.76 -48.17 80.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -57.98 -43.46 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.56 0.344 . . . . 0.0 110.377 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.4 -50.42 80.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.08 -28.65 68.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -103.46 -60.95 1.48 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.137 1.775 . . . . 0.0 111.495 -171.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.8 -175.75 21.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.405 1.955 . . . . 0.0 110.365 -170.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.62 164.02 37.81 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.88 -91.97 0.0 OUTLIER Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.921 2.2 . . . . 0.0 116.2 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.36 37.27 3.59 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 118.571 1.186 . . . . 0.0 112.471 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.3 ttt -117.93 122.84 30.12 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 125.547 1.539 . . . . 0.0 108.617 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -61.92 -38.54 57.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.873 2.382 . . . . 0.0 112.688 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.49 163.57 29.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 122.003 0.779 . . . . 0.0 111.849 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.73 22.28 63.99 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.408 0.527 . . . . 0.0 111.872 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mt -64.39 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.168 1.387 . . . . 0.0 109.748 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.95 144.28 38.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -138.78 158.34 44.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.261 0.937 . . . . 0.0 112.931 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.93 -136.27 41.93 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.263 0.935 . . . . 0.0 110.89 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.15 -37.72 3.29 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.259 1.424 . . . . 0.0 112.172 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -59.01 -56.35 23.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.704 0.801 . . . . 0.0 110.214 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.36 88.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.671 -0.643 . . . . 0.0 110.266 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.26 -53.1 58.2 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.311 0.644 . . . . 0.0 109.968 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.14 41.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.609 0.763 . . . . 0.0 109.888 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.9 t -50.72 -58.2 2.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 117.897 0.317 . . . . 0.0 110.36 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.72 -54.16 41.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.02 0.528 . . . . 0.0 110.771 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.18 59.47 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.083 0.468 . . . . 0.0 110.545 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.796 ' CH2' HD23 ' A' ' 88' ' ' LEU . 14.0 t90 -58.33 -47.73 82.8 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.892 0.477 . . . . 0.0 111.69 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.796 HD23 ' CH2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -75.19 -29.75 60.45 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.861 -1.149 . . . . 0.0 110.736 -172.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.04 -56.24 21.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 160.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.69 -8.45 52.11 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.767 -1.208 . . . . 0.0 112.037 -172.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -27.4 61.07 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.289 -0.882 . . . . 0.0 110.11 -176.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.7 pttp . . . . . 0 C--O 1.252 1.223 0 C-N-CA 124.941 1.296 . . . . 0.0 113.702 -150.393 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 t0 . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.29 76.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.575 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -70.62 -41.38 72.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -175.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.25 58.93 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.259 0.936 . . . . 0.0 110.919 174.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 31' ' ' LYS . 59.0 t -49.77 -59.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.554 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 33.1 t -71.11 -11.99 15.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 119.937 1.244 . . . . 0.0 114.071 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -93.51 0.36 56.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.126 2.17 . . . . 0.0 110.86 174.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -6.59 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.487 ' HG3' HG13 ' A' ' 27' ' ' VAL . 53.9 mmtt -112.25 -49.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.67 1.188 . . . . 0.0 109.947 -177.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -88.73 -37.93 15.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.124 0.569 . . . . 0.0 110.978 -170.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 28' ' ' VAL . 23.0 pt -46.89 -36.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.069 0.948 . . . . 0.0 111.317 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 m -37.9 -36.71 0.21 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.326 2.25 . . . . 0.0 112.884 174.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.53 -43.42 2.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.723 . . . . 0.0 111.189 173.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -74.46 -7.12 51.95 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.94 -71.77 0.26 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.088 0.851 . . . . 0.0 113.198 163.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.53 -77.46 0.06 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 5.5 5.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.984 1.313 . . . . 0.0 112.367 169.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 69.09 24.71 6.05 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.507 1.523 . . . . 0.0 110.965 176.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.7 p -70.73 -15.0 62.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.056 1.343 . . . . 0.0 111.153 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 97.79 1.9 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -99.0 -80.21 0.47 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.252 0.621 . . . . 0.0 109.831 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 1.94 55.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.228 1.411 . . . . 0.0 111.705 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.1 156.92 54.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 127.295 2.238 . . . . 0.0 105.347 -176.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.59 164.31 29.43 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.91 123.36 17.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.03 -5.49 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.746 170.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -41.28 -46.22 3.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.739 1.154 . . . . 0.0 111.336 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 0.73 54.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.106 0.962 . . . . 0.0 110.927 -172.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.9 -41.61 62.08 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 121.376 -0.827 . . . . 0.0 112.056 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.7 -24.75 8.23 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.629 0.633 . . . . 0.0 114.679 177.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.07 -30.34 31.36 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.815 0.807 . . . . 0.0 111.52 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -89.56 -44.57 10.0 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.857 0.863 . . . . 0.0 110.513 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -126.58 149.86 49.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.106 1.763 . . . . 0.0 107.876 -171.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.3 m -88.05 162.8 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.787 0.435 . . . . 0.0 111.113 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -42.6 -52.41 4.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.554 1.142 . . . . 0.0 110.32 175.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -48.03 -55.59 9.76 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.12 -49.51 76.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.721 0.772 . . . . 0.0 109.96 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 64' ' ' ILE . 67.2 mt -64.03 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.3 tp -49.41 -55.78 11.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.114 1.366 . . . . 0.0 110.185 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -44.19 90.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -61.69 -40.76 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.335 -0.853 . . . . 0.0 111.356 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 60' ' ' ILE . 26.1 mt -61.03 -47.59 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 120.905 -1.122 . . . . 0.0 109.464 177.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.51 -40.03 88.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.486 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.34 -50.88 5.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.46 1.504 . . . . 0.0 112.318 -169.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.1 -170.83 15.11 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.092 1.806 . . . . 0.0 111.211 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.431 ' H ' ' HB3' ' A' ' 71' ' ' MET . 1.0 OUTLIER -163.93 116.27 1.4 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 127.056 2.142 . . . . 0.0 105.495 168.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.9 -109.93 0.64 Allowed Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.062 1.301 . . . . 0.0 113.157 172.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -26.18 73.37 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 118.011 0.905 . . . . 0.0 113.061 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.431 ' HB3' ' H ' ' A' ' 68' ' ' GLN . 22.1 ttt -72.74 118.85 71.57 Favored Pre-proline 0 N--CA 1.454 -0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 109.911 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.32 -34.11 28.18 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.594 2.863 . . . . 0.0 112.582 -173.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.48 165.64 40.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -176.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.32 12.65 66.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.754 0.692 . . . . 0.0 112.278 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.78 -34.65 52.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.845 1.658 . . . . 0.0 110.36 177.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.53 149.46 49.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -145.85 155.66 43.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 179.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.68 -136.93 49.15 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -175.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.17 -37.44 4.46 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.795 1.238 . . . . 0.0 112.186 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -54.29 -61.4 2.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.237 1.015 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.91 74.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.725 -0.61 . . . . 0.0 111.145 -175.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.24 -52.86 63.87 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.441 0.564 . . . . 0.0 109.873 175.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.44 -52.47 53.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.98 -62.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 123.176 0.298 . . . . 0.0 110.786 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.97 69.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 111.285 -171.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.97 -53.37 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.317 0.58 . . . . 0.0 110.662 177.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.554 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 20.3 t90 -60.11 -31.31 69.93 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.786 0.834 . . . . 0.0 112.001 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -43.41 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 172.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.39 77.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.067 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.99 -16.41 58.15 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 13.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.877 3.271 . . . . 0.0 114.953 -177.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.095 0 O-C-N 119.981 -1.7 . . . . 0.0 112.88 -151.19 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.47 66.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.561 -169.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.84 -42.14 88.59 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.638 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.45 93.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.543 0.61 . . . . 0.0 109.881 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.03 -60.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.636 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.267 87.1 t -65.19 -43.25 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.726 -168.871 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.72 0.72 0.74 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.354 2.261 . . . . 0.0 114.032 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -138.29 -12.13 1.41 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 172.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -128.42 -20.51 3.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.152 1.381 . . . . 0.0 112.067 -171.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 18.4 m -110.93 -43.6 3.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.138 0.881 . . . . 0.0 110.671 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -49.42 -29.21 3.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.185 0.594 . . . . 0.0 111.845 176.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -38.06 -43.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.868 1.667 . . . . 0.0 112.007 174.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.7 m -114.11 -41.65 3.48 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 117.888 0.313 . . . . 0.0 110.644 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.78 -16.5 62.75 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.9 25.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.7 -61.51 1.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.581 1.563 . . . . 0.0 113.753 -173.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.24 -5.61 47.67 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.215 1.006 . . . . 0.0 112.419 -177.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 48' ' ' ILE . 4.2 mt 69.65 23.68 5.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.085 1.754 . . . . 0.0 111.096 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -78.79 -6.49 56.09 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.552 2.341 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 77.17 1.32 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-N 118.595 0.634 . . . . 0.0 112.064 167.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 -76.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.681 0.392 . . . . 0.0 111.458 177.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -99.52 2.73 45.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.827 1.651 . . . . 0.0 111.552 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.53 162.45 39.17 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.42 166.36 21.9 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.806 1.67 . . . . 0.0 111.299 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.69 122.27 16.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.33 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 40' ' ' LEU 0.311 2.1 pp -117.24 -0.97 8.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.401 173.166 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -34.61 -47.13 0.31 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 112.087 159.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -102.65 6.33 39.57 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.984 1.314 . . . . 0.0 112.765 -175.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.31 57.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.102 0.865 . . . . 0.0 111.691 177.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.88 -32.6 75.42 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 119.84 1.2 . . . . 0.0 113.229 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.49 27.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.9 1.35 . . . . 0.0 110.455 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.41 -39.57 62.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.281 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -123.11 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 128.009 2.524 . . . . 0.0 107.606 -173.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.4 m -135.88 171.28 14.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.835 -1.165 . . . . 0.0 109.999 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -39.37 68.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.107 0.563 . . . . 0.0 110.795 -166.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.55 -53.14 61.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -57.99 -50.35 73.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.935 0.894 . . . . 0.0 109.383 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.41 -49.67 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.91 -57.27 6.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.872 1.269 . . . . 0.0 109.921 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.85 -43.55 94.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.049 -176.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.03 -41.22 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.736 -0.602 . . . . 0.0 111.14 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.3 mt -59.25 -50.57 79.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 O-C-N 120.899 -1.126 . . . . 0.0 109.408 175.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.82 -36.31 83.47 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.651 -177.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.65 -51.62 3.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.158 1.383 . . . . 0.0 112.12 -168.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.34 -171.67 18.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.857 1.694 . . . . 0.0 110.33 -171.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -165.06 127.9 2.24 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.42 -112.18 0.61 Allowed Glycine 0 CA--C 1.538 1.479 0 CA-C-N 120.098 1.317 . . . . 0.0 112.876 176.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.17 -12.68 75.87 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 118.161 0.981 . . . . 0.0 113.996 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.2 ttt -64.34 125.11 87.69 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 118.46 1.13 . . . . 0.0 109.175 178.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.41 -36.55 54.57 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -172.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.2 165.19 31.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.48 27.49 68.01 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.3 -32.26 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.151 0.98 . . . . 0.0 109.373 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.44 46.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.751 1.621 . . . . 0.0 106.755 173.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -145.32 154.64 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.02 -140.57 48.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -40.52 -37.33 0.69 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.709 1.604 . . . . 0.0 112.557 176.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.32 -61.98 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.308 1.043 . . . . 0.0 110.319 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.67 87.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.748 -0.595 . . . . 0.0 110.29 -177.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.23 -48.38 78.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.649 0.78 . . . . 0.0 110.002 178.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.41 82.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.897 176.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.28 -48.95 75.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.707 174.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.63 -55.14 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.162 0.892 . . . . 0.0 110.195 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.02 -58.05 10.13 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.771 0.428 . . . . 0.0 111.475 178.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.636 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 54.9 t90 -57.14 -45.68 83.34 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.078 0.951 . . . . 0.0 111.482 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.485 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -70.78 -42.54 70.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.18 -175.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.65 66.86 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.021 -0.424 . . . . 0.0 110.651 169.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -74.04 -14.36 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.681 0.792 . . . . 0.0 112.438 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 -15.22 48.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.696 -1.253 . . . . 0.0 113.082 -166.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.923 1.289 . . . . 0.0 112.961 -153.716 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.84 -52.27 43.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.537 -167.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.34 -44.76 96.65 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.366 178.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.38 59.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 120.081 1.31 . . . . 0.0 110.849 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -46.99 -62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.557 HG13 ' SG ' ' A' ' 32' ' ' CYS . 40.2 t -77.78 2.42 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.363 -1.46 . . . . 0.0 113.239 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.28 0.9 38.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.569 2.348 . . . . 0.0 110.063 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -142.35 -13.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -106.93 -55.82 2.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.456 1.503 . . . . 0.0 109.574 -175.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' HG13 ' A' ' 28' ' ' VAL . 2.9 m -82.59 -37.2 25.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.475 0.31 . . . . 0.0 110.663 -171.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 28' ' ' VAL . 14.1 pt -48.31 -32.73 3.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 123.383 0.673 . . . . 0.0 111.284 178.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -45.14 -29.52 0.94 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 112.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -127.2 -44.41 1.59 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.439 0.696 . . . . 0.0 111.311 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -71.86 -14.62 62.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.307 -0.87 . . . . 0.0 113.283 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.86 154.95 28.12 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.804 0.716 . . . . 0.0 111.562 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.76 -49.89 8.75 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.215 1.388 . . . . 0.0 113.274 -175.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -84.15 -8.42 59.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.787 0.835 . . . . 0.0 111.857 -176.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.419 HD21 HG12 ' A' ' 28' ' ' VAL . 3.7 mt 69.68 21.45 6.56 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.642 1.577 . . . . 0.0 111.181 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -77.66 -8.23 57.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 128.223 2.609 . . . . 0.0 111.431 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.54 87.0 1.74 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.46 -81.16 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.843 0.457 . . . . 0.0 110.524 175.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -90.45 2.01 56.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.343 1.457 . . . . 0.0 112.138 177.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.75 43.55 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.6 166.08 21.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.797 1.665 . . . . 0.0 111.441 -178.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.1 117.59 7.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 88' ' ' LEU 0.281 2.5 pp -112.7 -3.32 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.067 176.509 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -38.03 -46.49 1.01 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.644 1.111 . . . . 0.0 113.152 163.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -98.15 4.75 49.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.076 1.75 . . . . 0.0 112.116 -177.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.07 -38.58 62.61 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.767 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.35 -27.33 65.39 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.619 1.1 . . . . 0.0 113.463 173.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.38 -48.25 20.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.8 -0.824 . . . . 0.0 109.701 177.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -74.08 -45.21 50.69 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 122.634 0.373 . . . . 0.0 111.684 -174.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -122.55 157.36 32.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.284 1.834 . . . . 0.0 109.265 -169.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -89.11 167.18 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.39 0.614 . . . . 0.0 110.813 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.73 -45.59 49.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.078 0.951 . . . . 0.0 109.858 174.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -54.5 -49.56 69.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.593 0.633 . . . . 0.0 112.521 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.7 -51.22 70.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.697 0.761 . . . . 0.0 109.791 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.54 -50.1 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -174.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -47.14 -58.12 4.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.183 1.393 . . . . 0.0 110.271 172.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.14 -47.69 80.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -175.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.74 -44.31 89.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 122.329 0.252 . . . . 0.0 110.673 -178.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.7 mt -60.97 -50.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 121.79 -0.569 . . . . 0.0 110.045 177.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.48 -36.43 84.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.778 -178.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.11 -59.3 2.0 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.1 1.76 . . . . 0.0 111.565 -169.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.36 106.79 2.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.45 1.5 . . . . 0.0 110.595 -168.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -55.19 155.29 4.96 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 160.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.78 -61.64 0.73 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.028 1.299 . . . . 0.0 115.469 -175.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.88 17.49 52.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 117.902 0.851 . . . . 0.0 113.386 -177.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.0 ttt -119.41 136.97 24.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.846 1.658 . . . . 0.0 108.396 -176.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.76 -36.91 17.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.104 1.87 . . . . 0.0 112.034 -172.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 163.69 27.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.4 23.52 62.56 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.01 -32.58 58.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 123.57 0.748 . . . . 0.0 109.976 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.49 48.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -144.97 153.21 41.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -137.67 49.51 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.3 -35.99 1.68 Allowed 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 112.352 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.25 -60.37 3.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 110.237 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.01 88.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.556 -0.715 . . . . 0.0 110.52 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.38 -48.33 82.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.307 0.643 . . . . 0.0 110.13 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.59 -49.57 70.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.317 0.647 . . . . 0.0 109.478 175.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 28' ' ' VAL . 61.9 t -52.44 -58.77 2.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.2 173.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.73 -55.12 6.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.932 0.893 . . . . 0.0 111.147 -172.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.87 29.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 110.965 178.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.544 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 65.3 t90 -58.99 -41.37 87.46 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.742 0.417 . . . . 0.0 111.515 -175.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.5 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -69.05 -46.02 68.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.293 1.037 . . . . 0.0 109.976 -179.622 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.35 59.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.871 0.468 . . . . 0.0 110.931 171.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.42 -17.93 60.72 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.866 1.267 . . . . 0.0 112.536 178.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 2.05 44.16 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.429 -1.419 . . . . 0.0 113.536 -164.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.305 1.442 . . . . 0.0 114.815 -148.444 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -49.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.27 -167.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.39 -39.65 91.47 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.544 178.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.46 96.65 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 120.274 1.397 . . . . 0.0 111.028 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -49.36 -65.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 167.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.806 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 48.1 t -58.97 -48.0 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.488 -167.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -56.58 -6.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.363 3.065 . . . . 0.0 113.268 174.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -132.75 2.22 3.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.992 0.917 . . . . 0.0 113.001 173.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -129.16 -59.85 1.09 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.124 0.97 . . . . 0.0 109.831 -169.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.644 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.3 m -86.9 -40.57 14.72 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.679 0.391 . . . . 0.0 110.284 -171.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.15 -26.78 8.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.77 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -46.73 -37.36 8.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.844 1.258 . . . . 0.0 111.549 176.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.5 m -116.02 -38.96 3.52 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 122.934 0.494 . . . . 0.0 111.301 174.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -76.16 -13.01 60.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.93 151.99 23.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -54.03 5.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.254 1.407 . . . . 0.0 112.902 -177.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 -7.56 58.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.82 1.648 . . . . 0.0 111.971 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.578 HD22 HD11 ' A' ' 48' ' ' ILE . 1.6 mt 69.08 21.35 7.35 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.808 1.643 . . . . 0.0 110.948 178.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 p -79.34 -5.54 54.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.011 2.524 . . . . 0.0 111.537 178.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.44 83.9 1.65 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 118.53 0.605 . . . . 0.0 111.701 167.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.12 -71.17 0.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.746 0.418 . . . . 0.0 110.853 177.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t -100.17 1.74 42.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.623 1.569 . . . . 0.0 110.839 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.23 163.9 29.79 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 126.273 1.829 . . . . 0.0 106.082 -173.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -63.26 160.64 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.633 1.555 . . . . 0.0 111.231 174.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 113.65 3.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.172 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 88' ' ' LEU . 2.1 pp -100.08 -5.86 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.748 173.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -37.89 6.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.839 1.199 . . . . 0.0 112.079 176.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -105.46 4.83 31.04 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.393 1.877 . . . . 0.0 112.371 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.9 -35.18 22.68 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 118.688 0.676 . . . . 0.0 110.882 176.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.11 -30.23 54.03 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.961 0.801 . . . . 0.0 114.588 174.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.51 -45.33 38.81 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 121.633 -0.922 . . . . 0.0 109.845 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -73.78 -38.41 64.66 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 122.869 0.467 . . . . 0.0 111.575 -171.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -135.85 154.23 51.24 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.322 1.849 . . . . 0.0 107.721 -171.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -89.46 168.23 12.37 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.161 -0.337 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.84 -43.39 65.99 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.928 0.491 . . . . 0.0 110.952 -175.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.58 -55.85 12.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.104 1.361 . . . . 0.0 112.713 174.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -53.88 -48.54 69.96 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.46 1.104 . . . . 0.0 109.854 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.48 -50.17 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -50.74 -55.58 15.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.872 1.269 . . . . 0.0 110.008 177.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -45.65 91.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.76 -41.25 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 121.378 -0.826 . . . . 0.0 111.25 -178.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.11 -52.3 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.849 0.75 . . . . 0.0 109.839 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.23 -36.92 84.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -174.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -90.28 -53.05 4.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.271 1.828 . . . . 0.0 111.508 -171.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 111.76 3.61 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -169.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -57.17 154.56 9.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 117.8 0.8 . . . . 0.0 108.846 167.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.59 86.8 0.03 OUTLIER Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.062 -1.024 . . . . 0.0 112.516 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.57 -12.38 4.29 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.161 2.315 . . . . 0.0 112.311 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.0 ttt -116.62 129.21 25.44 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 127.081 2.153 . . . . 0.0 108.783 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.45 136.18 33.14 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.306 1.337 . . . . 0.0 108.699 170.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.02 39.5 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.47 13.5 65.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.919 0.771 . . . . 0.0 112.339 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.45 -30.9 45.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.99 1.316 . . . . 0.0 110.204 175.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.47 148.42 42.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -139.92 156.11 46.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.271 0.941 . . . . 0.0 113.383 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.13 -139.02 41.85 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.42 -37.43 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.744 1.618 . . . . 0.0 112.714 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.53 -62.06 1.9 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.38 1.072 . . . . 0.0 109.675 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.38 82.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.65 -0.656 . . . . 0.0 110.761 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.16 -49.25 77.67 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.262 0.625 . . . . 0.0 109.994 178.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.81 76.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.57 -53.93 14.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.365 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.15 -56.34 8.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.588 0.755 . . . . 0.0 110.777 -174.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -54.49 45.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.806 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 7.6 t90 -60.29 -47.63 85.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.96 0.504 . . . . 0.0 112.151 -175.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -63.61 -43.05 98.02 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.367 -0.833 . . . . 0.0 108.957 -179.701 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.8 -44.02 73.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.315 -0.241 . . . . 0.0 110.866 171.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -73.82 -11.17 60.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.482 1.113 . . . . 0.0 111.927 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.13 60.17 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.028 -1.045 . . . . 0.0 110.277 -177.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.171 -158.982 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.84 -51.72 59.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.617 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.41 -43.73 98.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 118.194 -0.907 . . . . 0.0 109.142 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.18 81.57 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.558 1.072 . . . . 0.0 111.302 -176.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -45.8 -62.63 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.798 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.257 52.1 t -65.11 -40.65 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 118.564 -1.254 . . . . 0.0 113.262 -167.527 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.15 0.37 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.091 3.356 . . . . 0.0 113.196 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -137.37 -12.19 1.61 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -119.38 -25.77 5.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.132 1.373 . . . . 0.0 111.949 -168.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.649 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.7 m -114.12 -39.75 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.992 0.814 . . . . 0.0 111.004 -177.233 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -48.41 -32.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 122.545 0.338 . . . . 0.0 111.416 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -44.17 -30.67 0.81 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.222 1.409 . . . . 0.0 113.024 175.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -122.61 -43.98 2.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.689 0.796 . . . . 0.0 110.576 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -71.96 -10.06 59.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.49 -85.0 0.38 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.186 0.898 . . . . 0.0 112.746 163.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.59 -63.54 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -174.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.407 ' C ' HD22 ' A' ' 40' ' ' LEU . 4.7 m-20 -82.59 3.26 29.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 111.86 173.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 39' ' ' ASP . 1.2 mm? 65.29 25.8 12.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.873 1.669 . . . . 0.0 111.453 -172.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.6 -11.91 60.32 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.034 2.134 . . . . 0.0 111.42 177.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.43 89.44 1.82 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 168.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.18 -77.66 0.45 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.274 0.629 . . . . 0.0 110.616 177.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -92.96 2.34 56.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.071 1.349 . . . . 0.0 111.482 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 158.92 50.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -62.58 162.54 24.14 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.985 1.79 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 126.11 26.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.763 177.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.438 ' O ' HD11 ' A' ' 88' ' ' LEU 0.272 2.7 pp -116.78 -2.29 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.672 171.738 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -43.7 -45.69 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.499 1.045 . . . . 0.0 112.134 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -94.55 4.23 54.11 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.466 1.106 . . . . 0.0 112.463 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.68 -34.15 37.14 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.572 177.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.72 73.46 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.134 1.334 . . . . 0.0 114.018 173.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.26 -44.83 43.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.503 1.151 . . . . 0.0 110.037 170.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -73.31 -40.95 64.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.509 0.195 . . . . 0.0 111.269 -171.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -131.98 169.21 16.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.973 2.109 . . . . 0.0 107.194 -169.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 m -108.34 167.45 10.02 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.248 0.477 . . . . 0.0 109.764 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -50.57 -42.15 55.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.249 -176.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.3 -50.83 58.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.12 1.327 . . . . 0.0 112.035 177.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -61.87 -52.47 63.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 122.247 1.022 . . . . 0.0 109.252 -176.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 64' ' ' ILE . 37.2 mt -62.57 -47.17 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.21 -53.76 32.08 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.929 1.292 . . . . 0.0 110.047 176.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -56.66 -48.22 78.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.31 -45.7 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.367 -0.833 . . . . 0.0 111.251 -178.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 60' ' ' ILE . 29.5 mt -59.1 -48.0 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.094 -1.003 . . . . 0.0 109.59 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.1 -25.88 62.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.7 0.8 . . . . 0.0 113.104 -177.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.55 -60.29 1.65 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.508 1.523 . . . . 0.0 111.02 -171.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.31 -174.63 21.39 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.648 2.07 . . . . 0.0 109.884 -170.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -152.79 163.58 39.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -1.19 -91.78 0.0 OUTLIER Glycine 0 CA--C 1.543 1.814 0 C-N-CA 126.382 1.944 . . . . 0.0 116.622 175.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.98 12.29 67.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.501 1.151 . . . . 0.0 113.7 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.2 ttt -96.19 120.1 63.25 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.715 1.606 . . . . 0.0 109.023 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.96 -37.31 54.66 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.807 2.338 . . . . 0.0 112.176 -171.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.21 164.62 28.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-O 122.111 0.84 . . . . 0.0 111.743 177.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.51 17.14 61.79 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 122.407 -0.466 . . . . 0.0 112.159 -173.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.76 -31.28 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.441 1.496 . . . . 0.0 109.628 173.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.58 140.31 35.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -139.5 162.79 34.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.22 1.008 . . . . 0.0 111.768 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.73 -138.59 44.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.83 -37.48 2.81 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.98 1.312 . . . . 0.0 112.002 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.26 -58.37 8.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.836 0.454 . . . . 0.0 110.048 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.49 93.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.753 -0.592 . . . . 0.0 110.507 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.16 -54.07 47.94 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.157 0.583 . . . . 0.0 110.03 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.07 -54.44 30.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.377 0.671 . . . . 0.0 109.626 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.37 -66.99 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 123.432 0.458 . . . . 0.0 110.078 176.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.7 -46.78 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.241 0.617 . . . . 0.0 111.455 -170.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -58.72 7.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.367 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.948 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 9.6 t90 -53.14 -43.38 66.94 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.399 0.68 . . . . 0.0 110.793 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.948 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.62 -39.4 73.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.998 -1.064 . . . . 0.0 110.657 -175.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.56 72.39 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.889 -0.507 . . . . 0.0 110.978 166.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -16.25 60.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.648 0.779 . . . . 0.0 112.813 179.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -20.14 57.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.822 1.249 . . . . 0.0 111.472 -166.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -156.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.38 -52.66 7.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.495 1.118 . . . . 0.0 113.169 -170.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.27 -39.84 95.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.286 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.94 76.59 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 119.981 1.264 . . . . 0.0 110.381 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.9 t -52.31 -59.94 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.726 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 29.8 t -79.35 3.85 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -171.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -104.96 3.6 30.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.521 1.928 . . . . 0.0 110.465 170.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -128.79 -43.49 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.89 -14.28 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.247 1.419 . . . . 0.0 112.024 -159.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 4.5 m -120.91 -37.47 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.615 1.166 . . . . 0.0 111.026 -170.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 pt -50.97 -30.97 9.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.474 0.71 . . . . 0.0 111.659 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -38.18 -42.4 0.68 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.699 2.0 . . . . 0.0 112.737 173.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.3 m -121.3 -38.39 2.8 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.215 0.606 . . . . 0.0 110.799 -177.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -79.79 -8.05 59.03 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.517 -0.74 . . . . 0.0 112.851 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.61 156.21 19.3 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.16 -58.91 3.62 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.633 1.111 . . . . 0.0 112.534 -176.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.94 -4.52 47.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.622 1.169 . . . . 0.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt 72.0 20.43 4.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.764 1.626 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 p -80.23 -2.79 46.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.822 2.449 . . . . 0.0 112.112 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.18 102.36 1.56 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.916 0.77 . . . . 0.0 111.472 168.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.39 -70.66 0.75 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.924 0.862 . . . . 0.0 110.128 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -99.62 2.69 44.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.464 1.506 . . . . 0.0 111.109 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.84 161.79 44.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -175.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.36 163.4 29.65 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.781 1.654 . . . . 0.0 110.828 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.28 113.62 3.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.591 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.305 2.1 pp -105.2 0.69 10.21 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.009 172.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -41.42 14.57 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.239 -0.913 . . . . 0.0 112.801 170.253 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -97.88 4.99 49.54 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.656 1.183 . . . . 0.0 112.106 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.27 32.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.451 -1.261 . . . . 0.0 112.398 -178.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.73 -32.04 68.85 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 120.893 1.679 . . . . 0.0 113.881 174.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.17 -41.55 57.83 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.407 -1.055 . . . . 0.0 109.83 174.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -73.56 -35.17 65.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.828 -172.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -142.24 152.89 43.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.847 1.659 . . . . 0.0 108.674 -170.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.6 t -80.75 163.81 23.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.823 -0.548 . . . . 0.0 110.621 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.11 -44.92 68.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.24 -0.41 . . . . 0.0 109.951 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.53 -44.55 72.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.372 0.669 . . . . 0.0 112.494 178.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.9 -50.49 70.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.582 0.706 . . . . 0.0 109.833 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -62.53 -48.3 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 tp -48.38 -56.75 7.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.642 1.577 . . . . 0.0 109.97 175.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -56.54 -48.94 76.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -59.27 -43.73 90.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 122.248 -0.282 . . . . 0.0 110.454 -175.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.46 -50.38 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.525 -0.735 . . . . 0.0 109.559 177.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.23 -35.45 78.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.453 -179.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -102.48 -65.46 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.765 2.026 . . . . 0.0 112.527 -167.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.76 -176.96 22.82 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.952 1.739 . . . . 0.0 111.619 -170.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -157.07 170.44 22.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.875 3.27 . . . . 0.0 103.701 169.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -9.53 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 126.953 2.216 . . . . 0.0 116.343 175.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.88 42.01 2.0 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 118.599 1.199 . . . . 0.0 110.949 171.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.7 tpt -116.55 107.5 46.7 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -177.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.33 -36.22 88.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.499 2.8 . . . . 0.0 112.617 -162.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.17 161.49 17.66 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 122.264 0.924 . . . . 0.0 111.484 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.76 14.31 57.97 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 122.051 -0.676 . . . . 0.0 113.154 -177.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 -32.46 50.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.616 175.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.41 141.49 46.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -139.35 154.08 47.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 107.154 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.68 -139.54 35.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.86 -41.07 1.09 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.205 1.802 . . . . 0.0 112.418 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -57.17 -55.85 29.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.431 0.692 . . . . 0.0 110.032 178.728 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.84 78.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -178.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.87 -56.28 19.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.622 0.769 . . . . 0.0 109.879 177.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.53 -53.05 59.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.039 0.936 . . . . 0.0 109.762 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 80' ' ' GLU . 87.7 t -48.64 -63.09 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 O-C-N 123.641 0.588 . . . . 0.0 109.805 176.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.55 -55.16 17.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.528 0.731 . . . . 0.0 111.76 -171.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.17 -53.22 60.73 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.467 0.651 . . . . 0.0 110.793 -177.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.726 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 21.8 t90 -54.23 -45.81 72.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.287 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.718 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -62.97 -45.63 91.52 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.732 -1.23 . . . . 0.0 111.502 -177.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.6 51.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.672 0.789 . . . . 0.0 111.606 172.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.0 -26.91 33.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.241 1.016 . . . . 0.0 112.056 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -32.58 65.57 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.976 1.311 . . . . 0.0 110.91 -165.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 128.512 2.725 . . . . 0.0 112.822 -162.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.17 -53.01 56.78 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.311 -170.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.97 -43.76 97.92 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.446 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.48 76.14 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 119.904 1.229 . . . . 0.0 111.117 -177.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -46.68 -62.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 167.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG13 ' SG ' ' A' ' 32' ' ' CYS 0.28 73.7 t -70.82 -33.08 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.463 -161.313 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -63.1 -0.78 0.8 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 130.249 3.419 . . . . 0.0 113.315 169.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.24 -22.73 0.91 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 173.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -104.43 -23.75 13.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.29 1.836 . . . . 0.0 110.778 -171.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' HG13 ' A' ' 28' ' ' VAL . 2.3 m -117.57 -40.37 3.05 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.653 0.661 . . . . 0.0 111.781 -174.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 pt -49.74 -31.11 6.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 117.941 0.337 . . . . 0.0 111.397 178.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -37.11 -43.4 0.49 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.313 1.845 . . . . 0.0 111.904 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -114.25 -44.09 3.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.145 0.578 . . . . 0.0 110.853 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -73.67 -14.65 61.19 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.0 152.85 23.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.032 0.833 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.17 -63.46 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.033 1.778 . . . . 0.0 113.895 -173.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.79 -7.89 54.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.144 1.377 . . . . 0.0 112.658 -176.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mt 72.41 25.1 2.82 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.996 2.118 . . . . 0.0 110.672 -178.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -78.65 -6.01 54.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.355 2.662 . . . . 0.0 112.131 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 80.73 1.52 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 118.593 0.633 . . . . 0.0 112.033 168.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.59 -79.41 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.858 0.463 . . . . 0.0 111.135 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -94.78 2.08 55.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.521 1.528 . . . . 0.0 111.833 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.17 162.79 35.9 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 127.577 2.351 . . . . 0.0 104.677 -177.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.96 166.19 19.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.035 1.823 . . . . 0.0 111.656 -178.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.02 114.35 6.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 88' ' ' LEU 0.261 2.2 pp -108.78 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.652 177.394 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -37.16 -48.31 0.83 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.651 1.114 . . . . 0.0 112.846 165.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -97.71 4.82 49.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.689 1.996 . . . . 0.0 111.545 -174.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.25 -32.74 25.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.08 171.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.67 72.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.665 1.12 . . . . 0.0 114.203 173.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.38 -47.18 18.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.45 1.125 . . . . 0.0 109.865 171.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -74.06 -42.96 59.42 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.938 0.495 . . . . 0.0 111.047 -168.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.26 -179.87 4.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.473 2.309 . . . . 0.0 107.964 -176.257 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m -119.21 170.16 9.33 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.567 0.747 . . . . 0.0 110.219 -178.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -40.8 72.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.556 -174.05 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -53.47 -53.81 46.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.48 1.112 . . . . 0.0 111.714 176.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -59.13 -49.59 77.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.188 0.995 . . . . 0.0 109.33 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.31 -52.24 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.8 tp -48.61 -57.0 6.89 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.081 1.352 . . . . 0.0 109.858 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.95 -41.84 98.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -59.98 -41.82 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 121.586 -0.696 . . . . 0.0 111.283 177.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.39 -50.94 78.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 109.521 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.71 -38.45 91.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.376 -176.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.77 -53.79 4.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.657 1.583 . . . . 0.0 111.903 -171.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.87 110.11 3.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.389 1.471 . . . . 0.0 110.208 -167.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.3 151.61 5.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 157.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.46 -58.52 1.09 Allowed Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.924 1.249 . . . . 0.0 115.477 -172.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.57 12.64 62.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.951 0.876 . . . . 0.0 113.775 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -120.47 132.2 24.21 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 126.12 1.768 . . . . 0.0 107.923 -174.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 -36.83 42.64 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.964 1.776 . . . . 0.0 112.793 -169.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.09 163.21 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.804 0.669 . . . . 0.0 111.691 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.01 17.81 61.51 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.93 -38.17 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.117 1.367 . . . . 0.0 108.961 179.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.38 147.28 48.99 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -141.3 152.23 44.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.486 0.66 . . . . 0.0 111.8 -175.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.5 -142.61 46.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.75 -33.36 1.24 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.83 1.652 . . . . 0.0 112.926 -179.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -53.98 -66.79 0.33 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 109.946 171.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.53 87.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.263 0.625 . . . . 0.0 110.554 -176.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -55.97 -50.17 71.55 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.98 0.512 . . . . 0.0 109.695 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.3 85.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.315 177.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.448 HG22 ' CG2' ' A' ' 28' ' ' VAL . 59.2 t -50.56 -58.16 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.011 173.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.48 -58.71 2.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.868 0.867 . . . . 0.0 111.549 -174.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.06 -54.43 46.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.165 -179.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.491 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 47.8 t90 -56.87 -45.78 82.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 111.07 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.491 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.21 -45.61 84.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.296 1.038 . . . . 0.0 109.72 -178.378 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.46 63.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.791 0.436 . . . . 0.0 111.171 171.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.9 -16.75 60.65 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.184 1.393 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 -4.81 58.41 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.842 -1.161 . . . . 0.0 113.203 -167.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.752 1.621 . . . . 0.0 114.059 -157.053 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.91 -49.52 73.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.239 -165.167 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.35 -41.69 94.18 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.384 177.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.61 -46.9 87.87 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.31 0.959 . . . . 0.0 111.004 -176.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -46.57 -62.27 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.768 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 43.0 t -62.46 -41.96 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.782 -167.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.85 1.44 1.36 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.44 3.096 . . . . 0.0 113.306 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.31 -23.42 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.282 0.946 . . . . 0.0 113.457 168.49 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -116.74 -18.79 10.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.757 1.223 . . . . 0.0 112.762 -166.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.5 m -113.31 -43.27 3.37 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.489 1.041 . . . . 0.0 111.246 179.171 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 pt -51.99 -30.03 12.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -37.05 -40.5 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.016 1.327 . . . . 0.0 113.053 170.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.3 m -115.81 -42.15 3.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.932 0.493 . . . . 0.0 110.623 174.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -70.74 -17.34 62.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.56 -89.22 0.33 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.361 0.981 . . . . 0.0 112.465 165.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.98 -65.36 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.54 2.49 13.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.054 0.942 . . . . 0.0 111.792 170.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.481 HD21 HG12 ' A' ' 28' ' ' VAL . 4.1 mt 71.21 20.45 5.09 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.992 1.317 . . . . 0.0 110.353 177.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -76.48 -8.54 57.38 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.582 2.353 . . . . 0.0 111.722 -177.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.17 74.5 1.08 Allowed Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.446 0.567 . . . . 0.0 111.889 164.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.66 -77.38 0.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.541 0.336 . . . . 0.0 111.427 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 t -96.58 2.39 52.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.025 1.33 . . . . 0.0 111.419 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.34 162.01 39.0 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -176.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.2 164.56 24.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.876 1.717 . . . . 0.0 111.167 179.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.14 114.18 6.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.512 -177.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.444 ' O ' HD21 ' A' ' 88' ' ' LEU 0.291 2.7 pp -106.56 -2.26 9.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.515 173.829 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -33.23 -48.13 0.22 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.022 1.729 . . . . 0.0 112.51 163.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 4.84 28.74 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.705 2.002 . . . . 0.0 111.274 -171.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.25 -37.62 16.58 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.381 -175.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.06 -32.52 59.79 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 119.173 0.897 . . . . 0.0 114.592 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.01 54.74 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.529 -0.983 . . . . 0.0 110.32 174.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.3 -36.03 63.73 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.52 150.45 46.4 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.348 1.459 . . . . 0.0 108.956 -167.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 m -86.79 158.52 19.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.128 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -44.65 60.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.919 0.488 . . . . 0.0 110.79 -174.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -50.62 -48.13 58.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 112.95 174.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.42 -47.49 81.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.699 0.761 . . . . 0.0 109.32 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.2 -49.96 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -47.68 -57.51 5.42 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.9 1.68 . . . . 0.0 110.234 174.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.46 -46.3 83.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -61.44 -42.13 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 122.025 -0.422 . . . . 0.0 110.827 -177.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -58.43 -50.44 78.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.32 -37.82 88.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.699 0.399 . . . . 0.0 111.716 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -96.8 -56.63 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.459 1.504 . . . . 0.0 111.957 -168.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.76 -173.15 21.04 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.911 1.72 . . . . 0.0 110.585 -171.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -165.01 123.5 1.7 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.17 -113.42 1.08 Allowed Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.797 1.181 . . . . 0.0 112.811 175.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.11 -16.63 79.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.208 1.004 . . . . 0.0 113.695 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.4 ttt -65.92 122.21 79.81 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.219 1.009 . . . . 0.0 109.164 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.15 -34.58 56.7 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.985 2.457 . . . . 0.0 111.555 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.92 168.1 36.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 122.604 1.113 . . . . 0.0 111.507 177.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.88 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.142 -178.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -67.54 -32.45 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 127.531 2.333 . . . . 0.0 110.172 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.71 153.09 51.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 172.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 164.17 33.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.183 0.593 . . . . 0.0 112.388 178.231 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.15 -137.86 22.93 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.08 -38.33 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.411 1.484 . . . . 0.0 112.815 178.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -62.09 -58.67 6.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.92 85.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.735 -0.603 . . . . 0.0 110.744 -177.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -58.1 -52.66 64.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.005 0.922 . . . . 0.0 110.141 174.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.32 -50.21 67.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.81 -55.24 12.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.371 174.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.47 24.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.82 0.736 . . . . 0.0 110.604 -174.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.6 -58.07 9.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.962 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.768 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 2.5 t90 -54.95 -50.75 68.12 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.851 0.461 . . . . 0.0 110.936 -178.223 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.537 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.146 -0.971 . . . . 0.0 108.724 -175.046 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.28 -38.99 69.31 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 122.132 -0.355 . . . . 0.0 111.223 172.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -22.0 60.8 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.713 -0.617 . . . . 0.0 111.15 178.016 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.4 9.74 0.74 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.282 2.233 . . . . 0.0 114.637 -172.226 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.252 1.197 0 O-C-N 120.504 -1.373 . . . . 0.0 112.193 -162.75 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.66 46.25 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -160.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -62.73 -46.23 89.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.58 177.527 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -41.57 72.63 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 118.744 0.702 . . . . 0.0 110.954 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -50.59 -64.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 167.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.642 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 92.6 t -66.86 -38.45 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 120.761 1.619 . . . . 0.0 112.211 -166.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -59.97 0.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.04 2.936 . . . . 0.0 113.331 170.059 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -125.4 -37.38 2.38 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.764 1.226 . . . . 0.0 112.404 168.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -102.42 -24.06 13.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.421 1.488 . . . . 0.0 111.577 -159.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.566 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.3 m -120.43 -40.59 2.67 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.289 0.636 . . . . 0.0 111.172 -169.063 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -49.68 -30.84 5.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 122.283 0.233 . . . . 0.0 111.462 178.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -34.73 -41.48 0.13 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.367 2.267 . . . . 0.0 113.164 170.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 m -119.91 -36.33 3.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.445 0.698 . . . . 0.0 111.118 176.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -80.84 -2.54 47.74 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.89 -85.52 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 123.811 0.72 . . . . 0.0 112.464 164.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.68 -66.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -173.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.11 2.21 24.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.312 -0.522 . . . . 0.0 111.733 173.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 70.1 22.25 5.73 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.393 1.877 . . . . 0.0 111.389 -172.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -5.56 37.75 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.994 2.118 . . . . 0.0 112.063 173.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.44 147.03 21.91 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 174.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.76 -82.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.913 0.885 . . . . 0.0 109.992 174.091 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 m -92.13 -0.15 57.45 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.021 0.928 . . . . 0.0 111.047 171.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.33 157.18 63.53 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 105.635 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.33 167.06 19.46 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.688 2.258 . . . . 0.0 111.645 -175.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 113.56 3.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.028 175.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp -108.02 -1.89 9.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.411 172.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -34.95 -50.45 0.48 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.285 1.434 . . . . 0.0 111.648 162.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -92.37 0.9 57.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.075 1.35 . . . . 0.0 110.74 -171.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.3 70.63 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.032 -1.043 . . . . 0.0 111.777 -174.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.12 -32.58 76.48 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 119.818 1.19 . . . . 0.0 112.557 174.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.34 -38.05 36.06 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.305 -1.115 . . . . 0.0 111.607 175.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -74.2 -38.94 63.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.307 0.503 . . . . 0.0 111.81 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -133.63 170.86 14.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.973 1.709 . . . . 0.0 108.292 -167.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.3 t -105.86 169.38 8.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.068 0.547 . . . . 0.0 110.38 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -51.39 64.55 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.137 0.575 . . . . 0.0 109.778 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -42.94 -55.79 3.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.678 1.591 . . . . 0.0 113.165 173.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -56.72 -52.25 65.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.04 0.936 . . . . 0.0 109.844 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.01 -48.35 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -173.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.7 tp -49.9 -56.04 12.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.448 1.899 . . . . 0.0 109.997 175.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.56 -47.82 81.03 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -58.83 -42.5 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 122.111 -0.368 . . . . 0.0 110.451 -177.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.45 -50.03 82.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 121.26 -0.9 . . . . 0.0 109.764 176.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.76 -32.66 74.23 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.027 0.531 . . . . 0.0 112.193 -178.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -103.39 -59.19 1.75 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.043 1.737 . . . . 0.0 112.01 -168.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.47 -175.61 21.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.207 1.861 . . . . 0.0 110.74 -173.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -150.64 164.63 35.62 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 166.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 3.14 -94.88 0.01 OUTLIER Glycine 0 CA--C 1.541 1.682 0 C-N-CA 126.887 2.184 . . . . 0.0 116.403 173.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.92 26.01 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 118.494 1.147 . . . . 0.0 112.928 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -104.05 121.11 48.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.952 1.701 . . . . 0.0 108.178 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.65 -36.5 63.4 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.088 2.525 . . . . 0.0 112.545 -169.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.81 165.71 34.03 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 122.158 0.866 . . . . 0.0 111.694 178.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.97 25.48 67.97 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -173.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.08 -26.72 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.079 1.351 . . . . 0.0 110.182 -177.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.54 146.68 32.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -139.07 164.16 30.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.24 0.927 . . . . 0.0 111.338 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.91 -134.66 16.53 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.366 0.984 . . . . 0.0 110.658 -175.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.21 -38.48 3.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.958 1.303 . . . . 0.0 112.26 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.79 -54.24 47.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.2 86.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.649 -0.657 . . . . 0.0 111.138 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.43 -52.73 62.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.295 0.638 . . . . 0.0 110.113 177.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.65 -52.9 53.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.867 0.867 . . . . 0.0 109.833 178.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 28' ' ' VAL . 77.4 t -50.19 -63.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 123.341 0.4 . . . . 0.0 110.226 174.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.96 -49.69 49.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.86 0.864 . . . . 0.0 110.978 -171.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.87 -59.8 4.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 177.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.642 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 47.0 t90 -55.93 -35.7 66.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.058 0.943 . . . . 0.0 112.085 -177.384 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.41 -44.73 50.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.39 -0.819 . . . . 0.0 110.554 178.3 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.89 -22.37 66.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.604 -0.685 . . . . 0.0 112.169 174.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.48 -26.93 58.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.187 1.395 . . . . 0.0 111.652 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -9.87 56.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -149.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.4 pttt . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.933 -1.032 . . . . 0.0 113.016 -107.281 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -55.56 9.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.587 -170.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.15 -41.34 83.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.204 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.78 81.96 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.151 0.887 . . . . 0.0 110.499 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.62 -58.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 168.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 2.0 t -68.85 -39.48 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 116.898 -1.921 . . . . 0.0 110.406 -165.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -62.31 -0.2 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.971 3.308 . . . . 0.0 114.079 170.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.93 -11.54 0.98 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 171.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.04 -18.47 11.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.888 1.275 . . . . 0.0 111.022 -176.169 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.3 m -127.25 -46.15 1.51 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.602 0.637 . . . . 0.0 111.762 -167.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.6 pt -53.91 -24.66 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -49.24 -27.38 3.66 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.911 0.884 . . . . 0.0 112.301 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.13 -42.77 3.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.212 0.605 . . . . 0.0 110.868 167.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.86 -9.95 58.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.28 -88.36 0.4 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.18 1.371 . . . . 0.0 112.564 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.82 -60.49 0.02 OUTLIER Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -176.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.9 4.0 39.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.713 0.805 . . . . 0.0 111.735 172.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 28' ' ' VAL . 1.2 mt 74.85 20.86 2.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.134 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -76.49 -12.46 60.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.401 2.68 . . . . 0.0 111.321 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.32 83.4 1.71 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 169.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.1 -76.87 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.935 0.494 . . . . 0.0 110.663 177.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -94.62 2.06 55.61 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.405 1.082 . . . . 0.0 111.408 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.98 38.02 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 127.5 2.32 . . . . 0.0 105.414 -176.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.68 164.47 26.49 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.03 1.82 . . . . 0.0 111.68 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.18 13.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.959 0.904 . . . . 0.0 109.717 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.291 2.5 pp -112.1 -3.03 10.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 173.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -32.97 9.37 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.123 -0.985 . . . . 0.0 112.295 165.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.0 3.12 38.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.337 1.055 . . . . 0.0 112.629 177.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.33 -38.2 68.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 117.402 -1.285 . . . . 0.0 111.094 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.58 -26.69 60.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.841 1.655 . . . . 0.0 114.328 174.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.47 -47.08 16.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.958 0.879 . . . . 0.0 109.878 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -74.66 -44.82 48.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 122.501 0.32 . . . . 0.0 111.854 -173.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -123.3 157.2 33.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.658 1.983 . . . . 0.0 109.504 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -89.46 163.89 15.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 0.0 110.964 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -44.17 68.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.895 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -49.64 -53.12 26.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.861 1.665 . . . . 0.0 112.169 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.9 -48.91 79.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.491 0.717 . . . . 0.0 109.834 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.33 -52.24 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -48.9 -56.26 9.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.509 1.524 . . . . 0.0 110.076 177.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.14 -46.59 85.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -59.78 -38.86 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.904 -0.498 . . . . 0.0 111.387 -179.037 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -51.84 66.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 119.469 1.032 . . . . 0.0 109.755 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.15 -33.4 75.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.433 -175.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.7 -43.39 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.21 1.804 . . . . 0.0 112.238 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.07 111.4 2.65 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.163 1.363 . . . . 0.0 110.133 -169.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -55.19 145.88 20.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 161.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -13.48 -74.73 0.01 OUTLIER Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.902 2.191 . . . . 0.0 117.235 -175.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 -12.42 73.8 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.804 0.802 . . . . 0.0 113.775 -175.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.5 ttt -88.14 135.65 32.96 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 126.16 1.784 . . . . 0.0 109.518 -175.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.0 157.95 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.41 1.407 . . . . 0.0 110.959 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.89 146.99 18.67 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -175.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.32 71.7 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.5 mt -55.59 -35.42 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.549 1.14 . . . . 0.0 109.366 172.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.65 152.29 46.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -143.15 162.61 35.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.977 0.808 . . . . 0.0 111.413 177.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.91 -136.34 41.76 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.38 -36.26 4.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.582 1.153 . . . . 0.0 112.064 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.52 -55.79 24.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.17 85.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.553 -0.717 . . . . 0.0 110.408 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.66 -47.75 81.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.128 0.571 . . . . 0.0 110.998 177.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.82 62.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.16 -57.38 8.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.937 173.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.36 -55.99 5.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.12 0.873 . . . . 0.0 110.644 -175.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.04 -54.0 52.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.89 0.476 . . . . 0.0 111.306 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.66 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 57.3 t90 -62.3 -54.7 36.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.286 -176.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -40.54 79.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.872 -1.143 . . . . 0.0 110.083 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.15 -50.37 71.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.782 0.264 . . . . 0.0 111.028 170.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.28 -8.88 57.72 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.808 0.731 . . . . 0.0 112.264 -177.005 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -16.76 64.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.652 1.181 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.789 1.236 . . . . 0.0 113.055 -162.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -68.81 105.51 2.36 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.7 -46.77 81.03 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.607 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.2 -44.33 84.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -49.19 75.52 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 119.089 0.858 . . . . 0.0 111.436 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.7 t -49.03 -55.82 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.543 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.278 94.6 t -66.02 -43.18 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.512 -169.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -62.37 1.33 0.35 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.455 3.102 . . . . 0.0 114.115 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.73 -8.13 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -116.02 -26.01 7.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.853 1.261 . . . . 0.0 110.606 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -114.35 -42.06 3.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.489 0.586 . . . . 0.0 111.199 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -49.66 -30.91 5.8 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 122.673 0.389 . . . . 0.0 111.563 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.1 m -39.4 -38.52 0.56 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.57 1.548 . . . . 0.0 112.968 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.67 -43.95 2.77 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.758 0.423 . . . . 0.0 110.603 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -68.04 -17.24 64.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.82 155.45 31.53 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.13 -56.21 5.4 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.826 1.203 . . . . 0.0 113.97 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.61 0.33 43.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.254 0.621 . . . . 0.0 112.416 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.615 HD22 HD11 ' A' ' 48' ' ' ILE . 1.0 OUTLIER 62.58 27.73 16.35 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.962 1.305 . . . . 0.0 110.932 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 p -78.56 -8.81 58.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 128.778 2.831 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.84 76.75 1.23 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 118.293 0.497 . . . . 0.0 111.991 165.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.49 -85.31 0.1 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.897 0.479 . . . . 0.0 111.441 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.9 m -89.05 2.39 54.13 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 112.157 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.61 162.64 38.06 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.48 164.94 28.88 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.231 1.954 . . . . 0.0 111.128 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.93 119.31 10.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.389 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 40' ' ' LEU . 2.8 pp -113.77 -0.61 9.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 118.277 -0.868 . . . . 0.0 113.132 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -31.28 45.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 120.382 1.446 . . . . 0.0 112.147 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' NZ ' ' OXT' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -103.93 5.97 36.0 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.016 1.726 . . . . 0.0 112.552 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB3' HD22 ' A' ' 88' ' ' LEU . . . -54.37 -31.15 54.03 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.318 -1.489 . . . . 0.0 111.754 176.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.73 -27.61 68.61 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 120.324 1.42 . . . . 0.0 114.423 171.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.48 34.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.886 . . . . 0.0 109.03 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -73.86 -45.82 48.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.36 162.17 26.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.523 1.929 . . . . 0.0 109.262 -170.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 m -93.99 162.09 14.03 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.429 0.692 . . . . 0.0 110.331 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -50.56 -41.96 54.82 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.141 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.49 -58.24 5.54 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.099 0.863 . . . . 0.0 112.336 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -54.93 -51.1 67.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 110.085 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.596 HG23 HMA1 ' A' ' 93' ' ' HEC . 61.1 mt -64.61 -48.04 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -50.41 -55.42 15.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.47 1.908 . . . . 0.0 109.872 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -45.76 86.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 mt -59.77 -41.77 86.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.085 -1.009 . . . . 0.0 111.269 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 60' ' ' ILE . 19.6 mt -60.75 -47.72 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.046 -1.034 . . . . 0.0 109.544 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.275 0.63 . . . . 0.0 111.954 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -97.64 -54.26 3.18 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.585 1.554 . . . . 0.0 111.636 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.75 -169.63 19.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.317 1.913 . . . . 0.0 110.301 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -170.59 122.16 0.61 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 127.431 2.293 . . . . 0.0 105.109 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.19 -113.83 1.03 Allowed Glycine 0 CA--C 1.538 1.52 0 CA-C-N 120.146 1.339 . . . . 0.0 113.027 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.52 -14.65 82.23 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 118.235 1.018 . . . . 0.0 114.069 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.428 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.6 ttt -66.82 129.96 94.02 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 124.193 0.997 . . . . 0.0 109.966 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.484 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 51.9 Cg_endo -65.19 -40.01 21.28 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.08 2.52 . . . . 0.0 111.77 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.69 162.7 28.04 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.007 0.782 . . . . 0.0 111.774 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 17.65 66.27 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.737 0.684 . . . . 0.0 112.158 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 mm -61.16 -33.38 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.61 1.964 . . . . 0.0 110.391 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB1' ' HB3' ' A' ' 80' ' ' GLU . . . -134.75 144.34 47.65 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 157.99 43.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.437 0.695 . . . . 0.0 111.392 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.01 -137.34 32.65 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.08 -40.08 6.45 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.405 1.082 . . . . 0.0 112.726 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.7 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -53.0 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.531 0.605 . . . . 0.0 110.178 173.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.77 83.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.965 -0.46 . . . . 0.0 111.155 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -58.57 -55.15 38.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.411 0.684 . . . . 0.0 109.317 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.59 72.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.66 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG22 HG23 ' A' ' 28' ' ' VAL . 55.8 t -45.34 -66.94 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.79 70.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 111.601 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.38 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 110.769 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.525 ' CZ3' ' HG ' ' A' ' 88' ' ' LEU . 7.2 t90 -55.14 -43.16 73.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.096 0.558 . . . . 0.0 110.755 176.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.525 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.55 -49.76 75.37 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.508 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.93 -40.64 63.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.451 0.7 . . . . 0.0 110.667 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -73.91 -18.66 60.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.96 0.904 . . . . 0.0 112.331 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -13.12 61.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.776 1.23 . . . . 0.0 111.482 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' OXT' ' NZ ' ' A' ' 50' ' ' LYS . 8.4 pttt . . . . . 0 C--O 1.247 0.93 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -157.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.777 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -97.28 113.37 24.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -138.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.37 -53.23 23.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -156.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.63 -43.29 99.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.491 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.35 79.67 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.918 0.887 . . . . 0.0 110.983 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -51.43 -63.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.704 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 67.6 t -64.68 -40.43 89.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 121.066 -1.021 . . . . 0.0 112.498 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -61.23 0.76 0.23 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 128.808 2.843 . . . . 0.0 113.468 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.75 -25.6 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 165.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -104.5 -28.36 11.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.663 1.185 . . . . 0.0 111.452 -165.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.613 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.2 m -120.2 -39.79 2.77 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.248 0.619 . . . . 0.0 111.579 -167.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -48.62 -31.3 3.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 122.634 0.374 . . . . 0.0 111.143 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -36.75 -41.97 0.35 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.542 2.337 . . . . 0.0 113.38 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 m -116.9 -42.9 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.101 0.561 . . . . 0.0 110.649 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.84 -17.64 62.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.15 152.4 28.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.9 -53.91 7.12 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.037 1.303 . . . . 0.0 113.567 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.25 1.42 50.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.772 0.829 . . . . 0.0 112.056 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.69 HD22 HD11 ' A' ' 48' ' ' ILE . 9.7 mt 66.28 25.16 10.56 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.895 0.878 . . . . 0.0 110.961 171.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -84.61 -4.41 58.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.969 2.908 . . . . 0.0 111.13 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.63 77.12 1.32 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.399 0.545 . . . . 0.0 112.248 164.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.96 -78.43 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.067 0.434 . . . . 0.0 111.356 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -97.74 1.75 48.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.731 1.612 . . . . 0.0 111.965 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.92 162.7 39.65 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.54 164.75 31.69 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.839 1.692 . . . . 0.0 111.608 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.54 114.68 5.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.112 0.965 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.753 HD13 HD11 ' A' ' 88' ' ' LEU . 2.5 pp -102.52 -0.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 122.771 0.428 . . . . 0.0 111.845 173.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.06 -42.52 1.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.98 0.912 . . . . 0.0 111.986 162.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -99.81 5.09 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.058 1.343 . . . . 0.0 113.032 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.58 -42.65 34.42 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.634 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.72 68.28 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.604 1.093 . . . . 0.0 114.664 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.41 -47.66 26.35 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.12 0.96 . . . . 0.0 109.255 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -74.55 -39.3 62.39 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.236 0.615 . . . . 0.0 111.327 -170.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.74 161.58 34.3 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.02 2.128 . . . . 0.0 108.04 -171.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -99.6 156.51 17.03 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.062 0.945 . . . . 0.0 110.378 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.26 -51.1 6.37 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.893 0.877 . . . . 0.0 111.316 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -40.87 -52.77 3.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.753 1.621 . . . . 0.0 113.839 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.09 -47.89 75.63 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.355 -0.841 . . . . 0.0 109.842 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.53 HG23 HMA1 ' A' ' 93' ' ' HEC . 56.5 mt -61.77 -48.34 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -48.84 -56.28 9.18 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 126.748 2.019 . . . . 0.0 109.946 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.16 -48.29 76.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.7 mt -59.95 -42.24 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 O-C-N 122.028 -0.42 . . . . 0.0 110.749 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.39 -50.97 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.94 -36.86 85.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.962 0.505 . . . . 0.0 111.838 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -96.82 -58.39 2.05 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.572 1.549 . . . . 0.0 111.36 -169.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.29 -176.74 20.11 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.377 1.941 . . . . 0.0 110.354 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -145.33 163.21 35.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 103.298 -2.853 . . . . 0.0 103.298 166.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -23.63 -77.47 0.01 OUTLIER Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.704 1.621 . . . . 0.0 115.676 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.23 32.2 6.39 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 118.5 1.15 . . . . 0.0 113.506 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -124.32 124.72 25.78 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.197 1.399 . . . . 0.0 109.363 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.97 -38.73 55.8 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.866 2.378 . . . . 0.0 113.173 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.45 163.33 32.85 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 121.802 0.668 . . . . 0.0 112.237 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.48 66.9 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.8 mt -69.13 -29.07 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.177 1.391 . . . . 0.0 110.139 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.09 145.24 41.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -140.51 152.18 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.665 1.121 . . . . 0.0 113.267 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.06 -137.16 50.63 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.47 -38.68 4.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.236 1.414 . . . . 0.0 112.031 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -54.74 -57.37 11.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.826 1.25 . . . . 0.0 109.859 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.28 87.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 110.649 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.46 -53.36 55.21 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.332 0.653 . . . . 0.0 109.849 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.98 -55.12 25.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.99 0.916 . . . . 0.0 109.848 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.7 t -51.07 -54.41 10.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 122.922 0.139 . . . . 0.0 110.971 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.3 -52.34 65.75 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.092 0.557 . . . . 0.0 110.777 -172.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.23 -54.3 38.13 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.55 0.69 . . . . 0.0 109.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.704 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 51.6 t90 -57.6 -40.72 79.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.485 0.714 . . . . 0.0 112.14 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.753 HD11 HD13 ' A' ' 48' ' ' ILE 0.305 3.7 mt -68.05 -39.66 82.96 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 120.618 -1.301 . . . . 0.0 112.887 175.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.12 72.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.307 0.503 . . . . 0.0 111.108 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -73.24 -28.84 62.37 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.316 1.046 . . . . 0.0 111.211 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -20.72 66.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.548 1.139 . . . . 0.0 113.68 -169.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 pttt . . . . . 0 C--O 1.251 1.152 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -151.267 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.736 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 103.101 -2.926 . . . . 0.0 103.101 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.13 110.62 4.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.35 86.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.613 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.61 -43.31 73.02 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 -49.59 68.54 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 119.002 0.819 . . . . 0.0 111.246 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -47.99 -59.15 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.566 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.261 87.8 t -68.93 -38.47 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 116.83 -1.948 . . . . 0.0 111.37 -166.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.04 0.19 0.25 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 129.186 2.994 . . . . 0.0 113.947 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 -13.48 1.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.1 -26.63 8.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.93 1.292 . . . . 0.0 110.817 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.8 m -115.01 -40.72 3.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.706 0.684 . . . . 0.0 111.976 -172.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.6 pt -49.34 -30.14 4.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 122.619 0.368 . . . . 0.0 111.706 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.9 t -38.66 -42.24 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.067 1.747 . . . . 0.0 111.653 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -116.2 -42.65 3.02 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.267 0.627 . . . . 0.0 111.002 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -71.71 -13.21 61.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.24 153.0 21.71 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.01 -60.52 2.21 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.281 1.419 . . . . 0.0 113.53 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.55 -2.28 34.82 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.577 0.751 . . . . 0.0 112.571 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 28' ' ' VAL . 1.4 mt 66.84 26.53 9.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.23 1.812 . . . . 0.0 111.007 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -79.29 -7.99 58.71 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.701 2.8 . . . . 0.0 111.563 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.86 83.62 1.69 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 168.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.68 -84.09 0.18 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.011 0.524 . . . . 0.0 110.549 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -88.97 2.1 54.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.263 1.425 . . . . 0.0 111.89 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.79 41.32 Favored Pre-proline 0 N--CA 1.452 -0.36 0 C-N-CA 126.925 2.09 . . . . 0.0 105.413 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.47 164.37 23.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.922 1.748 . . . . 0.0 111.007 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.59 122.88 18.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.467 HD11 HD22 ' A' ' 40' ' ' LEU 0.296 1.9 pp -119.42 0.5 7.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.968 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -41.41 -43.95 2.7 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.783 1.174 . . . . 0.0 112.133 164.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -101.92 6.17 41.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.429 1.892 . . . . 0.0 112.12 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -33.02 42.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.02 -0.991 . . . . 0.0 111.552 172.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.1 -31.98 78.73 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.768 1.622 . . . . 0.0 113.647 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.0 -49.42 37.15 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 118.147 0.974 . . . . 0.0 109.746 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.79 -42.22 50.67 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.324 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -118.37 179.76 4.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.889 1.676 . . . . 0.0 107.639 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.2 m -120.14 163.37 17.81 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.577 -0.702 . . . . 0.0 109.987 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -52.51 19.45 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.471 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -35.69 -61.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.719 1.208 . . . . 0.0 113.421 168.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -55.77 30.81 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 121.855 0.835 . . . . 0.0 109.769 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.645 HG23 HMA1 ' A' ' 93' ' ' HEC . 64.5 mt -60.12 -47.06 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -171.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.9 -53.81 29.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.976 1.71 . . . . 0.0 109.99 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.11 -49.8 68.31 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.42 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.461 -0.775 . . . . 0.0 110.88 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 60' ' ' ILE . 22.0 mt -59.65 -49.11 84.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 O-C-N 120.813 -1.179 . . . . 0.0 109.638 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.3 -37.19 82.99 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.743 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -94.9 -58.15 2.25 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.211 1.404 . . . . 0.0 111.458 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.5 -171.03 21.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.177 2.322 . . . . 0.0 109.675 -168.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -156.73 163.73 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.48 -90.05 0.0 OUTLIER Glycine 0 CA--C 1.544 1.863 0 C-N-CA 126.27 1.89 . . . . 0.0 116.57 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.66 13.83 66.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.859 1.329 . . . . 0.0 114.202 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.432 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 21.6 ttt -99.12 126.14 39.16 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 125.569 1.547 . . . . 0.0 109.073 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.63 -40.65 22.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.698 2.266 . . . . 0.0 112.348 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.27 163.71 31.26 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.716 0.62 . . . . 0.0 112.161 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.44 20.11 65.25 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mt -66.97 -32.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 125.426 1.49 . . . . 0.0 109.619 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.02 146.49 47.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -146.73 162.83 37.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.2 -139.78 40.63 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.09 -38.56 1.06 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.546 1.539 . . . . 0.0 112.467 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -55.54 -61.09 2.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.405 1.082 . . . . 0.0 110.015 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.69 -38.01 80.0 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.699 -0.626 . . . . 0.0 110.788 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -55.49 -54.29 45.73 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.38 62.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.58 0.752 . . . . 0.0 109.663 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 HG23 ' A' ' 28' ' ' VAL . 58.6 t -46.82 -66.03 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 O-C-N 123.363 0.414 . . . . 0.0 110.256 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.24 -47.43 75.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.063 0.945 . . . . 0.0 110.616 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -56.31 23.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.385 0.274 . . . . 0.0 110.373 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.453 ' HZ3' HG11 ' A' ' 28' ' ' VAL . 45.5 t90 -55.31 -43.04 74.5 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.568 0.747 . . . . 0.0 110.946 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.04 -51.48 63.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.679 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.25 68.28 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.035 0.534 . . . . 0.0 110.959 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.79 -20.5 61.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.244 0.618 . . . . 0.0 110.764 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -70.84 -27.42 63.84 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.155 -0.966 . . . . 0.0 111.121 -165.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.788 2.435 . . . . 0.0 114.081 -151.575 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.758 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.34 102.72 2.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.27 1.428 . . . . 0.0 107.526 -164.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.42 -52.17 40.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.019 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -60.53 -40.75 92.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.815 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.79 -44.61 90.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.023 0.829 . . . . 0.0 110.659 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.6 t -49.5 -60.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.555 ' HA ' ' SG ' ' A' ' 32' ' ' CYS 0.258 17.3 t -65.01 -41.16 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 116.462 -2.095 . . . . 0.0 111.968 -168.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -61.29 0.4 0.28 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.074 2.95 . . . . 0.0 114.28 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.81 -13.43 0.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -114.65 -21.38 10.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.434 1.494 . . . . 0.0 111.427 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.6 m -123.26 -40.13 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.377 0.535 . . . . 0.0 111.183 -168.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -48.59 -30.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 C-N-CA 122.96 0.504 . . . . 0.0 111.746 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.7 m -40.82 -37.06 0.71 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.089 1.755 . . . . 0.0 112.885 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 m -119.66 -43.5 2.58 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 122.859 0.464 . . . . 0.0 110.739 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.4 -14.9 62.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.05 153.4 25.84 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.09 4.55 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.224 1.393 . . . . 0.0 113.564 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -81.52 -0.27 41.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.06 0.544 . . . . 0.0 112.136 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 HG12 ' A' ' 28' ' ' VAL . 4.8 mt 64.71 25.85 13.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.59 1.556 . . . . 0.0 111.003 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -81.38 -8.31 59.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 128.901 2.88 . . . . 0.0 111.407 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.52 79.27 1.45 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 118.332 0.515 . . . . 0.0 112.21 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.57 -81.74 0.14 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.708 0.403 . . . . 0.0 111.226 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -91.64 1.97 56.78 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.548 1.539 . . . . 0.0 112.015 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.15 162.03 45.08 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.96 164.15 25.82 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.845 1.697 . . . . 0.0 111.088 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.47 122.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 40' ' ' LEU 0.323 2.4 pp -116.5 1.07 8.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.877 174.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -35.26 18.74 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.143 1.338 . . . . 0.0 112.344 168.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -99.16 4.31 46.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.172 1.389 . . . . 0.0 112.309 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.49 -33.05 52.95 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 120.92 -1.113 . . . . 0.0 111.168 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.95 -31.15 79.62 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.45 1.023 . . . . 0.0 114.41 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -43.9 38.09 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.818 -0.813 . . . . 0.0 110.076 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -74.16 -39.92 62.93 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.678 0.391 . . . . 0.0 111.538 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -131.6 156.35 45.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.114 1.766 . . . . 0.0 108.054 -169.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -92.88 162.56 14.04 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.753 -0.592 . . . . 0.0 110.506 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -46.56 -46.59 19.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.224 0.609 . . . . 0.0 110.772 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.39 -57.38 4.09 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.822 1.249 . . . . 0.0 112.899 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 -50.94 71.5 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.046 0.927 . . . . 0.0 110.073 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.588 HG23 HMA1 ' A' ' 93' ' ' HEC . 59.9 mt -63.42 -47.26 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.1 tp -50.29 -54.89 18.08 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.745 1.618 . . . . 0.0 109.988 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.14 -49.8 70.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -58.29 -43.23 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.568 -0.708 . . . . 0.0 111.082 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 60' ' ' ILE . 28.7 mt -60.88 -51.05 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.03 -29.9 69.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.551 0.741 . . . . 0.0 112.542 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -102.5 -60.17 1.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.27 1.828 . . . . 0.0 111.268 -170.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.23 -173.18 21.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.558 2.028 . . . . 0.0 110.655 -168.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -152.62 161.04 43.11 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 102.741 -3.059 . . . . 0.0 102.741 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.32 -71.09 0.07 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 120.489 1.495 . . . . 0.0 115.427 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.47 23.37 28.14 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 118.058 0.929 . . . . 0.0 113.763 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -117.94 131.97 23.9 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.075 1.35 . . . . 0.0 109.34 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.503 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 43.7 Cg_endo -65.26 -40.72 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.661 2.241 . . . . 0.0 112.187 -172.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.22 157.57 17.99 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 121.699 0.611 . . . . 0.0 112.426 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 17.84 61.39 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mm -58.76 -37.2 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.529 1.132 . . . . 0.0 109.587 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.82 146.35 52.24 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -144.22 154.6 43.28 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.67 -139.21 48.1 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.6 -37.16 5.29 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.017 1.327 . . . . 0.0 111.738 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -53.74 -60.99 2.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.478 1.111 . . . . 0.0 110.061 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.35 79.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.814 -0.554 . . . . 0.0 110.667 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.94 -52.92 63.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.02 0.438 . . . . 0.0 109.913 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.03 -52.52 60.59 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.829 0.851 . . . . 0.0 109.607 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -48.24 -65.2 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 119.172 -0.442 . . . . 0.0 109.87 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.05 -49.93 49.44 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.429 1.091 . . . . 0.0 111.453 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.65 -57.08 14.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.999 0.428 . . . . 0.0 110.566 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.524 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 68.7 t90 -56.36 -34.47 66.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.569 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.74 -43.85 52.83 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.16 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.13 -32.74 66.66 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.74 -0.6 . . . . 0.0 111.008 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.09 -23.14 59.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.079 0.952 . . . . 0.0 111.924 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.51 4.09 0.42 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.519 2.328 . . . . 0.0 115.671 -165.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.103 0 O-C-N 119.993 -1.692 . . . . 0.0 113.457 -125.594 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.766 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.61 97.71 0.82 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 123.024 1.392 . . . . 0.0 107.727 -163.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.22 82.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.744 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -56.89 -45.32 82.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.942 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.58 96.46 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.687 0.676 . . . . 0.0 110.681 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -51.48 -65.76 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.794 HG13 ' HB2' ' A' ' 32' ' ' CYS . 73.7 t -63.1 -42.03 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 120.088 1.313 . . . . 0.0 110.793 -165.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -1.44 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.59 2.756 . . . . 0.0 113.261 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.78 0.96 2.05 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 169.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -125.01 -54.61 1.61 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.319 1.048 . . . . 0.0 109.986 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.794 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.9 m -90.0 -41.82 11.5 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.769 0.428 . . . . 0.0 110.248 -169.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 pt -52.74 -27.21 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.038 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -47.51 -29.33 2.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.923 1.289 . . . . 0.0 112.363 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 m -122.9 -41.58 2.34 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.542 0.61 . . . . 0.0 110.864 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -70.7 -17.35 62.83 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.81 150.15 18.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.46 -59.88 1.5 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.703 1.62 . . . . 0.0 113.969 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.01 -15.42 61.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.767 1.227 . . . . 0.0 112.77 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.589 HD22 HD11 ' A' ' 48' ' ' ILE . 1.4 mt 77.06 23.87 0.9 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.704 2.402 . . . . 0.0 111.098 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 p -75.73 -9.17 58.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 111.961 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.19 81.07 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.671 . . . . 0.0 111.797 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.66 -78.92 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.797 0.439 . . . . 0.0 111.1 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -93.98 2.6 56.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.609 1.563 . . . . 0.0 111.502 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.36 163.05 34.25 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.97 165.48 21.35 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.792 1.661 . . . . 0.0 111.189 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.77 119.7 11.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.825 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.589 HD11 HD22 ' A' ' 40' ' ' LEU 0.319 2.1 pp -115.65 1.3 8.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.734 174.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.52 -40.31 18.39 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.519 1.054 . . . . 0.0 111.606 167.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -93.12 2.8 56.55 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 125.699 1.599 . . . . 0.0 111.315 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.13 -34.92 66.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.184 0.902 . . . . 0.0 111.183 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.47 -31.75 78.62 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.479 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.42 -46.23 28.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.514 1.157 . . . . 0.0 110.455 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -74.37 -40.67 61.95 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 111.264 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -124.91 -177.94 4.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.52 2.328 . . . . 0.0 107.893 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -122.92 169.47 11.11 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.607 -0.683 . . . . 0.0 110.32 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -42.73 67.29 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.436 0.694 . . . . 0.0 110.374 -171.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -51.12 -56.26 13.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 112.913 175.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 31.5 mm-40 -56.55 -49.35 75.07 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.185 1.394 . . . . 0.0 109.176 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.89 -51.22 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.75 -56.15 11.32 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.253 1.021 . . . . 0.0 109.912 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.67 -41.12 97.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.705 -0.798 . . . . 0.0 108.904 -175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.8 mt -62.72 -39.98 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.817 -0.552 . . . . 0.0 111.325 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.413 HD11 HMB2 ' A' ' 93' ' ' HEC . 94.5 mt -59.47 -51.09 76.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 O-C-N 120.719 -1.238 . . . . 0.0 109.571 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.87 -42.1 99.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -91.82 -50.6 5.64 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 112.323 -168.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.33 -167.66 14.84 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.976 1.75 . . . . 0.0 110.112 -168.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -169.37 131.02 1.14 Allowed 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.13 -112.38 0.5 Allowed Glycine 0 CA--C 1.539 1.559 0 CA-C-N 120.486 1.494 . . . . 0.0 113.078 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 -10.31 76.11 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.363 1.082 . . . . 0.0 114.263 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.408 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.5 ttt -64.46 126.43 90.58 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 118.549 1.175 . . . . 0.0 109.405 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.88 -34.82 37.99 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.007 2.471 . . . . 0.0 112.621 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.57 164.32 36.4 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.55 19.4 68.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.667 0.651 . . . . 0.0 112.077 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.09 -29.77 48.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.698 1.199 . . . . 0.0 110.445 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.61 153.21 42.29 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -146.87 162.12 39.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.39 -138.53 45.91 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.1 -6.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.176 1.791 . . . . 0.0 114.909 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.59 -67.19 0.79 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.243 1.817 . . . . 0.0 108.223 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.44 90.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.454 -0.779 . . . . 0.0 111.004 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.23 -48.58 76.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.66 91.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.694 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.1 t -53.05 -49.45 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.47 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.59 -56.58 6.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.096 0.862 . . . . 0.0 110.391 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.87 -55.67 30.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.745 0.418 . . . . 0.0 111.611 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.62 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 55.8 t90 -58.05 -49.9 75.3 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.023 0.916 . . . . 0.0 111.351 -175.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.495 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -64.37 -43.27 95.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.182 0.993 . . . . 0.0 109.6 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.71 -41.81 67.4 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.625 170.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.99 -13.61 60.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.035 0.934 . . . . 0.0 112.459 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -15.56 56.33 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.704 -1.247 . . . . 0.0 113.242 -169.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.596 1.158 . . . . 0.0 113.765 -150.146 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.742 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.56 1.41 Allowed 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 125.509 1.524 . . . . 0.0 107.928 -160.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.35 63.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.901 -166.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -62.2 -43.08 99.63 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.283 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.31 85.9 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 119.452 1.024 . . . . 0.0 110.984 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -47.09 -64.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 32' ' ' CYS . 69.3 t -64.41 -43.46 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 117.711 -1.596 . . . . 0.0 112.244 -167.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -56.02 -2.32 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.564 3.145 . . . . 0.0 112.984 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.66 2.59 2.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.286 0.948 . . . . 0.0 113.507 170.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -129.33 -53.06 1.18 Allowed 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.141 0.977 . . . . 0.0 110.541 -168.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.691 ' HB2' HG13 ' A' ' 28' ' ' VAL . 1.9 m -95.62 -40.3 9.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.934 0.494 . . . . 0.0 109.756 -171.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 pt -52.45 -28.02 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.054 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.17 -30.26 2.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.115 1.366 . . . . 0.0 112.571 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.0 m -126.28 -37.25 2.24 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.409 0.683 . . . . 0.0 111.316 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -78.71 -10.56 59.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.27 153.11 22.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.121 0.867 . . . . 0.0 110.946 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -47.5 5.99 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.424 1.488 . . . . 0.0 113.665 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -85.14 -10.3 56.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.824 1.25 . . . . 0.0 112.224 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 48' ' ' ILE . 1.4 mt 70.18 23.05 5.32 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.855 2.062 . . . . 0.0 111.709 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -76.2 -7.37 54.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.722 2.409 . . . . 0.0 111.89 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.86 112.47 2.08 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.56 -72.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.469 0.708 . . . . 0.0 109.475 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -93.99 2.05 56.15 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.628 1.171 . . . . 0.0 110.737 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.63 162.06 38.01 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.579 1.951 . . . . 0.0 106.034 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.41 163.91 22.17 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.862 1.708 . . . . 0.0 110.622 174.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.46 121.55 14.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.595 HD11 HD22 ' A' ' 40' ' ' LEU 0.25 2.0 pp -115.62 -1.59 9.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.972 174.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -38.69 -46.82 1.28 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.359 0.982 . . . . 0.0 112.216 165.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -98.32 3.93 48.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.814 2.046 . . . . 0.0 111.177 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.25 -32.66 56.59 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.174 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.78 -30.42 72.69 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 119.886 1.221 . . . . 0.0 113.68 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.33 -45.55 38.8 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 118.281 1.04 . . . . 0.0 109.359 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -73.67 -41.16 63.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.048 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -130.4 165.01 23.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 127.186 2.194 . . . . 0.0 107.766 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 m -103.77 167.92 9.47 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.931 -0.481 . . . . 0.0 110.691 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -38.63 68.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.322 -173.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -53.87 -48.04 70.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.598 0.636 . . . . 0.0 112.449 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -66.17 -47.71 73.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 122.504 1.145 . . . . 0.0 108.503 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.72 -47.14 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.3 tp -51.81 -55.49 19.58 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 110.623 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.66 -54.57 11.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -63.8 -39.95 87.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.579 -171.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.83 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 121.294 -0.878 . . . . 0.0 109.396 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.46 -35.17 80.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -100.71 -55.79 2.5 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.376 1.471 . . . . 0.0 112.303 -168.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.12 -168.09 22.16 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.903 1.716 . . . . 0.0 110.383 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -164.06 160.99 22.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.16 2.984 . . . . 0.0 103.392 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 9.56 -99.41 0.01 OUTLIER Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.382 1.944 . . . . 0.0 116.302 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.55 17.79 57.13 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 118.491 1.146 . . . . 0.0 113.584 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.1 ttt -89.05 129.62 47.46 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 125.313 1.445 . . . . 0.0 108.464 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.509 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 36.3 Cg_endo -62.48 -41.22 33.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.833 2.356 . . . . 0.0 112.048 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 159.38 17.23 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.14 20.56 62.92 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 122.165 -0.609 . . . . 0.0 111.614 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.5 mm -63.5 -29.12 46.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 124.518 1.127 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 149.15 45.5 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -142.19 157.77 44.49 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.294 0.952 . . . . 0.0 113.248 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.84 -141.51 44.86 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.05 -35.71 2.23 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.197 1.399 . . . . 0.0 112.563 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.36 -62.55 1.58 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.607 1.163 . . . . 0.0 110.179 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.16 80.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.173 0.589 . . . . 0.0 110.715 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.66 -50.36 74.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.544 0.687 . . . . 0.0 109.634 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.52 -48.09 81.98 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.118 -0.467 . . . . 0.0 110.027 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 28' ' ' VAL . 78.0 t -49.95 -55.9 4.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.263 172.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.3 17.51 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.051 0.841 . . . . 0.0 110.556 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.85 78.96 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.005 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.616 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 71.7 t90 -61.13 -46.06 92.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.033 0.533 . . . . 0.0 111.72 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' CD2' ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -66.56 -43.83 83.97 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.64 -47.81 58.33 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.11 -10.17 59.41 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.341 -0.85 . . . . 0.0 112.172 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 -5.45 59.24 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.871 -1.143 . . . . 0.0 112.079 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 C--O 1.247 0.948 0 C-N-CA 125.957 1.703 . . . . 0.0 114.194 -164.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.774 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.5 98.15 2.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.414 1.085 . . . . 0.0 108.715 -161.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.9 58.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.97 -1.013 . . . . 0.0 113.06 -165.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.18 -44.24 97.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.208 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.11 77.25 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.557 0.617 . . . . 0.0 110.852 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.03 -60.89 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 170.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.708 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.25 63.2 t -66.85 -40.76 86.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 121.078 -1.014 . . . . 0.0 112.047 -168.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -60.34 1.05 0.14 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.04 2.936 . . . . 0.0 113.746 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.31 -22.64 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 168.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -15.96 11.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 111.999 -167.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.9 m -121.55 -41.39 2.49 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.58 0.627 . . . . 0.0 111.283 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.0 pt -48.68 -29.81 2.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 122.974 0.51 . . . . 0.0 111.561 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -38.1 -44.94 0.87 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.918 1.687 . . . . 0.0 112.02 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -113.19 -41.66 3.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.873 0.469 . . . . 0.0 110.73 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -71.27 -15.31 62.42 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.55 152.04 24.28 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -56.99 3.88 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.029 1.3 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 -5.86 49.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.956 1.302 . . . . 0.0 112.046 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 mt 66.53 20.38 10.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.099 1.759 . . . . 0.0 111.89 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 p -81.31 1.15 33.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.91 2.084 . . . . 0.0 111.647 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 79.21 1.44 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.596 0.635 . . . . 0.0 112.441 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.08 -80.37 0.13 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.973 0.387 . . . . 0.0 111.135 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m -94.51 1.94 55.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.442 1.497 . . . . 0.0 112.068 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.1 46.9 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.85 164.58 21.24 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.661 1.574 . . . . 0.0 110.992 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.85 113.22 6.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.861 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.437 ' O ' HD11 ' A' ' 88' ' ' LEU 0.262 2.3 pp -107.96 -2.02 10.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.604 178.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -32.92 -54.53 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.112 1.365 . . . . 0.0 112.261 163.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 3.14 54.73 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.923 2.089 . . . . 0.0 111.429 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.65 -37.76 42.57 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.196 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.97 -27.54 59.74 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 118.916 0.78 . . . . 0.0 115.001 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -44.5 55.67 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.266 1.033 . . . . 0.0 110.212 171.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -74.05 -38.45 63.98 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.66 0.384 . . . . 0.0 111.258 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -140.47 160.41 40.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.572 1.949 . . . . 0.0 108.348 -167.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -94.59 165.84 12.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.541 0.736 . . . . 0.0 111.127 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.18 -45.87 53.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.42 0.688 . . . . 0.0 110.387 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.26 -49.84 31.93 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.024 0.93 . . . . 0.0 112.573 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.48 -51.38 60.51 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.034 0.934 . . . . 0.0 110.276 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.24 -47.48 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.2 tp -48.02 -56.74 6.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.306 1.842 . . . . 0.0 110.12 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.34 -47.81 78.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.1 -44.18 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 122.277 -0.264 . . . . 0.0 110.762 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.2 mt -61.14 -50.65 79.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.115 -0.99 . . . . 0.0 109.724 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -39.74 89.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.562 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -94.81 -61.24 1.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.587 1.955 . . . . 0.0 111.59 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.33 -175.86 21.14 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.571 2.034 . . . . 0.0 110.202 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -150.97 164.46 36.32 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 167.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -4.97 -91.75 0.0 OUTLIER Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.965 2.221 . . . . 0.0 116.272 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.53 34.72 5.34 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.558 1.179 . . . . 0.0 112.58 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.413 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.7 ttt -114.49 123.97 31.43 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 125.592 1.557 . . . . 0.0 108.671 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.64 -38.67 59.83 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.869 2.38 . . . . 0.0 112.621 -170.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 162.61 27.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 122.077 0.82 . . . . 0.0 111.857 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.98 21.22 65.46 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 mt -64.55 -30.17 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.838 1.255 . . . . 0.0 109.559 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.48 149.48 44.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -143.83 164.5 30.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.231 0.923 . . . . 0.0 111.681 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.64 -140.85 43.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.38 -35.21 5.25 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.939 1.295 . . . . 0.0 112.095 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.04 -56.14 26.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.866 0.466 . . . . 0.0 109.921 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.32 81.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.643 -0.661 . . . . 0.0 110.72 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -56.53 -53.04 62.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.144 0.429 . . . . 0.0 110.214 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.01 57.27 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.402 0.681 . . . . 0.0 109.932 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.2 -61.96 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.28 -51.96 49.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.702 0.801 . . . . 0.0 111.374 -170.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.35 -56.18 25.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 110.656 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.964 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 20.4 t90 -54.09 -41.0 67.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.439 0.696 . . . . 0.0 111.467 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.964 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -79.02 -28.63 43.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.856 -1.153 . . . . 0.0 111.291 -175.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.88 67.28 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.576 0.75 . . . . 0.0 111.375 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.79 62.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.332 1.053 . . . . 0.0 110.75 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.504 ' HA ' ' CE ' ' A' ' 91' ' ' LYS 0.33 0.0 OUTLIER -62.64 9.4 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 118.924 2.935 . . . . 0.0 118.924 -163.102 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--O 1.251 1.166 0 O-C-N 120.77 -1.206 . . . . 0.0 113.26 -149.811 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.735 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.487 HG11 ' HG3' ' A' ' 80' ' ' GLU . 99.1 t . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -72.09 102.73 3.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -168.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.99 -49.6 20.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.445 1.098 . . . . 0.0 112.339 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -61.15 -44.77 96.8 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.751 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.1 82.92 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.414 1.006 . . . . 0.0 111.476 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -51.57 -63.2 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.678 HG22 ' SG ' ' A' ' 32' ' ' CYS 0.258 34.1 t -67.05 -39.54 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.696 -164.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.93 0.86 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.174 2.99 . . . . 0.0 112.987 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.45 -25.36 3.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.736 1.153 . . . . 0.0 113.996 165.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -117.85 -17.92 9.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.625 1.17 . . . . 0.0 113.041 -163.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.678 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.6 m -113.58 -39.72 3.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.679 1.127 . . . . 0.0 111.275 176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 pt -50.3 -29.29 5.91 Favored 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -47.6 -29.58 3.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.812 1.245 . . . . 0.0 112.813 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -123.61 -41.52 2.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.696 0.799 . . . . 0.0 110.624 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -74.63 -10.63 59.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.81 152.3 13.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.56 -57.97 2.64 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.476 1.512 . . . . 0.0 113.452 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -5.84 53.3 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.856 1.662 . . . . 0.0 112.523 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD21 HG12 ' A' ' 28' ' ' VAL . 8.0 mt 69.96 21.58 6.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.256 1.822 . . . . 0.0 111.485 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -75.28 -8.09 55.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.406 2.283 . . . . 0.0 111.766 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 99.29 1.49 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 -76.5 0.56 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.471 0.635 . . . . 0.0 109.811 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 m -93.98 2.06 56.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.506 1.523 . . . . 0.0 111.691 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.12 161.3 45.85 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 127.207 2.203 . . . . 0.0 105.303 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.7 165.67 22.48 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.33 2.02 . . . . 0.0 111.094 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 120.76 13.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.893 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 2.0 pp -117.23 0.54 8.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.063 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.26 -43.63 10.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.257 0.935 . . . . 0.0 111.207 164.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -96.53 3.89 52.39 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.561 1.544 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -52.81 -34.58 54.35 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.633 -0.667 . . . . 0.0 111.131 173.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.06 -30.47 75.68 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.045 0.839 . . . . 0.0 113.567 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.49 -47.24 17.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.987 0.893 . . . . 0.0 110.199 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.64 -44.58 49.73 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.704 0.402 . . . . 0.0 111.591 -171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.22 -178.28 3.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.833 2.053 . . . . 0.0 107.288 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.8 t -123.64 171.92 9.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 0.566 . . . . 0.0 110.294 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.79 -44.12 73.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.338 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -52.37 -48.19 65.73 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.959 0.8 . . . . 0.0 111.567 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.0 -50.38 64.48 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.512 0.672 . . . . 0.0 109.69 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.24 -47.16 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.4 tp -49.88 -55.48 14.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.76 -48.27 72.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.471 HG21 ' C3A' ' A' ' 93' ' ' HEC . 1.0 OUTLIER -58.74 -47.43 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.144 -0.348 . . . . 0.0 110.26 -179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.49 -48.32 87.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 120.835 -1.165 . . . . 0.0 110.022 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.7 -43.18 89.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -86.5 -56.42 3.43 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.19 1.396 . . . . 0.0 110.934 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.1 -160.69 21.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 126.841 2.162 . . . . 0.0 108.737 -166.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 0.0 OUTLIER -158.38 162.71 37.66 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 101.811 -3.403 . . . . 0.0 101.811 174.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.16 -54.56 1.23 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.865 1.221 . . . . 0.0 113.983 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -105.74 30.64 9.45 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 117.478 0.639 . . . . 0.0 113.264 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.6 ttt -137.8 129.52 16.22 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 118.664 1.232 . . . . 0.0 109.449 -176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.55 -41.98 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.103 2.535 . . . . 0.0 113.058 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.23 166.55 39.94 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-O 121.841 0.69 . . . . 0.0 112.18 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.47 19.48 68.82 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.3 -35.11 70.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 125.757 1.623 . . . . 0.0 109.63 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.49 146.12 41.64 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 165.3 30.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.066 0.546 . . . . 0.0 112.436 177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.47 -141.36 35.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -173.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.84 -38.94 0.73 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.746 1.619 . . . . 0.0 112.395 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.487 ' HG3' HG11 ' A' ' 22' ' ' VAL . 29.0 tt0 -59.38 -58.83 6.9 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.925 0.49 . . . . 0.0 110.191 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.0 90.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.567 -0.708 . . . . 0.0 110.67 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.22 -51.95 55.26 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.471 0.708 . . . . 0.0 109.77 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.49 69.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.36 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -48.84 -61.3 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 118.396 0.543 . . . . 0.0 110.026 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.42 -55.79 9.9 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.168 0.987 . . . . 0.0 111.805 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.94 -53.49 57.36 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.707 0.765 . . . . 0.0 110.637 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.652 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 57.8 t90 -57.41 -37.36 72.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.203 0.525 . . . . 0.0 111.625 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.527 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -72.53 -42.97 64.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 121.241 -0.912 . . . . 0.0 109.475 -177.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -36.92 64.13 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.255 0.222 . . . . 0.0 110.736 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.08 -18.68 60.78 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.733 -0.605 . . . . 0.0 112.411 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 7.62 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.962 2.505 . . . . 0.0 114.934 -172.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.251 1.158 0 O-C-N 119.791 -1.818 . . . . 0.0 113.144 -143.348 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.675 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.25 100.55 2.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.11 1.364 . . . . 0.0 107.591 -163.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.06 -50.68 35.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.179 0.991 . . . . 0.0 112.485 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.33 -44.51 97.07 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.715 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.96 78.58 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.181 0.901 . . . . 0.0 111.184 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.27 -64.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 72.3 t -67.64 -39.32 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 117.921 -1.512 . . . . 0.0 111.851 -163.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -57.89 0.46 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.999 3.32 . . . . 0.0 114.271 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.63 -37.58 1.57 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.607 1.094 . . . . 0.0 113.241 164.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 -32.32 15.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.436 1.494 . . . . 0.0 110.201 -163.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 1.9 m -110.77 -39.15 4.93 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.407 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 pt -51.6 -28.87 9.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 O-C-N 123.121 0.263 . . . . 0.0 111.651 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 t -37.55 -45.66 0.77 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.958 1.703 . . . . 0.0 111.768 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.9 m -110.88 -43.06 3.85 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 122.832 0.453 . . . . 0.0 110.619 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -72.49 -15.47 61.8 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.41 153.13 24.37 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.89 -56.93 4.25 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.15 1.357 . . . . 0.0 113.664 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.4 -0.8 38.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.913 0.485 . . . . 0.0 112.172 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD21 HG12 ' A' ' 28' ' ' VAL . 1.7 mt 66.28 23.65 10.75 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.134 1.774 . . . . 0.0 111.069 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -6.93 58.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.334 2.654 . . . . 0.0 111.565 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 78.21 1.38 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 118.434 0.561 . . . . 0.0 111.936 166.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.42 -78.27 0.17 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.643 0.377 . . . . 0.0 111.363 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.5 t -97.52 2.29 49.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.79 1.636 . . . . 0.0 111.64 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.36 162.09 41.34 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.01 165.23 19.66 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.773 1.649 . . . . 0.0 111.33 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.06 117.93 8.41 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.492 HD11 HD22 ' A' ' 40' ' ' LEU 0.294 2.0 pp -114.07 0.31 8.9 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.835 175.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -35.15 48.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.727 1.149 . . . . 0.0 112.034 171.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.49 4.43 50.46 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.914 1.286 . . . . 0.0 111.974 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . . . -53.2 -35.13 59.55 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.743 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.38 67.11 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.748 1.158 . . . . 0.0 114.526 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.99 -45.6 49.01 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.425 1.113 . . . . 0.0 109.535 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.608 -170.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -136.78 160.43 38.87 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.026 2.131 . . . . 0.0 108.236 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.1 m -95.31 169.26 10.2 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.417 0.287 . . . . 0.0 110.645 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -40.09 76.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.093 -174.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -53.24 -53.17 54.61 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.705 1.202 . . . . 0.0 111.757 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.18 -50.19 73.62 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.181 0.992 . . . . 0.0 109.528 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.1 -51.77 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -49.29 -55.01 14.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.105 1.362 . . . . 0.0 109.892 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -44.08 97.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.07 -41.92 84.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.625 -0.672 . . . . 0.0 110.786 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mt -63.5 -50.08 79.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -38.41 90.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.608 0.363 . . . . 0.0 111.5 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -89.38 -59.18 2.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.048 1.739 . . . . 0.0 111.355 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.28 115.92 3.04 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.879 1.704 . . . . 0.0 109.157 -165.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.13 150.31 10.9 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -26.47 -65.64 0.07 OUTLIER Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.826 1.203 . . . . 0.0 115.989 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.59 22.99 21.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.167 0.983 . . . . 0.0 113.67 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.2 ttt -139.23 121.48 10.24 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.822 1.249 . . . . 0.0 110.554 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.58 140.73 58.01 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 N-CA-C 108.825 -1.259 . . . . 0.0 108.825 171.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.98 -172.26 21.8 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.25 12.67 63.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.64 -30.47 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.785 1.234 . . . . 0.0 109.569 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.46 145.88 45.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 168.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -143.02 161.97 36.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.629 0.771 . . . . 0.0 111.122 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.67 -137.59 26.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.99 -37.6 1.4 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.221 1.409 . . . . 0.0 112.343 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -60.67 -59.18 5.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.014 0.526 . . . . 0.0 109.915 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.17 92.98 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.365 -0.835 . . . . 0.0 110.626 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.98 -52.16 61.61 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 109.735 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.48 -51.31 67.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.118 0.567 . . . . 0.0 110.313 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.2 -60.76 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.449 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.09 -53.46 42.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 118.53 0.604 . . . . 0.0 110.869 -169.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.54 38.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.102 0.477 . . . . 0.0 110.63 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.596 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 56.9 t90 -62.49 -39.3 93.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.657 0.741 . . . . 0.0 112.229 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.596 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -76.24 -34.03 59.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 120.731 -1.231 . . . . 0.0 109.268 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.37 -54.07 45.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 161.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.2 -8.25 52.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.104 -0.998 . . . . 0.0 112.161 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -24.28 66.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.558 1.143 . . . . 0.0 110.926 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.767 -1.111 . . . . 0.0 113.043 -156.351 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.758 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.29 101.65 1.95 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 125.614 1.566 . . . . 0.0 107.274 -162.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.87 -51.23 58.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.115 -166.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.95 -42.55 94.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.304 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.8 -44.56 86.4 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.931 1.241 . . . . 0.0 111.055 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -48.94 -60.51 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.649 HG21 ' CZ3' ' A' ' 87' ' ' TRP 0.299 89.5 t -65.19 -42.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.678 -167.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -60.37 0.89 0.15 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.556 3.542 . . . . 0.0 113.997 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.75 -20.07 1.02 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -25.22 11.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.993 1.317 . . . . 0.0 110.855 -173.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.0 m -118.86 -41.08 2.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.474 0.579 . . . . 0.0 111.742 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -49.26 -30.06 3.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 122.681 0.392 . . . . 0.0 111.52 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -36.25 -43.55 0.37 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.298 1.839 . . . . 0.0 111.641 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.79 -44.81 2.91 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 110.934 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -69.17 -16.85 63.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.85 154.52 27.39 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.22 -60.42 2.31 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.366 1.46 . . . . 0.0 114.085 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.64 -3.3 43.29 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 48' ' ' ILE . 1.2 mt 68.29 25.6 7.08 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.495 1.518 . . . . 0.0 110.548 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -78.16 -7.6 57.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 129.032 2.933 . . . . 0.0 111.265 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.19 76.99 1.31 Allowed Glycine 0 CA--C 1.526 0.724 0 CA-C-N 118.447 0.567 . . . . 0.0 112.191 164.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.16 -80.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.748 0.419 . . . . 0.0 111.598 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 m -92.04 2.23 56.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.022 1.729 . . . . 0.0 112.066 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.69 162.27 39.56 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.67 162.3 32.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.796 1.664 . . . . 0.0 111.39 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.48 115.1 4.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.091 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.616 HD11 HD22 ' A' ' 40' ' ' LEU . 2.4 pp -105.06 0.5 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 118.914 -0.565 . . . . 0.0 112.252 172.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -36.69 37.04 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.226 0.921 . . . . 0.0 111.658 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.67 3.55 55.31 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.176 0.991 . . . . 0.0 112.824 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.53 69.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 116.781 -1.58 . . . . 0.0 112.076 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.59 66.83 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 121.76 2.073 . . . . 0.0 114.073 171.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.36 -45.91 57.75 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.321 -1.105 . . . . 0.0 109.718 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.26 -37.93 63.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.882 0.473 . . . . 0.0 111.547 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.33 160.57 39.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.434 1.894 . . . . 0.0 108.464 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -94.74 166.67 11.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.274 0.559 . . . . 0.0 110.763 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.58 -44.49 36.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.697 1.199 . . . . 0.0 110.718 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.78 -55.86 17.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.444 1.098 . . . . 0.0 112.007 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.99 -51.54 67.38 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.672 1.189 . . . . 0.0 109.412 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -61.24 -50.39 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 tp -50.77 -55.31 17.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.795 1.238 . . . . 0.0 109.742 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.13 -46.11 89.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.039 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mt -58.55 -40.86 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 O-C-N 121.963 -0.46 . . . . 0.0 110.9 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.55 -50.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.25 -37.2 86.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.254 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -92.21 -45.19 8.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.88 1.672 . . . . 0.0 111.962 -170.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.81 113.66 3.03 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.32 1.438 . . . . 0.0 110.075 -168.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.448 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 3.4 tp60 -55.34 155.52 5.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 159.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -32.56 -64.53 0.26 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.315 1.436 . . . . 0.0 116.114 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.12 2.73 85.56 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 117.951 0.876 . . . . 0.0 113.484 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.6 ttt -103.43 132.26 21.27 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.286 1.434 . . . . 0.0 110.569 -172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.45 136.33 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.883 1.722 . . . . 0.0 110.163 174.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.53 148.54 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.41 79.93 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.6 mm -56.26 -33.52 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.712 1.205 . . . . 0.0 110.259 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.75 149.92 49.33 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttt -143.34 157.53 44.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.452 0.644 . . . . 0.0 112.357 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.64 -137.05 31.59 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.91 -37.59 1.34 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 125.306 1.442 . . . . 0.0 112.519 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.15 -60.6 3.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.467 0.707 . . . . 0.0 109.757 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.66 82.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.498 -0.751 . . . . 0.0 110.764 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.6 -49.74 76.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.211 0.605 . . . . 0.0 110.253 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.63 -49.93 66.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 28' ' ' VAL . 64.7 t -51.42 -60.74 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.202 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -46.36 -55.58 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.13 0.972 . . . . 0.0 110.982 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.32 69.44 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 111.242 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.649 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 18.7 t90 -63.59 -57.05 11.35 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.194 0.521 . . . . 0.0 111.481 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -57.23 -36.48 70.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.356 -1.465 . . . . 0.0 109.847 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.25 -58.04 10.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 168.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.32 -12.87 61.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.233 -0.917 . . . . 0.0 111.947 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -23.67 66.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.66 -174.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.2 pttt . . . . . 0 C--O 1.251 1.133 0 C-N-CA 127.337 2.255 . . . . 0.0 113.931 -153.654 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.744 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.19 97.62 1.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 125.157 1.383 . . . . 0.0 107.678 -160.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.69 -50.41 68.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.604 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.72 -44.79 96.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.197 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.61 -47.6 79.28 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.888 1.222 . . . . 0.0 111.32 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.3 t -47.23 -63.95 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 168.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.767 HG13 ' SG ' ' A' ' 32' ' ' CYS . 77.8 t -67.9 -39.41 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.99 -165.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -56.63 -3.88 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 129.142 2.977 . . . . 0.0 113.297 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.22 -5.52 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -119.47 -27.92 5.45 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.61 1.164 . . . . 0.0 111.464 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.767 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -114.3 -37.81 4.27 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.251 0.621 . . . . 0.0 111.246 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 pt -51.15 -30.75 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.313 0.245 . . . . 0.0 111.499 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 m -37.22 -41.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.326 1.45 . . . . 0.0 113.252 170.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -120.2 -40.86 2.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.086 0.554 . . . . 0.0 110.809 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -75.81 -9.1 58.32 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.416 -0.803 . . . . 0.0 113.052 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.58 154.74 12.84 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 118.954 0.797 . . . . 0.0 111.131 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.6 -56.87 4.08 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.197 1.38 . . . . 0.0 113.66 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -81.44 -1.86 47.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.124 0.569 . . . . 0.0 112.199 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.541 HD21 HG12 ' A' ' 28' ' ' VAL . 3.6 mt 70.46 22.67 5.13 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.02 1.728 . . . . 0.0 110.748 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 p -79.32 -7.79 58.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.634 2.774 . . . . 0.0 111.665 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.32 100.19 1.78 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.882 0.753 . . . . 0.0 111.613 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.8 -79.25 0.52 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.704 0.752 . . . . 0.0 110.042 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 m -92.4 1.5 57.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.47 160.73 55.84 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.577 1.951 . . . . 0.0 105.783 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.03 164.72 23.92 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.093 1.862 . . . . 0.0 111.421 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.67 14.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.43 ' O ' HD11 ' A' ' 88' ' ' LEU 0.296 2.2 pp -117.28 0.88 8.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.571 173.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -22.92 18.95 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.861 -1.149 . . . . 0.0 112.778 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 1.25 34.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.995 1.318 . . . . 0.0 112.724 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.69 67.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.481 1.037 . . . . 0.0 111.981 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.0 -30.01 74.25 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.354 1.434 . . . . 0.0 113.576 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.64 -46.11 23.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.113 0.957 . . . . 0.0 111.357 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -72.52 -42.78 64.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.69 173.35 8.6 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.794 1.637 . . . . 0.0 108.003 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.6 t -104.53 174.46 5.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.002 0.906 . . . . 0.0 112.548 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -44.01 92.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.03 -177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.9 -50.64 63.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.45 -51.9 66.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.502 0.721 . . . . 0.0 109.91 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.11 -51.67 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.6 tp -49.27 -56.46 9.33 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.67 -49.28 77.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -56.42 -44.03 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.968 0.507 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mt -63.75 -51.47 69.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 O-C-N 121.776 -0.578 . . . . 0.0 109.908 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.82 -25.27 67.14 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.283 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.4 -62.31 1.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.359 1.864 . . . . 0.0 111.311 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.62 105.68 2.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.687 1.613 . . . . 0.0 110.64 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 3.5 tp60 -57.07 154.07 10.45 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 161.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.76 -62.79 0.65 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.983 1.277 . . . . 0.0 115.191 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.77 22.17 22.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 117.83 0.815 . . . . 0.0 113.485 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -126.87 132.98 24.55 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 108.408 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.38 -35.88 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.131 1.887 . . . . 0.0 112.393 -171.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.91 161.71 26.64 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 121.854 0.697 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.06 26.59 61.27 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 122.367 -0.49 . . . . 0.0 111.99 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.2 mt -66.14 -30.47 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.24 1.016 . . . . 0.0 109.533 174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.68 145.57 36.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -145.55 156.09 43.48 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.264 0.938 . . . . 0.0 112.593 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.4 -143.66 48.67 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.47 -37.45 1.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.04 1.736 . . . . 0.0 112.455 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -53.96 -64.17 0.91 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.014 1.326 . . . . 0.0 110.208 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.04 92.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.576 -0.702 . . . . 0.0 110.313 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -52.26 -51.78 56.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.436 0.636 . . . . 0.0 109.362 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.4 81.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.767 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.31 -57.78 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-N 118.429 0.559 . . . . 0.0 110.186 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.75 -56.23 13.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.734 0.814 . . . . 0.0 110.784 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.4 -53.34 59.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.663 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.505 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 58.3 t90 -54.52 -54.19 44.42 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.816 0.446 . . . . 0.0 110.899 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.505 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -57.71 -45.7 85.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.179 -0.951 . . . . 0.0 110.316 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.04 65.96 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -88.69 -22.42 23.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.68 1.592 . . . . 0.0 110.829 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -28.44 66.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.412 -0.805 . . . . 0.0 110.064 -164.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 pttt . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.887 1.275 . . . . 0.0 111.763 -146.189 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.707 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.513 -0.477 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.39 98.36 1.78 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.84 -53.27 26.63 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.325 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.741 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.59 67.73 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.511 1.05 . . . . 0.0 110.171 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -51.68 -57.42 3.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.503 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 2.3 t -77.55 -1.36 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.128 -174.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 -99.89 1.64 43.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.787 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.27 -26.61 0.76 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -106.01 -14.52 15.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.709 1.204 . . . . 0.0 111.618 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 6.8 m -122.36 -41.49 2.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.845 0.858 . . . . 0.0 111.247 -168.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 28' ' ' VAL . 31.0 pt -49.03 -31.11 3.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -40.27 -39.8 1.02 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.907 1.683 . . . . 0.0 111.461 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.9 m -117.24 -42.15 2.93 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 122.7 0.4 . . . . 0.0 111.088 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -72.15 -15.67 61.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.07 155.03 30.53 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.97 -56.31 4.52 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.162 1.363 . . . . 0.0 113.111 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -82.87 0.66 43.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.775 0.83 . . . . 0.0 112.399 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 48' ' ' ILE . 5.3 mt 64.91 23.96 12.66 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.155 1.382 . . . . 0.0 111.559 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -80.86 -6.05 58.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 128.557 2.743 . . . . 0.0 111.662 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.67 76.82 1.32 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 118.442 0.565 . . . . 0.0 111.91 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 -75.81 0.23 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.393 . . . . 0.0 111.462 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -96.83 1.7 50.98 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.168 1.787 . . . . 0.0 111.045 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.41 32.96 Favored Pre-proline 0 N--CA 1.452 -0.355 0 C-N-CA 127.081 2.152 . . . . 0.0 105.296 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.97 162.31 26.32 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.574 1.516 . . . . 0.0 110.848 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.72 125.11 23.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.489 ' O ' HD11 ' A' ' 88' ' ' LEU 0.274 2.2 pp -119.72 -3.22 9.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.46 174.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -38.64 -45.8 1.14 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.817 1.19 . . . . 0.0 111.913 164.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 2.56 51.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.557 1.543 . . . . 0.0 111.992 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.59 -28.71 56.63 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.274 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.21 -28.06 73.42 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.279 0.945 . . . . 0.0 114.079 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.9 -44.23 32.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.678 0.739 . . . . 0.0 109.483 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -74.61 -43.98 52.85 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.47 164.31 21.41 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.199 2.2 . . . . 0.0 108.523 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.4 m -99.3 163.92 12.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.177 0.591 . . . . 0.0 111.284 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -47.91 -48.05 31.87 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 110.441 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -48.16 -48.53 34.27 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.076 0.95 . . . . 0.0 112.268 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.06 -52.7 46.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.522 0.729 . . . . 0.0 109.679 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.554 HG23 HMA1 ' A' ' 93' ' ' HEC . 62.9 mt -59.93 -47.12 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.4 tp -48.18 -56.3 8.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.482 1.513 . . . . 0.0 110.174 172.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.4 -50.03 68.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG21 ' C3A' ' A' ' 93' ' ' HEC . 1.1 mp -57.33 -44.22 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 25.8 mt -63.39 -46.02 96.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 O-C-N 120.433 -1.417 . . . . 0.0 110.08 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.79 -37.26 81.79 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.915 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -93.4 -36.67 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.985 2.114 . . . . 0.0 112.249 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.62 -178.75 27.63 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.955 1.74 . . . . 0.0 110.06 -163.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 6.0 tp-100 -137.76 164.27 29.29 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 168.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -30.81 -69.89 0.09 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.738 1.637 . . . . 0.0 114.868 -177.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 31.62 6.02 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.02 0.91 . . . . 0.0 113.348 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.462 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.2 ttt -139.6 121.17 9.78 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.652 1.181 . . . . 0.0 111.564 -174.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.36 157.87 55.62 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.03 1.82 . . . . 0.0 110.424 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 148.3 18.7 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -172.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.58 16.3 66.45 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.769 -0.461 . . . . 0.0 112.373 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.62 -41.22 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.911 0.884 . . . . 0.0 108.973 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB3' ' CG2' ' A' ' 64' ' ' ILE . . . -128.89 143.23 50.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -140.68 158.72 43.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 0.0 108.83 175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.98 -139.22 29.17 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.07 1.55 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.549 1.54 . . . . 0.0 112.384 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -59.02 6.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.134 0.574 . . . . 0.0 109.541 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.45 85.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.486 -0.759 . . . . 0.0 110.981 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.38 -52.65 64.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.265 0.626 . . . . 0.0 110.402 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.86 69.61 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.172 0.589 . . . . 0.0 109.522 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG22 ' CG2' ' A' ' 28' ' ' VAL . 53.2 t -48.4 -63.24 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 O-C-N 123.388 0.43 . . . . 0.0 109.877 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.8 51.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.21 1.004 . . . . 0.0 111.085 -171.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.04 -55.23 37.63 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.425 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 60.6 t90 -57.74 -38.46 75.38 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.183 0.593 . . . . 0.0 111.564 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.489 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -72.42 -45.35 60.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.559 0.744 . . . . 0.0 109.469 -178.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.07 -33.07 66.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.733 0.813 . . . . 0.0 111.264 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -21.81 60.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.851 0.86 . . . . 0.0 110.904 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -66.93 8.75 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -161.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 pttt . . . . . 0 C--O 1.247 0.962 0 O-C-N 120.9 -1.125 . . . . 0.0 112.969 -131.731 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.72 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.55 98.04 1.41 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.719 1.607 . . . . 0.0 107.137 -162.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.31 -49.73 42.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.936 -168.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.74 -45.74 93.13 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.556 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -44.91 82.46 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.482 1.037 . . . . 0.0 110.808 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.91 -62.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.668 HG13 ' SG ' ' A' ' 32' ' ' CYS . 72.1 t -66.69 -39.33 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.203 -168.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -59.08 0.26 0.1 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 129.141 2.976 . . . . 0.0 113.502 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 -15.43 1.57 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.08 -20.98 11.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.818 1.247 . . . . 0.0 111.503 -171.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.668 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.8 m -118.73 -40.98 2.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.989 0.813 . . . . 0.0 112.123 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.7 pt -50.7 -29.85 7.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 111.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -41.27 -39.15 1.3 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.949 1.699 . . . . 0.0 113.048 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -116.66 -43.31 2.91 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.33 0.652 . . . . 0.0 110.575 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -73.42 -12.94 60.98 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.88 153.28 25.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.11 -53.69 6.47 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.88 1.229 . . . . 0.0 113.111 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -81.79 -1.53 47.66 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.27 0.628 . . . . 0.0 112.205 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.46 HD21 HG12 ' A' ' 28' ' ' VAL . 5.6 mt 66.38 21.79 10.86 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.631 1.572 . . . . 0.0 111.26 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -78.98 -6.76 57.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.312 2.645 . . . . 0.0 111.572 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.56 82.92 1.65 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.461 0.573 . . . . 0.0 111.738 168.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.24 -77.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.768 0.427 . . . . 0.0 110.965 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -97.17 2.58 51.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.695 1.598 . . . . 0.0 111.58 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.0 161.28 46.26 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.98 163.19 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.73 1.62 . . . . 0.0 111.163 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 123.08 18.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.288 2.2 pp -119.04 -1.12 8.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.194 174.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -38.46 -45.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.574 1.079 . . . . 0.0 112.567 163.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.68 2.98 44.88 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.25 1.82 . . . . 0.0 112.59 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.14 -30.53 16.85 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.787 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.96 -30.29 76.75 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.12 0.873 . . . . 0.0 114.806 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.61 -44.15 44.42 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.663 -0.904 . . . . 0.0 109.374 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -73.36 -36.81 66.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.63 157.83 45.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 m -90.61 165.66 13.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.546 0.738 . . . . 0.0 111.806 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -46.72 63.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.474 0.71 . . . . 0.0 110.488 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -49.86 -49.03 50.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.053 . . . . 0.0 111.694 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.75 -49.72 71.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.467 0.651 . . . . 0.0 109.639 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.42 -48.05 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.3 tp -48.63 -53.51 18.28 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.653 1.181 . . . . 0.0 109.64 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.81 0.63 6.77 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.615 0.766 . . . . 0.0 113.037 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -104.35 -39.28 5.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 O-C-N 120.91 -1.119 . . . . 0.0 109.441 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 mt -66.24 -50.58 67.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.133 -0.98 . . . . 0.0 109.961 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.4 -39.8 94.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.469 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -88.38 -48.56 7.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.087 0.955 . . . . 0.0 112.373 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.12 107.99 3.06 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.641 1.591 . . . . 0.0 109.723 -167.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.48 149.52 16.95 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 163.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -19.18 -71.13 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 C-N-CA 126.286 1.898 . . . . 0.0 116.965 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.03 73.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 117.946 0.873 . . . . 0.0 113.793 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.8 ttt -87.99 127.49 57.44 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 126.095 1.758 . . . . 0.0 109.483 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.12 143.39 84.13 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 N-CA-C 109.237 -1.101 . . . . 0.0 109.237 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.45 166.97 28.39 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.52 18.05 75.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.922 -0.639 . . . . 0.0 112.307 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -54.66 -36.02 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.55 1.14 . . . . 0.0 109.967 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.28 146.38 38.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -143.0 154.76 44.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.395 1.078 . . . . 0.0 110.772 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.58 -136.36 49.59 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.53 -38.63 6.53 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.599 1.16 . . . . 0.0 111.978 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -51.9 -62.13 1.82 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.797 0.839 . . . . 0.0 109.348 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.21 -35.89 71.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.019 0.527 . . . . 0.0 110.904 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.32 -51.05 71.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 0.0 109.928 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -50.18 71.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.759 -0.638 . . . . 0.0 109.362 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.85 -61.76 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.986 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.1 -54.15 14.18 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 111.195 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -54.63 44.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 110.873 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.578 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 59.3 t90 -57.85 -41.1 81.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 111.749 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.447 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.55 -45.12 66.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 108.938 -177.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.58 -31.96 68.5 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.432 0.693 . . . . 0.0 112.125 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -21.18 60.95 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 110.701 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -68.82 7.67 0.64 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -158.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.5 pttt . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.478 -1.249 . . . . 0.0 113.075 -128.465 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.799 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.2 m-20 -72.36 162.42 29.5 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 127.16 2.184 . . . . 0.0 107.026 -172.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB1' ' CB ' ' A' ' 87' ' ' TRP . . . -101.51 -69.86 0.76 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.78 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -58.51 -41.38 85.29 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.421 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -57.17 -39.15 74.71 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.673 0.67 . . . . 0.0 111.303 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -55.82 -55.87 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.606 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 3.5 t -66.32 -41.05 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 117.015 -1.874 . . . . 0.0 110.615 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -59.92 0.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 129.844 3.258 . . . . 0.0 114.761 169.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.47 -15.51 0.95 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.6 -23.56 11.76 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.09 1.356 . . . . 0.0 110.519 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -122.82 -39.09 2.55 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.018 0.527 . . . . 0.0 111.615 -165.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -49.11 -30.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 C-N-CA 122.797 0.439 . . . . 0.0 111.647 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 m -38.46 -39.67 0.48 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.864 1.665 . . . . 0.0 113.068 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.85 -43.97 2.64 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.943 0.497 . . . . 0.0 110.519 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.93 -16.24 63.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 113.017 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.69 153.44 26.9 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.8 -59.12 2.48 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.189 1.376 . . . . 0.0 113.13 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.98 -2.19 38.98 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.188 0.995 . . . . 0.0 112.378 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD21 HG12 ' A' ' 28' ' ' VAL . 1.7 mt 65.33 24.15 12.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.026 1.73 . . . . 0.0 111.631 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -78.54 -8.33 58.46 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.765 2.826 . . . . 0.0 111.449 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.24 76.51 1.26 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-N 118.408 0.549 . . . . 0.0 111.984 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.59 -82.53 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.792 0.437 . . . . 0.0 111.443 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.72 1.46 56.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.699 1.999 . . . . 0.0 111.97 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.05 162.93 35.55 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.3 165.63 21.66 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.813 1.676 . . . . 0.0 111.148 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.45 117.2 7.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 40' ' ' LEU 0.265 2.2 pp -114.55 -3.78 11.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.279 -0.867 . . . . 0.0 112.207 176.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -38.23 -48.27 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.504 1.047 . . . . 0.0 111.996 165.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -99.95 5.55 45.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.395 1.878 . . . . 0.0 112.08 -176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -46.96 -44.46 20.05 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.918 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.49 -29.1 16.62 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.964 0.802 . . . . 0.0 114.839 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -42.08 68.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.413 -1.051 . . . . 0.0 110.497 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.77 -44.0 12.87 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.24 0.616 . . . . 0.0 110.816 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.25 154.85 38.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.817 2.047 . . . . 0.0 107.701 -171.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -95.44 169.82 9.79 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.736 0.415 . . . . 0.0 110.75 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -43.0 64.58 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.713 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -48.74 -52.71 22.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.43 1.092 . . . . 0.0 111.863 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.57 -53.91 50.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.841 0.856 . . . . 0.0 109.684 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.01 -46.97 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -171.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.1 tp -47.31 -56.33 7.04 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.013 1.725 . . . . 0.0 109.95 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -56.07 -48.4 76.15 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -46.94 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mt -59.64 -47.84 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.965 -1.084 . . . . 0.0 109.917 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.5 -27.04 64.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.47 0.708 . . . . 0.0 112.852 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.42 -60.77 1.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.47 1.508 . . . . 0.0 111.039 -171.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.83 -167.13 24.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.191 2.329 . . . . 0.0 109.469 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -157.97 163.89 37.36 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -15.81 -83.78 0.01 OUTLIER Glycine 0 CA--C 1.542 1.73 0 C-N-CA 126.005 1.764 . . . . 0.0 116.303 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.39 18.82 56.21 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.818 1.309 . . . . 0.0 113.566 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -103.81 127.71 28.83 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.01 1.324 . . . . 0.0 109.168 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.53 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 38.2 Cg_endo -64.1 -40.98 24.13 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.569 2.179 . . . . 0.0 112.13 -172.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 161.67 23.09 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 121.851 0.695 . . . . 0.0 111.732 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.61 22.17 65.7 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 122.178 -0.601 . . . . 0.0 111.827 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' CHC' ' A' ' 93' ' ' HEC . 7.9 mt -64.46 -29.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.448 1.499 . . . . 0.0 109.835 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.47 143.12 29.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -138.3 166.5 24.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.48 -135.09 41.78 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.9 -36.83 8.01 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.675 1.19 . . . . 0.0 112.027 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -60.63 -55.91 27.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.97 84.18 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.637 -0.664 . . . . 0.0 111.22 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.69 -54.14 49.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.305 0.502 . . . . 0.0 110.999 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.04 -51.19 62.55 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.8 t -50.03 -64.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.308 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.61 -51.87 25.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.495 1.118 . . . . 0.0 111.148 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -55.26 34.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 110.77 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 66.3 t90 -59.36 -39.59 83.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.006 0.432 . . . . 0.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -68.95 -41.65 77.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.265 -0.897 . . . . 0.0 110.671 -178.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.98 -39.08 73.98 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 122.129 -0.357 . . . . 0.0 110.522 168.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -73.14 -19.05 61.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.99 0.516 . . . . 0.0 111.28 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HA ' ' CE ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.71 9.08 0.94 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.953 1.701 . . . . 0.0 114.649 -171.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 C--O 1.25 1.12 0 O-C-N 120.635 -1.29 . . . . 0.0 112.73 -154.428 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.744 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 CA--C 1.514 -0.433 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.86 97.73 2.31 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.063 1.345 . . . . 0.0 108.093 -163.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.23 -53.05 60.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.555 -167.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.18 -43.59 98.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.088 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.32 78.13 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.168 0.895 . . . . 0.0 111.326 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -46.25 -63.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.732 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 80.2 t -67.97 -37.78 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 117.352 -1.739 . . . . 0.0 112.52 -166.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -60.1 -1.02 0.26 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.203 3.001 . . . . 0.0 113.179 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.6 -9.67 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 169.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -118.72 -25.19 6.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.188 1.395 . . . . 0.0 112.04 -171.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.9 m -117.21 -40.96 3.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.418 0.554 . . . . 0.0 110.499 -172.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 pt -48.33 -32.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 122.942 0.497 . . . . 0.0 111.612 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -38.64 -37.38 0.32 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 113.206 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -120.08 -41.72 2.63 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.622 0.769 . . . . 0.0 110.786 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.16 -6.33 49.04 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.66 -86.72 0.41 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.408 1.004 . . . . 0.0 112.788 163.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.53 -62.93 0.02 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.35 2.59 39.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 111.764 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.85 26.87 7.51 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.31 1.844 . . . . 0.0 111.505 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -72.83 -10.87 60.29 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.43 1.892 . . . . 0.0 111.721 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.21 104.14 1.8 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.4 -77.11 0.6 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.535 0.734 . . . . 0.0 110.01 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -92.26 2.1 56.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.922 1.289 . . . . 0.0 111.646 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.83 158.61 52.61 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -63.98 164.57 21.63 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.153 1.902 . . . . 0.0 111.105 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.24 123.72 18.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.631 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.415 ' O ' HD11 ' A' ' 88' ' ' LEU 0.253 2.5 pp -119.79 -2.42 8.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.322 -0.847 . . . . 0.0 112.266 172.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -42.06 -44.85 3.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.133 1.333 . . . . 0.0 111.594 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.68 4.14 45.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.608 1.563 . . . . 0.0 112.195 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.4 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -48.9 -36.97 18.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.358 176.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.07 -34.34 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 120.86 1.664 . . . . 0.0 114.379 173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -53.27 32.04 Favored 'General case' 0 C--N 1.337 0.056 0 O-C-N 121.446 -1.032 . . . . 0.0 110.276 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -74.31 -37.02 63.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.474 -169.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -132.01 151.53 51.69 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.831 1.652 . . . . 0.0 107.822 -171.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.34 166.95 12.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.665 0.745 . . . . 0.0 110.899 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -47.37 -47.83 26.02 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.026 1.331 . . . . 0.0 110.498 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.94 -46.34 68.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.853 0.751 . . . . 0.0 111.764 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.99 -53.68 42.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.511 0.724 . . . . 0.0 109.27 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.517 HG23 HMA1 ' A' ' 93' ' ' HEC . 69.6 mt -60.07 -47.6 91.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.0 tp -49.85 -54.47 19.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.13 1.372 . . . . 0.0 110.322 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -55.38 -49.66 71.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.99 -46.46 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 60' ' ' ILE . 32.1 mt -58.95 -48.84 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 121.245 -0.909 . . . . 0.0 109.635 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.75 -32.63 73.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.485 0.714 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -101.78 -61.55 1.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.015 1.726 . . . . 0.0 111.481 -169.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.09 -173.36 22.71 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 126.776 2.131 . . . . 0.0 110.388 -171.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.92 163.94 38.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 168.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -17.83 -81.97 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.178 1.847 . . . . 0.0 116.102 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.13 25.71 24.35 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.858 1.329 . . . . 0.0 113.441 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -112.46 126.77 27.81 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 124.948 1.299 . . . . 0.0 108.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.93 -40.88 49.16 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.101 2.534 . . . . 0.0 112.381 -172.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.67 161.47 25.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-O 121.958 0.755 . . . . 0.0 111.869 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.63 62.12 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.09 -35.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.437 0.695 . . . . 0.0 109.344 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.5 52.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -145.05 152.24 39.8 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.925 0.869 . . . . 0.0 113.233 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.94 -138.86 47.97 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.76 -34.26 11.87 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.706 1.203 . . . . 0.0 112.034 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.23 -57.01 13.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.086 0.954 . . . . 0.0 109.906 173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.77 -39.58 80.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.837 -0.539 . . . . 0.0 110.266 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -55.73 -53.38 57.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.909 0.322 . . . . 0.0 110.151 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -53.79 39.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.466 0.706 . . . . 0.0 109.643 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -49.24 -65.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 O-C-N 123.433 0.458 . . . . 0.0 110.21 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.86 -48.85 66.8 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.793 0.837 . . . . 0.0 111.235 -170.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.74 30.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.755 0.422 . . . . 0.0 110.337 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.732 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 31.9 t90 -54.9 -41.8 71.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.362 0.665 . . . . 0.0 111.247 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.88 -49.32 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.821 0.848 . . . . 0.0 110.366 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.07 69.22 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.522 0.729 . . . . 0.0 110.875 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.49 -23.21 60.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.427 1.091 . . . . 0.0 110.985 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -32.17 73.44 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.263 -0.898 . . . . 0.0 110.472 -166.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.989 1.716 . . . . 0.0 114.502 -145.446 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.754 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.14 98.63 1.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -169.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.64 -49.78 14.02 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.129 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -63.11 -44.03 96.78 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.928 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.43 75.37 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 120.002 1.273 . . . . 0.0 111.183 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -55.0 -63.52 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.769 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 25.6 t -65.32 -42.61 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.683 -164.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -3.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.025 2.93 . . . . 0.0 112.726 170.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.59 0.55 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mmtt -126.89 -30.51 2.73 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.114 0.966 . . . . 0.0 111.878 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.5 m -110.23 -38.47 5.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.76 0.709 . . . . 0.0 110.687 -178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.0 pt -51.55 -30.15 10.76 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -38.66 -39.22 0.47 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.396 1.878 . . . . 0.0 113.154 171.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -123.02 -38.8 2.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 110.993 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.16 -9.68 59.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.18 155.87 17.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.94 -57.02 3.63 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.257 1.408 . . . . 0.0 113.498 -174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.03 1.29 44.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 112.518 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt 68.42 21.36 8.28 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.051 1.341 . . . . 0.0 111.363 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -6.59 53.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.972 2.509 . . . . 0.0 111.654 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 113.51 2.34 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.64 -77.15 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.771 0.786 . . . . 0.0 109.449 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 m -93.08 1.85 57.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.938 1.295 . . . . 0.0 111.477 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.89 159.23 57.35 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 127.038 2.135 . . . . 0.0 105.591 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.0 164.66 21.36 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.08 1.854 . . . . 0.0 111.263 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 120.04 11.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.273 2.2 pp -115.14 -0.4 9.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-O 118.272 -0.871 . . . . 0.0 112.063 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -46.23 -41.26 12.65 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.46 1.027 . . . . 0.0 112.157 170.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.93 4.05 51.77 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.329 1.452 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -25.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.598 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.31 -33.03 76.79 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.901 1.228 . . . . 0.0 113.997 171.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.93 -43.21 59.05 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.624 -0.927 . . . . 0.0 109.646 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -74.36 -44.17 53.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.066 0.547 . . . . 0.0 111.109 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -129.49 164.43 23.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.707 2.003 . . . . 0.0 108.486 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.22 168.49 10.01 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.521 0.729 . . . . 0.0 111.6 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -44.0 73.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.34 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.158 0.983 . . . . 0.0 112.236 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.88 -49.21 78.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 64' ' ' ILE . 74.2 mt -63.53 -49.87 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -175.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.0 tp -47.39 -57.52 5.2 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.495 1.518 . . . . 0.0 110.121 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.5 -45.17 92.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.2 mt -59.63 -43.17 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.646 -0.659 . . . . 0.0 111.0 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 60' ' ' ILE . 31.0 mt -59.69 -48.4 87.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 O-C-N 120.941 -1.099 . . . . 0.0 109.449 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 mt -65.82 -34.8 79.0 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.327 0.651 . . . . 0.0 112.21 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -102.97 -53.79 2.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.572 1.549 . . . . 0.0 112.356 -167.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -171.72 20.23 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.411 1.958 . . . . 0.0 110.269 -170.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -166.08 135.83 3.31 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.02 -110.75 0.15 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 120.333 1.424 . . . . 0.0 113.465 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.85 -9.2 68.52 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.157 0.979 . . . . 0.0 114.232 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -63.18 127.52 91.08 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 118.498 1.149 . . . . 0.0 109.122 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -63.79 -37.84 42.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.14 2.56 . . . . 0.0 111.817 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.48 165.41 32.69 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-O 121.987 0.771 . . . . 0.0 111.668 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.24 68.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -65.13 -32.62 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.069 0.948 . . . . 0.0 110.192 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.37 150.41 51.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -144.11 153.26 41.96 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.217 0.917 . . . . 0.0 113.359 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.76 -142.21 47.31 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -42.6 -36.91 1.52 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.614 1.565 . . . . 0.0 112.437 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -54.27 -61.99 1.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.426 1.09 . . . . 0.0 110.04 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.88 -38.82 87.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.711 -0.618 . . . . 0.0 110.487 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.94 -50.62 72.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 109.851 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.08 73.56 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.559 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.84 -57.82 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.347 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.14 -54.36 13.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.4 1.08 . . . . 0.0 111.224 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.85 71.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.955 0.407 . . . . 0.0 110.707 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.769 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 64.3 t90 -62.84 -27.24 69.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.578 1.151 . . . . 0.0 112.809 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.607 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -84.73 -43.33 14.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.594 -0.691 . . . . 0.0 109.722 176.139 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.12 -42.88 73.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.162 -0.447 . . . . 0.0 110.721 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -5.6 41.35 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.27 0.941 . . . . 0.0 112.22 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.0 6.9 1.35 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -163.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.989 -124.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.745 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.97 102.75 5.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -170.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.94 -51.86 9.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.063 0.945 . . . . 0.0 111.916 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -62.73 -43.95 97.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.603 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.89 82.42 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 119.156 0.889 . . . . 0.0 110.858 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -49.99 -61.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 40.4 t -63.67 -41.99 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 116.803 -1.959 . . . . 0.0 112.697 -170.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -63.18 1.23 0.5 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.411 3.084 . . . . 0.0 113.628 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -134.92 -22.63 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -112.29 -20.42 11.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.719 1.608 . . . . 0.0 111.577 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -121.76 -42.65 2.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.463 0.574 . . . . 0.0 111.25 -171.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.1 pt -48.78 -32.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.696 0.398 . . . . 0.0 111.609 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.24 -36.88 0.25 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.067 1.747 . . . . 0.0 113.384 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.0 -42.38 2.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.272 0.629 . . . . 0.0 110.837 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.79 -7.95 54.95 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.41 -84.45 0.37 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.409 1.004 . . . . 0.0 112.813 163.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.25 -64.36 0.02 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.97 3.58 37.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.9 0.88 . . . . 0.0 111.866 173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 67.61 28.1 7.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.583 1.553 . . . . 0.0 111.576 -175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -73.62 -13.07 60.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.036 2.135 . . . . 0.0 111.075 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.38 98.64 1.62 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 172.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.56 -77.47 0.56 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.473 0.709 . . . . 0.0 110.157 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -90.71 1.42 56.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.603 1.161 . . . . 0.0 111.542 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.91 160.2 44.34 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.726 2.011 . . . . 0.0 105.686 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -64.2 164.52 22.42 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.25 1.967 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.62 25.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.227 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 88' ' ' LEU 0.274 2.8 pp -119.78 -1.06 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 122.76 0.424 . . . . 0.0 112.131 176.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -35.39 64.11 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.009 -1.057 . . . . 0.0 111.426 167.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 4.07 51.91 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.486 1.514 . . . . 0.0 111.677 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.36 -53.87 12.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.92 9.22 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 115.156 0.822 . . . . 0.0 115.156 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.35 -29.65 28.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.023 0.912 . . . . 0.0 110.971 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -92.76 -51.95 4.85 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 124.036 0.934 . . . . 0.0 110.113 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.46 146.13 40.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.518 2.327 . . . . 0.0 108.276 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.4 m -86.87 164.16 16.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.256 0.48 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.74 -45.52 58.76 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.898 0.479 . . . . 0.0 110.008 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -47.01 -53.31 12.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.371 1.468 . . . . 0.0 112.512 173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.39 -48.6 77.21 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.687 0.795 . . . . 0.0 110.175 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.557 HG23 HMA1 ' A' ' 93' ' ' HEC . 67.1 mt -63.05 -46.73 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -49.85 -55.29 14.84 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.084 1.753 . . . . 0.0 109.786 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -47.86 73.55 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.89 -37.15 77.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 121.307 -0.87 . . . . 0.0 111.62 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 21.8 mt -65.47 -44.87 94.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.501 -1.374 . . . . 0.0 109.819 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -68.74 -41.42 78.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.081 0.552 . . . . 0.0 111.594 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -91.28 -37.29 13.38 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.713 1.605 . . . . 0.0 111.62 -169.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.8 -167.17 18.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.308 1.433 . . . . 0.0 110.139 -166.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.465 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 5.2 tp-100 -149.69 163.03 39.04 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 173.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -31.33 -66.66 0.16 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.641 1.591 . . . . 0.0 114.754 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.25 32.35 6.27 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.708 0.67 . . . . 0.0 113.266 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.408 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.7 ttt -139.4 128.76 14.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.399 1.079 . . . . 0.0 111.594 -175.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.2 155.44 68.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.399 2.066 . . . . 0.0 111.312 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.25 142.67 15.57 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.34 24.95 60.08 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.877 0.751 . . . . 0.0 111.432 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.3 mt -51.83 -44.38 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 108.971 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HB1' ' HB3' ' A' ' 80' ' ' GLU . . . -134.47 140.19 46.04 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.5 2.32 . . . . 0.0 105.302 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -147.25 153.71 40.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.052 0.941 . . . . 0.0 109.189 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.78 -133.89 51.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.86 -46.89 11.03 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.436 1.095 . . . . 0.0 111.804 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.75 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 35.7 mp0 -52.42 -61.4 2.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.898 0.772 . . . . 0.0 110.432 175.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.42 97.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.911 -0.493 . . . . 0.0 110.839 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.46 -58.93 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.197 0.999 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.21 -53.55 49.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.725 1.21 . . . . 0.0 109.618 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -50.38 -61.9 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.045 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.34 -51.66 57.61 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.572 0.749 . . . . 0.0 110.571 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.91 63.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 110.798 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.604 ' CE3' HD12 ' A' ' 88' ' ' LEU . 72.2 t90 -61.86 -31.96 72.28 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.093 0.557 . . . . 0.0 111.665 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.604 HD12 ' CE3' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -75.76 -43.74 45.1 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.032 -1.043 . . . . 0.0 110.166 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.21 -37.71 62.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.599 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.4 -8.5 59.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.165 1.348 . . . . 0.0 113.443 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' CA ' ' HE2' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -73.21 5.24 3.67 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.053 2.141 . . . . 0.0 116.204 -170.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 pttp . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.534 -1.222 . . . . 0.0 111.192 -126.373 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.719 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 101.29 9.55 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -158.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -52.64 11.24 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 112.962 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.28 -46.55 89.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.315 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.52 78.56 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.093 0.86 . . . . 0.0 111.218 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.2 -61.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 170.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.888 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 81.9 t -68.92 -40.16 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 120.854 -1.154 . . . . 0.0 112.293 -167.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -58.06 0.61 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 129.136 2.974 . . . . 0.0 113.003 167.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.65 -12.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 13.5 mttt -122.59 -19.09 6.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.708 1.203 . . . . 0.0 112.101 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -116.93 -41.59 3.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.42 1.009 . . . . 0.0 111.699 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -48.83 -32.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 122.47 0.308 . . . . 0.0 111.43 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -36.09 -38.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.22 2.208 . . . . 0.0 113.464 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 m -117.52 -42.31 2.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.617 0.767 . . . . 0.0 110.699 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -74.25 -8.35 55.93 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.67 -90.38 0.43 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.577 1.084 . . . . 0.0 112.751 164.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.1 -58.67 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.59 3.42 47.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.802 0.841 . . . . 0.0 111.367 172.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 65.68 27.59 11.3 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.741 1.617 . . . . 0.0 111.149 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -78.38 -5.22 51.64 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.727 2.411 . . . . 0.0 111.667 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.65 92.47 1.57 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 118.713 0.688 . . . . 0.0 111.599 166.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.31 -79.78 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.38 0.672 . . . . 0.0 110.617 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.9 t -90.81 1.64 56.76 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.278 1.031 . . . . 0.0 111.25 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.86 160.13 44.74 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.49 161.47 27.67 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.018 1.812 . . . . 0.0 111.198 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.61 116.7 8.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.989 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.7 pp -106.58 -6.81 10.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.053 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -43.85 -50.87 7.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.779 1.172 . . . . 0.0 111.036 170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 1.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.534 -0.728 . . . . 0.0 112.103 -175.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -52.96 -40.45 63.69 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.049 -171.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.67 -26.28 24.18 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 119.028 0.831 . . . . 0.0 114.045 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.75 -45.3 62.13 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.31 -1.112 . . . . 0.0 110.264 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -80.82 -43.13 20.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.165 0.986 . . . . 0.0 111.099 -171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.61 158.96 37.86 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.959 2.103 . . . . 0.0 107.647 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -100.75 171.9 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.249 0.477 . . . . 0.0 112.028 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -40.57 75.11 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.47 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -53.34 -49.79 66.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.507 1.048 . . . . 0.0 111.429 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.56 -48.23 78.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.52 0.728 . . . . 0.0 110.029 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 64' ' ' ILE . 82.2 mt -64.33 -47.58 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.8 tp -49.24 -57.24 7.12 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.667 1.587 . . . . 0.0 110.365 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -46.28 82.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -59.97 -43.7 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.526 -0.734 . . . . 0.0 111.268 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 60' ' ' ILE . 30.9 mt -60.18 -47.4 92.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.104 -0.997 . . . . 0.0 109.536 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.36 -42.59 92.62 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -91.28 -51.8 5.12 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.368 1.467 . . . . 0.0 111.473 -166.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -166.94 17.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -164.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.438 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 0.0 OUTLIER -150.79 167.21 28.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 175.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.63 72.32 0.02 OUTLIER Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.84 1.2 . . . . 0.0 113.118 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.11 -15.6 3.25 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.374 1.94 . . . . 0.0 112.585 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 10.7 ttt -112.37 132.14 22.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.776 1.288 . . . . 0.0 108.459 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.93 -38.09 7.89 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.224 2.616 . . . . 0.0 113.528 -169.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.44 173.18 48.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-O 122.003 0.78 . . . . 0.0 112.218 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.95 -1.73 62.3 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.267 0.937 . . . . 0.0 112.629 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.09 -31.61 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.171 2.188 . . . . 0.0 111.036 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.87 139.65 38.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -141.79 155.17 45.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.468 1.507 . . . . 0.0 108.675 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.56 -136.49 43.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.15 -41.53 3.74 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.036 1.334 . . . . 0.0 111.796 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -52.92 -64.12 0.92 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.516 0.726 . . . . 0.0 109.377 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.94 96.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.995 -0.44 . . . . 0.0 110.918 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.06 -58.02 9.67 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.822 0.849 . . . . 0.0 110.077 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.41 -50.91 66.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.128 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 28' ' ' VAL . 61.3 t -49.15 -63.03 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 123.577 0.548 . . . . 0.0 110.365 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.19 62.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.159 0.984 . . . . 0.0 111.095 -171.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.06 -55.52 33.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.279 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.888 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 35.4 t90 -52.31 -39.41 60.54 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.361 0.664 . . . . 0.0 110.771 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.859 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.35 -41.52 73.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -27.92 62.91 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.142 -0.349 . . . . 0.0 110.877 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -88.82 -12.36 42.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.041 0.937 . . . . 0.0 112.977 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -83.35 -0.56 50.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 110.45 -174.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 O-C-N 119.867 -1.771 . . . . 0.0 112.407 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.776 ' CGD' HMD1 ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.59 104.29 5.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.316 1.447 . . . . 0.0 107.413 -167.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.56 -50.89 40.32 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.081 0.952 . . . . 0.0 112.485 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.37 -41.42 93.7 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.537 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.02 94.54 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.93 1.241 . . . . 0.0 111.216 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.9 -63.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 166.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.82 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 85.8 t -63.79 -41.27 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.517 -166.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -60.48 -1.98 0.44 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.227 3.011 . . . . 0.0 112.89 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.93 -11.62 2.26 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 168.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -119.74 -23.86 6.36 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.87 1.268 . . . . 0.0 112.793 -169.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.677 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.1 m -122.47 -41.32 2.4 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.812 0.733 . . . . 0.0 111.589 -172.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.3 pt -50.39 -30.04 7.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 122.408 0.283 . . . . 0.0 111.066 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -35.93 -41.06 0.22 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.57 2.348 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -118.44 -40.37 2.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.295 0.638 . . . . 0.0 110.848 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -78.14 -8.73 58.64 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.33 157.96 16.31 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.148 0.886 . . . . 0.0 112.038 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -36.34 -62.12 0.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.337 1.922 . . . . 0.0 115.952 -168.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -92.86 4.62 53.54 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.424 1.112 . . . . 0.0 111.988 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 77.39 28.29 0.6 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.671 1.988 . . . . 0.0 110.953 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.2 -10.7 59.87 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.234 2.214 . . . . 0.0 112.505 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.39 100.26 1.52 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.958 0.79 . . . . 0.0 111.562 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.56 -76.75 0.58 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 117.732 0.766 . . . . 0.0 110.188 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -94.86 2.24 55.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 111.654 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.02 160.97 50.81 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 127.121 2.169 . . . . 0.0 105.238 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.74 165.03 24.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.903 1.735 . . . . 0.0 111.103 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 115.7 4.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.4 pp -112.56 -0.96 9.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.492 174.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -44.48 -45.73 9.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.672 1.124 . . . . 0.0 112.049 168.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -90.65 3.84 53.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.249 1.42 . . . . 0.0 111.156 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.15 -31.58 65.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.774 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.76 -30.23 76.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 120.518 1.508 . . . . 0.0 113.195 170.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.44 54.38 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.016 -1.285 . . . . 0.0 110.487 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -74.21 -38.6 63.52 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.286 0.234 . . . . 0.0 111.302 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -135.31 175.64 9.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.253 2.221 . . . . 0.0 108.033 -172.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -112.18 167.74 10.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.247 0.619 . . . . 0.0 110.483 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -50.57 -41.28 54.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 111.531 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -57.01 -51.69 68.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.176 1.353 . . . . 0.0 111.959 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.34 -51.22 69.07 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.141 0.976 . . . . 0.0 109.261 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.49 -49.92 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.834 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.3 tp -48.81 -56.33 9.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.314 1.446 . . . . 0.0 110.333 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.43 -44.76 95.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.931 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.7 mt -59.93 -41.96 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 121.838 -0.539 . . . . 0.0 110.696 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.04 -50.04 81.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 O-C-N 121.138 -0.976 . . . . 0.0 109.659 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.83 -30.9 71.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.477 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -105.16 -57.31 2.05 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.441 1.497 . . . . 0.0 112.244 -168.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.57 -173.47 21.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.068 1.794 . . . . 0.0 110.554 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -165.48 125.02 1.75 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 171.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.88 -113.53 1.06 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.974 1.261 . . . . 0.0 112.779 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.26 82.61 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.207 1.004 . . . . 0.0 113.965 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.5 ttt -66.36 126.85 92.79 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.46 1.13 . . . . 0.0 109.468 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.25 -39.16 39.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.751 2.3 . . . . 0.0 112.082 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.18 163.74 28.78 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 121.956 0.753 . . . . 0.0 111.707 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.84 21.64 65.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.14 -35.3 73.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.286 1.434 . . . . 0.0 109.759 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.54 146.77 49.99 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -139.93 155.09 47.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.235 0.925 . . . . 0.0 112.903 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.84 -139.32 45.87 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.4 -37.21 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.366 1.467 . . . . 0.0 112.068 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.03 -61.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.2 -39.69 89.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.792 -0.568 . . . . 0.0 110.452 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -58.11 -50.9 71.88 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.048 0.539 . . . . 0.0 110.023 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.94 65.39 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.44 0.696 . . . . 0.0 109.687 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.13 -57.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.321 0 O-C-N 123.237 0.335 . . . . 0.0 110.179 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.7 -55.38 19.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.064 0.545 . . . . 0.0 111.279 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.39 58.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 110.783 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.82 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 21.0 t90 -51.13 -44.14 61.31 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.488 0.715 . . . . 0.0 111.187 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.818 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -76.2 -37.29 57.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.384 -0.823 . . . . 0.0 112.154 -173.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 109.462 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -76.22 -22.16 55.56 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.397 1.079 . . . . 0.0 113.256 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.0 -18.71 55.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.435 -1.415 . . . . 0.0 112.789 -168.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.955 1.702 . . . . 0.0 113.121 -156.055 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.744 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.7 109.98 8.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.795 1.238 . . . . 0.0 109.011 -155.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.39 -53.06 59.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.2 -161.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -61.94 -40.18 94.63 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.492 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.8 91.1 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.792 0.724 . . . . 0.0 111.315 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.7 t -48.02 -65.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 165.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.717 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 58.4 t -64.63 -41.37 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.526 -165.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.91 0.65 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.985 2.914 . . . . 0.0 113.382 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -126.56 -33.42 2.55 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.135 0.974 . . . . 0.0 113.257 167.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -107.62 -19.68 13.47 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.924 1.69 . . . . 0.0 112.675 -160.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.6 m -123.37 -40.07 2.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.316 0.507 . . . . 0.0 110.862 -171.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.6 pt -49.65 -28.55 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.558 0.343 . . . . 0.0 111.422 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -36.75 -43.7 0.44 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.962 2.105 . . . . 0.0 112.913 170.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.28 -37.68 3.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.56 0.744 . . . . 0.0 110.681 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -77.75 -9.42 59.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.4 153.19 10.11 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.8 -60.54 2.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.175 1.369 . . . . 0.0 113.314 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -3.23 39.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.513 1.125 . . . . 0.0 112.456 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD21 HG12 ' A' ' 28' ' ' VAL . 7.6 mt 71.06 24.38 3.95 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.138 1.775 . . . . 0.0 111.124 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -79.51 -6.03 56.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.397 2.279 . . . . 0.0 112.036 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.59 112.64 2.26 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -113.07 -73.23 0.67 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.148 0.974 . . . . 0.0 109.986 175.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -98.3 2.2 47.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.015 1.326 . . . . 0.0 111.442 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HA ' HMD3 ' A' ' 93' ' ' HEC . . . -141.46 160.55 56.54 Favored Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 127.356 2.262 . . . . 0.0 105.394 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.11 165.14 25.12 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.818 1.679 . . . . 0.0 110.751 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.98 122.49 15.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.316 2.2 pp -116.57 1.93 7.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.54 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -42.34 -48.81 5.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.662 1.119 . . . . 0.0 112.151 168.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -90.28 4.84 49.5 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.916 1.286 . . . . 0.0 112.02 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.24 -44.83 53.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.826 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.02 -33.52 44.54 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 120.862 1.665 . . . . 0.0 114.038 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.74 -35.77 77.54 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.375 -1.074 . . . . 0.0 110.891 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -89.78 -34.39 16.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.668 0.787 . . . . 0.0 111.166 -171.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -138.65 142.47 39.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.109 1.363 . . . . 0.0 108.035 -167.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 p -80.49 165.3 22.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.649 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -49.36 -49.56 43.89 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.367 1.067 . . . . 0.0 110.019 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -47.09 -52.6 14.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.646 1.179 . . . . 0.0 112.676 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.98 -49.01 77.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.515 -0.741 . . . . 0.0 110.336 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.98 -47.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.0 tp -50.29 -55.36 15.76 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.82 1.648 . . . . 0.0 109.943 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.76 -48.17 80.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -57.98 -43.46 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 122.56 0.344 . . . . 0.0 110.377 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.4 -50.42 80.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.08 -28.65 68.99 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -103.46 -60.95 1.48 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.137 1.775 . . . . 0.0 111.495 -171.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.8 -175.75 21.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.405 1.955 . . . . 0.0 110.365 -170.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -151.62 164.02 37.81 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -5.88 -91.97 0.0 OUTLIER Glycine 0 CA--C 1.54 1.628 0 C-N-CA 126.921 2.2 . . . . 0.0 116.2 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.36 37.27 3.59 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 118.571 1.186 . . . . 0.0 112.471 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.411 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.3 ttt -117.93 122.84 30.12 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 125.547 1.539 . . . . 0.0 108.617 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -61.92 -38.54 57.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.873 2.382 . . . . 0.0 112.688 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.49 163.57 29.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 122.003 0.779 . . . . 0.0 111.849 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.73 22.28 63.99 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.408 0.527 . . . . 0.0 111.872 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mt -64.39 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.168 1.387 . . . . 0.0 109.748 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.95 144.28 38.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -138.78 158.34 44.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.261 0.937 . . . . 0.0 112.931 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.93 -136.27 41.93 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.263 0.935 . . . . 0.0 110.89 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.15 -37.72 3.29 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.259 1.424 . . . . 0.0 112.172 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -59.01 -56.35 23.4 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.704 0.801 . . . . 0.0 110.214 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.36 88.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.671 -0.643 . . . . 0.0 110.266 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.26 -53.1 58.2 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.311 0.644 . . . . 0.0 109.968 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.14 41.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.609 0.763 . . . . 0.0 109.888 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.9 t -50.72 -58.2 2.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 117.897 0.317 . . . . 0.0 110.36 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.72 -54.16 41.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.02 0.528 . . . . 0.0 110.771 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.46 -53.18 59.47 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.083 0.468 . . . . 0.0 110.545 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.796 ' CH2' HD23 ' A' ' 88' ' ' LEU . 14.0 t90 -58.33 -47.73 82.8 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.892 0.477 . . . . 0.0 111.69 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.796 HD23 ' CH2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -75.19 -29.75 60.45 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.861 -1.149 . . . . 0.0 110.736 -172.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.04 -56.24 21.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 160.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.69 -8.45 52.11 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.767 -1.208 . . . . 0.0 112.037 -172.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -27.4 61.07 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.289 -0.882 . . . . 0.0 110.11 -176.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.7 pttp . . . . . 0 C--O 1.252 1.223 0 C-N-CA 124.941 1.296 . . . . 0.0 113.702 -150.393 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.748 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -70.17 108.04 3.96 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.29 76.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.575 -177.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -70.62 -41.38 72.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -175.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.25 58.93 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.259 0.936 . . . . 0.0 110.919 174.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 31' ' ' LYS . 59.0 t -49.77 -59.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.554 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 33.1 t -71.11 -11.99 15.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 119.937 1.244 . . . . 0.0 114.071 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -93.51 0.36 56.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.126 2.17 . . . . 0.0 110.86 174.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -6.59 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' HG3' HG13 ' A' ' 27' ' ' VAL . 53.9 mmtt -112.25 -49.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.67 1.188 . . . . 0.0 109.947 -177.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -88.73 -37.93 15.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.124 0.569 . . . . 0.0 110.978 -170.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 28' ' ' VAL . 23.0 pt -46.89 -36.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.069 0.948 . . . . 0.0 111.317 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 m -37.9 -36.71 0.21 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.326 2.25 . . . . 0.0 112.884 174.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.53 -43.42 2.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.509 0.723 . . . . 0.0 111.189 173.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -74.46 -7.12 51.95 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.94 -71.77 0.26 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.088 0.851 . . . . 0.0 113.198 163.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.53 -77.46 0.06 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 5.5 5.34 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.984 1.313 . . . . 0.0 112.367 169.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 69.09 24.71 6.05 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 125.507 1.523 . . . . 0.0 110.965 176.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.7 p -70.73 -15.0 62.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.056 1.343 . . . . 0.0 111.153 175.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 97.79 1.9 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -99.0 -80.21 0.47 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.252 0.621 . . . . 0.0 109.831 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 1.94 55.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.228 1.411 . . . . 0.0 111.705 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HA ' HMD3 ' A' ' 93' ' ' HEC . . . -145.1 156.92 54.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 127.295 2.238 . . . . 0.0 105.347 -176.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.59 164.31 29.43 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.91 123.36 17.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.03 -5.49 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.746 170.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -41.28 -46.22 3.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.739 1.154 . . . . 0.0 111.336 169.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 0.73 54.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.106 0.962 . . . . 0.0 110.927 -172.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.9 -41.61 62.08 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 121.376 -0.827 . . . . 0.0 112.056 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.7 -24.75 8.23 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.629 0.633 . . . . 0.0 114.679 177.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.07 -30.34 31.36 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.815 0.807 . . . . 0.0 111.52 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -89.56 -44.57 10.0 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 123.857 0.863 . . . . 0.0 110.513 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -126.58 149.86 49.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.106 1.763 . . . . 0.0 107.876 -171.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.3 m -88.05 162.8 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.787 0.435 . . . . 0.0 111.113 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -42.6 -52.41 4.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.554 1.142 . . . . 0.0 110.32 175.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -48.03 -55.59 9.76 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -58.12 -49.51 76.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.721 0.772 . . . . 0.0 109.96 -178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.579 HG23 HMA1 ' A' ' 93' ' ' HEC . 67.2 mt -64.03 -47.44 90.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.3 tp -49.41 -55.78 11.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.114 1.366 . . . . 0.0 110.185 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -44.19 90.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.9 mt -61.69 -40.76 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.335 -0.853 . . . . 0.0 111.356 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 60' ' ' ILE . 26.1 mt -61.03 -47.59 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 120.905 -1.122 . . . . 0.0 109.464 177.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.51 -40.03 88.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.486 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.34 -50.88 5.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.46 1.504 . . . . 0.0 112.318 -169.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.1 -170.83 15.11 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.092 1.806 . . . . 0.0 111.211 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.431 ' H ' ' HB3' ' A' ' 71' ' ' MET . 1.0 OUTLIER -163.93 116.27 1.4 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 127.056 2.142 . . . . 0.0 105.495 168.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.9 -109.93 0.64 Allowed Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.062 1.301 . . . . 0.0 113.157 172.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -26.18 73.37 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 118.011 0.905 . . . . 0.0 113.061 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.526 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 22.1 ttt -72.74 118.85 71.57 Favored Pre-proline 0 N--CA 1.454 -0.259 0 C-N-CA 124.42 1.088 . . . . 0.0 109.911 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.32 -34.11 28.18 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.594 2.863 . . . . 0.0 112.582 -173.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.48 165.64 40.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -176.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.32 12.65 66.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.754 0.692 . . . . 0.0 112.278 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.78 -34.65 52.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.845 1.658 . . . . 0.0 110.36 177.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.53 149.46 49.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -145.85 155.66 43.05 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 179.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.68 -136.93 49.15 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -175.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.17 -37.44 4.46 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.795 1.238 . . . . 0.0 112.186 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -54.29 -61.4 2.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.237 1.015 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.91 74.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.725 -0.61 . . . . 0.0 111.145 -175.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.24 -52.86 63.87 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.441 0.564 . . . . 0.0 109.873 175.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.44 -52.47 53.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.7 t -46.98 -62.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 123.176 0.298 . . . . 0.0 110.786 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.8 -48.97 69.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 111.285 -171.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.97 -53.37 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.317 0.58 . . . . 0.0 110.662 177.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.554 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 20.3 t90 -60.11 -31.31 69.93 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.786 0.834 . . . . 0.0 112.001 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -43.41 52.22 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 172.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.28 -40.39 77.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.067 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.99 -16.41 58.15 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 13.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.877 3.271 . . . . 0.0 114.953 -177.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 pttt . . . . . 0 C--O 1.25 1.095 0 O-C-N 119.981 -1.7 . . . . 0.0 112.88 -151.19 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.763 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 CA--C 1.513 -0.443 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.95 97.14 1.8 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.47 66.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.561 -169.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.84 -42.14 88.59 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.638 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.45 93.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.543 0.61 . . . . 0.0 109.881 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.03 -60.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.636 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.267 87.1 t -65.19 -43.25 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.726 -168.871 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.72 0.72 0.74 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.354 2.261 . . . . 0.0 114.032 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -138.29 -12.13 1.41 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 172.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -128.42 -20.51 3.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.152 1.381 . . . . 0.0 112.067 -171.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 18.4 m -110.93 -43.6 3.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.138 0.881 . . . . 0.0 110.671 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -49.42 -29.21 3.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.185 0.594 . . . . 0.0 111.845 176.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.8 t -38.06 -43.54 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.868 1.667 . . . . 0.0 112.007 174.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.7 m -114.11 -41.65 3.48 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 117.888 0.313 . . . . 0.0 110.644 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.78 -16.5 62.75 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.9 25.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.7 -61.51 1.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.581 1.563 . . . . 0.0 113.753 -173.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.24 -5.61 47.67 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.215 1.006 . . . . 0.0 112.419 -177.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 48' ' ' ILE . 4.2 mt 69.65 23.68 5.75 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.085 1.754 . . . . 0.0 111.096 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -78.79 -6.49 56.09 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.552 2.341 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 77.17 1.32 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-N 118.595 0.634 . . . . 0.0 112.064 167.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.58 -76.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.681 0.392 . . . . 0.0 111.458 177.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -99.52 2.73 45.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.827 1.651 . . . . 0.0 111.552 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.53 162.45 39.17 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.42 166.36 21.9 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.806 1.67 . . . . 0.0 111.299 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.69 122.27 16.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.33 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 40' ' ' LEU 0.311 2.1 pp -117.24 -0.97 8.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.401 173.166 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -34.61 -47.13 0.31 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 112.087 159.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -102.65 6.33 39.57 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.984 1.314 . . . . 0.0 112.765 -175.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.31 57.0 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.102 0.865 . . . . 0.0 111.691 177.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.88 -32.6 75.42 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 119.84 1.2 . . . . 0.0 113.229 172.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.49 27.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.9 1.35 . . . . 0.0 110.455 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.41 -39.57 62.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.281 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -123.11 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 128.009 2.524 . . . . 0.0 107.606 -173.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.4 m -135.88 171.28 14.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.835 -1.165 . . . . 0.0 109.999 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -39.37 68.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.107 0.563 . . . . 0.0 110.795 -166.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.55 -53.14 61.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -57.99 -50.35 73.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.935 0.894 . . . . 0.0 109.383 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -63.41 -49.67 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.91 -57.27 6.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.872 1.269 . . . . 0.0 109.921 175.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.85 -43.55 94.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.049 -176.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -62.03 -41.22 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.736 -0.602 . . . . 0.0 111.14 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.3 mt -59.25 -50.57 79.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 O-C-N 120.899 -1.126 . . . . 0.0 109.408 175.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.82 -36.31 83.47 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.651 -177.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.65 -51.62 3.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.158 1.383 . . . . 0.0 112.12 -168.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.34 -171.67 18.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.857 1.694 . . . . 0.0 110.33 -171.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -165.06 127.9 2.24 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.42 -112.18 0.61 Allowed Glycine 0 CA--C 1.538 1.479 0 CA-C-N 120.098 1.317 . . . . 0.0 112.876 176.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.17 -12.68 75.87 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 118.161 0.981 . . . . 0.0 113.996 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.409 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 16.2 ttt -64.34 125.11 87.69 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 118.46 1.13 . . . . 0.0 109.175 178.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.41 -36.55 54.57 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -172.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.2 165.19 31.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.48 27.49 68.01 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.3 -32.26 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.151 0.98 . . . . 0.0 109.373 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.44 46.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.751 1.621 . . . . 0.0 106.755 173.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -145.32 154.64 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 178.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.02 -140.57 48.06 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -40.52 -37.33 0.69 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.709 1.604 . . . . 0.0 112.557 176.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.32 -61.98 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.308 1.043 . . . . 0.0 110.319 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.67 87.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.748 -0.595 . . . . 0.0 110.29 -177.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.23 -48.38 78.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.649 0.78 . . . . 0.0 110.002 178.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.41 82.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.897 176.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.28 -48.95 75.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.707 174.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.63 -55.14 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.162 0.892 . . . . 0.0 110.195 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.02 -58.05 10.13 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.771 0.428 . . . . 0.0 111.475 178.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.636 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 54.9 t90 -57.14 -45.68 83.34 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.078 0.951 . . . . 0.0 111.482 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.485 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -70.78 -42.54 70.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.18 -175.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.65 66.86 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.021 -0.424 . . . . 0.0 110.651 169.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -74.04 -14.36 60.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.681 0.792 . . . . 0.0 112.438 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 -15.22 48.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.696 -1.253 . . . . 0.0 113.082 -166.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.923 1.289 . . . . 0.0 112.961 -153.716 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.746 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 CA--C 1.513 -0.48 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.72 99.94 1.79 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 126.044 1.737 . . . . 0.0 107.641 -163.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.84 -52.27 43.1 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.537 -167.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.34 -44.76 96.65 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.366 178.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.38 59.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 120.081 1.31 . . . . 0.0 110.849 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -46.99 -62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.557 HG13 ' SG ' ' A' ' 32' ' ' CYS . 40.2 t -77.78 2.42 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 O-C-N 120.363 -1.46 . . . . 0.0 113.239 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.28 0.9 38.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.569 2.348 . . . . 0.0 110.063 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -142.35 -13.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -106.93 -55.82 2.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.456 1.503 . . . . 0.0 109.574 -175.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' HG13 ' A' ' 28' ' ' VAL . 2.9 m -82.59 -37.2 25.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.475 0.31 . . . . 0.0 110.663 -171.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 28' ' ' VAL . 14.1 pt -48.31 -32.73 3.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 123.383 0.673 . . . . 0.0 111.284 178.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -45.14 -29.52 0.94 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 112.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -127.2 -44.41 1.59 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.439 0.696 . . . . 0.0 111.311 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -71.86 -14.62 62.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.307 -0.87 . . . . 0.0 113.283 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.86 154.95 28.12 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.804 0.716 . . . . 0.0 111.562 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.76 -49.89 8.75 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.215 1.388 . . . . 0.0 113.274 -175.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -84.15 -8.42 59.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.787 0.835 . . . . 0.0 111.857 -176.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.419 HD21 HG12 ' A' ' 28' ' ' VAL . 3.7 mt 69.68 21.45 6.56 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.642 1.577 . . . . 0.0 111.181 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -77.66 -8.23 57.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 128.223 2.609 . . . . 0.0 111.431 176.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.54 87.0 1.74 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.46 -81.16 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.843 0.457 . . . . 0.0 110.524 175.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.6 m -90.45 2.01 56.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.343 1.457 . . . . 0.0 112.138 177.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.75 43.55 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.6 166.08 21.0 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.797 1.665 . . . . 0.0 111.441 -178.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.1 117.59 7.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 88' ' ' LEU 0.281 2.5 pp -112.7 -3.32 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.067 176.509 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -38.03 -46.49 1.01 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.644 1.111 . . . . 0.0 113.152 163.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -98.15 4.75 49.02 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.076 1.75 . . . . 0.0 112.116 -177.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.07 -38.58 62.61 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.767 172.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.35 -27.33 65.39 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.619 1.1 . . . . 0.0 113.463 173.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.38 -48.25 20.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.8 -0.824 . . . . 0.0 109.701 177.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -74.08 -45.21 50.69 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 122.634 0.373 . . . . 0.0 111.684 -174.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -122.55 157.36 32.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.284 1.834 . . . . 0.0 109.265 -169.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m -89.11 167.18 13.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.39 0.614 . . . . 0.0 110.813 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.73 -45.59 49.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.078 0.951 . . . . 0.0 109.858 174.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -54.5 -49.56 69.88 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.593 0.633 . . . . 0.0 112.521 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.7 -51.22 70.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.697 0.761 . . . . 0.0 109.791 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.54 -50.1 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -174.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -47.14 -58.12 4.38 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.183 1.393 . . . . 0.0 110.271 172.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.14 -47.69 80.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -175.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.74 -44.31 89.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 122.329 0.252 . . . . 0.0 110.673 -178.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.646 HD11 HMB2 ' A' ' 93' ' ' HEC . 66.7 mt -60.97 -50.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 121.79 -0.569 . . . . 0.0 110.045 177.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.48 -36.43 84.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.778 -178.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.11 -59.3 2.0 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.1 1.76 . . . . 0.0 111.565 -169.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.36 106.79 2.69 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.45 1.5 . . . . 0.0 110.595 -168.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -55.19 155.29 4.96 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 160.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -35.78 -61.64 0.73 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.028 1.299 . . . . 0.0 115.469 -175.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.88 17.49 52.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 117.902 0.851 . . . . 0.0 113.386 -177.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.0 ttt -119.41 136.97 24.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 125.846 1.658 . . . . 0.0 108.396 -176.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.524 ' HD3' HBC2 ' A' ' 93' ' ' HEC . 54.7 Cg_endo -67.76 -36.91 17.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.104 1.87 . . . . 0.0 112.034 -172.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 163.69 27.13 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.4 23.52 62.56 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.01 -32.58 58.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 123.57 0.748 . . . . 0.0 109.976 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.49 48.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -144.97 153.21 41.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -137.67 49.51 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.3 -35.99 1.68 Allowed 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 112.352 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.25 -60.37 3.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.892 0.877 . . . . 0.0 110.237 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.01 88.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.556 -0.715 . . . . 0.0 110.52 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.38 -48.33 82.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.307 0.643 . . . . 0.0 110.13 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.59 -49.57 70.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.317 0.647 . . . . 0.0 109.478 175.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 28' ' ' VAL . 61.9 t -52.44 -58.77 2.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.2 173.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.73 -55.12 6.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.932 0.893 . . . . 0.0 111.147 -172.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.87 29.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 110.965 178.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.544 ' CZ3' ' HB ' ' A' ' 28' ' ' VAL . 65.3 t90 -58.99 -41.37 87.46 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.742 0.417 . . . . 0.0 111.515 -175.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.5 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -69.05 -46.02 68.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.293 1.037 . . . . 0.0 109.976 -179.622 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.35 59.62 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.871 0.468 . . . . 0.0 110.931 171.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.42 -17.93 60.72 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.866 1.267 . . . . 0.0 112.536 178.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 2.05 44.16 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.429 -1.419 . . . . 0.0 113.536 -164.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.305 1.442 . . . . 0.0 114.815 -148.444 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.743 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.512 -0.484 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.56 99.13 2.0 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.154 1.382 . . . . 0.0 107.582 -164.118 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -49.87 59.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.27 -167.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.39 -39.65 91.47 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.544 178.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.46 96.65 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 120.274 1.397 . . . . 0.0 111.028 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -49.36 -65.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 167.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.806 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 48.1 t -58.97 -48.0 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.488 -167.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -56.58 -6.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.363 3.065 . . . . 0.0 113.268 174.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -132.75 2.22 3.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.992 0.917 . . . . 0.0 113.001 173.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -129.16 -59.85 1.09 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.124 0.97 . . . . 0.0 109.831 -169.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.644 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.3 m -86.9 -40.57 14.72 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.679 0.391 . . . . 0.0 110.284 -171.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.15 -26.78 8.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.77 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -46.73 -37.36 8.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.844 1.258 . . . . 0.0 111.549 176.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.5 m -116.02 -38.96 3.52 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 122.934 0.494 . . . . 0.0 111.301 174.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -76.16 -13.01 60.2 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.93 151.99 23.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.69 -54.03 5.07 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.254 1.407 . . . . 0.0 112.902 -177.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 -7.56 58.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.82 1.648 . . . . 0.0 111.971 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.578 HD22 HD11 ' A' ' 48' ' ' ILE . 1.6 mt 69.08 21.35 7.35 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.808 1.643 . . . . 0.0 110.948 178.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 p -79.34 -5.54 54.75 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.011 2.524 . . . . 0.0 111.537 178.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.44 83.9 1.65 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 118.53 0.605 . . . . 0.0 111.701 167.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.12 -71.17 0.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.746 0.418 . . . . 0.0 110.853 177.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t -100.17 1.74 42.32 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.623 1.569 . . . . 0.0 110.839 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.23 163.9 29.79 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 126.273 1.829 . . . . 0.0 106.082 -173.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -63.26 160.64 33.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.633 1.555 . . . . 0.0 111.231 174.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 113.65 3.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.172 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 88' ' ' LEU . 2.1 pp -100.08 -5.86 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.748 173.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -37.89 6.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.839 1.199 . . . . 0.0 112.079 176.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -105.46 4.83 31.04 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.393 1.877 . . . . 0.0 112.371 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.9 -35.18 22.68 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 118.688 0.676 . . . . 0.0 110.882 176.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.11 -30.23 54.03 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.961 0.801 . . . . 0.0 114.588 174.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.51 -45.33 38.81 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 121.633 -0.922 . . . . 0.0 109.845 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -73.78 -38.41 64.66 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 122.869 0.467 . . . . 0.0 111.575 -171.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -135.85 154.23 51.24 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.322 1.849 . . . . 0.0 107.721 -171.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -89.46 168.23 12.37 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.161 -0.337 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.84 -43.39 65.99 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.928 0.491 . . . . 0.0 110.952 -175.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.58 -55.85 12.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.104 1.361 . . . . 0.0 112.713 174.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -53.88 -48.54 69.96 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.46 1.104 . . . . 0.0 109.854 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.48 -50.17 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -50.74 -55.58 15.99 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.872 1.269 . . . . 0.0 110.008 177.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -45.65 91.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.76 -41.25 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 O-C-N 121.378 -0.826 . . . . 0.0 111.25 -178.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HMB2 ' A' ' 93' ' ' HEC . 88.8 mt -60.11 -52.3 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.849 0.75 . . . . 0.0 109.839 175.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.0 mt -66.23 -36.92 84.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -174.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -90.28 -53.05 4.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.271 1.828 . . . . 0.0 111.508 -171.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 111.76 3.61 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -169.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.406 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 3.3 tp60 -57.17 154.56 9.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 117.8 0.8 . . . . 0.0 108.846 167.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.59 86.8 0.03 OUTLIER Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.062 -1.024 . . . . 0.0 112.516 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.57 -12.38 4.29 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.161 2.315 . . . . 0.0 112.311 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.0 ttt -116.62 129.21 25.44 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 127.081 2.153 . . . . 0.0 108.783 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.45 136.18 33.14 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.306 1.337 . . . . 0.0 108.699 170.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.02 39.5 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.47 13.5 65.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.919 0.771 . . . . 0.0 112.339 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.455 HD13 HMC2 ' A' ' 93' ' ' HEC . 61.4 mt -59.45 -30.9 45.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.99 1.316 . . . . 0.0 110.204 175.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.47 148.42 42.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -139.92 156.11 46.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.271 0.941 . . . . 0.0 113.383 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.13 -139.02 41.85 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.42 -37.43 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.744 1.618 . . . . 0.0 112.714 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.53 -62.06 1.9 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.38 1.072 . . . . 0.0 109.675 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.12 -38.38 82.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.65 -0.656 . . . . 0.0 110.761 -177.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -58.16 -49.25 77.67 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.262 0.625 . . . . 0.0 109.994 178.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.81 76.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.57 -53.93 14.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.365 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.15 -56.34 8.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.588 0.755 . . . . 0.0 110.777 -174.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -54.49 45.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.931 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.806 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 7.6 t90 -60.29 -47.63 85.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.96 0.504 . . . . 0.0 112.151 -175.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -63.61 -43.05 98.02 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.367 -0.833 . . . . 0.0 108.957 -179.701 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.8 -44.02 73.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.315 -0.241 . . . . 0.0 110.866 171.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -73.82 -11.17 60.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.482 1.113 . . . . 0.0 111.927 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.13 60.17 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.028 -1.045 . . . . 0.0 110.277 -177.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.171 -158.982 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.76 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.59 102.79 3.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.967 1.707 . . . . 0.0 108.187 -163.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.84 -51.72 59.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.617 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.41 -43.73 98.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 118.194 -0.907 . . . . 0.0 109.142 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.18 81.57 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.558 1.072 . . . . 0.0 111.302 -176.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.4 t -45.8 -62.63 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.798 HG21 ' HZ3' ' A' ' 87' ' ' TRP 0.257 52.1 t -65.11 -40.65 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 118.564 -1.254 . . . . 0.0 113.262 -167.527 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -62.15 0.37 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.091 3.356 . . . . 0.0 113.196 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -137.37 -12.19 1.61 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -119.38 -25.77 5.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.132 1.373 . . . . 0.0 111.949 -168.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.649 ' SG ' HG22 ' A' ' 28' ' ' VAL . 1.7 m -114.12 -39.75 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.992 0.814 . . . . 0.0 111.004 -177.233 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 pt -48.41 -32.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 C-N-CA 122.545 0.338 . . . . 0.0 111.416 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -44.17 -30.67 0.81 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.222 1.409 . . . . 0.0 113.024 175.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 m -122.61 -43.98 2.25 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.689 0.796 . . . . 0.0 110.576 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -71.96 -10.06 59.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.49 -85.0 0.38 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.186 0.898 . . . . 0.0 112.746 163.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.59 -63.54 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -174.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.407 ' C ' HD22 ' A' ' 40' ' ' LEU . 4.7 m-20 -82.59 3.26 29.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 111.86 173.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 39' ' ' ASP . 1.2 mm? 65.29 25.8 12.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.873 1.669 . . . . 0.0 111.453 -172.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -74.6 -11.91 60.32 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.034 2.134 . . . . 0.0 111.42 177.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.43 89.44 1.82 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 168.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.18 -77.66 0.45 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.274 0.629 . . . . 0.0 110.616 177.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -92.96 2.34 56.85 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.071 1.349 . . . . 0.0 111.482 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 158.92 50.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 -176.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -62.58 162.54 24.14 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.985 1.79 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 126.11 26.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.763 177.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.438 ' O ' HD11 ' A' ' 88' ' ' LEU 0.272 2.7 pp -116.78 -2.29 9.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.672 171.738 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -43.7 -45.69 7.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.499 1.045 . . . . 0.0 112.134 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -94.55 4.23 54.11 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.466 1.106 . . . . 0.0 112.463 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.68 -34.15 37.14 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.572 177.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.72 73.46 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.134 1.334 . . . . 0.0 114.018 173.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.26 -44.83 43.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.503 1.151 . . . . 0.0 110.037 170.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -73.31 -40.95 64.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.509 0.195 . . . . 0.0 111.269 -171.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -131.98 169.21 16.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.973 2.109 . . . . 0.0 107.194 -169.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 m -108.34 167.45 10.02 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.248 0.477 . . . . 0.0 109.764 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -50.57 -42.15 55.22 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.249 -176.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.3 -50.83 58.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.12 1.327 . . . . 0.0 112.035 177.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -61.87 -52.47 63.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 122.247 1.022 . . . . 0.0 109.252 -176.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.55 HG23 HMA1 ' A' ' 93' ' ' HEC . 37.2 mt -62.57 -47.17 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.21 -53.76 32.08 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 124.929 1.292 . . . . 0.0 110.047 176.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -56.66 -48.22 78.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.31 -45.7 89.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.367 -0.833 . . . . 0.0 111.251 -178.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 60' ' ' ILE . 29.5 mt -59.1 -48.0 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.094 -1.003 . . . . 0.0 109.59 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.1 -25.88 62.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.7 0.8 . . . . 0.0 113.104 -177.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.55 -60.29 1.65 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.508 1.523 . . . . 0.0 111.02 -171.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.31 -174.63 21.39 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.648 2.07 . . . . 0.0 109.884 -170.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -152.79 163.58 39.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -1.19 -91.78 0.0 OUTLIER Glycine 0 CA--C 1.543 1.814 0 C-N-CA 126.382 1.944 . . . . 0.0 116.622 175.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.98 12.29 67.17 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 118.501 1.151 . . . . 0.0 113.7 178.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.443 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.2 ttt -96.19 120.1 63.25 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 125.715 1.606 . . . . 0.0 109.023 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.96 -37.31 54.66 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.807 2.338 . . . . 0.0 112.176 -171.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.21 164.62 28.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-O 122.111 0.84 . . . . 0.0 111.743 177.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.51 17.14 61.79 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 122.407 -0.466 . . . . 0.0 112.159 -173.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.76 -31.28 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.441 1.496 . . . . 0.0 109.628 173.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.58 140.31 35.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 176.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -139.5 162.79 34.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.22 1.008 . . . . 0.0 111.768 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.73 -138.59 44.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.83 -37.48 2.81 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.98 1.312 . . . . 0.0 112.002 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.26 -58.37 8.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.836 0.454 . . . . 0.0 110.048 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.49 93.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.753 -0.592 . . . . 0.0 110.507 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.16 -54.07 47.94 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.157 0.583 . . . . 0.0 110.03 176.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.07 -54.44 30.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.377 0.671 . . . . 0.0 109.626 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.9 t -49.37 -66.99 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 123.432 0.458 . . . . 0.0 110.078 176.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.7 -46.78 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.241 0.617 . . . . 0.0 111.455 -170.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.23 -58.72 7.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.367 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.948 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 9.6 t90 -53.14 -43.38 66.94 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.399 0.68 . . . . 0.0 110.793 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.948 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -70.62 -39.4 73.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.998 -1.064 . . . . 0.0 110.657 -175.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.56 72.39 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.889 -0.507 . . . . 0.0 110.978 166.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -16.25 60.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.648 0.779 . . . . 0.0 112.813 179.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -20.14 57.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.822 1.249 . . . . 0.0 111.472 -166.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -156.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.761 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.88 100.18 4.01 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.787 1.635 . . . . 0.0 107.847 -167.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.38 -52.66 7.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.495 1.118 . . . . 0.0 113.169 -170.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.27 -39.84 95.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.286 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.94 76.59 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 119.981 1.264 . . . . 0.0 110.381 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.9 t -52.31 -59.94 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.726 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 29.8 t -79.35 3.85 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -171.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -104.96 3.6 30.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.521 1.928 . . . . 0.0 110.465 170.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -128.79 -43.49 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -97.89 -14.28 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.247 1.419 . . . . 0.0 112.024 -159.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 4.5 m -120.91 -37.47 2.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.615 1.166 . . . . 0.0 111.026 -170.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 pt -50.97 -30.97 9.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.474 0.71 . . . . 0.0 111.659 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -38.18 -42.4 0.68 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.699 2.0 . . . . 0.0 112.737 173.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.3 m -121.3 -38.39 2.8 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.215 0.606 . . . . 0.0 110.799 -177.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -79.79 -8.05 59.03 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.517 -0.74 . . . . 0.0 112.851 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.61 156.21 19.3 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.16 -58.91 3.62 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.633 1.111 . . . . 0.0 112.534 -176.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.94 -4.52 47.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.622 1.169 . . . . 0.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt 72.0 20.43 4.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.764 1.626 . . . . 0.0 111.335 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 p -80.23 -2.79 46.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.822 2.449 . . . . 0.0 112.112 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.18 102.36 1.56 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.916 0.77 . . . . 0.0 111.472 168.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.39 -70.66 0.75 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.924 0.862 . . . . 0.0 110.128 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -99.62 2.69 44.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.464 1.506 . . . . 0.0 111.109 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.84 161.79 44.31 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -175.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.36 163.4 29.65 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.781 1.654 . . . . 0.0 110.828 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.28 113.62 3.71 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.591 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.305 2.1 pp -105.2 0.69 10.21 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.009 172.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -41.42 14.57 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.239 -0.913 . . . . 0.0 112.801 170.253 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -97.88 4.99 49.54 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.656 1.183 . . . . 0.0 112.106 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.27 32.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.451 -1.261 . . . . 0.0 112.398 -178.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.73 -32.04 68.85 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 120.893 1.679 . . . . 0.0 113.881 174.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.17 -41.55 57.83 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.407 -1.055 . . . . 0.0 109.83 174.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -73.56 -35.17 65.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.828 -172.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -142.24 152.89 43.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.847 1.659 . . . . 0.0 108.674 -170.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.6 t -80.75 163.81 23.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.823 -0.548 . . . . 0.0 110.621 -179.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.11 -44.92 68.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.24 -0.41 . . . . 0.0 109.951 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.53 -44.55 72.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.372 0.669 . . . . 0.0 112.494 178.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.9 -50.49 70.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.582 0.706 . . . . 0.0 109.833 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG23 HMA1 ' A' ' 93' ' ' HEC . 63.7 mt -62.53 -48.3 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 tp -48.38 -56.75 7.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.642 1.577 . . . . 0.0 109.97 175.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -56.54 -48.94 76.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.6 mt -59.27 -43.73 90.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 122.248 -0.282 . . . . 0.0 110.454 -175.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.46 -50.38 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.525 -0.735 . . . . 0.0 109.559 177.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.23 -35.45 78.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.759 -0.639 . . . . 0.0 111.453 -179.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -102.48 -65.46 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.765 2.026 . . . . 0.0 112.527 -167.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.76 -176.96 22.82 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.952 1.739 . . . . 0.0 111.619 -170.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -157.07 170.44 22.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.875 3.27 . . . . 0.0 103.701 169.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -9.53 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.541 1.672 0 C-N-CA 126.953 2.216 . . . . 0.0 116.343 175.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.88 42.01 2.0 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 118.599 1.199 . . . . 0.0 110.949 171.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.495 ' HB2' ' C4D' ' A' ' 93' ' ' HEC . 7.7 tpt -116.55 107.5 46.7 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -177.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.33 -36.22 88.27 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.499 2.8 . . . . 0.0 112.617 -162.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.17 161.49 17.66 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 122.264 0.924 . . . . 0.0 111.484 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.76 14.31 57.97 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 122.051 -0.676 . . . . 0.0 113.154 -177.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 -32.46 50.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.616 175.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.41 141.49 46.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -139.35 154.08 47.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 107.154 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.68 -139.54 35.55 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -177.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -39.86 -41.07 1.09 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.205 1.802 . . . . 0.0 112.418 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -57.17 -55.85 29.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.431 0.692 . . . . 0.0 110.032 178.728 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.84 78.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -178.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.87 -56.28 19.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.622 0.769 . . . . 0.0 109.879 177.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.53 -53.05 59.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.039 0.936 . . . . 0.0 109.762 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 80' ' ' GLU . 87.7 t -48.64 -63.09 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 O-C-N 123.641 0.588 . . . . 0.0 109.805 176.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.55 -55.16 17.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.528 0.731 . . . . 0.0 111.76 -171.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.17 -53.22 60.73 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.467 0.651 . . . . 0.0 110.793 -177.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.726 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 21.8 t90 -54.23 -45.81 72.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.287 177.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.718 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -62.97 -45.63 91.52 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.732 -1.23 . . . . 0.0 111.502 -177.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.6 51.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.672 0.789 . . . . 0.0 111.606 172.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.0 -26.91 33.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.241 1.016 . . . . 0.0 112.056 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -32.58 65.57 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.976 1.311 . . . . 0.0 110.91 -165.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 128.512 2.725 . . . . 0.0 112.822 -162.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.766 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -70.42 97.65 1.31 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -169.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.17 -53.01 56.78 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.311 -170.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.97 -43.76 97.92 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.446 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.48 76.14 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 119.904 1.229 . . . . 0.0 111.117 -177.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -46.68 -62.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 167.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG13 ' SG ' ' A' ' 32' ' ' CYS 0.28 73.7 t -70.82 -33.08 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.463 -161.313 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -63.1 -0.78 0.8 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 130.249 3.419 . . . . 0.0 113.315 169.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.24 -22.73 0.91 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 173.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -104.43 -23.75 13.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.29 1.836 . . . . 0.0 110.778 -171.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' HG13 ' A' ' 28' ' ' VAL . 2.3 m -117.57 -40.37 3.05 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.653 0.661 . . . . 0.0 111.781 -174.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 pt -49.74 -31.11 6.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 117.941 0.337 . . . . 0.0 111.397 178.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -37.11 -43.4 0.49 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.313 1.845 . . . . 0.0 111.904 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -114.25 -44.09 3.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.145 0.578 . . . . 0.0 110.853 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -73.67 -14.65 61.19 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.0 152.85 23.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.032 0.833 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -38.17 -63.46 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.033 1.778 . . . . 0.0 113.895 -173.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.79 -7.89 54.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.144 1.377 . . . . 0.0 112.658 -176.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mt 72.41 25.1 2.82 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.996 2.118 . . . . 0.0 110.672 -178.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -78.65 -6.01 54.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.355 2.662 . . . . 0.0 112.131 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 80.73 1.52 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 118.593 0.633 . . . . 0.0 112.033 168.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.59 -79.41 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.858 0.463 . . . . 0.0 111.135 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -94.78 2.08 55.47 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.521 1.528 . . . . 0.0 111.833 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.17 162.79 35.9 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 127.577 2.351 . . . . 0.0 104.677 -177.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.96 166.19 19.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.035 1.823 . . . . 0.0 111.656 -178.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.02 114.35 6.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 88' ' ' LEU 0.261 2.2 pp -108.78 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.652 177.394 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -37.16 -48.31 0.83 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.651 1.114 . . . . 0.0 112.846 165.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -97.71 4.82 49.89 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.689 1.996 . . . . 0.0 111.545 -174.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.25 -32.74 25.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.08 171.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.67 72.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.665 1.12 . . . . 0.0 114.203 173.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.38 -47.18 18.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.45 1.125 . . . . 0.0 109.865 171.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -74.06 -42.96 59.42 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.938 0.495 . . . . 0.0 111.047 -168.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -124.26 -179.87 4.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.473 2.309 . . . . 0.0 107.964 -176.257 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.3 m -119.21 170.16 9.33 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.567 0.747 . . . . 0.0 110.219 -178.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -40.8 72.6 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.556 -174.05 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -53.47 -53.81 46.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.48 1.112 . . . . 0.0 111.714 176.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -59.13 -49.59 77.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.188 0.995 . . . . 0.0 109.33 -178.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.31 -52.24 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.8 tp -48.61 -57.0 6.89 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.081 1.352 . . . . 0.0 109.858 176.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.95 -41.84 98.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -59.98 -41.82 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 121.586 -0.696 . . . . 0.0 111.283 177.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.39 -50.94 78.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 109.521 177.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.71 -38.45 91.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.376 -176.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.77 -53.79 4.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.657 1.583 . . . . 0.0 111.903 -171.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.87 110.11 3.4 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.389 1.471 . . . . 0.0 110.208 -167.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HG2' HAD2 ' A' ' 93' ' ' HEC . 3.1 tp60 -53.3 151.61 5.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 157.325 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -36.46 -58.52 1.09 Allowed Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.924 1.249 . . . . 0.0 115.477 -172.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.57 12.64 62.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.951 0.876 . . . . 0.0 113.775 -176.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 ttt -120.47 132.2 24.21 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 126.12 1.768 . . . . 0.0 107.923 -174.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 -36.83 42.64 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.964 1.776 . . . . 0.0 112.793 -169.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.09 163.21 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.804 0.669 . . . . 0.0 111.691 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.01 17.81 61.51 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -174.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.93 -38.17 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.117 1.367 . . . . 0.0 108.961 179.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.38 147.28 48.99 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -141.3 152.23 44.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.486 0.66 . . . . 0.0 111.8 -175.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.5 -142.61 46.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.75 -33.36 1.24 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.83 1.652 . . . . 0.0 112.926 -179.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -53.98 -66.79 0.33 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.122 1.369 . . . . 0.0 109.946 171.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.53 87.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.263 0.625 . . . . 0.0 110.554 -176.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -55.97 -50.17 71.55 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.98 0.512 . . . . 0.0 109.695 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.3 85.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.315 177.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.448 HG22 ' CG2' ' A' ' 28' ' ' VAL . 59.2 t -50.56 -58.16 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.011 173.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -43.48 -58.71 2.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.868 0.867 . . . . 0.0 111.549 -174.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.06 -54.43 46.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.165 -179.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.491 ' CZ3' HD23 ' A' ' 88' ' ' LEU . 47.8 t90 -56.87 -45.78 82.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 111.07 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.491 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -65.21 -45.61 84.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.296 1.038 . . . . 0.0 109.72 -178.378 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.46 63.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.791 0.436 . . . . 0.0 111.171 171.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.9 -16.75 60.65 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.184 1.393 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 -4.81 58.41 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.842 -1.161 . . . . 0.0 113.203 -167.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.752 1.621 . . . . 0.0 114.059 -157.053 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.737 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.4 110.32 7.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.38 1.072 . . . . 0.0 108.473 -160.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.91 -49.52 73.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.239 -165.167 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.35 -41.69 94.18 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.384 177.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.61 -46.9 87.87 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.31 0.959 . . . . 0.0 111.004 -176.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.8 t -46.57 -62.27 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.768 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 43.0 t -62.46 -41.96 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.782 -167.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.85 1.44 1.36 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.44 3.096 . . . . 0.0 113.306 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.31 -23.42 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.282 0.946 . . . . 0.0 113.457 168.49 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -116.74 -18.79 10.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.757 1.223 . . . . 0.0 112.762 -166.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 2.5 m -113.31 -43.27 3.37 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.489 1.041 . . . . 0.0 111.246 179.171 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 pt -51.99 -30.03 12.16 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -37.05 -40.5 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.016 1.327 . . . . 0.0 113.053 170.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.3 m -115.81 -42.15 3.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.932 0.493 . . . . 0.0 110.623 174.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -70.74 -17.34 62.81 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.56 -89.22 0.33 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.361 0.981 . . . . 0.0 112.465 165.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.98 -65.36 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -178.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.54 2.49 13.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.054 0.942 . . . . 0.0 111.792 170.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.481 HD21 HG12 ' A' ' 28' ' ' VAL . 4.1 mt 71.21 20.45 5.09 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.992 1.317 . . . . 0.0 110.353 177.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -76.48 -8.54 57.38 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.582 2.353 . . . . 0.0 111.722 -177.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.17 74.5 1.08 Allowed Glycine 0 C--N 1.338 0.665 0 CA-C-N 118.446 0.567 . . . . 0.0 111.889 164.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.66 -77.38 0.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.541 0.336 . . . . 0.0 111.427 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 t -96.58 2.39 52.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.025 1.33 . . . . 0.0 111.419 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.34 162.01 39.0 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -176.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.2 164.56 24.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.876 1.717 . . . . 0.0 111.167 179.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.14 114.18 6.42 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.512 -177.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.444 ' O ' HD21 ' A' ' 88' ' ' LEU 0.291 2.7 pp -106.56 -2.26 9.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.909 -1.043 . . . . 0.0 112.515 173.829 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -33.23 -48.13 0.22 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.022 1.729 . . . . 0.0 112.51 163.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.47 4.84 28.74 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.705 2.002 . . . . 0.0 111.274 -171.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.25 -37.62 16.58 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.381 -175.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.06 -32.52 59.79 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 119.173 0.897 . . . . 0.0 114.592 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.01 54.74 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.529 -0.983 . . . . 0.0 110.32 174.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.3 -36.03 63.73 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -138.52 150.45 46.4 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.348 1.459 . . . . 0.0 108.956 -167.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 m -86.79 158.52 19.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.128 -178.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -44.65 60.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.919 0.488 . . . . 0.0 110.79 -174.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -50.62 -48.13 58.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 112.95 174.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.42 -47.49 81.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.699 0.761 . . . . 0.0 109.32 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.2 -49.96 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 tp -47.68 -57.51 5.42 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.9 1.68 . . . . 0.0 110.234 174.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.46 -46.3 83.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -61.44 -42.13 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 122.025 -0.422 . . . . 0.0 110.827 -177.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -58.43 -50.44 78.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.3 mt -63.32 -37.82 88.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.699 0.399 . . . . 0.0 111.716 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -96.8 -56.63 2.51 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.459 1.504 . . . . 0.0 111.957 -168.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.76 -173.15 21.04 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.911 1.72 . . . . 0.0 110.585 -171.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -165.01 123.5 1.7 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 171.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.17 -113.42 1.08 Allowed Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.797 1.181 . . . . 0.0 112.811 175.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.11 -16.63 79.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.208 1.004 . . . . 0.0 113.695 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.418 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.4 ttt -65.92 122.21 79.81 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 118.219 1.009 . . . . 0.0 109.164 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.15 -34.58 56.7 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.985 2.457 . . . . 0.0 111.555 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.92 168.1 36.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 122.604 1.113 . . . . 0.0 111.507 177.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.88 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.142 -178.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -67.54 -32.45 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 127.531 2.333 . . . . 0.0 110.172 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.71 153.09 51.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 172.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 164.17 33.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.183 0.593 . . . . 0.0 112.388 178.231 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.15 -137.86 22.93 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -41.08 -38.33 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.411 1.484 . . . . 0.0 112.815 178.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -62.09 -58.67 6.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.92 85.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.735 -0.603 . . . . 0.0 110.744 -177.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -58.1 -52.66 64.62 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.005 0.922 . . . . 0.0 110.141 174.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.32 -50.21 67.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.81 -55.24 12.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.371 174.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.47 24.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.82 0.736 . . . . 0.0 110.604 -174.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.6 -58.07 9.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.962 179.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.768 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 2.5 t90 -54.95 -50.75 68.12 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.851 0.461 . . . . 0.0 110.936 -178.223 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.537 ' HG ' ' CZ3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.146 -0.971 . . . . 0.0 108.724 -175.046 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.28 -38.99 69.31 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 122.132 -0.355 . . . . 0.0 111.223 172.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -22.0 60.8 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.713 -0.617 . . . . 0.0 111.15 178.016 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -71.4 9.74 0.74 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.282 2.233 . . . . 0.0 114.637 -172.226 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.252 1.197 0 O-C-N 120.504 -1.373 . . . . 0.0 112.193 -162.75 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.757 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.62 99.36 8.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -146.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.66 46.25 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -160.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -62.73 -46.23 89.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.58 177.527 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -41.57 72.63 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 118.744 0.702 . . . . 0.0 110.954 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -50.59 -64.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 167.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.642 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 92.6 t -66.86 -38.45 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 120.761 1.619 . . . . 0.0 112.211 -166.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -59.97 0.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.04 2.936 . . . . 0.0 113.331 170.059 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -125.4 -37.38 2.38 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.764 1.226 . . . . 0.0 112.404 168.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -102.42 -24.06 13.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.421 1.488 . . . . 0.0 111.577 -159.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.566 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.3 m -120.43 -40.59 2.67 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.289 0.636 . . . . 0.0 111.172 -169.063 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.7 pt -49.68 -30.84 5.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 122.283 0.233 . . . . 0.0 111.462 178.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -34.73 -41.48 0.13 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.367 2.267 . . . . 0.0 113.164 170.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 m -119.91 -36.33 3.31 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.445 0.698 . . . . 0.0 111.118 176.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -80.84 -2.54 47.74 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.89 -85.52 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 123.811 0.72 . . . . 0.0 112.464 164.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.68 -66.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -173.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.11 2.21 24.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.312 -0.522 . . . . 0.0 111.733 173.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 70.1 22.25 5.73 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.393 1.877 . . . . 0.0 111.389 -172.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -5.56 37.75 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.994 2.118 . . . . 0.0 112.063 173.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.44 147.03 21.91 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 174.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.76 -82.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.913 0.885 . . . . 0.0 109.992 174.091 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 m -92.13 -0.15 57.45 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.021 0.928 . . . . 0.0 111.047 171.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.33 157.18 63.53 Favored Pre-proline 0 N--CA 1.447 -0.604 0 C-N-CA 127.552 2.341 . . . . 0.0 105.635 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.33 167.06 19.46 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.688 2.258 . . . . 0.0 111.645 -175.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.05 113.56 3.58 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.028 175.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp -108.02 -1.89 9.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.411 172.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -34.95 -50.45 0.48 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.285 1.434 . . . . 0.0 111.648 162.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -92.37 0.9 57.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.075 1.35 . . . . 0.0 110.74 -171.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.3 70.63 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.032 -1.043 . . . . 0.0 111.777 -174.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.12 -32.58 76.48 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 119.818 1.19 . . . . 0.0 112.557 174.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.34 -38.05 36.06 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.305 -1.115 . . . . 0.0 111.607 175.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -74.2 -38.94 63.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.307 0.503 . . . . 0.0 111.81 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -133.63 170.86 14.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.973 1.709 . . . . 0.0 108.292 -167.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.3 t -105.86 169.38 8.52 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.068 0.547 . . . . 0.0 110.38 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -51.39 64.55 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.137 0.575 . . . . 0.0 109.778 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -42.94 -55.79 3.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.678 1.591 . . . . 0.0 113.165 173.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -56.72 -52.25 65.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.04 0.936 . . . . 0.0 109.844 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.01 -48.35 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -173.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.7 tp -49.9 -56.04 12.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.448 1.899 . . . . 0.0 109.997 175.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.56 -47.82 81.03 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -58.83 -42.5 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 122.111 -0.368 . . . . 0.0 110.451 -177.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.45 -50.03 82.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 121.26 -0.9 . . . . 0.0 109.764 176.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.76 -32.66 74.23 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.027 0.531 . . . . 0.0 112.193 -178.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -103.39 -59.19 1.75 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.043 1.737 . . . . 0.0 112.01 -168.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.47 -175.61 21.33 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.207 1.861 . . . . 0.0 110.74 -173.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -150.64 164.63 35.62 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 166.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 3.14 -94.88 0.01 OUTLIER Glycine 0 CA--C 1.541 1.682 0 C-N-CA 126.887 2.184 . . . . 0.0 116.403 173.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.37 25.92 26.01 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 118.494 1.147 . . . . 0.0 112.928 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.414 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.6 ttt -104.05 121.11 48.89 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.952 1.701 . . . . 0.0 108.178 177.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.65 -36.5 63.4 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.088 2.525 . . . . 0.0 112.545 -169.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.81 165.71 34.03 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 122.158 0.866 . . . . 0.0 111.694 178.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.97 25.48 67.97 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -173.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mt -70.08 -26.72 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.079 1.351 . . . . 0.0 110.182 -177.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.54 146.68 32.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -139.07 164.16 30.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.24 0.927 . . . . 0.0 111.338 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 47.91 -134.66 16.53 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.366 0.984 . . . . 0.0 110.658 -175.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.21 -38.48 3.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.958 1.303 . . . . 0.0 112.26 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.79 -54.24 47.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.2 86.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.649 -0.657 . . . . 0.0 111.138 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.43 -52.73 62.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.295 0.638 . . . . 0.0 110.113 177.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.65 -52.9 53.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.867 0.867 . . . . 0.0 109.833 178.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 28' ' ' VAL . 77.4 t -50.19 -63.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 O-C-N 123.341 0.4 . . . . 0.0 110.226 174.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.96 -49.69 49.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.86 0.864 . . . . 0.0 110.978 -171.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.87 -59.8 4.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 177.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.642 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 47.0 t90 -55.93 -35.7 66.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.058 0.943 . . . . 0.0 112.085 -177.384 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' CZ3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -74.41 -44.73 50.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.39 -0.819 . . . . 0.0 110.554 178.3 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.89 -22.37 66.67 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.604 -0.685 . . . . 0.0 112.169 174.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -75.48 -26.93 58.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.187 1.395 . . . . 0.0 111.652 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -9.87 56.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -149.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.4 pttt . . . . . 0 C--O 1.252 1.206 0 CA-C-O 117.933 -1.032 . . . . 0.0 113.016 -107.281 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.741 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.8 103.66 3.74 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.497 1.519 . . . . 0.0 107.066 -170.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -55.56 9.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.587 -170.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.15 -41.34 83.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.204 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.78 81.96 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.151 0.887 . . . . 0.0 110.499 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.62 -58.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 168.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 2.0 t -68.85 -39.48 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 116.898 -1.921 . . . . 0.0 110.406 -165.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -62.31 -0.2 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.971 3.308 . . . . 0.0 114.079 170.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.93 -11.54 0.98 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 171.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.04 -18.47 11.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.888 1.275 . . . . 0.0 111.022 -176.169 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.3 m -127.25 -46.15 1.51 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.602 0.637 . . . . 0.0 111.762 -167.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.6 pt -53.91 -24.66 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -49.24 -27.38 3.66 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.911 0.884 . . . . 0.0 112.301 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.13 -42.77 3.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.212 0.605 . . . . 0.0 110.868 167.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.86 -9.95 58.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.28 -88.36 0.4 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.18 1.371 . . . . 0.0 112.564 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.82 -60.49 0.02 OUTLIER Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -176.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.9 4.0 39.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.713 0.805 . . . . 0.0 111.735 172.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 28' ' ' VAL . 1.2 mt 74.85 20.86 2.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.134 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -76.49 -12.46 60.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.401 2.68 . . . . 0.0 111.321 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.32 83.4 1.71 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 169.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.1 -76.87 0.41 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.935 0.494 . . . . 0.0 110.663 177.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -94.62 2.06 55.61 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.405 1.082 . . . . 0.0 111.408 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.98 38.02 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 127.5 2.32 . . . . 0.0 105.414 -176.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.68 164.47 26.49 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.03 1.82 . . . . 0.0 111.68 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.18 13.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.959 0.904 . . . . 0.0 109.717 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.291 2.5 pp -112.1 -3.03 10.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 173.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -32.97 9.37 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.123 -0.985 . . . . 0.0 112.295 165.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.0 3.12 38.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.337 1.055 . . . . 0.0 112.629 177.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.33 -38.2 68.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 117.402 -1.285 . . . . 0.0 111.094 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.58 -26.69 60.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 120.841 1.655 . . . . 0.0 114.328 174.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.47 -47.08 16.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.958 0.879 . . . . 0.0 109.878 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -74.66 -44.82 48.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 122.501 0.32 . . . . 0.0 111.854 -173.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -123.3 157.2 33.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.658 1.983 . . . . 0.0 109.504 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -89.46 163.89 15.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 0.0 110.964 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -44.17 68.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.895 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -49.64 -53.12 26.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.861 1.665 . . . . 0.0 112.169 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.9 -48.91 79.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.491 0.717 . . . . 0.0 109.834 -178.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.33 -52.24 63.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -176.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -48.9 -56.26 9.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.509 1.524 . . . . 0.0 110.076 177.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.14 -46.59 85.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -59.78 -38.86 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.904 -0.498 . . . . 0.0 111.387 -179.037 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -51.84 66.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 119.469 1.032 . . . . 0.0 109.755 174.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.15 -33.4 75.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.433 -175.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -99.7 -43.39 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.21 1.804 . . . . 0.0 112.238 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.07 111.4 2.65 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.163 1.363 . . . . 0.0 110.133 -169.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -55.19 145.88 20.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 161.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -13.48 -74.73 0.01 OUTLIER Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.902 2.191 . . . . 0.0 117.235 -175.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.13 -12.42 73.8 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 117.804 0.802 . . . . 0.0 113.775 -175.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.5 ttt -88.14 135.65 32.96 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 126.16 1.784 . . . . 0.0 109.518 -175.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.0 157.95 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.41 1.407 . . . . 0.0 110.959 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.89 146.99 18.67 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -175.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.32 71.7 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.5 mt -55.59 -35.42 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.549 1.14 . . . . 0.0 109.366 172.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.65 152.29 46.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 172.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -143.15 162.61 35.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.977 0.808 . . . . 0.0 111.413 177.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.91 -136.34 41.76 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.38 -36.26 4.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.582 1.153 . . . . 0.0 112.064 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.52 -55.79 24.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.04 -42.17 85.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.553 -0.717 . . . . 0.0 110.408 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.66 -47.75 81.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.128 0.571 . . . . 0.0 110.998 177.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.82 62.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.16 -57.38 8.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.937 173.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.36 -55.99 5.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.12 0.873 . . . . 0.0 110.644 -175.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.04 -54.0 52.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.89 0.476 . . . . 0.0 111.306 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.66 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 57.3 t90 -62.3 -54.7 36.78 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.372 0.606 . . . . 0.0 111.286 -176.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -40.54 79.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.872 -1.143 . . . . 0.0 110.083 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.15 -50.37 71.34 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.782 0.264 . . . . 0.0 111.028 170.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.28 -8.88 57.72 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.808 0.731 . . . . 0.0 112.264 -177.005 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -16.76 64.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.652 1.181 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.789 1.236 . . . . 0.0 113.055 -162.987 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.811 HMD1 ' CGD' ' A' ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_